data_2jrs_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jrs _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo . . . . . 0 CA--C 1.54 0.824 0 N-CA-C 113.199 0.423 . . . . 0.0 113.199 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.7 ttt -148.55 140.87 24.17 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.354 -177.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 28' ' ' ARG . 41.9 ttp180 -115.25 128.33 56.07 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.831 0.348 . . . . 0.0 111.124 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.4 HD21 HD13 ' A' ' 85' ' ' LEU . 83.2 mt -103.5 150.05 24.26 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.168 0.509 . . . . 0.0 112.063 -177.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 78.3 t80 -107.25 106.8 17.43 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.537 176.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.42 HG23 HG21 ' A' ' 100' ' ' VAL . 51.4 t -105.72 125.18 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 120.799 0.333 . . . . 0.0 111.826 -177.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -127.64 96.91 0.45 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 121.248 -0.501 . . . . 0.0 113.7 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 96.6 p -163.96 11.2 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.054 0.454 . . . . 0.0 111.671 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.43 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 8.3 mt -83.06 81.46 8.67 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -171.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.414 ' O ' ' CD2' ' A' ' 35' ' ' HIS . 1.1 p-80 -80.38 71.35 7.19 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.738 0.78 . . . . 0.0 112.319 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 61.47 9.36 2.63 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 172.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -143.3 -8.81 0.77 Allowed 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.246 -0.909 . . . . 0.0 113.364 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.515 ' N ' HD12 ' A' ' 38' ' ' ILE . 2.5 mp -90.59 113.34 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 O-C-N 121.709 -0.62 . . . . 0.0 110.308 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.3 p -95.94 170.42 9.3 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -174.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -53.17 -44.14 67.64 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.683 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -64.13 -39.52 94.21 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.135 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.0 mmt -62.4 -53.05 60.64 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.329 0.585 . . . . 0.0 110.482 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.414 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 54.8 mt -54.67 -55.17 32.52 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.927 176.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.478 ' HB2' HD12 ' A' ' 56' ' ' ILE . 25.4 ttt85 -55.13 -44.1 74.74 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.6 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.12 -29.7 68.92 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.438 -0.41 . . . . 0.0 113.5 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.9 mt -83.46 -34.46 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 O-C-N 122.475 -0.426 . . . . 0.0 112.09 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.431 ' HD2' ' HZ ' ' A' ' 75' ' ' PHE . 6.9 m-85 -85.28 -32.16 22.69 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -174.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.15 -35.51 21.48 Favored Pre-proline 0 N--CA 1.479 1.0 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -45.47 -26.65 2.87 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.205 1.937 . . . . 0.0 113.117 170.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -80.18 -47.74 14.23 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.932 0.396 . . . . 0.0 111.027 174.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.423 ' HA3' ' SG ' ' A' ' 80' ' ' CYS . . . -161.44 -101.5 0.17 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.208 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 52' ' ' ARG . 38.3 ttt180 -164.66 146.13 8.1 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 122.569 -0.371 . . . . 0.0 111.015 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.458 ' N ' HD13 ' A' ' 53' ' ' ILE . 3.3 mp -108.79 130.62 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.835 0.35 . . . . 0.0 111.549 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -79.7 -49.4 12.14 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.853 0.359 . . . . 0.0 111.477 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.5 p -150.79 144.17 24.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.088 0.47 . . . . 0.0 111.57 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.478 HD12 ' HB2' ' A' ' 44' ' ' ARG . 61.9 mt -115.7 115.44 49.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 177.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -110.2 105.69 14.84 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.805 0.336 . . . . 0.0 111.082 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 72.1 mt -98.07 146.78 25.2 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.914 0.388 . . . . 0.0 111.087 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 66.6 mmm . . . . . 0 C--O 1.236 0.361 0 CA-C-O 120.975 0.417 . . . . 0.0 110.026 178.747 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 134.44 -15.41 4.43 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.601 -0.809 . . . . 0.0 114.123 177.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -137.36 150.66 47.86 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.399 0.599 . . . . 0.0 112.453 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.37 158.51 27.76 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 116.182 -0.463 . . . . 0.0 113.018 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -102.08 125.24 48.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.03 0.443 . . . . 0.0 111.352 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 73.4 mt -111.53 123.22 67.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.165 0.507 . . . . 0.0 111.249 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.4 m -99.54 119.26 37.76 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.443 ' HB2' ' HB3' ' A' ' 81' ' ' ALA . 49.1 m-85 -100.95 150.63 22.67 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.424 175.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.3 t -78.36 -30.01 47.8 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.994 0.426 . . . . 0.0 110.942 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -106.91 117.25 33.57 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.827 0.346 . . . . 0.0 111.434 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.9 p -59.5 -52.93 63.48 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.6 tp10 -55.15 -43.91 74.65 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.835 0.35 . . . . 0.0 111.481 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.423 ' SG ' ' HA3' ' A' ' 51' ' ' GLY . 52.6 t -62.9 -45.1 94.12 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.247 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . . . -60.86 -44.04 97.56 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.251 0.548 . . . . 0.0 111.225 176.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -61.71 -38.52 88.19 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.85 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -65.23 -46.78 79.24 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.163 176.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.59 -48.05 78.26 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.007 0.432 . . . . 0.0 110.634 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.414 HD22 ' C ' ' A' ' 85' ' ' LEU . 8.2 tt -55.58 -50.76 69.23 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.293 0.568 . . . . 0.0 110.668 174.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -62.26 -32.08 72.73 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.913 -173.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -94.88 -36.76 11.5 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.434 ' O ' ' HB3' ' A' ' 98' ' ' MET . 91.4 mt -87.97 -20.1 26.34 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -172.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -64.25 105.67 0.95 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.225 0.536 . . . . 0.0 110.411 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.49 -9.1 26.3 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.098 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -69.34 130.87 43.79 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 122.646 0.378 . . . . 0.0 112.005 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -89.22 103.95 16.53 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.208 0.528 . . . . 0.0 111.536 176.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.2 tp -87.79 -68.62 0.75 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.291 0.567 . . . . 0.0 111.386 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.53 45.36 1.01 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.434 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.0 26.31 74.8 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.211 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -151.85 133.15 7.87 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 123.11 0.564 . . . . 0.0 110.225 -175.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -54.43 150.77 32.76 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.894 2.396 . . . . 0.0 113.921 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.473 ' HG3' HG23 ' A' ' 100' ' ' VAL . 44.0 tpp -98.41 108.27 20.93 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.869 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -88.63 100.1 12.84 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 122.171 -0.331 . . . . 0.0 111.211 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.473 HG23 ' HG3' ' A' ' 98' ' ' MET . 59.9 t -117.54 107.96 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.938 0.399 . . . . 0.0 111.599 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -120.75 155.47 16.24 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.981 177.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 20.3 p80 . . . . . 0 N--CA 1.474 0.731 0 O-C-N 122.081 -0.658 . . . . 0.0 112.453 -177.955 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 38.6 Cg_exo . . . . . 0 CA--C 1.544 1.011 0 N-CA-C 113.216 0.429 . . . . 0.0 113.216 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 11.0 tpt -102.74 145.74 29.27 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.977 0.418 . . . . 0.0 111.689 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -114.52 127.56 55.87 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.043 0.449 . . . . 0.0 111.751 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.4 mt -104.31 149.89 24.94 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.188 0.518 . . . . 0.0 111.546 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -103.45 109.87 21.68 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.539 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -110.93 108.16 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 120.743 0.306 . . . . 0.0 111.047 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -121.77 88.59 0.42 Allowed Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.823 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.3 m -164.42 24.98 0.07 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 120.939 0.4 . . . . 0.0 111.283 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 34.2 mt -85.23 143.97 28.42 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.891 0.377 . . . . 0.0 111.661 -174.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.426 ' CE1' ' HB3' ' A' ' 37' ' ' ASN . 33.1 p80 -108.83 48.65 0.85 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.079 0.466 . . . . 0.0 111.708 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 50.1 t80 61.54 9.18 2.58 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.426 ' HB3' ' CE1' ' A' ' 35' ' ' HIS . 3.3 t-20 -142.5 37.06 1.49 Allowed 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.539 -0.725 . . . . 0.0 111.669 -178.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.3 mm -125.76 106.62 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 O-C-N 122.023 -0.423 . . . . 0.0 110.407 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.3 p -93.26 175.66 6.68 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.154 0.502 . . . . 0.0 112.304 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.4 ' HG3' HD11 ' A' ' 58' ' ' LEU . 2.7 mp0 -53.09 -36.01 60.22 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.214 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -56.45 -52.09 65.98 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.847 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.631 ' HE2' HD11 ' A' ' 46' ' ' ILE . 14.6 tpt -65.34 -47.9 74.9 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.188 0.518 . . . . 0.0 110.711 -178.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.0 mt -56.11 -44.11 78.78 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.248 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -65.15 -44.65 87.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.217 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.99 -31.89 65.72 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.267 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.631 HD11 ' HE2' ' A' ' 42' ' ' MET . 58.2 mt -86.0 -45.03 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.4 ' HB3' ' CZ ' ' A' ' 75' ' ' PHE . 37.5 m-85 -85.14 -43.7 13.61 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -172.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.446 ' CD ' HH11 ' A' ' 52' ' ' ARG . 36.1 tt0 -59.56 -35.1 26.57 Favored Pre-proline 0 N--CA 1.48 1.028 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -172.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 48' ' ' GLU . 60.3 Cg_exo -43.01 -29.39 1.55 Allowed 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 122.081 1.854 . . . . 0.0 113.523 172.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -82.11 -31.18 30.81 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.933 0.397 . . . . 0.0 111.482 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.557 ' HA3' ' HB3' ' A' ' 80' ' ' CYS . . . -175.89 134.47 2.66 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.279 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.446 HH11 ' CD ' ' A' ' 48' ' ' GLU . 14.1 tpt180 -48.22 125.14 8.85 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 122.946 0.498 . . . . 0.0 111.941 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 73.8 mt -94.73 133.95 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.171 0.51 . . . . 0.0 111.831 -175.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -83.92 -51.34 7.24 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.862 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.6 m -150.48 132.95 15.64 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.896 0.379 . . . . 0.0 111.694 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.516 HG22 HG12 ' A' ' 73' ' ' ILE . 58.4 mt -108.84 107.6 23.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.821 176.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -102.19 118.59 37.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.363 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.4 HD11 ' HG3' ' A' ' 40' ' ' GLU . 9.4 mp -98.43 139.63 33.9 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.078 0.466 . . . . 0.0 110.577 175.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.685 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 45.0 tpp . . . . . 0 C--O 1.238 0.449 0 CA-C-O 121.405 0.622 . . . . 0.0 111.387 -173.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.685 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 68.8 mttm . . . . . 0 N--CA 1.471 0.614 0 CA-C-O 120.677 0.275 . . . . 0.0 111.538 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.99 -6.55 8.86 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.992 -0.623 . . . . 0.0 114.31 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -138.01 160.0 40.53 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 117.719 0.76 . . . . 0.0 112.571 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -142.63 151.71 23.27 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.802 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -105.26 115.59 30.51 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.804 0.442 . . . . 0.0 111.448 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.516 HG12 HG22 ' A' ' 56' ' ' ILE . 68.5 mt -104.78 128.37 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 122.222 -0.299 . . . . 0.0 111.546 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.3 m -108.21 121.35 44.68 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 18.2 m-85 -98.5 151.61 20.43 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.294 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.3 t -69.09 -13.04 62.2 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.833 0.349 . . . . 0.0 111.737 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.619 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 16.4 t70 -133.59 153.29 51.78 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.049 0.452 . . . . 0.0 111.361 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 68.7 p -73.12 -51.96 16.03 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.199 -176.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -74.36 -23.05 58.95 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.619 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 92.3 m -60.72 -42.84 98.06 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.221 0.534 . . . . 0.0 109.942 170.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.91 -46.94 73.28 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.958 174.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -53.41 -47.71 69.33 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.647 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -60.33 -44.88 95.08 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.184 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.98 -40.14 83.9 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.143 0.497 . . . . 0.0 110.937 175.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.8 -57.98 9.76 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.826 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -61.72 -26.85 68.31 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -174.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -90.54 -34.7 15.43 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.453 ' HB3' ' HE2' ' A' ' 98' ' ' MET . 75.4 mt -97.84 -14.22 20.85 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -173.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -70.85 80.8 0.63 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.584 0.707 . . . . 0.0 110.702 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.64 -4.71 5.13 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.169 -174.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -59.61 140.08 56.65 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -73.37 84.9 1.46 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.953 0.406 . . . . 0.0 111.524 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 67.0 tp -90.59 116.01 28.15 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.291 -0.256 . . . . 0.0 110.854 176.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 59.49 16.9 5.58 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.89 11.85 48.6 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.512 -0.375 . . . . 0.0 112.903 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -132.27 138.46 32.31 Favored Pre-proline 0 N--CA 1.468 0.467 0 O-C-N 122.65 -0.324 . . . . 0.0 111.306 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.19 131.44 38.89 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.326 2.018 . . . . 0.0 112.169 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.453 ' HE2' ' HB3' ' A' ' 88' ' ' LEU . 45.4 ttp -97.01 118.99 34.63 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.289 0.566 . . . . 0.0 111.398 -175.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -88.38 104.91 17.21 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.72 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.9 t -111.6 111.44 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.11 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -133.77 150.8 20.01 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.324 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 21.1 p80 . . . . . 0 CA--C 1.54 0.594 0 CA-C-N 117.788 0.794 . . . . 0.0 111.017 -179.964 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo . . . . . 0 CA--C 1.542 0.899 0 N-CA-C 113.687 0.61 . . . . 0.0 113.687 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.3 ttt -102.08 135.82 42.98 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.857 0.36 . . . . 0.0 111.08 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.441 ' HD3' ' HB3' ' A' ' 72' ' ' PHE . 33.7 ttm180 -106.55 134.52 49.55 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -176.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.493 HD22 HD11 ' A' ' 85' ' ' LEU . 75.2 mt -113.11 147.68 36.83 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.191 0.519 . . . . 0.0 111.784 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -94.77 123.17 38.07 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.572 174.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.2 t -116.97 123.2 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 120.733 0.302 . . . . 0.0 111.245 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.3 96.84 0.53 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.277 -0.487 . . . . 0.0 113.345 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.539 ' HG ' HD23 ' A' ' 93' ' ' LEU . 78.3 p -174.72 15.46 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 177.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.422 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 20.8 mt -82.55 83.31 7.62 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.88 -0.513 . . . . 0.0 111.102 -173.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.415 ' O ' ' CG ' ' A' ' 35' ' ' HIS . 14.4 p80 -78.15 65.08 3.45 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.429 0.633 . . . . 0.0 112.012 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 56.5 t80 55.37 9.73 0.4 Allowed 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 176.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -139.64 1.63 1.94 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.343 -0.848 . . . . 0.0 112.762 -176.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.471 HD12 ' SD ' ' A' ' 42' ' ' MET . 31.6 mm -103.53 118.05 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 O-C-N 121.874 -0.516 . . . . 0.0 110.753 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 34.4 p -103.65 176.59 5.1 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.22 0.534 . . . . 0.0 112.138 -175.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -53.17 -48.58 67.88 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.463 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -59.12 -40.32 85.07 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.792 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.496 ' SD ' HD13 ' A' ' 93' ' ' LEU . 46.3 ttm -65.21 -46.56 80.16 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.256 0.551 . . . . 0.0 110.442 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.3 mt -57.95 -44.46 87.02 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.697 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 44' ' ' ARG . 43.5 ttm180 -56.65 -44.74 81.61 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.164 0.506 . . . . 0.0 110.817 175.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.72 -35.45 81.64 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.129 -0.558 . . . . 0.0 113.638 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.429 HD11 HD11 ' A' ' 93' ' ' LEU . 63.3 mt -84.72 -45.13 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -85.25 -34.04 22.05 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -173.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.619 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 36.4 tt0 -56.84 -41.48 91.53 Favored Pre-proline 0 N--CA 1.477 0.921 0 N-CA-C 113.682 0.994 . . . . 0.0 113.682 -172.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 48' ' ' GLU . 5.1 Cg_endo -47.3 -33.15 15.83 Favored 'Trans proline' 0 C--N 1.363 1.292 0 C-N-CA 122.232 1.954 . . . . 0.0 112.934 175.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -77.1 -47.8 19.5 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.164 0.507 . . . . 0.0 110.876 175.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -162.6 136.52 4.37 Favored Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.845 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 -54.98 134.57 48.95 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.007 0.432 . . . . 0.0 112.057 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.489 HG22 HG13 ' A' ' 56' ' ' ILE . 1.8 mp -81.82 129.38 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.103 0.478 . . . . 0.0 111.813 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -90.43 -43.52 10.22 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.334 176.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.0 p -151.98 148.21 27.47 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.715 0.293 . . . . 0.0 111.64 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.489 HG13 HG22 ' A' ' 53' ' ' ILE . 59.4 mt -127.53 106.61 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.891 0.377 . . . . 0.0 110.895 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -99.45 115.22 28.78 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.614 0.245 . . . . 0.0 110.936 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 80.4 mt -98.01 132.16 43.81 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.037 0.446 . . . . 0.0 110.99 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 89.1 mmm . . . . . 0 CA--C 1.536 0.405 0 CA-C-O 121.343 0.592 . . . . 0.0 111.295 -178.312 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.6 mttm . . . . . 0 N--CA 1.472 0.675 0 CA-C-O 120.871 0.367 . . . . 0.0 111.736 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 104.1 4.44 44.58 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 120.936 -0.649 . . . . 0.0 114.588 174.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -144.84 156.12 43.85 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 117.643 0.722 . . . . 0.0 112.649 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.94 160.73 28.76 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.793 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.441 ' HB3' ' HD3' ' A' ' 28' ' ' ARG . 90.7 m-85 -111.42 124.07 51.5 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 122.569 -0.371 . . . . 0.0 111.511 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.5 mt -112.85 132.98 60.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 120.914 0.388 . . . . 0.0 111.703 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.3 m -101.65 125.41 48.31 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.705 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.452 ' HB2' ' HB3' ' A' ' 81' ' ' ALA . 88.3 m-85 -108.99 151.21 26.64 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.811 0.445 . . . . 0.0 111.167 177.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.9 m -62.88 -31.19 72.19 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -177.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.616 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 25.3 t70 -126.88 148.04 50.03 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.073 0.464 . . . . 0.0 111.612 -172.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.1 t -76.17 -34.46 59.34 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -77.24 -36.54 54.51 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.726 0.298 . . . . 0.0 111.114 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.616 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 17.5 p -63.67 -44.17 94.54 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.086 0.47 . . . . 0.0 110.257 175.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.452 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . . . -64.63 -46.66 81.59 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.113 175.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -54.56 -43.72 72.3 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.627 175.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.86 -42.62 94.71 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.831 0.348 . . . . 0.0 111.285 177.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.56 -55.25 36.84 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.006 0.431 . . . . 0.0 111.071 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.493 HD11 HD22 ' A' ' 29' ' ' LEU . 8.6 tt -51.57 -55.89 16.63 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.826 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -54.15 -34.03 59.39 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.562 -175.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -97.39 -24.21 15.73 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.466 ' HB3' ' HE2' ' A' ' 98' ' ' MET . 97.7 mt -101.65 -11.21 19.37 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -173.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -68.54 85.9 0.3 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.966 0.889 . . . . 0.0 111.225 177.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 127.73 -2.13 6.94 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.309 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.418 ' HB3' ' HE3' ' A' ' 98' ' ' MET . 86.9 t80 -59.69 134.92 57.47 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.459 0.304 . . . . 0.0 111.357 178.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.34 91.38 1.72 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.23 0.538 . . . . 0.0 111.728 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.539 HD23 ' HG ' ' A' ' 33' ' ' SER . 55.0 tp -99.89 122.05 42.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.596 177.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 59.15 18.67 6.69 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.042 0.448 . . . . 0.0 111.812 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.3 -20.25 30.71 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 116.213 -0.448 . . . . 0.0 113.128 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -115.21 153.81 47.35 Favored Pre-proline 0 CA--C 1.537 0.475 0 O-C-N 122.768 -0.254 . . . . 0.0 111.614 -174.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -63.65 139.02 67.42 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.216 1.944 . . . . 0.0 112.772 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.466 ' HE2' ' HB3' ' A' ' 88' ' ' LEU . 44.3 ttp -97.84 120.37 38.11 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.04 -178.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -88.26 99.88 12.57 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.057 0.456 . . . . 0.0 112.155 -174.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 18.3 t -106.03 126.83 61.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.035 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -149.95 160.59 28.57 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.263 -0.494 . . . . 0.0 113.132 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.8 p80 . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 121.104 0.478 . . . . 0.0 112.162 175.161 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 CA--C 1.544 0.992 0 N-CA-C 111.187 -0.351 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.2 ttt -100.0 122.67 43.26 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.861 -0.525 . . . . 0.0 111.293 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -98.99 125.76 44.52 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.769 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.427 HD22 HD12 ' A' ' 85' ' ' LEU . 76.8 mt -110.9 133.54 53.29 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.391 0.615 . . . . 0.0 111.74 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -89.78 109.36 20.36 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.331 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.8 t -109.73 123.21 65.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.78 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -123.73 97.29 0.56 Allowed Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.522 -0.371 . . . . 0.0 113.154 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.479 ' HB3' ' HA ' ' A' ' 98' ' ' MET . 99.7 p -161.02 9.74 0.09 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.089 0.471 . . . . 0.0 111.494 176.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.447 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 10.6 mt -87.16 87.71 7.51 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 122.2 -0.312 . . . . 0.0 111.595 -170.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -73.48 72.8 1.39 Allowed 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 56.07 20.62 4.48 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 173.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -153.78 -37.24 0.1 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -175.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.4 mm -59.98 128.72 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 120.778 0.323 . . . . 0.0 111.517 -175.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 62.7 p -113.45 178.16 4.38 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -173.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -48.67 -46.1 39.76 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.964 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.66 -44.87 63.19 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.488 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.7 mmt -66.89 -47.06 72.97 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.461 0.648 . . . . 0.0 110.576 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.44 HD21 HD22 ' A' ' 34' ' ' LEU . 70.6 mt -59.46 -50.67 73.05 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.735 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -58.56 -44.7 89.79 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 122.27 -0.268 . . . . 0.0 111.657 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.36 -38.36 68.81 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.579 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.46 HD11 HD12 ' A' ' 93' ' ' LEU . 59.6 mt -86.8 -49.18 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 75' ' ' PHE . 51.6 m-85 -77.18 -41.76 40.28 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -170.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -62.85 -37.88 38.15 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -173.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -46.06 -18.06 0.37 Allowed 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.447 2.098 . . . . 0.0 114.112 172.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -82.23 -42.97 18.21 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.801 0.334 . . . . 0.0 111.417 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.17 -122.87 1.06 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.791 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -140.29 129.77 24.08 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.387 0.613 . . . . 0.0 111.449 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 74.9 mt -100.35 120.81 50.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.822 -175.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -73.45 -53.88 9.59 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.956 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.8 t -150.55 150.2 30.92 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.032 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.1 mt -120.65 116.7 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.372 175.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -118.01 129.18 55.43 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.722 0.296 . . . . 0.0 111.263 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.422 HD11 ' N ' ' A' ' 58' ' ' LEU . 6.0 mp -99.78 141.85 32.04 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.974 0.416 . . . . 0.0 111.075 177.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.451 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 31.0 tpp . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 121.767 0.794 . . . . 0.0 111.675 -176.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.451 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 57.2 mttp . . . . . 0 N--CA 1.473 0.719 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 112.7 3.12 25.4 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 120.937 -0.649 . . . . 0.0 114.495 177.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -140.76 158.77 43.48 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.818 0.809 . . . . 0.0 112.423 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -144.37 159.95 27.8 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.629 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -107.4 124.9 50.52 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 122.624 -0.339 . . . . 0.0 111.256 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 64.7 mt -110.21 130.82 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 120.896 0.379 . . . . 0.0 111.145 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.0 m -106.35 114.25 28.26 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 47' ' ' PHE . 38.5 m-85 -99.46 152.42 20.01 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.14 0.576 . . . . 0.0 110.763 177.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.8 t -93.65 -5.55 48.41 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.662 0.744 . . . . 0.0 110.002 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.423 ' HB2' ' HB2' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -119.8 101.81 8.15 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.186 -175.395 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.7 p -56.9 -55.21 37.5 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -176.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -58.23 -47.36 83.78 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.423 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 82.5 m -62.09 -40.86 97.26 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.846 0.355 . . . . 0.0 111.572 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.89 -42.68 89.96 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.064 0.459 . . . . 0.0 111.452 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -62.67 -36.38 82.71 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.093 0.473 . . . . 0.0 110.729 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -63.31 -52.05 63.54 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.086 0.47 . . . . 0.0 110.359 172.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.66 -43.69 57.4 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.201 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.427 HD12 HD22 ' A' ' 29' ' ' LEU . 9.5 tt -54.01 -62.76 1.44 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.185 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -74.9 -4.8 40.16 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -172.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -98.32 -29.72 13.0 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.95 -0.469 . . . . 0.0 111.495 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.416 ' HB3' ' HE2' ' A' ' 98' ' ' MET . 88.1 mt -106.71 -13.27 15.32 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -175.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -70.17 91.41 0.71 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.28 0.562 . . . . 0.0 110.247 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 125.98 -15.51 6.95 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.992 -172.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -59.73 133.9 56.53 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.072 0.549 . . . . 0.0 111.457 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -89.08 90.22 8.3 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.238 0.542 . . . . 0.0 111.923 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.46 HD12 HD11 ' A' ' 46' ' ' ILE . 36.2 tp -85.31 -65.5 1.0 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.41 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.04 38.56 0.66 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.879 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.89 17.27 75.19 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 121.241 -0.504 . . . . 0.0 111.954 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -157.68 151.59 19.67 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 115.505 -0.347 . . . . 0.0 110.349 -174.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.51 141.48 62.3 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.005 2.47 . . . . 0.0 113.039 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.479 ' HA ' ' HB3' ' A' ' 33' ' ' SER . 36.5 ttp -99.31 128.12 45.4 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.119 0.485 . . . . 0.0 111.48 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -89.12 101.46 14.12 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.533 -178.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.7 t -114.24 111.38 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 120.789 0.328 . . . . 0.0 111.321 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -127.38 151.11 18.33 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.298 -0.477 . . . . 0.0 113.272 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.1 p80 . . . . . 0 N--CA 1.473 0.68 0 O-C-N 122.32 -0.518 . . . . 0.0 111.705 178.955 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo . . . . . 0 CA--C 1.541 0.867 0 CA-C-O 120.752 0.23 . . . . 0.0 112.292 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.8 ttt -99.6 136.4 39.58 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.091 0.472 . . . . 0.0 111.471 -176.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -112.48 118.98 36.64 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.349 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.9 mt -102.4 145.65 29.22 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.347 0.594 . . . . 0.0 112.126 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -102.08 120.48 40.51 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.616 173.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.3 t -118.98 115.94 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.672 0.272 . . . . 0.0 110.997 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.55 87.51 0.38 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.334 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.4 m -166.13 28.72 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.164 0.585 . . . . 0.0 110.61 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.475 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 15.0 mt -95.25 103.09 14.94 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.768 -176.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -74.21 67.1 1.34 Allowed 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -176.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 50.72 20.83 0.8 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 174.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.16 -38.2 0.27 Allowed 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.99 -0.444 . . . . 0.0 111.784 -174.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.7 mm -60.38 109.63 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 120.824 0.345 . . . . 0.0 111.149 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 61.0 p -92.93 172.57 8.24 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -54.79 -42.72 72.13 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.726 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -63.38 -38.04 89.61 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.703 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.1 mmt -65.51 -52.73 50.58 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.408 0.623 . . . . 0.0 110.197 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 65.5 mt -55.2 -40.33 70.65 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.925 174.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 45.0 ttm180 -61.5 -46.76 88.64 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.876 0.37 . . . . 0.0 110.957 177.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.31 -32.03 60.09 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.139 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 58.1 mt -85.68 -50.12 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -82.48 -27.69 31.65 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -172.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.614 ' HG3' ' O ' ' A' ' 52' ' ' ARG . 22.1 tt0 -57.33 -48.23 97.68 Favored Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -173.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 80.3 Cg_exo -47.89 -18.88 1.23 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 122.621 2.214 . . . . 0.0 114.013 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -78.45 -40.31 36.05 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.42 ' HA3' ' HB3' ' A' ' 80' ' ' CYS . . . -169.8 37.93 0.19 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 119.838 -1.173 . . . . 0.0 115.438 -178.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.614 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 0.0 OUTLIER 72.67 -53.79 0.7 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.366 0.666 . . . . 0.0 112.541 174.593 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.437 ' HB ' ' O ' ' A' ' 52' ' ' ARG . 68.7 mt 79.82 137.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.756 0.823 . . . . 0.0 111.672 -177.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -85.01 -64.96 1.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.196 0.522 . . . . 0.0 110.151 174.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.2 t -147.59 146.36 29.36 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.046 0.451 . . . . 0.0 111.865 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.513 HG23 HG12 ' A' ' 73' ' ' ILE . 60.4 mt -115.36 130.19 70.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.894 174.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -125.07 122.45 37.26 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.924 0.393 . . . . 0.0 111.547 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.8 mt -99.13 149.73 22.75 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.657 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 82.8 mmm . . . . . 0 CA--C 1.537 0.458 0 CA-C-O 120.699 0.285 . . . . 0.0 110.727 179.898 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.2 mttm . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 145.27 -11.01 1.79 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.929 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -128.55 145.26 51.18 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 117.23 0.515 . . . . 0.0 111.858 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.33 160.87 28.75 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.651 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -113.25 127.25 56.1 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.007 0.432 . . . . 0.0 111.72 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.513 HG12 HG23 ' A' ' 56' ' ' ILE . 67.1 mt -110.12 134.71 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.771 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 38.8 m -116.25 123.3 47.39 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.025 0.44 . . . . 0.0 111.926 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -100.22 149.66 23.34 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.511 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.8 m -72.06 -9.46 58.42 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.066 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.626 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 19.8 t70 -138.12 150.23 46.65 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.874 0.369 . . . . 0.0 111.47 -177.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 71.2 p -68.72 -53.19 23.5 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -68.54 -30.17 68.9 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.626 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 93.8 m -58.03 -41.45 83.25 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.16 0.505 . . . . 0.0 111.183 174.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.39 -38.67 29.85 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.237 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -54.93 -48.94 72.48 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.308 0.575 . . . . 0.0 110.688 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -70.02 -41.97 73.59 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.566 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.06 -44.02 67.14 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.273 0.558 . . . . 0.0 110.873 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 tt -62.29 -62.25 1.89 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.521 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -56.54 -29.73 62.29 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -176.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -87.95 -38.6 15.42 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 122.09 -0.381 . . . . 0.0 111.728 -175.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 76.5 mt -96.16 -23.4 16.76 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -172.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -65.69 100.13 0.51 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.068 0.461 . . . . 0.0 110.641 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.47 -9.67 13.1 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.738 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -73.22 126.97 31.3 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 122.535 -0.391 . . . . 0.0 111.938 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 45.3 mt-10 -80.04 102.54 9.35 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.866 0.365 . . . . 0.0 111.143 176.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.407 HD21 ' HE2' ' A' ' 98' ' ' MET . 65.8 tp -89.53 -66.74 0.89 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.034 0.445 . . . . 0.0 111.516 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -92.15 32.4 1.17 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.955 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.61 4.99 79.2 Favored Glycine 0 C--N 1.332 0.343 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 -174.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 1.5 ptm85 -143.44 152.37 56.81 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 122.927 0.491 . . . . 0.0 110.695 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -61.16 155.59 50.12 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.118 2.545 . . . . 0.0 114.384 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.407 ' HE2' HD21 ' A' ' 93' ' ' LEU . 31.9 tpp -99.46 117.72 34.49 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.728 177.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.666 ' HB3' ' HZ1' ' A' ' 99' ' ' LYS . 7.7 mtpm? -89.32 101.97 14.64 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.121 -0.362 . . . . 0.0 111.419 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.6 t -120.52 118.1 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.886 0.374 . . . . 0.0 111.666 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -139.24 147.49 19.25 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.176 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 11.3 p80 . . . . . 0 N--CA 1.47 0.574 0 CA-C-N 117.663 0.732 . . . . 0.0 110.769 -179.675 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo . . . . . 0 CA--C 1.539 0.738 0 CA-C-O 121.014 0.339 . . . . 0.0 112.67 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.495 ' HB2' ' HA ' ' A' ' 78' ' ' SER . 27.0 ttt -113.11 133.15 55.15 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.972 0.415 . . . . 0.0 111.558 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -99.78 116.28 31.5 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.159 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.2 mt -99.55 143.06 30.23 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.13 0.491 . . . . 0.0 111.665 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -97.73 120.11 37.54 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.602 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 99' ' ' LYS . 58.4 t -115.17 112.55 40.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.478 176.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.56 93.35 0.22 Allowed Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.527 -0.844 . . . . 0.0 114.645 -174.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.637 ' OG ' ' HA ' ' A' ' 98' ' ' MET . 90.9 p -176.08 19.89 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 28.8 mt -84.88 150.33 25.06 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 122.279 -0.263 . . . . 0.0 111.43 -175.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.546 ' HE2' ' HB1' ' A' ' 94' ' ' ALA . 24.9 p80 -122.49 76.61 1.34 Allowed 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -176.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 23.7 t80 42.94 41.86 2.81 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.312 0.645 . . . . 0.0 112.616 173.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -152.99 -51.32 0.1 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.998 0.428 . . . . 0.0 111.374 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.64 ' HA ' ' SD ' ' A' ' 42' ' ' MET . 3.2 mp -62.59 127.9 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.137 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.438 ' OG1' ' HG3' ' A' ' 42' ' ' MET . 35.3 p -106.51 171.93 7.09 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.329 0.585 . . . . 0.0 112.078 -175.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.501 ' HG2' ' HG ' ' A' ' 58' ' ' LEU . 79.6 mt-10 -67.08 -32.88 74.35 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.793 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -64.17 -39.2 93.51 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.075 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.64 ' SD ' ' HA ' ' A' ' 38' ' ' ILE . 64.4 mtt -62.88 -52.4 63.23 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.442 0.639 . . . . 0.0 110.273 176.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.5 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 63.1 mt -54.47 -51.39 65.19 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.106 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -50.2 -50.1 50.58 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.888 0.375 . . . . 0.0 111.195 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.93 -28.77 66.57 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.656 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.8 mm -82.84 -38.33 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 O-C-N 122.453 -0.439 . . . . 0.0 111.97 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.5 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 44.5 m-85 -85.89 -30.83 22.56 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -174.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -56.7 -38.68 71.17 Favored Pre-proline 0 N--CA 1.483 1.197 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -47.18 -22.83 2.52 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.245 1.964 . . . . 0.0 113.408 171.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.415 ' HE1' ' HG3' ' A' ' 87' ' ' GLN . 81.5 m-85 -93.69 -44.9 7.94 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.087 0.47 . . . . 0.0 111.096 175.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -174.32 140.58 5.49 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.844 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.0 ttp85 -58.34 134.5 56.64 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.242 0.544 . . . . 0.0 112.082 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.492 HD11 ' N ' ' A' ' 53' ' ' ILE . 3.4 mp -94.01 137.9 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.144 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -87.99 -40.67 13.69 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.833 0.349 . . . . 0.0 111.806 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.9 t -150.96 132.36 14.64 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.117 0.484 . . . . 0.0 112.238 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.503 HG22 HG12 ' A' ' 73' ' ' ILE . 47.9 mt -117.64 133.2 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.211 173.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -137.89 118.83 14.27 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.844 0.355 . . . . 0.0 111.404 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.532 HD23 ' HA3' ' A' ' 71' ' ' GLY . 91.7 mt -96.48 149.81 21.32 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 174.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.564 ' SD ' ' CE2' ' A' ' 70' ' ' TYR . 60.9 mtp . . . . . 0 C--O 1.237 0.435 0 CA-C-O 121.798 0.808 . . . . 0.0 111.349 -177.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.3 mttt . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.03 3.57 87.62 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 114.963 0.745 . . . . 0.0 114.963 169.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.564 ' CE2' ' SD ' ' A' ' 59' ' ' MET . 49.4 p90 -133.09 145.98 51.24 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 117.805 0.802 . . . . 0.0 111.993 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.532 ' HA3' HD23 ' A' ' 58' ' ' LEU . . . -151.2 161.9 29.28 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 115.816 -0.629 . . . . 0.0 113.239 -177.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -105.2 129.04 53.67 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.914 0.388 . . . . 0.0 111.768 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.503 HG12 HG22 ' A' ' 56' ' ' ILE . 66.8 mt -111.76 132.69 59.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.025 178.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.7 m -112.57 118.54 35.39 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.44 ' HZ ' ' HD2' ' A' ' 47' ' ' PHE . 45.0 m-85 -99.12 152.13 20.21 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.792 0.437 . . . . 0.0 111.841 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.1 m -68.09 -10.81 56.83 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.624 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -139.64 161.04 38.49 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.081 0.467 . . . . 0.0 112.096 -176.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.495 ' HA ' ' HB2' ' A' ' 27' ' ' MET . 51.7 m -91.33 -37.31 13.33 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -79.4 -40.01 31.06 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.015 -0.428 . . . . 0.0 112.023 -177.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 76.5 m -58.13 -41.86 84.57 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.329 0.585 . . . . 0.0 110.765 174.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.6 -45.37 68.73 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.984 176.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.808 ' HZ1' ' HB2' ' A' ' 82' ' ' LYS . 5.0 ttmp? -57.25 -34.98 69.16 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.405 178.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.496 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 46.0 tttm -75.23 -37.74 60.93 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.965 0.412 . . . . 0.0 111.01 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.89 -33.19 64.38 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.501 0.667 . . . . 0.0 110.475 172.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 100' ' ' VAL . 7.6 tt -65.85 -55.38 17.34 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.766 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 83' ' ' LYS . 2.6 pp20? -64.74 -19.28 65.7 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -174.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.415 ' HG3' ' HE1' ' A' ' 50' ' ' PHE . 85.9 mm-40 -94.6 -46.46 6.94 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.871 -0.518 . . . . 0.0 111.893 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.482 ' HB3' ' HE2' ' A' ' 98' ' ' MET . 71.6 mt -89.61 -17.3 28.74 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -170.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -71.01 91.4 0.88 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.464 0.65 . . . . 0.0 110.187 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.42 -14.13 8.78 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.943 -173.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -61.77 120.26 10.34 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.703 0.401 . . . . 0.0 110.958 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -79.0 93.71 5.15 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.158 0.504 . . . . 0.0 111.67 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.5 tp -96.51 135.88 37.79 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.995 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.546 ' HB1' ' HE2' ' A' ' 35' ' ' HIS . . . 59.76 24.07 13.0 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.206 0.527 . . . . 0.0 111.146 -176.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.33 3.67 89.91 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.121 -0.491 . . . . 0.0 113.526 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -121.13 136.5 25.75 Favored Pre-proline 0 N--CA 1.473 0.676 0 CA-C-N 117.306 0.553 . . . . 0.0 111.731 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -59.99 129.31 29.81 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.473 2.115 . . . . 0.0 111.82 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.637 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 40.9 ttp -97.62 124.88 42.07 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.174 0.511 . . . . 0.0 111.781 -174.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 68.2 mttm -88.41 101.91 14.36 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.148 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.504 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 44.0 t -114.45 99.51 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.632 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -135.62 160.24 24.44 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.747 -0.739 . . . . 0.0 113.062 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 15.0 p80 . . . . . 0 CA--C 1.537 0.479 0 O-C-N 122.514 -0.403 . . . . 0.0 110.598 177.209 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo . . . . . 0 CA--C 1.541 0.874 0 N-CA-C 113.116 0.391 . . . . 0.0 113.116 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 26.3 ttt -99.12 141.27 32.09 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.677 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.471 ' HD3' ' HB3' ' A' ' 72' ' ' PHE . 42.4 ttm180 -115.71 130.95 57.05 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.171 0.51 . . . . 0.0 112.288 -171.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 85.5 mt -107.66 145.39 33.43 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.195 0.522 . . . . 0.0 111.831 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.494 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 39.0 t80 -97.32 111.79 23.89 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.961 173.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -106.23 107.44 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 120.805 0.336 . . . . 0.0 111.35 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.561 ' HA2' ' HB3' ' A' ' 70' ' ' TYR . . . -113.39 97.57 0.87 Allowed Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.244 -0.503 . . . . 0.0 113.831 -176.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.704 ' HB2' ' HA ' ' A' ' 98' ' ' MET . 30.7 t -174.81 15.25 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.39 0.614 . . . . 0.0 111.183 172.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.718 ' HA ' HD12 ' A' ' 38' ' ' ILE . 11.1 mt -85.59 88.62 7.55 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 122.029 -0.42 . . . . 0.0 110.405 -171.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -78.49 69.29 4.65 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.579 0.704 . . . . 0.0 112.377 -172.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 48.3 t80 57.68 9.62 0.87 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 175.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -124.18 -38.91 2.4 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.609 -0.682 . . . . 0.0 112.596 -177.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.718 HD12 ' HA ' ' A' ' 34' ' ' LEU . 58.8 mt -67.61 134.06 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.938 0.399 . . . . 0.0 111.978 -176.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 56.6 p -110.02 166.21 11.12 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.066 0.46 . . . . 0.0 112.205 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.478 ' HA ' HD13 ' A' ' 43' ' ' LEU . 2.5 mp0 -63.07 -36.54 83.93 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.248 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -66.67 -33.56 75.92 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.909 0.385 . . . . 0.0 111.277 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.569 ' HE2' HD13 ' A' ' 93' ' ' LEU . 27.1 ttt -68.18 -44.66 75.41 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.562 0.696 . . . . 0.0 110.107 174.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.478 HD13 ' HA ' ' A' ' 40' ' ' GLU . 92.2 mt -55.09 -55.26 33.0 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.722 178.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.493 ' HB3' HD12 ' A' ' 56' ' ' ILE . 14.2 ptm180 -61.78 -33.22 73.72 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.385 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.19 -36.8 69.81 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.63 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 63.2 mt -85.45 -49.21 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 177.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -82.31 -32.52 29.41 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -169.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.718 ' HG3' ' HA ' ' A' ' 52' ' ' ARG . 22.2 tt0 -62.07 -42.49 81.98 Favored Pre-proline 0 N--CA 1.48 1.056 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -174.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -47.78 -18.29 0.98 Allowed 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 122.529 2.152 . . . . 0.0 114.316 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -71.38 -51.9 21.58 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.525 ' N ' ' SG ' ' A' ' 80' ' ' CYS . . . -170.91 43.76 0.19 Allowed Glycine 0 N--CA 1.468 0.77 0 C-N-CA 120.079 -1.058 . . . . 0.0 114.092 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.718 ' HA ' ' HG3' ' A' ' 48' ' ' GLU . 0.3 OUTLIER 63.31 143.91 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.974 0.892 . . . . 0.0 113.39 178.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.42 HG13 ' HA ' ' A' ' 48' ' ' GLU . 89.2 mt -119.09 133.69 65.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.16 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -82.68 -56.48 3.83 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.674 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.7 p -150.12 138.34 20.39 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.255 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.52 HG12 HG21 ' A' ' 73' ' ' ILE . 46.0 mt -107.67 116.31 50.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.343 0.592 . . . . 0.0 111.113 177.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -99.36 115.72 29.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.993 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 27.9 tp -97.16 133.35 41.92 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.551 -0.718 . . . . 0.0 110.516 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.571 ' HG3' ' HD3' ' A' ' 68' ' ' LYS . 14.3 tpt . . . . . 0 C--O 1.235 0.302 0 CA-C-O 121.889 0.852 . . . . 0.0 111.142 -171.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.571 ' HD3' ' HG3' ' A' ' 59' ' ' MET . 26.0 mtpp . . . . . 0 CA--C 1.542 0.643 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 101.03 7.05 51.02 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 120.969 -0.634 . . . . 0.0 114.486 175.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.561 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -145.26 160.07 42.05 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 117.476 0.638 . . . . 0.0 112.567 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -145.29 147.57 18.77 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.955 -0.566 . . . . 0.0 113.147 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.471 ' HB3' ' HD3' ' A' ' 28' ' ' ARG . 95.8 m-85 -99.57 112.67 24.85 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.935 0.398 . . . . 0.0 111.266 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.52 HG21 HG12 ' A' ' 56' ' ' ILE . 67.8 mt -99.41 126.18 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.956 0.408 . . . . 0.0 111.586 -178.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 36.7 m -101.54 118.41 36.9 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.517 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -98.53 151.53 20.54 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.109 0.481 . . . . 0.0 112.17 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.0 t -72.19 -28.83 63.46 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.148 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -116.3 133.0 56.51 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.972 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.6 t -67.04 -51.17 58.09 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.941 0.401 . . . . 0.0 111.891 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -57.77 -34.37 69.5 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.098 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 51' ' ' GLY . 7.7 t -57.97 -46.3 85.38 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.824 175.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.4 ' O ' HD12 ' A' ' 29' ' ' LEU . . . -65.16 -41.77 94.35 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.07 0.462 . . . . 0.0 111.15 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -64.93 -35.67 81.91 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.564 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 85.6 tttt -72.35 -50.41 26.95 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.741 0.305 . . . . 0.0 111.318 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.15 -42.77 61.01 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.11 0.481 . . . . 0.0 110.954 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.8 tt -57.19 -55.9 28.7 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.511 173.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -53.67 -34.85 60.06 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.132 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 83' ' ' LYS . 11.1 mm100 -86.8 -35.43 19.12 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.911 -174.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.5 ' HB3' ' HE1' ' A' ' 98' ' ' MET . 73.8 mt -104.79 -7.02 19.76 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -171.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -62.91 99.71 0.17 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.028 0.442 . . . . 0.0 111.134 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.05 -2.42 44.31 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 116.264 -0.426 . . . . 0.0 113.342 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -67.15 131.69 46.31 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 122.607 -0.349 . . . . 0.0 111.578 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.82 103.34 1.41 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.987 0.423 . . . . 0.0 111.153 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.569 HD13 ' HE2' ' A' ' 42' ' ' MET . 56.6 tp -113.17 127.33 56.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.433 177.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 58.26 23.73 10.7 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.148 0.499 . . . . 0.0 111.754 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.99 -18.27 54.99 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.82 -0.627 . . . . 0.0 114.018 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 31.7 mtt85 -116.59 140.01 26.19 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 117.378 0.589 . . . . 0.0 111.997 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.23 132.12 48.74 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.778 2.318 . . . . 0.0 112.098 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.704 ' HA ' ' HB2' ' A' ' 33' ' ' SER . 38.5 ttp -96.75 119.35 35.07 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.361 0.6 . . . . 0.0 111.738 -171.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -87.8 94.19 9.68 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.64 -176.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.05 113.57 38.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.461 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 30' ' ' TYR . . . -142.08 131.59 4.8 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.25 -0.5 . . . . 0.0 112.548 176.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 25.9 p80 . . . . . 0 N--CA 1.477 0.881 0 CA-C-N 117.655 0.727 . . . . 0.0 112.128 -177.848 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo . . . . . 0 CA--C 1.543 0.958 0 N-CA-C 113.551 0.558 . . . . 0.0 113.551 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 11.7 tpt -126.23 147.51 49.66 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.763 0.315 . . . . 0.0 111.474 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 36.7 ttt85 -120.81 121.22 37.69 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.854 0.359 . . . . 0.0 111.308 -174.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 81.6 mt -106.01 143.66 33.82 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 55.2 t80 -91.66 116.06 28.57 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.495 172.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.44 HG23 HD13 ' A' ' 73' ' ' ILE . 60.0 t -118.73 109.14 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-O 121.093 0.473 . . . . 0.0 111.789 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.5 104.76 1.84 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.576 -0.345 . . . . 0.0 112.937 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.539 ' HB2' ' HA ' ' A' ' 98' ' ' MET . 39.7 t -171.64 14.61 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.248 0.547 . . . . 0.0 111.823 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.47 HD11 HD22 ' A' ' 58' ' ' LEU . 12.1 mt -86.16 85.44 7.35 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.722 -0.611 . . . . 0.0 111.529 -172.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.401 ' ND1' ' O ' ' A' ' 35' ' ' HIS . 33.8 p80 -78.64 66.58 4.18 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.672 0.748 . . . . 0.0 112.046 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 47.0 t80 60.18 9.24 1.8 Allowed 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.55 -34.95 1.53 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.584 -0.697 . . . . 0.0 111.483 -178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.456 HD12 ' HE3' ' A' ' 42' ' ' MET . 11.6 mm -73.21 107.36 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.931 0.396 . . . . 0.0 111.329 -175.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.5 p -99.54 179.23 4.62 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.957 0.408 . . . . 0.0 112.014 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -60.48 -43.13 97.28 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.275 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.31 -37.21 82.43 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.129 0.49 . . . . 0.0 110.959 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.691 ' HE2' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -67.54 -55.02 15.16 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.334 0.588 . . . . 0.0 110.246 178.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.4 mt -55.18 -44.12 74.94 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.444 176.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.497 HH21 ' NH1' ' A' ' 52' ' ' ARG . 53.9 ttt180 -58.7 -47.34 84.89 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.232 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.44 -31.59 60.05 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.998 177.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.8 mt -80.28 -54.48 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -79.76 -33.91 40.29 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -172.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.826 ' HG3' ' HA ' ' A' ' 52' ' ' ARG . 10.1 tt0 -60.78 -38.67 58.54 Favored Pre-proline 0 N--CA 1.476 0.867 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -172.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -46.3 -26.52 3.98 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.535 2.157 . . . . 0.0 113.798 172.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -66.91 -63.74 1.0 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.653 0.263 . . . . 0.0 111.595 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.472 ' HA3' ' SG ' ' A' ' 80' ' ' CYS . . . -165.65 40.02 0.28 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.472 -0.87 . . . . 0.0 114.314 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.826 ' HA ' ' HG3' ' A' ' 48' ' ' GLU . 43.7 tpt85 71.26 127.18 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 172.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.494 HG22 HG13 ' A' ' 56' ' ' ILE . 1.7 mp -82.89 141.31 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.038 0.447 . . . . 0.0 111.432 175.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -90.29 -56.22 3.3 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.309 0.576 . . . . 0.0 109.656 173.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.6 m -150.6 144.02 25.0 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.46 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.494 HG13 HG22 ' A' ' 53' ' ' ILE . 57.3 mt -122.29 109.87 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.023 0.44 . . . . 0.0 110.776 175.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -108.83 112.26 24.42 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.314 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.47 HD22 HD11 ' A' ' 34' ' ' LEU . 32.7 mt -98.69 141.91 30.92 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.81 0.338 . . . . 0.0 110.921 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 64.7 mtp . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 121.167 0.508 . . . . 0.0 111.488 -176.279 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.2 mttp . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.2 -6.63 19.17 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 120.917 -0.659 . . . . 0.0 114.439 174.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -135.56 151.72 50.58 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 117.376 0.588 . . . . 0.0 112.364 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.7 158.76 27.83 Favored Glycine 0 CA--C 1.527 0.844 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.734 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -101.51 120.44 40.3 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.601 -0.352 . . . . 0.0 111.603 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.494 HG12 HG23 ' A' ' 56' ' ' ILE . 70.9 mt -103.9 117.11 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.278 0.561 . . . . 0.0 111.249 178.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 51.9 m -99.85 125.71 45.85 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.68 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -103.3 150.44 23.75 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.782 175.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.8 t -72.92 -11.87 60.74 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.683 0.278 . . . . 0.0 111.65 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -126.24 144.38 50.8 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.852 0.358 . . . . 0.0 110.986 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 54.5 m -78.78 -43.67 24.94 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -69.69 -34.9 74.58 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.826 0.346 . . . . 0.0 111.508 -175.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.472 ' SG ' ' HA3' ' A' ' 51' ' ' GLY . 35.8 t -60.04 -43.39 95.36 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.068 0.461 . . . . 0.0 111.081 174.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.39 -40.97 96.84 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.01 176.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -56.67 -46.44 81.1 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.965 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.434 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 86.8 tttt -62.03 -54.04 47.06 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.288 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.92 -52.12 61.58 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.894 0.378 . . . . 0.0 111.836 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.9 tt -53.87 -54.6 36.29 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.621 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -64.67 -25.14 67.82 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -173.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 83' ' ' LYS . 8.3 mm-40 -95.72 -17.79 20.98 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.465 ' HB3' ' SD ' ' A' ' 98' ' ' MET . 90.2 mt -112.2 -24.53 9.79 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -175.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -60.03 101.41 0.12 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.169 0.509 . . . . 0.0 111.534 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.65 -15.98 9.69 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 116.063 -0.517 . . . . 0.0 113.013 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -63.41 129.98 42.53 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 122.658 -0.319 . . . . 0.0 111.784 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -65.86 94.31 0.21 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.993 0.425 . . . . 0.0 111.18 175.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.691 HD12 ' HE2' ' A' ' 42' ' ' MET . 66.9 tp -86.75 115.25 24.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.426 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 55.92 22.35 5.65 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 109.26 -9.41 33.32 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 114.098 0.399 . . . . 0.0 114.098 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -130.93 134.89 26.51 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 117.405 0.603 . . . . 0.0 110.78 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.66 149.42 13.87 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.819 2.346 . . . . 0.0 113.26 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.539 ' HA ' ' HB2' ' A' ' 33' ' ' SER . 43.9 ttm -96.85 104.78 16.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.234 0.54 . . . . 0.0 109.906 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.685 ' HZ2' ' HB3' ' A' ' 99' ' ' LYS . 2.0 mmmp? -87.84 89.9 8.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.708 -175.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 20.4 t -105.2 117.82 51.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.089 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -148.14 162.15 28.73 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.208 -0.52 . . . . 0.0 113.053 -176.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 . . . . . 0 CA--C 1.539 0.547 0 CA-C-O 121.305 0.574 . . . . 0.0 111.552 177.319 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.62 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 14.4 Cg_exo . . . . . 0 CA--C 1.548 1.186 0 N-CA-C 116.619 1.738 . . . . 0.0 116.619 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.9 ttt -139.46 138.22 36.24 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.46 170.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 62.8 mtt-85 -99.74 143.6 29.78 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.422 0.629 . . . . 0.0 112.483 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.0 mt -112.44 139.16 48.24 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.28 177.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -90.71 108.8 20.06 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.769 176.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.35 104.41 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.674 0.273 . . . . 0.0 111.201 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.511 ' HA2' ' HB3' ' A' ' 70' ' ' TYR . . . -114.64 91.68 0.57 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.201 -0.523 . . . . 0.0 113.945 -177.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 t -175.15 21.13 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.433 0.635 . . . . 0.0 111.174 175.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.45 HD21 HG23 ' A' ' 38' ' ' ILE . 13.1 mt -85.02 93.13 8.52 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.869 -0.52 . . . . 0.0 110.945 -173.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -81.44 62.1 5.18 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.293 0.568 . . . . 0.0 112.531 -174.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 62.0 t80 59.61 9.22 1.49 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 173.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -130.95 4.95 4.51 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.61 -0.681 . . . . 0.0 111.502 -178.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.543 HG21 ' SD ' ' A' ' 42' ' ' MET . 27.1 mm -105.25 127.98 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 122.111 -0.368 . . . . 0.0 110.81 -177.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.6 p -107.23 167.3 10.01 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.936 0.398 . . . . 0.0 111.788 -176.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -55.21 -44.5 75.42 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.125 0.488 . . . . 0.0 110.878 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -68.03 -31.63 71.43 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.184 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.543 ' SD ' HG21 ' A' ' 38' ' ' ILE . 52.5 ttm -62.14 -50.21 72.77 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.406 0.622 . . . . 0.0 109.887 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.42 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 48.9 mt -57.14 -44.15 83.13 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.495 173.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -53.27 -47.35 69.21 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.078 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.74 -29.49 74.06 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.306 -0.473 . . . . 0.0 113.387 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.1 mt -84.59 -44.06 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 O-C-N 122.386 -0.479 . . . . 0.0 112.158 178.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.42 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 38.9 m-85 -85.64 -29.12 24.29 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -171.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -52.81 -47.33 95.21 Favored Pre-proline 0 N--CA 1.486 1.334 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -49.93 -18.22 2.83 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 122.801 2.334 . . . . 0.0 114.919 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.468 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 79.3 m-85 -78.69 -70.48 0.49 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.431 ' N ' ' SG ' ' A' ' 80' ' ' CYS . . . -157.95 24.25 0.4 Allowed Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.713 -177.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 68.88 144.9 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.506 HD11 ' N ' ' A' ' 53' ' ' ILE . 4.0 mp -107.22 139.72 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.45 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -78.32 -48.37 15.78 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.434 0.635 . . . . 0.0 110.937 175.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 61.3 m -151.2 132.28 14.35 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.66 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.452 HG22 HG12 ' A' ' 73' ' ' ILE . 54.6 mt -106.45 129.05 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 173.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -130.41 134.44 47.14 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.851 0.358 . . . . 0.0 111.658 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 76.1 mt -98.72 144.02 28.44 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.81 0.338 . . . . 0.0 110.623 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 10.0 tpt . . . . . 0 CA--C 1.538 0.519 0 CA-C-O 121.315 0.579 . . . . 0.0 111.227 -176.839 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 73.6 mmtt . . . . . 0 CA--C 1.537 0.477 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.76 5.24 63.05 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.589 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.511 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 2.2 p90 -141.45 158.98 43.16 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.034 0.445 . . . . 0.0 111.851 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.47 161.25 28.9 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 116.256 -0.429 . . . . 0.0 113.04 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -109.15 123.08 48.63 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.169 0.509 . . . . 0.0 111.738 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.452 HG12 HG22 ' A' ' 56' ' ' ILE . 78.4 mt -107.69 122.27 61.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 178.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.46 ' O ' HG23 ' A' ' 53' ' ' ILE . 28.2 m -99.57 115.38 29.24 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -175.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.62 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 40.9 m-85 -97.66 141.41 30.72 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.59 0.233 . . . . 0.0 111.437 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.9 t -73.75 -3.3 27.58 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.377 176.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' A' ' 80' ' ' CYS . 11.2 t70 -132.95 121.03 22.2 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.787 0.327 . . . . 0.0 110.687 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.2 p -60.19 -51.81 67.98 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.12 -36.77 85.11 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.773 0.32 . . . . 0.0 110.993 -177.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.559 ' HB3' ' HB3' ' A' ' 77' ' ' ASP . 25.0 t -63.08 -40.75 98.57 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.797 0.332 . . . . 0.0 111.362 175.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.503 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . . . -63.86 -47.6 80.07 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.317 0.58 . . . . 0.0 110.551 175.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -57.44 -42.11 81.8 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.655 176.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -66.87 -49.58 65.23 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.817 0.341 . . . . 0.0 111.182 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.66 -44.45 69.66 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.204 0.526 . . . . 0.0 110.662 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.1 tt -56.96 -58.5 7.87 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.686 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -61.31 -25.88 67.42 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -174.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.594 ' N ' HE21 ' A' ' 87' ' ' GLN . 0.0 OUTLIER -89.16 -46.16 9.02 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.805 0.336 . . . . 0.0 111.754 -179.814 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 70.7 mt -89.81 -9.3 49.7 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -169.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -67.78 82.27 0.19 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.446 0.641 . . . . 0.0 110.826 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 142.7 -21.2 2.36 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.606 -175.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.456 ' HB3' ' HE3' ' A' ' 98' ' ' MET . 59.6 t80 -48.92 119.51 3.24 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.221 0.608 . . . . 0.0 111.52 178.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -69.37 93.6 0.66 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.27 0.557 . . . . 0.0 110.995 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.447 HD22 HG23 ' A' ' 38' ' ' ILE . 51.2 tp -85.46 111.59 20.11 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.223 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 63.02 2.78 1.09 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 126.69 -7.82 7.36 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.524 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -122.79 130.29 24.68 Favored Pre-proline 0 N--CA 1.47 0.555 0 CA-C-N 117.01 0.405 . . . . 0.0 110.906 176.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.55 136.51 41.07 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.427 2.085 . . . . 0.0 112.016 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.456 ' HE3' ' HB3' ' A' ' 91' ' ' PHE . 51.3 ttp -95.96 116.42 28.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.43 0.633 . . . . 0.0 111.077 -172.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -88.29 92.51 9.19 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.079 -176.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.7 t -99.83 107.31 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.642 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -134.95 161.22 24.53 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.569 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.8 p80 . . . . . 0 CA--C 1.541 0.613 0 O-C-N 122.479 -0.424 . . . . 0.0 111.908 175.914 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo . . . . . 0 CA--C 1.538 0.676 0 CA-C-O 120.947 0.311 . . . . 0.0 112.646 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 28.1 ttt -112.9 123.11 49.57 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.039 0.447 . . . . 0.0 111.268 -173.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.464 ' HD2' ' HB3' ' A' ' 72' ' ' PHE . 47.7 ttp180 -102.82 136.61 42.31 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.032 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.0 mt -107.51 148.59 29.01 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.233 0.54 . . . . 0.0 112.299 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -95.64 112.33 24.07 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.769 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.4 t -108.91 99.47 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.092 0.472 . . . . 0.0 111.207 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.78 89.13 0.84 Allowed Glycine 0 CA--C 1.524 0.642 0 C-N-CA 121.186 -0.53 . . . . 0.0 113.129 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.0 t -172.44 25.84 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.158 0.504 . . . . 0.0 111.107 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.4 HD21 ' HB ' ' A' ' 38' ' ' ILE . 62.4 mt -72.26 103.56 3.41 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.776 -0.578 . . . . 0.0 110.522 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -79.38 35.9 0.29 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 63.58 13.67 7.46 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 176.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -148.52 11.05 0.87 Allowed 'General case' 0 N--CA 1.473 0.725 0 O-C-N 122.065 -0.397 . . . . 0.0 111.692 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.542 HG21 ' SD ' ' A' ' 42' ' ' MET . 30.8 mm -83.33 140.11 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.639 0.256 . . . . 0.0 110.749 -178.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 79.1 p -116.8 161.27 19.54 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -55.41 -40.34 71.34 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.216 177.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -65.04 -39.55 93.49 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.533 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.542 ' SD ' HG21 ' A' ' 38' ' ' ILE . 50.5 ttm -61.83 -52.29 64.76 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.326 0.584 . . . . 0.0 110.525 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.445 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 55.8 mt -55.47 -53.64 53.75 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.2 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.502 ' HB2' HD13 ' A' ' 56' ' ' ILE . 53.0 ttt180 -54.36 -46.88 73.09 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.404 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.61 -31.02 69.84 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 116.288 -0.414 . . . . 0.0 113.447 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 68.7 mt -85.18 -37.6 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 O-C-N 122.504 -0.41 . . . . 0.0 112.08 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.445 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 37.8 m-85 -85.38 -30.1 23.9 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -174.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -58.27 -39.89 78.86 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -45.69 -15.34 0.13 Allowed 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 122.112 1.875 . . . . 0.0 114.253 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -103.97 -23.11 13.37 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.43 ' HA3' ' HB2' ' A' ' 80' ' ' CYS . . . -174.57 -128.6 1.1 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.275 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -151.82 124.94 8.67 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 122.402 -0.47 . . . . 0.0 110.358 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.5 HD11 ' N ' ' A' ' 53' ' ' ILE . 3.5 mp -86.7 138.5 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.412 -178.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -83.98 -54.74 4.64 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.895 0.379 . . . . 0.0 111.186 175.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.4 m -141.92 138.53 32.08 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.88 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.516 HG22 HG12 ' A' ' 73' ' ' ILE . 65.3 mt -108.11 112.2 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.807 0.337 . . . . 0.0 110.918 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -105.81 129.02 54.08 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.924 0.392 . . . . 0.0 110.758 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.6 mp -111.33 148.72 32.35 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.149 -0.345 . . . . 0.0 110.505 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 96.0 mmm . . . . . 0 C--N 1.326 -0.439 0 CA-C-O 121.292 0.568 . . . . 0.0 110.145 -179.782 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp . . . . . 0 CA--C 1.538 0.504 0 CA-C-O 120.886 0.374 . . . . 0.0 111.341 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.49 -6.13 65.26 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.044 -0.598 . . . . 0.0 114.552 175.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -143.9 155.97 44.28 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 117.453 0.627 . . . . 0.0 112.054 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -145.46 160.77 28.14 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.23 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.464 ' HB3' ' HD2' ' A' ' 28' ' ' ARG . 96.9 m-85 -119.12 116.54 26.58 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.26 0.552 . . . . 0.0 111.888 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.516 HG12 HG22 ' A' ' 56' ' ' ILE . 70.5 mt -104.13 126.7 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.669 -177.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.7 m -99.27 117.47 33.8 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -99.03 150.52 21.91 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.991 0.424 . . . . 0.0 111.569 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.2 t -80.92 -2.35 47.28 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.145 0.498 . . . . 0.0 111.458 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.548 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 29.3 t70 -142.52 143.86 32.7 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.12 0.486 . . . . 0.0 111.219 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.8 t -75.15 -42.93 55.07 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.849 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.51 -47.53 85.18 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -177.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.548 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 30.8 p -60.04 -40.81 90.67 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.996 0.427 . . . . 0.0 111.333 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.09 -45.94 83.14 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.253 0.549 . . . . 0.0 111.003 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -60.47 -38.64 84.86 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.053 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -67.86 -42.06 81.92 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.536 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.22 -49.71 76.52 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.106 176.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.458 ' C ' HD21 ' A' ' 85' ' ' LEU . 7.0 tt -53.89 -54.9 32.21 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.211 0.529 . . . . 0.0 110.205 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -47.15 -39.74 14.25 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.482 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -97.62 -33.48 11.31 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -174.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 92.6 mt -92.83 -15.54 26.37 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -173.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -67.0 93.64 0.29 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.23 0.538 . . . . 0.0 109.974 176.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.9 10.78 15.39 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.334 -174.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -77.54 133.76 38.44 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.518 0.327 . . . . 0.0 111.306 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -75.76 88.17 2.8 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.156 0.503 . . . . 0.0 111.762 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.489 HD21 ' HE1' ' A' ' 98' ' ' MET . 55.1 tp -90.42 125.9 35.71 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.58 175.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 55.75 26.79 9.87 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.157 0.503 . . . . 0.0 111.541 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.8 15.59 72.56 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 116.128 -0.487 . . . . 0.0 113.38 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 30.5 mtp180 -139.13 144.31 40.25 Favored Pre-proline 0 N--CA 1.472 0.641 0 O-C-N 122.604 -0.35 . . . . 0.0 111.743 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.67 138.0 83.99 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.379 2.719 . . . . 0.0 114.118 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.489 ' HE1' HD21 ' A' ' 93' ' ' LEU . 47.0 ttm -99.37 114.84 27.96 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.031 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -89.25 101.34 14.01 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 122.068 -0.395 . . . . 0.0 111.409 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.6 t -108.04 117.27 53.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.071 0.463 . . . . 0.0 112.064 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.55 160.87 12.91 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.523 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 21.0 p80 . . . . . 0 N--CA 1.479 0.978 0 O-C-N 122.147 -0.62 . . . . 0.0 112.327 -174.645 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo . . . . . 0 CA--C 1.542 0.886 0 CA-C-O 120.984 0.327 . . . . 0.0 112.217 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.471 ' HB2' ' HA ' ' A' ' 78' ' ' SER . 21.6 ttt -104.92 138.93 40.41 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.79 0.329 . . . . 0.0 111.226 -176.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -108.13 126.99 53.4 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.881 0.372 . . . . 0.0 111.524 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 75.2 mt -105.5 140.8 38.04 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.196 0.522 . . . . 0.0 111.779 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -95.17 115.21 27.13 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.152 173.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.7 t -109.26 101.22 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.054 0.454 . . . . 0.0 111.595 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.411 ' HA2' ' HB3' ' A' ' 70' ' ' TYR . . . -101.62 89.06 0.74 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.77 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.8 t -174.69 22.08 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.112 0.482 . . . . 0.0 111.353 178.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.461 HD22 HD21 ' A' ' 43' ' ' LEU . 14.6 mt -77.93 70.5 4.31 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.765 0.793 . . . . 0.0 110.222 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -66.06 78.97 0.09 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.014 -0.994 . . . . 0.0 113.036 -175.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.6 t80 45.99 38.71 4.87 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 121.287 0.565 . . . . 0.0 112.443 171.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -166.62 -41.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.7 mm -73.69 103.21 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 121.073 0.463 . . . . 0.0 112.059 -173.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.8 p -93.23 173.89 7.49 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.43 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.453 ' HA ' HD13 ' A' ' 43' ' ' LEU . 25.3 mt-10 -51.1 -39.45 56.16 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.695 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.06 -48.73 80.5 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.553 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.4 mmt -63.42 -40.68 97.83 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.961 0.41 . . . . 0.0 110.762 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.461 HD21 HD22 ' A' ' 34' ' ' LEU . 77.0 mt -57.04 -44.68 83.17 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.429 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -60.93 -47.12 87.88 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.999 0.428 . . . . 0.0 111.099 174.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.42 -32.32 64.13 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.579 -178.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.7 mt -86.49 -50.93 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 121.099 0.475 . . . . 0.0 112.208 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 75' ' ' PHE . 42.5 m-85 -85.29 -40.55 16.45 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -171.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -58.6 -37.57 55.76 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -175.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -51.98 -12.7 1.43 Allowed 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 122.217 1.945 . . . . 0.0 114.088 171.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -91.49 -31.26 16.03 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.108 0.48 . . . . 0.0 111.052 173.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' A' ' 80' ' ' CYS . . . -178.85 134.66 2.39 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.461 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.04 129.97 18.14 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.095 0.474 . . . . 0.0 111.698 -178.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.9 mt -95.34 128.72 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.076 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.417 ' HG2' ' OG ' ' A' ' 76' ' ' SER . 14.7 mm-40 -73.11 -57.43 4.03 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.972 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.9 t -151.76 148.99 28.53 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.716 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.422 HG12 HG21 ' A' ' 73' ' ' ILE . 45.6 mt -120.84 140.46 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.599 175.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -122.65 110.07 15.07 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.447 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.408 HD22 ' N ' ' A' ' 59' ' ' MET . 3.4 tt -98.39 129.51 45.03 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -177.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.408 ' N ' HD22 ' A' ' 58' ' ' LEU . 55.0 mtp . . . . . 0 CA--C 1.537 0.446 0 CA-C-O 121.676 0.75 . . . . 0.0 112.452 -174.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.9 mttp . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.24 15.17 57.81 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.454 0.942 . . . . 0.0 115.454 169.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.411 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 3.2 p90 -147.36 152.75 38.71 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.167 0.984 . . . . 0.0 112.754 177.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.81 160.58 28.68 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 115.496 -0.775 . . . . 0.0 113.059 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -108.77 126.41 52.99 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 122.579 -0.365 . . . . 0.0 111.463 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.422 HG21 HG12 ' A' ' 56' ' ' ILE . 69.9 mt -112.31 131.36 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.806 0.336 . . . . 0.0 111.598 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 91.9 m -108.36 120.06 41.29 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 120.683 0.278 . . . . 0.0 111.537 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 47' ' ' PHE . 34.4 m-85 -98.94 150.19 22.19 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.731 0.301 . . . . 0.0 111.261 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.417 ' OG ' ' HG2' ' A' ' 54' ' ' GLU . 13.3 m -75.98 10.8 1.69 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -153.79 146.01 23.82 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.815 0.341 . . . . 0.0 110.779 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.471 ' HA ' ' HB2' ' A' ' 27' ' ' MET . 31.3 t -75.07 -48.09 25.62 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.866 0.365 . . . . 0.0 111.984 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -71.1 -31.16 67.44 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 122.274 -0.266 . . . . 0.0 111.49 -175.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.426 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . 93.2 m -59.85 -46.57 88.86 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.851 0.357 . . . . 0.0 111.2 174.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.69 -44.49 77.62 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.038 0.447 . . . . 0.0 110.868 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -54.28 -47.03 72.82 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.304 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.543 ' HB2' ' HZ3' ' A' ' 83' ' ' LYS . 4.1 ttmp? -67.58 -42.95 81.72 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.491 178.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.07 -45.43 71.73 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.079 0.466 . . . . 0.0 110.988 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 tt -57.48 -52.81 63.88 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.624 176.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -56.07 -35.84 67.43 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -87.7 -36.4 17.42 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -174.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 80.7 mt -95.88 -15.1 22.66 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -173.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -64.01 104.91 0.77 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.943 0.401 . . . . 0.0 110.127 174.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.95 16.91 42.79 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.88 -176.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -77.28 133.92 38.69 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.428 0.291 . . . . 0.0 111.201 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.32 92.88 5.21 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.5 tp -100.03 126.39 46.22 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 122.276 -0.265 . . . . 0.0 110.327 175.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 64.75 12.15 7.42 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.859 0.362 . . . . 0.0 111.773 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.89 2.66 58.3 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.515 -0.374 . . . . 0.0 113.409 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -130.77 154.17 81.78 Favored Pre-proline 0 CA--C 1.543 0.708 0 O-C-N 122.46 -0.435 . . . . 0.0 111.032 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.2 151.63 84.82 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.878 2.385 . . . . 0.0 114.414 -174.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 46.2 ttm -109.47 120.45 42.53 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.216 177.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -89.33 99.19 12.23 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.914 0.388 . . . . 0.0 111.668 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.1 t -108.85 116.58 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.246 176.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -140.41 139.96 10.18 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.394 -0.431 . . . . 0.0 112.667 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 29.2 p80 . . . . . 0 N--CA 1.472 0.66 0 O-C-N 122.133 -0.628 . . . . 0.0 111.562 -177.282 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 CA--C 1.54 0.817 0 CA-C-O 120.759 0.233 . . . . 0.0 112.222 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 28.2 ttt -123.59 122.81 39.12 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.913 0.387 . . . . 0.0 111.317 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 36.4 ttp-105 -104.34 133.44 49.24 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.106 0.479 . . . . 0.0 111.64 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.511 HD22 HD11 ' A' ' 85' ' ' LEU . 67.2 mt -107.33 140.53 40.1 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.148 0.499 . . . . 0.0 111.817 -177.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -99.02 116.92 32.36 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.805 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.3 t -115.69 130.83 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 120.744 0.307 . . . . 0.0 111.611 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.06 105.52 0.61 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 121.229 -0.51 . . . . 0.0 113.733 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.3 t -175.05 16.27 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.228 0.537 . . . . 0.0 111.689 175.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.515 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 10.7 mt -87.03 87.3 7.42 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.962 -0.461 . . . . 0.0 111.692 -170.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -80.65 60.94 4.16 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.361 0.601 . . . . 0.0 112.075 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 46.6 t80 57.48 8.96 0.69 Allowed 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -126.88 -2.8 6.54 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.704 -0.622 . . . . 0.0 111.858 -176.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.495 HD13 ' HB3' ' A' ' 94' ' ' ALA . 17.7 mm -108.76 122.38 63.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 122.185 -0.322 . . . . 0.0 110.636 -178.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.2 p -98.08 161.91 13.48 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.826 0.346 . . . . 0.0 111.886 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -56.28 -35.16 67.16 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.441 0.639 . . . . 0.0 110.033 173.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.93 -39.53 93.65 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.374 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.3 mmt -68.88 -43.87 74.43 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.103 0.478 . . . . 0.0 110.857 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.428 ' HB3' HD12 ' A' ' 73' ' ' ILE . 78.7 mt -56.29 -42.64 77.84 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.141 0.496 . . . . 0.0 110.661 174.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.411 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 66.6 ttp85 -60.62 -49.87 75.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.089 176.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.89 -33.53 63.77 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 121.375 -0.44 . . . . 0.0 113.404 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.9 mm -80.6 -40.69 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.415 ' HB3' ' HZ ' ' A' ' 75' ' ' PHE . 26.5 m-85 -85.5 -26.42 26.26 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -175.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 44' ' ' ARG . 1.8 mt-10 -59.2 -38.2 60.92 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -45.88 -20.67 0.78 Allowed 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.171 1.914 . . . . 0.0 113.852 172.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -96.17 -29.56 13.99 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.49 -142.1 3.31 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.831 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 57.8 ttm-85 -103.47 -38.71 7.05 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -177.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.1 mt 69.18 107.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.12 0.568 . . . . 0.0 111.351 -172.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -80.89 -41.09 23.62 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.992 0.425 . . . . 0.0 111.379 -176.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 93.3 p -151.34 142.2 22.92 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.866 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.0 mt -123.58 106.19 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 120.873 0.368 . . . . 0.0 110.782 172.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -99.72 110.97 23.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.849 0.356 . . . . 0.0 110.559 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.419 HD23 ' N ' ' A' ' 59' ' ' MET . 6.7 tt -97.99 133.73 42.07 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.419 ' N ' HD23 ' A' ' 58' ' ' LEU . 55.0 mtp . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 121.363 0.601 . . . . 0.0 110.566 -176.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.7 mttm . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 124.84 -7.4 8.26 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 120.929 -0.653 . . . . 0.0 114.355 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -140.23 152.13 45.72 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 117.45 0.625 . . . . 0.0 112.603 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.02 160.35 28.6 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.812 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -110.7 121.74 46.09 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.547 -0.384 . . . . 0.0 111.477 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.428 HD12 ' HB3' ' A' ' 43' ' ' LEU . 71.8 mt -110.09 119.94 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.966 0.412 . . . . 0.0 111.317 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 45.6 m -100.19 125.55 46.35 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -174.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.415 ' HZ ' ' HB3' ' A' ' 47' ' ' PHE . 82.8 m-85 -106.24 144.86 32.33 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.033 173.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.7 t -69.14 -32.66 72.18 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.103 0.478 . . . . 0.0 110.806 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -108.28 132.52 53.6 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.36 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.4 t -71.21 -35.42 71.52 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -67.29 -44.82 78.31 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.096 0.474 . . . . 0.0 110.832 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 67.4 m -60.46 -36.3 77.92 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.029 0.443 . . . . 0.0 110.751 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.49 -44.63 82.11 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.505 176.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -60.64 -47.27 86.97 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.878 0.37 . . . . 0.0 111.514 176.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.32 -43.08 88.02 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.205 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.6 -53.2 55.39 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.018 0.437 . . . . 0.0 111.112 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.511 HD11 HD22 ' A' ' 29' ' ' LEU . 9.8 tt -53.47 -53.5 50.59 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.456 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.56 -34.64 78.34 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -174.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -88.12 -24.76 23.28 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 89.8 mt -95.36 -13.8 24.42 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -56.52 101.88 0.07 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.241 0.543 . . . . 0.0 110.582 168.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.77 30.56 11.32 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.027 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -92.44 103.98 16.35 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.752 0.31 . . . . 0.0 110.484 173.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -71.01 85.57 0.71 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.395 0.617 . . . . 0.0 111.571 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 61.1 tp -74.57 -68.29 0.55 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.3 0.571 . . . . 0.0 110.907 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.495 ' HB3' HD13 ' A' ' 38' ' ' ILE . . . -86.56 38.17 0.77 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.336 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.19 21.81 66.5 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.22 -173.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 28.4 mtp-105 -139.28 141.74 30.26 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 122.86 0.464 . . . . 0.0 110.553 -175.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -52.97 142.01 54.59 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.265 2.644 . . . . 0.0 113.823 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 52.0 tpp -98.9 123.02 42.89 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.984 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -99.92 102.21 13.54 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 122.398 -0.189 . . . . 0.0 110.661 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 85' ' ' LEU . 26.5 t -118.66 108.24 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.011 0.434 . . . . 0.0 111.626 -178.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -129.06 154.18 20.15 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.005 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 21.8 p80 . . . . . 0 N--CA 1.47 0.55 0 O-C-N 122.213 -0.58 . . . . 0.0 110.902 178.671 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 CA--C 1.543 0.951 0 N-CA-C 113.554 0.559 . . . . 0.0 113.554 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 14.2 tpt -104.08 122.57 45.55 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.256 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -99.47 139.87 34.49 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.81 0.338 . . . . 0.0 111.358 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.0 mt -121.0 129.65 53.48 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.135 0.493 . . . . 0.0 111.406 176.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -91.58 112.83 24.9 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.393 175.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.7 t -103.67 99.76 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.011 0.434 . . . . 0.0 110.745 176.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.8 89.2 0.6 Allowed Glycine 0 CA--C 1.521 0.426 0 C-N-CA 121.003 -0.618 . . . . 0.0 113.107 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.412 ' CB ' ' HA ' ' A' ' 98' ' ' MET . 25.0 t -175.08 25.79 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.445 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 41.9 mt -69.41 107.4 3.31 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.362 -0.836 . . . . 0.0 109.499 176.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.487 ' CE1' ' HB3' ' A' ' 96' ' ' ARG . 29.3 m-70 -78.5 44.78 0.53 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -173.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 60.83 16.79 7.13 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.786 0.434 . . . . 0.0 111.988 -177.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -146.09 -33.52 0.32 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.6 mm -60.9 131.81 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.985 0.422 . . . . 0.0 111.788 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 74.7 p -116.63 169.57 9.25 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.048 0.452 . . . . 0.0 111.756 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.445 ' H ' HD13 ' A' ' 58' ' ' LEU . 2.3 pt-20 -61.73 -28.12 69.2 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.852 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -60.84 -40.0 91.17 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.937 0.399 . . . . 0.0 111.53 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.8 mtt -65.66 -53.66 38.18 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.255 0.55 . . . . 0.0 110.417 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.43 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 43.6 mt -56.15 -55.06 37.68 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.052 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -49.01 -46.78 44.54 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.576 176.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.46 -33.39 81.14 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 121.325 -0.464 . . . . 0.0 113.844 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 59.6 mt -86.3 -40.16 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.43 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 54.1 m-85 -77.73 -31.78 52.4 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.482 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 2.8 tm-20 -52.18 -48.6 88.42 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 90.5 Cg_exo -45.6 -28.81 4.64 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 122.538 2.159 . . . . 0.0 113.963 175.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -83.72 -47.97 10.63 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.907 0.384 . . . . 0.0 111.365 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.32 149.0 13.25 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 112.043 -0.423 . . . . 0.0 112.043 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.73 115.38 5.82 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.856 0.36 . . . . 0.0 110.793 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.465 HD12 ' H ' ' A' ' 53' ' ' ILE . 3.6 mp -66.97 138.55 22.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 120.939 0.399 . . . . 0.0 112.03 -178.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -80.3 -55.65 4.76 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.09 0.472 . . . . 0.0 110.817 173.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.5 p -151.33 140.72 21.47 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.78 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.455 HG13 HG22 ' A' ' 53' ' ' ILE . 49.2 mt -116.77 140.48 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 120.948 0.404 . . . . 0.0 110.511 172.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.431 HE21 ' HA ' ' A' ' 57' ' ' GLN . 0.1 OUTLIER -129.37 121.22 26.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.185 -179.113 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.445 HD13 ' H ' ' A' ' 40' ' ' GLU . 70.4 mt -96.68 130.49 43.9 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.724 0.297 . . . . 0.0 110.292 173.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 92.3 mmm . . . . . 0 CA--C 1.536 0.415 0 CA-C-O 121.275 0.56 . . . . 0.0 111.068 -177.921 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.4 mttt . . . . . 0 N--CA 1.469 0.492 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 95.56 6.25 59.77 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 114.855 0.702 . . . . 0.0 114.855 173.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -149.94 156.52 41.88 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.312 1.056 . . . . 0.0 112.907 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.64 161.12 28.89 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.73 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -115.06 139.04 50.2 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 122.461 -0.435 . . . . 0.0 111.656 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 60.4 mt -122.65 144.26 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.723 0.297 . . . . 0.0 111.185 178.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.6 m -115.76 134.05 55.41 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -126.08 147.83 49.49 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.839 0.352 . . . . 0.0 111.331 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.0 m -93.38 13.26 22.08 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 120.899 0.38 . . . . 0.0 111.31 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.6 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 15.6 t70 -142.82 109.14 5.29 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.929 0.395 . . . . 0.0 110.698 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.0 m -66.32 -31.51 72.34 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -176.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -65.72 -57.73 7.34 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.788 0.328 . . . . 0.0 111.322 -176.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.6 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 31.2 p -58.06 -38.51 76.47 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.927 0.394 . . . . 0.0 111.144 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.52 -41.16 98.5 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.555 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -60.41 -44.18 95.98 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.944 0.402 . . . . 0.0 110.699 176.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -65.14 -47.46 77.0 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.349 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.15 -51.82 55.6 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.13 0.491 . . . . 0.0 110.934 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 100' ' ' VAL . 9.3 tt -55.51 -53.48 55.83 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.92 176.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -62.62 -28.44 69.9 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -174.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.594 ' N ' HE21 ' A' ' 87' ' ' GLN . 0.0 OUTLIER -89.96 -38.26 13.78 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.011 -0.431 . . . . 0.0 111.944 -179.008 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.417 ' HB3' ' HE2' ' A' ' 98' ' ' MET . 73.5 mt -92.24 -23.3 19.38 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -172.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -69.83 101.02 1.63 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.133 0.492 . . . . 0.0 110.837 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 117.25 -14.81 13.43 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 -173.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -70.57 125.5 27.0 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.835 0.35 . . . . 0.0 110.679 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -77.95 90.43 4.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.204 0.526 . . . . 0.0 112.046 -177.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.5 tp -81.14 132.1 35.34 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.727 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 62.13 25.1 15.01 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.074 0.464 . . . . 0.0 111.372 -176.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.8 32.66 53.22 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.12 -0.491 . . . . 0.0 113.221 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.487 ' HB3' ' CE1' ' A' ' 35' ' ' HIS . 55.7 ttt180 -159.09 131.62 4.41 Favored Pre-proline 0 CA--C 1.545 0.763 0 O-C-N 122.619 -0.342 . . . . 0.0 110.472 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -48.96 127.73 17.67 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 C-N-CA 123.557 2.838 . . . . 0.0 115.095 -172.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.417 ' HE2' ' HB3' ' A' ' 88' ' ' LEU . 50.1 ttp -99.56 117.88 34.92 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.723 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -89.49 105.7 17.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.908 0.385 . . . . 0.0 111.787 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.403 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 39.8 t -106.99 99.18 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 121.029 0.442 . . . . 0.0 111.159 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -107.89 162.4 13.2 Favored Glycine 0 C--O 1.223 -0.558 0 N-CA-C 112.136 -0.386 . . . . 0.0 112.136 178.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 . . . . . 0 N--CA 1.475 0.779 0 CA-C-N 117.78 0.79 . . . . 0.0 110.616 177.307 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo . . . . . 0 CA--C 1.541 0.859 0 CA-C-O 120.963 0.318 . . . . 0.0 111.997 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 13.4 tpt -98.96 128.98 45.24 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.81 0.338 . . . . 0.0 110.809 -176.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -109.45 128.46 55.17 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.887 0.375 . . . . 0.0 111.28 -173.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.4 mt -100.06 144.94 28.51 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.223 0.535 . . . . 0.0 111.555 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -108.71 105.9 15.7 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.049 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.594 HG22 HG22 ' A' ' 100' ' ' VAL . 46.5 t -99.77 98.15 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.716 176.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.97 88.95 0.47 Allowed Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.761 -176.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.4 p -175.99 29.22 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.124 0.488 . . . . 0.0 110.991 176.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 30.9 mt -86.9 130.45 34.46 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.429 -174.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -83.24 63.1 7.03 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.289 0.566 . . . . 0.0 112.161 -174.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 55.29 8.92 0.31 Allowed 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -163.52 69.32 0.21 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.137 0.494 . . . . 0.0 112.043 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.0 mm -130.67 118.7 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 169.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.513 ' OG1' ' SD ' ' A' ' 42' ' ' MET . 14.6 p -91.08 163.35 14.33 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.312 0.577 . . . . 0.0 112.464 -172.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -61.07 -30.05 70.11 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.635 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.64 -47.66 71.86 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.378 -177.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.513 ' SD ' ' OG1' ' A' ' 39' ' ' THR . 1.3 mpt? -61.64 -48.39 81.08 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.101 0.477 . . . . 0.0 110.825 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.412 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 77.9 mt -54.62 -50.65 67.57 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.308 177.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.445 ' HG2' ' HG3' ' A' ' 48' ' ' GLU . 30.1 ttp-105 -52.63 -52.82 53.74 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.839 0.352 . . . . 0.0 110.887 178.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -54.81 -31.07 54.04 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 116.102 -0.499 . . . . 0.0 113.712 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.6 mt -79.68 -41.62 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 O-C-N 122.514 -0.404 . . . . 0.0 111.818 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.412 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 19.0 m-85 -82.66 -26.25 32.32 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -175.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.445 ' HG3' ' HG2' ' A' ' 44' ' ' ARG . 32.4 mt-10 -54.79 -47.57 97.85 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -178.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -48.79 -20.85 3.12 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.692 2.262 . . . . 0.0 114.686 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -82.12 -38.43 24.79 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.918 -0.489 . . . . 0.0 111.413 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -162.96 -99.89 0.14 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.681 -0.567 . . . . 0.0 111.681 176.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.7 ttp180 -162.76 153.7 17.18 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.768 0.318 . . . . 0.0 110.144 171.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.485 HG22 HG13 ' A' ' 56' ' ' ILE . 1.7 mp -84.12 139.94 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.126 0.488 . . . . 0.0 111.997 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -96.01 -60.51 1.62 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 174.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.3 t -150.63 126.62 10.47 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.251 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.527 HG23 HG12 ' A' ' 73' ' ' ILE . 54.8 mt -99.66 150.36 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 120.833 0.349 . . . . 0.0 111.284 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -149.82 134.8 17.9 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.683 0.278 . . . . 0.0 110.695 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.2 mt -97.28 142.68 28.87 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.739 0.304 . . . . 0.0 110.512 173.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.482 ' HB3' ' HB2' ' A' ' 70' ' ' TYR . 13.0 tpt . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 121.306 0.574 . . . . 0.0 109.788 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp . . . . . 0 CA--C 1.54 0.594 0 CA-C-O 121.032 0.444 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.23 15.29 48.45 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 116.165 -0.47 . . . . 0.0 113.732 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.482 ' HB2' ' HB3' ' A' ' 59' ' ' MET . 4.3 m-85 -130.79 160.85 33.15 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 122.475 -0.426 . . . . 0.0 111.546 -178.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.4 135.73 5.34 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 121.439 -0.41 . . . . 0.0 112.901 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -106.94 115.11 29.62 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 122.347 -0.502 . . . . 0.0 111.581 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 56' ' ' ILE . 58.7 mt -111.27 123.79 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.868 0.366 . . . . 0.0 111.344 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.5 m -99.68 131.32 45.75 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -176.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.421 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 80.9 m-85 -117.11 151.5 36.71 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.941 0.496 . . . . 0.0 111.327 177.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.6 t -73.72 -34.92 65.0 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.101 0.477 . . . . 0.0 110.924 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -100.28 124.98 46.41 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.825 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 63.3 m -60.42 -37.11 79.81 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.316 176.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -71.2 -50.47 32.78 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.886 -177.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 96.2 m -54.35 -41.4 69.07 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 120.915 0.388 . . . . 0.0 111.144 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -61.66 -47.58 84.72 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.159 175.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.705 ' HB3' ' HZ2' ' A' ' 82' ' ' LYS . 6.8 ttpm? -63.56 -32.8 74.37 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.534 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -68.67 -48.4 64.03 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.734 0.302 . . . . 0.0 110.635 176.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.79 -46.96 67.86 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.202 0.525 . . . . 0.0 110.499 174.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.8 tt -57.96 -54.37 47.66 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.946 174.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -57.87 -31.64 66.9 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.378 -174.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.618 ' N ' HE21 ' A' ' 87' ' ' GLN . 0.0 OUTLIER -92.52 -43.46 9.15 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.147 -0.346 . . . . 0.0 111.931 -178.465 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 84.5 mt -85.1 -22.39 28.92 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -171.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -63.41 104.29 0.61 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.085 0.469 . . . . 0.0 110.174 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 110.11 -11.93 31.57 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.881 -177.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -65.69 127.47 32.06 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.856 0.36 . . . . 0.0 111.819 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -89.23 100.85 13.55 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.996 0.427 . . . . 0.0 110.935 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 60.1 tp -86.28 -81.33 0.22 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.937 0.399 . . . . 0.0 111.732 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.86 52.33 2.44 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.866 0.365 . . . . 0.0 111.124 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.11 15.56 58.67 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.453 -174.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -135.68 140.56 34.15 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 122.945 0.498 . . . . 0.0 110.591 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.23 145.35 98.73 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.829 2.352 . . . . 0.0 113.081 176.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.431 ' HG2' HG21 ' A' ' 100' ' ' VAL . 46.9 ttm -99.09 108.76 21.48 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.287 175.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -89.09 93.13 9.48 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.857 0.36 . . . . 0.0 111.276 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.594 HG22 HG22 ' A' ' 31' ' ' VAL . 44.8 t -105.38 105.74 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.706 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -115.61 154.47 16.9 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.367 -0.444 . . . . 0.0 112.231 176.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 14.6 p80 . . . . . 0 N--CA 1.475 0.775 0 CA-C-N 117.755 0.777 . . . . 0.0 111.83 -179.623 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo . . . . . 0 CA--C 1.541 0.853 0 N-CA-C 113.262 0.447 . . . . 0.0 113.262 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 26.9 ttt -126.65 125.51 42.02 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.847 0.356 . . . . 0.0 111.558 -178.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 74' ' ' THR . 11.1 ttp180 -98.85 138.14 36.41 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.153 0.501 . . . . 0.0 111.373 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.56 HD22 HD11 ' A' ' 85' ' ' LEU . 23.6 mt -117.04 146.83 42.83 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.247 -172.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 55.7 t80 -89.85 115.6 27.3 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 122.781 0.432 . . . . 0.0 110.961 175.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.6 t -111.6 98.84 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.107 0.48 . . . . 0.0 110.943 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.88 96.15 1.14 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.406 -0.426 . . . . 0.0 113.76 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.4 t -174.73 9.85 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.3 mt -69.12 93.33 0.59 Allowed 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.728 -0.607 . . . . 0.0 111.19 -172.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -76.67 69.09 3.02 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -175.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 47.0 t80 53.15 39.86 30.31 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 172.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -171.03 -31.58 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.3 mm -64.66 95.28 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.13 0.49 . . . . 0.0 111.327 -178.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.8 p -92.47 -178.37 4.89 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.49 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.486 ' HG3' HD11 ' A' ' 58' ' ' LEU . 2.1 mp0 -52.57 -40.52 62.7 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.065 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.65 -52.32 62.68 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.583 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 20.8 mmt -62.29 -52.51 63.39 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.438 0.637 . . . . 0.0 110.676 -177.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.462 ' HB3' HD13 ' A' ' 73' ' ' ILE . 61.7 mt -55.34 -49.96 70.88 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.613 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -57.21 -50.57 72.44 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.392 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.26 -31.12 62.0 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.369 -0.444 . . . . 0.0 113.857 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.7 mt -85.15 -37.56 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -85.08 -32.3 22.91 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -173.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -59.64 -36.98 45.49 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -46.76 -19.48 0.77 Allowed 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 122.144 1.896 . . . . 0.0 113.847 171.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -90.83 -35.44 14.81 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.781 0.324 . . . . 0.0 111.262 174.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.403 ' HA3' ' SG ' ' A' ' 80' ' ' CYS . . . -172.85 -123.08 0.7 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.413 -0.422 . . . . 0.0 112.742 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -149.54 128.22 12.43 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 122.282 -0.54 . . . . 0.0 110.681 177.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.483 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.7 mp -87.33 138.98 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.765 -176.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -81.42 -48.57 11.73 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.048 0.452 . . . . 0.0 111.104 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 96.0 p -148.98 143.4 26.11 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.356 -178.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.509 HG22 HG12 ' A' ' 73' ' ' ILE . 52.1 mt -121.3 104.74 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 120.997 0.427 . . . . 0.0 110.709 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -102.75 111.76 24.22 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -175.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.486 HD11 ' HG3' ' A' ' 40' ' ' GLU . 7.8 mp -98.51 139.68 33.87 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.919 -0.488 . . . . 0.0 110.89 177.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.598 ' HA ' ' HE2' ' A' ' 59' ' ' MET . 18.2 mmt . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 121.072 0.463 . . . . 0.0 111.03 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.639 ' HZ3' ' HB3' ' A' ' 68' ' ' LYS . 8.0 mtpm? . . . . . 0 CA--C 1.54 0.584 0 CA-C-O 120.804 0.335 . . . . 0.0 111.58 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.48 2.29 61.83 Favored Glycine 0 CA--C 1.531 1.094 0 N-CA-C 115.108 0.803 . . . . 0.0 115.108 173.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.524 ' CE2' ' HG3' ' A' ' 59' ' ' MET . 34.1 p90 -143.11 148.98 37.5 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.122 0.961 . . . . 0.0 112.542 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -138.3 146.76 18.62 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.48 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 95.2 m-85 -100.18 121.76 41.95 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 122.594 -0.356 . . . . 0.0 111.523 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.509 HG12 HG22 ' A' ' 56' ' ' ILE . 77.8 mt -110.36 125.03 67.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 120.794 0.331 . . . . 0.0 111.596 -178.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 27.2 m -101.35 120.6 40.51 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -175.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.425 ' HB2' ' HB3' ' A' ' 81' ' ' ALA . 70.3 m-85 -100.08 152.05 20.68 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.325 173.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.7 t -75.46 -14.4 60.43 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.891 0.377 . . . . 0.0 111.685 -177.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -136.46 138.85 41.88 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.689 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.9 t -70.02 -27.34 64.59 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -80.97 -40.94 23.62 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.772 -0.58 . . . . 0.0 110.509 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.403 ' SG ' ' HA3' ' A' ' 51' ' ' GLY . 50.4 t -61.46 -39.26 90.21 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.123 0.487 . . . . 0.0 110.349 169.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.427 ' HB1' HD23 ' A' ' 29' ' ' LEU . . . -60.49 -48.69 80.67 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.228 174.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -68.39 -24.98 64.83 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 111.625 0.232 . . . . 0.0 111.625 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -63.6 -55.57 22.69 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.295 0.569 . . . . 0.0 110.104 175.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.67 -51.83 67.72 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.828 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.56 HD11 HD22 ' A' ' 29' ' ' LEU . 6.4 tt -49.11 -63.85 0.98 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.444 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.45 ' HA ' HD22 ' A' ' 89' ' ' ASN . 6.7 mm-40 -67.01 -20.92 65.95 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -172.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -94.95 -14.71 24.18 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.522 ' HB3' ' HE2' ' A' ' 98' ' ' MET . 94.1 mt -110.21 -14.71 14.14 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -176.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.459 ' ND2' HD22 ' A' ' 85' ' ' LEU . 10.0 p30 -69.3 97.13 0.92 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.876 0.846 . . . . 0.0 111.178 176.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.96 -2.1 22.84 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.168 -174.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -64.97 127.31 31.06 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 122.592 0.357 . . . . 0.0 111.147 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -76.88 96.26 4.28 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.33 0.586 . . . . 0.0 110.987 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.8 tp -98.34 120.71 39.23 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.463 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 58.35 20.24 7.12 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.03 0.443 . . . . 0.0 112.116 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.87 8.13 58.29 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 116.203 -0.453 . . . . 0.0 113.436 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -130.88 132.23 23.76 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.592 -0.357 . . . . 0.0 110.906 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.53 133.09 49.66 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 122.341 2.028 . . . . 0.0 112.793 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.522 ' HE2' ' HB3' ' A' ' 88' ' ' LEU . 44.0 ttp -99.06 116.91 32.38 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.099 0.476 . . . . 0.0 111.538 -177.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -89.98 103.72 16.36 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.896 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.456 HG12 ' HG ' ' A' ' 85' ' ' LEU . 21.6 t -113.93 112.83 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.596 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -151.47 78.24 0.21 Allowed Glycine 0 CA--C 1.534 1.225 0 C-N-CA 119.951 -1.119 . . . . 0.0 115.169 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 27.0 p80 . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 174.658 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo . . . . . 0 CA--C 1.542 0.886 0 CA-C-O 121.4 0.5 . . . . 0.0 112.946 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -99.77 142.68 30.93 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.586 -178.641 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.548 ' N ' ' SD ' ' A' ' 27' ' ' MET . 34.2 ttm105 -118.58 116.54 26.83 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.997 0.427 . . . . 0.0 112.026 -175.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.516 HD22 HD13 ' A' ' 85' ' ' LEU . 73.3 mt -99.45 128.38 45.56 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.562 178.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -91.49 114.9 27.55 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.131 0.491 . . . . 0.0 111.13 175.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.1 t -107.21 107.83 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.246 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.7 89.53 0.54 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.613 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.5 p -175.09 18.02 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 120.923 0.392 . . . . 0.0 111.976 176.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.526 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 17.8 mt -83.3 81.22 8.8 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.986 -0.447 . . . . 0.0 111.372 -173.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -78.14 75.7 4.67 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 121.188 0.518 . . . . 0.0 112.313 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 16.3 p90 39.25 26.53 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 176.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -140.28 8.89 2.26 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 122.0 -0.437 . . . . 0.0 111.501 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.445 ' N ' HD13 ' A' ' 38' ' ' ILE . 3.7 mp -118.48 123.91 72.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.596 -177.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 57.3 p -105.83 175.55 5.46 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -54.55 -49.2 70.86 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.729 176.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -73.15 -19.0 61.22 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -174.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.4 tpt -70.51 -54.77 10.9 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 172.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.3 mt -59.21 -55.76 30.78 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.781 175.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -53.89 -35.27 61.42 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.498 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.32 -35.71 92.3 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.137 -0.554 . . . . 0.0 113.073 177.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.8 mt -86.21 -38.5 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-O 120.998 0.428 . . . . 0.0 111.985 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.411 ' HB3' ' HZ ' ' A' ' 75' ' ' PHE . 35.0 m-85 -79.59 -44.63 20.69 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -173.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.414 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 27.1 tt0 -64.84 -32.35 6.68 Favored Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -172.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 48' ' ' GLU . 89.1 Cg_exo -47.89 -22.86 3.65 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.124 1.883 . . . . 0.0 113.629 169.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -77.26 -23.37 51.22 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 122.149 -0.345 . . . . 0.0 111.698 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.756 ' HA3' ' SG ' ' A' ' 80' ' ' CYS . . . -177.89 -100.06 0.13 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.46 175.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.66 130.4 6.59 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.097 0.475 . . . . 0.0 111.481 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.3 mt -111.04 140.82 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.699 -174.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -90.77 -62.36 1.47 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.847 0.356 . . . . 0.0 111.787 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.5 t -145.7 147.65 32.18 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.874 0.369 . . . . 0.0 111.623 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.54 HG12 HG21 ' A' ' 73' ' ' ILE . 55.2 mt -123.88 125.23 70.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.076 0.465 . . . . 0.0 110.852 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -108.89 117.39 34.07 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.879 0.371 . . . . 0.0 110.952 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 82.1 mt -98.42 136.63 38.29 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.75 0.309 . . . . 0.0 110.665 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 22.4 mmt . . . . . 0 C--O 1.236 0.383 0 CA-C-O 121.738 0.78 . . . . 0.0 112.196 -175.813 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm . . . . . 0 N--CA 1.471 0.624 0 CA-C-O 120.947 0.403 . . . . 0.0 111.488 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 111.05 13.06 14.23 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.818 -0.705 . . . . 0.0 114.555 175.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -149.82 156.11 41.24 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.59 0.695 . . . . 0.0 111.757 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.91 160.54 28.67 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.418 -0.42 . . . . 0.0 113.064 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -112.61 121.35 44.53 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.768 0.318 . . . . 0.0 111.402 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.54 HG21 HG12 ' A' ' 56' ' ' ILE . 67.3 mt -103.69 133.92 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.811 0.338 . . . . 0.0 111.323 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 68.1 m -110.14 118.37 36.21 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.457 ' HB2' ' HB3' ' A' ' 81' ' ' ALA . 31.3 m-85 -99.09 150.72 21.73 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.163 175.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.2 t -82.67 1.78 36.77 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.012 0.434 . . . . 0.0 111.565 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -142.28 135.85 29.18 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.041 0.448 . . . . 0.0 111.35 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.8 t -65.72 -47.84 73.96 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -71.7 -35.42 70.22 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.246 -0.284 . . . . 0.0 111.495 -176.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.756 ' SG ' ' HA3' ' A' ' 51' ' ' GLY . 43.9 t -59.38 -44.65 92.74 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.118 0.485 . . . . 0.0 110.918 173.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . . . -65.53 -47.53 75.59 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.678 177.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.8 ttpp -60.76 -34.21 74.11 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.823 0.344 . . . . 0.0 111.349 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -66.43 -49.25 67.39 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.912 0.387 . . . . 0.0 110.919 176.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.02 -44.7 87.45 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.127 0.489 . . . . 0.0 111.169 176.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.516 HD13 HD22 ' A' ' 29' ' ' LEU . 8.6 tt -56.76 -59.08 5.55 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.987 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.93 -25.18 67.43 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -173.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -89.68 -31.12 17.64 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 122.032 -0.418 . . . . 0.0 112.056 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.437 ' HB3' ' HE1' ' A' ' 98' ' ' MET . 79.0 mt -103.24 -6.74 21.78 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -175.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -66.07 92.37 0.17 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.221 0.534 . . . . 0.0 110.614 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 115.07 3.18 21.66 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.943 -176.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.424 ' HB3' ' HE2' ' A' ' 98' ' ' MET . 90.3 t80 -64.63 135.79 56.31 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.589 0.355 . . . . 0.0 111.709 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -70.13 79.87 0.51 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.177 0.513 . . . . 0.0 111.383 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.558 HD21 ' SD ' ' A' ' 98' ' ' MET . 56.8 tp -84.33 118.49 24.25 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.907 0.384 . . . . 0.0 111.657 -177.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 57.15 26.86 12.63 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 176.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.44 11.39 59.61 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 116.075 -0.512 . . . . 0.0 113.4 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -145.49 139.81 15.27 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 122.478 0.311 . . . . 0.0 110.807 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -55.41 136.73 75.07 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.491 2.127 . . . . 0.0 112.887 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.558 ' SD ' HD21 ' A' ' 93' ' ' LEU . 44.8 ttp -98.67 118.45 35.42 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.229 0.538 . . . . 0.0 111.395 -176.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -88.98 96.31 10.67 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.333 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 18.7 t -104.71 105.91 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.993 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -133.22 151.8 20.19 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.451 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.5 p80 . . . . . 0 N--CA 1.47 0.556 0 O-C-N 122.29 -0.535 . . . . 0.0 110.904 177.717 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 CA--C 1.539 0.735 0 CA-C-O 120.95 0.312 . . . . 0.0 111.969 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 14.3 tpt -102.9 131.64 49.67 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.887 0.375 . . . . 0.0 111.922 -172.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.8 ttm-85 -102.72 118.46 36.89 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.856 0.36 . . . . 0.0 110.896 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 76.0 mt -102.68 150.57 23.31 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.281 0.562 . . . . 0.0 111.829 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -105.59 131.43 52.99 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.299 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.6 t -125.94 106.44 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.569 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -125.38 88.52 0.37 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.829 -176.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.452 ' OG ' ' HA ' ' A' ' 98' ' ' MET . 89.6 p -175.79 23.71 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.97 0.414 . . . . 0.0 111.41 178.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.535 ' HB3' HG13 ' A' ' 38' ' ' ILE . 53.4 mt -83.64 166.86 17.8 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.198 -176.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.426 ' ND1' ' O ' ' A' ' 35' ' ' HIS . 33.6 p80 -141.85 80.44 1.72 Allowed 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 60.1 t80 50.61 8.34 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -143.34 52.59 1.35 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.091 -1.005 . . . . 0.0 110.535 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.535 HG13 ' HB3' ' A' ' 34' ' ' LEU . 30.1 mm -133.24 125.08 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.625 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.42 ' OG1' ' HG3' ' A' ' 42' ' ' MET . 41.8 p -108.03 158.88 17.01 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.861 0.362 . . . . 0.0 111.835 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -54.9 -32.04 60.62 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.108 0.48 . . . . 0.0 110.742 172.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -62.64 -42.41 99.58 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.527 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.431 ' SD ' ' HA ' ' A' ' 38' ' ' ILE . 59.0 mtt -64.06 -55.41 22.37 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.538 0.685 . . . . 0.0 110.686 179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.434 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 45.6 mt -56.72 -54.83 41.7 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.357 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -53.13 -47.88 68.34 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.314 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.09 -30.22 75.01 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 121.305 -0.474 . . . . 0.0 113.741 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 74.1 mt -82.98 -40.46 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 O-C-N 122.377 -0.484 . . . . 0.0 112.23 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.478 ' HB3' ' HE2' ' A' ' 75' ' ' PHE . 77.2 m-85 -85.77 -30.78 22.78 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -173.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.4 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 30.1 mt-10 -55.32 -41.63 91.75 Favored Pre-proline 0 N--CA 1.484 1.226 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 48' ' ' GLU . 51.7 Cg_exo -41.09 -39.29 3.5 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 122.378 2.052 . . . . 0.0 113.058 172.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -76.65 -57.67 3.72 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.067 0.46 . . . . 0.0 110.881 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -157.98 135.01 4.12 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.017 -175.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -56.3 122.26 11.41 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 122.6 0.36 . . . . 0.0 111.236 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 53' ' ' ILE . 2.9 mp -79.6 135.27 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.148 0.499 . . . . 0.0 111.911 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -87.74 -51.05 6.08 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.148 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.8 m -150.41 140.34 21.92 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.812 0.339 . . . . 0.0 111.877 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.51 HG23 HG12 ' A' ' 73' ' ' ILE . 53.8 mt -116.66 140.58 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.911 177.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -136.86 110.19 7.88 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.716 0.293 . . . . 0.0 111.764 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.417 HD12 ' N ' ' A' ' 58' ' ' LEU . 5.1 mp -99.57 150.66 22.01 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.648 0.261 . . . . 0.0 110.391 175.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.423 ' HG3' ' CE2' ' A' ' 70' ' ' TYR . 20.4 mmt . . . . . 0 N--CA 1.467 0.382 0 CA-C-O 121.569 0.699 . . . . 0.0 112.747 -177.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.4 mttp . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.81 6.62 18.91 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.502 -0.856 . . . . 0.0 115.018 174.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.423 ' CE2' ' HG3' ' A' ' 59' ' ' MET . 35.3 p90 -130.24 147.84 52.01 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.156 0.978 . . . . 0.0 111.824 176.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -149.52 160.24 28.38 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 116.097 -0.501 . . . . 0.0 113.315 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -113.68 139.05 49.38 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.659 0.383 . . . . 0.0 110.999 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.51 HG12 HG23 ' A' ' 56' ' ' ILE . 75.0 mt -124.11 125.67 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.795 0.331 . . . . 0.0 111.447 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.9 m -99.53 118.24 35.66 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.885 0.374 . . . . 0.0 111.549 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.478 ' HE2' ' HB3' ' A' ' 47' ' ' PHE . 43.8 m-85 -99.64 150.08 22.64 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.313 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.1 t -75.77 -18.74 59.42 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.113 0.482 . . . . 0.0 111.067 173.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -110.06 152.81 25.49 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.076 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.1 p -100.41 -59.86 1.63 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 120.967 0.413 . . . . 0.0 112.081 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -65.36 -39.87 92.88 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -175.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 77.9 m -61.6 -31.03 71.08 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.08 0.467 . . . . 0.0 110.541 174.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.32 -33.93 67.71 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.845 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -54.6 -50.44 68.05 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.019 0.438 . . . . 0.0 110.181 172.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.475 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . 6.9 ttpm? -64.48 -40.95 96.64 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.033 177.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.4 -41.64 69.52 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.358 0.599 . . . . 0.0 110.934 176.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 tt -63.91 -62.73 1.45 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.664 177.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' A' ' 83' ' ' LYS . 14.8 pt-20 -66.42 -18.37 65.32 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.497 -173.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -86.2 -40.97 15.06 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.746 0.308 . . . . 0.0 111.554 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 81.2 mt -97.38 -13.2 21.99 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -168.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' A' ' 86' ' ' GLU . 10.7 p30 -65.41 81.12 0.06 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 121.699 0.761 . . . . 0.0 111.705 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 141.88 -14.52 2.63 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.706 -175.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -65.72 135.03 54.41 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 122.939 0.496 . . . . 0.0 111.302 177.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -82.74 104.82 13.27 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.099 0.475 . . . . 0.0 112.073 -177.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.6 tp -101.63 128.25 48.0 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.277 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 61.05 22.78 13.01 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.051 0.453 . . . . 0.0 111.243 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 85.78 12.05 72.67 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 116.135 -0.484 . . . . 0.0 113.37 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.7 ttt85 -134.96 134.13 21.54 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 122.52 -0.4 . . . . 0.0 110.631 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -53.64 142.15 61.69 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.922 2.415 . . . . 0.0 113.38 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.452 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 44.9 ttm -99.34 114.43 27.3 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.309 -177.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -89.69 97.82 11.42 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.959 0.409 . . . . 0.0 110.936 177.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.2 t -103.9 127.52 57.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.499 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -150.0 159.38 28.08 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.543 175.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 11.0 p80 . . . . . 0 N--CA 1.472 0.651 0 O-C-N 122.208 -0.583 . . . . 0.0 111.002 177.152 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 51.3 Cg_exo . . . . . 0 CA--C 1.544 1.018 0 N-CA-C 114.083 0.763 . . . . 0.0 114.083 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 28.1 ttt -100.66 133.83 44.52 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.319 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.3 ttm-85 -111.19 129.39 55.97 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.984 0.421 . . . . 0.0 111.873 -174.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 80.5 mt -103.8 142.7 33.92 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.497 0.665 . . . . 0.0 111.9 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -99.69 113.36 25.76 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.198 175.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -116.93 115.4 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -175.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.72 104.37 1.37 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.656 -0.307 . . . . 0.0 113.685 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.537 ' HB2' ' HA ' ' A' ' 98' ' ' MET . 23.9 t -174.82 20.99 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.357 0.599 . . . . 0.0 111.268 175.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.9 mt -93.49 91.85 7.33 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.805 -174.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -80.1 61.51 3.98 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -174.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 22.6 t80 50.29 41.23 24.07 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.641 0.734 . . . . 0.0 110.979 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -149.9 -50.8 0.14 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.754 -171.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.413 HD12 ' HB2' ' A' ' 94' ' ' ALA . 60.8 mt -78.96 133.97 28.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.239 -172.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.3 p -114.27 178.37 4.31 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.198 0.523 . . . . 0.0 112.087 -177.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.424 ' HG3' ' CD1' ' A' ' 58' ' ' LEU . 2.1 mp0 -50.41 -45.35 55.6 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.881 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -55.87 -44.6 78.27 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.577 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.422 ' O ' HG12 ' A' ' 46' ' ' ILE . 12.5 tpt -66.49 -49.9 65.06 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.185 0.517 . . . . 0.0 110.29 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.433 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 71.4 mt -54.25 -53.54 52.2 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.093 176.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.2 ttm105 -51.01 -43.21 60.79 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.536 176.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.96 -28.22 71.64 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.349 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 42' ' ' MET . 42.4 mm -85.17 -37.26 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 120.911 0.386 . . . . 0.0 111.929 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.433 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 46.8 m-85 -86.17 -28.03 24.18 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -174.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -57.7 -38.1 63.48 Favored Pre-proline 0 N--CA 1.484 1.268 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -47.92 -19.9 1.75 Allowed 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 122.086 1.857 . . . . 0.0 113.581 170.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -94.75 -46.66 6.82 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.808 0.337 . . . . 0.0 111.527 175.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.47 -133.5 1.49 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.595 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -129.77 143.8 50.99 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 122.089 -0.654 . . . . 0.0 111.427 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.517 HG22 HG13 ' A' ' 56' ' ' ILE . 2.4 mp -94.97 138.69 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.017 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -95.45 -45.33 7.15 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.911 0.386 . . . . 0.0 111.064 174.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.2 t -152.14 147.03 25.96 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.506 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.527 HG12 HG21 ' A' ' 73' ' ' ILE . 51.8 mt -130.46 106.62 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 120.81 0.338 . . . . 0.0 110.863 175.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -108.93 119.98 41.17 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.754 0.311 . . . . 0.0 111.323 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.424 ' CD1' ' HG3' ' A' ' 40' ' ' GLU . 7.2 mp -98.22 141.55 30.99 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.064 0.459 . . . . 0.0 111.538 -177.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.594 ' SD ' ' HE2' ' A' ' 72' ' ' PHE . 56.8 mtp . . . . . 0 CA--C 1.536 0.432 0 CA-C-O 121.432 0.634 . . . . 0.0 111.851 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.564 ' HB2' ' O ' ' A' ' 59' ' ' MET . 57.8 mttp . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 120.887 0.375 . . . . 0.0 110.776 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.44 23.22 8.53 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 114.863 0.705 . . . . 0.0 114.863 172.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.536 ' HE1' ' SD ' ' A' ' 59' ' ' MET . 27.6 p90 -143.49 152.06 41.04 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.775 0.788 . . . . 0.0 112.088 177.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.8 158.13 23.66 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.945 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.594 ' HE2' ' SD ' ' A' ' 59' ' ' MET . 98.2 m-85 -110.02 125.08 52.53 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.831 0.348 . . . . 0.0 111.17 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.527 HG21 HG12 ' A' ' 56' ' ' ILE . 59.9 mt -113.43 135.14 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.593 -178.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.2 m -100.01 133.97 43.62 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.492 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 96.1 m-85 -125.14 143.86 50.72 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.509 0.324 . . . . 0.0 111.27 177.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.2 m -81.48 -5.63 58.14 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 120.745 0.307 . . . . 0.0 111.708 176.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.417 ' HB3' ' HB2' ' A' ' 80' ' ' CYS . 8.4 t0 -124.18 115.84 21.75 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.939 0.399 . . . . 0.0 110.842 -178.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 48.8 m -71.76 -22.27 61.62 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.75 -36.65 15.04 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 72.6 m -66.13 -39.99 90.31 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.963 0.411 . . . . 0.0 110.591 174.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.14 -40.49 82.43 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.033 0.444 . . . . 0.0 110.958 174.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.81 ' HB2' ' HZ3' ' A' ' 82' ' ' LYS . 4.7 ttmp? -62.23 -42.69 99.54 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.081 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.407 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 86.6 tttt -61.45 -50.89 70.96 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.61 0.243 . . . . 0.0 110.478 173.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.12 -40.99 47.73 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.19 0.519 . . . . 0.0 111.055 177.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.3 tt -61.46 -48.34 81.59 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.24 175.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -67.62 -34.2 76.5 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -177.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 83' ' ' LYS . 7.9 mm100 -90.8 -32.84 15.94 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -173.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.0 mt -99.52 -11.26 21.2 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -172.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -65.93 94.89 0.24 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.316 0.579 . . . . 0.0 110.246 176.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 106.8 22.43 7.65 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.177 -173.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.406 ' HB3' ' HE3' ' A' ' 98' ' ' MET . 89.0 t80 -80.92 142.83 33.13 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 122.732 -0.276 . . . . 0.0 111.715 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -75.06 85.06 2.31 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.852 0.358 . . . . 0.0 111.263 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.569 HD23 ' SD ' ' A' ' 98' ' ' MET . 54.9 tp -103.02 124.84 49.28 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.724 0.297 . . . . 0.0 111.292 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.413 ' HB2' HD12 ' A' ' 38' ' ' ILE . . . 59.82 16.19 5.44 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.85 11.12 59.35 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.42 -0.419 . . . . 0.0 113.309 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 96' ' ' ARG . 16.3 mtp180 -133.7 154.97 80.85 Favored Pre-proline 0 N--CA 1.47 0.57 0 O-C-N 122.474 -0.427 . . . . 0.0 111.877 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.57 130.32 23.3 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.779 2.319 . . . . 0.0 112.26 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.569 ' SD ' HD23 ' A' ' 93' ' ' LEU . 48.6 ttp -97.84 125.67 42.82 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.299 0.571 . . . . 0.0 111.851 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -89.1 108.35 19.55 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.489 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.1 t -116.18 122.28 69.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 121.285 0.564 . . . . 0.0 112.053 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -146.1 146.8 17.26 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.959 175.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.3 p80 . . . . . 0 N--CA 1.47 0.554 0 CA-C-N 118.268 1.034 . . . . 0.0 110.93 -176.748 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo . . . . . 0 CA--C 1.541 0.851 0 CA-C-O 120.796 0.248 . . . . 0.0 112.729 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.2 ttt -124.05 145.73 49.03 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.003 0.43 . . . . 0.0 111.547 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -116.62 119.39 35.39 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.677 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.514 HD23 HD12 ' A' ' 85' ' ' LEU . 60.7 mt -99.25 138.41 36.38 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.087 0.47 . . . . 0.0 112.202 -178.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -92.8 107.26 19.08 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.539 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.7 t -101.06 97.91 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.004 0.431 . . . . 0.0 111.14 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.76 88.99 0.83 Allowed Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.629 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.3 t -175.49 24.18 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.993 0.425 . . . . 0.0 111.359 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 43.0 mt -73.79 92.66 2.05 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.879 -0.513 . . . . 0.0 110.517 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -78.98 65.56 4.19 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -174.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 55.23 8.74 0.29 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.919 1.452 . . . . 0.0 114.919 170.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -155.16 8.73 0.29 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.411 0.55 . . . . 0.0 112.244 178.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.6 mm -78.06 131.41 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 121.946 -0.471 . . . . 0.0 110.811 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.454 ' OG1' ' HG3' ' A' ' 42' ' ' MET . 49.4 p -106.01 160.49 15.25 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -177.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -55.09 -38.49 68.17 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.319 0.58 . . . . 0.0 110.556 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -61.04 -41.41 96.53 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.107 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.454 ' HG3' ' OG1' ' A' ' 39' ' ' THR . 66.8 mtt -62.77 -55.52 25.77 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.251 0.548 . . . . 0.0 110.529 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.1 mt -54.59 -46.58 73.81 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.104 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 50.9 ttt85 -60.22 -46.48 89.62 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.502 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.07 -29.71 59.82 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.117 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.7 mm -86.54 -53.16 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.4 ' HB3' ' CZ ' ' A' ' 75' ' ' PHE . 34.0 m-85 -79.83 -36.71 36.46 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -171.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.481 ' HA ' HG13 ' A' ' 53' ' ' ILE . 0.6 OUTLIER -56.43 -48.06 97.75 Favored Pre-proline 0 N--CA 1.482 1.134 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -172.92 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -47.07 -20.93 1.41 Allowed 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.649 2.232 . . . . 0.0 114.248 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -70.91 -51.6 25.1 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 178.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 52' ' ' ARG . . . -173.52 45.77 0.16 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 119.652 -1.261 . . . . 0.0 115.176 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.415 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 73.1 ttt180 72.19 137.19 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 172.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.481 HG13 ' HA ' ' A' ' 48' ' ' GLU . 66.0 mt -128.06 133.18 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.316 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -108.15 -48.09 3.43 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -176.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.7 m -126.94 122.06 33.5 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -176.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 51.8 mt -115.65 106.23 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.853 0.359 . . . . 0.0 110.808 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -99.34 116.3 31.2 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.716 0.293 . . . . 0.0 111.524 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.7 mt -99.0 130.73 45.36 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 173.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 85.0 mmm . . . . . 0 CA--C 1.535 0.39 0 CA-C-O 121.34 0.591 . . . . 0.0 111.551 -174.385 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp . . . . . 0 N--CA 1.471 0.578 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.95 4.16 31.53 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.718 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -141.14 154.34 45.83 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.322 0.561 . . . . 0.0 112.072 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.32 161.15 28.85 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.839 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -116.17 122.1 44.06 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.523 -0.398 . . . . 0.0 111.828 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.5 mt -108.75 133.09 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 120.96 0.41 . . . . 0.0 111.592 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.4 m -109.52 123.98 50.32 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.735 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.426 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 7.0 m-85 -106.1 150.62 25.62 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.26 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.6 m -70.86 -11.62 61.06 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.081 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -136.76 122.97 20.48 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.031 0.443 . . . . 0.0 111.518 -178.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.8 m -65.1 -41.72 94.7 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.151 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -64.21 -46.49 83.65 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.024 0.44 . . . . 0.0 111.535 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.9 m -64.3 -38.52 91.34 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.211 177.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.426 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -64.53 -42.69 95.61 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.149 0.499 . . . . 0.0 111.386 176.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.425 ' HE3' ' HB2' ' A' ' 82' ' ' LYS . 37.8 ttmt -60.61 -40.93 93.63 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.943 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.46 -45.47 83.61 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.232 174.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.47 -48.63 68.72 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.203 0.525 . . . . 0.0 110.992 176.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.514 HD12 HD23 ' A' ' 29' ' ' LEU . 9.0 tt -54.49 -56.81 15.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.199 175.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -61.17 -36.43 79.79 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -175.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -79.98 -30.57 39.74 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.191 0.519 . . . . 0.0 111.17 -175.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 64.9 mt -103.31 -4.18 24.58 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -176.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -64.81 98.19 0.26 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.878 0.37 . . . . 0.0 110.548 175.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.27 0.18 40.83 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.012 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -68.03 125.44 26.33 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 122.618 -0.342 . . . . 0.0 110.739 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -79.62 91.58 5.24 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.224 0.535 . . . . 0.0 110.472 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.5 tp -77.61 -70.62 0.46 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.713 -174.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.79 45.67 1.31 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.2 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.92 8.68 64.71 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.925 -174.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -141.72 144.1 31.65 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 122.794 0.437 . . . . 0.0 110.332 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.95 135.8 51.41 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.227 2.618 . . . . 0.0 113.637 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.6 ttp -103.23 121.01 41.8 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.387 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -89.05 105.12 17.58 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.767 0.318 . . . . 0.0 111.627 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.427 HG13 ' HA ' ' A' ' 85' ' ' LEU . 11.1 t -106.06 105.37 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.737 0.303 . . . . 0.0 110.421 175.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.69 161.65 12.68 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.346 -0.454 . . . . 0.0 113.616 -176.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 179.012 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 56.5 Cg_endo . . . . . 0 CA--C 1.538 0.701 0 N-CA-C 113.21 0.427 . . . . 0.0 113.21 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 13.3 tpt -122.51 138.44 54.56 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.616 176.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.416 ' HD3' ' HB3' ' A' ' 72' ' ' PHE . 36.5 ttm180 -110.94 135.21 51.8 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.07 0.462 . . . . 0.0 111.955 -173.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.9 mt -109.91 137.7 47.33 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.204 0.526 . . . . 0.0 111.945 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -89.94 110.31 21.28 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.524 172.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.7 t -110.71 101.76 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.815 0.34 . . . . 0.0 111.046 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 70' ' ' TYR . . . -113.62 89.72 0.52 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.72 -178.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.41 ' HB2' ' HA ' ' A' ' 98' ' ' MET . 22.6 t -166.39 21.22 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.576 0.703 . . . . 0.0 110.852 176.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.45 ' HB3' ' HB ' ' A' ' 38' ' ' ILE . 18.8 mt -85.72 99.77 11.55 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.704 -176.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.439 ' O ' ' CG ' ' A' ' 35' ' ' HIS . 12.3 p80 -70.01 76.04 0.49 Allowed 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.547 0.689 . . . . 0.0 112.383 -175.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 50.41 16.25 0.26 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 171.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.81 -44.01 0.27 Allowed 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.799 -0.563 . . . . 0.0 112.036 -174.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.569 HD13 ' SD ' ' A' ' 42' ' ' MET . 37.8 mm -49.32 130.86 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -174.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 54.2 p -97.35 170.45 9.06 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.218 0.533 . . . . 0.0 112.158 -176.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.528 ' HG3' HD23 ' A' ' 58' ' ' LEU . 2.6 mp0 -62.59 -38.03 88.54 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.432 175.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.37 -37.81 88.83 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.487 -177.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.569 ' SD ' HD13 ' A' ' 38' ' ' ILE . 28.0 ttt -63.34 -50.5 69.75 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.426 0.632 . . . . 0.0 110.1 177.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.438 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 64.4 mt -56.16 -53.24 59.51 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.257 176.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -52.62 -40.63 62.94 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.383 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.41 -33.96 78.61 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.291 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 63.2 mt -85.08 -44.04 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.472 ' HD2' ' HZ ' ' A' ' 75' ' ' PHE . 36.8 m-85 -80.81 -31.54 35.6 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -173.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.495 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 25.2 tp10 -54.73 -46.75 99.31 Favored Pre-proline 0 N--CA 1.481 1.105 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 73.0 Cg_exo -52.13 -18.68 7.68 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 122.736 2.29 . . . . 0.0 114.318 176.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -82.61 -29.8 29.91 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.079 -0.388 . . . . 0.0 112.029 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.436 ' HA3' ' HB3' ' A' ' 80' ' ' CYS . . . -169.83 -99.25 0.12 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.316 -0.469 . . . . 0.0 112.447 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -166.43 136.98 3.36 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.143 0.497 . . . . 0.0 111.784 173.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.448 HG22 HG13 ' A' ' 56' ' ' ILE . 3.5 mp -96.89 129.26 47.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.311 177.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -77.61 -55.37 5.41 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.455 0.645 . . . . 0.0 110.345 173.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 95.9 p -150.67 150.55 31.25 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.13 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.448 HG13 HG22 ' A' ' 53' ' ' ILE . 60.9 mt -119.77 126.97 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 121.004 0.43 . . . . 0.0 111.212 176.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -101.79 118.4 36.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.981 0.42 . . . . 0.0 110.276 173.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.528 HD23 ' HG3' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -98.34 131.19 44.85 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.5 tpt . . . . . 0 CA--C 1.537 0.45 0 CA-C-O 121.643 0.735 . . . . 0.0 111.047 -171.367 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 120.801 0.334 . . . . 0.0 111.48 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.98 12.64 33.78 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.803 175.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.401 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 2.7 m-85 -121.87 160.56 24.48 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.397 -0.473 . . . . 0.0 110.734 178.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.36 130.51 3.27 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.456 -0.402 . . . . 0.0 112.372 175.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.416 ' HB3' ' HD3' ' A' ' 28' ' ' ARG . 89.4 m-85 -98.99 107.2 19.57 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.06 0.457 . . . . 0.0 111.078 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.42 HD11 ' HB3' ' A' ' 43' ' ' LEU . 69.5 mt -99.49 127.92 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.689 -176.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.9 m -103.25 122.82 45.55 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.007 0.432 . . . . 0.0 111.711 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 44.3 m-85 -99.31 151.45 21.04 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.453 177.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.1 t -76.91 -5.67 49.4 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.735 0.302 . . . . 0.0 111.205 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.499 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 29.0 t70 -142.6 147.62 36.13 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.021 0.439 . . . . 0.0 111.488 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.6 p -72.26 -42.71 65.31 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.054 -178.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -69.13 -38.12 78.69 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.641 0.258 . . . . 0.0 111.359 -177.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.499 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 83.7 m -55.4 -45.5 76.65 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.205 0.526 . . . . 0.0 111.178 175.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.08 -40.99 82.58 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.292 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -58.29 -44.5 88.52 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.072 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -65.23 -49.44 69.66 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.625 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.27 -47.47 72.28 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.945 0.403 . . . . 0.0 111.228 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.8 tt -57.51 -50.7 72.2 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.79 174.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -54.02 -35.09 61.55 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.912 -175.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -93.31 -42.85 9.09 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.487 ' HB3' ' HE2' ' A' ' 98' ' ' MET . 79.7 mt -87.61 -17.21 32.44 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -169.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -71.0 107.98 4.35 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.116 0.484 . . . . 0.0 110.616 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.93 -13.78 37.82 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.245 -174.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -65.67 135.11 54.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.957 0.408 . . . . 0.0 111.885 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 92' ' ' GLU . 9.0 pt-20 -73.73 95.0 2.3 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.195 0.521 . . . . 0.0 111.105 177.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 67.2 tp -67.4 -77.21 0.07 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.28 0.562 . . . . 0.0 111.787 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -108.08 46.41 0.96 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.247 0.546 . . . . 0.0 110.895 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.94 3.42 89.21 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.098 -174.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -128.69 139.68 36.29 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 123.138 0.575 . . . . 0.0 110.255 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.23 134.43 63.97 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.536 2.157 . . . . 0.0 112.048 175.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.487 ' HE2' ' HB3' ' A' ' 88' ' ' LEU . 39.3 ttp -98.44 121.73 40.74 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.106 0.479 . . . . 0.0 111.465 -174.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -87.63 100.58 12.91 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.891 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 28.1 t -111.65 102.21 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.829 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -120.18 138.82 13.29 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.725 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 19.9 p80 . . . . . 0 N--CA 1.473 0.698 0 O-C-N 122.379 -0.483 . . . . 0.0 111.724 -179.514 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.626 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 120.81 0.338 . . . . 0.0 111.068 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -86.16 -135.45 3.94 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.511 175.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.9 t60 61.09 88.88 0.08 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.277 0.561 . . . . 0.0 112.06 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -70.62 125.82 27.87 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.285 0.564 . . . . 0.0 112.385 -177.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -113.84 109.25 18.23 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.458 175.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -160.68 110.21 1.71 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.958 0.408 . . . . 0.0 111.367 -176.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -120.89 6.72 10.39 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.808 0.337 . . . . 0.0 111.04 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 54.0 t60 -59.85 -20.12 55.17 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.301 0.572 . . . . 0.0 110.912 176.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.0 m -68.84 98.52 0.93 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.159 172.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -56.02 96.05 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.801 -177.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 62.1 mtt 69.64 179.68 0.24 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.441 0.696 . . . . 0.0 112.231 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 73.0 -52.44 0.71 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.404 0.682 . . . . 0.0 112.554 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.62 -36.26 71.56 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.44 -61.44 1.79 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.07 0.462 . . . . 0.0 111.716 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 28.3 ttt -87.26 85.53 7.19 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.207 0.527 . . . . 0.0 110.484 177.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.4 -29.74 5.06 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.839 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -79.47 126.1 30.41 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.61 0.243 . . . . 0.0 110.99 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -61.86 -25.97 67.86 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -176.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 76.2 mt -95.95 -18.1 20.53 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 57.68 90.25 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.292 0.568 . . . . 0.0 110.961 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -61.06 -35.2 76.32 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -171.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -145.72 -160.26 8.56 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.86 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.5 t 68.77 -166.64 0.18 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.777 0.431 . . . . 0.0 111.695 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 72.4 -11.57 0.8 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 176.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.14 -100.63 0.52 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.129 -0.557 . . . . 0.0 113.322 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -77.36 163.29 30.16 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.659 2.239 . . . . 0.0 113.199 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.7 ttt -148.55 140.87 24.17 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.354 -177.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 28' ' ' ARG . 41.9 ttp180 -115.25 128.33 56.07 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.831 0.348 . . . . 0.0 111.124 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.4 HD21 HD13 ' A' ' 85' ' ' LEU . 83.2 mt -103.5 150.05 24.26 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.168 0.509 . . . . 0.0 112.063 -177.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 78.3 t80 -107.25 106.8 17.43 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.537 176.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.42 HG23 HG21 ' A' ' 100' ' ' VAL . 51.4 t -105.72 125.18 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 120.799 0.333 . . . . 0.0 111.826 -177.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -127.64 96.91 0.45 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 121.248 -0.501 . . . . 0.0 113.7 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 96.6 p -163.96 11.2 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.054 0.454 . . . . 0.0 111.671 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.43 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 8.3 mt -83.06 81.46 8.67 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -171.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.414 ' O ' ' CD2' ' A' ' 35' ' ' HIS . 1.1 p-80 -80.38 71.35 7.19 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.738 0.78 . . . . 0.0 112.319 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 61.47 9.36 2.63 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 172.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -143.3 -8.81 0.77 Allowed 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.246 -0.909 . . . . 0.0 113.364 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.515 ' N ' HD12 ' A' ' 38' ' ' ILE . 2.5 mp -90.59 113.34 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 O-C-N 121.709 -0.62 . . . . 0.0 110.308 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.3 p -95.94 170.42 9.3 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -174.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -53.17 -44.14 67.64 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.683 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -64.13 -39.52 94.21 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.135 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.0 mmt -62.4 -53.05 60.64 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.329 0.585 . . . . 0.0 110.482 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.414 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 54.8 mt -54.67 -55.17 32.52 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.927 176.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.478 ' HB2' HD12 ' A' ' 56' ' ' ILE . 25.4 ttt85 -55.13 -44.1 74.74 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.6 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.12 -29.7 68.92 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.438 -0.41 . . . . 0.0 113.5 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.9 mt -83.46 -34.46 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 O-C-N 122.475 -0.426 . . . . 0.0 112.09 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.431 ' HD2' ' HZ ' ' A' ' 75' ' ' PHE . 6.9 m-85 -85.28 -32.16 22.69 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -174.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.15 -35.51 21.48 Favored Pre-proline 0 N--CA 1.479 1.0 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -45.47 -26.65 2.87 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.205 1.937 . . . . 0.0 113.117 170.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -80.18 -47.74 14.23 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.932 0.396 . . . . 0.0 111.027 174.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.423 ' HA3' ' SG ' ' A' ' 80' ' ' CYS . . . -161.44 -101.5 0.17 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.208 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 52' ' ' ARG . 38.3 ttt180 -164.66 146.13 8.1 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 122.569 -0.371 . . . . 0.0 111.015 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.458 ' N ' HD13 ' A' ' 53' ' ' ILE . 3.3 mp -108.79 130.62 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.835 0.35 . . . . 0.0 111.549 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -79.7 -49.4 12.14 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.853 0.359 . . . . 0.0 111.477 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.5 p -150.79 144.17 24.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.088 0.47 . . . . 0.0 111.57 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.478 HD12 ' HB2' ' A' ' 44' ' ' ARG . 61.9 mt -115.7 115.44 49.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 177.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -110.2 105.69 14.84 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.805 0.336 . . . . 0.0 111.082 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 72.1 mt -98.07 146.78 25.2 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.914 0.388 . . . . 0.0 111.087 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 66.6 mmm -93.87 110.07 21.74 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.975 0.417 . . . . 0.0 110.026 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.3 ptt? -128.5 143.47 50.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.087 0.47 . . . . 0.0 111.802 -174.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -66.61 88.45 0.14 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.033 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.6 t -59.39 -13.67 9.28 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.414 0.626 . . . . 0.0 110.797 175.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -60.81 -41.05 94.94 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.524 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.441 HG21 ' HG3' ' A' ' 66' ' ' ARG . 11.1 t -132.27 -7.05 3.39 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -177.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.94 53.03 3.63 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.417 -0.421 . . . . 0.0 113.332 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.441 ' HG3' HG21 ' A' ' 64' ' ' THR . 71.7 mtt-85 -137.08 162.0 34.58 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 122.502 -0.411 . . . . 0.0 111.417 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 54.3 m -85.13 128.07 34.51 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 122.314 -0.241 . . . . 0.0 111.378 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -71.04 -31.57 68.06 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 134.44 -15.41 4.43 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.601 -0.809 . . . . 0.0 114.123 177.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -137.36 150.66 47.86 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.399 0.599 . . . . 0.0 112.453 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.37 158.51 27.76 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 116.182 -0.463 . . . . 0.0 113.018 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -102.08 125.24 48.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.03 0.443 . . . . 0.0 111.352 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 73.4 mt -111.53 123.22 67.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.165 0.507 . . . . 0.0 111.249 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.4 m -99.54 119.26 37.76 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.443 ' HB2' ' HB3' ' A' ' 81' ' ' ALA . 49.1 m-85 -100.95 150.63 22.67 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.424 175.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.3 t -78.36 -30.01 47.8 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.994 0.426 . . . . 0.0 110.942 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -106.91 117.25 33.57 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.827 0.346 . . . . 0.0 111.434 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.9 p -59.5 -52.93 63.48 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.6 tp10 -55.15 -43.91 74.65 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.835 0.35 . . . . 0.0 111.481 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.423 ' SG ' ' HA3' ' A' ' 51' ' ' GLY . 52.6 t -62.9 -45.1 94.12 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.247 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . . . -60.86 -44.04 97.56 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.251 0.548 . . . . 0.0 111.225 176.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -61.71 -38.52 88.19 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.85 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -65.23 -46.78 79.24 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.163 176.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.59 -48.05 78.26 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.007 0.432 . . . . 0.0 110.634 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.414 HD22 ' C ' ' A' ' 85' ' ' LEU . 8.2 tt -55.58 -50.76 69.23 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.293 0.568 . . . . 0.0 110.668 174.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -62.26 -32.08 72.73 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.913 -173.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -94.88 -36.76 11.5 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.434 ' O ' ' HB3' ' A' ' 98' ' ' MET . 91.4 mt -87.97 -20.1 26.34 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -172.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -64.25 105.67 0.95 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.225 0.536 . . . . 0.0 110.411 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.49 -9.1 26.3 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.098 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -69.34 130.87 43.79 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 122.646 0.378 . . . . 0.0 112.005 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -89.22 103.95 16.53 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.208 0.528 . . . . 0.0 111.536 176.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.2 tp -87.79 -68.62 0.75 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.291 0.567 . . . . 0.0 111.386 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.53 45.36 1.01 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.434 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.0 26.31 74.8 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.211 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -151.85 133.15 7.87 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 123.11 0.564 . . . . 0.0 110.225 -175.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -54.43 150.77 32.76 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.894 2.396 . . . . 0.0 113.921 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.473 ' HG3' HG23 ' A' ' 100' ' ' VAL . 44.0 tpp -98.41 108.27 20.93 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.869 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -88.63 100.1 12.84 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 122.171 -0.331 . . . . 0.0 111.211 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.473 HG23 ' HG3' ' A' ' 98' ' ' MET . 59.9 t -117.54 107.96 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.938 0.399 . . . . 0.0 111.599 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -120.75 155.47 16.24 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.981 177.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.503 ' CE1' ' HG2' ' A' ' 105' ' ' GLU . 20.3 p80 -82.0 46.64 1.03 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 122.081 -0.658 . . . . 0.0 112.453 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.2 t 56.69 -78.6 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.9 t -87.92 129.65 35.17 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -173.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.503 ' HG2' ' CE1' ' A' ' 102' ' ' HIS . 79.1 mt-10 -142.65 -50.47 0.36 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.903 174.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -131.51 47.56 2.52 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.159 0.504 . . . . 0.0 111.225 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.2 p -56.09 -64.87 0.72 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.2 t0 . . . . . 0 C--O 1.252 1.187 0 CA-C-O 118.743 -0.646 . . . . 0.0 111.552 -178.325 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.615 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.79 0.329 . . . . 0.0 111.285 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.89 37.57 94.46 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.346 -0.454 . . . . 0.0 113.47 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 72.3 m80 63.54 161.88 0.1 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.145 0.497 . . . . 0.0 111.85 -175.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -141.3 36.45 1.7 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.173 0.511 . . . . 0.0 110.906 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -74.34 71.97 1.78 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.998 0.428 . . . . 0.0 111.077 -176.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -133.58 22.88 3.99 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.058 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 21.6 p80 55.0 130.98 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.671 1.189 . . . . 0.0 113.995 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -158.26 -171.02 3.32 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.63 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.0 m -52.21 116.26 2.13 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -177.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -105.33 162.87 13.06 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.939 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 51.2 mtm 68.31 1.31 2.83 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 176.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.16 116.71 22.48 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.107 0.163 . . . . 0.0 111.091 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 66.81 124.14 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.09 16.67 0.95 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.834 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.602 ' SD ' ' N ' ' A' ' 15' ' ' MET . 1.0 OUTLIER -80.72 137.07 36.26 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -176.325 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 61.2 78.46 0.29 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.406 0.622 . . . . 0.0 111.667 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -84.42 75.05 10.28 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.172 0.511 . . . . 0.0 111.882 -176.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -79.86 44.73 0.66 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.261 0.553 . . . . 0.0 111.437 177.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.467 HD11 ' N ' ' A' ' 20' ' ' GLN . 2.5 pp -78.86 -17.28 55.88 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.098 0.475 . . . . 0.0 111.116 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.467 ' N ' HD11 ' A' ' 19' ' ' LEU . 17.1 pt20 -94.12 99.53 11.79 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.775 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -67.21 -44.32 79.85 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.226 0.536 . . . . 0.0 110.227 176.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -156.97 143.71 9.91 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.021 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 85.5 p -68.31 -18.58 64.54 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 117.207 0.504 . . . . 0.0 111.449 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -113.42 101.44 9.37 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.348 172.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -176.81 -165.24 31.99 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.473 -0.394 . . . . 0.0 112.413 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 38.6 Cg_exo -57.64 101.77 0.11 Allowed 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.598 2.199 . . . . 0.0 113.216 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 11.0 tpt -102.74 145.74 29.27 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.977 0.418 . . . . 0.0 111.689 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -114.52 127.56 55.87 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.043 0.449 . . . . 0.0 111.751 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.4 mt -104.31 149.89 24.94 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.188 0.518 . . . . 0.0 111.546 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -103.45 109.87 21.68 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.539 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -110.93 108.16 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 120.743 0.306 . . . . 0.0 111.047 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -121.77 88.59 0.42 Allowed Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.823 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.3 m -164.42 24.98 0.07 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 120.939 0.4 . . . . 0.0 111.283 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 34.2 mt -85.23 143.97 28.42 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.891 0.377 . . . . 0.0 111.661 -174.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.426 ' CE1' ' HB3' ' A' ' 37' ' ' ASN . 33.1 p80 -108.83 48.65 0.85 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.079 0.466 . . . . 0.0 111.708 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 50.1 t80 61.54 9.18 2.58 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.426 ' HB3' ' CE1' ' A' ' 35' ' ' HIS . 3.3 t-20 -142.5 37.06 1.49 Allowed 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.539 -0.725 . . . . 0.0 111.669 -178.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.3 mm -125.76 106.62 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 O-C-N 122.023 -0.423 . . . . 0.0 110.407 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.3 p -93.26 175.66 6.68 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.154 0.502 . . . . 0.0 112.304 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.4 ' HG3' HD11 ' A' ' 58' ' ' LEU . 2.7 mp0 -53.09 -36.01 60.22 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.214 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -56.45 -52.09 65.98 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.847 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.631 ' HE2' HD11 ' A' ' 46' ' ' ILE . 14.6 tpt -65.34 -47.9 74.9 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.188 0.518 . . . . 0.0 110.711 -178.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.0 mt -56.11 -44.11 78.78 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.248 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -65.15 -44.65 87.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.217 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.99 -31.89 65.72 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.267 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.631 HD11 ' HE2' ' A' ' 42' ' ' MET . 58.2 mt -86.0 -45.03 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.4 ' HB3' ' CZ ' ' A' ' 75' ' ' PHE . 37.5 m-85 -85.14 -43.7 13.61 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -172.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.446 ' CD ' HH11 ' A' ' 52' ' ' ARG . 36.1 tt0 -59.56 -35.1 26.57 Favored Pre-proline 0 N--CA 1.48 1.028 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -172.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 48' ' ' GLU . 60.3 Cg_exo -43.01 -29.39 1.55 Allowed 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 122.081 1.854 . . . . 0.0 113.523 172.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -82.11 -31.18 30.81 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.933 0.397 . . . . 0.0 111.482 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.557 ' HA3' ' HB3' ' A' ' 80' ' ' CYS . . . -175.89 134.47 2.66 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.279 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.446 HH11 ' CD ' ' A' ' 48' ' ' GLU . 14.1 tpt180 -48.22 125.14 8.85 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 122.946 0.498 . . . . 0.0 111.941 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 73.8 mt -94.73 133.95 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.171 0.51 . . . . 0.0 111.831 -175.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -83.92 -51.34 7.24 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.862 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.6 m -150.48 132.95 15.64 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.896 0.379 . . . . 0.0 111.694 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.516 HG22 HG12 ' A' ' 73' ' ' ILE . 58.4 mt -108.84 107.6 23.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.821 176.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -102.19 118.59 37.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.363 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.4 HD11 ' HG3' ' A' ' 40' ' ' GLU . 9.4 mp -98.43 139.63 33.9 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.078 0.466 . . . . 0.0 110.577 175.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.685 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 45.0 tpp -93.1 99.69 12.24 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.405 0.622 . . . . 0.0 111.387 -173.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.487 ' O ' ' HE2' ' A' ' 68' ' ' LYS . 65.5 mtt -85.84 -177.44 6.35 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.391 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.1 p-10 -79.55 -13.54 59.47 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.607 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.8 p 59.28 17.43 5.77 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.604 0.762 . . . . 0.0 111.717 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -118.6 -61.18 1.69 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.147 -175.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.1 p -112.66 -29.5 7.42 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.543 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 117.19 38.22 0.88 Allowed Glycine 0 CA--C 1.529 0.925 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.551 -177.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -110.22 159.46 17.37 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.587 -0.36 . . . . 0.0 111.01 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.9 m -92.76 128.41 38.61 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.684 -175.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.685 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 68.8 mttm -71.2 -25.95 62.73 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.677 0.275 . . . . 0.0 111.538 177.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.99 -6.55 8.86 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.992 -0.623 . . . . 0.0 114.31 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -138.01 160.0 40.53 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 117.719 0.76 . . . . 0.0 112.571 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -142.63 151.71 23.27 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.802 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -105.26 115.59 30.51 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.804 0.442 . . . . 0.0 111.448 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.516 HG12 HG22 ' A' ' 56' ' ' ILE . 68.5 mt -104.78 128.37 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 122.222 -0.299 . . . . 0.0 111.546 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.3 m -108.21 121.35 44.68 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 18.2 m-85 -98.5 151.61 20.43 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.294 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.3 t -69.09 -13.04 62.2 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.833 0.349 . . . . 0.0 111.737 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.619 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 16.4 t70 -133.59 153.29 51.78 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.049 0.452 . . . . 0.0 111.361 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 68.7 p -73.12 -51.96 16.03 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.199 -176.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -74.36 -23.05 58.95 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.619 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 92.3 m -60.72 -42.84 98.06 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.221 0.534 . . . . 0.0 109.942 170.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.91 -46.94 73.28 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.958 174.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -53.41 -47.71 69.33 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.647 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -60.33 -44.88 95.08 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.184 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.98 -40.14 83.9 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.143 0.497 . . . . 0.0 110.937 175.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.8 -57.98 9.76 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.826 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -61.72 -26.85 68.31 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -174.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -90.54 -34.7 15.43 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.453 ' HB3' ' HE2' ' A' ' 98' ' ' MET . 75.4 mt -97.84 -14.22 20.85 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -173.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -70.85 80.8 0.63 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.584 0.707 . . . . 0.0 110.702 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.64 -4.71 5.13 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.169 -174.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -59.61 140.08 56.65 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -73.37 84.9 1.46 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.953 0.406 . . . . 0.0 111.524 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 67.0 tp -90.59 116.01 28.15 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.291 -0.256 . . . . 0.0 110.854 176.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 59.49 16.9 5.58 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.89 11.85 48.6 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.512 -0.375 . . . . 0.0 112.903 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -132.27 138.46 32.31 Favored Pre-proline 0 N--CA 1.468 0.467 0 O-C-N 122.65 -0.324 . . . . 0.0 111.306 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.19 131.44 38.89 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.326 2.018 . . . . 0.0 112.169 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.453 ' HE2' ' HB3' ' A' ' 88' ' ' LEU . 45.4 ttp -97.01 118.99 34.63 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.289 0.566 . . . . 0.0 111.398 -175.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -88.38 104.91 17.21 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.72 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.9 t -111.6 111.44 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.11 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -133.77 150.8 20.01 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.324 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -66.99 143.92 56.5 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 117.788 0.794 . . . . 0.0 111.017 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.7 t -68.37 147.12 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.089 0.471 . . . . 0.0 111.895 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 45.1 m -74.65 150.26 39.66 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 174.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -53.99 -50.04 67.47 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -177.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -81.29 83.39 6.89 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.973 -0.454 . . . . 0.0 111.774 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.1 t -94.4 -28.51 15.47 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.751 175.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.7 t70 . . . . . 0 C--O 1.252 1.224 0 CA-C-O 118.236 -0.888 . . . . 0.0 112.185 -177.918 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptp . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 120.663 0.268 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 161.41 154.01 7.28 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 120.753 -0.737 . . . . 0.0 113.622 176.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -88.24 -22.53 23.91 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.904 0.383 . . . . 0.0 111.12 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -165.01 118.23 1.24 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.331 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -109.25 138.32 45.78 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -75.51 142.97 42.74 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.773 0.321 . . . . 0.0 110.361 173.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -83.44 97.62 9.07 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -168.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -116.68 -27.69 6.6 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.262 163.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 10' ' ' HIS . 22.4 m -57.43 124.57 19.4 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.14 173.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.404 ' HB3' ' O ' ' A' ' 9' ' ' SER . 70.6 t60 72.12 -41.93 0.52 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.349 0.66 . . . . 0.0 112.593 -177.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.6 ttt -70.31 79.03 0.54 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.253 0.549 . . . . 0.0 111.948 -176.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.74 74.9 1.02 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.962 172.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 64.25 -70.64 0.08 Allowed 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.699 -173.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -176.26 177.43 1.53 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.118 0.567 . . . . 0.0 110.856 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.483 ' N ' ' SD ' ' A' ' 15' ' ' MET . 3.4 mpp? -59.46 150.47 26.6 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.519 0.2 . . . . 0.0 111.326 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 67.17 99.86 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.25 0.548 . . . . 0.0 112.153 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.01 114.6 11.86 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.015 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.7 t30 66.61 138.89 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.5 0.667 . . . . 0.0 111.931 -172.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.618 ' H ' HD22 ' A' ' 19' ' ' LEU . 2.1 pt? -128.36 -0.13 5.68 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.32 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.414 ' OE1' ' HA ' ' A' ' 20' ' ' GLN . 6.1 tp60 -107.02 152.93 23.33 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.092 0.473 . . . . 0.0 111.505 -176.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -84.75 129.02 34.88 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.484 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.16 108.62 2.25 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 121.164 -0.541 . . . . 0.0 113.066 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.3 t -89.54 21.9 3.22 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 122.455 -0.438 . . . . 0.0 111.784 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 73.34 -35.31 0.31 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.71 -175.57 23.45 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.509 -0.377 . . . . 0.0 112.905 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.37 130.62 29.61 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.163 2.576 . . . . 0.0 113.687 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.3 ttt -102.08 135.82 42.98 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.857 0.36 . . . . 0.0 111.08 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.441 ' HD3' ' HB3' ' A' ' 72' ' ' PHE . 33.7 ttm180 -106.55 134.52 49.55 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -176.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.493 HD22 HD11 ' A' ' 85' ' ' LEU . 75.2 mt -113.11 147.68 36.83 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.191 0.519 . . . . 0.0 111.784 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -94.77 123.17 38.07 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.572 174.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.2 t -116.97 123.2 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 120.733 0.302 . . . . 0.0 111.245 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.3 96.84 0.53 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.277 -0.487 . . . . 0.0 113.345 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.539 ' HG ' HD23 ' A' ' 93' ' ' LEU . 78.3 p -174.72 15.46 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 177.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.422 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 20.8 mt -82.55 83.31 7.62 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.88 -0.513 . . . . 0.0 111.102 -173.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.415 ' O ' ' CG ' ' A' ' 35' ' ' HIS . 14.4 p80 -78.15 65.08 3.45 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.429 0.633 . . . . 0.0 112.012 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 56.5 t80 55.37 9.73 0.4 Allowed 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 176.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -139.64 1.63 1.94 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.343 -0.848 . . . . 0.0 112.762 -176.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.471 HD12 ' SD ' ' A' ' 42' ' ' MET . 31.6 mm -103.53 118.05 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 O-C-N 121.874 -0.516 . . . . 0.0 110.753 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 34.4 p -103.65 176.59 5.1 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.22 0.534 . . . . 0.0 112.138 -175.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -53.17 -48.58 67.88 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.463 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -59.12 -40.32 85.07 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.792 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.496 ' SD ' HD13 ' A' ' 93' ' ' LEU . 46.3 ttm -65.21 -46.56 80.16 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.256 0.551 . . . . 0.0 110.442 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.3 mt -57.95 -44.46 87.02 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.697 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 44' ' ' ARG . 43.5 ttm180 -56.65 -44.74 81.61 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.164 0.506 . . . . 0.0 110.817 175.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.72 -35.45 81.64 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.129 -0.558 . . . . 0.0 113.638 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.429 HD11 HD11 ' A' ' 93' ' ' LEU . 63.3 mt -84.72 -45.13 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -85.25 -34.04 22.05 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -173.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.619 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 36.4 tt0 -56.84 -41.48 91.53 Favored Pre-proline 0 N--CA 1.477 0.921 0 N-CA-C 113.682 0.994 . . . . 0.0 113.682 -172.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 48' ' ' GLU . 5.1 Cg_endo -47.3 -33.15 15.83 Favored 'Trans proline' 0 C--N 1.363 1.292 0 C-N-CA 122.232 1.954 . . . . 0.0 112.934 175.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -77.1 -47.8 19.5 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.164 0.507 . . . . 0.0 110.876 175.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -162.6 136.52 4.37 Favored Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.845 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 -54.98 134.57 48.95 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.007 0.432 . . . . 0.0 112.057 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.489 HG22 HG13 ' A' ' 56' ' ' ILE . 1.8 mp -81.82 129.38 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.103 0.478 . . . . 0.0 111.813 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -90.43 -43.52 10.22 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.334 176.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.0 p -151.98 148.21 27.47 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.715 0.293 . . . . 0.0 111.64 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.489 HG13 HG22 ' A' ' 53' ' ' ILE . 59.4 mt -127.53 106.61 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.891 0.377 . . . . 0.0 110.895 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -99.45 115.22 28.78 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.614 0.245 . . . . 0.0 110.936 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 80.4 mt -98.01 132.16 43.81 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.037 0.446 . . . . 0.0 110.99 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 89.1 mmm -94.49 98.9 11.18 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.343 0.592 . . . . 0.0 111.295 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 22.9 ptp -117.4 152.41 35.03 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.562 176.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -79.83 113.38 17.95 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.8 t -74.25 -12.98 60.71 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.838 0.827 . . . . 0.0 109.256 167.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -68.04 -53.85 22.7 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.066 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 74.8 p -108.84 -9.13 15.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.157 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.34 18.24 80.0 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.602 -176.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -112.99 -163.9 0.88 Allowed 'General case' 0 CA--C 1.544 0.726 0 O-C-N 122.452 -0.44 . . . . 0.0 111.065 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.1 m -111.7 137.14 49.99 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 122.071 -0.393 . . . . 0.0 111.927 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -78.83 -25.59 44.15 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.871 0.367 . . . . 0.0 111.736 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 104.1 4.44 44.58 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 120.936 -0.649 . . . . 0.0 114.588 174.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -144.84 156.12 43.85 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 117.643 0.722 . . . . 0.0 112.649 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.94 160.73 28.76 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.793 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.441 ' HB3' ' HD3' ' A' ' 28' ' ' ARG . 90.7 m-85 -111.42 124.07 51.5 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 122.569 -0.371 . . . . 0.0 111.511 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.5 mt -112.85 132.98 60.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 120.914 0.388 . . . . 0.0 111.703 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.3 m -101.65 125.41 48.31 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.705 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.452 ' HB2' ' HB3' ' A' ' 81' ' ' ALA . 88.3 m-85 -108.99 151.21 26.64 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.811 0.445 . . . . 0.0 111.167 177.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.9 m -62.88 -31.19 72.19 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -177.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.616 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 25.3 t70 -126.88 148.04 50.03 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.073 0.464 . . . . 0.0 111.612 -172.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.1 t -76.17 -34.46 59.34 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -77.24 -36.54 54.51 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.726 0.298 . . . . 0.0 111.114 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.616 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 17.5 p -63.67 -44.17 94.54 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.086 0.47 . . . . 0.0 110.257 175.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.452 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . . . -64.63 -46.66 81.59 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.113 175.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -54.56 -43.72 72.3 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.627 175.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.86 -42.62 94.71 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.831 0.348 . . . . 0.0 111.285 177.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.56 -55.25 36.84 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.006 0.431 . . . . 0.0 111.071 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.493 HD11 HD22 ' A' ' 29' ' ' LEU . 8.6 tt -51.57 -55.89 16.63 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.826 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -54.15 -34.03 59.39 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.562 -175.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -97.39 -24.21 15.73 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.466 ' HB3' ' HE2' ' A' ' 98' ' ' MET . 97.7 mt -101.65 -11.21 19.37 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -173.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -68.54 85.9 0.3 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.966 0.889 . . . . 0.0 111.225 177.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 127.73 -2.13 6.94 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.309 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.418 ' HB3' ' HE3' ' A' ' 98' ' ' MET . 86.9 t80 -59.69 134.92 57.47 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.459 0.304 . . . . 0.0 111.357 178.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.34 91.38 1.72 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.23 0.538 . . . . 0.0 111.728 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.539 HD23 ' HG ' ' A' ' 33' ' ' SER . 55.0 tp -99.89 122.05 42.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.596 177.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 59.15 18.67 6.69 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.042 0.448 . . . . 0.0 111.812 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.3 -20.25 30.71 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 116.213 -0.448 . . . . 0.0 113.128 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -115.21 153.81 47.35 Favored Pre-proline 0 CA--C 1.537 0.475 0 O-C-N 122.768 -0.254 . . . . 0.0 111.614 -174.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -63.65 139.02 67.42 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.216 1.944 . . . . 0.0 112.772 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.466 ' HE2' ' HB3' ' A' ' 88' ' ' LEU . 44.3 ttp -97.84 120.37 38.11 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.04 -178.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -88.26 99.88 12.57 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.057 0.456 . . . . 0.0 112.155 -174.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 18.3 t -106.03 126.83 61.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.035 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -149.95 160.59 28.57 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.263 -0.494 . . . . 0.0 113.132 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -65.33 176.74 1.28 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.104 0.478 . . . . 0.0 112.162 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.747 HG13 ' H ' ' A' ' 104' ' ' THR . 6.0 t -71.46 -179.75 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.508 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.747 ' H ' HG13 ' A' ' 103' ' ' VAL . 75.3 p -43.34 -55.78 3.89 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -175.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 103' ' ' VAL . 12.7 mm-40 74.82 -40.87 0.45 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 178.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 48.2 mtm105 -52.97 143.2 17.7 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.745 1.016 . . . . 0.0 113.745 -174.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.4 t -80.43 6.39 12.41 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 C--O 1.252 1.216 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.519 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 120.719 0.295 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 59.08 -154.3 29.15 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.163 -0.541 . . . . 0.0 113.467 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 72.1 m80 66.95 121.25 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.313 0.578 . . . . 0.0 111.926 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -68.14 85.99 0.25 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.415 0.626 . . . . 0.0 111.244 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -126.3 126.13 43.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.432 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -67.44 -179.18 0.99 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.796 0.332 . . . . 0.0 111.532 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -69.95 -75.52 0.11 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 122.299 -0.251 . . . . 0.0 111.182 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 81.1 t60 62.96 142.64 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.4 m 67.19 170.84 0.26 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.711 0.767 . . . . 0.0 112.531 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -154.61 76.42 1.02 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.56 172.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 62.9 mtm -86.66 103.51 15.2 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.726 -175.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.83 -175.37 2.65 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.477 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -118.24 146.42 44.28 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.761 0.315 . . . . 0.0 111.465 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.34 122.63 17.57 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.233 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.4 mmt -55.65 104.97 0.15 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.213 0.53 . . . . 0.0 111.689 -178.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.78 -3.53 54.1 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -64.98 82.88 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.492 0.663 . . . . 0.0 111.011 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -174.91 -45.8 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.32 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 73.6 mt -83.84 47.56 1.32 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.745 0.783 . . . . 0.0 109.802 173.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.4 ' NE2' ' HD1' ' A' ' 102' ' ' HIS . 16.5 tp60 -93.45 90.7 6.82 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.791 -169.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -156.26 138.69 14.87 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.84 165.63 31.63 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.983 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.3 p -141.02 155.82 46.13 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.867 0.365 . . . . 0.0 110.362 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.454 ' O ' ' HD2' ' A' ' 26' ' ' PRO . . . -77.91 8.66 4.36 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.6 -74.5 0.21 Allowed Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 -172.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.454 ' HD2' ' O ' ' A' ' 24' ' ' ALA . 47.1 Cg_endo -68.54 153.78 72.99 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 122.269 1.98 . . . . 0.0 111.187 166.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.2 ttt -100.0 122.67 43.26 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.861 -0.525 . . . . 0.0 111.293 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -98.99 125.76 44.52 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.769 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.427 HD22 HD12 ' A' ' 85' ' ' LEU . 76.8 mt -110.9 133.54 53.29 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.391 0.615 . . . . 0.0 111.74 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -89.78 109.36 20.36 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.331 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.8 t -109.73 123.21 65.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.78 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -123.73 97.29 0.56 Allowed Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.522 -0.371 . . . . 0.0 113.154 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.479 ' HB3' ' HA ' ' A' ' 98' ' ' MET . 99.7 p -161.02 9.74 0.09 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.089 0.471 . . . . 0.0 111.494 176.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.447 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 10.6 mt -87.16 87.71 7.51 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 122.2 -0.312 . . . . 0.0 111.595 -170.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -73.48 72.8 1.39 Allowed 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 56.07 20.62 4.48 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 173.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -153.78 -37.24 0.1 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -175.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.4 mm -59.98 128.72 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 120.778 0.323 . . . . 0.0 111.517 -175.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 62.7 p -113.45 178.16 4.38 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -173.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -48.67 -46.1 39.76 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.964 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.66 -44.87 63.19 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.488 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.7 mmt -66.89 -47.06 72.97 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.461 0.648 . . . . 0.0 110.576 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.44 HD21 HD22 ' A' ' 34' ' ' LEU . 70.6 mt -59.46 -50.67 73.05 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.735 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -58.56 -44.7 89.79 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 122.27 -0.268 . . . . 0.0 111.657 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.36 -38.36 68.81 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.579 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.46 HD11 HD12 ' A' ' 93' ' ' LEU . 59.6 mt -86.8 -49.18 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 75' ' ' PHE . 51.6 m-85 -77.18 -41.76 40.28 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -170.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -62.85 -37.88 38.15 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -173.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -46.06 -18.06 0.37 Allowed 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.447 2.098 . . . . 0.0 114.112 172.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -82.23 -42.97 18.21 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.801 0.334 . . . . 0.0 111.417 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.17 -122.87 1.06 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.791 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -140.29 129.77 24.08 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.387 0.613 . . . . 0.0 111.449 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 74.9 mt -100.35 120.81 50.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.822 -175.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -73.45 -53.88 9.59 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.956 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.8 t -150.55 150.2 30.92 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.032 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.1 mt -120.65 116.7 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.372 175.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -118.01 129.18 55.43 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.722 0.296 . . . . 0.0 111.263 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.422 HD11 ' N ' ' A' ' 58' ' ' LEU . 6.0 mp -99.78 141.85 32.04 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.974 0.416 . . . . 0.0 111.075 177.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.451 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 31.0 tpp -93.6 101.42 13.58 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.767 0.794 . . . . 0.0 111.675 -176.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -130.6 131.74 45.13 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.55 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -81.25 106.59 13.35 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.93 0.395 . . . . 0.0 110.992 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 62.9 p -74.56 -12.97 60.6 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -62.32 -54.33 42.08 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.898 0.38 . . . . 0.0 110.299 174.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.5 t -175.15 -10.72 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.25 -24.34 73.58 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.895 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 79.6 mtm-85 61.01 -157.68 0.34 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 122.883 0.473 . . . . 0.0 111.729 175.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.9 m -54.52 111.68 0.85 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.451 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 57.2 mttp -77.98 -25.21 47.96 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 112.7 3.12 25.4 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 120.937 -0.649 . . . . 0.0 114.495 177.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -140.76 158.77 43.48 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.818 0.809 . . . . 0.0 112.423 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -144.37 159.95 27.8 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.629 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -107.4 124.9 50.52 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 122.624 -0.339 . . . . 0.0 111.256 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 64.7 mt -110.21 130.82 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 120.896 0.379 . . . . 0.0 111.145 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.0 m -106.35 114.25 28.26 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 47' ' ' PHE . 38.5 m-85 -99.46 152.42 20.01 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.14 0.576 . . . . 0.0 110.763 177.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.8 t -93.65 -5.55 48.41 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.662 0.744 . . . . 0.0 110.002 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.423 ' HB2' ' HB2' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -119.8 101.81 8.15 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.186 -175.395 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.7 p -56.9 -55.21 37.5 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -176.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -58.23 -47.36 83.78 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.423 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 82.5 m -62.09 -40.86 97.26 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.846 0.355 . . . . 0.0 111.572 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.89 -42.68 89.96 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.064 0.459 . . . . 0.0 111.452 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -62.67 -36.38 82.71 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.093 0.473 . . . . 0.0 110.729 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -63.31 -52.05 63.54 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.086 0.47 . . . . 0.0 110.359 172.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.66 -43.69 57.4 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.201 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.427 HD12 HD22 ' A' ' 29' ' ' LEU . 9.5 tt -54.01 -62.76 1.44 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.185 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -74.9 -4.8 40.16 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -172.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -98.32 -29.72 13.0 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.95 -0.469 . . . . 0.0 111.495 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.416 ' HB3' ' HE2' ' A' ' 98' ' ' MET . 88.1 mt -106.71 -13.27 15.32 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -175.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -70.17 91.41 0.71 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.28 0.562 . . . . 0.0 110.247 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 125.98 -15.51 6.95 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.992 -172.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -59.73 133.9 56.53 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.072 0.549 . . . . 0.0 111.457 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -89.08 90.22 8.3 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.238 0.542 . . . . 0.0 111.923 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.46 HD12 HD11 ' A' ' 46' ' ' ILE . 36.2 tp -85.31 -65.5 1.0 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.41 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.04 38.56 0.66 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.879 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.89 17.27 75.19 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 121.241 -0.504 . . . . 0.0 111.954 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -157.68 151.59 19.67 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 115.505 -0.347 . . . . 0.0 110.349 -174.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.51 141.48 62.3 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.005 2.47 . . . . 0.0 113.039 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.479 ' HA ' ' HB3' ' A' ' 33' ' ' SER . 36.5 ttp -99.31 128.12 45.4 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.119 0.485 . . . . 0.0 111.48 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -89.12 101.46 14.12 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.533 -178.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.7 t -114.24 111.38 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 120.789 0.328 . . . . 0.0 111.321 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -127.38 151.11 18.33 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.298 -0.477 . . . . 0.0 113.272 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.4 ' HD1' ' NE2' ' A' ' 20' ' ' GLN . 5.1 p80 -71.02 122.95 20.98 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 122.32 -0.518 . . . . 0.0 111.705 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 90.8 t -74.79 -59.3 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.4 ' OG1' ' NE2' ' A' ' 20' ' ' GLN . 72.5 p 51.21 92.44 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.43 0.692 . . . . 0.0 111.901 -176.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.96 -41.73 9.86 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -170.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -135.53 148.55 49.19 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -176.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.1 t -110.21 126.21 53.89 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.236 173.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.5 t70 . . . . . 0 C--O 1.254 1.304 0 CA-C-O 118.877 -0.582 . . . . 0.0 112.045 -174.68 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -85.09 -55.26 2.67 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.968 -175.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -131.21 135.62 47.54 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -172.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -156.88 126.83 6.32 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.993 173.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -70.96 92.65 0.94 Allowed 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.698 0.761 . . . . 0.0 112.882 -172.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -142.05 -36.77 0.41 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.808 172.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 -79.34 110.5 14.68 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.234 0.54 . . . . 0.0 110.226 174.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -77.04 116.87 18.07 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.005 0.431 . . . . 0.0 110.981 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 75.6 p -123.33 -71.58 0.72 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.987 0.422 . . . . 0.0 111.534 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.8 m80 -140.16 -45.53 0.42 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.975 0.417 . . . . 0.0 111.2 175.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.6 mtt -72.75 92.65 1.58 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.998 0.428 . . . . 0.0 111.533 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.17 -47.79 0.13 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.669 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.64 -74.72 0.14 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 177.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -163.96 145.88 9.09 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.835 0.35 . . . . 0.0 111.347 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 15.0 tpt -93.07 -8.84 41.64 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.213 0.53 . . . . 0.0 110.968 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.96 -9.48 52.36 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -174.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -93.12 2.13 56.86 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.003 0.43 . . . . 0.0 111.602 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -67.0 118.72 10.84 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.9 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.6 tp -73.29 87.98 1.51 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.864 0.84 . . . . 0.0 110.277 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -88.76 160.39 17.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.903 -176.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.2 tttt -81.06 136.81 36.01 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.819 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.08 91.0 0.03 OUTLIER Glycine 0 CA--C 1.53 0.987 0 N-CA-C 114.181 0.432 . . . . 0.0 114.181 -174.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.3 t -78.05 -57.05 4.0 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.948 0.404 . . . . 0.0 111.172 176.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -141.92 -50.67 0.4 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.951 0.405 . . . . 0.0 111.673 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.73 78.79 1.3 Allowed Glycine 0 CA--C 1.531 1.072 0 CA-C-N 116.275 -0.421 . . . . 0.0 113.978 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.49 137.69 56.32 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.635 2.223 . . . . 0.0 112.292 174.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.8 ttt -99.6 136.4 39.58 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.091 0.472 . . . . 0.0 111.471 -176.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -112.48 118.98 36.64 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.349 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.9 mt -102.4 145.65 29.22 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.347 0.594 . . . . 0.0 112.126 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -102.08 120.48 40.51 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.616 173.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.3 t -118.98 115.94 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.672 0.272 . . . . 0.0 110.997 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.55 87.51 0.38 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.334 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.4 m -166.13 28.72 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.164 0.585 . . . . 0.0 110.61 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.475 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 15.0 mt -95.25 103.09 14.94 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.768 -176.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -74.21 67.1 1.34 Allowed 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -176.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 50.72 20.83 0.8 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 174.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.16 -38.2 0.27 Allowed 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.99 -0.444 . . . . 0.0 111.784 -174.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.7 mm -60.38 109.63 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 120.824 0.345 . . . . 0.0 111.149 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 61.0 p -92.93 172.57 8.24 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -54.79 -42.72 72.13 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.726 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -63.38 -38.04 89.61 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.703 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.1 mmt -65.51 -52.73 50.58 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.408 0.623 . . . . 0.0 110.197 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 65.5 mt -55.2 -40.33 70.65 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.925 174.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 45.0 ttm180 -61.5 -46.76 88.64 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.876 0.37 . . . . 0.0 110.957 177.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.31 -32.03 60.09 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.139 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 58.1 mt -85.68 -50.12 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -82.48 -27.69 31.65 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -172.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.614 ' HG3' ' O ' ' A' ' 52' ' ' ARG . 22.1 tt0 -57.33 -48.23 97.68 Favored Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -173.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 80.3 Cg_exo -47.89 -18.88 1.23 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 122.621 2.214 . . . . 0.0 114.013 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -78.45 -40.31 36.05 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.42 ' HA3' ' HB3' ' A' ' 80' ' ' CYS . . . -169.8 37.93 0.19 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 119.838 -1.173 . . . . 0.0 115.438 -178.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.614 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 0.0 OUTLIER 72.67 -53.79 0.7 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.366 0.666 . . . . 0.0 112.541 174.593 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.437 ' HB ' ' O ' ' A' ' 52' ' ' ARG . 68.7 mt 79.82 137.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.756 0.823 . . . . 0.0 111.672 -177.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -85.01 -64.96 1.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.196 0.522 . . . . 0.0 110.151 174.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.2 t -147.59 146.36 29.36 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.046 0.451 . . . . 0.0 111.865 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.513 HG23 HG12 ' A' ' 73' ' ' ILE . 60.4 mt -115.36 130.19 70.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.894 174.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -125.07 122.45 37.26 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.924 0.393 . . . . 0.0 111.547 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.8 mt -99.13 149.73 22.75 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.657 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 82.8 mmm -97.13 111.24 23.56 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.699 0.285 . . . . 0.0 110.727 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -115.8 148.9 39.36 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.159 0.504 . . . . 0.0 111.925 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -75.47 151.79 37.99 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.498 173.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.6 t -108.53 20.75 18.19 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -173.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -116.67 -67.18 1.01 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.184 0.516 . . . . 0.0 109.866 172.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.0 t -161.79 13.99 0.09 Allowed 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.361 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.92 -27.59 45.23 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.817 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.507 ' NE ' ' HA ' ' A' ' 66' ' ' ARG . 3.5 mmp_? 59.33 -154.5 0.37 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.534 0.334 . . . . 0.0 111.84 176.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.5 m -52.92 99.46 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -54.24 -49.88 68.45 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -174.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 145.27 -11.01 1.79 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.929 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -128.55 145.26 51.18 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 117.23 0.515 . . . . 0.0 111.858 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.33 160.87 28.75 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.651 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -113.25 127.25 56.1 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.007 0.432 . . . . 0.0 111.72 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.513 HG12 HG23 ' A' ' 56' ' ' ILE . 67.1 mt -110.12 134.71 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.771 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 38.8 m -116.25 123.3 47.39 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.025 0.44 . . . . 0.0 111.926 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -100.22 149.66 23.34 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.511 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.8 m -72.06 -9.46 58.42 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.066 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.626 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 19.8 t70 -138.12 150.23 46.65 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.874 0.369 . . . . 0.0 111.47 -177.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 71.2 p -68.72 -53.19 23.5 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -68.54 -30.17 68.9 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.626 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 93.8 m -58.03 -41.45 83.25 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.16 0.505 . . . . 0.0 111.183 174.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.39 -38.67 29.85 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.237 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -54.93 -48.94 72.48 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.308 0.575 . . . . 0.0 110.688 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -70.02 -41.97 73.59 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.566 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.06 -44.02 67.14 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.273 0.558 . . . . 0.0 110.873 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 tt -62.29 -62.25 1.89 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.521 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -56.54 -29.73 62.29 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -176.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -87.95 -38.6 15.42 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 122.09 -0.381 . . . . 0.0 111.728 -175.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 76.5 mt -96.16 -23.4 16.76 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -172.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -65.69 100.13 0.51 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.068 0.461 . . . . 0.0 110.641 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.47 -9.67 13.1 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.738 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -73.22 126.97 31.3 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 122.535 -0.391 . . . . 0.0 111.938 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 45.3 mt-10 -80.04 102.54 9.35 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.866 0.365 . . . . 0.0 111.143 176.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.407 HD21 ' HE2' ' A' ' 98' ' ' MET . 65.8 tp -89.53 -66.74 0.89 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.034 0.445 . . . . 0.0 111.516 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -92.15 32.4 1.17 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.955 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.61 4.99 79.2 Favored Glycine 0 C--N 1.332 0.343 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 -174.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 1.5 ptm85 -143.44 152.37 56.81 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 122.927 0.491 . . . . 0.0 110.695 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -61.16 155.59 50.12 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.118 2.545 . . . . 0.0 114.384 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.407 ' HE2' HD21 ' A' ' 93' ' ' LEU . 31.9 tpp -99.46 117.72 34.49 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.728 177.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.666 ' HB3' ' HZ1' ' A' ' 99' ' ' LYS . 7.7 mtpm? -89.32 101.97 14.64 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.121 -0.362 . . . . 0.0 111.419 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.6 t -120.52 118.1 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.886 0.374 . . . . 0.0 111.666 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -139.24 147.49 19.25 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.176 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -66.73 150.34 49.24 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 117.663 0.732 . . . . 0.0 110.769 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.1 m -72.53 178.01 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.051 0.453 . . . . 0.0 111.623 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 74.1 p -82.09 86.23 6.63 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 122.018 -0.426 . . . . 0.0 111.734 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -84.99 94.9 8.92 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 172.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -135.35 148.67 49.5 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.215 0.531 . . . . 0.0 111.926 -177.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 97.7 m -100.25 -43.89 6.13 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.103 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--O 1.253 1.284 0 CA-C-O 118.343 -0.837 . . . . 0.0 112.383 -179.131 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 120.62 0.247 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.96 -70.76 1.19 Allowed Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.752 -174.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.441 ' O ' ' HB2' ' A' ' 4' ' ' HIS . 16.3 m-70 -84.93 139.74 31.61 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 169.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.441 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 9.1 m-70 68.98 97.44 0.06 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.185 0.517 . . . . 0.0 111.853 -173.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -84.09 -19.85 33.6 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.177 0.513 . . . . 0.0 110.505 174.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -103.24 103.5 13.54 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.304 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -83.45 -9.47 58.98 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.846 0.355 . . . . 0.0 111.132 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -119.24 112.29 19.29 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.884 0.373 . . . . 0.0 110.778 173.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.4 t -94.86 -178.65 4.58 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.827 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 68.31 32.64 4.57 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.511 176.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.3 ttt 58.73 94.31 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.197 0.523 . . . . 0.0 111.211 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.67 ' HB1' ' HB1' ' A' ' 16' ' ' ALA . . . -86.5 -79.3 0.26 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -175.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 55.86 -83.96 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -95.17 -24.96 16.59 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.879 0.371 . . . . 0.0 111.45 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.507 ' N ' ' SD ' ' A' ' 15' ' ' MET . 1.3 mpt? -86.39 8.47 21.49 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.67 ' HB1' ' HB1' ' A' ' 12' ' ' ALA . . . -81.49 87.6 6.21 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.706 0.289 . . . . 0.0 110.731 176.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 64.41 86.55 0.12 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.646 -172.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -78.0 126.7 31.23 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.091 0.472 . . . . 0.0 112.238 -176.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 58.1 tp -90.02 -44.56 9.77 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.295 0.569 . . . . 0.0 110.644 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 22.4 tm0? -84.96 90.8 7.9 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.827 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.406 ' HE3' ' HB2' ' A' ' 21' ' ' LYS . 35.8 ttmt -178.43 155.41 0.87 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.665 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.62 81.91 0.06 OUTLIER Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.428 -0.415 . . . . 0.0 113.822 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.3 t -96.84 119.64 35.69 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.614 -0.345 . . . . 0.0 111.061 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.53 138.27 33.49 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.854 0.359 . . . . 0.0 111.251 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.66 -74.85 0.4 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.795 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.53 134.67 29.05 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.834 2.356 . . . . 0.0 112.67 176.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.495 ' HB2' ' HA ' ' A' ' 78' ' ' SER . 27.0 ttt -113.11 133.15 55.15 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.972 0.415 . . . . 0.0 111.558 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -99.78 116.28 31.5 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.159 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.2 mt -99.55 143.06 30.23 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.13 0.491 . . . . 0.0 111.665 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -97.73 120.11 37.54 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.602 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 99' ' ' LYS . 58.4 t -115.17 112.55 40.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.478 176.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.56 93.35 0.22 Allowed Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.527 -0.844 . . . . 0.0 114.645 -174.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.637 ' OG ' ' HA ' ' A' ' 98' ' ' MET . 90.9 p -176.08 19.89 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 28.8 mt -84.88 150.33 25.06 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 122.279 -0.263 . . . . 0.0 111.43 -175.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.546 ' HE2' ' HB1' ' A' ' 94' ' ' ALA . 24.9 p80 -122.49 76.61 1.34 Allowed 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -176.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.402 ' HD1' ' HB3' ' A' ' 67' ' ' SER . 23.7 t80 42.94 41.86 2.81 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.312 0.645 . . . . 0.0 112.616 173.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -152.99 -51.32 0.1 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.998 0.428 . . . . 0.0 111.374 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.64 ' HA ' ' SD ' ' A' ' 42' ' ' MET . 3.2 mp -62.59 127.9 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.137 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.438 ' OG1' ' HG3' ' A' ' 42' ' ' MET . 35.3 p -106.51 171.93 7.09 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.329 0.585 . . . . 0.0 112.078 -175.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.501 ' HG2' ' HG ' ' A' ' 58' ' ' LEU . 79.6 mt-10 -67.08 -32.88 74.35 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.793 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -64.17 -39.2 93.51 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.075 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.64 ' SD ' ' HA ' ' A' ' 38' ' ' ILE . 64.4 mtt -62.88 -52.4 63.23 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.442 0.639 . . . . 0.0 110.273 176.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.5 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 63.1 mt -54.47 -51.39 65.19 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.106 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -50.2 -50.1 50.58 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.888 0.375 . . . . 0.0 111.195 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.93 -28.77 66.57 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.656 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.8 mm -82.84 -38.33 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 O-C-N 122.453 -0.439 . . . . 0.0 111.97 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.5 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 44.5 m-85 -85.89 -30.83 22.56 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -174.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -56.7 -38.68 71.17 Favored Pre-proline 0 N--CA 1.483 1.197 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -47.18 -22.83 2.52 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.245 1.964 . . . . 0.0 113.408 171.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.415 ' HE1' ' HG3' ' A' ' 87' ' ' GLN . 81.5 m-85 -93.69 -44.9 7.94 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.087 0.47 . . . . 0.0 111.096 175.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -174.32 140.58 5.49 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.844 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.0 ttp85 -58.34 134.5 56.64 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.242 0.544 . . . . 0.0 112.082 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.492 HD11 ' N ' ' A' ' 53' ' ' ILE . 3.4 mp -94.01 137.9 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.144 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -87.99 -40.67 13.69 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.833 0.349 . . . . 0.0 111.806 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.9 t -150.96 132.36 14.64 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.117 0.484 . . . . 0.0 112.238 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.503 HG22 HG12 ' A' ' 73' ' ' ILE . 47.9 mt -117.64 133.2 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.211 173.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -137.89 118.83 14.27 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.844 0.355 . . . . 0.0 111.404 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.532 HD23 ' HA3' ' A' ' 71' ' ' GLY . 91.7 mt -96.48 149.81 21.32 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 174.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.564 ' SD ' ' CE2' ' A' ' 70' ' ' TYR . 60.9 mtp -92.48 112.93 25.06 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.798 0.808 . . . . 0.0 111.349 -177.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.1 ptm -147.01 145.71 29.81 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.031 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.801 ' HB2' ' HA3' ' A' ' 65' ' ' GLY . 45.4 m-20 -121.68 109.35 14.64 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.801 0.334 . . . . 0.0 111.833 -174.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.8 t -55.24 -33.88 63.52 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -57.62 -39.04 76.0 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.2 t 175.42 -14.08 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -177.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.801 ' HA3' ' HB2' ' A' ' 61' ' ' ASP . . . -63.3 -31.84 82.11 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.327 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 66.89 -68.45 0.14 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 171.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.402 ' HB3' ' HD1' ' A' ' 36' ' ' PHE . 46.6 t -167.05 116.46 0.85 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.88 0.371 . . . . 0.0 111.059 177.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -85.94 -5.15 59.28 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.03 3.57 87.62 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 114.963 0.745 . . . . 0.0 114.963 169.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.564 ' CE2' ' SD ' ' A' ' 59' ' ' MET . 49.4 p90 -133.09 145.98 51.24 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 117.805 0.802 . . . . 0.0 111.993 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.532 ' HA3' HD23 ' A' ' 58' ' ' LEU . . . -151.2 161.9 29.28 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 115.816 -0.629 . . . . 0.0 113.239 -177.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -105.2 129.04 53.67 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.914 0.388 . . . . 0.0 111.768 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.503 HG12 HG22 ' A' ' 56' ' ' ILE . 66.8 mt -111.76 132.69 59.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.025 178.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.7 m -112.57 118.54 35.39 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.44 ' HZ ' ' HD2' ' A' ' 47' ' ' PHE . 45.0 m-85 -99.12 152.13 20.21 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.792 0.437 . . . . 0.0 111.841 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.1 m -68.09 -10.81 56.83 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.624 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -139.64 161.04 38.49 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.081 0.467 . . . . 0.0 112.096 -176.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.495 ' HA ' ' HB2' ' A' ' 27' ' ' MET . 51.7 m -91.33 -37.31 13.33 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -79.4 -40.01 31.06 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.015 -0.428 . . . . 0.0 112.023 -177.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 76.5 m -58.13 -41.86 84.57 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.329 0.585 . . . . 0.0 110.765 174.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.6 -45.37 68.73 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.984 176.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.808 ' HZ1' ' HB2' ' A' ' 82' ' ' LYS . 5.0 ttmp? -57.25 -34.98 69.16 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.405 178.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.496 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 46.0 tttm -75.23 -37.74 60.93 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.965 0.412 . . . . 0.0 111.01 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.89 -33.19 64.38 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.501 0.667 . . . . 0.0 110.475 172.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 100' ' ' VAL . 7.6 tt -65.85 -55.38 17.34 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.766 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 83' ' ' LYS . 2.6 pp20? -64.74 -19.28 65.7 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -174.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.415 ' HG3' ' HE1' ' A' ' 50' ' ' PHE . 85.9 mm-40 -94.6 -46.46 6.94 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.871 -0.518 . . . . 0.0 111.893 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.482 ' HB3' ' HE2' ' A' ' 98' ' ' MET . 71.6 mt -89.61 -17.3 28.74 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -170.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -71.01 91.4 0.88 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.464 0.65 . . . . 0.0 110.187 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.42 -14.13 8.78 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.943 -173.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -61.77 120.26 10.34 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.703 0.401 . . . . 0.0 110.958 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -79.0 93.71 5.15 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.158 0.504 . . . . 0.0 111.67 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.5 tp -96.51 135.88 37.79 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.995 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.546 ' HB1' ' HE2' ' A' ' 35' ' ' HIS . . . 59.76 24.07 13.0 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.206 0.527 . . . . 0.0 111.146 -176.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.33 3.67 89.91 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.121 -0.491 . . . . 0.0 113.526 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -121.13 136.5 25.75 Favored Pre-proline 0 N--CA 1.473 0.676 0 CA-C-N 117.306 0.553 . . . . 0.0 111.731 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -59.99 129.31 29.81 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.473 2.115 . . . . 0.0 111.82 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.637 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 40.9 ttp -97.62 124.88 42.07 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.174 0.511 . . . . 0.0 111.781 -174.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 68.2 mttm -88.41 101.91 14.36 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.148 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.504 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 44.0 t -114.45 99.51 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.632 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -135.62 160.24 24.44 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.747 -0.739 . . . . 0.0 113.062 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -72.68 151.94 41.97 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 122.514 -0.403 . . . . 0.0 110.598 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.5 t -62.79 85.07 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.318 0.58 . . . . 0.0 112.423 -173.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 57.6 m -124.49 85.79 2.47 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.463 0.649 . . . . 0.0 110.141 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -82.09 -33.13 29.94 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.409 -174.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -98.3 114.1 26.27 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -173.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 68.3 p -94.9 -66.48 0.91 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 167.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.5 t70 . . . . . 0 C--O 1.254 1.34 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 172.021 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.56 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 120.592 0.234 . . . . 0.0 111.211 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -61.78 83.06 0.03 OUTLIER Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.364 -0.446 . . . . 0.0 113.356 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 51.53 -110.17 0.48 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.107 0.563 . . . . 0.0 111.664 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -147.61 99.8 3.16 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.964 0.412 . . . . 0.0 110.517 176.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -80.42 65.38 5.55 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.117 0.484 . . . . 0.0 111.307 -177.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -81.78 39.05 0.53 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.484 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -70.4 86.49 0.61 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.913 -176.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.1 p80 -154.83 9.93 0.33 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.6 m 63.09 172.19 0.15 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -73.81 85.23 1.69 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.273 0.558 . . . . 0.0 111.781 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.7 ttt -59.13 -48.94 79.77 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.878 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.29 -71.66 0.19 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 58.68 17.62 5.24 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -105.29 147.4 28.15 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.904 0.383 . . . . 0.0 111.438 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 83.5 mtp -96.43 131.85 42.57 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.92 0.391 . . . . 0.0 111.397 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.09 80.27 8.87 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.075 0.464 . . . . 0.0 111.445 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -134.92 94.09 3.11 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.407 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -77.83 -69.34 0.55 Allowed 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.2 tp 63.44 -76.92 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.191 0.597 . . . . 0.0 111.623 175.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -148.89 3.33 0.62 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 176.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -74.76 -44.75 48.11 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.145 0.498 . . . . 0.0 111.198 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.9 59.23 4.75 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.385 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.8 p 49.49 -83.23 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.537 0.735 . . . . 0.0 112.8 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.22 140.82 51.69 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.511 0.325 . . . . 0.0 110.972 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -139.78 -174.02 13.5 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.518 -177.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.07 128.22 29.61 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.904 2.403 . . . . 0.0 113.116 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 26.3 ttt -99.12 141.27 32.09 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.677 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.471 ' HD3' ' HB3' ' A' ' 72' ' ' PHE . 42.4 ttm180 -115.71 130.95 57.05 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.171 0.51 . . . . 0.0 112.288 -171.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 85.5 mt -107.66 145.39 33.43 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.195 0.522 . . . . 0.0 111.831 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.494 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 39.0 t80 -97.32 111.79 23.89 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.961 173.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -106.23 107.44 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 120.805 0.336 . . . . 0.0 111.35 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.561 ' HA2' ' HB3' ' A' ' 70' ' ' TYR . . . -113.39 97.57 0.87 Allowed Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.244 -0.503 . . . . 0.0 113.831 -176.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.704 ' HB2' ' HA ' ' A' ' 98' ' ' MET . 30.7 t -174.81 15.25 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.39 0.614 . . . . 0.0 111.183 172.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.718 ' HA ' HD12 ' A' ' 38' ' ' ILE . 11.1 mt -85.59 88.62 7.55 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 122.029 -0.42 . . . . 0.0 110.405 -171.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -78.49 69.29 4.65 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.579 0.704 . . . . 0.0 112.377 -172.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 48.3 t80 57.68 9.62 0.87 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 175.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -124.18 -38.91 2.4 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.609 -0.682 . . . . 0.0 112.596 -177.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.718 HD12 ' HA ' ' A' ' 34' ' ' LEU . 58.8 mt -67.61 134.06 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.938 0.399 . . . . 0.0 111.978 -176.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 56.6 p -110.02 166.21 11.12 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.066 0.46 . . . . 0.0 112.205 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.478 ' HA ' HD13 ' A' ' 43' ' ' LEU . 2.5 mp0 -63.07 -36.54 83.93 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.248 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -66.67 -33.56 75.92 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.909 0.385 . . . . 0.0 111.277 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.569 ' HE2' HD13 ' A' ' 93' ' ' LEU . 27.1 ttt -68.18 -44.66 75.41 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.562 0.696 . . . . 0.0 110.107 174.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.478 HD13 ' HA ' ' A' ' 40' ' ' GLU . 92.2 mt -55.09 -55.26 33.0 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.722 178.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.493 ' HB3' HD12 ' A' ' 56' ' ' ILE . 14.2 ptm180 -61.78 -33.22 73.72 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.385 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.19 -36.8 69.81 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.63 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 63.2 mt -85.45 -49.21 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 177.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -82.31 -32.52 29.41 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -169.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.718 ' HG3' ' HA ' ' A' ' 52' ' ' ARG . 22.2 tt0 -62.07 -42.49 81.98 Favored Pre-proline 0 N--CA 1.48 1.056 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -174.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -47.78 -18.29 0.98 Allowed 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 122.529 2.152 . . . . 0.0 114.316 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -71.38 -51.9 21.58 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.525 ' N ' ' SG ' ' A' ' 80' ' ' CYS . . . -170.91 43.76 0.19 Allowed Glycine 0 N--CA 1.468 0.77 0 C-N-CA 120.079 -1.058 . . . . 0.0 114.092 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.718 ' HA ' ' HG3' ' A' ' 48' ' ' GLU . 0.3 OUTLIER 63.31 143.91 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.974 0.892 . . . . 0.0 113.39 178.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.42 HG13 ' HA ' ' A' ' 48' ' ' GLU . 89.2 mt -119.09 133.69 65.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.16 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -82.68 -56.48 3.83 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.674 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.7 p -150.12 138.34 20.39 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.255 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.52 HG12 HG21 ' A' ' 73' ' ' ILE . 46.0 mt -107.67 116.31 50.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.343 0.592 . . . . 0.0 111.113 177.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -99.36 115.72 29.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.993 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 27.9 tp -97.16 133.35 41.92 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.551 -0.718 . . . . 0.0 110.516 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.571 ' HG3' ' HD3' ' A' ' 68' ' ' LYS . 14.3 tpt -92.28 99.29 12.09 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.889 0.852 . . . . 0.0 111.142 -171.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.505 ' HA ' ' HG3' ' A' ' 68' ' ' LYS . 19.5 ptp -132.0 149.28 52.47 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.069 177.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -66.94 92.2 0.23 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.302 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.2 m -56.8 -9.07 0.7 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.303 0.573 . . . . 0.0 111.496 175.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -76.5 -43.01 41.42 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.18 177.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 77.5 p -121.63 0.72 9.94 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -175.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.02 20.73 76.54 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 121.548 -0.358 . . . . 0.0 113.7 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.1 mmt85 -100.08 148.31 24.7 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.23 -0.57 . . . . 0.0 112.044 -176.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.5 m -85.88 128.97 34.95 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.122 -178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.571 ' HD3' ' HG3' ' A' ' 59' ' ' MET . 26.0 mtpp -86.94 -15.02 40.13 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 101.03 7.05 51.02 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 120.969 -0.634 . . . . 0.0 114.486 175.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.561 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -145.26 160.07 42.05 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 117.476 0.638 . . . . 0.0 112.567 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -145.29 147.57 18.77 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.955 -0.566 . . . . 0.0 113.147 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.471 ' HB3' ' HD3' ' A' ' 28' ' ' ARG . 95.8 m-85 -99.57 112.67 24.85 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.935 0.398 . . . . 0.0 111.266 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.52 HG21 HG12 ' A' ' 56' ' ' ILE . 67.8 mt -99.41 126.18 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.956 0.408 . . . . 0.0 111.586 -178.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 36.7 m -101.54 118.41 36.9 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.517 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -98.53 151.53 20.54 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.109 0.481 . . . . 0.0 112.17 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.0 t -72.19 -28.83 63.46 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.148 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -116.3 133.0 56.51 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.972 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.6 t -67.04 -51.17 58.09 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.941 0.401 . . . . 0.0 111.891 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -57.77 -34.37 69.5 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.098 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 51' ' ' GLY . 7.7 t -57.97 -46.3 85.38 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.824 175.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.4 ' O ' HD12 ' A' ' 29' ' ' LEU . . . -65.16 -41.77 94.35 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.07 0.462 . . . . 0.0 111.15 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -64.93 -35.67 81.91 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.564 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 85.6 tttt -72.35 -50.41 26.95 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.741 0.305 . . . . 0.0 111.318 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.15 -42.77 61.01 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.11 0.481 . . . . 0.0 110.954 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.8 tt -57.19 -55.9 28.7 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.511 173.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -53.67 -34.85 60.06 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.132 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 83' ' ' LYS . 11.1 mm100 -86.8 -35.43 19.12 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.911 -174.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.5 ' HB3' ' HE1' ' A' ' 98' ' ' MET . 73.8 mt -104.79 -7.02 19.76 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -171.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -62.91 99.71 0.17 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.028 0.442 . . . . 0.0 111.134 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.05 -2.42 44.31 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 116.264 -0.426 . . . . 0.0 113.342 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -67.15 131.69 46.31 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 122.607 -0.349 . . . . 0.0 111.578 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.82 103.34 1.41 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.987 0.423 . . . . 0.0 111.153 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.569 HD13 ' HE2' ' A' ' 42' ' ' MET . 56.6 tp -113.17 127.33 56.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.433 177.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 58.26 23.73 10.7 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.148 0.499 . . . . 0.0 111.754 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.99 -18.27 54.99 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.82 -0.627 . . . . 0.0 114.018 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 31.7 mtt85 -116.59 140.01 26.19 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 117.378 0.589 . . . . 0.0 111.997 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.23 132.12 48.74 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.778 2.318 . . . . 0.0 112.098 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.704 ' HA ' ' HB2' ' A' ' 33' ' ' SER . 38.5 ttp -96.75 119.35 35.07 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.361 0.6 . . . . 0.0 111.738 -171.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -87.8 94.19 9.68 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.64 -176.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.05 113.57 38.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.461 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 30' ' ' TYR . . . -142.08 131.59 4.8 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.25 -0.5 . . . . 0.0 112.548 176.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -63.2 94.98 0.08 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 117.655 0.727 . . . . 0.0 112.128 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.511 HG12 ' HG2' ' A' ' 105' ' ' GLU . 43.0 t 49.93 86.92 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.832 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.7 t -73.37 82.3 1.41 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.653 0.74 . . . . 0.0 112.61 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.511 ' HG2' HG12 ' A' ' 103' ' ' VAL . 19.8 mm-40 -94.55 -69.37 0.75 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.121 173.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.7 tpm_? 71.5 -57.56 0.6 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.166 0.586 . . . . 0.0 112.454 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.2 m -53.36 119.86 5.32 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.984 0.421 . . . . 0.0 111.986 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.5 t70 . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.903 -0.57 . . . . 0.0 111.875 -179.999 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.9 ttm . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.875 0.369 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -96.78 -159.71 31.73 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.316 174.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -129.61 97.01 4.4 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 117.28 0.54 . . . . 0.0 111.829 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -130.85 128.92 41.61 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.783 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -80.69 144.53 32.17 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.036 0.446 . . . . 0.0 111.263 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -118.31 11.68 13.17 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.065 0.46 . . . . 0.0 111.321 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -76.88 131.84 38.8 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.847 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 76.9 t60 63.89 98.86 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.8 m -130.83 -68.7 0.67 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.803 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.3 t60 53.87 30.7 11.91 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.107 0.563 . . . . 0.0 111.831 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.0 tpt 61.11 -72.47 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.487 0.715 . . . . 0.0 112.054 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.15 104.48 4.64 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.855 0.359 . . . . 0.0 111.489 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.1 175.78 10.06 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 68.54 4.91 4.53 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.0 mmt -101.35 118.4 36.89 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 122.489 0.316 . . . . 0.0 110.582 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -159.79 -168.09 2.16 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.224 0.535 . . . . 0.0 111.784 -176.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -77.47 2.53 15.94 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.286 -0.416 . . . . 0.0 112.08 176.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -137.9 -179.99 6.09 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 122.359 0.264 . . . . 0.0 110.882 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.421 ' O ' ' HB3' ' A' ' 20' ' ' GLN . 87.2 mt -92.89 43.81 1.13 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.907 0.384 . . . . 0.0 110.664 -176.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.648 HE21 ' HA ' ' A' ' 20' ' ' GLN . 0.0 OUTLIER 75.28 -23.63 0.23 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.435 0.694 . . . . 0.0 112.359 -178.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 70.83 -66.34 0.3 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.189 0.596 . . . . 0.0 112.001 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.02 138.02 4.91 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.481 -0.39 . . . . 0.0 112.593 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 79.7 p -99.77 13.01 35.16 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -177.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 69.89 -167.9 0.17 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.878 0.471 . . . . 0.0 112.073 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -163.5 -59.85 0.02 OUTLIER Glycine 0 CA--C 1.531 1.075 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.486 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.16 155.86 43.17 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.689 2.26 . . . . 0.0 113.551 176.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 11.7 tpt -126.23 147.51 49.66 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.763 0.315 . . . . 0.0 111.474 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 36.7 ttt85 -120.81 121.22 37.69 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.854 0.359 . . . . 0.0 111.308 -174.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 81.6 mt -106.01 143.66 33.82 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 55.2 t80 -91.66 116.06 28.57 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.495 172.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.44 HG23 HD13 ' A' ' 73' ' ' ILE . 60.0 t -118.73 109.14 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-O 121.093 0.473 . . . . 0.0 111.789 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.5 104.76 1.84 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.576 -0.345 . . . . 0.0 112.937 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.539 ' HB2' ' HA ' ' A' ' 98' ' ' MET . 39.7 t -171.64 14.61 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.248 0.547 . . . . 0.0 111.823 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.47 HD11 HD22 ' A' ' 58' ' ' LEU . 12.1 mt -86.16 85.44 7.35 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.722 -0.611 . . . . 0.0 111.529 -172.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.401 ' O ' ' ND1' ' A' ' 35' ' ' HIS . 33.8 p80 -78.64 66.58 4.18 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.672 0.748 . . . . 0.0 112.046 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 47.0 t80 60.18 9.24 1.8 Allowed 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.55 -34.95 1.53 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.584 -0.697 . . . . 0.0 111.483 -178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.456 HD12 ' HE3' ' A' ' 42' ' ' MET . 11.6 mm -73.21 107.36 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.931 0.396 . . . . 0.0 111.329 -175.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.5 p -99.54 179.23 4.62 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.957 0.408 . . . . 0.0 112.014 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -60.48 -43.13 97.28 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.275 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.31 -37.21 82.43 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.129 0.49 . . . . 0.0 110.959 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.691 ' HE2' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -67.54 -55.02 15.16 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.334 0.588 . . . . 0.0 110.246 178.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.4 mt -55.18 -44.12 74.94 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.444 176.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.497 HH21 ' NH1' ' A' ' 52' ' ' ARG . 53.9 ttt180 -58.7 -47.34 84.89 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.232 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.44 -31.59 60.05 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.998 177.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.8 mt -80.28 -54.48 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -79.76 -33.91 40.29 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -172.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.826 ' HG3' ' HA ' ' A' ' 52' ' ' ARG . 10.1 tt0 -60.78 -38.67 58.54 Favored Pre-proline 0 N--CA 1.476 0.867 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -172.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -46.3 -26.52 3.98 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.535 2.157 . . . . 0.0 113.798 172.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -66.91 -63.74 1.0 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.653 0.263 . . . . 0.0 111.595 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.472 ' HA3' ' SG ' ' A' ' 80' ' ' CYS . . . -165.65 40.02 0.28 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.472 -0.87 . . . . 0.0 114.314 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.826 ' HA ' ' HG3' ' A' ' 48' ' ' GLU . 43.7 tpt85 71.26 127.18 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 172.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.494 HG22 HG13 ' A' ' 56' ' ' ILE . 1.7 mp -82.89 141.31 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.038 0.447 . . . . 0.0 111.432 175.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -90.29 -56.22 3.3 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.309 0.576 . . . . 0.0 109.656 173.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.6 m -150.6 144.02 25.0 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.46 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.494 HG13 HG22 ' A' ' 53' ' ' ILE . 57.3 mt -122.29 109.87 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.023 0.44 . . . . 0.0 110.776 175.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -108.83 112.26 24.42 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.314 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.47 HD22 HD11 ' A' ' 34' ' ' LEU . 32.7 mt -98.69 141.91 30.92 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.81 0.338 . . . . 0.0 110.921 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 64.7 mtp -93.66 103.38 15.54 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.167 0.508 . . . . 0.0 111.488 -176.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.579 ' HG2' ' HA ' ' A' ' 67' ' ' SER . 65.4 mtm -124.57 152.88 42.96 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.984 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.439 ' HB3' ' CA ' ' A' ' 65' ' ' GLY . 11.4 t70 -98.83 114.46 27.05 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 174.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.2 p -75.09 -19.69 59.83 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -172.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -71.04 -68.29 0.45 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.152 0.501 . . . . 0.0 110.713 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.3 t -162.51 11.87 0.07 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.322 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.439 ' CA ' ' HB3' ' A' ' 61' ' ' ASP . . . -89.82 -27.73 20.78 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.558 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.7 mtt-85 61.49 -160.42 0.31 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.981 0.513 . . . . 0.0 111.729 174.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.579 ' HA ' ' HG2' ' A' ' 60' ' ' MET . 60.6 m -56.07 113.13 1.4 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -70.23 -27.05 64.16 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.2 -6.63 19.17 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 120.917 -0.659 . . . . 0.0 114.439 174.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -135.56 151.72 50.58 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 117.376 0.588 . . . . 0.0 112.364 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.7 158.76 27.83 Favored Glycine 0 CA--C 1.527 0.844 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.734 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -101.51 120.44 40.3 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.601 -0.352 . . . . 0.0 111.603 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.494 HG12 HG23 ' A' ' 56' ' ' ILE . 70.9 mt -103.9 117.11 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.278 0.561 . . . . 0.0 111.249 178.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 51.9 m -99.85 125.71 45.85 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.68 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -103.3 150.44 23.75 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.782 175.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.8 t -72.92 -11.87 60.74 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.683 0.278 . . . . 0.0 111.65 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -126.24 144.38 50.8 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.852 0.358 . . . . 0.0 110.986 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 54.5 m -78.78 -43.67 24.94 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -69.69 -34.9 74.58 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.826 0.346 . . . . 0.0 111.508 -175.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.472 ' SG ' ' HA3' ' A' ' 51' ' ' GLY . 35.8 t -60.04 -43.39 95.36 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.068 0.461 . . . . 0.0 111.081 174.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.39 -40.97 96.84 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.01 176.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -56.67 -46.44 81.1 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.965 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.434 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 86.8 tttt -62.03 -54.04 47.06 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.288 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.92 -52.12 61.58 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.894 0.378 . . . . 0.0 111.836 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.9 tt -53.87 -54.6 36.29 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.621 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -64.67 -25.14 67.82 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -173.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 83' ' ' LYS . 8.3 mm-40 -95.72 -17.79 20.98 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.465 ' HB3' ' SD ' ' A' ' 98' ' ' MET . 90.2 mt -112.2 -24.53 9.79 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -175.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -60.03 101.41 0.12 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.169 0.509 . . . . 0.0 111.534 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.65 -15.98 9.69 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 116.063 -0.517 . . . . 0.0 113.013 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -63.41 129.98 42.53 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 122.658 -0.319 . . . . 0.0 111.784 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -65.86 94.31 0.21 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.993 0.425 . . . . 0.0 111.18 175.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.691 HD12 ' HE2' ' A' ' 42' ' ' MET . 66.9 tp -86.75 115.25 24.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.426 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 55.92 22.35 5.65 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 109.26 -9.41 33.32 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 114.098 0.399 . . . . 0.0 114.098 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -130.93 134.89 26.51 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 117.405 0.603 . . . . 0.0 110.78 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.66 149.42 13.87 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.819 2.346 . . . . 0.0 113.26 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.539 ' HA ' ' HB2' ' A' ' 33' ' ' SER . 43.9 ttm -96.85 104.78 16.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.234 0.54 . . . . 0.0 109.906 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.685 ' HZ2' ' HB3' ' A' ' 99' ' ' LYS . 2.0 mmmp? -87.84 89.9 8.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.708 -175.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 20.4 t -105.2 117.82 51.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.089 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -148.14 162.15 28.73 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.208 -0.52 . . . . 0.0 113.053 -176.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -64.18 158.9 21.82 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.305 0.574 . . . . 0.0 111.552 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 103' ' ' VAL . 12.1 t -91.12 11.39 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 121.668 0.747 . . . . 0.0 109.846 177.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 34.4 m 78.1 -19.7 0.42 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.032 0.933 . . . . 0.0 111.281 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 61.68 136.74 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.699 0.8 . . . . 0.0 112.961 176.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -76.3 65.92 2.3 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.337 0.589 . . . . 0.0 112.123 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.7 m -157.18 132.52 9.11 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.101 175.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 C--O 1.254 1.333 0 CA-C-O 118.572 -0.728 . . . . 0.0 112.342 -179.402 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.465 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.575 0.226 . . . . 0.0 111.124 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -114.56 -52.93 0.43 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.326 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -62.26 105.17 0.57 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.784 0.326 . . . . 0.0 110.619 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -75.36 -61.36 1.93 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -173.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -161.47 -56.15 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -77.46 98.65 5.37 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.053 0.454 . . . . 0.0 111.475 -175.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -135.35 15.74 3.45 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.507 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -98.81 24.32 7.77 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 120.857 0.36 . . . . 0.0 111.265 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.9 p -130.39 -83.68 0.54 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 55.44 38.63 30.54 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 121.557 0.694 . . . . 0.0 111.158 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 83.2 mtp -96.63 99.18 10.82 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.563 -176.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.04 -29.54 15.15 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.059 0.456 . . . . 0.0 111.393 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.39 25.43 0.74 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.163 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -119.82 131.13 55.21 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.657 0.265 . . . . 0.0 111.158 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.2 mtt -85.27 -99.37 0.06 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.231 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 67.87 -24.9 0.12 Allowed 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 175.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -54.76 127.87 30.27 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.399 0.619 . . . . 0.0 112.237 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -81.34 21.49 0.76 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.609 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.0 tp -67.51 -22.87 65.42 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.411 0.624 . . . . 0.0 110.651 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -95.11 12.34 29.03 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.491 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 84.4 tttt 63.97 109.09 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.076 0.551 . . . . 0.0 111.23 -174.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.4 173.47 22.66 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.959 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.9 p -90.32 163.62 14.66 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.196 0.522 . . . . 0.0 111.674 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.35 -58.41 3.29 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.178 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.573 ' N ' ' HD2' ' A' ' 26' ' ' PRO . . . 143.47 -43.36 1.02 Allowed Glycine 0 CA--C 1.543 1.798 0 CA-C-O 119.074 -0.848 . . . . 0.0 115.198 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.62 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 14.4 Cg_exo -26.29 112.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.363 1.317 0 C-N-CA 124.782 3.655 . . . . 0.0 116.619 -176.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.9 ttt -139.46 138.22 36.24 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.46 170.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 62.8 mtt-85 -99.74 143.6 29.78 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.422 0.629 . . . . 0.0 112.483 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.0 mt -112.44 139.16 48.24 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.28 177.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -90.71 108.8 20.06 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.769 176.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.35 104.41 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.674 0.273 . . . . 0.0 111.201 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.511 ' HA2' ' HB3' ' A' ' 70' ' ' TYR . . . -114.64 91.68 0.57 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.201 -0.523 . . . . 0.0 113.945 -177.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 t -175.15 21.13 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.433 0.635 . . . . 0.0 111.174 175.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.45 HD21 HG23 ' A' ' 38' ' ' ILE . 13.1 mt -85.02 93.13 8.52 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.869 -0.52 . . . . 0.0 110.945 -173.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -81.44 62.1 5.18 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.293 0.568 . . . . 0.0 112.531 -174.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 62.0 t80 59.61 9.22 1.49 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 173.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -130.95 4.95 4.51 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.61 -0.681 . . . . 0.0 111.502 -178.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.543 HG21 ' SD ' ' A' ' 42' ' ' MET . 27.1 mm -105.25 127.98 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 122.111 -0.368 . . . . 0.0 110.81 -177.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.6 p -107.23 167.3 10.01 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.936 0.398 . . . . 0.0 111.788 -176.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -55.21 -44.5 75.42 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.125 0.488 . . . . 0.0 110.878 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -68.03 -31.63 71.43 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.184 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.543 ' SD ' HG21 ' A' ' 38' ' ' ILE . 52.5 ttm -62.14 -50.21 72.77 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.406 0.622 . . . . 0.0 109.887 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.42 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 48.9 mt -57.14 -44.15 83.13 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.495 173.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -53.27 -47.35 69.21 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.078 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.74 -29.49 74.06 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.306 -0.473 . . . . 0.0 113.387 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.1 mt -84.59 -44.06 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 O-C-N 122.386 -0.479 . . . . 0.0 112.158 178.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.42 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 38.9 m-85 -85.64 -29.12 24.29 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -171.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -52.81 -47.33 95.21 Favored Pre-proline 0 N--CA 1.486 1.334 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -49.93 -18.22 2.83 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 122.801 2.334 . . . . 0.0 114.919 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.468 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 79.3 m-85 -78.69 -70.48 0.49 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.431 ' N ' ' SG ' ' A' ' 80' ' ' CYS . . . -157.95 24.25 0.4 Allowed Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.713 -177.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 68.88 144.9 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.506 HD11 ' N ' ' A' ' 53' ' ' ILE . 4.0 mp -107.22 139.72 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.45 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -78.32 -48.37 15.78 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.434 0.635 . . . . 0.0 110.937 175.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 61.3 m -151.2 132.28 14.35 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.66 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.452 HG22 HG12 ' A' ' 73' ' ' ILE . 54.6 mt -106.45 129.05 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 173.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -130.41 134.44 47.14 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.851 0.358 . . . . 0.0 111.658 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 76.1 mt -98.72 144.02 28.44 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.81 0.338 . . . . 0.0 110.623 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 10.0 tpt -94.08 116.15 28.54 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.315 0.579 . . . . 0.0 111.227 -176.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.0 mtt -111.61 173.83 6.16 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.375 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.484 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 23.6 t70 -81.47 118.76 22.98 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.79 0.328 . . . . 0.0 110.782 177.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.0 t -61.28 -9.78 5.74 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -174.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -102.52 -66.18 0.94 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.009 0.433 . . . . 0.0 111.698 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.452 ' OG1' ' HG2' ' A' ' 66' ' ' ARG . 57.2 p -96.18 -14.63 22.62 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -173.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.96 18.28 63.54 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 120.877 -0.678 . . . . 0.0 113.573 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.452 ' HG2' ' OG1' ' A' ' 64' ' ' THR . 11.1 mmm180 -68.21 170.03 9.35 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.255 0.55 . . . . 0.0 111.876 177.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.8 m -89.48 124.73 34.76 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.76 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.484 ' HE2' ' HA ' ' A' ' 61' ' ' ASP . 73.6 mmtt -79.99 -23.76 41.33 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 122.076 -0.39 . . . . 0.0 111.89 177.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.76 5.24 63.05 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.589 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.511 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 2.2 p90 -141.45 158.98 43.16 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.034 0.445 . . . . 0.0 111.851 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.47 161.25 28.9 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 116.256 -0.429 . . . . 0.0 113.04 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -109.15 123.08 48.63 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.169 0.509 . . . . 0.0 111.738 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.452 HG12 HG22 ' A' ' 56' ' ' ILE . 78.4 mt -107.69 122.27 61.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 178.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.46 ' O ' HG23 ' A' ' 53' ' ' ILE . 28.2 m -99.57 115.38 29.24 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -175.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.62 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 40.9 m-85 -97.66 141.41 30.72 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.59 0.233 . . . . 0.0 111.437 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.9 t -73.75 -3.3 27.58 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.377 176.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' A' ' 80' ' ' CYS . 11.2 t70 -132.95 121.03 22.2 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.787 0.327 . . . . 0.0 110.687 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.2 p -60.19 -51.81 67.98 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.12 -36.77 85.11 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.773 0.32 . . . . 0.0 110.993 -177.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.559 ' HB3' ' HB3' ' A' ' 77' ' ' ASP . 25.0 t -63.08 -40.75 98.57 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.797 0.332 . . . . 0.0 111.362 175.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.503 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . . . -63.86 -47.6 80.07 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.317 0.58 . . . . 0.0 110.551 175.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -57.44 -42.11 81.8 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.655 176.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -66.87 -49.58 65.23 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.817 0.341 . . . . 0.0 111.182 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.66 -44.45 69.66 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.204 0.526 . . . . 0.0 110.662 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.1 tt -56.96 -58.5 7.87 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.686 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -61.31 -25.88 67.42 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -174.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.594 ' N ' HE21 ' A' ' 87' ' ' GLN . 0.0 OUTLIER -89.16 -46.16 9.02 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.805 0.336 . . . . 0.0 111.754 -179.814 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 70.7 mt -89.81 -9.3 49.7 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -169.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -67.78 82.27 0.19 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.446 0.641 . . . . 0.0 110.826 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 142.7 -21.2 2.36 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.606 -175.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.456 ' HB3' ' HE3' ' A' ' 98' ' ' MET . 59.6 t80 -48.92 119.51 3.24 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.221 0.608 . . . . 0.0 111.52 178.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -69.37 93.6 0.66 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.27 0.557 . . . . 0.0 110.995 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.447 HD22 HG23 ' A' ' 38' ' ' ILE . 51.2 tp -85.46 111.59 20.11 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.223 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 63.02 2.78 1.09 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 126.69 -7.82 7.36 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.524 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -122.79 130.29 24.68 Favored Pre-proline 0 N--CA 1.47 0.555 0 CA-C-N 117.01 0.405 . . . . 0.0 110.906 176.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.55 136.51 41.07 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.427 2.085 . . . . 0.0 112.016 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.456 ' HE3' ' HB3' ' A' ' 91' ' ' PHE . 51.3 ttp -95.96 116.42 28.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.43 0.633 . . . . 0.0 111.077 -172.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -88.29 92.51 9.19 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.079 -176.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.7 t -99.83 107.31 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.642 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -134.95 161.22 24.53 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.569 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -56.71 143.48 36.29 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.479 -0.424 . . . . 0.0 111.908 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 49.0 t -51.85 -31.81 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 120.961 0.41 . . . . 0.0 111.893 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 91.5 m -51.2 120.9 5.42 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.089 174.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -71.31 76.92 0.74 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.249 0.547 . . . . 0.0 111.926 -177.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 44.36 -102.03 0.05 Allowed 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.908 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.9 m 70.25 -35.45 0.32 Allowed 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -177.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 . . . . . 0 C--O 1.253 1.264 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.792 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.547 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 120.869 0.366 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -109.5 -97.72 2.48 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 116.396 -0.366 . . . . 0.0 113.288 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.7 p-80 49.36 101.85 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.11 0.964 . . . . 0.0 113.011 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 77.5 m80 61.03 31.11 19.87 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.133 0.492 . . . . 0.0 111.069 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -82.55 -3.13 55.51 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -171.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -106.45 -30.52 9.04 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.856 0.36 . . . . 0.0 111.598 176.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -78.76 129.4 34.6 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.999 0.428 . . . . 0.0 111.791 -175.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -66.61 91.49 0.19 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.047 0.451 . . . . 0.0 111.501 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.0 t -166.44 175.92 7.78 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -141.7 158.97 43.16 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.735 0.302 . . . . 0.0 111.086 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -65.37 -28.06 69.01 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -174.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.85 -57.88 3.23 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.713 0.292 . . . . 0.0 111.294 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 68.15 -68.27 0.17 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 176.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.51 -61.41 1.93 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.94 36.33 2.8 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -175.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.36 103.84 0.27 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 120.874 0.368 . . . . 0.0 111.979 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -110.57 -49.11 3.08 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -23.15 106.42 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -172.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.4 mt -80.06 9.69 5.2 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -175.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 64.55 -164.73 0.25 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.1 mttt 69.35 -71.44 0.12 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.587 0.755 . . . . 0.0 112.478 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.37 -120.7 0.61 Allowed Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.587 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 84.8 p 57.02 23.72 8.69 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.466 0.707 . . . . 0.0 112.787 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -147.2 175.82 10.45 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.55 -58.82 9.26 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 116.194 -0.457 . . . . 0.0 113.562 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -49.53 118.59 3.82 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.831 2.354 . . . . 0.0 112.646 176.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 28.1 ttt -112.9 123.11 49.57 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.039 0.447 . . . . 0.0 111.268 -173.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.464 ' HD2' ' HB3' ' A' ' 72' ' ' PHE . 47.7 ttp180 -102.82 136.61 42.31 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.032 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.0 mt -107.51 148.59 29.01 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.233 0.54 . . . . 0.0 112.299 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -95.64 112.33 24.07 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.769 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.4 t -108.91 99.47 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.092 0.472 . . . . 0.0 111.207 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.78 89.13 0.84 Allowed Glycine 0 CA--C 1.524 0.642 0 C-N-CA 121.186 -0.53 . . . . 0.0 113.129 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.0 t -172.44 25.84 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.158 0.504 . . . . 0.0 111.107 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.4 HD21 ' HB ' ' A' ' 38' ' ' ILE . 62.4 mt -72.26 103.56 3.41 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.776 -0.578 . . . . 0.0 110.522 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -79.38 35.9 0.29 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 63.58 13.67 7.46 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 176.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -148.52 11.05 0.87 Allowed 'General case' 0 N--CA 1.473 0.725 0 O-C-N 122.065 -0.397 . . . . 0.0 111.692 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.542 HG21 ' SD ' ' A' ' 42' ' ' MET . 30.8 mm -83.33 140.11 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.639 0.256 . . . . 0.0 110.749 -178.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 79.1 p -116.8 161.27 19.54 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -55.41 -40.34 71.34 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.216 177.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -65.04 -39.55 93.49 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.533 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.542 ' SD ' HG21 ' A' ' 38' ' ' ILE . 50.5 ttm -61.83 -52.29 64.76 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.326 0.584 . . . . 0.0 110.525 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.445 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 55.8 mt -55.47 -53.64 53.75 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.2 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.502 ' HB2' HD13 ' A' ' 56' ' ' ILE . 53.0 ttt180 -54.36 -46.88 73.09 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.404 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.61 -31.02 69.84 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 116.288 -0.414 . . . . 0.0 113.447 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 68.7 mt -85.18 -37.6 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 O-C-N 122.504 -0.41 . . . . 0.0 112.08 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.445 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 37.8 m-85 -85.38 -30.1 23.9 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -174.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -58.27 -39.89 78.86 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -45.69 -15.34 0.13 Allowed 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 122.112 1.875 . . . . 0.0 114.253 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -103.97 -23.11 13.37 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.43 ' HA3' ' HB2' ' A' ' 80' ' ' CYS . . . -174.57 -128.6 1.1 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.275 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -151.82 124.94 8.67 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 122.402 -0.47 . . . . 0.0 110.358 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.5 HD11 ' N ' ' A' ' 53' ' ' ILE . 3.5 mp -86.7 138.5 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.412 -178.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -83.98 -54.74 4.64 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.895 0.379 . . . . 0.0 111.186 175.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.4 m -141.92 138.53 32.08 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.88 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.516 HG22 HG12 ' A' ' 73' ' ' ILE . 65.3 mt -108.11 112.2 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.807 0.337 . . . . 0.0 110.918 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -105.81 129.02 54.08 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.924 0.392 . . . . 0.0 110.758 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.6 mp -111.33 148.72 32.35 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.149 -0.345 . . . . 0.0 110.505 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 96.0 mmm -92.14 104.53 16.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.292 0.568 . . . . 0.0 110.145 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 73.7 mtm -118.99 159.37 23.96 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.277 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -51.98 -21.82 3.42 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.223 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.3 m 75.24 -37.02 0.32 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 176.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -84.97 -67.64 0.78 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.198 0.523 . . . . 0.0 109.798 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.7 p -72.12 -33.78 68.08 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.419 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.45 23.28 26.91 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 115.524 -0.762 . . . . 0.0 113.378 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -85.86 161.29 19.16 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 122.709 -0.289 . . . . 0.0 110.993 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.3 t -82.94 141.49 32.11 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -176.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -91.53 -3.35 56.61 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.341 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.49 -6.13 65.26 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.044 -0.598 . . . . 0.0 114.552 175.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -143.9 155.97 44.28 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 117.453 0.627 . . . . 0.0 112.054 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -145.46 160.77 28.14 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.23 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.464 ' HB3' ' HD2' ' A' ' 28' ' ' ARG . 96.9 m-85 -119.12 116.54 26.58 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.26 0.552 . . . . 0.0 111.888 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.516 HG12 HG22 ' A' ' 56' ' ' ILE . 70.5 mt -104.13 126.7 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.669 -177.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.7 m -99.27 117.47 33.8 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -99.03 150.52 21.91 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.991 0.424 . . . . 0.0 111.569 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.2 t -80.92 -2.35 47.28 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.145 0.498 . . . . 0.0 111.458 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.548 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 29.3 t70 -142.52 143.86 32.7 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.12 0.486 . . . . 0.0 111.219 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.8 t -75.15 -42.93 55.07 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.849 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.51 -47.53 85.18 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -177.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.548 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 30.8 p -60.04 -40.81 90.67 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.996 0.427 . . . . 0.0 111.333 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.09 -45.94 83.14 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.253 0.549 . . . . 0.0 111.003 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -60.47 -38.64 84.86 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.053 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -67.86 -42.06 81.92 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.536 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.22 -49.71 76.52 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.106 176.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.458 ' C ' HD21 ' A' ' 85' ' ' LEU . 7.0 tt -53.89 -54.9 32.21 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.211 0.529 . . . . 0.0 110.205 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -47.15 -39.74 14.25 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.482 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -97.62 -33.48 11.31 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -174.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 92.6 mt -92.83 -15.54 26.37 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -173.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -67.0 93.64 0.29 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.23 0.538 . . . . 0.0 109.974 176.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.9 10.78 15.39 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.334 -174.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -77.54 133.76 38.44 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.518 0.327 . . . . 0.0 111.306 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -75.76 88.17 2.8 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.156 0.503 . . . . 0.0 111.762 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.489 HD21 ' HE1' ' A' ' 98' ' ' MET . 55.1 tp -90.42 125.9 35.71 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.58 175.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 55.75 26.79 9.87 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.157 0.503 . . . . 0.0 111.541 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.8 15.59 72.56 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 116.128 -0.487 . . . . 0.0 113.38 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 30.5 mtp180 -139.13 144.31 40.25 Favored Pre-proline 0 N--CA 1.472 0.641 0 O-C-N 122.604 -0.35 . . . . 0.0 111.743 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.67 138.0 83.99 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.379 2.719 . . . . 0.0 114.118 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.489 ' HE1' HD21 ' A' ' 93' ' ' LEU . 47.0 ttm -99.37 114.84 27.96 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.031 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -89.25 101.34 14.01 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 122.068 -0.395 . . . . 0.0 111.409 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.6 t -108.04 117.27 53.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.071 0.463 . . . . 0.0 112.064 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.55 160.87 12.91 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.523 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -95.11 37.21 1.17 Allowed 'General case' 0 N--CA 1.479 0.978 0 O-C-N 122.147 -0.62 . . . . 0.0 112.327 -174.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.438 ' C ' ' H ' ' A' ' 105' ' ' GLU . 23.3 m 44.44 -174.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.639 0.776 . . . . 0.0 112.627 -172.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.8 m 71.66 -39.46 0.45 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 120.916 0.389 . . . . 0.0 110.823 -172.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.438 ' H ' ' C ' ' A' ' 103' ' ' VAL . 39.8 mt-10 -58.71 89.27 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.202 0.601 . . . . 0.0 111.51 176.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.26 -8.13 3.37 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.556 175.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 43.5 p -101.42 175.64 5.5 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.333 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.623 -0.703 . . . . 0.0 111.991 178.508 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.527 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.3 mpp? . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.829 0.347 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.3 148.37 45.6 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.279 174.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -70.09 81.37 0.5 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.451 0.643 . . . . 0.0 111.384 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -66.51 108.94 2.58 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.883 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -98.33 -40.67 8.21 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.186 0.517 . . . . 0.0 110.786 176.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -102.4 159.55 15.32 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.573 -177.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 47.7 m80 -94.06 162.11 14.01 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.958 0.408 . . . . 0.0 111.741 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -76.89 -16.45 59.39 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -172.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 94.3 p -57.46 105.86 0.28 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.951 0.405 . . . . 0.0 111.995 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.608 ' HB3' ' SD ' ' A' ' 11' ' ' MET . 85.0 m-70 -138.53 -92.58 0.2 Allowed 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 177.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.608 ' SD ' ' HB3' ' A' ' 10' ' ' HIS . 2.1 mpt? -132.44 -175.15 3.66 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.171 0.51 . . . . 0.0 111.452 -177.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.67 118.83 11.47 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.018 176.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 59.51 29.35 18.91 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.453 ' HB1' ' HB2' ' A' ' 11' ' ' MET . . . -85.53 26.25 0.96 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.0 ttt -83.41 -1.68 54.02 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.277 0.561 . . . . 0.0 111.207 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.89 125.9 35.89 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.364 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -66.39 110.76 3.22 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.887 0.375 . . . . 0.0 111.437 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.498 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 17.1 m120 64.48 -86.54 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.832 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 7.3 tt 167.69 -56.44 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -176.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 44.17 104.61 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 177.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -71.83 90.6 1.11 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.884 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.59 -168.36 51.31 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.381 -0.438 . . . . 0.0 112.572 -176.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.2 t -65.03 128.11 34.4 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.462 -0.434 . . . . 0.0 111.077 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -151.47 134.3 15.69 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.117 0.484 . . . . 0.0 112.035 -177.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.7 65.44 0.83 Allowed Glycine 0 CA--C 1.532 1.139 0 CA-C-N 116.063 -0.517 . . . . 0.0 113.556 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -81.17 118.37 3.31 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.538 2.159 . . . . 0.0 112.217 176.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.471 ' HB2' ' HA ' ' A' ' 78' ' ' SER . 21.6 ttt -104.92 138.93 40.41 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.79 0.329 . . . . 0.0 111.226 -176.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -108.13 126.99 53.4 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.881 0.372 . . . . 0.0 111.524 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 75.2 mt -105.5 140.8 38.04 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.196 0.522 . . . . 0.0 111.779 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -95.17 115.21 27.13 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.152 173.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.7 t -109.26 101.22 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.054 0.454 . . . . 0.0 111.595 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.411 ' HA2' ' HB3' ' A' ' 70' ' ' TYR . . . -101.62 89.06 0.74 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.77 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.8 t -174.69 22.08 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.112 0.482 . . . . 0.0 111.353 178.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.461 HD22 HD21 ' A' ' 43' ' ' LEU . 14.6 mt -77.93 70.5 4.31 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.765 0.793 . . . . 0.0 110.222 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -66.06 78.97 0.09 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.014 -0.994 . . . . 0.0 113.036 -175.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.6 t80 45.99 38.71 4.87 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 121.287 0.565 . . . . 0.0 112.443 171.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -166.62 -41.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.7 mm -73.69 103.21 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 121.073 0.463 . . . . 0.0 112.059 -173.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.8 p -93.23 173.89 7.49 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.43 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.453 ' HA ' HD13 ' A' ' 43' ' ' LEU . 25.3 mt-10 -51.1 -39.45 56.16 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.695 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.06 -48.73 80.5 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.553 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.4 mmt -63.42 -40.68 97.83 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.961 0.41 . . . . 0.0 110.762 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.461 HD21 HD22 ' A' ' 34' ' ' LEU . 77.0 mt -57.04 -44.68 83.17 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.429 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -60.93 -47.12 87.88 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.999 0.428 . . . . 0.0 111.099 174.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.42 -32.32 64.13 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.579 -178.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.7 mt -86.49 -50.93 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 121.099 0.475 . . . . 0.0 112.208 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 75' ' ' PHE . 42.5 m-85 -85.29 -40.55 16.45 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -171.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -58.6 -37.57 55.76 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -175.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -51.98 -12.7 1.43 Allowed 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 122.217 1.945 . . . . 0.0 114.088 171.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -91.49 -31.26 16.03 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.108 0.48 . . . . 0.0 111.052 173.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' A' ' 80' ' ' CYS . . . -178.85 134.66 2.39 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.461 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.04 129.97 18.14 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.095 0.474 . . . . 0.0 111.698 -178.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.9 mt -95.34 128.72 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.076 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.417 ' HG2' ' OG ' ' A' ' 76' ' ' SER . 14.7 mm-40 -73.11 -57.43 4.03 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.972 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.9 t -151.76 148.99 28.53 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.716 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.422 HG12 HG21 ' A' ' 73' ' ' ILE . 45.6 mt -120.84 140.46 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.599 175.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -122.65 110.07 15.07 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.447 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.522 HD23 ' HG3' ' A' ' 60' ' ' MET . 3.4 tt -98.39 129.51 45.03 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -177.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.408 ' N ' HD22 ' A' ' 58' ' ' LEU . 55.0 mtp -93.61 94.78 8.81 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.676 0.75 . . . . 0.0 112.452 -174.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.522 ' HG3' HD23 ' A' ' 58' ' ' LEU . 65.3 mtt -112.16 146.49 37.99 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.079 171.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.43 ' CG ' ' HZ3' ' A' ' 68' ' ' LYS . 6.8 m-20 -63.98 101.51 0.4 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.655 0.264 . . . . 0.0 111.403 176.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.8 m -63.29 -5.17 3.12 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.933 0.396 . . . . 0.0 111.751 176.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -81.49 -58.58 2.96 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.336 0.588 . . . . 0.0 111.081 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.6 p -102.65 -31.63 10.28 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.156 -176.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.67 26.93 8.26 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 116.301 -0.409 . . . . 0.0 112.698 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.0 mmm180 -98.06 156.5 16.62 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.089 0.471 . . . . 0.0 112.014 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.7 m -95.41 114.62 26.41 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.867 -177.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.43 ' HZ3' ' CG ' ' A' ' 61' ' ' ASP . 29.9 mttp -76.06 -11.78 60.0 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.24 15.17 57.81 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.454 0.942 . . . . 0.0 115.454 169.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.411 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 3.2 p90 -147.36 152.75 38.71 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.167 0.984 . . . . 0.0 112.754 177.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.81 160.58 28.68 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 115.496 -0.775 . . . . 0.0 113.059 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -108.77 126.41 52.99 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 122.579 -0.365 . . . . 0.0 111.463 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.422 HG21 HG12 ' A' ' 56' ' ' ILE . 69.9 mt -112.31 131.36 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.806 0.336 . . . . 0.0 111.598 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 91.9 m -108.36 120.06 41.29 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 120.683 0.278 . . . . 0.0 111.537 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 47' ' ' PHE . 34.4 m-85 -98.94 150.19 22.19 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.731 0.301 . . . . 0.0 111.261 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.417 ' OG ' ' HG2' ' A' ' 54' ' ' GLU . 13.3 m -75.98 10.8 1.69 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -153.79 146.01 23.82 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.815 0.341 . . . . 0.0 110.779 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.471 ' HA ' ' HB2' ' A' ' 27' ' ' MET . 31.3 t -75.07 -48.09 25.62 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.866 0.365 . . . . 0.0 111.984 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -71.1 -31.16 67.44 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 122.274 -0.266 . . . . 0.0 111.49 -175.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.426 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . 93.2 m -59.85 -46.57 88.86 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.851 0.357 . . . . 0.0 111.2 174.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.69 -44.49 77.62 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.038 0.447 . . . . 0.0 110.868 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -54.28 -47.03 72.82 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.304 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.543 ' HB2' ' HZ3' ' A' ' 83' ' ' LYS . 4.1 ttmp? -67.58 -42.95 81.72 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.491 178.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.07 -45.43 71.73 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.079 0.466 . . . . 0.0 110.988 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 tt -57.48 -52.81 63.88 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.624 176.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -56.07 -35.84 67.43 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -87.7 -36.4 17.42 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -174.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 80.7 mt -95.88 -15.1 22.66 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -173.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -64.01 104.91 0.77 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.943 0.401 . . . . 0.0 110.127 174.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.95 16.91 42.79 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.88 -176.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -77.28 133.92 38.69 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.428 0.291 . . . . 0.0 111.201 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.32 92.88 5.21 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.5 tp -100.03 126.39 46.22 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 122.276 -0.265 . . . . 0.0 110.327 175.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 64.75 12.15 7.42 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.859 0.362 . . . . 0.0 111.773 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.89 2.66 58.3 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.515 -0.374 . . . . 0.0 113.409 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -130.77 154.17 81.78 Favored Pre-proline 0 CA--C 1.543 0.708 0 O-C-N 122.46 -0.435 . . . . 0.0 111.032 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.2 151.63 84.82 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.878 2.385 . . . . 0.0 114.414 -174.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 46.2 ttm -109.47 120.45 42.53 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.216 177.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -89.33 99.19 12.23 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.914 0.388 . . . . 0.0 111.668 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.1 t -108.85 116.58 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.246 176.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -140.41 139.96 10.18 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.394 -0.431 . . . . 0.0 112.667 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -76.26 74.85 3.07 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 122.133 -0.628 . . . . 0.0 111.562 -177.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 103' ' ' VAL . 16.1 t 54.65 37.01 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-O 122.197 0.999 . . . . 0.0 110.129 -178.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.9 m -76.42 -15.18 59.99 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.657 -173.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -62.59 122.9 16.97 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -175.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 32.7 mtp180 57.26 32.07 21.13 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.985 176.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.6 p 59.16 -74.22 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.987 0.915 . . . . 0.0 112.85 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.3 t70 . . . . . 0 C--O 1.255 1.356 0 CA-C-O 119.086 -0.483 . . . . 0.0 111.276 -179.818 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ttt . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 3' ' ' HIS . . . 80.64 -67.35 3.55 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 114.381 0.512 . . . . 0.0 114.381 172.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.437 ' HB2' ' O ' ' A' ' 2' ' ' GLY . 14.1 m170 73.31 -56.12 0.66 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.2 p-80 -56.65 91.4 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -173.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -132.67 98.61 4.38 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.535 ' HD2' ' HB2' ' A' ' 9' ' ' SER . 10.2 p-80 -168.24 66.81 0.07 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.21 0.529 . . . . 0.0 111.012 172.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 41.2 m80 55.91 26.91 10.33 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.101 -175.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 63.82 -72.52 0.05 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.666 -169.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.535 ' HB2' ' HD2' ' A' ' 6' ' ' HIS . 41.5 m 48.76 26.98 1.41 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.219 0.533 . . . . 0.0 112.013 177.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.4 t60 -70.75 136.01 48.61 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.557 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.438 ' N ' ' SD ' ' A' ' 11' ' ' MET . 0.0 OUTLIER -56.56 133.32 53.42 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.066 0.46 . . . . 0.0 111.698 -177.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.1 -153.05 0.45 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.742 -177.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.5 13.21 3.16 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 177.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.75 146.56 28.05 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.763 0.316 . . . . 0.0 110.9 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.504 ' SD ' HD22 ' A' ' 19' ' ' LEU . 68.1 mtm -92.36 -79.36 0.39 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -172.54 -176.73 1.59 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.407 -176.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 58.9 m-20 -75.55 -37.85 59.71 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.208 0.528 . . . . 0.0 110.461 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.35 132.23 37.37 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.12 176.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.504 HD22 ' SD ' ' A' ' 15' ' ' MET . 57.4 tp -116.36 -56.42 2.3 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.124 0.487 . . . . 0.0 112.306 -174.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -76.7 -44.73 32.36 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.933 0.396 . . . . 0.0 111.745 -175.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -117.25 107.13 14.04 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.096 0.475 . . . . 0.0 111.126 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -133.7 -82.35 0.19 Allowed Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.145 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.1 t 57.0 17.23 3.25 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 175.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.14 25.94 3.07 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.104 -0.373 . . . . 0.0 111.849 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -110.12 101.04 1.36 Allowed Glycine 0 CA--C 1.531 1.09 0 C-N-CA 121.34 -0.457 . . . . 0.0 113.47 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -82.72 168.09 14.38 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.674 2.249 . . . . 0.0 112.222 174.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 28.2 ttt -123.59 122.81 39.12 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.913 0.387 . . . . 0.0 111.317 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 36.4 ttp-105 -104.34 133.44 49.24 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.106 0.479 . . . . 0.0 111.64 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.511 HD22 HD11 ' A' ' 85' ' ' LEU . 67.2 mt -107.33 140.53 40.1 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.148 0.499 . . . . 0.0 111.817 -177.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -99.02 116.92 32.36 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.805 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.3 t -115.69 130.83 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 120.744 0.307 . . . . 0.0 111.611 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.06 105.52 0.61 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 121.229 -0.51 . . . . 0.0 113.733 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.3 t -175.05 16.27 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.228 0.537 . . . . 0.0 111.689 175.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.515 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 10.7 mt -87.03 87.3 7.42 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.962 -0.461 . . . . 0.0 111.692 -170.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -80.65 60.94 4.16 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.361 0.601 . . . . 0.0 112.075 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.492 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 46.6 t80 57.48 8.96 0.69 Allowed 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 177.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -126.88 -2.8 6.54 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.704 -0.622 . . . . 0.0 111.858 -176.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.495 HD13 ' HB3' ' A' ' 94' ' ' ALA . 17.7 mm -108.76 122.38 63.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 122.185 -0.322 . . . . 0.0 110.636 -178.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.2 p -98.08 161.91 13.48 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.826 0.346 . . . . 0.0 111.886 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -56.28 -35.16 67.16 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.441 0.639 . . . . 0.0 110.033 173.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.93 -39.53 93.65 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.374 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.3 mmt -68.88 -43.87 74.43 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.103 0.478 . . . . 0.0 110.857 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.428 ' HB3' HD12 ' A' ' 73' ' ' ILE . 78.7 mt -56.29 -42.64 77.84 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.141 0.496 . . . . 0.0 110.661 174.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.411 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 66.6 ttp85 -60.62 -49.87 75.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.089 176.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.89 -33.53 63.77 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 121.375 -0.44 . . . . 0.0 113.404 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.9 mm -80.6 -40.69 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.415 ' HB3' ' HZ ' ' A' ' 75' ' ' PHE . 26.5 m-85 -85.5 -26.42 26.26 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -175.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 44' ' ' ARG . 1.8 mt-10 -59.2 -38.2 60.92 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -45.88 -20.67 0.78 Allowed 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.171 1.914 . . . . 0.0 113.852 172.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -96.17 -29.56 13.99 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.49 -142.1 3.31 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.831 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 57.8 ttm-85 -103.47 -38.71 7.05 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -177.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.1 mt 69.18 107.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.12 0.568 . . . . 0.0 111.351 -172.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -80.89 -41.09 23.62 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.992 0.425 . . . . 0.0 111.379 -176.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 93.3 p -151.34 142.2 22.92 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.866 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.0 mt -123.58 106.19 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 120.873 0.368 . . . . 0.0 110.782 172.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -99.72 110.97 23.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.849 0.356 . . . . 0.0 110.559 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.419 HD23 ' N ' ' A' ' 59' ' ' MET . 6.7 tt -97.99 133.73 42.07 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.419 ' N ' HD23 ' A' ' 58' ' ' LEU . 55.0 mtp -91.93 113.38 25.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.363 0.601 . . . . 0.0 110.566 -176.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -138.44 139.09 38.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.816 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -72.54 83.9 1.12 Allowed 'General case' 0 C--O 1.237 0.435 0 CA-C-O 120.839 0.352 . . . . 0.0 110.41 174.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.7 m -56.2 -15.71 4.22 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -175.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.439 ' O ' ' HB ' ' A' ' 64' ' ' THR . 31.2 mm-40 -53.16 -48.5 67.92 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.234 0.54 . . . . 0.0 109.817 172.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.439 ' HB ' ' O ' ' A' ' 63' ' ' GLU . 14.0 t 164.4 -4.82 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.768 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.25 -24.39 75.51 Favored Glycine 0 C--N 1.34 0.8 0 C-N-CA 121.24 -0.505 . . . . 0.0 111.985 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 46.9 mtt180 70.43 -158.8 0.14 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 122.723 0.409 . . . . 0.0 112.081 170.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.492 ' HB3' ' HA ' ' A' ' 36' ' ' PHE . 36.0 t -50.68 115.55 1.54 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -174.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -71.36 -30.81 66.6 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.065 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 124.84 -7.4 8.26 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 120.929 -0.653 . . . . 0.0 114.355 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -140.23 152.13 45.72 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 117.45 0.625 . . . . 0.0 112.603 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.02 160.35 28.6 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.812 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -110.7 121.74 46.09 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.547 -0.384 . . . . 0.0 111.477 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.428 HD12 ' HB3' ' A' ' 43' ' ' LEU . 71.8 mt -110.09 119.94 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.966 0.412 . . . . 0.0 111.317 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 45.6 m -100.19 125.55 46.35 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -174.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.415 ' HZ ' ' HB3' ' A' ' 47' ' ' PHE . 82.8 m-85 -106.24 144.86 32.33 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.033 173.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.7 t -69.14 -32.66 72.18 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.103 0.478 . . . . 0.0 110.806 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -108.28 132.52 53.6 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.36 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.4 t -71.21 -35.42 71.52 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -67.29 -44.82 78.31 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.096 0.474 . . . . 0.0 110.832 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 67.4 m -60.46 -36.3 77.92 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.029 0.443 . . . . 0.0 110.751 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.49 -44.63 82.11 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.505 176.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -60.64 -47.27 86.97 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.878 0.37 . . . . 0.0 111.514 176.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.32 -43.08 88.02 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.205 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.6 -53.2 55.39 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.018 0.437 . . . . 0.0 111.112 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.511 HD11 HD22 ' A' ' 29' ' ' LEU . 9.8 tt -53.47 -53.5 50.59 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.456 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.56 -34.64 78.34 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -174.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -88.12 -24.76 23.28 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 89.8 mt -95.36 -13.8 24.42 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -56.52 101.88 0.07 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.241 0.543 . . . . 0.0 110.582 168.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.77 30.56 11.32 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.027 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -92.44 103.98 16.35 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.752 0.31 . . . . 0.0 110.484 173.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -71.01 85.57 0.71 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.395 0.617 . . . . 0.0 111.571 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 61.1 tp -74.57 -68.29 0.55 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.3 0.571 . . . . 0.0 110.907 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.495 ' HB3' HD13 ' A' ' 38' ' ' ILE . . . -86.56 38.17 0.77 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.336 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.19 21.81 66.5 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.22 -173.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 28.4 mtp-105 -139.28 141.74 30.26 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 122.86 0.464 . . . . 0.0 110.553 -175.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -52.97 142.01 54.59 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.265 2.644 . . . . 0.0 113.823 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 52.0 tpp -98.9 123.02 42.89 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.984 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -99.92 102.21 13.54 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 122.398 -0.189 . . . . 0.0 110.661 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 85' ' ' LEU . 26.5 t -118.66 108.24 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.011 0.434 . . . . 0.0 111.626 -178.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -129.06 154.18 20.15 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.005 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -70.48 147.32 49.53 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 122.213 -0.58 . . . . 0.0 110.902 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 28.1 m -62.38 137.65 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 120.95 0.405 . . . . 0.0 111.027 175.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 56.4 p -78.77 138.9 38.44 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.686 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -162.26 -90.13 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 106' ' ' ARG . 14.3 ttt-85 -139.34 8.44 2.44 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.443 0.64 . . . . 0.0 110.5 176.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.7 p -84.94 -20.12 31.14 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.911 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 C--O 1.252 1.2 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.4 -176.286 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.545 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.747 0.308 . . . . 0.0 111.064 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 135.84 -139.0 10.36 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.505 -0.378 . . . . 0.0 112.293 -178.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.53 134.27 54.08 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.997 0.427 . . . . 0.0 112.083 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -91.3 154.58 19.15 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.009 0.433 . . . . 0.0 111.08 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -78.69 134.38 37.11 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -173.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -167.1 140.89 3.71 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.68 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -70.51 8.33 0.85 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.2 t60 65.44 48.49 2.05 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.245 0.545 . . . . 0.0 111.32 175.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.5 t -79.62 104.26 10.09 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 175.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -67.71 88.04 0.23 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.5 mmt -128.87 22.19 5.82 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.114 177.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.57 52.09 2.0 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -176.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.8 -17.41 23.14 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.71 -21.47 66.53 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 178.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.1 mmt 64.98 -77.55 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.278 0.631 . . . . 0.0 112.488 177.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.73 133.3 51.79 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -159.61 155.01 25.49 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.886 0.374 . . . . 0.0 111.235 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -91.59 95.23 9.81 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.736 0.303 . . . . 0.0 111.021 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 47.0 tp -76.2 -45.35 33.62 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.374 0.607 . . . . 0.0 110.26 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -97.65 54.68 1.18 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.4 0.619 . . . . 0.0 110.802 176.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -57.61 102.3 0.09 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.577 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.08 -7.92 75.82 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.378 -0.439 . . . . 0.0 113.322 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 63.8 m 64.28 134.25 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.413 0.625 . . . . 0.0 112.565 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.11 -27.74 29.96 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.019 0.437 . . . . 0.0 110.774 172.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -129.55 160.75 22.76 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.695 176.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.54 146.01 30.3 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.825 2.35 . . . . 0.0 113.554 -178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 14.2 tpt -104.08 122.57 45.55 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.256 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -99.47 139.87 34.49 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.81 0.338 . . . . 0.0 111.358 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.0 mt -121.0 129.65 53.48 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.135 0.493 . . . . 0.0 111.406 176.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -91.58 112.83 24.9 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.393 175.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.7 t -103.67 99.76 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.011 0.434 . . . . 0.0 110.745 176.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.8 89.2 0.6 Allowed Glycine 0 CA--C 1.521 0.426 0 C-N-CA 121.003 -0.618 . . . . 0.0 113.107 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.412 ' CB ' ' HA ' ' A' ' 98' ' ' MET . 25.0 t -175.08 25.79 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.445 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 41.9 mt -69.41 107.4 3.31 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.362 -0.836 . . . . 0.0 109.499 176.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.487 ' CE1' ' HB3' ' A' ' 96' ' ' ARG . 29.3 m-70 -78.5 44.78 0.53 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -173.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.52 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 94.4 m-85 60.83 16.79 7.13 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.786 0.434 . . . . 0.0 111.988 -177.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -146.09 -33.52 0.32 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.6 mm -60.9 131.81 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.985 0.422 . . . . 0.0 111.788 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 74.7 p -116.63 169.57 9.25 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.048 0.452 . . . . 0.0 111.756 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.445 ' H ' HD13 ' A' ' 58' ' ' LEU . 2.3 pt-20 -61.73 -28.12 69.2 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.852 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -60.84 -40.0 91.17 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.937 0.399 . . . . 0.0 111.53 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.8 mtt -65.66 -53.66 38.18 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.255 0.55 . . . . 0.0 110.417 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.43 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 43.6 mt -56.15 -55.06 37.68 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.052 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -49.01 -46.78 44.54 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.576 176.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.46 -33.39 81.14 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 121.325 -0.464 . . . . 0.0 113.844 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 59.6 mt -86.3 -40.16 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.43 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 54.1 m-85 -77.73 -31.78 52.4 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.482 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 2.8 tm-20 -52.18 -48.6 88.42 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 90.5 Cg_exo -45.6 -28.81 4.64 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 122.538 2.159 . . . . 0.0 113.963 175.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -83.72 -47.97 10.63 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.907 0.384 . . . . 0.0 111.365 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.32 149.0 13.25 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 112.043 -0.423 . . . . 0.0 112.043 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.73 115.38 5.82 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.856 0.36 . . . . 0.0 110.793 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 53' ' ' ILE . 3.6 mp -66.97 138.55 22.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 120.939 0.399 . . . . 0.0 112.03 -178.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -80.3 -55.65 4.76 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.09 0.472 . . . . 0.0 110.817 173.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.5 p -151.33 140.72 21.47 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.78 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.455 HG13 HG22 ' A' ' 53' ' ' ILE . 49.2 mt -116.77 140.48 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 120.948 0.404 . . . . 0.0 110.511 172.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.431 HE21 ' HA ' ' A' ' 57' ' ' GLN . 0.1 OUTLIER -129.37 121.22 26.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.185 -179.113 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.445 HD13 ' H ' ' A' ' 40' ' ' GLU . 70.4 mt -96.68 130.49 43.9 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.724 0.297 . . . . 0.0 110.292 173.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 92.3 mmm -93.13 101.37 13.67 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.275 0.56 . . . . 0.0 111.068 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 62.9 mtt -97.83 156.38 16.61 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.715 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.657 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 9.2 m-20 -73.98 107.4 6.17 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.614 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 99.5 p -60.96 -14.41 22.51 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.038 0.447 . . . . 0.0 111.542 177.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -68.77 -32.43 72.17 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.43 0.633 . . . . 0.0 111.083 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.455 ' OG1' ' HG2' ' A' ' 66' ' ' ARG . 51.2 p -142.68 -50.67 0.36 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.988 -174.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.45 21.73 1.42 Allowed Glycine 0 CA--C 1.525 0.714 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.402 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.455 ' HG2' ' OG1' ' A' ' 64' ' ' THR . 28.0 mmm180 -86.6 -161.46 0.66 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.352 0.261 . . . . 0.0 110.927 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.52 ' HB3' ' HA ' ' A' ' 36' ' ' PHE . 37.6 t -113.07 130.56 56.12 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 121.814 -0.553 . . . . 0.0 111.516 178.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.657 ' HE3' ' HA ' ' A' ' 61' ' ' ASP . 97.4 mttt -81.88 -7.16 59.58 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 95.56 6.25 59.77 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 114.855 0.702 . . . . 0.0 114.855 173.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -149.94 156.52 41.88 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.312 1.056 . . . . 0.0 112.907 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.64 161.12 28.89 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.73 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -115.06 139.04 50.2 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 122.461 -0.435 . . . . 0.0 111.656 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 60.4 mt -122.65 144.26 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.723 0.297 . . . . 0.0 111.185 178.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.6 m -115.76 134.05 55.41 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -126.08 147.83 49.49 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.839 0.352 . . . . 0.0 111.331 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.0 m -93.38 13.26 22.08 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 120.899 0.38 . . . . 0.0 111.31 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.6 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 15.6 t70 -142.82 109.14 5.29 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.929 0.395 . . . . 0.0 110.698 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.0 m -66.32 -31.51 72.34 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -176.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -65.72 -57.73 7.34 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.788 0.328 . . . . 0.0 111.322 -176.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.6 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 31.2 p -58.06 -38.51 76.47 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.927 0.394 . . . . 0.0 111.144 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.52 -41.16 98.5 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.555 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -60.41 -44.18 95.98 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.944 0.402 . . . . 0.0 110.699 176.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -65.14 -47.46 77.0 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.349 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.15 -51.82 55.6 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.13 0.491 . . . . 0.0 110.934 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 100' ' ' VAL . 9.3 tt -55.51 -53.48 55.83 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.92 176.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -62.62 -28.44 69.9 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -174.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.594 ' N ' HE21 ' A' ' 87' ' ' GLN . 0.0 OUTLIER -89.96 -38.26 13.78 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.011 -0.431 . . . . 0.0 111.944 -179.008 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.417 ' HB3' ' HE2' ' A' ' 98' ' ' MET . 73.5 mt -92.24 -23.3 19.38 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -172.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -69.83 101.02 1.63 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.133 0.492 . . . . 0.0 110.837 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 117.25 -14.81 13.43 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 -173.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -70.57 125.5 27.0 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.835 0.35 . . . . 0.0 110.679 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -77.95 90.43 4.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.204 0.526 . . . . 0.0 112.046 -177.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.5 tp -81.14 132.1 35.34 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.727 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 62.13 25.1 15.01 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.074 0.464 . . . . 0.0 111.372 -176.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.8 32.66 53.22 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.12 -0.491 . . . . 0.0 113.221 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.487 ' HB3' ' CE1' ' A' ' 35' ' ' HIS . 55.7 ttt180 -159.09 131.62 4.41 Favored Pre-proline 0 CA--C 1.545 0.763 0 O-C-N 122.619 -0.342 . . . . 0.0 110.472 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -48.96 127.73 17.67 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 C-N-CA 123.557 2.838 . . . . 0.0 115.095 -172.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.417 ' HE2' ' HB3' ' A' ' 88' ' ' LEU . 50.1 ttp -99.56 117.88 34.92 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.723 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -89.49 105.7 17.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.908 0.385 . . . . 0.0 111.787 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.403 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 39.8 t -106.99 99.18 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 121.029 0.442 . . . . 0.0 111.159 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -107.89 162.4 13.2 Favored Glycine 0 C--O 1.223 -0.558 0 N-CA-C 112.136 -0.386 . . . . 0.0 112.136 178.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 -52.75 -84.76 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 117.78 0.79 . . . . 0.0 110.616 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.2 t -139.44 47.3 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 170.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.746 HG22 ' H ' ' A' ' 105' ' ' GLU . 4.3 m 64.35 -171.92 0.18 Allowed 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.415 -169.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.746 ' H ' HG22 ' A' ' 104' ' ' THR . 39.8 mm-40 72.77 -84.91 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 170.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -94.28 99.91 12.06 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -168.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 89.9 m -123.66 -59.26 1.54 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.954 168.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 . . . . . 0 C--O 1.251 1.132 0 CA-C-O 119.14 -0.457 . . . . 0.0 111.531 176.113 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.784 0.326 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -67.33 78.69 0.17 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.376 -0.44 . . . . 0.0 112.784 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -73.85 130.75 40.55 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.129 0.49 . . . . 0.0 111.935 -177.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -125.93 91.43 3.39 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.227 0.536 . . . . 0.0 111.886 -177.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -102.19 153.72 19.69 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.52 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -80.97 -17.78 49.23 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -171.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -63.15 91.69 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.434 0.635 . . . . 0.0 112.421 -176.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -145.22 16.84 1.53 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.316 176.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.4 m -85.45 19.85 2.22 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -173.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 9.8 t60 72.77 -48.71 0.69 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.103 0.561 . . . . 0.0 112.417 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 65.3 mtt -59.9 115.06 3.14 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.217 0.532 . . . . 0.0 111.962 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.35 -171.93 3.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.65 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.7 74.09 10.19 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.083 0.468 . . . . 0.0 110.912 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.39 -45.43 46.03 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -175.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.8 ttt -62.67 -51.69 66.26 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.849 0.357 . . . . 0.0 111.497 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -170.06 -83.47 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.938 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -167.88 -74.78 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 174.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 59.59 -76.98 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.51 0.724 . . . . 0.0 112.901 172.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 66.2 mt -89.84 88.98 7.55 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.933 0.396 . . . . 0.0 111.36 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -85.77 93.23 8.83 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.246 0.546 . . . . 0.0 111.855 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -112.72 -49.53 2.94 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.577 171.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.86 77.73 0.4 Allowed Glycine 0 CA--C 1.528 0.903 0 CA-C-N 116.247 -0.433 . . . . 0.0 113.516 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.6 t -66.3 -59.79 3.38 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.147 0.498 . . . . 0.0 110.935 176.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -95.02 -73.76 0.57 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.029 0.442 . . . . 0.0 110.88 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 155.39 97.13 0.13 Allowed Glycine 0 CA--C 1.527 0.826 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.06 178.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.78 120.64 7.85 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.232 1.955 . . . . 0.0 111.997 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 13.4 tpt -98.96 128.98 45.24 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.81 0.338 . . . . 0.0 110.809 -176.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -109.45 128.46 55.17 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.887 0.375 . . . . 0.0 111.28 -173.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.4 mt -100.06 144.94 28.51 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.223 0.535 . . . . 0.0 111.555 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -108.71 105.9 15.7 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.049 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.594 HG22 HG22 ' A' ' 100' ' ' VAL . 46.5 t -99.77 98.15 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.716 176.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.97 88.95 0.47 Allowed Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.761 -176.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.4 p -175.99 29.22 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.124 0.488 . . . . 0.0 110.991 176.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 30.9 mt -86.9 130.45 34.46 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.429 -174.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -83.24 63.1 7.03 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.289 0.566 . . . . 0.0 112.161 -174.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 55.29 8.92 0.31 Allowed 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -163.52 69.32 0.21 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.137 0.494 . . . . 0.0 112.043 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.0 mm -130.67 118.7 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 169.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.513 ' OG1' ' SD ' ' A' ' 42' ' ' MET . 14.6 p -91.08 163.35 14.33 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.312 0.577 . . . . 0.0 112.464 -172.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -61.07 -30.05 70.11 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.635 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.64 -47.66 71.86 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.378 -177.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.513 ' SD ' ' OG1' ' A' ' 39' ' ' THR . 1.3 mpt? -61.64 -48.39 81.08 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.101 0.477 . . . . 0.0 110.825 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.412 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 77.9 mt -54.62 -50.65 67.57 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.308 177.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.445 ' HG2' ' HG3' ' A' ' 48' ' ' GLU . 30.1 ttp-105 -52.63 -52.82 53.74 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.839 0.352 . . . . 0.0 110.887 178.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -54.81 -31.07 54.04 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 116.102 -0.499 . . . . 0.0 113.712 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.6 mt -79.68 -41.62 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 O-C-N 122.514 -0.404 . . . . 0.0 111.818 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.412 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 19.0 m-85 -82.66 -26.25 32.32 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -175.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.445 ' HG3' ' HG2' ' A' ' 44' ' ' ARG . 32.4 mt-10 -54.79 -47.57 97.85 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -178.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -48.79 -20.85 3.12 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.692 2.262 . . . . 0.0 114.686 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -82.12 -38.43 24.79 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.918 -0.489 . . . . 0.0 111.413 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -162.96 -99.89 0.14 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.681 -0.567 . . . . 0.0 111.681 176.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.7 ttp180 -162.76 153.7 17.18 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.768 0.318 . . . . 0.0 110.144 171.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.485 HG22 HG13 ' A' ' 56' ' ' ILE . 1.7 mp -84.12 139.94 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.126 0.488 . . . . 0.0 111.997 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -96.01 -60.51 1.62 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 174.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.3 t -150.63 126.62 10.47 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.251 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.527 HG23 HG12 ' A' ' 73' ' ' ILE . 54.8 mt -99.66 150.36 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 120.833 0.349 . . . . 0.0 111.284 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -149.82 134.8 17.9 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.683 0.278 . . . . 0.0 110.695 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.2 mt -97.28 142.68 28.87 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.739 0.304 . . . . 0.0 110.512 173.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.482 ' HB3' ' HB2' ' A' ' 70' ' ' TYR . 13.0 tpt -93.48 91.96 7.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.306 0.574 . . . . 0.0 109.788 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.543 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 21.6 ptp -111.78 177.07 4.77 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.001 -175.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -89.79 142.69 27.45 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.472 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 79.8 p -80.02 3.47 20.08 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -91.39 -66.79 0.9 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.286 0.565 . . . . 0.0 111.097 -178.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.453 ' OG1' ' HG3' ' A' ' 66' ' ' ARG . 32.8 p -102.39 -10.53 19.36 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.647 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.65 50.43 48.64 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.362 -0.447 . . . . 0.0 113.077 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.453 ' HG3' ' OG1' ' A' ' 64' ' ' THR . 64.3 mtt-85 -109.4 -79.63 0.58 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 122.424 -0.457 . . . . 0.0 111.862 -177.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 60' ' ' MET . 42.5 t 179.14 140.39 0.11 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -90.95 -2.37 57.72 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.455 169.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.23 15.29 48.45 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 116.165 -0.47 . . . . 0.0 113.732 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.482 ' HB2' ' HB3' ' A' ' 59' ' ' MET . 4.3 m-85 -130.79 160.85 33.15 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 122.475 -0.426 . . . . 0.0 111.546 -178.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.4 135.73 5.34 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 121.439 -0.41 . . . . 0.0 112.901 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -106.94 115.11 29.62 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 122.347 -0.502 . . . . 0.0 111.581 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 56' ' ' ILE . 58.7 mt -111.27 123.79 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.868 0.366 . . . . 0.0 111.344 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.5 m -99.68 131.32 45.75 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -176.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.421 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 80.9 m-85 -117.11 151.5 36.71 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.941 0.496 . . . . 0.0 111.327 177.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.6 t -73.72 -34.92 65.0 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.101 0.477 . . . . 0.0 110.924 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -100.28 124.98 46.41 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.825 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 63.3 m -60.42 -37.11 79.81 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.316 176.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -71.2 -50.47 32.78 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.886 -177.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 96.2 m -54.35 -41.4 69.07 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 120.915 0.388 . . . . 0.0 111.144 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -61.66 -47.58 84.72 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.159 175.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.705 ' HB3' ' HZ2' ' A' ' 82' ' ' LYS . 6.8 ttpm? -63.56 -32.8 74.37 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.534 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -68.67 -48.4 64.03 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.734 0.302 . . . . 0.0 110.635 176.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.79 -46.96 67.86 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.202 0.525 . . . . 0.0 110.499 174.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.8 tt -57.96 -54.37 47.66 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.946 174.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -57.87 -31.64 66.9 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.378 -174.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.618 ' N ' HE21 ' A' ' 87' ' ' GLN . 0.0 OUTLIER -92.52 -43.46 9.15 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.147 -0.346 . . . . 0.0 111.931 -178.465 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 84.5 mt -85.1 -22.39 28.92 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -171.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -63.41 104.29 0.61 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.085 0.469 . . . . 0.0 110.174 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 110.11 -11.93 31.57 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.881 -177.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -65.69 127.47 32.06 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.856 0.36 . . . . 0.0 111.819 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -89.23 100.85 13.55 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.996 0.427 . . . . 0.0 110.935 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 60.1 tp -86.28 -81.33 0.22 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.937 0.399 . . . . 0.0 111.732 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.86 52.33 2.44 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.866 0.365 . . . . 0.0 111.124 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.11 15.56 58.67 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.453 -174.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -135.68 140.56 34.15 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 122.945 0.498 . . . . 0.0 110.591 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.23 145.35 98.73 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.829 2.352 . . . . 0.0 113.081 176.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.431 ' HG2' HG21 ' A' ' 100' ' ' VAL . 46.9 ttm -99.09 108.76 21.48 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.287 175.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -89.09 93.13 9.48 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.857 0.36 . . . . 0.0 111.276 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.594 HG22 HG22 ' A' ' 31' ' ' VAL . 44.8 t -105.38 105.74 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.706 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -115.61 154.47 16.9 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.367 -0.444 . . . . 0.0 112.231 176.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -79.54 56.26 2.15 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 117.755 0.777 . . . . 0.0 111.83 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 50.3 t 50.07 87.93 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 121.432 0.634 . . . . 0.0 111.989 -177.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 51.9 m -149.08 86.94 1.51 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.529 0.68 . . . . 0.0 110.492 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -152.02 11.35 0.56 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.571 -175.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -168.66 16.82 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.046 -166.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.1 p -103.23 -41.39 6.07 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.953 -174.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 35.6 t70 . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.427 -0.797 . . . . 0.0 111.14 -179.452 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.795 0.331 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.37 -172.27 18.79 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.754 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -75.95 74.33 2.86 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.421 0.629 . . . . 0.0 111.428 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -119.18 80.25 1.53 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.983 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -112.63 -1.85 14.71 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.406 0.622 . . . . 0.0 110.106 172.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -161.6 132.22 5.09 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.281 173.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -118.05 11.57 13.38 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -148.42 152.56 37.18 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.158 0.583 . . . . 0.0 109.843 170.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.8 p -156.29 136.23 12.7 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.22 0.533 . . . . 0.0 112.234 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -131.98 18.07 4.6 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.584 0.707 . . . . 0.0 110.014 173.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.7 ptm -81.73 29.62 0.38 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.604 -173.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -125.17 21.76 8.0 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.09 -49.49 13.83 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.054 0.454 . . . . 0.0 111.123 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.9 96.39 9.78 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.388 178.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.499 ' C ' ' SD ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -85.13 106.13 16.36 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.092 0.472 . . . . 0.0 111.037 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.403 ' C ' ' H ' ' A' ' 18' ' ' ASN . . . -136.47 -62.69 0.65 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.396 176.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 65.53 -14.14 0.13 Allowed 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 175.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.403 ' H ' ' C ' ' A' ' 16' ' ' ALA . 7.1 t30 -57.02 105.18 0.2 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.132 0.424 . . . . 0.0 110.263 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.7 mt 61.73 77.24 0.34 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.713 0.768 . . . . 0.0 109.933 -168.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.52 ' NE2' ' H ' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -68.83 -20.85 64.32 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.302 -172.065 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -117.16 94.56 4.62 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.053 0.454 . . . . 0.0 110.381 175.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 161.86 -146.39 12.03 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 121.19 -0.529 . . . . 0.0 112.833 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.478 ' HA ' ' HB3' ' A' ' 78' ' ' SER . 42.7 t 68.51 -65.42 0.27 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.086 0.554 . . . . 0.0 112.156 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.64 71.9 1.01 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.189 0.519 . . . . 0.0 111.297 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -172.66 168.83 41.96 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.541 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.21 126.0 11.93 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.75 2.3 . . . . 0.0 113.262 -175.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 26.9 ttt -126.65 125.51 42.02 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.847 0.356 . . . . 0.0 111.558 -178.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 74' ' ' THR . 11.1 ttp180 -98.85 138.14 36.41 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.153 0.501 . . . . 0.0 111.373 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.56 HD22 HD11 ' A' ' 85' ' ' LEU . 23.6 mt -117.04 146.83 42.83 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.247 -172.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 55.7 t80 -89.85 115.6 27.3 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 122.781 0.432 . . . . 0.0 110.961 175.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.6 t -111.6 98.84 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.107 0.48 . . . . 0.0 110.943 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.88 96.15 1.14 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.406 -0.426 . . . . 0.0 113.76 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.4 t -174.73 9.85 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.3 mt -69.12 93.33 0.59 Allowed 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.728 -0.607 . . . . 0.0 111.19 -172.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -76.67 69.09 3.02 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -175.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 47.0 t80 53.15 39.86 30.31 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 172.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -171.03 -31.58 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.3 mm -64.66 95.28 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.13 0.49 . . . . 0.0 111.327 -178.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.8 p -92.47 -178.37 4.89 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.49 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.486 ' HG3' HD11 ' A' ' 58' ' ' LEU . 2.1 mp0 -52.57 -40.52 62.7 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.065 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.65 -52.32 62.68 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.583 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 20.8 mmt -62.29 -52.51 63.39 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.438 0.637 . . . . 0.0 110.676 -177.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.462 ' HB3' HD13 ' A' ' 73' ' ' ILE . 61.7 mt -55.34 -49.96 70.88 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.613 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -57.21 -50.57 72.44 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.392 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.26 -31.12 62.0 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.369 -0.444 . . . . 0.0 113.857 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.7 mt -85.15 -37.56 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -85.08 -32.3 22.91 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -173.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -59.64 -36.98 45.49 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -46.76 -19.48 0.77 Allowed 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 122.144 1.896 . . . . 0.0 113.847 171.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -90.83 -35.44 14.81 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.781 0.324 . . . . 0.0 111.262 174.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.403 ' HA3' ' SG ' ' A' ' 80' ' ' CYS . . . -172.85 -123.08 0.7 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.413 -0.422 . . . . 0.0 112.742 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -149.54 128.22 12.43 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 122.282 -0.54 . . . . 0.0 110.681 177.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.483 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.7 mp -87.33 138.98 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.765 -176.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -81.42 -48.57 11.73 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.048 0.452 . . . . 0.0 111.104 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 96.0 p -148.98 143.4 26.11 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.356 -178.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.509 HG22 HG12 ' A' ' 73' ' ' ILE . 52.1 mt -121.3 104.74 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 120.997 0.427 . . . . 0.0 110.709 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -102.75 111.76 24.22 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -175.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.486 HD11 ' HG3' ' A' ' 40' ' ' GLU . 7.8 mp -98.51 139.68 33.87 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.919 -0.488 . . . . 0.0 110.89 177.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.598 ' HE2' ' HA ' ' A' ' 59' ' ' MET . 18.2 mmt -94.12 100.41 12.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.072 0.463 . . . . 0.0 111.03 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -148.95 112.71 5.09 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.301 0.572 . . . . 0.0 111.408 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.556 ' HB2' ' HA3' ' A' ' 65' ' ' GLY . 9.1 m-20 -80.11 77.66 6.8 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.129 0.49 . . . . 0.0 110.697 178.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.3 m -47.62 -28.78 2.51 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -170.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -56.13 -46.11 79.3 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.417 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 7.6 t -168.04 -23.7 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -175.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.556 ' HA3' ' HB2' ' A' ' 61' ' ' ASP . . . -72.84 -29.52 65.04 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.957 -0.639 . . . . 0.0 111.546 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 64' ' ' THR . 47.6 mtm-85 63.46 -170.33 0.18 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.052 0.541 . . . . 0.0 112.263 172.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.8 t -57.64 114.26 2.18 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.639 ' HB3' ' HZ3' ' A' ' 68' ' ' LYS . 8.0 mtpm? -77.72 -9.11 58.83 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.804 0.335 . . . . 0.0 111.58 177.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.48 2.29 61.83 Favored Glycine 0 CA--C 1.531 1.094 0 N-CA-C 115.108 0.803 . . . . 0.0 115.108 173.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.524 ' CE2' ' HG3' ' A' ' 59' ' ' MET . 34.1 p90 -143.11 148.98 37.5 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.122 0.961 . . . . 0.0 112.542 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -138.3 146.76 18.62 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.48 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 95.2 m-85 -100.18 121.76 41.95 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 122.594 -0.356 . . . . 0.0 111.523 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.509 HG12 HG22 ' A' ' 56' ' ' ILE . 77.8 mt -110.36 125.03 67.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 120.794 0.331 . . . . 0.0 111.596 -178.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 27.2 m -101.35 120.6 40.51 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -175.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.425 ' HB2' ' HB3' ' A' ' 81' ' ' ALA . 70.3 m-85 -100.08 152.05 20.68 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.325 173.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.7 t -75.46 -14.4 60.43 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.891 0.377 . . . . 0.0 111.685 -177.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -136.46 138.85 41.88 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.689 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.478 ' HB3' ' HA ' ' A' ' 23' ' ' SER . 28.9 t -70.02 -27.34 64.59 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -80.97 -40.94 23.62 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.772 -0.58 . . . . 0.0 110.509 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.403 ' SG ' ' HA3' ' A' ' 51' ' ' GLY . 50.4 t -61.46 -39.26 90.21 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.123 0.487 . . . . 0.0 110.349 169.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.427 ' HB1' HD23 ' A' ' 29' ' ' LEU . . . -60.49 -48.69 80.67 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.228 174.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -68.39 -24.98 64.83 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 111.625 0.232 . . . . 0.0 111.625 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -63.6 -55.57 22.69 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.295 0.569 . . . . 0.0 110.104 175.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.67 -51.83 67.72 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.828 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.56 HD11 HD22 ' A' ' 29' ' ' LEU . 6.4 tt -49.11 -63.85 0.98 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.444 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.45 ' HA ' HD22 ' A' ' 89' ' ' ASN . 6.7 mm-40 -67.01 -20.92 65.95 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -172.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -94.95 -14.71 24.18 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.522 ' HB3' ' HE2' ' A' ' 98' ' ' MET . 94.1 mt -110.21 -14.71 14.14 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -176.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.459 ' ND2' HD22 ' A' ' 85' ' ' LEU . 10.0 p30 -69.3 97.13 0.92 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.876 0.846 . . . . 0.0 111.178 176.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.96 -2.1 22.84 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.168 -174.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -64.97 127.31 31.06 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 122.592 0.357 . . . . 0.0 111.147 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -76.88 96.26 4.28 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.33 0.586 . . . . 0.0 110.987 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.8 tp -98.34 120.71 39.23 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.463 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 58.35 20.24 7.12 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.03 0.443 . . . . 0.0 112.116 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.87 8.13 58.29 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 116.203 -0.453 . . . . 0.0 113.436 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -130.88 132.23 23.76 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.592 -0.357 . . . . 0.0 110.906 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.53 133.09 49.66 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 122.341 2.028 . . . . 0.0 112.793 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.522 ' HE2' ' HB3' ' A' ' 88' ' ' LEU . 44.0 ttp -99.06 116.91 32.38 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.099 0.476 . . . . 0.0 111.538 -177.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -89.98 103.72 16.36 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.896 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.456 HG12 ' HG ' ' A' ' 85' ' ' LEU . 21.6 t -113.93 112.83 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.596 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -151.47 78.24 0.21 Allowed Glycine 0 CA--C 1.534 1.225 0 C-N-CA 119.951 -1.119 . . . . 0.0 115.169 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 27.0 p80 39.13 -162.19 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 174.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.9 t -80.49 116.07 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 170.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 65.9 p -50.66 -87.06 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -166.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -78.92 155.61 28.93 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -166.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 35.5 ptt-85 -138.12 -166.01 1.9 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.701 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.0 m -76.99 87.52 3.51 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 122.179 -0.325 . . . . 0.0 111.761 177.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.6 t70 . . . . . 0 C--O 1.259 1.569 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 175.392 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ptp . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.737 0.303 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.39 81.38 0.6 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.505 172.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -63.32 87.17 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 121.39 0.614 . . . . 0.0 112.513 -175.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -95.01 -59.8 1.82 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.814 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.6 m80 64.18 -13.17 0.1 Allowed 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -83.48 63.12 7.16 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.268 0.556 . . . . 0.0 111.706 -171.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -100.63 123.03 44.27 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -82.58 91.8 7.0 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.306 0.574 . . . . 0.0 111.274 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.7 m -66.45 86.63 0.11 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.303 0.573 . . . . 0.0 111.236 178.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -154.91 151.63 28.79 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.16 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 51.7 ttm -49.87 -37.35 30.66 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.57 83.39 2.61 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.226 0.536 . . . . 0.0 111.576 176.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -128.59 82.07 2.06 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.017 0.437 . . . . 0.0 110.897 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -178.66 -36.94 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.28 -177.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 56.3 ttp 66.86 -72.36 0.09 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.979 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.75 42.14 1.1 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.946 0.403 . . . . 0.0 111.428 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.0 m120 60.08 -170.81 0.14 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.666 -176.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -103.74 -26.76 12.62 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -177.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp -133.0 11.68 4.27 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -76.32 117.69 18.25 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 122.144 -0.348 . . . . 0.0 111.161 178.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -87.31 120.69 28.86 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.301 0.572 . . . . 0.0 111.458 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.87 169.75 17.08 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.145 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.3 m -110.19 -22.34 11.81 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -162.69 133.31 4.74 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.815 0.34 . . . . 0.0 111.413 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -163.16 -78.46 0.03 OUTLIER Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.826 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.69 101.12 0.36 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.662 2.241 . . . . 0.0 112.946 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -99.77 142.68 30.93 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.586 -178.641 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.548 ' N ' ' SD ' ' A' ' 27' ' ' MET . 34.2 ttm105 -118.58 116.54 26.83 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.997 0.427 . . . . 0.0 112.026 -175.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.516 HD22 HD13 ' A' ' 85' ' ' LEU . 73.3 mt -99.45 128.38 45.56 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.562 178.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -91.49 114.9 27.55 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.131 0.491 . . . . 0.0 111.13 175.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.1 t -107.21 107.83 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.246 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.7 89.53 0.54 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.613 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.5 p -175.09 18.02 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 120.923 0.392 . . . . 0.0 111.976 176.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.526 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 17.8 mt -83.3 81.22 8.8 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.986 -0.447 . . . . 0.0 111.372 -173.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -78.14 75.7 4.67 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 121.188 0.518 . . . . 0.0 112.313 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.426 ' HB3' ' OG ' ' A' ' 67' ' ' SER . 16.3 p90 39.25 26.53 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 176.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -140.28 8.89 2.26 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 122.0 -0.437 . . . . 0.0 111.501 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.445 ' N ' HD13 ' A' ' 38' ' ' ILE . 3.7 mp -118.48 123.91 72.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.596 -177.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 57.3 p -105.83 175.55 5.46 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -54.55 -49.2 70.86 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.729 176.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -73.15 -19.0 61.22 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -174.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.4 tpt -70.51 -54.77 10.9 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 172.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.3 mt -59.21 -55.76 30.78 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.781 175.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -53.89 -35.27 61.42 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.498 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.32 -35.71 92.3 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.137 -0.554 . . . . 0.0 113.073 177.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.8 mt -86.21 -38.5 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-O 120.998 0.428 . . . . 0.0 111.985 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.411 ' HB3' ' HZ ' ' A' ' 75' ' ' PHE . 35.0 m-85 -79.59 -44.63 20.69 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -173.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.414 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 27.1 tt0 -64.84 -32.35 6.68 Favored Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -172.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 48' ' ' GLU . 89.1 Cg_exo -47.89 -22.86 3.65 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.124 1.883 . . . . 0.0 113.629 169.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -77.26 -23.37 51.22 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 122.149 -0.345 . . . . 0.0 111.698 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.756 ' HA3' ' SG ' ' A' ' 80' ' ' CYS . . . -177.89 -100.06 0.13 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.46 175.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.66 130.4 6.59 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.097 0.475 . . . . 0.0 111.481 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.3 mt -111.04 140.82 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.699 -174.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -90.77 -62.36 1.47 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.847 0.356 . . . . 0.0 111.787 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.5 t -145.7 147.65 32.18 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.874 0.369 . . . . 0.0 111.623 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.54 HG12 HG21 ' A' ' 73' ' ' ILE . 55.2 mt -123.88 125.23 70.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.076 0.465 . . . . 0.0 110.852 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -108.89 117.39 34.07 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.879 0.371 . . . . 0.0 110.952 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 82.1 mt -98.42 136.63 38.29 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.75 0.309 . . . . 0.0 110.665 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 22.4 mmt -93.39 120.99 34.31 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.738 0.78 . . . . 0.0 112.196 -175.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.6 mtt -121.16 177.27 5.21 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.298 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.423 ' HB3' ' N ' ' A' ' 66' ' ' ARG . 15.9 t70 -82.42 137.48 34.69 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.893 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 90.3 p -89.11 -2.59 58.6 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -173.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.21 -75.75 0.59 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.206 0.527 . . . . 0.0 110.894 -177.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.522 HG21 ' HG3' ' A' ' 66' ' ' ARG . 1.8 t -93.06 -15.91 25.58 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.044 -177.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.93 26.27 13.05 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.067 -0.587 . . . . 0.0 114.437 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.522 ' HG3' HG21 ' A' ' 64' ' ' THR . 20.1 mtm180 -76.82 -166.19 0.65 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 117.268 0.534 . . . . 0.0 111.241 176.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.426 ' OG ' ' HB3' ' A' ' 36' ' ' PHE . 88.7 p -105.5 152.73 22.67 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.854 -0.529 . . . . 0.0 111.275 178.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -96.22 -37.71 10.43 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.947 0.403 . . . . 0.0 111.488 175.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 111.05 13.06 14.23 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.818 -0.705 . . . . 0.0 114.555 175.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -149.82 156.11 41.24 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.59 0.695 . . . . 0.0 111.757 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.91 160.54 28.67 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.418 -0.42 . . . . 0.0 113.064 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -112.61 121.35 44.53 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.768 0.318 . . . . 0.0 111.402 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.54 HG21 HG12 ' A' ' 56' ' ' ILE . 67.3 mt -103.69 133.92 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.811 0.338 . . . . 0.0 111.323 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 68.1 m -110.14 118.37 36.21 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.457 ' HB2' ' HB3' ' A' ' 81' ' ' ALA . 31.3 m-85 -99.09 150.72 21.73 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.163 175.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.2 t -82.67 1.78 36.77 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.012 0.434 . . . . 0.0 111.565 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -142.28 135.85 29.18 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.041 0.448 . . . . 0.0 111.35 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.8 t -65.72 -47.84 73.96 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -71.7 -35.42 70.22 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.246 -0.284 . . . . 0.0 111.495 -176.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.756 ' SG ' ' HA3' ' A' ' 51' ' ' GLY . 43.9 t -59.38 -44.65 92.74 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.118 0.485 . . . . 0.0 110.918 173.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . . . -65.53 -47.53 75.59 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.678 177.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.8 ttpp -60.76 -34.21 74.11 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.823 0.344 . . . . 0.0 111.349 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -66.43 -49.25 67.39 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.912 0.387 . . . . 0.0 110.919 176.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.02 -44.7 87.45 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.127 0.489 . . . . 0.0 111.169 176.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.516 HD13 HD22 ' A' ' 29' ' ' LEU . 8.6 tt -56.76 -59.08 5.55 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.987 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.93 -25.18 67.43 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -173.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -89.68 -31.12 17.64 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 122.032 -0.418 . . . . 0.0 112.056 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.437 ' HB3' ' HE1' ' A' ' 98' ' ' MET . 79.0 mt -103.24 -6.74 21.78 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -175.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -66.07 92.37 0.17 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.221 0.534 . . . . 0.0 110.614 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 115.07 3.18 21.66 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.943 -176.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.424 ' HB3' ' HE2' ' A' ' 98' ' ' MET . 90.3 t80 -64.63 135.79 56.31 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.589 0.355 . . . . 0.0 111.709 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -70.13 79.87 0.51 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.177 0.513 . . . . 0.0 111.383 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.558 HD21 ' SD ' ' A' ' 98' ' ' MET . 56.8 tp -84.33 118.49 24.25 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.907 0.384 . . . . 0.0 111.657 -177.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 57.15 26.86 12.63 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 176.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.44 11.39 59.61 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 116.075 -0.512 . . . . 0.0 113.4 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -145.49 139.81 15.27 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 122.478 0.311 . . . . 0.0 110.807 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -55.41 136.73 75.07 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.491 2.127 . . . . 0.0 112.887 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.558 ' SD ' HD21 ' A' ' 93' ' ' LEU . 44.8 ttp -98.67 118.45 35.42 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.229 0.538 . . . . 0.0 111.395 -176.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -88.98 96.31 10.67 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.333 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 18.7 t -104.71 105.91 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.993 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -133.22 151.8 20.19 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.451 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.5 p80 -69.58 173.2 6.29 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 122.29 -0.535 . . . . 0.0 110.904 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.453 HG23 HH11 ' A' ' 28' ' ' ARG . 41.9 t -63.86 136.68 25.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.647 0.261 . . . . 0.0 110.633 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 40.8 p -67.9 0.38 3.5 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -172.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -73.52 109.74 7.27 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.118 0.485 . . . . 0.0 111.103 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -135.51 130.98 35.46 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.313 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.2 m -122.38 89.15 3.06 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.084 0.469 . . . . 0.0 110.606 172.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.0 t70 . . . . . 0 C--O 1.253 1.25 0 CA-C-O 119.023 -0.513 . . . . 0.0 110.699 -178.66 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttt . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 120.815 0.34 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.1 73.8 1.71 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.375 -0.441 . . . . 0.0 113.885 -176.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -151.42 -177.27 5.97 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.76 0.424 . . . . 0.0 110.857 175.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -76.13 72.41 2.94 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.4 m80 58.61 -79.16 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 171.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -71.06 88.38 0.78 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.49 0.662 . . . . 0.0 111.654 -175.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -73.11 98.98 2.68 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.92 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -86.18 114.42 23.0 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.97 0.414 . . . . 0.0 110.757 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.4 t -80.06 -176.82 5.72 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.088 0.47 . . . . 0.0 111.67 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -147.54 168.98 20.57 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.736 0.303 . . . . 0.0 111.56 -177.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.3 mmt -60.71 127.53 32.11 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.028 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.65 24.09 10.46 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -174.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 63.26 53.87 2.15 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.966 0.412 . . . . 0.0 111.529 -177.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 68.11 115.31 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.577 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.568 ' N ' ' SD ' ' A' ' 15' ' ' MET . 1.1 mpt? -77.22 144.65 38.11 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.53 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.08 105.6 17.92 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.129 0.49 . . . . 0.0 111.759 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -85.54 157.92 20.28 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.128 176.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.5 t30 56.51 59.36 3.64 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.444 0.64 . . . . 0.0 111.035 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.405 ' O ' HD23 ' A' ' 19' ' ' LEU . 8.5 tt -84.65 -34.04 23.12 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.2 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.404 ' HB2' ' H ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -100.31 -160.8 0.82 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.275 177.351 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.404 ' H ' ' HB2' ' A' ' 20' ' ' GLN . 53.9 mtpt -69.35 103.05 1.89 Allowed 'General case' 0 CA--C 1.539 0.526 0 O-C-N 122.307 -0.246 . . . . 0.0 111.563 177.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.65 91.49 0.03 OUTLIER Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.347 -0.454 . . . . 0.0 113.006 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.5 p -139.83 108.84 6.02 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.045 0.45 . . . . 0.0 111.595 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -153.87 -75.38 0.12 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.326 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 59.86 -114.47 6.37 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 116.443 -0.344 . . . . 0.0 113.069 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.67 127.13 12.76 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.321 2.014 . . . . 0.0 111.969 176.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 14.3 tpt -102.9 131.64 49.67 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.887 0.375 . . . . 0.0 111.922 -172.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.8 ttm-85 -102.72 118.46 36.89 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.856 0.36 . . . . 0.0 110.896 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 76.0 mt -102.68 150.57 23.31 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.281 0.562 . . . . 0.0 111.829 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -105.59 131.43 52.99 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.299 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.6 t -125.94 106.44 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.569 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -125.38 88.52 0.37 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.829 -176.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.452 ' OG ' ' HA ' ' A' ' 98' ' ' MET . 89.6 p -175.79 23.71 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.97 0.414 . . . . 0.0 111.41 178.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.535 ' HB3' HG13 ' A' ' 38' ' ' ILE . 53.4 mt -83.64 166.86 17.8 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.198 -176.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.426 ' O ' ' ND1' ' A' ' 35' ' ' HIS . 33.6 p80 -141.85 80.44 1.72 Allowed 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 60.1 t80 50.61 8.34 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -143.34 52.59 1.35 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.091 -1.005 . . . . 0.0 110.535 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.535 HG13 ' HB3' ' A' ' 34' ' ' LEU . 30.1 mm -133.24 125.08 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.625 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.42 ' OG1' ' HG3' ' A' ' 42' ' ' MET . 41.8 p -108.03 158.88 17.01 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.861 0.362 . . . . 0.0 111.835 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -54.9 -32.04 60.62 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.108 0.48 . . . . 0.0 110.742 172.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -62.64 -42.41 99.58 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.527 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.431 ' SD ' ' HA ' ' A' ' 38' ' ' ILE . 59.0 mtt -64.06 -55.41 22.37 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.538 0.685 . . . . 0.0 110.686 179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.434 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 45.6 mt -56.72 -54.83 41.7 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.357 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -53.13 -47.88 68.34 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.314 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.09 -30.22 75.01 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 121.305 -0.474 . . . . 0.0 113.741 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 74.1 mt -82.98 -40.46 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 O-C-N 122.377 -0.484 . . . . 0.0 112.23 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.478 ' HB3' ' HE2' ' A' ' 75' ' ' PHE . 77.2 m-85 -85.77 -30.78 22.78 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -173.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.4 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 30.1 mt-10 -55.32 -41.63 91.75 Favored Pre-proline 0 N--CA 1.484 1.226 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 48' ' ' GLU . 51.7 Cg_exo -41.09 -39.29 3.5 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 122.378 2.052 . . . . 0.0 113.058 172.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -76.65 -57.67 3.72 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.067 0.46 . . . . 0.0 110.881 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -157.98 135.01 4.12 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.017 -175.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -56.3 122.26 11.41 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 122.6 0.36 . . . . 0.0 111.236 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 53' ' ' ILE . 2.9 mp -79.6 135.27 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.148 0.499 . . . . 0.0 111.911 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -87.74 -51.05 6.08 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.148 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.8 m -150.41 140.34 21.92 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.812 0.339 . . . . 0.0 111.877 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.51 HG23 HG12 ' A' ' 73' ' ' ILE . 53.8 mt -116.66 140.58 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.911 177.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -136.86 110.19 7.88 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.716 0.293 . . . . 0.0 111.764 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.417 ' N ' HD12 ' A' ' 58' ' ' LEU . 5.1 mp -99.57 150.66 22.01 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.648 0.261 . . . . 0.0 110.391 175.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.423 ' HG3' ' CE2' ' A' ' 70' ' ' TYR . 20.4 mmt -94.6 122.01 36.75 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.569 0.699 . . . . 0.0 112.747 -177.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -152.5 145.82 24.76 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.821 -1.082 . . . . 0.0 111.121 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.544 ' HB3' ' HA3' ' A' ' 65' ' ' GLY . 22.0 t70 -117.02 118.67 33.03 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.749 0.309 . . . . 0.0 110.801 176.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.4 t -73.73 -15.82 61.2 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -174.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -73.26 -70.06 0.39 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.207 0.527 . . . . 0.0 110.687 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.7 t -160.05 16.25 0.14 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.243 0.544 . . . . 0.0 111.909 178.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.544 ' HA3' ' HB3' ' A' ' 61' ' ' ASP . . . -89.42 -30.91 12.43 Favored Glycine 0 CA--C 1.517 0.182 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.433 175.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 57.1 mtp85 60.69 -168.92 0.16 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 122.971 0.508 . . . . 0.0 111.904 176.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.0 m -69.01 105.44 2.41 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.196 -0.315 . . . . 0.0 111.442 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -62.14 -37.91 86.96 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.81 6.62 18.91 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.502 -0.856 . . . . 0.0 115.018 174.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.423 ' CE2' ' HG3' ' A' ' 59' ' ' MET . 35.3 p90 -130.24 147.84 52.01 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.156 0.978 . . . . 0.0 111.824 176.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -149.52 160.24 28.38 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 116.097 -0.501 . . . . 0.0 113.315 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -113.68 139.05 49.38 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.659 0.383 . . . . 0.0 110.999 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.51 HG12 HG23 ' A' ' 56' ' ' ILE . 75.0 mt -124.11 125.67 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.795 0.331 . . . . 0.0 111.447 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.9 m -99.53 118.24 35.66 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.885 0.374 . . . . 0.0 111.549 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.478 ' HE2' ' HB3' ' A' ' 47' ' ' PHE . 43.8 m-85 -99.64 150.08 22.64 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.313 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.1 t -75.77 -18.74 59.42 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.113 0.482 . . . . 0.0 111.067 173.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -110.06 152.81 25.49 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.076 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.1 p -100.41 -59.86 1.63 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 120.967 0.413 . . . . 0.0 112.081 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -65.36 -39.87 92.88 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -175.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 77.9 m -61.6 -31.03 71.08 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.08 0.467 . . . . 0.0 110.541 174.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.32 -33.93 67.71 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.845 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -54.6 -50.44 68.05 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.019 0.438 . . . . 0.0 110.181 172.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.475 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . 6.9 ttpm? -64.48 -40.95 96.64 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.033 177.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.4 -41.64 69.52 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.358 0.599 . . . . 0.0 110.934 176.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 tt -63.91 -62.73 1.45 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.664 177.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' A' ' 83' ' ' LYS . 14.8 pt-20 -66.42 -18.37 65.32 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.497 -173.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -86.2 -40.97 15.06 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.746 0.308 . . . . 0.0 111.554 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 81.2 mt -97.38 -13.2 21.99 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -168.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' A' ' 86' ' ' GLU . 10.7 p30 -65.41 81.12 0.06 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 121.699 0.761 . . . . 0.0 111.705 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 141.88 -14.52 2.63 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.706 -175.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -65.72 135.03 54.41 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 122.939 0.496 . . . . 0.0 111.302 177.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -82.74 104.82 13.27 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.099 0.475 . . . . 0.0 112.073 -177.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.6 tp -101.63 128.25 48.0 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.277 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 61.05 22.78 13.01 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.051 0.453 . . . . 0.0 111.243 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 85.78 12.05 72.67 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 116.135 -0.484 . . . . 0.0 113.37 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.7 ttt85 -134.96 134.13 21.54 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 122.52 -0.4 . . . . 0.0 110.631 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -53.64 142.15 61.69 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.922 2.415 . . . . 0.0 113.38 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.452 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 44.9 ttm -99.34 114.43 27.3 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.309 -177.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -89.69 97.82 11.42 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.959 0.409 . . . . 0.0 110.936 177.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.2 t -103.9 127.52 57.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.499 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -150.0 159.38 28.08 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.543 175.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.404 ' O ' HG23 ' A' ' 104' ' ' THR . 11.0 p80 -72.44 155.02 40.56 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 122.208 -0.583 . . . . 0.0 111.002 177.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 52.1 t -58.02 95.9 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.122 0.487 . . . . 0.0 111.222 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 102' ' ' HIS . 81.4 p -84.31 -173.37 4.68 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.605 0.717 . . . . 0.0 112.636 -176.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -103.0 169.5 8.53 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.887 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 64.4 106.16 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 99.1 m -89.35 110.11 20.94 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 168.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.5 t70 . . . . . 0 C--O 1.252 1.224 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -172.143 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.524 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.737 0.303 . . . . 0.0 111.528 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.64 -65.62 2.81 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.833 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.7 p-80 -106.42 112.87 26.07 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.241 0.543 . . . . 0.0 111.098 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -100.19 -13.85 18.75 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.254 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -138.49 154.94 48.82 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.033 0.533 . . . . 0.0 110.349 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -164.8 -32.13 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 -68.14 -20.71 64.92 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.5 m80 66.95 -71.29 0.1 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.089 0.556 . . . . 0.0 111.9 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.3 m -136.47 -173.37 3.39 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.835 0.35 . . . . 0.0 111.109 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -67.58 -26.23 66.18 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.97 0.415 . . . . 0.0 110.542 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 12.8 tmm? -70.31 87.7 0.62 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.414 0.626 . . . . 0.0 109.864 172.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -178.8 -42.97 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.798 -177.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.42 141.47 48.12 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.139 173.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 72.31 -54.86 0.68 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.973 0.509 . . . . 0.0 112.108 -176.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 24.7 mmt -80.25 110.97 16.18 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.218 -0.301 . . . . 0.0 111.184 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.13 167.49 29.7 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.118 0.485 . . . . 0.0 111.979 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -92.04 100.86 13.43 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.443 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -127.95 -56.55 1.27 Allowed 'General case' 0 N--CA 1.471 0.608 0 O-C-N 122.025 -0.422 . . . . 0.0 111.964 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.0 tp -93.49 94.96 8.96 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.236 0.541 . . . . 0.0 110.802 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -97.26 -60.78 1.51 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.715 -178.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -144.4 93.49 2.44 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.462 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.76 -84.31 0.09 OUTLIER Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.488 -0.387 . . . . 0.0 113.577 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.4 m -147.65 156.4 42.75 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.343 -0.504 . . . . 0.0 111.654 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -140.79 165.4 27.59 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.731 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -156.24 -116.13 0.52 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.925 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 51.3 Cg_exo -54.06 122.27 11.12 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.156 2.57 . . . . 0.0 114.083 -173.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 28.1 ttt -100.66 133.83 44.52 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.319 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.3 ttm-85 -111.19 129.39 55.97 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.984 0.421 . . . . 0.0 111.873 -174.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 80.5 mt -103.8 142.7 33.92 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.497 0.665 . . . . 0.0 111.9 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -99.69 113.36 25.76 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.198 175.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -116.93 115.4 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -175.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.72 104.37 1.37 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.656 -0.307 . . . . 0.0 113.685 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.537 ' HB2' ' HA ' ' A' ' 98' ' ' MET . 23.9 t -174.82 20.99 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.357 0.599 . . . . 0.0 111.268 175.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.9 mt -93.49 91.85 7.33 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.805 -174.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -80.1 61.51 3.98 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -174.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 22.6 t80 50.29 41.23 24.07 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.641 0.734 . . . . 0.0 110.979 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -149.9 -50.8 0.14 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.754 -171.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.413 HD12 ' HB2' ' A' ' 94' ' ' ALA . 60.8 mt -78.96 133.97 28.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.239 -172.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.3 p -114.27 178.37 4.31 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.198 0.523 . . . . 0.0 112.087 -177.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.424 ' HG3' ' CD1' ' A' ' 58' ' ' LEU . 2.1 mp0 -50.41 -45.35 55.6 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.881 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -55.87 -44.6 78.27 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.577 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.422 ' O ' HG12 ' A' ' 46' ' ' ILE . 12.5 tpt -66.49 -49.9 65.06 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.185 0.517 . . . . 0.0 110.29 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.433 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 71.4 mt -54.25 -53.54 52.2 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.093 176.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.2 ttm105 -51.01 -43.21 60.79 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.536 176.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.96 -28.22 71.64 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.349 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 42' ' ' MET . 42.4 mm -85.17 -37.26 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 120.911 0.386 . . . . 0.0 111.929 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.433 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 46.8 m-85 -86.17 -28.03 24.18 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -174.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -57.7 -38.1 63.48 Favored Pre-proline 0 N--CA 1.484 1.268 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -47.92 -19.9 1.75 Allowed 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 122.086 1.857 . . . . 0.0 113.581 170.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -94.75 -46.66 6.82 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.808 0.337 . . . . 0.0 111.527 175.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.47 -133.5 1.49 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.595 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -129.77 143.8 50.99 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 122.089 -0.654 . . . . 0.0 111.427 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.517 HG22 HG13 ' A' ' 56' ' ' ILE . 2.4 mp -94.97 138.69 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.017 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -95.45 -45.33 7.15 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.911 0.386 . . . . 0.0 111.064 174.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.2 t -152.14 147.03 25.96 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.506 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.527 HG12 HG21 ' A' ' 73' ' ' ILE . 51.8 mt -130.46 106.62 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 120.81 0.338 . . . . 0.0 110.863 175.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -108.93 119.98 41.17 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.754 0.311 . . . . 0.0 111.323 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.424 ' CD1' ' HG3' ' A' ' 40' ' ' GLU . 7.2 mp -98.22 141.55 30.99 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.064 0.459 . . . . 0.0 111.538 -177.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.594 ' SD ' ' HE2' ' A' ' 72' ' ' PHE . 56.8 mtp -101.45 101.36 11.95 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.432 0.634 . . . . 0.0 111.851 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.434 ' O ' ' N ' ' A' ' 62' ' ' SER . 14.1 ptt? -119.31 113.45 20.85 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 168.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.552 ' HB3' ' O ' ' A' ' 66' ' ' ARG . 5.1 p-10 32.94 -76.31 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -166.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 60' ' ' MET . 28.2 t 45.73 37.38 3.34 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.903 0.858 . . . . 0.0 109.839 -168.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -162.39 -50.71 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.75 -169.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.4 t -126.72 -33.29 2.52 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -172.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.47 22.03 7.3 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 120.47 -0.871 . . . . 0.0 113.327 -173.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.552 ' O ' ' HB3' ' A' ' 61' ' ' ASP . 68.0 mtm-85 -119.41 -175.83 3.02 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 122.432 -0.452 . . . . 0.0 111.147 176.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.7 p -106.28 130.41 54.13 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.609 -0.682 . . . . 0.0 112.167 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.564 ' HB2' ' O ' ' A' ' 59' ' ' MET . 57.8 mttp -89.39 -59.22 2.27 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.887 0.375 . . . . 0.0 110.776 173.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.44 23.22 8.53 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 114.863 0.705 . . . . 0.0 114.863 172.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.536 ' HE1' ' SD ' ' A' ' 59' ' ' MET . 27.6 p90 -143.49 152.06 41.04 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.775 0.788 . . . . 0.0 112.088 177.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.8 158.13 23.66 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.945 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.594 ' HE2' ' SD ' ' A' ' 59' ' ' MET . 98.2 m-85 -110.02 125.08 52.53 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.831 0.348 . . . . 0.0 111.17 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.527 HG21 HG12 ' A' ' 56' ' ' ILE . 59.9 mt -113.43 135.14 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.593 -178.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.2 m -100.01 133.97 43.62 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.492 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 96.1 m-85 -125.14 143.86 50.72 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.509 0.324 . . . . 0.0 111.27 177.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.2 m -81.48 -5.63 58.14 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 120.745 0.307 . . . . 0.0 111.708 176.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.417 ' HB3' ' HB2' ' A' ' 80' ' ' CYS . 8.4 t0 -124.18 115.84 21.75 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.939 0.399 . . . . 0.0 110.842 -178.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 48.8 m -71.76 -22.27 61.62 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.75 -36.65 15.04 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 72.6 m -66.13 -39.99 90.31 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.963 0.411 . . . . 0.0 110.591 174.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.14 -40.49 82.43 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.033 0.444 . . . . 0.0 110.958 174.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.81 ' HB2' ' HZ3' ' A' ' 82' ' ' LYS . 4.7 ttmp? -62.23 -42.69 99.54 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.081 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.407 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 86.6 tttt -61.45 -50.89 70.96 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.61 0.243 . . . . 0.0 110.478 173.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.12 -40.99 47.73 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.19 0.519 . . . . 0.0 111.055 177.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.3 tt -61.46 -48.34 81.59 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.24 175.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -67.62 -34.2 76.5 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -177.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 83' ' ' LYS . 7.9 mm100 -90.8 -32.84 15.94 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -173.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.0 mt -99.52 -11.26 21.2 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -172.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -65.93 94.89 0.24 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.316 0.579 . . . . 0.0 110.246 176.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 106.8 22.43 7.65 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.177 -173.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.406 ' HB3' ' HE3' ' A' ' 98' ' ' MET . 89.0 t80 -80.92 142.83 33.13 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 122.732 -0.276 . . . . 0.0 111.715 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -75.06 85.06 2.31 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.852 0.358 . . . . 0.0 111.263 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.569 HD23 ' SD ' ' A' ' 98' ' ' MET . 54.9 tp -103.02 124.84 49.28 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.724 0.297 . . . . 0.0 111.292 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.413 ' HB2' HD12 ' A' ' 38' ' ' ILE . . . 59.82 16.19 5.44 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.85 11.12 59.35 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.42 -0.419 . . . . 0.0 113.309 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 96' ' ' ARG . 16.3 mtp180 -133.7 154.97 80.85 Favored Pre-proline 0 N--CA 1.47 0.57 0 O-C-N 122.474 -0.427 . . . . 0.0 111.877 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.57 130.32 23.3 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.779 2.319 . . . . 0.0 112.26 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.569 ' SD ' HD23 ' A' ' 93' ' ' LEU . 48.6 ttp -97.84 125.67 42.82 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.299 0.571 . . . . 0.0 111.851 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -89.1 108.35 19.55 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.489 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.1 t -116.18 122.28 69.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 121.285 0.564 . . . . 0.0 112.053 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -146.1 146.8 17.26 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.959 175.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -76.26 142.09 41.49 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.268 1.034 . . . . 0.0 110.93 -176.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.1 m -59.54 122.93 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 121.299 0.571 . . . . 0.0 111.412 -177.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.2 t -161.03 61.17 0.29 Allowed 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.892 0.854 . . . . 0.0 110.802 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -78.0 74.81 4.55 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.59 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 106' ' ' ARG . 12.0 ptm180 -142.48 173.69 11.31 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.587 -176.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 50.9 m -100.96 146.36 27.5 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.466 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.1 t70 . . . . . 0 C--O 1.252 1.205 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.319 177.324 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 120.538 0.208 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -56.62 -34.55 64.48 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.428 -0.415 . . . . 0.0 113.986 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -64.36 -29.57 70.64 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -118.32 106.37 12.69 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.869 0.366 . . . . 0.0 110.991 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -89.77 -48.63 7.13 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.546 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -147.08 -110.41 0.09 Allowed 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 111.722 0.267 . . . . 0.0 111.722 176.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.0 m80 58.2 111.61 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.374 0.607 . . . . 0.0 111.962 -172.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -66.36 103.55 1.05 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.555 -178.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 81.1 p -62.91 112.34 2.53 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.785 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -112.57 13.08 19.98 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 177.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.441 ' C ' ' SD ' ' A' ' 11' ' ' MET . 0.2 OUTLIER 74.49 -53.19 0.68 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.589 0.756 . . . . 0.0 113.001 176.076 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.07 25.38 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -172.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.71 -15.63 29.95 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.887 -0.508 . . . . 0.0 111.955 177.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.45 111.6 2.39 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.3 mpt? 56.91 21.76 6.48 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.93 95.79 3.03 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.886 0.374 . . . . 0.0 111.636 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -93.25 -68.87 0.78 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.279 177.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 48.57 95.26 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 176.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 84.5 mt -77.55 76.07 4.09 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.271 0.557 . . . . 0.0 110.469 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.56 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 17.8 pt20 -84.07 167.65 16.62 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.116 -177.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.621 ' HZ1' ' HB2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER 64.6 -32.31 0.14 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 125.362 1.465 . . . . 0.0 114.362 177.022 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.88 -27.74 59.75 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.195 -0.526 . . . . 0.0 114.297 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.6 m -128.32 12.99 6.58 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 122.544 -0.386 . . . . 0.0 111.916 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -127.27 162.0 27.25 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -173.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -120.56 90.84 0.47 Allowed Glycine 0 CA--C 1.53 1.004 0 CA-C-N 116.218 -0.447 . . . . 0.0 113.096 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -88.54 169.69 5.71 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.13 2.553 . . . . 0.0 112.729 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.2 ttt -124.05 145.73 49.03 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.003 0.43 . . . . 0.0 111.547 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -116.62 119.39 35.39 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.677 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.514 HD23 HD12 ' A' ' 85' ' ' LEU . 60.7 mt -99.25 138.41 36.38 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.087 0.47 . . . . 0.0 112.202 -178.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -92.8 107.26 19.08 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.539 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.7 t -101.06 97.91 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.004 0.431 . . . . 0.0 111.14 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.76 88.99 0.83 Allowed Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.629 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.3 t -175.49 24.18 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.993 0.425 . . . . 0.0 111.359 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 43.0 mt -73.79 92.66 2.05 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.879 -0.513 . . . . 0.0 110.517 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -78.98 65.56 4.19 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -174.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 55.23 8.74 0.29 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.919 1.452 . . . . 0.0 114.919 170.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -155.16 8.73 0.29 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.411 0.55 . . . . 0.0 112.244 178.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.6 mm -78.06 131.41 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 121.946 -0.471 . . . . 0.0 110.811 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.454 ' OG1' ' HG3' ' A' ' 42' ' ' MET . 49.4 p -106.01 160.49 15.25 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -177.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -55.09 -38.49 68.17 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.319 0.58 . . . . 0.0 110.556 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -61.04 -41.41 96.53 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.107 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.454 ' HG3' ' OG1' ' A' ' 39' ' ' THR . 66.8 mtt -62.77 -55.52 25.77 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.251 0.548 . . . . 0.0 110.529 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.1 mt -54.59 -46.58 73.81 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.104 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 50.9 ttt85 -60.22 -46.48 89.62 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.502 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.07 -29.71 59.82 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.117 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.7 mm -86.54 -53.16 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.4 ' HB3' ' CZ ' ' A' ' 75' ' ' PHE . 34.0 m-85 -79.83 -36.71 36.46 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -171.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.481 ' HA ' HG13 ' A' ' 53' ' ' ILE . 0.6 OUTLIER -56.43 -48.06 97.75 Favored Pre-proline 0 N--CA 1.482 1.134 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -172.92 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -47.07 -20.93 1.41 Allowed 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.649 2.232 . . . . 0.0 114.248 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -70.91 -51.6 25.1 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 178.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 52' ' ' ARG . . . -173.52 45.77 0.16 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 119.652 -1.261 . . . . 0.0 115.176 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.415 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 73.1 ttt180 72.19 137.19 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 172.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.481 HG13 ' HA ' ' A' ' 48' ' ' GLU . 66.0 mt -128.06 133.18 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.316 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -108.15 -48.09 3.43 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -176.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.7 m -126.94 122.06 33.5 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -176.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 51.8 mt -115.65 106.23 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.853 0.359 . . . . 0.0 110.808 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -99.34 116.3 31.2 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.716 0.293 . . . . 0.0 111.524 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.7 mt -99.0 130.73 45.36 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 173.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 85.0 mmm -93.53 113.41 25.52 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.34 0.591 . . . . 0.0 111.551 -174.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 23.9 ptp -128.95 153.58 47.39 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.895 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.97 103.65 2.74 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.827 0.346 . . . . 0.0 110.667 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.5 t -73.36 70.68 1.22 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.345 0.593 . . . . 0.0 110.844 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -179.24 -59.51 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.8 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.2 p -94.05 -20.24 20.12 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.612 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.78 21.22 66.58 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.202 -0.523 . . . . 0.0 113.536 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -88.84 144.84 25.95 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.059 0.456 . . . . 0.0 111.546 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.7 m -80.92 125.56 30.28 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.276 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -68.94 -38.1 79.28 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.95 4.16 31.53 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.718 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -141.14 154.34 45.83 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.322 0.561 . . . . 0.0 112.072 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.32 161.15 28.85 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.839 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -116.17 122.1 44.06 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.523 -0.398 . . . . 0.0 111.828 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.5 mt -108.75 133.09 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 120.96 0.41 . . . . 0.0 111.592 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.4 m -109.52 123.98 50.32 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.735 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.426 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 7.0 m-85 -106.1 150.62 25.62 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.26 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.6 m -70.86 -11.62 61.06 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.081 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -136.76 122.97 20.48 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.031 0.443 . . . . 0.0 111.518 -178.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.8 m -65.1 -41.72 94.7 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.151 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -64.21 -46.49 83.65 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.024 0.44 . . . . 0.0 111.535 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.9 m -64.3 -38.52 91.34 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.211 177.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.426 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -64.53 -42.69 95.61 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.149 0.499 . . . . 0.0 111.386 176.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.425 ' HE3' ' HB2' ' A' ' 82' ' ' LYS . 37.8 ttmt -60.61 -40.93 93.63 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.943 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.46 -45.47 83.61 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.232 174.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.47 -48.63 68.72 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.203 0.525 . . . . 0.0 110.992 176.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.514 HD12 HD23 ' A' ' 29' ' ' LEU . 9.0 tt -54.49 -56.81 15.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.199 175.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -61.17 -36.43 79.79 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -175.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -79.98 -30.57 39.74 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.191 0.519 . . . . 0.0 111.17 -175.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 64.9 mt -103.31 -4.18 24.58 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -176.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -64.81 98.19 0.26 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.878 0.37 . . . . 0.0 110.548 175.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.27 0.18 40.83 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.012 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -68.03 125.44 26.33 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 122.618 -0.342 . . . . 0.0 110.739 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -79.62 91.58 5.24 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.224 0.535 . . . . 0.0 110.472 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.5 tp -77.61 -70.62 0.46 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.713 -174.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.79 45.67 1.31 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.2 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.92 8.68 64.71 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.925 -174.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -141.72 144.1 31.65 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 122.794 0.437 . . . . 0.0 110.332 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.95 135.8 51.41 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.227 2.618 . . . . 0.0 113.637 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.6 ttp -103.23 121.01 41.8 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.387 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -89.05 105.12 17.58 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.767 0.318 . . . . 0.0 111.627 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.427 HG13 ' HA ' ' A' ' 85' ' ' LEU . 11.1 t -106.06 105.37 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.737 0.303 . . . . 0.0 110.421 175.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 103' ' ' VAL . . . -114.69 161.65 12.68 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.346 -0.454 . . . . 0.0 113.616 -176.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -72.17 21.34 0.06 Allowed 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.431 ' H ' ' C ' ' A' ' 101' ' ' GLY . 86.4 t 69.47 120.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.208 0.603 . . . . 0.0 111.799 -177.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.3 t -51.12 160.55 0.5 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -50.73 -32.22 18.93 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.55 ' HG3' HG23 ' A' ' 107' ' ' THR . 10.4 ptp180 -155.12 -49.59 0.09 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.956 0.408 . . . . 0.0 110.907 -178.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.55 HG23 ' HG3' ' A' ' 106' ' ' ARG . 8.8 t 177.23 22.0 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.737 0.779 . . . . 0.0 109.788 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.7 t70 . . . . . 0 C--O 1.254 1.318 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.952 -167.733 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 120.705 0.288 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 56.33 -154.04 16.7 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 116.324 -0.398 . . . . 0.0 113.93 178.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -144.19 -89.78 0.11 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 122.738 0.415 . . . . 0.0 109.929 175.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 50.73 18.65 0.51 Allowed 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 169.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 60.17 107.18 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 O-C-N 122.248 -0.282 . . . . 0.0 111.115 -174.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -65.37 -21.06 66.64 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -176.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 64.09 2.19 1.38 Allowed 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 166.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -90.83 118.75 30.48 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -176.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.5 m -111.77 119.96 40.36 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.55 169.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -59.13 -19.27 43.3 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 16.2 tpt 59.05 97.33 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.131 0.491 . . . . 0.0 112.077 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.98 -25.16 0.74 Allowed 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.27 103.93 0.08 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -174.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -173.94 3.58 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 177.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.0 mtt 64.86 -71.86 0.07 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.096 0.558 . . . . 0.0 111.695 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 51.23 85.43 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 176.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -98.76 -5.17 31.82 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.947 0.404 . . . . 0.0 111.381 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -112.32 123.81 51.09 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.551 -176.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.9 tp -141.38 -58.22 0.49 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.266 0.555 . . . . 0.0 110.17 175.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -158.37 96.76 1.44 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.919 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -48.7 109.33 0.24 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.465 0.65 . . . . 0.0 112.235 -176.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.9 -25.85 7.39 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.219 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.3 p 52.56 110.9 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.506 0.723 . . . . 0.0 112.413 -177.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -42.72 -54.47 4.04 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -173.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.85 72.85 0.04 OUTLIER Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.182 -0.533 . . . . 0.0 112.702 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 56.5 Cg_endo -69.29 124.67 11.51 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.561 2.174 . . . . 0.0 113.21 -176.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 13.3 tpt -122.51 138.44 54.56 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.616 176.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.416 ' HD3' ' HB3' ' A' ' 72' ' ' PHE . 36.5 ttm180 -110.94 135.21 51.8 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.07 0.462 . . . . 0.0 111.955 -173.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.9 mt -109.91 137.7 47.33 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.204 0.526 . . . . 0.0 111.945 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -89.94 110.31 21.28 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.524 172.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.7 t -110.71 101.76 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.815 0.34 . . . . 0.0 111.046 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 70' ' ' TYR . . . -113.62 89.72 0.52 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.72 -178.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.41 ' HB2' ' HA ' ' A' ' 98' ' ' MET . 22.6 t -166.39 21.22 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.576 0.703 . . . . 0.0 110.852 176.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.45 ' HB3' ' HB ' ' A' ' 38' ' ' ILE . 18.8 mt -85.72 99.77 11.55 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.704 -176.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.439 ' O ' ' CG ' ' A' ' 35' ' ' HIS . 12.3 p80 -70.01 76.04 0.49 Allowed 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.547 0.689 . . . . 0.0 112.383 -175.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 50.41 16.25 0.26 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 171.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.81 -44.01 0.27 Allowed 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.799 -0.563 . . . . 0.0 112.036 -174.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.569 HD13 ' SD ' ' A' ' 42' ' ' MET . 37.8 mm -49.32 130.86 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -174.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 54.2 p -97.35 170.45 9.06 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.218 0.533 . . . . 0.0 112.158 -176.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.528 ' HG3' HD23 ' A' ' 58' ' ' LEU . 2.6 mp0 -62.59 -38.03 88.54 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.432 175.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.37 -37.81 88.83 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.487 -177.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.569 ' SD ' HD13 ' A' ' 38' ' ' ILE . 28.0 ttt -63.34 -50.5 69.75 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.426 0.632 . . . . 0.0 110.1 177.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.438 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 64.4 mt -56.16 -53.24 59.51 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.257 176.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -52.62 -40.63 62.94 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.383 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.41 -33.96 78.61 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.291 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 63.2 mt -85.08 -44.04 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.472 ' HD2' ' HZ ' ' A' ' 75' ' ' PHE . 36.8 m-85 -80.81 -31.54 35.6 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -173.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.495 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 25.2 tp10 -54.73 -46.75 99.31 Favored Pre-proline 0 N--CA 1.481 1.105 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 73.0 Cg_exo -52.13 -18.68 7.68 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 122.736 2.29 . . . . 0.0 114.318 176.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -82.61 -29.8 29.91 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.079 -0.388 . . . . 0.0 112.029 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.436 ' HA3' ' HB3' ' A' ' 80' ' ' CYS . . . -169.83 -99.25 0.12 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.316 -0.469 . . . . 0.0 112.447 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -166.43 136.98 3.36 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.143 0.497 . . . . 0.0 111.784 173.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.448 HG22 HG13 ' A' ' 56' ' ' ILE . 3.5 mp -96.89 129.26 47.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.311 177.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -77.61 -55.37 5.41 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.455 0.645 . . . . 0.0 110.345 173.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 95.9 p -150.67 150.55 31.25 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.13 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.448 HG13 HG22 ' A' ' 53' ' ' ILE . 60.9 mt -119.77 126.97 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 121.004 0.43 . . . . 0.0 111.212 176.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -101.79 118.4 36.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.981 0.42 . . . . 0.0 110.276 173.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.528 HD23 ' HG3' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -98.34 131.19 44.85 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.5 tpt -92.01 93.47 8.78 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.643 0.735 . . . . 0.0 111.047 -171.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 22.1 ptp -132.94 166.32 22.62 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.622 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -99.73 104.83 16.58 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.874 0.368 . . . . 0.0 110.931 -177.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.7 p -80.78 5.19 16.59 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -175.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -96.7 -55.09 3.01 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.364 0.602 . . . . 0.0 110.812 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.6 p -87.82 -22.06 24.71 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.913 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.39 46.62 5.19 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.433 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -128.07 179.5 5.56 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.734 0.414 . . . . 0.0 111.197 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.8 m -124.69 140.07 53.28 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.597 0.237 . . . . 0.0 111.246 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -85.5 -31.3 22.83 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.801 0.334 . . . . 0.0 111.48 178.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.98 12.64 33.78 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.803 175.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.401 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 2.7 m-85 -121.87 160.56 24.48 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.397 -0.473 . . . . 0.0 110.734 178.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.36 130.51 3.27 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.456 -0.402 . . . . 0.0 112.372 175.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.416 ' HB3' ' HD3' ' A' ' 28' ' ' ARG . 89.4 m-85 -98.99 107.2 19.57 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.06 0.457 . . . . 0.0 111.078 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.42 HD11 ' HB3' ' A' ' 43' ' ' LEU . 69.5 mt -99.49 127.92 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.689 -176.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.9 m -103.25 122.82 45.55 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.007 0.432 . . . . 0.0 111.711 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 44.3 m-85 -99.31 151.45 21.04 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.453 177.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.1 t -76.91 -5.67 49.4 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.735 0.302 . . . . 0.0 111.205 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.499 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 29.0 t70 -142.6 147.62 36.13 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.021 0.439 . . . . 0.0 111.488 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.6 p -72.26 -42.71 65.31 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.054 -178.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -69.13 -38.12 78.69 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.641 0.258 . . . . 0.0 111.359 -177.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.499 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 83.7 m -55.4 -45.5 76.65 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.205 0.526 . . . . 0.0 111.178 175.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.08 -40.99 82.58 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.292 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -58.29 -44.5 88.52 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.072 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -65.23 -49.44 69.66 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.625 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.27 -47.47 72.28 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.945 0.403 . . . . 0.0 111.228 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.8 tt -57.51 -50.7 72.2 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.79 174.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -54.02 -35.09 61.55 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.912 -175.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -93.31 -42.85 9.09 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.487 ' HB3' ' HE2' ' A' ' 98' ' ' MET . 79.7 mt -87.61 -17.21 32.44 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -169.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -71.0 107.98 4.35 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.116 0.484 . . . . 0.0 110.616 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.93 -13.78 37.82 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.245 -174.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -65.67 135.11 54.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.957 0.408 . . . . 0.0 111.885 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 92' ' ' GLU . 9.0 pt-20 -73.73 95.0 2.3 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.195 0.521 . . . . 0.0 111.105 177.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 67.2 tp -67.4 -77.21 0.07 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.28 0.562 . . . . 0.0 111.787 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -108.08 46.41 0.96 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.247 0.546 . . . . 0.0 110.895 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.94 3.42 89.21 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.098 -174.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -128.69 139.68 36.29 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 123.138 0.575 . . . . 0.0 110.255 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.23 134.43 63.97 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.536 2.157 . . . . 0.0 112.048 175.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.487 ' HE2' ' HB3' ' A' ' 88' ' ' LEU . 39.3 ttp -98.44 121.73 40.74 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.106 0.479 . . . . 0.0 111.465 -174.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -87.63 100.58 12.91 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.891 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 28.1 t -111.65 102.21 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.829 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -120.18 138.82 13.29 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.725 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -76.33 53.1 0.81 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 122.379 -0.483 . . . . 0.0 111.724 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.2 t 45.07 77.22 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.445 0.641 . . . . 0.0 111.23 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 77.4 p -67.52 149.21 50.46 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.208 -174.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -34.64 62.48 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.565 178.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -86.88 -16.14 36.92 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.777 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.5 m 72.33 -55.56 0.67 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.609 0.764 . . . . 0.0 112.117 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 . . . . . 0 C--O 1.253 1.285 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 174.31 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo . . . . . 0 CA--C 1.54 0.824 0 N-CA-C 113.199 0.423 . . . . 0.0 113.199 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.7 ttt -148.55 140.87 24.17 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.354 -177.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 28' ' ' ARG . 41.9 ttp180 -115.25 128.33 56.07 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.831 0.348 . . . . 0.0 111.124 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.2 mt -103.5 150.05 24.26 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.168 0.509 . . . . 0.0 112.063 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 78.3 t80 -107.25 106.8 17.43 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.537 176.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.422 HG22 HG22 ' A' ' 100' ' ' VAL . 51.4 t -105.72 125.18 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 120.799 0.333 . . . . 0.0 111.826 -177.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -127.64 96.91 0.45 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 121.248 -0.501 . . . . 0.0 113.7 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 96.6 p -163.96 11.2 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.054 0.454 . . . . 0.0 111.671 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.436 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 8.3 mt -83.06 81.46 8.67 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -171.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.38 71.35 7.19 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.738 0.78 . . . . 0.0 112.319 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 61.47 9.36 2.63 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 172.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -143.3 -8.81 0.77 Allowed 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.246 -0.909 . . . . 0.0 113.364 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.534 ' N ' HD12 ' A' ' 38' ' ' ILE . 2.5 mp -90.59 113.34 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 O-C-N 121.709 -0.62 . . . . 0.0 110.308 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.3 p -95.94 170.42 9.3 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -174.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -53.17 -44.14 67.64 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.683 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -64.13 -39.52 94.21 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.135 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.0 mmt -62.4 -53.05 60.64 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.329 0.585 . . . . 0.0 110.482 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.417 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 54.8 mt -54.67 -55.17 32.52 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.927 176.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.48 ' HB2' HD11 ' A' ' 56' ' ' ILE . 25.4 ttt85 -55.13 -44.1 74.74 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.6 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.12 -29.7 68.92 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.438 -0.41 . . . . 0.0 113.5 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.9 mt -83.46 -34.46 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 O-C-N 122.475 -0.426 . . . . 0.0 112.09 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.428 ' HD2' ' HZ ' ' A' ' 75' ' ' PHE . 6.9 m-85 -85.28 -32.16 22.69 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -174.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.15 -35.51 21.48 Favored Pre-proline 0 N--CA 1.479 1.0 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -45.47 -26.65 2.87 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.205 1.937 . . . . 0.0 113.117 170.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -80.18 -47.74 14.23 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.932 0.396 . . . . 0.0 111.027 174.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.424 ' HA3' ' SG ' ' A' ' 80' ' ' CYS . . . -161.44 -101.5 0.17 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.208 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 52' ' ' ARG . 38.3 ttt180 -164.66 146.13 8.1 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 122.569 -0.371 . . . . 0.0 111.015 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.448 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.3 mp -108.79 130.62 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.835 0.35 . . . . 0.0 111.549 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -79.7 -49.4 12.14 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.853 0.359 . . . . 0.0 111.477 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.5 p -150.79 144.17 24.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.088 0.47 . . . . 0.0 111.57 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.48 HD11 ' HB2' ' A' ' 44' ' ' ARG . 61.9 mt -115.7 115.44 49.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 177.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -110.2 105.69 14.84 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.805 0.336 . . . . 0.0 111.082 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 72.1 mt -98.07 146.78 25.2 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.914 0.388 . . . . 0.0 111.087 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 66.6 mmm . . . . . 0 C--O 1.236 0.361 0 CA-C-O 120.975 0.417 . . . . 0.0 110.026 178.747 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 134.44 -15.41 4.43 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.601 -0.809 . . . . 0.0 114.123 177.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -137.36 150.66 47.86 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.399 0.599 . . . . 0.0 112.453 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.37 158.51 27.76 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 116.182 -0.463 . . . . 0.0 113.018 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -102.08 125.24 48.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.03 0.443 . . . . 0.0 111.352 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.41 HG12 HG23 ' A' ' 56' ' ' ILE . 73.4 mt -111.53 123.22 67.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.165 0.507 . . . . 0.0 111.249 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.4 m -99.54 119.26 37.76 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.458 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 49.1 m-85 -100.95 150.63 22.67 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.424 175.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.3 t -78.36 -30.01 47.8 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.994 0.426 . . . . 0.0 110.942 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -106.91 117.25 33.57 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.827 0.346 . . . . 0.0 111.434 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.9 p -59.5 -52.93 63.48 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.6 tp10 -55.15 -43.91 74.65 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.835 0.35 . . . . 0.0 111.481 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.424 ' SG ' ' HA3' ' A' ' 51' ' ' GLY . 52.6 t -62.9 -45.1 94.12 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.247 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -60.86 -44.04 97.56 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.251 0.548 . . . . 0.0 111.225 176.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.435 ' HB3' ' HE2' ' A' ' 82' ' ' LYS . 35.7 ttpt -61.71 -38.52 88.19 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.85 177.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -65.23 -46.78 79.24 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.163 176.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.59 -48.05 78.26 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.007 0.432 . . . . 0.0 110.634 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.428 HD23 ' C ' ' A' ' 85' ' ' LEU . 8.2 tt -55.58 -50.76 69.23 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.293 0.568 . . . . 0.0 110.668 174.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -62.26 -32.08 72.73 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.913 -173.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -94.88 -36.76 11.5 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.439 ' O ' ' HB3' ' A' ' 98' ' ' MET . 91.4 mt -87.97 -20.1 26.34 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -172.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -64.25 105.67 0.95 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.225 0.536 . . . . 0.0 110.411 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.49 -9.1 26.3 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.098 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -69.34 130.87 43.79 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 122.646 0.378 . . . . 0.0 112.005 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -89.22 103.95 16.53 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.208 0.528 . . . . 0.0 111.536 176.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.2 tp -87.79 -68.62 0.75 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.291 0.567 . . . . 0.0 111.386 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.53 45.36 1.01 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.434 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.0 26.31 74.8 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.211 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -151.85 133.15 7.87 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 123.11 0.564 . . . . 0.0 110.225 -175.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -54.43 150.77 32.76 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.894 2.396 . . . . 0.0 113.921 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.497 ' HG3' HG23 ' A' ' 100' ' ' VAL . 44.0 tpp -98.41 108.27 20.93 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.869 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -88.63 100.1 12.84 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 122.171 -0.331 . . . . 0.0 111.211 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.497 HG23 ' HG3' ' A' ' 98' ' ' MET . 59.9 t -117.54 107.96 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.938 0.399 . . . . 0.0 111.599 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -120.75 155.47 16.24 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.981 177.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 20.3 p80 . . . . . 0 N--CA 1.474 0.731 0 O-C-N 122.081 -0.658 . . . . 0.0 112.453 -177.955 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 38.6 Cg_exo . . . . . 0 CA--C 1.544 1.011 0 N-CA-C 113.216 0.429 . . . . 0.0 113.216 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 11.0 tpt -102.74 145.74 29.27 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.977 0.418 . . . . 0.0 111.689 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -114.52 127.56 55.87 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.043 0.449 . . . . 0.0 111.751 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.4 mt -104.31 149.89 24.94 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.188 0.518 . . . . 0.0 111.546 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.409 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 59.4 t80 -103.45 109.87 21.68 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.539 176.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -110.93 108.16 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 120.743 0.306 . . . . 0.0 111.047 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -121.77 88.59 0.42 Allowed Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.823 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.3 m -164.42 24.98 0.07 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 120.939 0.4 . . . . 0.0 111.283 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 34.2 mt -85.23 143.97 28.42 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.891 0.377 . . . . 0.0 111.661 -174.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.438 ' CE1' ' HB3' ' A' ' 37' ' ' ASN . 33.1 p80 -108.83 48.65 0.85 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.079 0.466 . . . . 0.0 111.708 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 50.1 t80 61.54 9.18 2.58 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.438 ' HB3' ' CE1' ' A' ' 35' ' ' HIS . 65.5 t30 -142.5 37.06 1.49 Allowed 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.539 -0.725 . . . . 0.0 111.669 -178.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.3 mm -125.76 106.62 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 O-C-N 122.023 -0.423 . . . . 0.0 110.407 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.3 p -93.26 175.66 6.68 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.154 0.502 . . . . 0.0 112.304 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.468 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 2.7 mp0 -53.09 -36.01 60.22 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.214 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -56.45 -52.09 65.98 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.847 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.6 tpt -65.34 -47.9 74.9 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.188 0.518 . . . . 0.0 110.711 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.0 mt -56.11 -44.11 78.78 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.248 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -65.15 -44.65 87.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.217 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.99 -31.89 65.72 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.267 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 58.2 mt -86.0 -45.03 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 75' ' ' PHE . 37.5 m-85 -85.14 -43.7 13.61 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -172.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.466 ' CD ' HH11 ' A' ' 52' ' ' ARG . 36.1 tt0 -59.56 -35.1 26.57 Favored Pre-proline 0 N--CA 1.48 1.028 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -172.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 48' ' ' GLU . 60.3 Cg_exo -43.01 -29.39 1.55 Allowed 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 122.081 1.854 . . . . 0.0 113.523 172.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -82.11 -31.18 30.81 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.933 0.397 . . . . 0.0 111.482 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.564 ' HA3' ' HB3' ' A' ' 80' ' ' CYS . . . -175.89 134.47 2.66 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.279 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.466 HH11 ' CD ' ' A' ' 48' ' ' GLU . 14.1 tpt180 -48.22 125.14 8.85 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 122.946 0.498 . . . . 0.0 111.941 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 73.8 mt -94.73 133.95 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.171 0.51 . . . . 0.0 111.831 -175.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -83.92 -51.34 7.24 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.862 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.6 m -150.48 132.95 15.64 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.896 0.379 . . . . 0.0 111.694 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.541 HG23 HG12 ' A' ' 73' ' ' ILE . 58.4 mt -108.84 107.6 23.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.821 176.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -102.19 118.59 37.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.363 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.4 HD13 ' HG3' ' A' ' 40' ' ' GLU . 9.4 mp -98.43 139.63 33.9 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.078 0.466 . . . . 0.0 110.577 175.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.701 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 45.0 tpp . . . . . 0 C--O 1.238 0.449 0 CA-C-O 121.405 0.622 . . . . 0.0 111.387 -173.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.701 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 68.8 mttm . . . . . 0 N--CA 1.471 0.614 0 CA-C-O 120.677 0.275 . . . . 0.0 111.538 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.99 -6.55 8.86 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.992 -0.623 . . . . 0.0 114.31 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -138.01 160.0 40.53 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 117.719 0.76 . . . . 0.0 112.571 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -142.63 151.71 23.27 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.802 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -105.26 115.59 30.51 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.804 0.442 . . . . 0.0 111.448 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.541 HG12 HG23 ' A' ' 56' ' ' ILE . 68.5 mt -104.78 128.37 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 122.222 -0.299 . . . . 0.0 111.546 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.3 m -108.21 121.35 44.68 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 18.2 m-85 -98.5 151.61 20.43 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.294 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.3 t -69.09 -13.04 62.2 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.833 0.349 . . . . 0.0 111.737 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.627 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 16.4 t70 -133.59 153.29 51.78 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.049 0.452 . . . . 0.0 111.361 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 68.7 p -73.12 -51.96 16.03 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.199 -176.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -74.36 -23.05 58.95 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 92.3 m -60.72 -42.84 98.06 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.221 0.534 . . . . 0.0 109.942 170.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.91 -46.94 73.28 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.958 174.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -53.41 -47.71 69.33 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.647 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -60.33 -44.88 95.08 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.184 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.98 -40.14 83.9 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.143 0.497 . . . . 0.0 110.937 175.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.8 -57.98 9.76 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.826 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -61.72 -26.85 68.31 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -174.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -90.54 -34.7 15.43 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.4 mt -97.84 -14.22 20.85 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -173.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -70.85 80.8 0.63 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.584 0.707 . . . . 0.0 110.702 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.64 -4.71 5.13 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.169 -174.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -59.61 140.08 56.65 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -73.37 84.9 1.46 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.953 0.406 . . . . 0.0 111.524 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 67.0 tp -90.59 116.01 28.15 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.291 -0.256 . . . . 0.0 110.854 176.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 59.49 16.9 5.58 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.89 11.85 48.6 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.512 -0.375 . . . . 0.0 112.903 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -132.27 138.46 32.31 Favored Pre-proline 0 N--CA 1.468 0.467 0 O-C-N 122.65 -0.324 . . . . 0.0 111.306 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.19 131.44 38.89 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.326 2.018 . . . . 0.0 112.169 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.4 ttp -97.01 118.99 34.63 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.289 0.566 . . . . 0.0 111.398 -175.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -88.38 104.91 17.21 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.72 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.9 t -111.6 111.44 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.11 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 30' ' ' TYR . . . -133.77 150.8 20.01 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.324 177.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 21.1 p80 . . . . . 0 CA--C 1.54 0.594 0 CA-C-N 117.788 0.794 . . . . 0.0 111.017 -179.964 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo . . . . . 0 CA--C 1.542 0.899 0 N-CA-C 113.687 0.61 . . . . 0.0 113.687 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.3 ttt -102.08 135.82 42.98 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.857 0.36 . . . . 0.0 111.08 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.449 ' HD3' ' HB3' ' A' ' 72' ' ' PHE . 33.7 ttm180 -106.55 134.52 49.55 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -176.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.516 HD22 HD12 ' A' ' 85' ' ' LEU . 75.2 mt -113.11 147.68 36.83 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.191 0.519 . . . . 0.0 111.784 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -94.77 123.17 38.07 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.572 174.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.2 t -116.97 123.2 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 120.733 0.302 . . . . 0.0 111.245 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.3 96.84 0.53 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.277 -0.487 . . . . 0.0 113.345 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.442 ' HB3' ' HA ' ' A' ' 98' ' ' MET . 78.3 p -174.72 15.46 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 177.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.432 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 20.8 mt -82.55 83.31 7.62 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.88 -0.513 . . . . 0.0 111.102 -173.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.415 ' O ' ' CG ' ' A' ' 35' ' ' HIS . 14.4 p80 -78.15 65.08 3.45 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.429 0.633 . . . . 0.0 112.012 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 56.5 t80 55.37 9.73 0.4 Allowed 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 176.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -139.64 1.63 1.94 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.343 -0.848 . . . . 0.0 112.762 -176.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.478 HD12 ' SD ' ' A' ' 42' ' ' MET . 31.6 mm -103.53 118.05 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 O-C-N 121.874 -0.516 . . . . 0.0 110.753 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 34.4 p -103.65 176.59 5.1 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.22 0.534 . . . . 0.0 112.138 -175.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -53.17 -48.58 67.88 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.463 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -59.12 -40.32 85.07 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.792 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.511 ' SD ' HD11 ' A' ' 93' ' ' LEU . 46.3 ttm -65.21 -46.56 80.16 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.256 0.551 . . . . 0.0 110.442 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.3 mt -57.95 -44.46 87.02 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.697 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 44' ' ' ARG . 43.5 ttm180 -56.65 -44.74 81.61 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.164 0.506 . . . . 0.0 110.817 175.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.72 -35.45 81.64 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.129 -0.558 . . . . 0.0 113.638 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.45 HD11 HD13 ' A' ' 93' ' ' LEU . 63.3 mt -84.72 -45.13 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -85.25 -34.04 22.05 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -173.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.619 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 36.4 tt0 -56.84 -41.48 91.53 Favored Pre-proline 0 N--CA 1.477 0.921 0 N-CA-C 113.682 0.994 . . . . 0.0 113.682 -172.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 48' ' ' GLU . 5.1 Cg_endo -47.3 -33.15 15.83 Favored 'Trans proline' 0 C--N 1.363 1.292 0 C-N-CA 122.232 1.954 . . . . 0.0 112.934 175.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -77.1 -47.8 19.5 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.164 0.507 . . . . 0.0 110.876 175.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -162.6 136.52 4.37 Favored Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.845 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 -54.98 134.57 48.95 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.007 0.432 . . . . 0.0 112.057 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.491 HG21 HG13 ' A' ' 56' ' ' ILE . 1.8 mp -81.82 129.38 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.103 0.478 . . . . 0.0 111.813 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -90.43 -43.52 10.22 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.334 176.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.0 p -151.98 148.21 27.47 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.715 0.293 . . . . 0.0 111.64 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.491 HG13 HG21 ' A' ' 53' ' ' ILE . 59.4 mt -127.53 106.61 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.891 0.377 . . . . 0.0 110.895 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -99.45 115.22 28.78 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.614 0.245 . . . . 0.0 110.936 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 80.4 mt -98.01 132.16 43.81 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.037 0.446 . . . . 0.0 110.99 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 89.1 mmm . . . . . 0 CA--C 1.536 0.405 0 CA-C-O 121.343 0.592 . . . . 0.0 111.295 -178.312 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.6 mttm . . . . . 0 N--CA 1.472 0.675 0 CA-C-O 120.871 0.367 . . . . 0.0 111.736 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 104.1 4.44 44.58 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 120.936 -0.649 . . . . 0.0 114.588 174.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -144.84 156.12 43.85 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 117.643 0.722 . . . . 0.0 112.649 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.94 160.73 28.76 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.793 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.449 ' HB3' ' HD3' ' A' ' 28' ' ' ARG . 90.7 m-85 -111.42 124.07 51.5 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 122.569 -0.371 . . . . 0.0 111.511 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.5 mt -112.85 132.98 60.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 120.914 0.388 . . . . 0.0 111.703 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.3 m -101.65 125.41 48.31 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.705 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.469 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 88.3 m-85 -108.99 151.21 26.64 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.811 0.445 . . . . 0.0 111.167 177.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.9 m -62.88 -31.19 72.19 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -177.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.62 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 25.3 t70 -126.88 148.04 50.03 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.073 0.464 . . . . 0.0 111.612 -172.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.1 t -76.17 -34.46 59.34 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -77.24 -36.54 54.51 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.726 0.298 . . . . 0.0 111.114 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.62 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 17.5 p -63.67 -44.17 94.54 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.086 0.47 . . . . 0.0 110.257 175.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -64.63 -46.66 81.59 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.113 175.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -54.56 -43.72 72.3 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.627 175.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.86 -42.62 94.71 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.831 0.348 . . . . 0.0 111.285 177.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.56 -55.25 36.84 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.006 0.431 . . . . 0.0 111.071 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.516 HD12 HD22 ' A' ' 29' ' ' LEU . 8.6 tt -51.57 -55.89 16.63 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.826 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -54.15 -34.03 59.39 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.562 -175.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -97.39 -24.21 15.73 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 97.7 mt -101.65 -11.21 19.37 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -173.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -68.54 85.9 0.3 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.966 0.889 . . . . 0.0 111.225 177.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 127.73 -2.13 6.94 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.309 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -59.69 134.92 57.47 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.459 0.304 . . . . 0.0 111.357 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.34 91.38 1.72 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.23 0.538 . . . . 0.0 111.728 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.511 HD11 ' SD ' ' A' ' 42' ' ' MET . 55.0 tp -99.89 122.05 42.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.596 177.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 59.15 18.67 6.69 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.042 0.448 . . . . 0.0 111.812 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.3 -20.25 30.71 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 116.213 -0.448 . . . . 0.0 113.128 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -115.21 153.81 47.35 Favored Pre-proline 0 CA--C 1.537 0.475 0 O-C-N 122.768 -0.254 . . . . 0.0 111.614 -174.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -63.65 139.02 67.42 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.216 1.944 . . . . 0.0 112.772 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.442 ' HA ' ' HB3' ' A' ' 33' ' ' SER . 44.3 ttp -97.84 120.37 38.11 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.04 -178.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -88.26 99.88 12.57 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.057 0.456 . . . . 0.0 112.155 -174.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 18.3 t -106.03 126.83 61.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.035 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -149.95 160.59 28.57 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.263 -0.494 . . . . 0.0 113.132 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.8 p80 . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 121.104 0.478 . . . . 0.0 112.162 175.161 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 CA--C 1.544 0.992 0 N-CA-C 111.187 -0.351 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.2 ttt -100.0 122.67 43.26 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.861 -0.525 . . . . 0.0 111.293 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -98.99 125.76 44.52 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.769 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.45 HD22 HD12 ' A' ' 85' ' ' LEU . 76.8 mt -110.9 133.54 53.29 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.391 0.615 . . . . 0.0 111.74 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -89.78 109.36 20.36 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.331 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.8 t -109.73 123.21 65.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.78 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -123.73 97.29 0.56 Allowed Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.522 -0.371 . . . . 0.0 113.154 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.494 ' HB3' ' HA ' ' A' ' 98' ' ' MET . 99.7 p -161.02 9.74 0.09 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.089 0.471 . . . . 0.0 111.494 176.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.472 HD21 HD21 ' A' ' 43' ' ' LEU . 10.6 mt -87.16 87.71 7.51 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 122.2 -0.312 . . . . 0.0 111.595 -170.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.48 72.8 1.39 Allowed 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 56.07 20.62 4.48 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 173.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -153.78 -37.24 0.1 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -175.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.4 mm -59.98 128.72 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 120.778 0.323 . . . . 0.0 111.517 -175.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 62.7 p -113.45 178.16 4.38 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -173.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -48.67 -46.1 39.76 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.964 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.66 -44.87 63.19 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.488 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.7 mmt -66.89 -47.06 72.97 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.461 0.648 . . . . 0.0 110.576 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.472 HD21 HD21 ' A' ' 34' ' ' LEU . 70.6 mt -59.46 -50.67 73.05 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.735 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 44' ' ' ARG . 8.2 ttm180 -58.56 -44.7 89.79 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 122.27 -0.268 . . . . 0.0 111.657 177.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.36 -38.36 68.81 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.579 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.489 HD11 HD13 ' A' ' 93' ' ' LEU . 59.6 mt -86.8 -49.18 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 75' ' ' PHE . 51.6 m-85 -77.18 -41.76 40.28 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -170.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.413 ' HB2' HD12 ' A' ' 53' ' ' ILE . 29.6 tt0 -62.85 -37.88 38.15 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -173.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -46.06 -18.06 0.37 Allowed 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.447 2.098 . . . . 0.0 114.112 172.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -82.23 -42.97 18.21 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.801 0.334 . . . . 0.0 111.417 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.17 -122.87 1.06 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.791 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.401 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 29.8 mmt180 -140.29 129.77 24.08 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.387 0.613 . . . . 0.0 111.449 175.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.413 HD12 ' HB2' ' A' ' 48' ' ' GLU . 74.9 mt -100.35 120.81 50.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.822 -175.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -73.45 -53.88 9.59 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.956 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.8 t -150.55 150.2 30.92 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.032 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.1 mt -120.65 116.7 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.372 175.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -118.01 129.18 55.43 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.722 0.296 . . . . 0.0 111.263 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.438 HD12 ' N ' ' A' ' 58' ' ' LEU . 6.0 mp -99.78 141.85 32.04 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.974 0.416 . . . . 0.0 111.075 177.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.462 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 31.0 tpp . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 121.767 0.794 . . . . 0.0 111.675 -176.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.462 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 57.2 mttp . . . . . 0 N--CA 1.473 0.719 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 112.7 3.12 25.4 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 120.937 -0.649 . . . . 0.0 114.495 177.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -140.76 158.77 43.48 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.818 0.809 . . . . 0.0 112.423 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -144.37 159.95 27.8 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.629 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -107.4 124.9 50.52 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 122.624 -0.339 . . . . 0.0 111.256 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 64.7 mt -110.21 130.82 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 120.896 0.379 . . . . 0.0 111.145 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.0 m -106.35 114.25 28.26 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.417 ' CZ ' ' HB3' ' A' ' 47' ' ' PHE . 38.5 m-85 -99.46 152.42 20.01 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.14 0.576 . . . . 0.0 110.763 177.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.8 t -93.65 -5.55 48.41 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.662 0.744 . . . . 0.0 110.002 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -119.8 101.81 8.15 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.186 -175.395 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.7 p -56.9 -55.21 37.5 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -176.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -58.23 -47.36 83.78 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 82.5 m -62.09 -40.86 97.26 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.846 0.355 . . . . 0.0 111.572 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.89 -42.68 89.96 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.064 0.459 . . . . 0.0 111.452 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -62.67 -36.38 82.71 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.093 0.473 . . . . 0.0 110.729 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -63.31 -52.05 63.54 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.086 0.47 . . . . 0.0 110.359 172.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.66 -43.69 57.4 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.201 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.45 HD12 HD22 ' A' ' 29' ' ' LEU . 9.5 tt -54.01 -62.76 1.44 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.185 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -74.9 -4.8 40.16 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -172.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -98.32 -29.72 13.0 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.95 -0.469 . . . . 0.0 111.495 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 88.1 mt -106.71 -13.27 15.32 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -175.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -70.17 91.41 0.71 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.28 0.562 . . . . 0.0 110.247 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 125.98 -15.51 6.95 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.992 -172.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -59.73 133.9 56.53 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.072 0.549 . . . . 0.0 111.457 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 30.8 mt-10 -89.08 90.22 8.3 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.238 0.542 . . . . 0.0 111.923 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.489 HD13 HD11 ' A' ' 46' ' ' ILE . 36.2 tp -85.31 -65.5 1.0 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.41 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.04 38.56 0.66 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.879 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.89 17.27 75.19 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 121.241 -0.504 . . . . 0.0 111.954 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 9.7 ptm85 -157.68 151.59 19.67 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 115.505 -0.347 . . . . 0.0 110.349 -174.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.51 141.48 62.3 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.005 2.47 . . . . 0.0 113.039 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.494 ' HA ' ' HB3' ' A' ' 33' ' ' SER . 36.5 ttp -99.31 128.12 45.4 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.119 0.485 . . . . 0.0 111.48 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -89.12 101.46 14.12 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.533 -178.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.7 t -114.24 111.38 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 120.789 0.328 . . . . 0.0 111.321 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -127.38 151.11 18.33 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.298 -0.477 . . . . 0.0 113.272 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.1 p80 . . . . . 0 N--CA 1.473 0.68 0 O-C-N 122.32 -0.518 . . . . 0.0 111.705 178.955 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo . . . . . 0 CA--C 1.541 0.867 0 CA-C-O 120.752 0.23 . . . . 0.0 112.292 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.8 ttt -99.6 136.4 39.58 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.091 0.472 . . . . 0.0 111.471 -176.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -112.48 118.98 36.64 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.349 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.9 mt -102.4 145.65 29.22 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.347 0.594 . . . . 0.0 112.126 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -102.08 120.48 40.51 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.616 173.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.3 t -118.98 115.94 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.672 0.272 . . . . 0.0 110.997 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.55 87.51 0.38 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.334 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.4 m -166.13 28.72 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.164 0.585 . . . . 0.0 110.61 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.493 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 15.0 mt -95.25 103.09 14.94 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.768 -176.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -74.21 67.1 1.34 Allowed 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -176.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 50.72 20.83 0.8 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 174.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.16 -38.2 0.27 Allowed 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.99 -0.444 . . . . 0.0 111.784 -174.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.7 mm -60.38 109.63 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 120.824 0.345 . . . . 0.0 111.149 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 61.0 p -92.93 172.57 8.24 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -54.79 -42.72 72.13 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.726 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -63.38 -38.04 89.61 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.703 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.1 mmt -65.51 -52.73 50.58 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.408 0.623 . . . . 0.0 110.197 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 65.5 mt -55.2 -40.33 70.65 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.925 174.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 44' ' ' ARG . 45.0 ttm180 -61.5 -46.76 88.64 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.876 0.37 . . . . 0.0 110.957 177.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.31 -32.03 60.09 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.139 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 58.1 mt -85.68 -50.12 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -82.48 -27.69 31.65 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -172.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.632 ' HG3' ' O ' ' A' ' 52' ' ' ARG . 22.1 tt0 -57.33 -48.23 97.68 Favored Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -173.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 80.3 Cg_exo -47.89 -18.88 1.23 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 122.621 2.214 . . . . 0.0 114.013 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -78.45 -40.31 36.05 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.42 ' HA3' ' HB3' ' A' ' 80' ' ' CYS . . . -169.8 37.93 0.19 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 119.838 -1.173 . . . . 0.0 115.438 -178.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.632 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 0.0 OUTLIER 72.67 -53.79 0.7 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.366 0.666 . . . . 0.0 112.541 174.593 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.447 ' HB ' ' O ' ' A' ' 52' ' ' ARG . 68.7 mt 79.82 137.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.756 0.823 . . . . 0.0 111.672 -177.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -85.01 -64.96 1.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.196 0.522 . . . . 0.0 110.151 174.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.2 t -147.59 146.36 29.36 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.046 0.451 . . . . 0.0 111.865 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.527 HG23 HG12 ' A' ' 73' ' ' ILE . 60.4 mt -115.36 130.19 70.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.894 174.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -125.07 122.45 37.26 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.924 0.393 . . . . 0.0 111.547 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.8 mt -99.13 149.73 22.75 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.657 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 82.8 mmm . . . . . 0 CA--C 1.537 0.458 0 CA-C-O 120.699 0.285 . . . . 0.0 110.727 179.898 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.2 mttm . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 145.27 -11.01 1.79 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.929 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -128.55 145.26 51.18 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 117.23 0.515 . . . . 0.0 111.858 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.33 160.87 28.75 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.651 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -113.25 127.25 56.1 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.007 0.432 . . . . 0.0 111.72 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 56' ' ' ILE . 67.1 mt -110.12 134.71 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.771 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 38.8 m -116.25 123.3 47.39 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.025 0.44 . . . . 0.0 111.926 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -100.22 149.66 23.34 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.511 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.8 m -72.06 -9.46 58.42 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.066 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.632 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 19.8 t70 -138.12 150.23 46.65 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.874 0.369 . . . . 0.0 111.47 -177.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 71.2 p -68.72 -53.19 23.5 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -68.54 -30.17 68.9 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 93.8 m -58.03 -41.45 83.25 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.16 0.505 . . . . 0.0 111.183 174.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.39 -38.67 29.85 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.237 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -54.93 -48.94 72.48 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.308 0.575 . . . . 0.0 110.688 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -70.02 -41.97 73.59 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.566 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.06 -44.02 67.14 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.273 0.558 . . . . 0.0 110.873 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 tt -62.29 -62.25 1.89 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.521 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -56.54 -29.73 62.29 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -176.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -87.95 -38.6 15.42 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 122.09 -0.381 . . . . 0.0 111.728 -175.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 76.5 mt -96.16 -23.4 16.76 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -172.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -65.69 100.13 0.51 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.068 0.461 . . . . 0.0 110.641 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.47 -9.67 13.1 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.738 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -73.22 126.97 31.3 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 122.535 -0.391 . . . . 0.0 111.938 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 45.3 mt-10 -80.04 102.54 9.35 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.866 0.365 . . . . 0.0 111.143 176.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 65.8 tp -89.53 -66.74 0.89 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.034 0.445 . . . . 0.0 111.516 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -92.15 32.4 1.17 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.955 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.61 4.99 79.2 Favored Glycine 0 C--N 1.332 0.343 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 -174.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 1.5 ptm85 -143.44 152.37 56.81 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 122.927 0.491 . . . . 0.0 110.695 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -61.16 155.59 50.12 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.118 2.545 . . . . 0.0 114.384 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 31.9 tpp -99.46 117.72 34.49 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.728 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.587 ' NZ ' ' HB3' ' A' ' 99' ' ' LYS . 7.7 mtpm? -89.32 101.97 14.64 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.121 -0.362 . . . . 0.0 111.419 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.6 t -120.52 118.1 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.886 0.374 . . . . 0.0 111.666 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -139.24 147.49 19.25 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.176 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 11.3 p80 . . . . . 0 N--CA 1.47 0.574 0 CA-C-N 117.663 0.732 . . . . 0.0 110.769 -179.675 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo . . . . . 0 CA--C 1.539 0.738 0 CA-C-O 121.014 0.339 . . . . 0.0 112.67 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.505 ' HB2' ' HA ' ' A' ' 78' ' ' SER . 27.0 ttt -113.11 133.15 55.15 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.972 0.415 . . . . 0.0 111.558 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -99.78 116.28 31.5 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.159 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.2 mt -99.55 143.06 30.23 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.13 0.491 . . . . 0.0 111.665 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -97.73 120.11 37.54 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.602 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 99' ' ' LYS . 58.4 t -115.17 112.55 40.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.478 176.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.56 93.35 0.22 Allowed Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.527 -0.844 . . . . 0.0 114.645 -174.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.645 ' OG ' ' HA ' ' A' ' 98' ' ' MET . 90.9 p -176.08 19.89 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 28.8 mt -84.88 150.33 25.06 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 122.279 -0.263 . . . . 0.0 111.43 -175.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.4 ' O ' ' ND1' ' A' ' 35' ' ' HIS . 24.9 p80 -122.49 76.61 1.34 Allowed 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -176.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 23.7 t80 42.94 41.86 2.81 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.312 0.645 . . . . 0.0 112.616 173.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -152.99 -51.32 0.1 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.998 0.428 . . . . 0.0 111.374 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.64 ' HA ' ' SD ' ' A' ' 42' ' ' MET . 3.2 mp -62.59 127.9 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.137 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.437 ' OG1' ' HG3' ' A' ' 42' ' ' MET . 35.3 p -106.51 171.93 7.09 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.329 0.585 . . . . 0.0 112.078 -175.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.522 ' HG2' ' HG ' ' A' ' 58' ' ' LEU . 79.6 mt-10 -67.08 -32.88 74.35 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.793 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -64.17 -39.2 93.51 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.075 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.64 ' SD ' ' HA ' ' A' ' 38' ' ' ILE . 64.4 mtt -62.88 -52.4 63.23 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.442 0.639 . . . . 0.0 110.273 176.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.503 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 63.1 mt -54.47 -51.39 65.19 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.106 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -50.2 -50.1 50.58 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.888 0.375 . . . . 0.0 111.195 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.93 -28.77 66.57 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.656 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.8 mm -82.84 -38.33 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 O-C-N 122.453 -0.439 . . . . 0.0 111.97 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.503 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 44.5 m-85 -85.89 -30.83 22.56 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -174.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -56.7 -38.68 71.17 Favored Pre-proline 0 N--CA 1.483 1.197 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -47.18 -22.83 2.52 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.245 1.964 . . . . 0.0 113.408 171.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.429 ' HE1' ' HG3' ' A' ' 87' ' ' GLN . 81.5 m-85 -93.69 -44.9 7.94 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.087 0.47 . . . . 0.0 111.096 175.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -174.32 140.58 5.49 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.844 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.0 ttp85 -58.34 134.5 56.64 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.242 0.544 . . . . 0.0 112.082 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.4 mp -94.01 137.9 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.144 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -87.99 -40.67 13.69 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.833 0.349 . . . . 0.0 111.806 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.9 t -150.96 132.36 14.64 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.117 0.484 . . . . 0.0 112.238 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.534 HG23 HG12 ' A' ' 73' ' ' ILE . 47.9 mt -117.64 133.2 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.211 173.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -137.89 118.83 14.27 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.844 0.355 . . . . 0.0 111.404 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.605 HD23 ' HA3' ' A' ' 71' ' ' GLY . 91.7 mt -96.48 149.81 21.32 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 174.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.564 ' SD ' ' CE2' ' A' ' 70' ' ' TYR . 60.9 mtp . . . . . 0 C--O 1.237 0.435 0 CA-C-O 121.798 0.808 . . . . 0.0 111.349 -177.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.3 mttt . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.03 3.57 87.62 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 114.963 0.745 . . . . 0.0 114.963 169.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.564 ' CE2' ' SD ' ' A' ' 59' ' ' MET . 49.4 p90 -133.09 145.98 51.24 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 117.805 0.802 . . . . 0.0 111.993 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.605 ' HA3' HD23 ' A' ' 58' ' ' LEU . . . -151.2 161.9 29.28 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 115.816 -0.629 . . . . 0.0 113.239 -177.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -105.2 129.04 53.67 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.914 0.388 . . . . 0.0 111.768 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.534 HG12 HG23 ' A' ' 56' ' ' ILE . 66.8 mt -111.76 132.69 59.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.025 178.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.7 m -112.57 118.54 35.39 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.441 ' HZ ' ' HD2' ' A' ' 47' ' ' PHE . 45.0 m-85 -99.12 152.13 20.21 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.792 0.437 . . . . 0.0 111.841 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.1 m -68.09 -10.81 56.83 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.624 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -139.64 161.04 38.49 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.081 0.467 . . . . 0.0 112.096 -176.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.505 ' HA ' ' HB2' ' A' ' 27' ' ' MET . 51.7 m -91.33 -37.31 13.33 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -79.4 -40.01 31.06 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.015 -0.428 . . . . 0.0 112.023 -177.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 76.5 m -58.13 -41.86 84.57 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.329 0.585 . . . . 0.0 110.765 174.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.6 -45.37 68.73 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.984 176.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.518 ' NZ ' ' HB2' ' A' ' 82' ' ' LYS . 5.0 ttmp? -57.25 -34.98 69.16 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.405 178.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 46.0 tttm -75.23 -37.74 60.93 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.965 0.412 . . . . 0.0 111.01 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.89 -33.19 64.38 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.501 0.667 . . . . 0.0 110.475 172.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 100' ' ' VAL . 7.6 tt -65.85 -55.38 17.34 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.766 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 83' ' ' LYS . 2.6 pp20? -64.74 -19.28 65.7 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -174.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.429 ' HG3' ' HE1' ' A' ' 50' ' ' PHE . 85.9 mm-40 -94.6 -46.46 6.94 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.871 -0.518 . . . . 0.0 111.893 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 71.6 mt -89.61 -17.3 28.74 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -170.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -71.01 91.4 0.88 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.464 0.65 . . . . 0.0 110.187 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.42 -14.13 8.78 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.943 -173.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -61.77 120.26 10.34 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.703 0.401 . . . . 0.0 110.958 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 43.0 mt-10 -79.0 93.71 5.15 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.158 0.504 . . . . 0.0 111.67 -177.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.5 tp -96.51 135.88 37.79 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.995 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 59.76 24.07 13.0 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.206 0.527 . . . . 0.0 111.146 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.33 3.67 89.91 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.121 -0.491 . . . . 0.0 113.526 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 44.9 mtp180 -121.13 136.5 25.75 Favored Pre-proline 0 N--CA 1.473 0.676 0 CA-C-N 117.306 0.553 . . . . 0.0 111.731 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -59.99 129.31 29.81 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.473 2.115 . . . . 0.0 111.82 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.645 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 40.9 ttp -97.62 124.88 42.07 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.174 0.511 . . . . 0.0 111.781 -174.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 68.2 mttm -88.41 101.91 14.36 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.148 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.515 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 44.0 t -114.45 99.51 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.632 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -135.62 160.24 24.44 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.747 -0.739 . . . . 0.0 113.062 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 15.0 p80 . . . . . 0 CA--C 1.537 0.479 0 O-C-N 122.514 -0.403 . . . . 0.0 110.598 177.209 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo . . . . . 0 CA--C 1.541 0.874 0 N-CA-C 113.116 0.391 . . . . 0.0 113.116 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 26.3 ttt -99.12 141.27 32.09 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.677 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.489 ' HD3' ' HB3' ' A' ' 72' ' ' PHE . 42.4 ttm180 -115.71 130.95 57.05 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.171 0.51 . . . . 0.0 112.288 -171.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.427 HD11 ' O ' ' A' ' 81' ' ' ALA . 85.5 mt -107.66 145.39 33.43 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.195 0.522 . . . . 0.0 111.831 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.51 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 39.0 t80 -97.32 111.79 23.89 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.961 173.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -106.23 107.44 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 120.805 0.336 . . . . 0.0 111.35 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.592 ' HA2' ' HB3' ' A' ' 70' ' ' TYR . . . -113.39 97.57 0.87 Allowed Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.244 -0.503 . . . . 0.0 113.831 -176.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.73 ' HB2' ' HA ' ' A' ' 98' ' ' MET . 30.7 t -174.81 15.25 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.39 0.614 . . . . 0.0 111.183 172.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.725 ' HA ' HD12 ' A' ' 38' ' ' ILE . 11.1 mt -85.59 88.62 7.55 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 122.029 -0.42 . . . . 0.0 110.405 -171.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -78.49 69.29 4.65 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.579 0.704 . . . . 0.0 112.377 -172.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 48.3 t80 57.68 9.62 0.87 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 175.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -124.18 -38.91 2.4 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.609 -0.682 . . . . 0.0 112.596 -177.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.725 HD12 ' HA ' ' A' ' 34' ' ' LEU . 58.8 mt -67.61 134.06 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.938 0.399 . . . . 0.0 111.978 -176.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 56.6 p -110.02 166.21 11.12 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.066 0.46 . . . . 0.0 112.205 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.493 ' HA ' HD12 ' A' ' 43' ' ' LEU . 2.5 mp0 -63.07 -36.54 83.93 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.248 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -66.67 -33.56 75.92 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.909 0.385 . . . . 0.0 111.277 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.47 ' SD ' HG23 ' A' ' 38' ' ' ILE . 27.1 ttt -68.18 -44.66 75.41 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.562 0.696 . . . . 0.0 110.107 174.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 40' ' ' GLU . 92.2 mt -55.09 -55.26 33.0 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.722 178.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.534 ' HB3' HD11 ' A' ' 56' ' ' ILE . 14.2 ptm180 -61.78 -33.22 73.72 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.385 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.19 -36.8 69.81 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.63 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 63.2 mt -85.45 -49.21 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 177.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -82.31 -32.52 29.41 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -169.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.749 ' HG3' ' HA ' ' A' ' 52' ' ' ARG . 22.2 tt0 -62.07 -42.49 81.98 Favored Pre-proline 0 N--CA 1.48 1.056 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -174.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -47.78 -18.29 0.98 Allowed 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 122.529 2.152 . . . . 0.0 114.316 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -71.38 -51.9 21.58 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.525 ' N ' ' SG ' ' A' ' 80' ' ' CYS . . . -170.91 43.76 0.19 Allowed Glycine 0 N--CA 1.468 0.77 0 C-N-CA 120.079 -1.058 . . . . 0.0 114.092 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.749 ' HA ' ' HG3' ' A' ' 48' ' ' GLU . 0.3 OUTLIER 63.31 143.91 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.974 0.892 . . . . 0.0 113.39 178.787 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.41 HG13 ' HA ' ' A' ' 48' ' ' GLU . 89.2 mt -119.09 133.69 65.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.16 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -82.68 -56.48 3.83 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.674 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.7 p -150.12 138.34 20.39 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.255 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 44' ' ' ARG . 46.0 mt -107.67 116.31 50.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.343 0.592 . . . . 0.0 111.113 177.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -99.36 115.72 29.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.993 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 27.9 tp -97.16 133.35 41.92 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.551 -0.718 . . . . 0.0 110.516 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.6 ' HG3' ' HD3' ' A' ' 68' ' ' LYS . 14.3 tpt . . . . . 0 C--O 1.235 0.302 0 CA-C-O 121.889 0.852 . . . . 0.0 111.142 -171.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.6 ' HD3' ' HG3' ' A' ' 59' ' ' MET . 26.0 mtpp . . . . . 0 CA--C 1.542 0.643 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 101.03 7.05 51.02 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 120.969 -0.634 . . . . 0.0 114.486 175.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.592 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -145.26 160.07 42.05 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 117.476 0.638 . . . . 0.0 112.567 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -145.29 147.57 18.77 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.955 -0.566 . . . . 0.0 113.147 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.489 ' HB3' ' HD3' ' A' ' 28' ' ' ARG . 95.8 m-85 -99.57 112.67 24.85 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.935 0.398 . . . . 0.0 111.266 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.529 HG23 HG12 ' A' ' 56' ' ' ILE . 67.8 mt -99.41 126.18 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.956 0.408 . . . . 0.0 111.586 -178.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 36.7 m -101.54 118.41 36.9 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.517 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -98.53 151.53 20.54 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.109 0.481 . . . . 0.0 112.17 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.0 t -72.19 -28.83 63.46 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.148 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -116.3 133.0 56.51 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.972 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.6 t -67.04 -51.17 58.09 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.941 0.401 . . . . 0.0 111.891 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -57.77 -34.37 69.5 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.098 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 51' ' ' GLY . 7.7 t -57.97 -46.3 85.38 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.824 175.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.427 ' O ' HD11 ' A' ' 29' ' ' LEU . . . -65.16 -41.77 94.35 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.07 0.462 . . . . 0.0 111.15 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -64.93 -35.67 81.91 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.564 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 85.6 tttt -72.35 -50.41 26.95 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.741 0.305 . . . . 0.0 111.318 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.15 -42.77 61.01 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.11 0.481 . . . . 0.0 110.954 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.409 HD23 ' C ' ' A' ' 85' ' ' LEU . 7.8 tt -57.19 -55.9 28.7 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.511 173.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -53.67 -34.85 60.06 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.132 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 83' ' ' LYS . 11.1 mm100 -86.8 -35.43 19.12 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.911 -174.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 73.8 mt -104.79 -7.02 19.76 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -171.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -62.91 99.71 0.17 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.028 0.442 . . . . 0.0 111.134 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.05 -2.42 44.31 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 116.264 -0.426 . . . . 0.0 113.342 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -67.15 131.69 46.31 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 122.607 -0.349 . . . . 0.0 111.578 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.82 103.34 1.41 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.987 0.423 . . . . 0.0 111.153 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 56.6 tp -113.17 127.33 56.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.433 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 58.26 23.73 10.7 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.148 0.499 . . . . 0.0 111.754 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.99 -18.27 54.99 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.82 -0.627 . . . . 0.0 114.018 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 31.7 mtt85 -116.59 140.01 26.19 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 117.378 0.589 . . . . 0.0 111.997 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.23 132.12 48.74 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.778 2.318 . . . . 0.0 112.098 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.73 ' HA ' ' HB2' ' A' ' 33' ' ' SER . 38.5 ttp -96.75 119.35 35.07 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.361 0.6 . . . . 0.0 111.738 -171.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -87.8 94.19 9.68 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.64 -176.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.05 113.57 38.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.461 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.51 ' O ' ' HB3' ' A' ' 30' ' ' TYR . . . -142.08 131.59 4.8 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.25 -0.5 . . . . 0.0 112.548 176.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 25.9 p80 . . . . . 0 N--CA 1.477 0.881 0 CA-C-N 117.655 0.727 . . . . 0.0 112.128 -177.848 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo . . . . . 0 CA--C 1.543 0.958 0 N-CA-C 113.551 0.558 . . . . 0.0 113.551 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 11.7 tpt -126.23 147.51 49.66 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.763 0.315 . . . . 0.0 111.474 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 36.7 ttt85 -120.81 121.22 37.69 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.854 0.359 . . . . 0.0 111.308 -174.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 81.6 mt -106.01 143.66 33.82 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 55.2 t80 -91.66 116.06 28.57 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.495 172.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.465 HG21 HD12 ' A' ' 73' ' ' ILE . 60.0 t -118.73 109.14 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-O 121.093 0.473 . . . . 0.0 111.789 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.5 104.76 1.84 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.576 -0.345 . . . . 0.0 112.937 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.555 ' HB2' ' HA ' ' A' ' 98' ' ' MET . 39.7 t -171.64 14.61 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.248 0.547 . . . . 0.0 111.823 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.494 HD11 HD22 ' A' ' 58' ' ' LEU . 12.1 mt -86.16 85.44 7.35 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.722 -0.611 . . . . 0.0 111.529 -172.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.401 ' ND1' ' O ' ' A' ' 35' ' ' HIS . 33.8 p80 -78.64 66.58 4.18 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.672 0.748 . . . . 0.0 112.046 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 47.0 t80 60.18 9.24 1.8 Allowed 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.55 -34.95 1.53 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.584 -0.697 . . . . 0.0 111.483 -178.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.427 ' HB ' HD22 ' A' ' 34' ' ' LEU . 11.6 mm -73.21 107.36 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.931 0.396 . . . . 0.0 111.329 -175.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.5 p -99.54 179.23 4.62 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.957 0.408 . . . . 0.0 112.014 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -60.48 -43.13 97.28 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.275 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.31 -37.21 82.43 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.129 0.49 . . . . 0.0 110.959 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.403 ' SD ' HG23 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -67.54 -55.02 15.16 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.334 0.588 . . . . 0.0 110.246 178.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.4 mt -55.18 -44.12 74.94 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.444 176.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.511 HH21 ' NH1' ' A' ' 52' ' ' ARG . 53.9 ttt180 -58.7 -47.34 84.89 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.232 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.44 -31.59 60.05 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.998 177.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.8 mt -80.28 -54.48 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -79.76 -33.91 40.29 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -172.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.858 ' HG3' ' HA ' ' A' ' 52' ' ' ARG . 10.1 tt0 -60.78 -38.67 58.54 Favored Pre-proline 0 N--CA 1.476 0.867 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -172.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -46.3 -26.52 3.98 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.535 2.157 . . . . 0.0 113.798 172.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -66.91 -63.74 1.0 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.653 0.263 . . . . 0.0 111.595 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.465 ' HA3' ' SG ' ' A' ' 80' ' ' CYS . . . -165.65 40.02 0.28 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.472 -0.87 . . . . 0.0 114.314 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.858 ' HA ' ' HG3' ' A' ' 48' ' ' GLU . 43.7 tpt85 71.26 127.18 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 172.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.481 HG21 HG13 ' A' ' 56' ' ' ILE . 1.7 mp -82.89 141.31 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.038 0.447 . . . . 0.0 111.432 175.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -90.29 -56.22 3.3 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.309 0.576 . . . . 0.0 109.656 173.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.6 m -150.6 144.02 25.0 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.46 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.512 HG23 HG12 ' A' ' 73' ' ' ILE . 57.3 mt -122.29 109.87 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.023 0.44 . . . . 0.0 110.776 175.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -108.83 112.26 24.42 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.314 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.494 HD22 HD11 ' A' ' 34' ' ' LEU . 32.7 mt -98.69 141.91 30.92 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.81 0.338 . . . . 0.0 110.921 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 64.7 mtp . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 121.167 0.508 . . . . 0.0 111.488 -176.279 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.2 mttp . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.2 -6.63 19.17 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 120.917 -0.659 . . . . 0.0 114.439 174.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -135.56 151.72 50.58 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 117.376 0.588 . . . . 0.0 112.364 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.7 158.76 27.83 Favored Glycine 0 CA--C 1.527 0.844 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.734 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -101.51 120.44 40.3 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.601 -0.352 . . . . 0.0 111.603 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.512 HG12 HG23 ' A' ' 56' ' ' ILE . 70.9 mt -103.9 117.11 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.278 0.561 . . . . 0.0 111.249 178.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 51.9 m -99.85 125.71 45.85 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.68 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -103.3 150.44 23.75 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.782 175.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.8 t -72.92 -11.87 60.74 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.683 0.278 . . . . 0.0 111.65 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -126.24 144.38 50.8 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.852 0.358 . . . . 0.0 110.986 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 54.5 m -78.78 -43.67 24.94 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -69.69 -34.9 74.58 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.826 0.346 . . . . 0.0 111.508 -175.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.465 ' SG ' ' HA3' ' A' ' 51' ' ' GLY . 35.8 t -60.04 -43.39 95.36 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.068 0.461 . . . . 0.0 111.081 174.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.39 -40.97 96.84 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.01 176.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -56.67 -46.44 81.1 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.965 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 86.8 tttt -62.03 -54.04 47.06 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.288 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.92 -52.12 61.58 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.894 0.378 . . . . 0.0 111.836 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.9 tt -53.87 -54.6 36.29 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.621 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -64.67 -25.14 67.82 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -173.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 83' ' ' LYS . 8.3 mm-40 -95.72 -17.79 20.98 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.473 ' HB3' ' SD ' ' A' ' 98' ' ' MET . 90.2 mt -112.2 -24.53 9.79 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -175.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -60.03 101.41 0.12 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.169 0.509 . . . . 0.0 111.534 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.65 -15.98 9.69 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 116.063 -0.517 . . . . 0.0 113.013 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -63.41 129.98 42.53 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 122.658 -0.319 . . . . 0.0 111.784 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -65.86 94.31 0.21 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.993 0.425 . . . . 0.0 111.18 175.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 66.9 tp -86.75 115.25 24.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.426 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 55.92 22.35 5.65 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 109.26 -9.41 33.32 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 114.098 0.399 . . . . 0.0 114.098 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -130.93 134.89 26.51 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 117.405 0.603 . . . . 0.0 110.78 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.66 149.42 13.87 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.819 2.346 . . . . 0.0 113.26 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.555 ' HA ' ' HB2' ' A' ' 33' ' ' SER . 43.9 ttm -96.85 104.78 16.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.234 0.54 . . . . 0.0 109.906 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.414 ' NZ ' ' HB3' ' A' ' 99' ' ' LYS . 2.0 mmmp? -87.84 89.9 8.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.708 -175.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 20.4 t -105.2 117.82 51.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.089 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -148.14 162.15 28.73 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.208 -0.52 . . . . 0.0 113.053 -176.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 . . . . . 0 CA--C 1.539 0.547 0 CA-C-O 121.305 0.574 . . . . 0.0 111.552 177.319 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.701 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 14.4 Cg_exo . . . . . 0 CA--C 1.548 1.186 0 N-CA-C 116.619 1.738 . . . . 0.0 116.619 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.9 ttt -139.46 138.22 36.24 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.46 170.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 28' ' ' ARG . 62.8 mtt-85 -99.74 143.6 29.78 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.422 0.629 . . . . 0.0 112.483 -177.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.0 mt -112.44 139.16 48.24 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.28 177.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -90.71 108.8 20.06 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.769 176.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.35 104.41 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.674 0.273 . . . . 0.0 111.201 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.533 ' HA2' ' HB3' ' A' ' 70' ' ' TYR . . . -114.64 91.68 0.57 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.201 -0.523 . . . . 0.0 113.945 -177.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 t -175.15 21.13 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.433 0.635 . . . . 0.0 111.174 175.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.485 HD22 HG21 ' A' ' 38' ' ' ILE . 13.1 mt -85.02 93.13 8.52 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.869 -0.52 . . . . 0.0 110.945 -173.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -81.44 62.1 5.18 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.293 0.568 . . . . 0.0 112.531 -174.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 62.0 t80 59.61 9.22 1.49 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 173.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -130.95 4.95 4.51 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.61 -0.681 . . . . 0.0 111.502 -178.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.55 HG23 ' SD ' ' A' ' 42' ' ' MET . 27.1 mm -105.25 127.98 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 122.111 -0.368 . . . . 0.0 110.81 -177.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.6 p -107.23 167.3 10.01 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.936 0.398 . . . . 0.0 111.788 -176.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -55.21 -44.5 75.42 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.125 0.488 . . . . 0.0 110.878 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -68.03 -31.63 71.43 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.184 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.55 ' SD ' HG23 ' A' ' 38' ' ' ILE . 52.5 ttm -62.14 -50.21 72.77 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.406 0.622 . . . . 0.0 109.887 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.42 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 48.9 mt -57.14 -44.15 83.13 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.495 173.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -53.27 -47.35 69.21 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.078 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.74 -29.49 74.06 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.306 -0.473 . . . . 0.0 113.387 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.1 mt -84.59 -44.06 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 O-C-N 122.386 -0.479 . . . . 0.0 112.158 178.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.42 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 38.9 m-85 -85.64 -29.12 24.29 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -171.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -52.81 -47.33 95.21 Favored Pre-proline 0 N--CA 1.486 1.334 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -49.93 -18.22 2.83 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 122.801 2.334 . . . . 0.0 114.919 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.489 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 79.3 m-85 -78.69 -70.48 0.49 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.431 ' N ' ' SG ' ' A' ' 80' ' ' CYS . . . -157.95 24.25 0.4 Allowed Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.713 -177.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 68.88 144.9 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.502 ' N ' HD12 ' A' ' 53' ' ' ILE . 4.0 mp -107.22 139.72 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.45 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -78.32 -48.37 15.78 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.434 0.635 . . . . 0.0 110.937 175.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 61.3 m -151.2 132.28 14.35 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.66 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.477 HG23 HG12 ' A' ' 73' ' ' ILE . 54.6 mt -106.45 129.05 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 173.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -130.41 134.44 47.14 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.851 0.358 . . . . 0.0 111.658 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 76.1 mt -98.72 144.02 28.44 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.81 0.338 . . . . 0.0 110.623 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 10.0 tpt . . . . . 0 CA--C 1.538 0.519 0 CA-C-O 121.315 0.579 . . . . 0.0 111.227 -176.839 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 73.6 mmtt . . . . . 0 CA--C 1.537 0.477 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.76 5.24 63.05 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.589 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.533 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 2.2 p90 -141.45 158.98 43.16 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.034 0.445 . . . . 0.0 111.851 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.47 161.25 28.9 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 116.256 -0.429 . . . . 0.0 113.04 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -109.15 123.08 48.63 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.169 0.509 . . . . 0.0 111.738 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.477 HG12 HG23 ' A' ' 56' ' ' ILE . 78.4 mt -107.69 122.27 61.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 178.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.452 ' O ' HG23 ' A' ' 53' ' ' ILE . 28.2 m -99.57 115.38 29.24 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -175.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.701 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 40.9 m-85 -97.66 141.41 30.72 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.59 0.233 . . . . 0.0 111.437 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.9 t -73.75 -3.3 27.58 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.377 176.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' A' ' 80' ' ' CYS . 11.2 t70 -132.95 121.03 22.2 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.787 0.327 . . . . 0.0 110.687 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.2 p -60.19 -51.81 67.98 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.12 -36.77 85.11 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.773 0.32 . . . . 0.0 110.993 -177.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.575 ' HB3' ' HB3' ' A' ' 77' ' ' ASP . 25.0 t -63.08 -40.75 98.57 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.797 0.332 . . . . 0.0 111.362 175.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.517 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -63.86 -47.6 80.07 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.317 0.58 . . . . 0.0 110.551 175.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -57.44 -42.11 81.8 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.655 176.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -66.87 -49.58 65.23 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.817 0.341 . . . . 0.0 111.182 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.66 -44.45 69.66 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.204 0.526 . . . . 0.0 110.662 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.431 HD23 ' C ' ' A' ' 85' ' ' LEU . 7.1 tt -56.96 -58.5 7.87 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.686 175.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -61.31 -25.88 67.42 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -174.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.16 -46.16 9.02 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.805 0.336 . . . . 0.0 111.754 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 70.7 mt -89.81 -9.3 49.7 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -169.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -67.78 82.27 0.19 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.446 0.641 . . . . 0.0 110.826 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 142.7 -21.2 2.36 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.606 -175.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -48.92 119.51 3.24 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.221 0.608 . . . . 0.0 111.52 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -69.37 93.6 0.66 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.27 0.557 . . . . 0.0 110.995 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.438 HD21 HG21 ' A' ' 38' ' ' ILE . 51.2 tp -85.46 111.59 20.11 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.223 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 63.02 2.78 1.09 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 126.69 -7.82 7.36 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.524 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -122.79 130.29 24.68 Favored Pre-proline 0 N--CA 1.47 0.555 0 CA-C-N 117.01 0.405 . . . . 0.0 110.906 176.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.55 136.51 41.07 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.427 2.085 . . . . 0.0 112.016 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 51.3 ttp -95.96 116.42 28.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.43 0.633 . . . . 0.0 111.077 -172.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -88.29 92.51 9.19 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.079 -176.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.7 t -99.83 107.31 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.642 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -134.95 161.22 24.53 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.569 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.8 p80 . . . . . 0 CA--C 1.541 0.613 0 O-C-N 122.479 -0.424 . . . . 0.0 111.908 175.914 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo . . . . . 0 CA--C 1.538 0.676 0 CA-C-O 120.947 0.311 . . . . 0.0 112.646 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 28.1 ttt -112.9 123.11 49.57 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.039 0.447 . . . . 0.0 111.268 -173.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.471 ' HD2' ' HB3' ' A' ' 72' ' ' PHE . 47.7 ttp180 -102.82 136.61 42.31 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.032 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.0 mt -107.51 148.59 29.01 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.233 0.54 . . . . 0.0 112.299 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -95.64 112.33 24.07 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.769 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.4 t -108.91 99.47 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.092 0.472 . . . . 0.0 111.207 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.78 89.13 0.84 Allowed Glycine 0 CA--C 1.524 0.642 0 C-N-CA 121.186 -0.53 . . . . 0.0 113.129 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.0 t -172.44 25.84 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.158 0.504 . . . . 0.0 111.107 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.407 HD22 ' HB ' ' A' ' 38' ' ' ILE . 62.4 mt -72.26 103.56 3.41 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.776 -0.578 . . . . 0.0 110.522 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -79.38 35.9 0.29 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 63.58 13.67 7.46 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 176.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -148.52 11.05 0.87 Allowed 'General case' 0 N--CA 1.473 0.725 0 O-C-N 122.065 -0.397 . . . . 0.0 111.692 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.545 HG23 ' SD ' ' A' ' 42' ' ' MET . 30.8 mm -83.33 140.11 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.639 0.256 . . . . 0.0 110.749 -178.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 79.1 p -116.8 161.27 19.54 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -55.41 -40.34 71.34 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.216 177.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -65.04 -39.55 93.49 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.533 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.545 ' SD ' HG23 ' A' ' 38' ' ' ILE . 50.5 ttm -61.83 -52.29 64.76 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.326 0.584 . . . . 0.0 110.525 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.448 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 55.8 mt -55.47 -53.64 53.75 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.2 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.504 ' HB2' HD11 ' A' ' 56' ' ' ILE . 53.0 ttt180 -54.36 -46.88 73.09 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.404 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.61 -31.02 69.84 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 116.288 -0.414 . . . . 0.0 113.447 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 68.7 mt -85.18 -37.6 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 O-C-N 122.504 -0.41 . . . . 0.0 112.08 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.448 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 37.8 m-85 -85.38 -30.1 23.9 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -174.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -58.27 -39.89 78.86 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -45.69 -15.34 0.13 Allowed 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 122.112 1.875 . . . . 0.0 114.253 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -103.97 -23.11 13.37 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.438 ' HA3' ' HB2' ' A' ' 80' ' ' CYS . . . -174.57 -128.6 1.1 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.275 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -151.82 124.94 8.67 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 122.402 -0.47 . . . . 0.0 110.358 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.505 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.5 mp -86.7 138.5 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.412 -178.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -83.98 -54.74 4.64 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.895 0.379 . . . . 0.0 111.186 175.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.4 m -141.92 138.53 32.08 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.88 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.533 HG23 HG12 ' A' ' 73' ' ' ILE . 65.3 mt -108.11 112.2 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.807 0.337 . . . . 0.0 110.918 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -105.81 129.02 54.08 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.924 0.392 . . . . 0.0 110.758 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 58' ' ' LEU . 6.6 mp -111.33 148.72 32.35 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.149 -0.345 . . . . 0.0 110.505 175.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 96.0 mmm . . . . . 0 C--N 1.326 -0.439 0 CA-C-O 121.292 0.568 . . . . 0.0 110.145 -179.782 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp . . . . . 0 CA--C 1.538 0.504 0 CA-C-O 120.886 0.374 . . . . 0.0 111.341 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.49 -6.13 65.26 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.044 -0.598 . . . . 0.0 114.552 175.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -143.9 155.97 44.28 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 117.453 0.627 . . . . 0.0 112.054 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -145.46 160.77 28.14 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.23 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.471 ' HB3' ' HD2' ' A' ' 28' ' ' ARG . 96.9 m-85 -119.12 116.54 26.58 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.26 0.552 . . . . 0.0 111.888 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.533 HG12 HG23 ' A' ' 56' ' ' ILE . 70.5 mt -104.13 126.7 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.669 -177.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.7 m -99.27 117.47 33.8 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -99.03 150.52 21.91 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.991 0.424 . . . . 0.0 111.569 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.2 t -80.92 -2.35 47.28 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.145 0.498 . . . . 0.0 111.458 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.547 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 29.3 t70 -142.52 143.86 32.7 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.12 0.486 . . . . 0.0 111.219 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.8 t -75.15 -42.93 55.07 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.849 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.51 -47.53 85.18 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -177.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.547 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 30.8 p -60.04 -40.81 90.67 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.996 0.427 . . . . 0.0 111.333 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.09 -45.94 83.14 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.253 0.549 . . . . 0.0 111.003 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -60.47 -38.64 84.86 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.053 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -67.86 -42.06 81.92 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.536 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.22 -49.71 76.52 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.106 176.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.48 HD23 ' C ' ' A' ' 85' ' ' LEU . 7.0 tt -53.89 -54.9 32.21 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.211 0.529 . . . . 0.0 110.205 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -47.15 -39.74 14.25 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.482 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -97.62 -33.48 11.31 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -174.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 92.6 mt -92.83 -15.54 26.37 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -173.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -67.0 93.64 0.29 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.23 0.538 . . . . 0.0 109.974 176.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.9 10.78 15.39 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.334 -174.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -77.54 133.76 38.44 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.518 0.327 . . . . 0.0 111.306 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -75.76 88.17 2.8 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.156 0.503 . . . . 0.0 111.762 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.1 tp -90.42 125.9 35.71 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.58 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 55.75 26.79 9.87 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.157 0.503 . . . . 0.0 111.541 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.8 15.59 72.56 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 116.128 -0.487 . . . . 0.0 113.38 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 30.5 mtp180 -139.13 144.31 40.25 Favored Pre-proline 0 N--CA 1.472 0.641 0 O-C-N 122.604 -0.35 . . . . 0.0 111.743 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.67 138.0 83.99 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.379 2.719 . . . . 0.0 114.118 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 47.0 ttm -99.37 114.84 27.96 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.031 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -89.25 101.34 14.01 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 122.068 -0.395 . . . . 0.0 111.409 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.6 t -108.04 117.27 53.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.071 0.463 . . . . 0.0 112.064 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.55 160.87 12.91 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.523 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 21.0 p80 . . . . . 0 N--CA 1.479 0.978 0 O-C-N 122.147 -0.62 . . . . 0.0 112.327 -174.645 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo . . . . . 0 CA--C 1.542 0.886 0 CA-C-O 120.984 0.327 . . . . 0.0 112.217 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.489 ' HB2' ' HA ' ' A' ' 78' ' ' SER . 21.6 ttt -104.92 138.93 40.41 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.79 0.329 . . . . 0.0 111.226 -176.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -108.13 126.99 53.4 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.881 0.372 . . . . 0.0 111.524 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 75.2 mt -105.5 140.8 38.04 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.196 0.522 . . . . 0.0 111.779 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.405 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 48.4 t80 -95.17 115.21 27.13 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.152 173.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.7 t -109.26 101.22 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.054 0.454 . . . . 0.0 111.595 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 70' ' ' TYR . . . -101.62 89.06 0.74 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.77 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.8 t -174.69 22.08 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.112 0.482 . . . . 0.0 111.353 178.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.495 HD21 HD21 ' A' ' 43' ' ' LEU . 14.6 mt -77.93 70.5 4.31 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.765 0.793 . . . . 0.0 110.222 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -66.06 78.97 0.09 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.014 -0.994 . . . . 0.0 113.036 -175.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.6 t80 45.99 38.71 4.87 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 121.287 0.565 . . . . 0.0 112.443 171.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -166.62 -41.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.7 mm -73.69 103.21 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 121.073 0.463 . . . . 0.0 112.059 -173.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.8 p -93.23 173.89 7.49 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.43 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.473 ' HA ' HD12 ' A' ' 43' ' ' LEU . 25.3 mt-10 -51.1 -39.45 56.16 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.695 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.06 -48.73 80.5 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.553 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.4 mmt -63.42 -40.68 97.83 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.961 0.41 . . . . 0.0 110.762 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.495 HD21 HD21 ' A' ' 34' ' ' LEU . 77.0 mt -57.04 -44.68 83.17 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.429 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -60.93 -47.12 87.88 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.999 0.428 . . . . 0.0 111.099 174.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.42 -32.32 64.13 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.579 -178.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.7 mt -86.49 -50.93 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 121.099 0.475 . . . . 0.0 112.208 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 75' ' ' PHE . 42.5 m-85 -85.29 -40.55 16.45 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -171.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -58.6 -37.57 55.76 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -175.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -51.98 -12.7 1.43 Allowed 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 122.217 1.945 . . . . 0.0 114.088 171.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -91.49 -31.26 16.03 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.108 0.48 . . . . 0.0 111.052 173.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.433 ' HA3' ' HB3' ' A' ' 80' ' ' CYS . . . -178.85 134.66 2.39 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.461 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.04 129.97 18.14 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.095 0.474 . . . . 0.0 111.698 -178.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.9 mt -95.34 128.72 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.076 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.425 ' HG2' ' OG ' ' A' ' 76' ' ' SER . 14.7 mm-40 -73.11 -57.43 4.03 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.972 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.9 t -151.76 148.99 28.53 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.716 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.433 HG12 HG23 ' A' ' 73' ' ' ILE . 45.6 mt -120.84 140.46 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.599 175.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -122.65 110.07 15.07 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.447 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.421 HD23 ' N ' ' A' ' 59' ' ' MET . 3.4 tt -98.39 129.51 45.03 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -177.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.421 ' N ' HD23 ' A' ' 58' ' ' LEU . 55.0 mtp . . . . . 0 CA--C 1.537 0.446 0 CA-C-O 121.676 0.75 . . . . 0.0 112.452 -174.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.9 mttp . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.24 15.17 57.81 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.454 0.942 . . . . 0.0 115.454 169.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.439 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 3.2 p90 -147.36 152.75 38.71 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.167 0.984 . . . . 0.0 112.754 177.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.81 160.58 28.68 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 115.496 -0.775 . . . . 0.0 113.059 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -108.77 126.41 52.99 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 122.579 -0.365 . . . . 0.0 111.463 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.433 HG23 HG12 ' A' ' 56' ' ' ILE . 69.9 mt -112.31 131.36 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.806 0.336 . . . . 0.0 111.598 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 91.9 m -108.36 120.06 41.29 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 120.683 0.278 . . . . 0.0 111.537 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 47' ' ' PHE . 34.4 m-85 -98.94 150.19 22.19 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.731 0.301 . . . . 0.0 111.261 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.425 ' OG ' ' HG2' ' A' ' 54' ' ' GLU . 13.3 m -75.98 10.8 1.69 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -153.79 146.01 23.82 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.815 0.341 . . . . 0.0 110.779 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.489 ' HA ' ' HB2' ' A' ' 27' ' ' MET . 31.3 t -75.07 -48.09 25.62 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.866 0.365 . . . . 0.0 111.984 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -71.1 -31.16 67.44 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 122.274 -0.266 . . . . 0.0 111.49 -175.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.433 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . 93.2 m -59.85 -46.57 88.86 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.851 0.357 . . . . 0.0 111.2 174.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.69 -44.49 77.62 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.038 0.447 . . . . 0.0 110.868 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 39.4 ttmt -54.28 -47.03 72.82 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.304 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -67.58 -42.95 81.72 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.491 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.07 -45.43 71.73 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.079 0.466 . . . . 0.0 110.988 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 tt -57.48 -52.81 63.88 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.624 176.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 82' ' ' LYS . 47.8 mm-40 -56.07 -35.84 67.43 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -177.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -87.7 -36.4 17.42 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -174.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 80.7 mt -95.88 -15.1 22.66 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -173.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -64.01 104.91 0.77 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.943 0.401 . . . . 0.0 110.127 174.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.95 16.91 42.79 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.88 -176.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -77.28 133.92 38.69 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.428 0.291 . . . . 0.0 111.201 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.32 92.88 5.21 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.5 tp -100.03 126.39 46.22 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 122.276 -0.265 . . . . 0.0 110.327 175.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 64.75 12.15 7.42 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.859 0.362 . . . . 0.0 111.773 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.89 2.66 58.3 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.515 -0.374 . . . . 0.0 113.409 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -130.77 154.17 81.78 Favored Pre-proline 0 CA--C 1.543 0.708 0 O-C-N 122.46 -0.435 . . . . 0.0 111.032 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.2 151.63 84.82 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.878 2.385 . . . . 0.0 114.414 -174.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 46.2 ttm -109.47 120.45 42.53 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.216 177.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -89.33 99.19 12.23 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.914 0.388 . . . . 0.0 111.668 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.1 t -108.85 116.58 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.246 176.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 30' ' ' TYR . . . -140.41 139.96 10.18 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.394 -0.431 . . . . 0.0 112.667 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 29.2 p80 . . . . . 0 N--CA 1.472 0.66 0 O-C-N 122.133 -0.628 . . . . 0.0 111.562 -177.282 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 CA--C 1.54 0.817 0 CA-C-O 120.759 0.233 . . . . 0.0 112.222 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 28.2 ttt -123.59 122.81 39.12 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.913 0.387 . . . . 0.0 111.317 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 74' ' ' THR . 36.4 ttp-105 -104.34 133.44 49.24 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.106 0.479 . . . . 0.0 111.64 -178.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.541 HD22 HD12 ' A' ' 85' ' ' LEU . 67.2 mt -107.33 140.53 40.1 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.148 0.499 . . . . 0.0 111.817 -177.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -99.02 116.92 32.36 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.805 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.3 t -115.69 130.83 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 120.744 0.307 . . . . 0.0 111.611 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.06 105.52 0.61 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 121.229 -0.51 . . . . 0.0 113.733 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.3 t -175.05 16.27 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.228 0.537 . . . . 0.0 111.689 175.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.526 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 10.7 mt -87.03 87.3 7.42 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.962 -0.461 . . . . 0.0 111.692 -170.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -80.65 60.94 4.16 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.361 0.601 . . . . 0.0 112.075 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 46.6 t80 57.48 8.96 0.69 Allowed 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -126.88 -2.8 6.54 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.704 -0.622 . . . . 0.0 111.858 -176.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.524 HD11 ' HB2' ' A' ' 94' ' ' ALA . 17.7 mm -108.76 122.38 63.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 122.185 -0.322 . . . . 0.0 110.636 -178.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.2 p -98.08 161.91 13.48 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.826 0.346 . . . . 0.0 111.886 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 1.8 mp0 -56.28 -35.16 67.16 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.441 0.639 . . . . 0.0 110.033 173.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.93 -39.53 93.65 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.374 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.3 mmt -68.88 -43.87 74.43 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.103 0.478 . . . . 0.0 110.857 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.438 ' HB3' HD11 ' A' ' 73' ' ' ILE . 78.7 mt -56.29 -42.64 77.84 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.141 0.496 . . . . 0.0 110.661 174.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 66.6 ttp85 -60.62 -49.87 75.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.089 176.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.89 -33.53 63.77 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 121.375 -0.44 . . . . 0.0 113.404 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.9 mm -80.6 -40.69 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.456 ' HB2' HD11 ' A' ' 53' ' ' ILE . 26.5 m-85 -85.5 -26.42 26.26 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -175.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 44' ' ' ARG . 1.8 mt-10 -59.2 -38.2 60.92 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -45.88 -20.67 0.78 Allowed 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.171 1.914 . . . . 0.0 113.852 172.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -96.17 -29.56 13.99 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.49 -142.1 3.31 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.831 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 57.8 ttm-85 -103.47 -38.71 7.05 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -177.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.456 HD11 ' HB2' ' A' ' 47' ' ' PHE . 66.1 mt 69.18 107.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.12 0.568 . . . . 0.0 111.351 -172.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -80.89 -41.09 23.62 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.992 0.425 . . . . 0.0 111.379 -176.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 93.3 p -151.34 142.2 22.92 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.866 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.0 mt -123.58 106.19 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 120.873 0.368 . . . . 0.0 110.782 172.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -99.72 110.97 23.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.849 0.356 . . . . 0.0 110.559 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 59' ' ' MET . 6.7 tt -97.99 133.73 42.07 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.43 ' N ' HD23 ' A' ' 58' ' ' LEU . 55.0 mtp . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 121.363 0.601 . . . . 0.0 110.566 -176.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.7 mttm . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 124.84 -7.4 8.26 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 120.929 -0.653 . . . . 0.0 114.355 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -140.23 152.13 45.72 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 117.45 0.625 . . . . 0.0 112.603 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.02 160.35 28.6 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.812 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -110.7 121.74 46.09 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.547 -0.384 . . . . 0.0 111.477 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.438 HD11 ' HB3' ' A' ' 43' ' ' LEU . 71.8 mt -110.09 119.94 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.966 0.412 . . . . 0.0 111.317 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 45.6 m -100.19 125.55 46.35 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -174.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.42 ' HZ ' ' HB3' ' A' ' 47' ' ' PHE . 82.8 m-85 -106.24 144.86 32.33 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.033 173.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.7 t -69.14 -32.66 72.18 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.103 0.478 . . . . 0.0 110.806 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -108.28 132.52 53.6 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.36 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.4 t -71.21 -35.42 71.52 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -67.29 -44.82 78.31 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.096 0.474 . . . . 0.0 110.832 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 67.4 m -60.46 -36.3 77.92 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.029 0.443 . . . . 0.0 110.751 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.49 -44.63 82.11 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.505 176.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -60.64 -47.27 86.97 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.878 0.37 . . . . 0.0 111.514 176.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.32 -43.08 88.02 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.205 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.6 -53.2 55.39 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.018 0.437 . . . . 0.0 111.112 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.56 ' HA ' HG11 ' A' ' 100' ' ' VAL . 9.8 tt -53.47 -53.5 50.59 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.456 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.56 -34.64 78.34 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -174.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -88.12 -24.76 23.28 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 89.8 mt -95.36 -13.8 24.42 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -56.52 101.88 0.07 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.241 0.543 . . . . 0.0 110.582 168.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.77 30.56 11.32 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.027 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.422 ' H ' ' HB3' ' A' ' 98' ' ' MET . 84.5 t80 -92.44 103.98 16.35 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.752 0.31 . . . . 0.0 110.484 173.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -71.01 85.57 0.71 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.395 0.617 . . . . 0.0 111.571 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 61.1 tp -74.57 -68.29 0.55 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.3 0.571 . . . . 0.0 110.907 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.524 ' HB2' HD11 ' A' ' 38' ' ' ILE . . . -86.56 38.17 0.77 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.336 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.19 21.81 66.5 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.22 -173.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 28.4 mtp-105 -139.28 141.74 30.26 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 122.86 0.464 . . . . 0.0 110.553 -175.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -52.97 142.01 54.59 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.265 2.644 . . . . 0.0 113.823 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.422 ' HB3' ' H ' ' A' ' 91' ' ' PHE . 52.0 tpp -98.9 123.02 42.89 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.984 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -99.92 102.21 13.54 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 122.398 -0.189 . . . . 0.0 110.661 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.56 HG11 ' HA ' ' A' ' 85' ' ' LEU . 26.5 t -118.66 108.24 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.011 0.434 . . . . 0.0 111.626 -178.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -129.06 154.18 20.15 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.005 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 21.8 p80 . . . . . 0 N--CA 1.47 0.55 0 O-C-N 122.213 -0.58 . . . . 0.0 110.902 178.671 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 CA--C 1.543 0.951 0 N-CA-C 113.554 0.559 . . . . 0.0 113.554 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 14.2 tpt -104.08 122.57 45.55 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.256 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -99.47 139.87 34.49 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.81 0.338 . . . . 0.0 111.358 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.0 mt -121.0 129.65 53.48 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.135 0.493 . . . . 0.0 111.406 176.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -91.58 112.83 24.9 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.393 175.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.7 t -103.67 99.76 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.011 0.434 . . . . 0.0 110.745 176.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.8 89.2 0.6 Allowed Glycine 0 CA--C 1.521 0.426 0 C-N-CA 121.003 -0.618 . . . . 0.0 113.107 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.42 ' CB ' ' HA ' ' A' ' 98' ' ' MET . 25.0 t -175.08 25.79 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.464 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 41.9 mt -69.41 107.4 3.31 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.362 -0.836 . . . . 0.0 109.499 176.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.538 ' CE1' ' HB3' ' A' ' 96' ' ' ARG . 14.0 m80 -78.5 44.78 0.53 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -173.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 60.83 16.79 7.13 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.786 0.434 . . . . 0.0 111.988 -177.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -146.09 -33.52 0.32 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.6 mm -60.9 131.81 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.985 0.422 . . . . 0.0 111.788 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 74.7 p -116.63 169.57 9.25 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.048 0.452 . . . . 0.0 111.756 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.494 ' H ' HD11 ' A' ' 58' ' ' LEU . 2.3 pt-20 -61.73 -28.12 69.2 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.852 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -60.84 -40.0 91.17 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.937 0.399 . . . . 0.0 111.53 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.8 mtt -65.66 -53.66 38.18 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.255 0.55 . . . . 0.0 110.417 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.43 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 43.6 mt -56.15 -55.06 37.68 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.052 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 80.0 ttt180 -49.01 -46.78 44.54 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.576 176.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.46 -33.39 81.14 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 121.325 -0.464 . . . . 0.0 113.844 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 59.6 mt -86.3 -40.16 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.43 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 54.1 m-85 -77.73 -31.78 52.4 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.504 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 2.8 tm-20 -52.18 -48.6 88.42 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 90.5 Cg_exo -45.6 -28.81 4.64 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 122.538 2.159 . . . . 0.0 113.963 175.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -83.72 -47.97 10.63 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.907 0.384 . . . . 0.0 111.365 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.32 149.0 13.25 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 112.043 -0.423 . . . . 0.0 112.043 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.73 115.38 5.82 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.856 0.36 . . . . 0.0 110.793 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.513 HD12 ' H ' ' A' ' 53' ' ' ILE . 3.6 mp -66.97 138.55 22.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 120.939 0.399 . . . . 0.0 112.03 -178.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -80.3 -55.65 4.76 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.09 0.472 . . . . 0.0 110.817 173.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.5 p -151.33 140.72 21.47 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.78 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.484 HG13 HG21 ' A' ' 53' ' ' ILE . 49.2 mt -116.77 140.48 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 120.948 0.404 . . . . 0.0 110.511 172.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -129.37 121.22 26.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.185 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.494 HD11 ' H ' ' A' ' 40' ' ' GLU . 70.4 mt -96.68 130.49 43.9 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.724 0.297 . . . . 0.0 110.292 173.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 92.3 mmm . . . . . 0 CA--C 1.536 0.415 0 CA-C-O 121.275 0.56 . . . . 0.0 111.068 -177.921 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.4 mttt . . . . . 0 N--CA 1.469 0.492 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 95.56 6.25 59.77 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 114.855 0.702 . . . . 0.0 114.855 173.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -149.94 156.52 41.88 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.312 1.056 . . . . 0.0 112.907 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.64 161.12 28.89 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.73 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -115.06 139.04 50.2 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 122.461 -0.435 . . . . 0.0 111.656 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.41 HG12 HG23 ' A' ' 56' ' ' ILE . 60.4 mt -122.65 144.26 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.723 0.297 . . . . 0.0 111.185 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.6 m -115.76 134.05 55.41 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -126.08 147.83 49.49 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.839 0.352 . . . . 0.0 111.331 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.0 m -93.38 13.26 22.08 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 120.899 0.38 . . . . 0.0 111.31 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.598 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 15.6 t70 -142.82 109.14 5.29 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.929 0.395 . . . . 0.0 110.698 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.0 m -66.32 -31.51 72.34 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -176.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -65.72 -57.73 7.34 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.788 0.328 . . . . 0.0 111.322 -176.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.598 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 31.2 p -58.06 -38.51 76.47 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.927 0.394 . . . . 0.0 111.144 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.52 -41.16 98.5 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.555 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -60.41 -44.18 95.98 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.944 0.402 . . . . 0.0 110.699 176.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -65.14 -47.46 77.0 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.349 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.15 -51.82 55.6 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.13 0.491 . . . . 0.0 110.934 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.3 tt -55.51 -53.48 55.83 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.92 176.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -62.62 -28.44 69.9 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -174.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.641 ' N ' HE21 ' A' ' 87' ' ' GLN . 0.0 OUTLIER -89.96 -38.26 13.78 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.011 -0.431 . . . . 0.0 111.944 -179.008 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 73.5 mt -92.24 -23.3 19.38 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -172.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -69.83 101.02 1.63 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.133 0.492 . . . . 0.0 110.837 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 117.25 -14.81 13.43 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 -173.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -70.57 125.5 27.0 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.835 0.35 . . . . 0.0 110.679 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -77.95 90.43 4.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.204 0.526 . . . . 0.0 112.046 -177.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.5 tp -81.14 132.1 35.34 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.727 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 62.13 25.1 15.01 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.074 0.464 . . . . 0.0 111.372 -176.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.8 32.66 53.22 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.12 -0.491 . . . . 0.0 113.221 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.538 ' HB3' ' CE1' ' A' ' 35' ' ' HIS . 55.7 ttt180 -159.09 131.62 4.41 Favored Pre-proline 0 CA--C 1.545 0.763 0 O-C-N 122.619 -0.342 . . . . 0.0 110.472 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 96' ' ' ARG . 77.9 Cg_exo -48.96 127.73 17.67 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 C-N-CA 123.557 2.838 . . . . 0.0 115.095 -172.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.42 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 50.1 ttp -99.56 117.88 34.92 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.723 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.4 ' H ' ' HB2' ' A' ' 33' ' ' SER . 92.5 mttt -89.49 105.7 17.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.908 0.385 . . . . 0.0 111.787 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.8 t -106.99 99.18 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 121.029 0.442 . . . . 0.0 111.159 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -107.89 162.4 13.2 Favored Glycine 0 C--O 1.223 -0.558 0 N-CA-C 112.136 -0.386 . . . . 0.0 112.136 178.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 . . . . . 0 N--CA 1.475 0.779 0 CA-C-N 117.78 0.79 . . . . 0.0 110.616 177.307 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo . . . . . 0 CA--C 1.541 0.859 0 CA-C-O 120.963 0.318 . . . . 0.0 111.997 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 13.4 tpt -98.96 128.98 45.24 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.81 0.338 . . . . 0.0 110.809 -176.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -109.45 128.46 55.17 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.887 0.375 . . . . 0.0 111.28 -173.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.4 mt -100.06 144.94 28.51 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.223 0.535 . . . . 0.0 111.555 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -108.71 105.9 15.7 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.049 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.603 HG22 HG22 ' A' ' 100' ' ' VAL . 46.5 t -99.77 98.15 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.716 176.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.97 88.95 0.47 Allowed Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.761 -176.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.4 p -175.99 29.22 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.124 0.488 . . . . 0.0 110.991 176.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 30.9 mt -86.9 130.45 34.46 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.429 -174.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -83.24 63.1 7.03 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.289 0.566 . . . . 0.0 112.161 -174.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 55.29 8.92 0.31 Allowed 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -163.52 69.32 0.21 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.137 0.494 . . . . 0.0 112.043 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.0 mm -130.67 118.7 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 169.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.513 ' OG1' ' SD ' ' A' ' 42' ' ' MET . 14.6 p -91.08 163.35 14.33 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.312 0.577 . . . . 0.0 112.464 -172.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -61.07 -30.05 70.11 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.635 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.64 -47.66 71.86 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.378 -177.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.513 ' SD ' ' OG1' ' A' ' 39' ' ' THR . 1.3 mpt? -61.64 -48.39 81.08 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.101 0.477 . . . . 0.0 110.825 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.412 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 77.9 mt -54.62 -50.65 67.57 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.308 177.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.475 ' HG2' ' HG3' ' A' ' 48' ' ' GLU . 30.1 ttp-105 -52.63 -52.82 53.74 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.839 0.352 . . . . 0.0 110.887 178.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -54.81 -31.07 54.04 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 116.102 -0.499 . . . . 0.0 113.712 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.6 mt -79.68 -41.62 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 O-C-N 122.514 -0.404 . . . . 0.0 111.818 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.412 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 19.0 m-85 -82.66 -26.25 32.32 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -175.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.475 ' HG3' ' HG2' ' A' ' 44' ' ' ARG . 32.4 mt-10 -54.79 -47.57 97.85 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -178.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -48.79 -20.85 3.12 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.692 2.262 . . . . 0.0 114.686 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -82.12 -38.43 24.79 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.918 -0.489 . . . . 0.0 111.413 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -162.96 -99.89 0.14 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.681 -0.567 . . . . 0.0 111.681 176.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.7 ttp180 -162.76 153.7 17.18 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.768 0.318 . . . . 0.0 110.144 171.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.49 HG21 HG13 ' A' ' 56' ' ' ILE . 1.7 mp -84.12 139.94 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.126 0.488 . . . . 0.0 111.997 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -96.01 -60.51 1.62 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 174.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.3 t -150.63 126.62 10.47 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.251 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.548 HG23 HG12 ' A' ' 73' ' ' ILE . 54.8 mt -99.66 150.36 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 120.833 0.349 . . . . 0.0 111.284 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -149.82 134.8 17.9 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.683 0.278 . . . . 0.0 110.695 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.2 mt -97.28 142.68 28.87 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.739 0.304 . . . . 0.0 110.512 173.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.498 ' HB3' ' HB2' ' A' ' 70' ' ' TYR . 13.0 tpt . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 121.306 0.574 . . . . 0.0 109.788 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp . . . . . 0 CA--C 1.54 0.594 0 CA-C-O 121.032 0.444 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.23 15.29 48.45 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 116.165 -0.47 . . . . 0.0 113.732 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.498 ' HB2' ' HB3' ' A' ' 59' ' ' MET . 4.3 m-85 -130.79 160.85 33.15 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 122.475 -0.426 . . . . 0.0 111.546 -178.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.4 135.73 5.34 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 121.439 -0.41 . . . . 0.0 112.901 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -106.94 115.11 29.62 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 122.347 -0.502 . . . . 0.0 111.581 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.548 HG12 HG23 ' A' ' 56' ' ' ILE . 58.7 mt -111.27 123.79 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.868 0.366 . . . . 0.0 111.344 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.5 m -99.68 131.32 45.75 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -176.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.437 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 80.9 m-85 -117.11 151.5 36.71 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.941 0.496 . . . . 0.0 111.327 177.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.6 t -73.72 -34.92 65.0 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.101 0.477 . . . . 0.0 110.924 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -100.28 124.98 46.41 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.825 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 63.3 m -60.42 -37.11 79.81 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.316 176.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -71.2 -50.47 32.78 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.886 -177.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 96.2 m -54.35 -41.4 69.07 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 120.915 0.388 . . . . 0.0 111.144 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -61.66 -47.58 84.72 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.159 175.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.405 ' HB3' ' NZ ' ' A' ' 82' ' ' LYS . 6.8 ttpm? -63.56 -32.8 74.37 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.534 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -68.67 -48.4 64.03 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.734 0.302 . . . . 0.0 110.635 176.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.79 -46.96 67.86 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.202 0.525 . . . . 0.0 110.499 174.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.41 HD23 ' C ' ' A' ' 85' ' ' LEU . 7.8 tt -57.96 -54.37 47.66 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.946 174.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -57.87 -31.64 66.9 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.378 -174.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.663 ' N ' HE21 ' A' ' 87' ' ' GLN . 0.0 OUTLIER -92.52 -43.46 9.15 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.147 -0.346 . . . . 0.0 111.931 -178.465 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 84.5 mt -85.1 -22.39 28.92 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -171.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -63.41 104.29 0.61 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.085 0.469 . . . . 0.0 110.174 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 110.11 -11.93 31.57 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.881 -177.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -65.69 127.47 32.06 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.856 0.36 . . . . 0.0 111.819 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -89.23 100.85 13.55 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.996 0.427 . . . . 0.0 110.935 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 60.1 tp -86.28 -81.33 0.22 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.937 0.399 . . . . 0.0 111.732 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.86 52.33 2.44 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.866 0.365 . . . . 0.0 111.124 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.11 15.56 58.67 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.453 -174.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -135.68 140.56 34.15 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 122.945 0.498 . . . . 0.0 110.591 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.23 145.35 98.73 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.829 2.352 . . . . 0.0 113.081 176.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.43 ' HG2' HG23 ' A' ' 100' ' ' VAL . 46.9 ttm -99.09 108.76 21.48 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.287 175.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -89.09 93.13 9.48 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.857 0.36 . . . . 0.0 111.276 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.603 HG22 HG22 ' A' ' 31' ' ' VAL . 44.8 t -105.38 105.74 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.706 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -115.61 154.47 16.9 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.367 -0.444 . . . . 0.0 112.231 176.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 14.6 p80 . . . . . 0 N--CA 1.475 0.775 0 CA-C-N 117.755 0.777 . . . . 0.0 111.83 -179.623 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo . . . . . 0 CA--C 1.541 0.853 0 N-CA-C 113.262 0.447 . . . . 0.0 113.262 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 26.9 ttt -126.65 125.51 42.02 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.847 0.356 . . . . 0.0 111.558 -178.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 74' ' ' THR . 11.1 ttp180 -98.85 138.14 36.41 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.153 0.501 . . . . 0.0 111.373 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.654 HD22 HD12 ' A' ' 85' ' ' LEU . 23.6 mt -117.04 146.83 42.83 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.247 -172.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 55.7 t80 -89.85 115.6 27.3 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 122.781 0.432 . . . . 0.0 110.961 175.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.6 t -111.6 98.84 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.107 0.48 . . . . 0.0 110.943 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.88 96.15 1.14 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.406 -0.426 . . . . 0.0 113.76 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.4 t -174.73 9.85 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.3 mt -69.12 93.33 0.59 Allowed 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.728 -0.607 . . . . 0.0 111.19 -172.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.67 69.09 3.02 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -175.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 47.0 t80 53.15 39.86 30.31 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 172.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -171.03 -31.58 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.3 mm -64.66 95.28 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.13 0.49 . . . . 0.0 111.327 -178.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.8 p -92.47 -178.37 4.89 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.49 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.533 ' HG3' HD13 ' A' ' 58' ' ' LEU . 2.1 mp0 -52.57 -40.52 62.7 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.065 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.65 -52.32 62.68 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.583 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 20.8 mmt -62.29 -52.51 63.39 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.438 0.637 . . . . 0.0 110.676 -177.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.469 ' HB3' HD11 ' A' ' 73' ' ' ILE . 61.7 mt -55.34 -49.96 70.88 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.613 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -57.21 -50.57 72.44 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.392 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.26 -31.12 62.0 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.369 -0.444 . . . . 0.0 113.857 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.7 mt -85.15 -37.56 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -85.08 -32.3 22.91 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -173.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -59.64 -36.98 45.49 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -46.76 -19.48 0.77 Allowed 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 122.144 1.896 . . . . 0.0 113.847 171.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -90.83 -35.44 14.81 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.781 0.324 . . . . 0.0 111.262 174.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.413 ' HA3' ' SG ' ' A' ' 80' ' ' CYS . . . -172.85 -123.08 0.7 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.413 -0.422 . . . . 0.0 112.742 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -149.54 128.22 12.43 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 122.282 -0.54 . . . . 0.0 110.681 177.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.491 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.7 mp -87.33 138.98 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.765 -176.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -81.42 -48.57 11.73 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.048 0.452 . . . . 0.0 111.104 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 96.0 p -148.98 143.4 26.11 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.356 -178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.527 HG23 HG12 ' A' ' 73' ' ' ILE . 52.1 mt -121.3 104.74 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 120.997 0.427 . . . . 0.0 110.709 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -102.75 111.76 24.22 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -175.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.533 HD13 ' HG3' ' A' ' 40' ' ' GLU . 7.8 mp -98.51 139.68 33.87 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.919 -0.488 . . . . 0.0 110.89 177.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.533 ' HG3' ' CE2' ' A' ' 70' ' ' TYR . 18.2 mmt . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 121.072 0.463 . . . . 0.0 111.03 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.419 ' NZ ' ' HB3' ' A' ' 68' ' ' LYS . 8.0 mtpm? . . . . . 0 CA--C 1.54 0.584 0 CA-C-O 120.804 0.335 . . . . 0.0 111.58 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.48 2.29 61.83 Favored Glycine 0 CA--C 1.531 1.094 0 N-CA-C 115.108 0.803 . . . . 0.0 115.108 173.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.533 ' CE2' ' HG3' ' A' ' 59' ' ' MET . 34.1 p90 -143.11 148.98 37.5 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.122 0.961 . . . . 0.0 112.542 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -138.3 146.76 18.62 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.48 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 95.2 m-85 -100.18 121.76 41.95 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 122.594 -0.356 . . . . 0.0 111.523 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 56' ' ' ILE . 77.8 mt -110.36 125.03 67.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 120.794 0.331 . . . . 0.0 111.596 -178.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 27.2 m -101.35 120.6 40.51 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -175.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.471 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 70.3 m-85 -100.08 152.05 20.68 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.325 173.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.7 t -75.46 -14.4 60.43 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.891 0.377 . . . . 0.0 111.685 -177.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -136.46 138.85 41.88 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.689 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.9 t -70.02 -27.34 64.59 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -80.97 -40.94 23.62 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.772 -0.58 . . . . 0.0 110.509 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.413 ' SG ' ' HA3' ' A' ' 51' ' ' GLY . 50.4 t -61.46 -39.26 90.21 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.123 0.487 . . . . 0.0 110.349 169.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.471 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -60.49 -48.69 80.67 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.228 174.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -68.39 -24.98 64.83 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 111.625 0.232 . . . . 0.0 111.625 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -63.6 -55.57 22.69 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.295 0.569 . . . . 0.0 110.104 175.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.67 -51.83 67.72 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.828 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.654 HD12 HD22 ' A' ' 29' ' ' LEU . 6.4 tt -49.11 -63.85 0.98 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.444 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -67.01 -20.92 65.95 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -172.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -94.95 -14.71 24.18 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 94.1 mt -110.21 -14.71 14.14 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -176.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.3 97.13 0.92 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.876 0.846 . . . . 0.0 111.178 176.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.96 -2.1 22.84 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.168 -174.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -64.97 127.31 31.06 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 122.592 0.357 . . . . 0.0 111.147 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -76.88 96.26 4.28 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.33 0.586 . . . . 0.0 110.987 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.8 tp -98.34 120.71 39.23 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.463 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 58.35 20.24 7.12 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.03 0.443 . . . . 0.0 112.116 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.87 8.13 58.29 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 116.203 -0.453 . . . . 0.0 113.436 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -130.88 132.23 23.76 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.592 -0.357 . . . . 0.0 110.906 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.53 133.09 49.66 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 122.341 2.028 . . . . 0.0 112.793 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.0 ttp -99.06 116.91 32.38 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.099 0.476 . . . . 0.0 111.538 -177.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -89.98 103.72 16.36 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.896 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.501 HG12 ' HG ' ' A' ' 85' ' ' LEU . 21.6 t -113.93 112.83 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.596 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -151.47 78.24 0.21 Allowed Glycine 0 CA--C 1.534 1.225 0 C-N-CA 119.951 -1.119 . . . . 0.0 115.169 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 27.0 p80 . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 174.658 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 37.9 Cg_endo . . . . . 0 CA--C 1.542 0.886 0 CA-C-O 121.4 0.5 . . . . 0.0 112.946 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -99.77 142.68 30.93 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.586 -178.641 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.548 ' N ' ' SD ' ' A' ' 27' ' ' MET . 34.2 ttm105 -118.58 116.54 26.83 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.997 0.427 . . . . 0.0 112.026 -175.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.558 HD22 HD12 ' A' ' 85' ' ' LEU . 73.3 mt -99.45 128.38 45.56 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.562 178.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -91.49 114.9 27.55 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.131 0.491 . . . . 0.0 111.13 175.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.1 t -107.21 107.83 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.246 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.7 89.53 0.54 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.613 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.5 p -175.09 18.02 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 120.923 0.392 . . . . 0.0 111.976 176.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.544 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 17.8 mt -83.3 81.22 8.8 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.986 -0.447 . . . . 0.0 111.372 -173.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -78.14 75.7 4.67 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 121.188 0.518 . . . . 0.0 112.313 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 16.3 p90 39.25 26.53 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 176.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -140.28 8.89 2.26 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 122.0 -0.437 . . . . 0.0 111.501 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 38' ' ' ILE . 3.7 mp -118.48 123.91 72.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.596 -177.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 57.3 p -105.83 175.55 5.46 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -54.55 -49.2 70.86 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.729 176.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -73.15 -19.0 61.22 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -174.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.4 tpt -70.51 -54.77 10.9 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 172.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.3 mt -59.21 -55.76 30.78 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.781 175.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -53.89 -35.27 61.42 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.498 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.32 -35.71 92.3 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.137 -0.554 . . . . 0.0 113.073 177.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.8 mt -86.21 -38.5 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-O 120.998 0.428 . . . . 0.0 111.985 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.414 ' HB3' ' HZ ' ' A' ' 75' ' ' PHE . 35.0 m-85 -79.59 -44.63 20.69 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -173.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.414 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 27.1 tt0 -64.84 -32.35 6.68 Favored Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -172.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 48' ' ' GLU . 89.1 Cg_exo -47.89 -22.86 3.65 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.124 1.883 . . . . 0.0 113.629 169.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -77.26 -23.37 51.22 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 122.149 -0.345 . . . . 0.0 111.698 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.761 ' HA3' ' SG ' ' A' ' 80' ' ' CYS . . . -177.89 -100.06 0.13 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.46 175.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.66 130.4 6.59 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.097 0.475 . . . . 0.0 111.481 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.3 mt -111.04 140.82 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.699 -174.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -90.77 -62.36 1.47 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.847 0.356 . . . . 0.0 111.787 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.5 t -145.7 147.65 32.18 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.874 0.369 . . . . 0.0 111.623 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.554 HG12 HG23 ' A' ' 73' ' ' ILE . 55.2 mt -123.88 125.23 70.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.076 0.465 . . . . 0.0 110.852 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -108.89 117.39 34.07 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.879 0.371 . . . . 0.0 110.952 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 82.1 mt -98.42 136.63 38.29 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.75 0.309 . . . . 0.0 110.665 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 22.4 mmt . . . . . 0 C--O 1.236 0.383 0 CA-C-O 121.738 0.78 . . . . 0.0 112.196 -175.813 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm . . . . . 0 N--CA 1.471 0.624 0 CA-C-O 120.947 0.403 . . . . 0.0 111.488 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 111.05 13.06 14.23 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.818 -0.705 . . . . 0.0 114.555 175.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -149.82 156.11 41.24 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.59 0.695 . . . . 0.0 111.757 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.91 160.54 28.67 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.418 -0.42 . . . . 0.0 113.064 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -112.61 121.35 44.53 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.768 0.318 . . . . 0.0 111.402 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.554 HG23 HG12 ' A' ' 56' ' ' ILE . 67.3 mt -103.69 133.92 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.811 0.338 . . . . 0.0 111.323 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 68.1 m -110.14 118.37 36.21 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.481 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 31.3 m-85 -99.09 150.72 21.73 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.163 175.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.2 t -82.67 1.78 36.77 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.012 0.434 . . . . 0.0 111.565 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -142.28 135.85 29.18 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.041 0.448 . . . . 0.0 111.35 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.8 t -65.72 -47.84 73.96 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -71.7 -35.42 70.22 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.246 -0.284 . . . . 0.0 111.495 -176.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.761 ' SG ' ' HA3' ' A' ' 51' ' ' GLY . 43.9 t -59.38 -44.65 92.74 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.118 0.485 . . . . 0.0 110.918 173.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.481 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -65.53 -47.53 75.59 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.678 177.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.8 ttpp -60.76 -34.21 74.11 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.823 0.344 . . . . 0.0 111.349 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -66.43 -49.25 67.39 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.912 0.387 . . . . 0.0 110.919 176.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.02 -44.7 87.45 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.127 0.489 . . . . 0.0 111.169 176.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.558 HD12 HD22 ' A' ' 29' ' ' LEU . 8.6 tt -56.76 -59.08 5.55 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.987 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.93 -25.18 67.43 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -173.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -89.68 -31.12 17.64 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 122.032 -0.418 . . . . 0.0 112.056 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.0 mt -103.24 -6.74 21.78 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -66.07 92.37 0.17 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.221 0.534 . . . . 0.0 110.614 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 115.07 3.18 21.66 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.943 -176.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -64.63 135.79 56.31 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.589 0.355 . . . . 0.0 111.709 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -70.13 79.87 0.51 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.177 0.513 . . . . 0.0 111.383 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.572 HD22 ' SD ' ' A' ' 98' ' ' MET . 56.8 tp -84.33 118.49 24.25 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.907 0.384 . . . . 0.0 111.657 -177.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 57.15 26.86 12.63 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 176.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.44 11.39 59.61 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 116.075 -0.512 . . . . 0.0 113.4 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -145.49 139.81 15.27 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 122.478 0.311 . . . . 0.0 110.807 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -55.41 136.73 75.07 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.491 2.127 . . . . 0.0 112.887 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.572 ' SD ' HD22 ' A' ' 93' ' ' LEU . 44.8 ttp -98.67 118.45 35.42 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.229 0.538 . . . . 0.0 111.395 -176.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -88.98 96.31 10.67 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.333 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 18.7 t -104.71 105.91 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.993 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -133.22 151.8 20.19 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.451 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.5 p80 . . . . . 0 N--CA 1.47 0.556 0 O-C-N 122.29 -0.535 . . . . 0.0 110.904 177.717 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 CA--C 1.539 0.735 0 CA-C-O 120.95 0.312 . . . . 0.0 111.969 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 14.3 tpt -102.9 131.64 49.67 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.887 0.375 . . . . 0.0 111.922 -172.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.8 ttm-85 -102.72 118.46 36.89 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.856 0.36 . . . . 0.0 110.896 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 76.0 mt -102.68 150.57 23.31 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.281 0.562 . . . . 0.0 111.829 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -105.59 131.43 52.99 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.299 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.6 t -125.94 106.44 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.569 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -125.38 88.52 0.37 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.829 -176.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.497 ' HG ' ' HA ' ' A' ' 98' ' ' MET . 89.6 p -175.79 23.71 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.97 0.414 . . . . 0.0 111.41 178.181 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.557 ' HB3' HG13 ' A' ' 38' ' ' ILE . 53.4 mt -83.64 166.86 17.8 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.198 -176.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.426 ' ND1' ' O ' ' A' ' 35' ' ' HIS . 33.6 p80 -141.85 80.44 1.72 Allowed 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 60.1 t80 50.61 8.34 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.407 ' O ' HD13 ' A' ' 38' ' ' ILE . 4.8 t30 -143.34 52.59 1.35 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.091 -1.005 . . . . 0.0 110.535 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.557 HG13 ' HB3' ' A' ' 34' ' ' LEU . 30.1 mm -133.24 125.08 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.625 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.417 ' OG1' ' HG3' ' A' ' 42' ' ' MET . 41.8 p -108.03 158.88 17.01 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.861 0.362 . . . . 0.0 111.835 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -54.9 -32.04 60.62 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.108 0.48 . . . . 0.0 110.742 172.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -62.64 -42.41 99.58 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.527 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.427 ' SD ' ' HA ' ' A' ' 38' ' ' ILE . 59.0 mtt -64.06 -55.41 22.37 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.538 0.685 . . . . 0.0 110.686 179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.435 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 45.6 mt -56.72 -54.83 41.7 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.357 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -53.13 -47.88 68.34 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.314 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.09 -30.22 75.01 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 121.305 -0.474 . . . . 0.0 113.741 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 74.1 mt -82.98 -40.46 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 O-C-N 122.377 -0.484 . . . . 0.0 112.23 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.485 ' HB3' ' HE2' ' A' ' 75' ' ' PHE . 77.2 m-85 -85.77 -30.78 22.78 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -173.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.413 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 30.1 mt-10 -55.32 -41.63 91.75 Favored Pre-proline 0 N--CA 1.484 1.226 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 48' ' ' GLU . 51.7 Cg_exo -41.09 -39.29 3.5 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 122.378 2.052 . . . . 0.0 113.058 172.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -76.65 -57.67 3.72 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.067 0.46 . . . . 0.0 110.881 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -157.98 135.01 4.12 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.017 -175.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -56.3 122.26 11.41 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 122.6 0.36 . . . . 0.0 111.236 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 53' ' ' ILE . 2.9 mp -79.6 135.27 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.148 0.499 . . . . 0.0 111.911 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -87.74 -51.05 6.08 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.148 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.8 m -150.41 140.34 21.92 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.812 0.339 . . . . 0.0 111.877 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.537 HG23 HG12 ' A' ' 73' ' ' ILE . 53.8 mt -116.66 140.58 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.911 177.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -136.86 110.19 7.88 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.716 0.293 . . . . 0.0 111.764 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.429 HD12 ' N ' ' A' ' 58' ' ' LEU . 5.1 mp -99.57 150.66 22.01 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.648 0.261 . . . . 0.0 110.391 175.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.445 ' HG3' ' CE2' ' A' ' 70' ' ' TYR . 20.4 mmt . . . . . 0 N--CA 1.467 0.382 0 CA-C-O 121.569 0.699 . . . . 0.0 112.747 -177.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.4 mttp . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.81 6.62 18.91 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.502 -0.856 . . . . 0.0 115.018 174.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.445 ' CE2' ' HG3' ' A' ' 59' ' ' MET . 35.3 p90 -130.24 147.84 52.01 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.156 0.978 . . . . 0.0 111.824 176.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -149.52 160.24 28.38 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 116.097 -0.501 . . . . 0.0 113.315 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -113.68 139.05 49.38 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.659 0.383 . . . . 0.0 110.999 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.537 HG12 HG23 ' A' ' 56' ' ' ILE . 75.0 mt -124.11 125.67 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.795 0.331 . . . . 0.0 111.447 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.9 m -99.53 118.24 35.66 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.885 0.374 . . . . 0.0 111.549 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.485 ' HE2' ' HB3' ' A' ' 47' ' ' PHE . 43.8 m-85 -99.64 150.08 22.64 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.313 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.1 t -75.77 -18.74 59.42 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.113 0.482 . . . . 0.0 111.067 173.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -110.06 152.81 25.49 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.076 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.1 p -100.41 -59.86 1.63 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 120.967 0.413 . . . . 0.0 112.081 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -65.36 -39.87 92.88 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -175.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 77.9 m -61.6 -31.03 71.08 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.08 0.467 . . . . 0.0 110.541 174.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.32 -33.93 67.71 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.845 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -54.6 -50.44 68.05 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.019 0.438 . . . . 0.0 110.181 172.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.494 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . 6.9 ttpm? -64.48 -40.95 96.64 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.033 177.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.4 -41.64 69.52 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.358 0.599 . . . . 0.0 110.934 176.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.431 HD23 ' C ' ' A' ' 85' ' ' LEU . 7.0 tt -63.91 -62.73 1.45 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.664 177.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.494 ' HG2' ' HA ' ' A' ' 83' ' ' LYS . 14.8 pt-20 -66.42 -18.37 65.32 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.497 -173.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -86.2 -40.97 15.06 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.746 0.308 . . . . 0.0 111.554 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 81.2 mt -97.38 -13.2 21.99 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -168.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.41 81.12 0.06 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 121.699 0.761 . . . . 0.0 111.705 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 141.88 -14.52 2.63 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.706 -175.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -65.72 135.03 54.41 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 122.939 0.496 . . . . 0.0 111.302 177.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -82.74 104.82 13.27 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.099 0.475 . . . . 0.0 112.073 -177.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.6 tp -101.63 128.25 48.0 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.277 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 61.05 22.78 13.01 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.051 0.453 . . . . 0.0 111.243 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 85.78 12.05 72.67 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 116.135 -0.484 . . . . 0.0 113.37 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.7 ttt85 -134.96 134.13 21.54 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 122.52 -0.4 . . . . 0.0 110.631 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -53.64 142.15 61.69 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.922 2.415 . . . . 0.0 113.38 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.497 ' HA ' ' HG ' ' A' ' 33' ' ' SER . 44.9 ttm -99.34 114.43 27.3 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.309 -177.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -89.69 97.82 11.42 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.959 0.409 . . . . 0.0 110.936 177.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.2 t -103.9 127.52 57.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.499 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -150.0 159.38 28.08 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.543 175.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 . . . . . 0 N--CA 1.472 0.651 0 O-C-N 122.208 -0.583 . . . . 0.0 111.002 177.152 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 51.3 Cg_exo . . . . . 0 CA--C 1.544 1.018 0 N-CA-C 114.083 0.763 . . . . 0.0 114.083 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 28.1 ttt -100.66 133.83 44.52 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.319 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.3 ttm-85 -111.19 129.39 55.97 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.984 0.421 . . . . 0.0 111.873 -174.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 80.5 mt -103.8 142.7 33.92 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.497 0.665 . . . . 0.0 111.9 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -99.69 113.36 25.76 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.198 175.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -116.93 115.4 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -175.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.72 104.37 1.37 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.656 -0.307 . . . . 0.0 113.685 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.543 ' HB2' ' HA ' ' A' ' 98' ' ' MET . 23.9 t -174.82 20.99 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.357 0.599 . . . . 0.0 111.268 175.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.9 mt -93.49 91.85 7.33 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.805 -174.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -80.1 61.51 3.98 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -174.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 22.6 t80 50.29 41.23 24.07 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.641 0.734 . . . . 0.0 110.979 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -149.9 -50.8 0.14 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.754 -171.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.411 HD11 ' HB2' ' A' ' 94' ' ' ALA . 60.8 mt -78.96 133.97 28.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.239 -172.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.3 p -114.27 178.37 4.31 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.198 0.523 . . . . 0.0 112.087 -177.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.429 ' HG3' ' CD1' ' A' ' 58' ' ' LEU . 2.1 mp0 -50.41 -45.35 55.6 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.881 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -55.87 -44.6 78.27 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.577 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.436 ' O ' HG12 ' A' ' 46' ' ' ILE . 12.5 tpt -66.49 -49.9 65.06 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.185 0.517 . . . . 0.0 110.29 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.435 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 71.4 mt -54.25 -53.54 52.2 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.093 176.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.2 ttm105 -51.01 -43.21 60.79 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.536 176.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.96 -28.22 71.64 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.349 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 42' ' ' MET . 42.4 mm -85.17 -37.26 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 120.911 0.386 . . . . 0.0 111.929 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.435 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 46.8 m-85 -86.17 -28.03 24.18 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -174.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -57.7 -38.1 63.48 Favored Pre-proline 0 N--CA 1.484 1.268 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -47.92 -19.9 1.75 Allowed 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 122.086 1.857 . . . . 0.0 113.581 170.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -94.75 -46.66 6.82 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.808 0.337 . . . . 0.0 111.527 175.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.47 -133.5 1.49 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.595 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -129.77 143.8 50.99 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 122.089 -0.654 . . . . 0.0 111.427 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.533 HG21 HG13 ' A' ' 56' ' ' ILE . 2.4 mp -94.97 138.69 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.017 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -95.45 -45.33 7.15 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.911 0.386 . . . . 0.0 111.064 174.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.2 t -152.14 147.03 25.96 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.506 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.551 HG12 HG23 ' A' ' 73' ' ' ILE . 51.8 mt -130.46 106.62 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 120.81 0.338 . . . . 0.0 110.863 175.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -108.93 119.98 41.17 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.754 0.311 . . . . 0.0 111.323 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.43 ' N ' HD12 ' A' ' 58' ' ' LEU . 7.2 mp -98.22 141.55 30.99 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.064 0.459 . . . . 0.0 111.538 -177.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.595 ' SD ' ' HE2' ' A' ' 72' ' ' PHE . 56.8 mtp . . . . . 0 CA--C 1.536 0.432 0 CA-C-O 121.432 0.634 . . . . 0.0 111.851 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.579 ' HB2' ' O ' ' A' ' 59' ' ' MET . 57.8 mttp . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 120.887 0.375 . . . . 0.0 110.776 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.44 23.22 8.53 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 114.863 0.705 . . . . 0.0 114.863 172.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.535 ' HE1' ' SD ' ' A' ' 59' ' ' MET . 27.6 p90 -143.49 152.06 41.04 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.775 0.788 . . . . 0.0 112.088 177.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.8 158.13 23.66 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.945 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.595 ' HE2' ' SD ' ' A' ' 59' ' ' MET . 98.2 m-85 -110.02 125.08 52.53 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.831 0.348 . . . . 0.0 111.17 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.551 HG23 HG12 ' A' ' 56' ' ' ILE . 59.9 mt -113.43 135.14 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.593 -178.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.2 m -100.01 133.97 43.62 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.492 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 96.1 m-85 -125.14 143.86 50.72 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.509 0.324 . . . . 0.0 111.27 177.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.2 m -81.48 -5.63 58.14 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 120.745 0.307 . . . . 0.0 111.708 176.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 80' ' ' CYS . 8.4 t0 -124.18 115.84 21.75 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.939 0.399 . . . . 0.0 110.842 -178.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 48.8 m -71.76 -22.27 61.62 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.75 -36.65 15.04 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 72.6 m -66.13 -39.99 90.31 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.963 0.411 . . . . 0.0 110.591 174.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.14 -40.49 82.43 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.033 0.444 . . . . 0.0 110.958 174.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.565 ' HZ2' ' HB2' ' A' ' 82' ' ' LYS . 4.7 ttmp? -62.23 -42.69 99.54 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.081 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 86.6 tttt -61.45 -50.89 70.96 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.61 0.243 . . . . 0.0 110.478 173.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.12 -40.99 47.73 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.19 0.519 . . . . 0.0 111.055 177.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.3 tt -61.46 -48.34 81.59 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.24 175.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -67.62 -34.2 76.5 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -177.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 83' ' ' LYS . 48.0 mm-40 -90.8 -32.84 15.94 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -173.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.0 mt -99.52 -11.26 21.2 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -172.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -65.93 94.89 0.24 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.316 0.579 . . . . 0.0 110.246 176.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 106.8 22.43 7.65 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.177 -173.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -80.92 142.83 33.13 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 122.732 -0.276 . . . . 0.0 111.715 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -75.06 85.06 2.31 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.852 0.358 . . . . 0.0 111.263 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.559 HD22 ' SD ' ' A' ' 98' ' ' MET . 54.9 tp -103.02 124.84 49.28 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.724 0.297 . . . . 0.0 111.292 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.411 ' HB2' HD11 ' A' ' 38' ' ' ILE . . . 59.82 16.19 5.44 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.85 11.12 59.35 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.42 -0.419 . . . . 0.0 113.309 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 96' ' ' ARG . 16.3 mtp180 -133.7 154.97 80.85 Favored Pre-proline 0 N--CA 1.47 0.57 0 O-C-N 122.474 -0.427 . . . . 0.0 111.877 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.57 130.32 23.3 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.779 2.319 . . . . 0.0 112.26 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.559 ' SD ' HD22 ' A' ' 93' ' ' LEU . 48.6 ttp -97.84 125.67 42.82 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.299 0.571 . . . . 0.0 111.851 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -89.1 108.35 19.55 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.489 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.1 t -116.18 122.28 69.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 121.285 0.564 . . . . 0.0 112.053 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -146.1 146.8 17.26 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.959 175.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.3 p80 . . . . . 0 N--CA 1.47 0.554 0 CA-C-N 118.268 1.034 . . . . 0.0 110.93 -176.748 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo . . . . . 0 CA--C 1.541 0.851 0 CA-C-O 120.796 0.248 . . . . 0.0 112.729 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.2 ttt -124.05 145.73 49.03 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.003 0.43 . . . . 0.0 111.547 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -116.62 119.39 35.39 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.677 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.591 HD22 HD12 ' A' ' 85' ' ' LEU . 60.7 mt -99.25 138.41 36.38 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.087 0.47 . . . . 0.0 112.202 -178.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -92.8 107.26 19.08 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.539 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.7 t -101.06 97.91 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.004 0.431 . . . . 0.0 111.14 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.76 88.99 0.83 Allowed Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.629 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.3 t -175.49 24.18 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.993 0.425 . . . . 0.0 111.359 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 43.0 mt -73.79 92.66 2.05 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.879 -0.513 . . . . 0.0 110.517 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -78.98 65.56 4.19 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -174.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 55.23 8.74 0.29 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.919 1.452 . . . . 0.0 114.919 170.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -155.16 8.73 0.29 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.411 0.55 . . . . 0.0 112.244 178.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.6 mm -78.06 131.41 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 121.946 -0.471 . . . . 0.0 110.811 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.453 ' OG1' ' HG3' ' A' ' 42' ' ' MET . 49.4 p -106.01 160.49 15.25 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -177.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -55.09 -38.49 68.17 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.319 0.58 . . . . 0.0 110.556 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -61.04 -41.41 96.53 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.107 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.453 ' HG3' ' OG1' ' A' ' 39' ' ' THR . 66.8 mtt -62.77 -55.52 25.77 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.251 0.548 . . . . 0.0 110.529 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.1 mt -54.59 -46.58 73.81 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.104 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 50.9 ttt85 -60.22 -46.48 89.62 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.502 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.07 -29.71 59.82 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.117 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.7 mm -86.54 -53.16 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 75' ' ' PHE . 34.0 m-85 -79.83 -36.71 36.46 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -171.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.473 ' HA ' HG13 ' A' ' 53' ' ' ILE . 0.6 OUTLIER -56.43 -48.06 97.75 Favored Pre-proline 0 N--CA 1.482 1.134 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -172.92 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -47.07 -20.93 1.41 Allowed 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.649 2.232 . . . . 0.0 114.248 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -70.91 -51.6 25.1 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 178.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 52' ' ' ARG . . . -173.52 45.77 0.16 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 119.652 -1.261 . . . . 0.0 115.176 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 73.1 ttt180 72.19 137.19 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 172.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.473 HG13 ' HA ' ' A' ' 48' ' ' GLU . 66.0 mt -128.06 133.18 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.316 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -108.15 -48.09 3.43 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -176.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.7 m -126.94 122.06 33.5 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -176.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 51.8 mt -115.65 106.23 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.853 0.359 . . . . 0.0 110.808 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -99.34 116.3 31.2 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.716 0.293 . . . . 0.0 111.524 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.7 mt -99.0 130.73 45.36 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 173.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 85.0 mmm . . . . . 0 CA--C 1.535 0.39 0 CA-C-O 121.34 0.591 . . . . 0.0 111.551 -174.385 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.404 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 34.2 mmtp . . . . . 0 N--CA 1.471 0.578 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.95 4.16 31.53 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.718 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 68' ' ' LYS . 4.4 p90 -141.14 154.34 45.83 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.322 0.561 . . . . 0.0 112.072 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.32 161.15 28.85 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.839 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -116.17 122.1 44.06 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.523 -0.398 . . . . 0.0 111.828 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.5 mt -108.75 133.09 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 120.96 0.41 . . . . 0.0 111.592 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.4 m -109.52 123.98 50.32 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.735 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.434 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 7.0 m-85 -106.1 150.62 25.62 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.26 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.6 m -70.86 -11.62 61.06 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.081 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -136.76 122.97 20.48 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.031 0.443 . . . . 0.0 111.518 -178.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.8 m -65.1 -41.72 94.7 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.151 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -64.21 -46.49 83.65 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.024 0.44 . . . . 0.0 111.535 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.9 m -64.3 -38.52 91.34 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.211 177.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.434 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -64.53 -42.69 95.61 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.149 0.499 . . . . 0.0 111.386 176.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.433 ' HE3' ' HB2' ' A' ' 82' ' ' LYS . 37.8 ttmt -60.61 -40.93 93.63 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.943 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.46 -45.47 83.61 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.232 174.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.47 -48.63 68.72 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.203 0.525 . . . . 0.0 110.992 176.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.591 HD12 HD22 ' A' ' 29' ' ' LEU . 9.0 tt -54.49 -56.81 15.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.199 175.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -61.17 -36.43 79.79 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -175.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -79.98 -30.57 39.74 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.191 0.519 . . . . 0.0 111.17 -175.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 64.9 mt -103.31 -4.18 24.58 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -176.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -64.81 98.19 0.26 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.878 0.37 . . . . 0.0 110.548 175.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.27 0.18 40.83 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.012 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -68.03 125.44 26.33 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 122.618 -0.342 . . . . 0.0 110.739 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -79.62 91.58 5.24 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.224 0.535 . . . . 0.0 110.472 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.5 tp -77.61 -70.62 0.46 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.713 -174.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.79 45.67 1.31 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.2 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.92 8.68 64.71 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.925 -174.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -141.72 144.1 31.65 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 122.794 0.437 . . . . 0.0 110.332 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.95 135.8 51.41 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.227 2.618 . . . . 0.0 113.637 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.6 ttp -103.23 121.01 41.8 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.387 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -89.05 105.12 17.58 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.767 0.318 . . . . 0.0 111.627 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 85' ' ' LEU . 11.1 t -106.06 105.37 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.737 0.303 . . . . 0.0 110.421 175.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.69 161.65 12.68 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.346 -0.454 . . . . 0.0 113.616 -176.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 179.012 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 56.5 Cg_endo . . . . . 0 CA--C 1.538 0.701 0 N-CA-C 113.21 0.427 . . . . 0.0 113.21 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 13.3 tpt -122.51 138.44 54.56 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.616 176.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.431 ' HD3' ' HB3' ' A' ' 72' ' ' PHE . 36.5 ttm180 -110.94 135.21 51.8 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.07 0.462 . . . . 0.0 111.955 -173.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.9 mt -109.91 137.7 47.33 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.204 0.526 . . . . 0.0 111.945 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -89.94 110.31 21.28 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.524 172.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.7 t -110.71 101.76 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.815 0.34 . . . . 0.0 111.046 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 70' ' ' TYR . . . -113.62 89.72 0.52 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.72 -178.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.43 ' HB2' ' HA ' ' A' ' 98' ' ' MET . 22.6 t -166.39 21.22 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.576 0.703 . . . . 0.0 110.852 176.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.46 ' HB3' ' HB ' ' A' ' 38' ' ' ILE . 18.8 mt -85.72 99.77 11.55 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.704 -176.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.439 ' O ' ' CG ' ' A' ' 35' ' ' HIS . 12.3 p80 -70.01 76.04 0.49 Allowed 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.547 0.689 . . . . 0.0 112.383 -175.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 50.41 16.25 0.26 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 171.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.81 -44.01 0.27 Allowed 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.799 -0.563 . . . . 0.0 112.036 -174.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.582 HD12 ' SD ' ' A' ' 42' ' ' MET . 37.8 mm -49.32 130.86 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -174.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 54.2 p -97.35 170.45 9.06 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.218 0.533 . . . . 0.0 112.158 -176.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.542 ' HG3' HD23 ' A' ' 58' ' ' LEU . 2.6 mp0 -62.59 -38.03 88.54 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.432 175.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.37 -37.81 88.83 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.487 -177.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.582 ' SD ' HD12 ' A' ' 38' ' ' ILE . 28.0 ttt -63.34 -50.5 69.75 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.426 0.632 . . . . 0.0 110.1 177.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.457 ' HB3' HD11 ' A' ' 73' ' ' ILE . 64.4 mt -56.16 -53.24 59.51 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.257 176.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -52.62 -40.63 62.94 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.383 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.41 -33.96 78.61 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.291 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 63.2 mt -85.08 -44.04 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.471 ' HD2' ' HZ ' ' A' ' 75' ' ' PHE . 36.8 m-85 -80.81 -31.54 35.6 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -173.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.504 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 25.2 tp10 -54.73 -46.75 99.31 Favored Pre-proline 0 N--CA 1.481 1.105 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.096 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 73.0 Cg_exo -52.13 -18.68 7.68 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 122.736 2.29 . . . . 0.0 114.318 176.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -82.61 -29.8 29.91 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.079 -0.388 . . . . 0.0 112.029 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.428 ' HA3' ' HB3' ' A' ' 80' ' ' CYS . . . -169.83 -99.25 0.12 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.316 -0.469 . . . . 0.0 112.447 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -166.43 136.98 3.36 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.143 0.497 . . . . 0.0 111.784 173.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.457 HG21 HG13 ' A' ' 56' ' ' ILE . 3.5 mp -96.89 129.26 47.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.311 177.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -77.61 -55.37 5.41 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.455 0.645 . . . . 0.0 110.345 173.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 95.9 p -150.67 150.55 31.25 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.13 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.457 HG13 HG21 ' A' ' 53' ' ' ILE . 60.9 mt -119.77 126.97 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 121.004 0.43 . . . . 0.0 111.212 176.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -101.79 118.4 36.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.981 0.42 . . . . 0.0 110.276 173.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.542 HD23 ' HG3' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -98.34 131.19 44.85 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.5 tpt . . . . . 0 CA--C 1.537 0.45 0 CA-C-O 121.643 0.735 . . . . 0.0 111.047 -171.367 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 120.801 0.334 . . . . 0.0 111.48 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.98 12.64 33.78 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.803 175.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.423 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 2.7 m-85 -121.87 160.56 24.48 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.397 -0.473 . . . . 0.0 110.734 178.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.36 130.51 3.27 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.456 -0.402 . . . . 0.0 112.372 175.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.431 ' HB3' ' HD3' ' A' ' 28' ' ' ARG . 89.4 m-85 -98.99 107.2 19.57 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.06 0.457 . . . . 0.0 111.078 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' A' ' 43' ' ' LEU . 69.5 mt -99.49 127.92 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.689 -176.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.9 m -103.25 122.82 45.55 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.007 0.432 . . . . 0.0 111.711 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.503 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 44.3 m-85 -99.31 151.45 21.04 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.453 177.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.1 t -76.91 -5.67 49.4 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.735 0.302 . . . . 0.0 111.205 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.505 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 29.0 t70 -142.6 147.62 36.13 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.021 0.439 . . . . 0.0 111.488 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.6 p -72.26 -42.71 65.31 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.054 -178.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -69.13 -38.12 78.69 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.641 0.258 . . . . 0.0 111.359 -177.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.505 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 83.7 m -55.4 -45.5 76.65 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.205 0.526 . . . . 0.0 111.178 175.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.08 -40.99 82.58 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.292 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -58.29 -44.5 88.52 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.072 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -65.23 -49.44 69.66 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.625 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.27 -47.47 72.28 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.945 0.403 . . . . 0.0 111.228 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 85' ' ' LEU . 8.8 tt -57.51 -50.7 72.2 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.79 174.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -54.02 -35.09 61.55 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.912 -175.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -93.31 -42.85 9.09 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.7 mt -87.61 -17.21 32.44 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -169.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -71.0 107.98 4.35 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.116 0.484 . . . . 0.0 110.616 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.93 -13.78 37.82 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.245 -174.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -65.67 135.11 54.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.957 0.408 . . . . 0.0 111.885 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 92' ' ' GLU . 9.0 pt-20 -73.73 95.0 2.3 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.195 0.521 . . . . 0.0 111.105 177.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 67.2 tp -67.4 -77.21 0.07 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.28 0.562 . . . . 0.0 111.787 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -108.08 46.41 0.96 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.247 0.546 . . . . 0.0 110.895 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.94 3.42 89.21 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.098 -174.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -128.69 139.68 36.29 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 123.138 0.575 . . . . 0.0 110.255 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.23 134.43 63.97 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.536 2.157 . . . . 0.0 112.048 175.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.43 ' HA ' ' HB2' ' A' ' 33' ' ' SER . 39.3 ttp -98.44 121.73 40.74 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.106 0.479 . . . . 0.0 111.465 -174.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -87.63 100.58 12.91 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.891 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 28.1 t -111.65 102.21 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.829 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -120.18 138.82 13.29 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.725 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 19.9 p80 . . . . . 0 N--CA 1.473 0.698 0 O-C-N 122.379 -0.483 . . . . 0.0 111.724 -179.514 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.626 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 120.81 0.338 . . . . 0.0 111.068 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -86.16 -135.45 3.94 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.511 175.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.9 t60 61.09 88.88 0.08 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.277 0.561 . . . . 0.0 112.06 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -70.62 125.82 27.87 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.285 0.564 . . . . 0.0 112.385 -177.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -113.84 109.25 18.23 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.458 175.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -160.68 110.21 1.71 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.958 0.408 . . . . 0.0 111.367 -176.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -120.89 6.72 10.39 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.808 0.337 . . . . 0.0 111.04 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 54.0 t60 -59.85 -20.12 55.17 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.301 0.572 . . . . 0.0 110.912 176.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.0 m -68.84 98.52 0.93 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.159 172.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -56.02 96.05 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.801 -177.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 62.1 mtt 69.64 179.68 0.24 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.441 0.696 . . . . 0.0 112.231 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 73.0 -52.44 0.71 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.404 0.682 . . . . 0.0 112.554 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.62 -36.26 71.56 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.44 -61.44 1.79 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.07 0.462 . . . . 0.0 111.716 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 28.3 ttt -87.26 85.53 7.19 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.207 0.527 . . . . 0.0 110.484 177.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.4 -29.74 5.06 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.839 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -79.47 126.1 30.41 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.61 0.243 . . . . 0.0 110.99 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -61.86 -25.97 67.86 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -176.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 76.2 mt -95.95 -18.1 20.53 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 57.68 90.25 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.292 0.568 . . . . 0.0 110.961 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -61.06 -35.2 76.32 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -171.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -145.72 -160.26 8.56 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.86 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.5 t 68.77 -166.64 0.18 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.777 0.431 . . . . 0.0 111.695 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 72.4 -11.57 0.8 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 176.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.14 -100.63 0.52 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.129 -0.557 . . . . 0.0 113.322 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -77.36 163.29 30.16 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.659 2.239 . . . . 0.0 113.199 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.7 ttt -148.55 140.87 24.17 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.354 -177.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 28' ' ' ARG . 41.9 ttp180 -115.25 128.33 56.07 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.831 0.348 . . . . 0.0 111.124 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.2 mt -103.5 150.05 24.26 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.168 0.509 . . . . 0.0 112.063 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 78.3 t80 -107.25 106.8 17.43 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.537 176.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.422 HG22 HG22 ' A' ' 100' ' ' VAL . 51.4 t -105.72 125.18 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 120.799 0.333 . . . . 0.0 111.826 -177.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -127.64 96.91 0.45 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 121.248 -0.501 . . . . 0.0 113.7 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 96.6 p -163.96 11.2 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.054 0.454 . . . . 0.0 111.671 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.436 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 8.3 mt -83.06 81.46 8.67 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -171.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.38 71.35 7.19 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.738 0.78 . . . . 0.0 112.319 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 61.47 9.36 2.63 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 172.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -143.3 -8.81 0.77 Allowed 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.246 -0.909 . . . . 0.0 113.364 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.534 HD12 ' N ' ' A' ' 38' ' ' ILE . 2.5 mp -90.59 113.34 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 O-C-N 121.709 -0.62 . . . . 0.0 110.308 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.3 p -95.94 170.42 9.3 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -174.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -53.17 -44.14 67.64 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.683 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -64.13 -39.52 94.21 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.135 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.0 mmt -62.4 -53.05 60.64 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.329 0.585 . . . . 0.0 110.482 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.417 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 54.8 mt -54.67 -55.17 32.52 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.927 176.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.48 ' HB2' HD11 ' A' ' 56' ' ' ILE . 25.4 ttt85 -55.13 -44.1 74.74 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.6 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.12 -29.7 68.92 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.438 -0.41 . . . . 0.0 113.5 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.9 mt -83.46 -34.46 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 O-C-N 122.475 -0.426 . . . . 0.0 112.09 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.428 ' HD2' ' HZ ' ' A' ' 75' ' ' PHE . 6.9 m-85 -85.28 -32.16 22.69 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -174.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.15 -35.51 21.48 Favored Pre-proline 0 N--CA 1.479 1.0 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -45.47 -26.65 2.87 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.205 1.937 . . . . 0.0 113.117 170.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -80.18 -47.74 14.23 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.932 0.396 . . . . 0.0 111.027 174.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.424 ' HA3' ' SG ' ' A' ' 80' ' ' CYS . . . -161.44 -101.5 0.17 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.208 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 52' ' ' ARG . 38.3 ttt180 -164.66 146.13 8.1 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 122.569 -0.371 . . . . 0.0 111.015 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.448 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.3 mp -108.79 130.62 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.835 0.35 . . . . 0.0 111.549 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -79.7 -49.4 12.14 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.853 0.359 . . . . 0.0 111.477 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.5 p -150.79 144.17 24.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.088 0.47 . . . . 0.0 111.57 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.48 HD11 ' HB2' ' A' ' 44' ' ' ARG . 61.9 mt -115.7 115.44 49.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 177.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -110.2 105.69 14.84 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.805 0.336 . . . . 0.0 111.082 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 72.1 mt -98.07 146.78 25.2 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.914 0.388 . . . . 0.0 111.087 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 66.6 mmm -93.87 110.07 21.74 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.975 0.417 . . . . 0.0 110.026 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.3 ptt? -128.5 143.47 50.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.087 0.47 . . . . 0.0 111.802 -174.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -66.61 88.45 0.14 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.033 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.6 t -59.39 -13.67 9.28 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.414 0.626 . . . . 0.0 110.797 175.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -60.81 -41.05 94.94 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.524 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.442 HG23 ' HG3' ' A' ' 66' ' ' ARG . 11.1 t -132.27 -7.05 3.39 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -177.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.94 53.03 3.63 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.417 -0.421 . . . . 0.0 113.332 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.442 ' HG3' HG23 ' A' ' 64' ' ' THR . 71.7 mtt-85 -137.08 162.0 34.58 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 122.502 -0.411 . . . . 0.0 111.417 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 54.3 m -85.13 128.07 34.51 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 122.314 -0.241 . . . . 0.0 111.378 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -71.04 -31.57 68.06 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 134.44 -15.41 4.43 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.601 -0.809 . . . . 0.0 114.123 177.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -137.36 150.66 47.86 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.399 0.599 . . . . 0.0 112.453 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.37 158.51 27.76 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 116.182 -0.463 . . . . 0.0 113.018 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -102.08 125.24 48.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.03 0.443 . . . . 0.0 111.352 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.41 HG12 HG23 ' A' ' 56' ' ' ILE . 73.4 mt -111.53 123.22 67.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.165 0.507 . . . . 0.0 111.249 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.4 m -99.54 119.26 37.76 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.458 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 49.1 m-85 -100.95 150.63 22.67 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.424 175.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.3 t -78.36 -30.01 47.8 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.994 0.426 . . . . 0.0 110.942 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -106.91 117.25 33.57 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.827 0.346 . . . . 0.0 111.434 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.9 p -59.5 -52.93 63.48 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.6 tp10 -55.15 -43.91 74.65 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.835 0.35 . . . . 0.0 111.481 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.424 ' SG ' ' HA3' ' A' ' 51' ' ' GLY . 52.6 t -62.9 -45.1 94.12 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.247 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -60.86 -44.04 97.56 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.251 0.548 . . . . 0.0 111.225 176.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.435 ' HB3' ' HE2' ' A' ' 82' ' ' LYS . 35.7 ttpt -61.71 -38.52 88.19 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.85 177.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -65.23 -46.78 79.24 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.163 176.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.59 -48.05 78.26 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.007 0.432 . . . . 0.0 110.634 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.428 HD23 ' C ' ' A' ' 85' ' ' LEU . 8.2 tt -55.58 -50.76 69.23 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.293 0.568 . . . . 0.0 110.668 174.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -62.26 -32.08 72.73 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.913 -173.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -94.88 -36.76 11.5 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.439 ' O ' ' HB3' ' A' ' 98' ' ' MET . 91.4 mt -87.97 -20.1 26.34 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -172.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -64.25 105.67 0.95 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.225 0.536 . . . . 0.0 110.411 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.49 -9.1 26.3 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.098 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -69.34 130.87 43.79 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 122.646 0.378 . . . . 0.0 112.005 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -89.22 103.95 16.53 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.208 0.528 . . . . 0.0 111.536 176.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.2 tp -87.79 -68.62 0.75 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.291 0.567 . . . . 0.0 111.386 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.53 45.36 1.01 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.434 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.0 26.31 74.8 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.211 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -151.85 133.15 7.87 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 123.11 0.564 . . . . 0.0 110.225 -175.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -54.43 150.77 32.76 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.894 2.396 . . . . 0.0 113.921 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.497 ' HG3' HG23 ' A' ' 100' ' ' VAL . 44.0 tpp -98.41 108.27 20.93 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.869 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -88.63 100.1 12.84 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 122.171 -0.331 . . . . 0.0 111.211 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.497 HG23 ' HG3' ' A' ' 98' ' ' MET . 59.9 t -117.54 107.96 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.938 0.399 . . . . 0.0 111.599 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -120.75 155.47 16.24 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.981 177.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.52 ' CE1' ' HG2' ' A' ' 105' ' ' GLU . 20.3 p80 -82.0 46.64 1.03 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 122.081 -0.658 . . . . 0.0 112.453 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.2 t 56.69 -78.6 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.9 t -87.92 129.65 35.17 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -173.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.52 ' HG2' ' CE1' ' A' ' 102' ' ' HIS . 79.1 mt-10 -142.65 -50.47 0.36 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.903 174.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -131.51 47.56 2.52 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.159 0.504 . . . . 0.0 111.225 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.2 p -56.09 -64.87 0.72 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.2 t0 . . . . . 0 C--O 1.252 1.187 0 CA-C-O 118.743 -0.646 . . . . 0.0 111.552 -178.325 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.544 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.79 0.329 . . . . 0.0 111.285 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.89 37.57 94.46 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.346 -0.454 . . . . 0.0 113.47 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 72.3 m80 63.54 161.88 0.1 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.145 0.497 . . . . 0.0 111.85 -175.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -141.3 36.45 1.7 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.173 0.511 . . . . 0.0 110.906 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -74.34 71.97 1.78 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.998 0.428 . . . . 0.0 111.077 -176.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -133.58 22.88 3.99 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.058 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 21.6 p80 55.0 130.98 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.671 1.189 . . . . 0.0 113.995 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -158.26 -171.02 3.32 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.63 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.0 m -52.21 116.26 2.13 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -177.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -105.33 162.87 13.06 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.939 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 51.2 mtm 68.31 1.31 2.83 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 176.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.16 116.71 22.48 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.107 0.163 . . . . 0.0 111.091 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 66.81 124.14 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.09 16.67 0.95 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.834 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.602 ' SD ' ' N ' ' A' ' 15' ' ' MET . 1.0 OUTLIER -80.72 137.07 36.26 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -176.325 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 61.2 78.46 0.29 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.406 0.622 . . . . 0.0 111.667 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -84.42 75.05 10.28 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.172 0.511 . . . . 0.0 111.882 -176.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -79.86 44.73 0.66 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.261 0.553 . . . . 0.0 111.437 177.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.473 HD12 ' N ' ' A' ' 20' ' ' GLN . 2.5 pp -78.86 -17.28 55.88 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.098 0.475 . . . . 0.0 111.116 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.473 ' N ' HD12 ' A' ' 19' ' ' LEU . 17.1 pt20 -94.12 99.53 11.79 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.775 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -67.21 -44.32 79.85 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.226 0.536 . . . . 0.0 110.227 176.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -156.97 143.71 9.91 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.021 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 85.5 p -68.31 -18.58 64.54 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 117.207 0.504 . . . . 0.0 111.449 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -113.42 101.44 9.37 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.348 172.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -176.81 -165.24 31.99 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.473 -0.394 . . . . 0.0 112.413 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 38.6 Cg_exo -57.64 101.77 0.11 Allowed 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.598 2.199 . . . . 0.0 113.216 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 11.0 tpt -102.74 145.74 29.27 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.977 0.418 . . . . 0.0 111.689 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -114.52 127.56 55.87 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.043 0.449 . . . . 0.0 111.751 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.4 mt -104.31 149.89 24.94 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.188 0.518 . . . . 0.0 111.546 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.409 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 59.4 t80 -103.45 109.87 21.68 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.539 176.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -110.93 108.16 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 120.743 0.306 . . . . 0.0 111.047 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -121.77 88.59 0.42 Allowed Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.823 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.3 m -164.42 24.98 0.07 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 120.939 0.4 . . . . 0.0 111.283 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 34.2 mt -85.23 143.97 28.42 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.891 0.377 . . . . 0.0 111.661 -174.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.438 ' CE1' ' HB3' ' A' ' 37' ' ' ASN . 33.1 p80 -108.83 48.65 0.85 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.079 0.466 . . . . 0.0 111.708 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 50.1 t80 61.54 9.18 2.58 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.438 ' HB3' ' CE1' ' A' ' 35' ' ' HIS . 65.5 t30 -142.5 37.06 1.49 Allowed 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.539 -0.725 . . . . 0.0 111.669 -178.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.3 mm -125.76 106.62 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 O-C-N 122.023 -0.423 . . . . 0.0 110.407 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.3 p -93.26 175.66 6.68 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.154 0.502 . . . . 0.0 112.304 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.468 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 2.7 mp0 -53.09 -36.01 60.22 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.214 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -56.45 -52.09 65.98 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.847 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.6 tpt -65.34 -47.9 74.9 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.188 0.518 . . . . 0.0 110.711 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.0 mt -56.11 -44.11 78.78 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.248 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -65.15 -44.65 87.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.217 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.99 -31.89 65.72 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.267 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 58.2 mt -86.0 -45.03 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 75' ' ' PHE . 37.5 m-85 -85.14 -43.7 13.61 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -172.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.466 ' CD ' HH11 ' A' ' 52' ' ' ARG . 36.1 tt0 -59.56 -35.1 26.57 Favored Pre-proline 0 N--CA 1.48 1.028 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -172.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 48' ' ' GLU . 60.3 Cg_exo -43.01 -29.39 1.55 Allowed 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 122.081 1.854 . . . . 0.0 113.523 172.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -82.11 -31.18 30.81 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.933 0.397 . . . . 0.0 111.482 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.564 ' HA3' ' HB3' ' A' ' 80' ' ' CYS . . . -175.89 134.47 2.66 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.279 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.466 HH11 ' CD ' ' A' ' 48' ' ' GLU . 14.1 tpt180 -48.22 125.14 8.85 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 122.946 0.498 . . . . 0.0 111.941 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 73.8 mt -94.73 133.95 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.171 0.51 . . . . 0.0 111.831 -175.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -83.92 -51.34 7.24 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.862 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.6 m -150.48 132.95 15.64 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.896 0.379 . . . . 0.0 111.694 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.541 HG23 HG12 ' A' ' 73' ' ' ILE . 58.4 mt -108.84 107.6 23.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.821 176.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -102.19 118.59 37.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.363 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.4 HD13 ' HG3' ' A' ' 40' ' ' GLU . 9.4 mp -98.43 139.63 33.9 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.078 0.466 . . . . 0.0 110.577 175.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.701 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 45.0 tpp -93.1 99.69 12.24 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.405 0.622 . . . . 0.0 111.387 -173.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.495 ' O ' ' HE2' ' A' ' 68' ' ' LYS . 65.5 mtt -85.84 -177.44 6.35 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.391 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.1 p-10 -79.55 -13.54 59.47 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.607 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.8 p 59.28 17.43 5.77 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.604 0.762 . . . . 0.0 111.717 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -118.6 -61.18 1.69 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.147 -175.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.1 p -112.66 -29.5 7.42 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.543 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 117.19 38.22 0.88 Allowed Glycine 0 CA--C 1.529 0.925 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.551 -177.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -110.22 159.46 17.37 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.587 -0.36 . . . . 0.0 111.01 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.9 m -92.76 128.41 38.61 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.684 -175.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.701 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 68.8 mttm -71.2 -25.95 62.73 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.677 0.275 . . . . 0.0 111.538 177.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.99 -6.55 8.86 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.992 -0.623 . . . . 0.0 114.31 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -138.01 160.0 40.53 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 117.719 0.76 . . . . 0.0 112.571 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -142.63 151.71 23.27 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.802 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -105.26 115.59 30.51 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.804 0.442 . . . . 0.0 111.448 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.541 HG12 HG23 ' A' ' 56' ' ' ILE . 68.5 mt -104.78 128.37 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 122.222 -0.299 . . . . 0.0 111.546 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.3 m -108.21 121.35 44.68 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 18.2 m-85 -98.5 151.61 20.43 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.294 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.3 t -69.09 -13.04 62.2 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.833 0.349 . . . . 0.0 111.737 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.627 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 16.4 t70 -133.59 153.29 51.78 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.049 0.452 . . . . 0.0 111.361 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 68.7 p -73.12 -51.96 16.03 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.199 -176.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -74.36 -23.05 58.95 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 92.3 m -60.72 -42.84 98.06 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.221 0.534 . . . . 0.0 109.942 170.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.91 -46.94 73.28 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.958 174.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -53.41 -47.71 69.33 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.647 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -60.33 -44.88 95.08 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.184 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.98 -40.14 83.9 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.143 0.497 . . . . 0.0 110.937 175.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.8 -57.98 9.76 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.826 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -61.72 -26.85 68.31 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -174.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -90.54 -34.7 15.43 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.4 mt -97.84 -14.22 20.85 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -173.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -70.85 80.8 0.63 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.584 0.707 . . . . 0.0 110.702 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.64 -4.71 5.13 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.169 -174.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -59.61 140.08 56.65 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -73.37 84.9 1.46 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.953 0.406 . . . . 0.0 111.524 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 67.0 tp -90.59 116.01 28.15 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.291 -0.256 . . . . 0.0 110.854 176.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 59.49 16.9 5.58 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.89 11.85 48.6 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.512 -0.375 . . . . 0.0 112.903 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -132.27 138.46 32.31 Favored Pre-proline 0 N--CA 1.468 0.467 0 O-C-N 122.65 -0.324 . . . . 0.0 111.306 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.19 131.44 38.89 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.326 2.018 . . . . 0.0 112.169 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.4 ttp -97.01 118.99 34.63 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.289 0.566 . . . . 0.0 111.398 -175.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -88.38 104.91 17.21 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.72 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.9 t -111.6 111.44 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.11 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 30' ' ' TYR . . . -133.77 150.8 20.01 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.324 177.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -66.99 143.92 56.5 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 117.788 0.794 . . . . 0.0 111.017 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.7 t -68.37 147.12 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.089 0.471 . . . . 0.0 111.895 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 45.1 m -74.65 150.26 39.66 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 174.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -53.99 -50.04 67.47 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -177.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -81.29 83.39 6.89 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.973 -0.454 . . . . 0.0 111.774 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.1 t -94.4 -28.51 15.47 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.751 175.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.7 t70 . . . . . 0 C--O 1.252 1.224 0 CA-C-O 118.236 -0.888 . . . . 0.0 112.185 -177.918 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptp . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 120.663 0.268 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 161.41 154.01 7.28 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 120.753 -0.737 . . . . 0.0 113.622 176.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -88.24 -22.53 23.91 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.904 0.383 . . . . 0.0 111.12 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -165.01 118.23 1.24 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.331 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -109.25 138.32 45.78 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -75.51 142.97 42.74 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.773 0.321 . . . . 0.0 110.361 173.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -83.44 97.62 9.07 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -168.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -116.68 -27.69 6.6 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.262 163.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 10' ' ' HIS . 22.4 m -57.43 124.57 19.4 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.14 173.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' HB3' ' O ' ' A' ' 9' ' ' SER . 70.6 t60 72.12 -41.93 0.52 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.349 0.66 . . . . 0.0 112.593 -177.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.6 ttt -70.31 79.03 0.54 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.253 0.549 . . . . 0.0 111.948 -176.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.74 74.9 1.02 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.962 172.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 64.25 -70.64 0.08 Allowed 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.699 -173.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -176.26 177.43 1.53 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.118 0.567 . . . . 0.0 110.856 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.483 ' N ' ' SD ' ' A' ' 15' ' ' MET . 3.4 mpp? -59.46 150.47 26.6 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.519 0.2 . . . . 0.0 111.326 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 67.17 99.86 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.25 0.548 . . . . 0.0 112.153 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.01 114.6 11.86 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.015 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.7 t30 66.61 138.89 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.5 0.667 . . . . 0.0 111.931 -172.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.691 HD23 ' H ' ' A' ' 19' ' ' LEU . 2.1 pt? -128.36 -0.13 5.68 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.32 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.417 ' OE1' ' HA ' ' A' ' 20' ' ' GLN . 6.1 tp60 -107.02 152.93 23.33 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.092 0.473 . . . . 0.0 111.505 -176.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -84.75 129.02 34.88 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.484 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.16 108.62 2.25 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 121.164 -0.541 . . . . 0.0 113.066 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.3 t -89.54 21.9 3.22 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 122.455 -0.438 . . . . 0.0 111.784 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 73.34 -35.31 0.31 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.71 -175.57 23.45 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.509 -0.377 . . . . 0.0 112.905 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.37 130.62 29.61 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.163 2.576 . . . . 0.0 113.687 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.3 ttt -102.08 135.82 42.98 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.857 0.36 . . . . 0.0 111.08 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.449 ' HD3' ' HB3' ' A' ' 72' ' ' PHE . 33.7 ttm180 -106.55 134.52 49.55 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -176.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.516 HD22 HD12 ' A' ' 85' ' ' LEU . 75.2 mt -113.11 147.68 36.83 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.191 0.519 . . . . 0.0 111.784 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -94.77 123.17 38.07 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.572 174.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.2 t -116.97 123.2 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 120.733 0.302 . . . . 0.0 111.245 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.3 96.84 0.53 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.277 -0.487 . . . . 0.0 113.345 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.442 ' HB3' ' HA ' ' A' ' 98' ' ' MET . 78.3 p -174.72 15.46 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 177.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.432 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 20.8 mt -82.55 83.31 7.62 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.88 -0.513 . . . . 0.0 111.102 -173.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.415 ' O ' ' CG ' ' A' ' 35' ' ' HIS . 14.4 p80 -78.15 65.08 3.45 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.429 0.633 . . . . 0.0 112.012 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 56.5 t80 55.37 9.73 0.4 Allowed 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 176.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -139.64 1.63 1.94 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.343 -0.848 . . . . 0.0 112.762 -176.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.478 HD12 ' SD ' ' A' ' 42' ' ' MET . 31.6 mm -103.53 118.05 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 O-C-N 121.874 -0.516 . . . . 0.0 110.753 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 34.4 p -103.65 176.59 5.1 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.22 0.534 . . . . 0.0 112.138 -175.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -53.17 -48.58 67.88 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.463 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -59.12 -40.32 85.07 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.792 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.511 ' SD ' HD11 ' A' ' 93' ' ' LEU . 46.3 ttm -65.21 -46.56 80.16 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.256 0.551 . . . . 0.0 110.442 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.3 mt -57.95 -44.46 87.02 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.697 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 44' ' ' ARG . 43.5 ttm180 -56.65 -44.74 81.61 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.164 0.506 . . . . 0.0 110.817 175.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.72 -35.45 81.64 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.129 -0.558 . . . . 0.0 113.638 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.45 HD11 HD13 ' A' ' 93' ' ' LEU . 63.3 mt -84.72 -45.13 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -85.25 -34.04 22.05 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -173.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.619 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 36.4 tt0 -56.84 -41.48 91.53 Favored Pre-proline 0 N--CA 1.477 0.921 0 N-CA-C 113.682 0.994 . . . . 0.0 113.682 -172.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 48' ' ' GLU . 5.1 Cg_endo -47.3 -33.15 15.83 Favored 'Trans proline' 0 C--N 1.363 1.292 0 C-N-CA 122.232 1.954 . . . . 0.0 112.934 175.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -77.1 -47.8 19.5 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.164 0.507 . . . . 0.0 110.876 175.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -162.6 136.52 4.37 Favored Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.845 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 -54.98 134.57 48.95 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.007 0.432 . . . . 0.0 112.057 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.491 HG21 HG13 ' A' ' 56' ' ' ILE . 1.8 mp -81.82 129.38 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.103 0.478 . . . . 0.0 111.813 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -90.43 -43.52 10.22 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.334 176.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.0 p -151.98 148.21 27.47 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.715 0.293 . . . . 0.0 111.64 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.491 HG13 HG21 ' A' ' 53' ' ' ILE . 59.4 mt -127.53 106.61 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.891 0.377 . . . . 0.0 110.895 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -99.45 115.22 28.78 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.614 0.245 . . . . 0.0 110.936 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 80.4 mt -98.01 132.16 43.81 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.037 0.446 . . . . 0.0 110.99 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 89.1 mmm -94.49 98.9 11.18 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.343 0.592 . . . . 0.0 111.295 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 22.9 ptp -117.4 152.41 35.03 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.562 176.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -79.83 113.38 17.95 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.8 t -74.25 -12.98 60.71 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.838 0.827 . . . . 0.0 109.256 167.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -68.04 -53.85 22.7 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.066 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 74.8 p -108.84 -9.13 15.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.157 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.34 18.24 80.0 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.602 -176.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -112.99 -163.9 0.88 Allowed 'General case' 0 CA--C 1.544 0.726 0 O-C-N 122.452 -0.44 . . . . 0.0 111.065 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.1 m -111.7 137.14 49.99 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 122.071 -0.393 . . . . 0.0 111.927 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -78.83 -25.59 44.15 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.871 0.367 . . . . 0.0 111.736 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 104.1 4.44 44.58 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 120.936 -0.649 . . . . 0.0 114.588 174.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -144.84 156.12 43.85 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 117.643 0.722 . . . . 0.0 112.649 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.94 160.73 28.76 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.793 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.449 ' HB3' ' HD3' ' A' ' 28' ' ' ARG . 90.7 m-85 -111.42 124.07 51.5 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 122.569 -0.371 . . . . 0.0 111.511 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.5 mt -112.85 132.98 60.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 120.914 0.388 . . . . 0.0 111.703 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.3 m -101.65 125.41 48.31 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.705 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.469 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 88.3 m-85 -108.99 151.21 26.64 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.811 0.445 . . . . 0.0 111.167 177.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.9 m -62.88 -31.19 72.19 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -177.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.62 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 25.3 t70 -126.88 148.04 50.03 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.073 0.464 . . . . 0.0 111.612 -172.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.1 t -76.17 -34.46 59.34 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -77.24 -36.54 54.51 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.726 0.298 . . . . 0.0 111.114 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.62 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 17.5 p -63.67 -44.17 94.54 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.086 0.47 . . . . 0.0 110.257 175.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -64.63 -46.66 81.59 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.113 175.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -54.56 -43.72 72.3 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.627 175.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.86 -42.62 94.71 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.831 0.348 . . . . 0.0 111.285 177.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.56 -55.25 36.84 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.006 0.431 . . . . 0.0 111.071 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.516 HD12 HD22 ' A' ' 29' ' ' LEU . 8.6 tt -51.57 -55.89 16.63 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.826 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -54.15 -34.03 59.39 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.562 -175.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -97.39 -24.21 15.73 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 97.7 mt -101.65 -11.21 19.37 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -173.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -68.54 85.9 0.3 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.966 0.889 . . . . 0.0 111.225 177.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 127.73 -2.13 6.94 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.309 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -59.69 134.92 57.47 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.459 0.304 . . . . 0.0 111.357 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.34 91.38 1.72 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.23 0.538 . . . . 0.0 111.728 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.511 HD11 ' SD ' ' A' ' 42' ' ' MET . 55.0 tp -99.89 122.05 42.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.596 177.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 59.15 18.67 6.69 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.042 0.448 . . . . 0.0 111.812 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.3 -20.25 30.71 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 116.213 -0.448 . . . . 0.0 113.128 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -115.21 153.81 47.35 Favored Pre-proline 0 CA--C 1.537 0.475 0 O-C-N 122.768 -0.254 . . . . 0.0 111.614 -174.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -63.65 139.02 67.42 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.216 1.944 . . . . 0.0 112.772 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.442 ' HA ' ' HB3' ' A' ' 33' ' ' SER . 44.3 ttp -97.84 120.37 38.11 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.04 -178.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -88.26 99.88 12.57 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.057 0.456 . . . . 0.0 112.155 -174.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 18.3 t -106.03 126.83 61.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.035 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -149.95 160.59 28.57 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.263 -0.494 . . . . 0.0 113.132 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -65.33 176.74 1.28 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.104 0.478 . . . . 0.0 112.162 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.762 HG12 ' H ' ' A' ' 104' ' ' THR . 6.0 t -71.46 -179.75 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.508 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.762 ' H ' HG12 ' A' ' 103' ' ' VAL . 75.3 p -43.34 -55.78 3.89 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -175.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 103' ' ' VAL . 12.7 mm-40 74.82 -40.87 0.45 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 178.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.411 ' HB3' ' OD1' ' A' ' 108' ' ' ASP . 48.2 mtm105 -52.97 143.2 17.7 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.745 1.016 . . . . 0.0 113.745 -174.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.4 t -80.43 6.39 12.41 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.411 ' OD1' ' HB3' ' A' ' 106' ' ' ARG . 3.6 m-20 . . . . . 0 C--O 1.252 1.216 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 120.719 0.295 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 59.08 -154.3 29.15 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.163 -0.541 . . . . 0.0 113.467 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 72.1 m80 66.95 121.25 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.313 0.578 . . . . 0.0 111.926 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -68.14 85.99 0.25 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.415 0.626 . . . . 0.0 111.244 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -126.3 126.13 43.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.432 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -67.44 -179.18 0.99 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.796 0.332 . . . . 0.0 111.532 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -69.95 -75.52 0.11 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 122.299 -0.251 . . . . 0.0 111.182 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 62.96 142.64 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.4 m 67.19 170.84 0.26 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.711 0.767 . . . . 0.0 112.531 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -154.61 76.42 1.02 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.56 172.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 62.9 mtm -86.66 103.51 15.2 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.726 -175.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.83 -175.37 2.65 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.477 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -118.24 146.42 44.28 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.761 0.315 . . . . 0.0 111.465 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.34 122.63 17.57 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.233 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.4 mmt -55.65 104.97 0.15 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.213 0.53 . . . . 0.0 111.689 -178.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.78 -3.53 54.1 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -64.98 82.88 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.492 0.663 . . . . 0.0 111.011 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -174.91 -45.8 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.32 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 73.6 mt -83.84 47.56 1.32 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.745 0.783 . . . . 0.0 109.802 173.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -93.45 90.7 6.82 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.791 -169.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -156.26 138.69 14.87 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.84 165.63 31.63 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.983 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.3 p -141.02 155.82 46.13 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.867 0.365 . . . . 0.0 110.362 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.471 ' O ' ' HD2' ' A' ' 26' ' ' PRO . . . -77.91 8.66 4.36 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.6 -74.5 0.21 Allowed Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 -172.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' A' ' 24' ' ' ALA . 47.1 Cg_endo -68.54 153.78 72.99 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 122.269 1.98 . . . . 0.0 111.187 166.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.2 ttt -100.0 122.67 43.26 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.861 -0.525 . . . . 0.0 111.293 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -98.99 125.76 44.52 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.769 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.45 HD22 HD12 ' A' ' 85' ' ' LEU . 76.8 mt -110.9 133.54 53.29 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.391 0.615 . . . . 0.0 111.74 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -89.78 109.36 20.36 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.331 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.8 t -109.73 123.21 65.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.78 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -123.73 97.29 0.56 Allowed Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.522 -0.371 . . . . 0.0 113.154 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.494 ' HB3' ' HA ' ' A' ' 98' ' ' MET . 99.7 p -161.02 9.74 0.09 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.089 0.471 . . . . 0.0 111.494 176.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.472 HD21 HD21 ' A' ' 43' ' ' LEU . 10.6 mt -87.16 87.71 7.51 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 122.2 -0.312 . . . . 0.0 111.595 -170.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.48 72.8 1.39 Allowed 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 56.07 20.62 4.48 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 173.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -153.78 -37.24 0.1 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -175.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.4 mm -59.98 128.72 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 120.778 0.323 . . . . 0.0 111.517 -175.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 62.7 p -113.45 178.16 4.38 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -173.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -48.67 -46.1 39.76 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.964 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.66 -44.87 63.19 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.488 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.7 mmt -66.89 -47.06 72.97 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.461 0.648 . . . . 0.0 110.576 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.472 HD21 HD21 ' A' ' 34' ' ' LEU . 70.6 mt -59.46 -50.67 73.05 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.735 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 44' ' ' ARG . 8.2 ttm180 -58.56 -44.7 89.79 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 122.27 -0.268 . . . . 0.0 111.657 177.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.36 -38.36 68.81 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.579 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.489 HD11 HD13 ' A' ' 93' ' ' LEU . 59.6 mt -86.8 -49.18 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 75' ' ' PHE . 51.6 m-85 -77.18 -41.76 40.28 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -170.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.413 ' HB2' HD12 ' A' ' 53' ' ' ILE . 29.6 tt0 -62.85 -37.88 38.15 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -173.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -46.06 -18.06 0.37 Allowed 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.447 2.098 . . . . 0.0 114.112 172.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -82.23 -42.97 18.21 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.801 0.334 . . . . 0.0 111.417 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.17 -122.87 1.06 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.791 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.401 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 29.8 mmt180 -140.29 129.77 24.08 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.387 0.613 . . . . 0.0 111.449 175.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.413 HD12 ' HB2' ' A' ' 48' ' ' GLU . 74.9 mt -100.35 120.81 50.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.822 -175.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -73.45 -53.88 9.59 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.956 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.8 t -150.55 150.2 30.92 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.032 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.1 mt -120.65 116.7 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.372 175.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -118.01 129.18 55.43 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.722 0.296 . . . . 0.0 111.263 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.438 HD12 ' N ' ' A' ' 58' ' ' LEU . 6.0 mp -99.78 141.85 32.04 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.974 0.416 . . . . 0.0 111.075 177.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.462 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 31.0 tpp -93.6 101.42 13.58 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.767 0.794 . . . . 0.0 111.675 -176.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -130.6 131.74 45.13 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.55 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -81.25 106.59 13.35 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.93 0.395 . . . . 0.0 110.992 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 62.9 p -74.56 -12.97 60.6 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -62.32 -54.33 42.08 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.898 0.38 . . . . 0.0 110.299 174.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.5 t -175.15 -10.72 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.25 -24.34 73.58 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.895 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 79.6 mtm-85 61.01 -157.68 0.34 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 122.883 0.473 . . . . 0.0 111.729 175.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.9 m -54.52 111.68 0.85 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.462 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 57.2 mttp -77.98 -25.21 47.96 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 112.7 3.12 25.4 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 120.937 -0.649 . . . . 0.0 114.495 177.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -140.76 158.77 43.48 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.818 0.809 . . . . 0.0 112.423 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -144.37 159.95 27.8 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.629 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -107.4 124.9 50.52 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 122.624 -0.339 . . . . 0.0 111.256 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 64.7 mt -110.21 130.82 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 120.896 0.379 . . . . 0.0 111.145 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.0 m -106.35 114.25 28.26 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.417 ' CZ ' ' HB3' ' A' ' 47' ' ' PHE . 38.5 m-85 -99.46 152.42 20.01 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.14 0.576 . . . . 0.0 110.763 177.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.8 t -93.65 -5.55 48.41 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.662 0.744 . . . . 0.0 110.002 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -119.8 101.81 8.15 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.186 -175.395 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.7 p -56.9 -55.21 37.5 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -176.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -58.23 -47.36 83.78 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 82.5 m -62.09 -40.86 97.26 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.846 0.355 . . . . 0.0 111.572 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.89 -42.68 89.96 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.064 0.459 . . . . 0.0 111.452 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -62.67 -36.38 82.71 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.093 0.473 . . . . 0.0 110.729 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -63.31 -52.05 63.54 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.086 0.47 . . . . 0.0 110.359 172.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.66 -43.69 57.4 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.201 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.45 HD12 HD22 ' A' ' 29' ' ' LEU . 9.5 tt -54.01 -62.76 1.44 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.185 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -74.9 -4.8 40.16 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -172.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -98.32 -29.72 13.0 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.95 -0.469 . . . . 0.0 111.495 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 88.1 mt -106.71 -13.27 15.32 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -175.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -70.17 91.41 0.71 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.28 0.562 . . . . 0.0 110.247 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 125.98 -15.51 6.95 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.992 -172.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -59.73 133.9 56.53 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.072 0.549 . . . . 0.0 111.457 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 30.8 mt-10 -89.08 90.22 8.3 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.238 0.542 . . . . 0.0 111.923 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.489 HD13 HD11 ' A' ' 46' ' ' ILE . 36.2 tp -85.31 -65.5 1.0 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.41 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.04 38.56 0.66 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.879 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.89 17.27 75.19 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 121.241 -0.504 . . . . 0.0 111.954 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 9.7 ptm85 -157.68 151.59 19.67 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 115.505 -0.347 . . . . 0.0 110.349 -174.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.51 141.48 62.3 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.005 2.47 . . . . 0.0 113.039 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.494 ' HA ' ' HB3' ' A' ' 33' ' ' SER . 36.5 ttp -99.31 128.12 45.4 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.119 0.485 . . . . 0.0 111.48 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -89.12 101.46 14.12 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.533 -178.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.7 t -114.24 111.38 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 120.789 0.328 . . . . 0.0 111.321 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -127.38 151.11 18.33 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.298 -0.477 . . . . 0.0 113.272 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -71.02 122.95 20.98 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 122.32 -0.518 . . . . 0.0 111.705 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 90.8 t -74.79 -59.3 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.5 p 51.21 92.44 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.43 0.692 . . . . 0.0 111.901 -176.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.46 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -92.96 -41.73 9.86 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -170.143 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -135.53 148.55 49.19 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -176.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.1 t -110.21 126.21 53.89 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.236 173.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.5 t70 . . . . . 0 C--O 1.254 1.304 0 CA-C-O 118.877 -0.582 . . . . 0.0 112.045 -174.68 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -85.09 -55.26 2.67 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.968 -175.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -131.21 135.62 47.54 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -172.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -156.88 126.83 6.32 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.993 173.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -70.96 92.65 0.94 Allowed 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.698 0.761 . . . . 0.0 112.882 -172.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -142.05 -36.77 0.41 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.808 172.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 -79.34 110.5 14.68 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.234 0.54 . . . . 0.0 110.226 174.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -77.04 116.87 18.07 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.005 0.431 . . . . 0.0 110.981 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 75.6 p -123.33 -71.58 0.72 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.987 0.422 . . . . 0.0 111.534 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.8 m80 -140.16 -45.53 0.42 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.975 0.417 . . . . 0.0 111.2 175.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.6 mtt -72.75 92.65 1.58 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.998 0.428 . . . . 0.0 111.533 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.17 -47.79 0.13 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.669 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.64 -74.72 0.14 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 177.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -163.96 145.88 9.09 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.835 0.35 . . . . 0.0 111.347 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 15.0 tpt -93.07 -8.84 41.64 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.213 0.53 . . . . 0.0 110.968 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.96 -9.48 52.36 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -174.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -93.12 2.13 56.86 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.003 0.43 . . . . 0.0 111.602 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -67.0 118.72 10.84 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.9 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.6 tp -73.29 87.98 1.51 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.864 0.84 . . . . 0.0 110.277 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -88.76 160.39 17.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.903 -176.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.2 tttt -81.06 136.81 36.01 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.819 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.08 91.0 0.03 OUTLIER Glycine 0 CA--C 1.53 0.987 0 N-CA-C 114.181 0.432 . . . . 0.0 114.181 -174.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.3 t -78.05 -57.05 4.0 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.948 0.404 . . . . 0.0 111.172 176.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -141.92 -50.67 0.4 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.951 0.405 . . . . 0.0 111.673 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.73 78.79 1.3 Allowed Glycine 0 CA--C 1.531 1.072 0 CA-C-N 116.275 -0.421 . . . . 0.0 113.978 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.49 137.69 56.32 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.635 2.223 . . . . 0.0 112.292 174.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.8 ttt -99.6 136.4 39.58 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.091 0.472 . . . . 0.0 111.471 -176.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -112.48 118.98 36.64 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.349 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.9 mt -102.4 145.65 29.22 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.347 0.594 . . . . 0.0 112.126 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -102.08 120.48 40.51 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.616 173.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.3 t -118.98 115.94 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.672 0.272 . . . . 0.0 110.997 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.55 87.51 0.38 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.334 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.4 m -166.13 28.72 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.164 0.585 . . . . 0.0 110.61 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.493 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 15.0 mt -95.25 103.09 14.94 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.768 -176.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -74.21 67.1 1.34 Allowed 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -176.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 50.72 20.83 0.8 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 174.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.16 -38.2 0.27 Allowed 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.99 -0.444 . . . . 0.0 111.784 -174.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.7 mm -60.38 109.63 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 120.824 0.345 . . . . 0.0 111.149 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 61.0 p -92.93 172.57 8.24 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -54.79 -42.72 72.13 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.726 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -63.38 -38.04 89.61 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.703 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.1 mmt -65.51 -52.73 50.58 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.408 0.623 . . . . 0.0 110.197 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 65.5 mt -55.2 -40.33 70.65 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.925 174.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 44' ' ' ARG . 45.0 ttm180 -61.5 -46.76 88.64 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.876 0.37 . . . . 0.0 110.957 177.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.31 -32.03 60.09 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.139 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 58.1 mt -85.68 -50.12 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -82.48 -27.69 31.65 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -172.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.632 ' HG3' ' O ' ' A' ' 52' ' ' ARG . 22.1 tt0 -57.33 -48.23 97.68 Favored Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -173.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 80.3 Cg_exo -47.89 -18.88 1.23 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 122.621 2.214 . . . . 0.0 114.013 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -78.45 -40.31 36.05 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.42 ' HA3' ' HB3' ' A' ' 80' ' ' CYS . . . -169.8 37.93 0.19 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 119.838 -1.173 . . . . 0.0 115.438 -178.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.632 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 0.0 OUTLIER 72.67 -53.79 0.7 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.366 0.666 . . . . 0.0 112.541 174.593 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.447 ' HB ' ' O ' ' A' ' 52' ' ' ARG . 68.7 mt 79.82 137.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.756 0.823 . . . . 0.0 111.672 -177.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -85.01 -64.96 1.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.196 0.522 . . . . 0.0 110.151 174.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.2 t -147.59 146.36 29.36 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.046 0.451 . . . . 0.0 111.865 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.527 HG23 HG12 ' A' ' 73' ' ' ILE . 60.4 mt -115.36 130.19 70.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.894 174.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -125.07 122.45 37.26 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.924 0.393 . . . . 0.0 111.547 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.8 mt -99.13 149.73 22.75 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.657 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 82.8 mmm -97.13 111.24 23.56 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.699 0.285 . . . . 0.0 110.727 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -115.8 148.9 39.36 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.159 0.504 . . . . 0.0 111.925 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -75.47 151.79 37.99 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.498 173.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.6 t -108.53 20.75 18.19 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -173.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -116.67 -67.18 1.01 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.184 0.516 . . . . 0.0 109.866 172.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.0 t -161.79 13.99 0.09 Allowed 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.361 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.92 -27.59 45.23 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.817 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.491 ' NE ' ' HA ' ' A' ' 66' ' ' ARG . 3.5 mmp_? 59.33 -154.5 0.37 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.534 0.334 . . . . 0.0 111.84 176.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.5 m -52.92 99.46 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -54.24 -49.88 68.45 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -174.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 145.27 -11.01 1.79 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.929 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -128.55 145.26 51.18 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 117.23 0.515 . . . . 0.0 111.858 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.33 160.87 28.75 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.651 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -113.25 127.25 56.1 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.007 0.432 . . . . 0.0 111.72 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 56' ' ' ILE . 67.1 mt -110.12 134.71 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.771 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 38.8 m -116.25 123.3 47.39 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.025 0.44 . . . . 0.0 111.926 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -100.22 149.66 23.34 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.511 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.8 m -72.06 -9.46 58.42 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.066 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.632 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 19.8 t70 -138.12 150.23 46.65 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.874 0.369 . . . . 0.0 111.47 -177.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 71.2 p -68.72 -53.19 23.5 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -68.54 -30.17 68.9 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 93.8 m -58.03 -41.45 83.25 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.16 0.505 . . . . 0.0 111.183 174.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.39 -38.67 29.85 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.237 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -54.93 -48.94 72.48 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.308 0.575 . . . . 0.0 110.688 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -70.02 -41.97 73.59 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.566 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.06 -44.02 67.14 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.273 0.558 . . . . 0.0 110.873 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 tt -62.29 -62.25 1.89 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.521 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -56.54 -29.73 62.29 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -176.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -87.95 -38.6 15.42 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 122.09 -0.381 . . . . 0.0 111.728 -175.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 76.5 mt -96.16 -23.4 16.76 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -172.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -65.69 100.13 0.51 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.068 0.461 . . . . 0.0 110.641 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.47 -9.67 13.1 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.738 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -73.22 126.97 31.3 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 122.535 -0.391 . . . . 0.0 111.938 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 45.3 mt-10 -80.04 102.54 9.35 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.866 0.365 . . . . 0.0 111.143 176.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 65.8 tp -89.53 -66.74 0.89 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.034 0.445 . . . . 0.0 111.516 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -92.15 32.4 1.17 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.955 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.61 4.99 79.2 Favored Glycine 0 C--N 1.332 0.343 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 -174.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 1.5 ptm85 -143.44 152.37 56.81 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 122.927 0.491 . . . . 0.0 110.695 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -61.16 155.59 50.12 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.118 2.545 . . . . 0.0 114.384 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 31.9 tpp -99.46 117.72 34.49 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.728 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.587 ' NZ ' ' HB3' ' A' ' 99' ' ' LYS . 7.7 mtpm? -89.32 101.97 14.64 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.121 -0.362 . . . . 0.0 111.419 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.6 t -120.52 118.1 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.886 0.374 . . . . 0.0 111.666 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -139.24 147.49 19.25 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.176 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -66.73 150.34 49.24 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 117.663 0.732 . . . . 0.0 110.769 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.1 m -72.53 178.01 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.051 0.453 . . . . 0.0 111.623 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 74.1 p -82.09 86.23 6.63 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 122.018 -0.426 . . . . 0.0 111.734 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -84.99 94.9 8.92 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 172.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -135.35 148.67 49.5 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.215 0.531 . . . . 0.0 111.926 -177.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 97.7 m -100.25 -43.89 6.13 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.103 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--O 1.253 1.284 0 CA-C-O 118.343 -0.837 . . . . 0.0 112.383 -179.131 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 120.62 0.247 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.96 -70.76 1.19 Allowed Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.752 -174.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.452 ' O ' ' HB2' ' A' ' 4' ' ' HIS . 16.3 m-70 -84.93 139.74 31.61 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 169.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 9.1 m-70 68.98 97.44 0.06 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.185 0.517 . . . . 0.0 111.853 -173.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -84.09 -19.85 33.6 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.177 0.513 . . . . 0.0 110.505 174.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -103.24 103.5 13.54 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.304 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -83.45 -9.47 58.98 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.846 0.355 . . . . 0.0 111.132 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -119.24 112.29 19.29 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.884 0.373 . . . . 0.0 110.778 173.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.4 t -94.86 -178.65 4.58 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.827 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 68.31 32.64 4.57 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.511 176.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.3 ttt 58.73 94.31 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.197 0.523 . . . . 0.0 111.211 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.707 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -86.5 -79.3 0.26 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -175.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 55.86 -83.96 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -177.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -95.17 -24.96 16.59 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.879 0.371 . . . . 0.0 111.45 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.507 ' N ' ' SD ' ' A' ' 15' ' ' MET . 1.3 mpt? -86.39 8.47 21.49 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.707 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . . . -81.49 87.6 6.21 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.706 0.289 . . . . 0.0 110.731 176.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 64.41 86.55 0.12 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.646 -172.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -78.0 126.7 31.23 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.091 0.472 . . . . 0.0 112.238 -176.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 58.1 tp -90.02 -44.56 9.77 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.295 0.569 . . . . 0.0 110.644 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 22.4 tm0? -84.96 90.8 7.9 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.827 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.41 ' HE3' ' HB2' ' A' ' 21' ' ' LYS . 35.8 ttmt -178.43 155.41 0.87 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.665 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.62 81.91 0.06 OUTLIER Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.428 -0.415 . . . . 0.0 113.822 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.3 t -96.84 119.64 35.69 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.614 -0.345 . . . . 0.0 111.061 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.53 138.27 33.49 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.854 0.359 . . . . 0.0 111.251 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.66 -74.85 0.4 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.795 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.53 134.67 29.05 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.834 2.356 . . . . 0.0 112.67 176.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.505 ' HB2' ' HA ' ' A' ' 78' ' ' SER . 27.0 ttt -113.11 133.15 55.15 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.972 0.415 . . . . 0.0 111.558 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -99.78 116.28 31.5 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.159 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.2 mt -99.55 143.06 30.23 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.13 0.491 . . . . 0.0 111.665 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -97.73 120.11 37.54 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.602 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 99' ' ' LYS . 58.4 t -115.17 112.55 40.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.478 176.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.56 93.35 0.22 Allowed Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.527 -0.844 . . . . 0.0 114.645 -174.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.645 ' OG ' ' HA ' ' A' ' 98' ' ' MET . 90.9 p -176.08 19.89 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 28.8 mt -84.88 150.33 25.06 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 122.279 -0.263 . . . . 0.0 111.43 -175.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.4 ' O ' ' ND1' ' A' ' 35' ' ' HIS . 24.9 p80 -122.49 76.61 1.34 Allowed 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -176.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.422 ' HD1' ' HB3' ' A' ' 67' ' ' SER . 23.7 t80 42.94 41.86 2.81 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.312 0.645 . . . . 0.0 112.616 173.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -152.99 -51.32 0.1 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.998 0.428 . . . . 0.0 111.374 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.64 ' HA ' ' SD ' ' A' ' 42' ' ' MET . 3.2 mp -62.59 127.9 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.137 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.437 ' OG1' ' HG3' ' A' ' 42' ' ' MET . 35.3 p -106.51 171.93 7.09 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.329 0.585 . . . . 0.0 112.078 -175.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.522 ' HG2' ' HG ' ' A' ' 58' ' ' LEU . 79.6 mt-10 -67.08 -32.88 74.35 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.793 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -64.17 -39.2 93.51 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.075 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.64 ' SD ' ' HA ' ' A' ' 38' ' ' ILE . 64.4 mtt -62.88 -52.4 63.23 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.442 0.639 . . . . 0.0 110.273 176.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.503 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 63.1 mt -54.47 -51.39 65.19 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.106 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -50.2 -50.1 50.58 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.888 0.375 . . . . 0.0 111.195 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.93 -28.77 66.57 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.656 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.8 mm -82.84 -38.33 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 O-C-N 122.453 -0.439 . . . . 0.0 111.97 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.503 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 44.5 m-85 -85.89 -30.83 22.56 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -174.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -56.7 -38.68 71.17 Favored Pre-proline 0 N--CA 1.483 1.197 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -47.18 -22.83 2.52 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.245 1.964 . . . . 0.0 113.408 171.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.429 ' HE1' ' HG3' ' A' ' 87' ' ' GLN . 81.5 m-85 -93.69 -44.9 7.94 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.087 0.47 . . . . 0.0 111.096 175.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -174.32 140.58 5.49 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.844 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.0 ttp85 -58.34 134.5 56.64 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.242 0.544 . . . . 0.0 112.082 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.4 mp -94.01 137.9 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.144 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -87.99 -40.67 13.69 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.833 0.349 . . . . 0.0 111.806 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.9 t -150.96 132.36 14.64 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.117 0.484 . . . . 0.0 112.238 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.534 HG23 HG12 ' A' ' 73' ' ' ILE . 47.9 mt -117.64 133.2 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.211 173.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -137.89 118.83 14.27 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.844 0.355 . . . . 0.0 111.404 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.605 HD23 ' HA3' ' A' ' 71' ' ' GLY . 91.7 mt -96.48 149.81 21.32 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 174.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.564 ' SD ' ' CE2' ' A' ' 70' ' ' TYR . 60.9 mtp -92.48 112.93 25.06 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.798 0.808 . . . . 0.0 111.349 -177.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.1 ptm -147.01 145.71 29.81 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.031 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.783 ' HB2' ' HA3' ' A' ' 65' ' ' GLY . 45.4 m-20 -121.68 109.35 14.64 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.801 0.334 . . . . 0.0 111.833 -174.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.8 t -55.24 -33.88 63.52 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -57.62 -39.04 76.0 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.2 t 175.42 -14.08 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -177.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.783 ' HA3' ' HB2' ' A' ' 61' ' ' ASP . . . -63.3 -31.84 82.11 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.327 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 66.89 -68.45 0.14 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 171.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.422 ' HB3' ' HD1' ' A' ' 36' ' ' PHE . 46.6 t -167.05 116.46 0.85 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.88 0.371 . . . . 0.0 111.059 177.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -85.94 -5.15 59.28 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.03 3.57 87.62 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 114.963 0.745 . . . . 0.0 114.963 169.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.564 ' CE2' ' SD ' ' A' ' 59' ' ' MET . 49.4 p90 -133.09 145.98 51.24 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 117.805 0.802 . . . . 0.0 111.993 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.605 ' HA3' HD23 ' A' ' 58' ' ' LEU . . . -151.2 161.9 29.28 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 115.816 -0.629 . . . . 0.0 113.239 -177.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -105.2 129.04 53.67 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.914 0.388 . . . . 0.0 111.768 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.534 HG12 HG23 ' A' ' 56' ' ' ILE . 66.8 mt -111.76 132.69 59.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.025 178.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.7 m -112.57 118.54 35.39 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.441 ' HZ ' ' HD2' ' A' ' 47' ' ' PHE . 45.0 m-85 -99.12 152.13 20.21 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.792 0.437 . . . . 0.0 111.841 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.1 m -68.09 -10.81 56.83 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.624 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -139.64 161.04 38.49 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.081 0.467 . . . . 0.0 112.096 -176.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.505 ' HA ' ' HB2' ' A' ' 27' ' ' MET . 51.7 m -91.33 -37.31 13.33 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -79.4 -40.01 31.06 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.015 -0.428 . . . . 0.0 112.023 -177.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 76.5 m -58.13 -41.86 84.57 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.329 0.585 . . . . 0.0 110.765 174.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.6 -45.37 68.73 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.984 176.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.518 ' NZ ' ' HB2' ' A' ' 82' ' ' LYS . 5.0 ttmp? -57.25 -34.98 69.16 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.405 178.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 46.0 tttm -75.23 -37.74 60.93 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.965 0.412 . . . . 0.0 111.01 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.89 -33.19 64.38 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.501 0.667 . . . . 0.0 110.475 172.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 100' ' ' VAL . 7.6 tt -65.85 -55.38 17.34 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.766 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 83' ' ' LYS . 2.6 pp20? -64.74 -19.28 65.7 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -174.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.429 ' HG3' ' HE1' ' A' ' 50' ' ' PHE . 85.9 mm-40 -94.6 -46.46 6.94 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.871 -0.518 . . . . 0.0 111.893 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 71.6 mt -89.61 -17.3 28.74 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -170.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -71.01 91.4 0.88 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.464 0.65 . . . . 0.0 110.187 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.42 -14.13 8.78 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.943 -173.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -61.77 120.26 10.34 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.703 0.401 . . . . 0.0 110.958 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 43.0 mt-10 -79.0 93.71 5.15 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.158 0.504 . . . . 0.0 111.67 -177.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.5 tp -96.51 135.88 37.79 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.995 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 59.76 24.07 13.0 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.206 0.527 . . . . 0.0 111.146 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.33 3.67 89.91 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.121 -0.491 . . . . 0.0 113.526 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 44.9 mtp180 -121.13 136.5 25.75 Favored Pre-proline 0 N--CA 1.473 0.676 0 CA-C-N 117.306 0.553 . . . . 0.0 111.731 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -59.99 129.31 29.81 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.473 2.115 . . . . 0.0 111.82 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.645 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 40.9 ttp -97.62 124.88 42.07 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.174 0.511 . . . . 0.0 111.781 -174.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 68.2 mttm -88.41 101.91 14.36 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.148 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.515 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 44.0 t -114.45 99.51 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.632 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -135.62 160.24 24.44 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.747 -0.739 . . . . 0.0 113.062 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -72.68 151.94 41.97 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 122.514 -0.403 . . . . 0.0 110.598 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.5 t -62.79 85.07 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.318 0.58 . . . . 0.0 112.423 -173.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 57.6 m -124.49 85.79 2.47 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.463 0.649 . . . . 0.0 110.141 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -82.09 -33.13 29.94 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.409 -174.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -98.3 114.1 26.27 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -173.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 68.3 p -94.9 -66.48 0.91 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 167.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.5 t70 . . . . . 0 C--O 1.254 1.34 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 172.021 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.438 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 120.592 0.234 . . . . 0.0 111.211 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -61.78 83.06 0.03 OUTLIER Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.364 -0.446 . . . . 0.0 113.356 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 51.53 -110.17 0.48 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.107 0.563 . . . . 0.0 111.664 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -147.61 99.8 3.16 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.964 0.412 . . . . 0.0 110.517 176.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -80.42 65.38 5.55 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.117 0.484 . . . . 0.0 111.307 -177.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -81.78 39.05 0.53 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.484 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -70.4 86.49 0.61 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.913 -176.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.1 p80 -154.83 9.93 0.33 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.6 m 63.09 172.19 0.15 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -73.81 85.23 1.69 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.273 0.558 . . . . 0.0 111.781 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.7 ttt -59.13 -48.94 79.77 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.878 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.29 -71.66 0.19 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 58.68 17.62 5.24 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -105.29 147.4 28.15 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.904 0.383 . . . . 0.0 111.438 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 83.5 mtp -96.43 131.85 42.57 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.92 0.391 . . . . 0.0 111.397 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.09 80.27 8.87 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.075 0.464 . . . . 0.0 111.445 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -134.92 94.09 3.11 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.407 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -77.83 -69.34 0.55 Allowed 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.2 tp 63.44 -76.92 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.191 0.597 . . . . 0.0 111.623 175.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.89 3.33 0.62 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 176.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -74.76 -44.75 48.11 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.145 0.498 . . . . 0.0 111.198 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.9 59.23 4.75 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.385 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.8 p 49.49 -83.23 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.537 0.735 . . . . 0.0 112.8 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.22 140.82 51.69 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.511 0.325 . . . . 0.0 110.972 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -139.78 -174.02 13.5 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.518 -177.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.07 128.22 29.61 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.904 2.403 . . . . 0.0 113.116 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 26.3 ttt -99.12 141.27 32.09 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.677 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.489 ' HD3' ' HB3' ' A' ' 72' ' ' PHE . 42.4 ttm180 -115.71 130.95 57.05 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.171 0.51 . . . . 0.0 112.288 -171.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.427 HD11 ' O ' ' A' ' 81' ' ' ALA . 85.5 mt -107.66 145.39 33.43 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.195 0.522 . . . . 0.0 111.831 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.51 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 39.0 t80 -97.32 111.79 23.89 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.961 173.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -106.23 107.44 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 120.805 0.336 . . . . 0.0 111.35 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.592 ' HA2' ' HB3' ' A' ' 70' ' ' TYR . . . -113.39 97.57 0.87 Allowed Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.244 -0.503 . . . . 0.0 113.831 -176.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.73 ' HB2' ' HA ' ' A' ' 98' ' ' MET . 30.7 t -174.81 15.25 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.39 0.614 . . . . 0.0 111.183 172.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.725 ' HA ' HD12 ' A' ' 38' ' ' ILE . 11.1 mt -85.59 88.62 7.55 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 122.029 -0.42 . . . . 0.0 110.405 -171.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -78.49 69.29 4.65 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.579 0.704 . . . . 0.0 112.377 -172.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 48.3 t80 57.68 9.62 0.87 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 175.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -124.18 -38.91 2.4 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.609 -0.682 . . . . 0.0 112.596 -177.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.725 HD12 ' HA ' ' A' ' 34' ' ' LEU . 58.8 mt -67.61 134.06 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.938 0.399 . . . . 0.0 111.978 -176.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 56.6 p -110.02 166.21 11.12 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.066 0.46 . . . . 0.0 112.205 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.493 ' HA ' HD12 ' A' ' 43' ' ' LEU . 2.5 mp0 -63.07 -36.54 83.93 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.248 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -66.67 -33.56 75.92 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.909 0.385 . . . . 0.0 111.277 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.47 ' SD ' HG23 ' A' ' 38' ' ' ILE . 27.1 ttt -68.18 -44.66 75.41 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.562 0.696 . . . . 0.0 110.107 174.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 40' ' ' GLU . 92.2 mt -55.09 -55.26 33.0 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.722 178.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.534 ' HB3' HD11 ' A' ' 56' ' ' ILE . 14.2 ptm180 -61.78 -33.22 73.72 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.385 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.19 -36.8 69.81 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.63 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 63.2 mt -85.45 -49.21 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 177.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -82.31 -32.52 29.41 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -169.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.749 ' HG3' ' HA ' ' A' ' 52' ' ' ARG . 22.2 tt0 -62.07 -42.49 81.98 Favored Pre-proline 0 N--CA 1.48 1.056 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -174.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -47.78 -18.29 0.98 Allowed 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 122.529 2.152 . . . . 0.0 114.316 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -71.38 -51.9 21.58 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.525 ' N ' ' SG ' ' A' ' 80' ' ' CYS . . . -170.91 43.76 0.19 Allowed Glycine 0 N--CA 1.468 0.77 0 C-N-CA 120.079 -1.058 . . . . 0.0 114.092 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.749 ' HA ' ' HG3' ' A' ' 48' ' ' GLU . 0.3 OUTLIER 63.31 143.91 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.974 0.892 . . . . 0.0 113.39 178.787 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.41 HG13 ' HA ' ' A' ' 48' ' ' GLU . 89.2 mt -119.09 133.69 65.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.16 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -82.68 -56.48 3.83 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.674 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.7 p -150.12 138.34 20.39 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.255 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 44' ' ' ARG . 46.0 mt -107.67 116.31 50.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.343 0.592 . . . . 0.0 111.113 177.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -99.36 115.72 29.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.993 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 27.9 tp -97.16 133.35 41.92 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.551 -0.718 . . . . 0.0 110.516 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.6 ' HG3' ' HD3' ' A' ' 68' ' ' LYS . 14.3 tpt -92.28 99.29 12.09 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.889 0.852 . . . . 0.0 111.142 -171.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.509 ' HA ' ' HG3' ' A' ' 68' ' ' LYS . 19.5 ptp -132.0 149.28 52.47 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.069 177.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -66.94 92.2 0.23 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.302 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.2 m -56.8 -9.07 0.7 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.303 0.573 . . . . 0.0 111.496 175.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -76.5 -43.01 41.42 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.18 177.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 77.5 p -121.63 0.72 9.94 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -175.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.02 20.73 76.54 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 121.548 -0.358 . . . . 0.0 113.7 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.1 mmt85 -100.08 148.31 24.7 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.23 -0.57 . . . . 0.0 112.044 -176.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.5 m -85.88 128.97 34.95 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.122 -178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.6 ' HD3' ' HG3' ' A' ' 59' ' ' MET . 26.0 mtpp -86.94 -15.02 40.13 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 101.03 7.05 51.02 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 120.969 -0.634 . . . . 0.0 114.486 175.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.592 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -145.26 160.07 42.05 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 117.476 0.638 . . . . 0.0 112.567 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -145.29 147.57 18.77 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.955 -0.566 . . . . 0.0 113.147 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.489 ' HB3' ' HD3' ' A' ' 28' ' ' ARG . 95.8 m-85 -99.57 112.67 24.85 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.935 0.398 . . . . 0.0 111.266 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.529 HG23 HG12 ' A' ' 56' ' ' ILE . 67.8 mt -99.41 126.18 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.956 0.408 . . . . 0.0 111.586 -178.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 36.7 m -101.54 118.41 36.9 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.517 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -98.53 151.53 20.54 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.109 0.481 . . . . 0.0 112.17 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.0 t -72.19 -28.83 63.46 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.148 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -116.3 133.0 56.51 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.972 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.6 t -67.04 -51.17 58.09 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.941 0.401 . . . . 0.0 111.891 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -57.77 -34.37 69.5 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.098 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 51' ' ' GLY . 7.7 t -57.97 -46.3 85.38 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.824 175.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.427 ' O ' HD11 ' A' ' 29' ' ' LEU . . . -65.16 -41.77 94.35 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.07 0.462 . . . . 0.0 111.15 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -64.93 -35.67 81.91 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.564 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 85.6 tttt -72.35 -50.41 26.95 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.741 0.305 . . . . 0.0 111.318 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.15 -42.77 61.01 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.11 0.481 . . . . 0.0 110.954 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.409 HD23 ' C ' ' A' ' 85' ' ' LEU . 7.8 tt -57.19 -55.9 28.7 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.511 173.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -53.67 -34.85 60.06 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.132 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 83' ' ' LYS . 11.1 mm100 -86.8 -35.43 19.12 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.911 -174.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 73.8 mt -104.79 -7.02 19.76 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -171.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -62.91 99.71 0.17 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.028 0.442 . . . . 0.0 111.134 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.05 -2.42 44.31 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 116.264 -0.426 . . . . 0.0 113.342 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -67.15 131.69 46.31 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 122.607 -0.349 . . . . 0.0 111.578 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.82 103.34 1.41 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.987 0.423 . . . . 0.0 111.153 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 56.6 tp -113.17 127.33 56.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.433 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 58.26 23.73 10.7 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.148 0.499 . . . . 0.0 111.754 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.99 -18.27 54.99 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.82 -0.627 . . . . 0.0 114.018 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 31.7 mtt85 -116.59 140.01 26.19 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 117.378 0.589 . . . . 0.0 111.997 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.23 132.12 48.74 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.778 2.318 . . . . 0.0 112.098 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.73 ' HA ' ' HB2' ' A' ' 33' ' ' SER . 38.5 ttp -96.75 119.35 35.07 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.361 0.6 . . . . 0.0 111.738 -171.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -87.8 94.19 9.68 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.64 -176.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.05 113.57 38.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.461 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.51 ' O ' ' HB3' ' A' ' 30' ' ' TYR . . . -142.08 131.59 4.8 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.25 -0.5 . . . . 0.0 112.548 176.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -63.2 94.98 0.08 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 117.655 0.727 . . . . 0.0 112.128 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.538 HG12 ' HG2' ' A' ' 105' ' ' GLU . 43.0 t 49.93 86.92 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.832 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.7 t -73.37 82.3 1.41 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.653 0.74 . . . . 0.0 112.61 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.538 ' HG2' HG12 ' A' ' 103' ' ' VAL . 19.8 mm-40 -94.55 -69.37 0.75 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.121 173.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.7 tpm_? 71.5 -57.56 0.6 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.166 0.586 . . . . 0.0 112.454 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.2 m -53.36 119.86 5.32 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.984 0.421 . . . . 0.0 111.986 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.5 t70 . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.903 -0.57 . . . . 0.0 111.875 -179.999 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.9 ttm . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.875 0.369 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -96.78 -159.71 31.73 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.316 174.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -129.61 97.01 4.4 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 117.28 0.54 . . . . 0.0 111.829 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -130.85 128.92 41.61 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.783 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -80.69 144.53 32.17 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.036 0.446 . . . . 0.0 111.263 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -118.31 11.68 13.17 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.065 0.46 . . . . 0.0 111.321 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -76.88 131.84 38.8 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.847 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 76.9 t60 63.89 98.86 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.8 m -130.83 -68.7 0.67 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.803 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.3 t60 53.87 30.7 11.91 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.107 0.563 . . . . 0.0 111.831 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.0 tpt 61.11 -72.47 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.487 0.715 . . . . 0.0 112.054 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.15 104.48 4.64 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.855 0.359 . . . . 0.0 111.489 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.1 175.78 10.06 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 68.54 4.91 4.53 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.0 mmt -101.35 118.4 36.89 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 122.489 0.316 . . . . 0.0 110.582 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -159.79 -168.09 2.16 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.224 0.535 . . . . 0.0 111.784 -176.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -77.47 2.53 15.94 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.286 -0.416 . . . . 0.0 112.08 176.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -137.9 -179.99 6.09 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 122.359 0.264 . . . . 0.0 110.882 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.431 ' O ' ' HB3' ' A' ' 20' ' ' GLN . 87.2 mt -92.89 43.81 1.13 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.907 0.384 . . . . 0.0 110.664 -176.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.431 ' HB3' ' O ' ' A' ' 19' ' ' LEU . 7.4 tp60 75.28 -23.63 0.23 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.435 0.694 . . . . 0.0 112.359 -178.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 70.83 -66.34 0.3 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.189 0.596 . . . . 0.0 112.001 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.02 138.02 4.91 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.481 -0.39 . . . . 0.0 112.593 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 79.7 p -99.77 13.01 35.16 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -177.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 69.89 -167.9 0.17 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.878 0.471 . . . . 0.0 112.073 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -163.5 -59.85 0.02 OUTLIER Glycine 0 CA--C 1.531 1.075 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.486 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.16 155.86 43.17 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.689 2.26 . . . . 0.0 113.551 176.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 11.7 tpt -126.23 147.51 49.66 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.763 0.315 . . . . 0.0 111.474 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 36.7 ttt85 -120.81 121.22 37.69 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.854 0.359 . . . . 0.0 111.308 -174.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 81.6 mt -106.01 143.66 33.82 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 55.2 t80 -91.66 116.06 28.57 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.495 172.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.465 HG21 HD12 ' A' ' 73' ' ' ILE . 60.0 t -118.73 109.14 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-O 121.093 0.473 . . . . 0.0 111.789 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.5 104.76 1.84 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.576 -0.345 . . . . 0.0 112.937 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.555 ' HB2' ' HA ' ' A' ' 98' ' ' MET . 39.7 t -171.64 14.61 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.248 0.547 . . . . 0.0 111.823 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.494 HD11 HD22 ' A' ' 58' ' ' LEU . 12.1 mt -86.16 85.44 7.35 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.722 -0.611 . . . . 0.0 111.529 -172.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.401 ' O ' ' ND1' ' A' ' 35' ' ' HIS . 33.8 p80 -78.64 66.58 4.18 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.672 0.748 . . . . 0.0 112.046 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 47.0 t80 60.18 9.24 1.8 Allowed 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.55 -34.95 1.53 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.584 -0.697 . . . . 0.0 111.483 -178.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.427 ' HB ' HD22 ' A' ' 34' ' ' LEU . 11.6 mm -73.21 107.36 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.931 0.396 . . . . 0.0 111.329 -175.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.5 p -99.54 179.23 4.62 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.957 0.408 . . . . 0.0 112.014 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -60.48 -43.13 97.28 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.275 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.31 -37.21 82.43 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.129 0.49 . . . . 0.0 110.959 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.403 ' SD ' HG23 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -67.54 -55.02 15.16 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.334 0.588 . . . . 0.0 110.246 178.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.4 mt -55.18 -44.12 74.94 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.444 176.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.511 HH21 ' NH1' ' A' ' 52' ' ' ARG . 53.9 ttt180 -58.7 -47.34 84.89 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.232 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.44 -31.59 60.05 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.998 177.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.8 mt -80.28 -54.48 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -79.76 -33.91 40.29 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -172.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.858 ' HG3' ' HA ' ' A' ' 52' ' ' ARG . 10.1 tt0 -60.78 -38.67 58.54 Favored Pre-proline 0 N--CA 1.476 0.867 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -172.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -46.3 -26.52 3.98 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.535 2.157 . . . . 0.0 113.798 172.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -66.91 -63.74 1.0 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.653 0.263 . . . . 0.0 111.595 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.465 ' HA3' ' SG ' ' A' ' 80' ' ' CYS . . . -165.65 40.02 0.28 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.472 -0.87 . . . . 0.0 114.314 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.858 ' HA ' ' HG3' ' A' ' 48' ' ' GLU . 43.7 tpt85 71.26 127.18 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 172.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.481 HG21 HG13 ' A' ' 56' ' ' ILE . 1.7 mp -82.89 141.31 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.038 0.447 . . . . 0.0 111.432 175.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -90.29 -56.22 3.3 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.309 0.576 . . . . 0.0 109.656 173.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.6 m -150.6 144.02 25.0 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.46 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.512 HG23 HG12 ' A' ' 73' ' ' ILE . 57.3 mt -122.29 109.87 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.023 0.44 . . . . 0.0 110.776 175.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -108.83 112.26 24.42 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.314 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.494 HD22 HD11 ' A' ' 34' ' ' LEU . 32.7 mt -98.69 141.91 30.92 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.81 0.338 . . . . 0.0 110.921 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 64.7 mtp -93.66 103.38 15.54 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.167 0.508 . . . . 0.0 111.488 -176.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.582 ' HG2' ' HA ' ' A' ' 67' ' ' SER . 65.4 mtm -124.57 152.88 42.96 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.984 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.448 ' HB3' ' CA ' ' A' ' 65' ' ' GLY . 11.4 t70 -98.83 114.46 27.05 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 174.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.2 p -75.09 -19.69 59.83 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -172.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -71.04 -68.29 0.45 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.152 0.501 . . . . 0.0 110.713 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.3 t -162.51 11.87 0.07 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.322 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.448 ' CA ' ' HB3' ' A' ' 61' ' ' ASP . . . -89.82 -27.73 20.78 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.558 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.7 mtt-85 61.49 -160.42 0.31 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.981 0.513 . . . . 0.0 111.729 174.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.582 ' HA ' ' HG2' ' A' ' 60' ' ' MET . 60.6 m -56.07 113.13 1.4 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -70.23 -27.05 64.16 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.2 -6.63 19.17 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 120.917 -0.659 . . . . 0.0 114.439 174.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -135.56 151.72 50.58 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 117.376 0.588 . . . . 0.0 112.364 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.7 158.76 27.83 Favored Glycine 0 CA--C 1.527 0.844 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.734 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -101.51 120.44 40.3 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.601 -0.352 . . . . 0.0 111.603 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.512 HG12 HG23 ' A' ' 56' ' ' ILE . 70.9 mt -103.9 117.11 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.278 0.561 . . . . 0.0 111.249 178.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 51.9 m -99.85 125.71 45.85 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.68 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -103.3 150.44 23.75 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.782 175.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.8 t -72.92 -11.87 60.74 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.683 0.278 . . . . 0.0 111.65 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -126.24 144.38 50.8 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.852 0.358 . . . . 0.0 110.986 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 54.5 m -78.78 -43.67 24.94 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -69.69 -34.9 74.58 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.826 0.346 . . . . 0.0 111.508 -175.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.465 ' SG ' ' HA3' ' A' ' 51' ' ' GLY . 35.8 t -60.04 -43.39 95.36 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.068 0.461 . . . . 0.0 111.081 174.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.39 -40.97 96.84 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.01 176.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -56.67 -46.44 81.1 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.965 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 86.8 tttt -62.03 -54.04 47.06 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.288 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.92 -52.12 61.58 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.894 0.378 . . . . 0.0 111.836 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.9 tt -53.87 -54.6 36.29 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.621 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -64.67 -25.14 67.82 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -173.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 83' ' ' LYS . 8.3 mm-40 -95.72 -17.79 20.98 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.473 ' HB3' ' SD ' ' A' ' 98' ' ' MET . 90.2 mt -112.2 -24.53 9.79 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -175.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -60.03 101.41 0.12 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.169 0.509 . . . . 0.0 111.534 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.65 -15.98 9.69 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 116.063 -0.517 . . . . 0.0 113.013 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -63.41 129.98 42.53 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 122.658 -0.319 . . . . 0.0 111.784 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -65.86 94.31 0.21 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.993 0.425 . . . . 0.0 111.18 175.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 66.9 tp -86.75 115.25 24.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.426 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 55.92 22.35 5.65 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 109.26 -9.41 33.32 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 114.098 0.399 . . . . 0.0 114.098 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -130.93 134.89 26.51 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 117.405 0.603 . . . . 0.0 110.78 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.66 149.42 13.87 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.819 2.346 . . . . 0.0 113.26 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.555 ' HA ' ' HB2' ' A' ' 33' ' ' SER . 43.9 ttm -96.85 104.78 16.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.234 0.54 . . . . 0.0 109.906 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.414 ' NZ ' ' HB3' ' A' ' 99' ' ' LYS . 2.0 mmmp? -87.84 89.9 8.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.708 -175.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 20.4 t -105.2 117.82 51.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.089 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -148.14 162.15 28.73 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.208 -0.52 . . . . 0.0 113.053 -176.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -64.18 158.9 21.82 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.305 0.574 . . . . 0.0 111.552 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 103' ' ' VAL . 12.1 t -91.12 11.39 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 121.668 0.747 . . . . 0.0 109.846 177.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 34.4 m 78.1 -19.7 0.42 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.032 0.933 . . . . 0.0 111.281 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 61.68 136.74 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.699 0.8 . . . . 0.0 112.961 176.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -76.3 65.92 2.3 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.337 0.589 . . . . 0.0 112.123 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.7 m -157.18 132.52 9.11 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.101 175.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 C--O 1.254 1.333 0 CA-C-O 118.572 -0.728 . . . . 0.0 112.342 -179.402 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.465 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.575 0.226 . . . . 0.0 111.124 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -114.56 -52.93 0.43 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.326 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -62.26 105.17 0.57 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.784 0.326 . . . . 0.0 110.619 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -75.36 -61.36 1.93 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -173.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -161.47 -56.15 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -77.46 98.65 5.37 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.053 0.454 . . . . 0.0 111.475 -175.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -135.35 15.74 3.45 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.507 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -98.81 24.32 7.77 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 120.857 0.36 . . . . 0.0 111.265 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.9 p -130.39 -83.68 0.54 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 55.44 38.63 30.54 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 121.557 0.694 . . . . 0.0 111.158 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 83.2 mtp -96.63 99.18 10.82 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.563 -176.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.04 -29.54 15.15 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.059 0.456 . . . . 0.0 111.393 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.39 25.43 0.74 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.163 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -119.82 131.13 55.21 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.657 0.265 . . . . 0.0 111.158 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.2 mtt -85.27 -99.37 0.06 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.231 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 67.87 -24.9 0.12 Allowed 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 175.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -54.76 127.87 30.27 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.399 0.619 . . . . 0.0 112.237 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -81.34 21.49 0.76 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.609 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.0 tp -67.51 -22.87 65.42 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.411 0.624 . . . . 0.0 110.651 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -95.11 12.34 29.03 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.491 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 84.4 tttt 63.97 109.09 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.076 0.551 . . . . 0.0 111.23 -174.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.4 173.47 22.66 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.959 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.9 p -90.32 163.62 14.66 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.196 0.522 . . . . 0.0 111.674 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.35 -58.41 3.29 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.178 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.587 ' N ' ' HD2' ' A' ' 26' ' ' PRO . . . 143.47 -43.36 1.02 Allowed Glycine 0 CA--C 1.543 1.798 0 CA-C-O 119.074 -0.848 . . . . 0.0 115.198 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.701 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 14.4 Cg_exo -26.29 112.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.363 1.317 0 C-N-CA 124.782 3.655 . . . . 0.0 116.619 -176.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.9 ttt -139.46 138.22 36.24 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.46 170.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 28' ' ' ARG . 62.8 mtt-85 -99.74 143.6 29.78 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.422 0.629 . . . . 0.0 112.483 -177.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.0 mt -112.44 139.16 48.24 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.28 177.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -90.71 108.8 20.06 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.769 176.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.35 104.41 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.674 0.273 . . . . 0.0 111.201 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.533 ' HA2' ' HB3' ' A' ' 70' ' ' TYR . . . -114.64 91.68 0.57 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.201 -0.523 . . . . 0.0 113.945 -177.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 t -175.15 21.13 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.433 0.635 . . . . 0.0 111.174 175.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.485 HD22 HG21 ' A' ' 38' ' ' ILE . 13.1 mt -85.02 93.13 8.52 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.869 -0.52 . . . . 0.0 110.945 -173.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -81.44 62.1 5.18 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.293 0.568 . . . . 0.0 112.531 -174.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 62.0 t80 59.61 9.22 1.49 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 173.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -130.95 4.95 4.51 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.61 -0.681 . . . . 0.0 111.502 -178.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.55 HG23 ' SD ' ' A' ' 42' ' ' MET . 27.1 mm -105.25 127.98 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 122.111 -0.368 . . . . 0.0 110.81 -177.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.6 p -107.23 167.3 10.01 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.936 0.398 . . . . 0.0 111.788 -176.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -55.21 -44.5 75.42 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.125 0.488 . . . . 0.0 110.878 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -68.03 -31.63 71.43 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.184 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.55 ' SD ' HG23 ' A' ' 38' ' ' ILE . 52.5 ttm -62.14 -50.21 72.77 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.406 0.622 . . . . 0.0 109.887 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.42 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 48.9 mt -57.14 -44.15 83.13 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.495 173.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -53.27 -47.35 69.21 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.078 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.74 -29.49 74.06 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.306 -0.473 . . . . 0.0 113.387 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.1 mt -84.59 -44.06 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 O-C-N 122.386 -0.479 . . . . 0.0 112.158 178.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.42 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 38.9 m-85 -85.64 -29.12 24.29 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -171.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -52.81 -47.33 95.21 Favored Pre-proline 0 N--CA 1.486 1.334 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -49.93 -18.22 2.83 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 122.801 2.334 . . . . 0.0 114.919 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.489 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 79.3 m-85 -78.69 -70.48 0.49 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.431 ' N ' ' SG ' ' A' ' 80' ' ' CYS . . . -157.95 24.25 0.4 Allowed Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.713 -177.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 68.88 144.9 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.502 ' N ' HD12 ' A' ' 53' ' ' ILE . 4.0 mp -107.22 139.72 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.45 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -78.32 -48.37 15.78 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.434 0.635 . . . . 0.0 110.937 175.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 61.3 m -151.2 132.28 14.35 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.66 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.477 HG23 HG12 ' A' ' 73' ' ' ILE . 54.6 mt -106.45 129.05 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 173.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -130.41 134.44 47.14 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.851 0.358 . . . . 0.0 111.658 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 76.1 mt -98.72 144.02 28.44 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.81 0.338 . . . . 0.0 110.623 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 10.0 tpt -94.08 116.15 28.54 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.315 0.579 . . . . 0.0 111.227 -176.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.0 mtt -111.61 173.83 6.16 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.375 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.498 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 23.6 t70 -81.47 118.76 22.98 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.79 0.328 . . . . 0.0 110.782 177.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.0 t -61.28 -9.78 5.74 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -174.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -102.52 -66.18 0.94 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.009 0.433 . . . . 0.0 111.698 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.472 ' OG1' ' HG2' ' A' ' 66' ' ' ARG . 57.2 p -96.18 -14.63 22.62 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -173.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.96 18.28 63.54 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 120.877 -0.678 . . . . 0.0 113.573 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.472 ' HG2' ' OG1' ' A' ' 64' ' ' THR . 11.1 mmm180 -68.21 170.03 9.35 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.255 0.55 . . . . 0.0 111.876 177.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.8 m -89.48 124.73 34.76 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.76 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.498 ' HE2' ' HA ' ' A' ' 61' ' ' ASP . 73.6 mmtt -79.99 -23.76 41.33 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 122.076 -0.39 . . . . 0.0 111.89 177.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.76 5.24 63.05 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.589 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.533 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 2.2 p90 -141.45 158.98 43.16 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.034 0.445 . . . . 0.0 111.851 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.47 161.25 28.9 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 116.256 -0.429 . . . . 0.0 113.04 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -109.15 123.08 48.63 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.169 0.509 . . . . 0.0 111.738 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.477 HG12 HG23 ' A' ' 56' ' ' ILE . 78.4 mt -107.69 122.27 61.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 178.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.452 ' O ' HG23 ' A' ' 53' ' ' ILE . 28.2 m -99.57 115.38 29.24 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -175.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.701 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 40.9 m-85 -97.66 141.41 30.72 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.59 0.233 . . . . 0.0 111.437 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.9 t -73.75 -3.3 27.58 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.377 176.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' A' ' 80' ' ' CYS . 11.2 t70 -132.95 121.03 22.2 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.787 0.327 . . . . 0.0 110.687 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.2 p -60.19 -51.81 67.98 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.12 -36.77 85.11 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.773 0.32 . . . . 0.0 110.993 -177.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.575 ' HB3' ' HB3' ' A' ' 77' ' ' ASP . 25.0 t -63.08 -40.75 98.57 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.797 0.332 . . . . 0.0 111.362 175.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.517 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -63.86 -47.6 80.07 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.317 0.58 . . . . 0.0 110.551 175.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -57.44 -42.11 81.8 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.655 176.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -66.87 -49.58 65.23 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.817 0.341 . . . . 0.0 111.182 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.66 -44.45 69.66 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.204 0.526 . . . . 0.0 110.662 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.431 HD23 ' C ' ' A' ' 85' ' ' LEU . 7.1 tt -56.96 -58.5 7.87 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.686 175.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -61.31 -25.88 67.42 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -174.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.16 -46.16 9.02 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.805 0.336 . . . . 0.0 111.754 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 70.7 mt -89.81 -9.3 49.7 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -169.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -67.78 82.27 0.19 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.446 0.641 . . . . 0.0 110.826 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 142.7 -21.2 2.36 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.606 -175.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -48.92 119.51 3.24 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.221 0.608 . . . . 0.0 111.52 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -69.37 93.6 0.66 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.27 0.557 . . . . 0.0 110.995 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.438 HD21 HG21 ' A' ' 38' ' ' ILE . 51.2 tp -85.46 111.59 20.11 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.223 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 63.02 2.78 1.09 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 126.69 -7.82 7.36 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.524 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -122.79 130.29 24.68 Favored Pre-proline 0 N--CA 1.47 0.555 0 CA-C-N 117.01 0.405 . . . . 0.0 110.906 176.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.55 136.51 41.07 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.427 2.085 . . . . 0.0 112.016 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 51.3 ttp -95.96 116.42 28.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.43 0.633 . . . . 0.0 111.077 -172.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -88.29 92.51 9.19 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.079 -176.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.7 t -99.83 107.31 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.642 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -134.95 161.22 24.53 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.569 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -56.71 143.48 36.29 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.479 -0.424 . . . . 0.0 111.908 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 49.0 t -51.85 -31.81 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 120.961 0.41 . . . . 0.0 111.893 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 91.5 m -51.2 120.9 5.42 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.089 174.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -71.31 76.92 0.74 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.249 0.547 . . . . 0.0 111.926 -177.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 44.36 -102.03 0.05 Allowed 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.908 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.9 m 70.25 -35.45 0.32 Allowed 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -177.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 . . . . . 0 C--O 1.253 1.264 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.792 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.509 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 120.869 0.366 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -109.5 -97.72 2.48 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 116.396 -0.366 . . . . 0.0 113.288 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.7 p-80 49.36 101.85 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.11 0.964 . . . . 0.0 113.011 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 77.5 m80 61.03 31.11 19.87 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.133 0.492 . . . . 0.0 111.069 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -82.55 -3.13 55.51 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -171.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -106.45 -30.52 9.04 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.856 0.36 . . . . 0.0 111.598 176.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -78.76 129.4 34.6 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.999 0.428 . . . . 0.0 111.791 -175.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -66.61 91.49 0.19 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.047 0.451 . . . . 0.0 111.501 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.0 t -166.44 175.92 7.78 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -141.7 158.97 43.16 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.735 0.302 . . . . 0.0 111.086 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -65.37 -28.06 69.01 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -174.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.85 -57.88 3.23 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.713 0.292 . . . . 0.0 111.294 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 68.15 -68.27 0.17 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 176.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.51 -61.41 1.93 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.94 36.33 2.8 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -175.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.36 103.84 0.27 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 120.874 0.368 . . . . 0.0 111.979 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -110.57 -49.11 3.08 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -23.15 106.42 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -172.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.4 mt -80.06 9.69 5.2 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -175.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 64.55 -164.73 0.25 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.1 mttt 69.35 -71.44 0.12 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.587 0.755 . . . . 0.0 112.478 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.37 -120.7 0.61 Allowed Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.587 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 84.8 p 57.02 23.72 8.69 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.466 0.707 . . . . 0.0 112.787 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -147.2 175.82 10.45 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.55 -58.82 9.26 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 116.194 -0.457 . . . . 0.0 113.562 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -49.53 118.59 3.82 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.831 2.354 . . . . 0.0 112.646 176.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 28.1 ttt -112.9 123.11 49.57 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.039 0.447 . . . . 0.0 111.268 -173.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.471 ' HD2' ' HB3' ' A' ' 72' ' ' PHE . 47.7 ttp180 -102.82 136.61 42.31 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.032 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.0 mt -107.51 148.59 29.01 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.233 0.54 . . . . 0.0 112.299 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -95.64 112.33 24.07 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.769 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.4 t -108.91 99.47 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.092 0.472 . . . . 0.0 111.207 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.78 89.13 0.84 Allowed Glycine 0 CA--C 1.524 0.642 0 C-N-CA 121.186 -0.53 . . . . 0.0 113.129 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.0 t -172.44 25.84 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.158 0.504 . . . . 0.0 111.107 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.407 HD22 ' HB ' ' A' ' 38' ' ' ILE . 62.4 mt -72.26 103.56 3.41 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.776 -0.578 . . . . 0.0 110.522 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -79.38 35.9 0.29 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 63.58 13.67 7.46 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 176.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -148.52 11.05 0.87 Allowed 'General case' 0 N--CA 1.473 0.725 0 O-C-N 122.065 -0.397 . . . . 0.0 111.692 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.545 HG23 ' SD ' ' A' ' 42' ' ' MET . 30.8 mm -83.33 140.11 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.639 0.256 . . . . 0.0 110.749 -178.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 79.1 p -116.8 161.27 19.54 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -55.41 -40.34 71.34 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.216 177.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -65.04 -39.55 93.49 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.533 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.545 ' SD ' HG23 ' A' ' 38' ' ' ILE . 50.5 ttm -61.83 -52.29 64.76 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.326 0.584 . . . . 0.0 110.525 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.448 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 55.8 mt -55.47 -53.64 53.75 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.2 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.504 ' HB2' HD11 ' A' ' 56' ' ' ILE . 53.0 ttt180 -54.36 -46.88 73.09 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.404 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.61 -31.02 69.84 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 116.288 -0.414 . . . . 0.0 113.447 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 68.7 mt -85.18 -37.6 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 O-C-N 122.504 -0.41 . . . . 0.0 112.08 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.448 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 37.8 m-85 -85.38 -30.1 23.9 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -174.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -58.27 -39.89 78.86 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -45.69 -15.34 0.13 Allowed 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 122.112 1.875 . . . . 0.0 114.253 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -103.97 -23.11 13.37 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.438 ' HA3' ' HB2' ' A' ' 80' ' ' CYS . . . -174.57 -128.6 1.1 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.275 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -151.82 124.94 8.67 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 122.402 -0.47 . . . . 0.0 110.358 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.505 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.5 mp -86.7 138.5 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.412 -178.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -83.98 -54.74 4.64 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.895 0.379 . . . . 0.0 111.186 175.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.4 m -141.92 138.53 32.08 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.88 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.533 HG23 HG12 ' A' ' 73' ' ' ILE . 65.3 mt -108.11 112.2 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.807 0.337 . . . . 0.0 110.918 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -105.81 129.02 54.08 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.924 0.392 . . . . 0.0 110.758 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 58' ' ' LEU . 6.6 mp -111.33 148.72 32.35 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.149 -0.345 . . . . 0.0 110.505 175.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 96.0 mmm -92.14 104.53 16.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.292 0.568 . . . . 0.0 110.145 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 73.7 mtm -118.99 159.37 23.96 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.277 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -51.98 -21.82 3.42 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.223 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.3 m 75.24 -37.02 0.32 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 176.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -84.97 -67.64 0.78 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.198 0.523 . . . . 0.0 109.798 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.7 p -72.12 -33.78 68.08 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.419 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.45 23.28 26.91 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 115.524 -0.762 . . . . 0.0 113.378 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -85.86 161.29 19.16 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 122.709 -0.289 . . . . 0.0 110.993 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.3 t -82.94 141.49 32.11 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -176.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -91.53 -3.35 56.61 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.341 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.49 -6.13 65.26 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.044 -0.598 . . . . 0.0 114.552 175.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -143.9 155.97 44.28 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 117.453 0.627 . . . . 0.0 112.054 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -145.46 160.77 28.14 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.23 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.471 ' HB3' ' HD2' ' A' ' 28' ' ' ARG . 96.9 m-85 -119.12 116.54 26.58 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.26 0.552 . . . . 0.0 111.888 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.533 HG12 HG23 ' A' ' 56' ' ' ILE . 70.5 mt -104.13 126.7 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.669 -177.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.7 m -99.27 117.47 33.8 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -99.03 150.52 21.91 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.991 0.424 . . . . 0.0 111.569 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.2 t -80.92 -2.35 47.28 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.145 0.498 . . . . 0.0 111.458 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.547 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 29.3 t70 -142.52 143.86 32.7 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.12 0.486 . . . . 0.0 111.219 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.8 t -75.15 -42.93 55.07 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.849 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.51 -47.53 85.18 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -177.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.547 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 30.8 p -60.04 -40.81 90.67 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.996 0.427 . . . . 0.0 111.333 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.09 -45.94 83.14 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.253 0.549 . . . . 0.0 111.003 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -60.47 -38.64 84.86 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.053 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -67.86 -42.06 81.92 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.536 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.22 -49.71 76.52 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.106 176.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.48 HD23 ' C ' ' A' ' 85' ' ' LEU . 7.0 tt -53.89 -54.9 32.21 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.211 0.529 . . . . 0.0 110.205 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -47.15 -39.74 14.25 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.482 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -97.62 -33.48 11.31 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -174.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 92.6 mt -92.83 -15.54 26.37 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -173.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -67.0 93.64 0.29 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.23 0.538 . . . . 0.0 109.974 176.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.9 10.78 15.39 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.334 -174.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -77.54 133.76 38.44 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.518 0.327 . . . . 0.0 111.306 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -75.76 88.17 2.8 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.156 0.503 . . . . 0.0 111.762 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.1 tp -90.42 125.9 35.71 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.58 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 55.75 26.79 9.87 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.157 0.503 . . . . 0.0 111.541 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.8 15.59 72.56 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 116.128 -0.487 . . . . 0.0 113.38 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 30.5 mtp180 -139.13 144.31 40.25 Favored Pre-proline 0 N--CA 1.472 0.641 0 O-C-N 122.604 -0.35 . . . . 0.0 111.743 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.67 138.0 83.99 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.379 2.719 . . . . 0.0 114.118 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 47.0 ttm -99.37 114.84 27.96 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.031 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -89.25 101.34 14.01 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 122.068 -0.395 . . . . 0.0 111.409 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.6 t -108.04 117.27 53.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.071 0.463 . . . . 0.0 112.064 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.55 160.87 12.91 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.523 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -95.11 37.21 1.17 Allowed 'General case' 0 N--CA 1.479 0.978 0 O-C-N 122.147 -0.62 . . . . 0.0 112.327 -174.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.419 ' C ' ' H ' ' A' ' 105' ' ' GLU . 23.3 m 44.44 -174.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.639 0.776 . . . . 0.0 112.627 -172.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.8 m 71.66 -39.46 0.45 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 120.916 0.389 . . . . 0.0 110.823 -172.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.419 ' H ' ' C ' ' A' ' 103' ' ' VAL . 39.8 mt-10 -58.71 89.27 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.202 0.601 . . . . 0.0 111.51 176.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.26 -8.13 3.37 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.556 175.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 43.5 p -101.42 175.64 5.5 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.333 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.623 -0.703 . . . . 0.0 111.991 178.508 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mpp? . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.829 0.347 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.3 148.37 45.6 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.279 174.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -70.09 81.37 0.5 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.451 0.643 . . . . 0.0 111.384 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -66.51 108.94 2.58 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.883 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -98.33 -40.67 8.21 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.186 0.517 . . . . 0.0 110.786 176.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -102.4 159.55 15.32 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.573 -177.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 47.7 m80 -94.06 162.11 14.01 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.958 0.408 . . . . 0.0 111.741 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -76.89 -16.45 59.39 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -172.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 94.3 p -57.46 105.86 0.28 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.951 0.405 . . . . 0.0 111.995 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.62 ' HB3' ' SD ' ' A' ' 11' ' ' MET . 85.0 m-70 -138.53 -92.58 0.2 Allowed 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 177.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.62 ' SD ' ' HB3' ' A' ' 10' ' ' HIS . 2.1 mpt? -132.44 -175.15 3.66 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.171 0.51 . . . . 0.0 111.452 -177.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.67 118.83 11.47 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.018 176.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 59.51 29.35 18.91 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.454 ' HB2' ' HB2' ' A' ' 11' ' ' MET . . . -85.53 26.25 0.96 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.0 ttt -83.41 -1.68 54.02 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.277 0.561 . . . . 0.0 111.207 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.89 125.9 35.89 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.364 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -66.39 110.76 3.22 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.887 0.375 . . . . 0.0 111.437 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 17.1 m120 64.48 -86.54 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.832 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 7.3 tt 167.69 -56.44 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -176.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 44.17 104.61 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 177.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -71.83 90.6 1.11 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.884 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.59 -168.36 51.31 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.381 -0.438 . . . . 0.0 112.572 -176.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.2 t -65.03 128.11 34.4 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.462 -0.434 . . . . 0.0 111.077 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -151.47 134.3 15.69 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.117 0.484 . . . . 0.0 112.035 -177.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.7 65.44 0.83 Allowed Glycine 0 CA--C 1.532 1.139 0 CA-C-N 116.063 -0.517 . . . . 0.0 113.556 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -81.17 118.37 3.31 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.538 2.159 . . . . 0.0 112.217 176.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.489 ' HB2' ' HA ' ' A' ' 78' ' ' SER . 21.6 ttt -104.92 138.93 40.41 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.79 0.329 . . . . 0.0 111.226 -176.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -108.13 126.99 53.4 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.881 0.372 . . . . 0.0 111.524 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 75.2 mt -105.5 140.8 38.04 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.196 0.522 . . . . 0.0 111.779 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.405 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 48.4 t80 -95.17 115.21 27.13 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.152 173.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.7 t -109.26 101.22 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.054 0.454 . . . . 0.0 111.595 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 70' ' ' TYR . . . -101.62 89.06 0.74 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.77 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.8 t -174.69 22.08 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.112 0.482 . . . . 0.0 111.353 178.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.495 HD21 HD21 ' A' ' 43' ' ' LEU . 14.6 mt -77.93 70.5 4.31 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.765 0.793 . . . . 0.0 110.222 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -66.06 78.97 0.09 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.014 -0.994 . . . . 0.0 113.036 -175.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.6 t80 45.99 38.71 4.87 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 121.287 0.565 . . . . 0.0 112.443 171.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -166.62 -41.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.7 mm -73.69 103.21 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 121.073 0.463 . . . . 0.0 112.059 -173.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.8 p -93.23 173.89 7.49 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.43 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.473 ' HA ' HD12 ' A' ' 43' ' ' LEU . 25.3 mt-10 -51.1 -39.45 56.16 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.695 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.06 -48.73 80.5 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.553 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.4 mmt -63.42 -40.68 97.83 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.961 0.41 . . . . 0.0 110.762 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.495 HD21 HD21 ' A' ' 34' ' ' LEU . 77.0 mt -57.04 -44.68 83.17 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.429 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -60.93 -47.12 87.88 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.999 0.428 . . . . 0.0 111.099 174.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.42 -32.32 64.13 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.579 -178.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.7 mt -86.49 -50.93 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 121.099 0.475 . . . . 0.0 112.208 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 75' ' ' PHE . 42.5 m-85 -85.29 -40.55 16.45 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -171.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -58.6 -37.57 55.76 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -175.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -51.98 -12.7 1.43 Allowed 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 122.217 1.945 . . . . 0.0 114.088 171.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -91.49 -31.26 16.03 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.108 0.48 . . . . 0.0 111.052 173.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.433 ' HA3' ' HB3' ' A' ' 80' ' ' CYS . . . -178.85 134.66 2.39 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.461 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.04 129.97 18.14 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.095 0.474 . . . . 0.0 111.698 -178.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.9 mt -95.34 128.72 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.076 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.425 ' HG2' ' OG ' ' A' ' 76' ' ' SER . 14.7 mm-40 -73.11 -57.43 4.03 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.972 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.9 t -151.76 148.99 28.53 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.716 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.433 HG12 HG23 ' A' ' 73' ' ' ILE . 45.6 mt -120.84 140.46 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.599 175.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -122.65 110.07 15.07 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.447 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.54 HD22 ' HG3' ' A' ' 60' ' ' MET . 3.4 tt -98.39 129.51 45.03 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -177.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.421 ' N ' HD23 ' A' ' 58' ' ' LEU . 55.0 mtp -93.61 94.78 8.81 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.676 0.75 . . . . 0.0 112.452 -174.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.54 ' HG3' HD22 ' A' ' 58' ' ' LEU . 65.3 mtt -112.16 146.49 37.99 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.079 171.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -63.98 101.51 0.4 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.655 0.264 . . . . 0.0 111.403 176.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.8 m -63.29 -5.17 3.12 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.933 0.396 . . . . 0.0 111.751 176.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -81.49 -58.58 2.96 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.336 0.588 . . . . 0.0 111.081 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.6 p -102.65 -31.63 10.28 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.156 -176.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.67 26.93 8.26 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 116.301 -0.409 . . . . 0.0 112.698 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.0 mmm180 -98.06 156.5 16.62 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.089 0.471 . . . . 0.0 112.014 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.7 m -95.41 114.62 26.41 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.867 -177.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -76.06 -11.78 60.0 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 178.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.24 15.17 57.81 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.454 0.942 . . . . 0.0 115.454 169.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.439 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 3.2 p90 -147.36 152.75 38.71 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.167 0.984 . . . . 0.0 112.754 177.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.81 160.58 28.68 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 115.496 -0.775 . . . . 0.0 113.059 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -108.77 126.41 52.99 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 122.579 -0.365 . . . . 0.0 111.463 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.433 HG23 HG12 ' A' ' 56' ' ' ILE . 69.9 mt -112.31 131.36 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.806 0.336 . . . . 0.0 111.598 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 91.9 m -108.36 120.06 41.29 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 120.683 0.278 . . . . 0.0 111.537 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 47' ' ' PHE . 34.4 m-85 -98.94 150.19 22.19 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.731 0.301 . . . . 0.0 111.261 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.425 ' OG ' ' HG2' ' A' ' 54' ' ' GLU . 13.3 m -75.98 10.8 1.69 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -153.79 146.01 23.82 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.815 0.341 . . . . 0.0 110.779 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.489 ' HA ' ' HB2' ' A' ' 27' ' ' MET . 31.3 t -75.07 -48.09 25.62 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.866 0.365 . . . . 0.0 111.984 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -71.1 -31.16 67.44 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 122.274 -0.266 . . . . 0.0 111.49 -175.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.433 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . 93.2 m -59.85 -46.57 88.86 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.851 0.357 . . . . 0.0 111.2 174.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.69 -44.49 77.62 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.038 0.447 . . . . 0.0 110.868 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 39.4 ttmt -54.28 -47.03 72.82 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.304 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -67.58 -42.95 81.72 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.491 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.07 -45.43 71.73 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.079 0.466 . . . . 0.0 110.988 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 tt -57.48 -52.81 63.88 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.624 176.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 82' ' ' LYS . 47.8 mm-40 -56.07 -35.84 67.43 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -177.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -87.7 -36.4 17.42 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -174.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 80.7 mt -95.88 -15.1 22.66 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -173.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -64.01 104.91 0.77 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.943 0.401 . . . . 0.0 110.127 174.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.95 16.91 42.79 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.88 -176.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -77.28 133.92 38.69 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.428 0.291 . . . . 0.0 111.201 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.32 92.88 5.21 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.5 tp -100.03 126.39 46.22 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 122.276 -0.265 . . . . 0.0 110.327 175.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 64.75 12.15 7.42 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.859 0.362 . . . . 0.0 111.773 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.89 2.66 58.3 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.515 -0.374 . . . . 0.0 113.409 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -130.77 154.17 81.78 Favored Pre-proline 0 CA--C 1.543 0.708 0 O-C-N 122.46 -0.435 . . . . 0.0 111.032 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.2 151.63 84.82 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.878 2.385 . . . . 0.0 114.414 -174.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 46.2 ttm -109.47 120.45 42.53 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.216 177.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -89.33 99.19 12.23 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.914 0.388 . . . . 0.0 111.668 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.1 t -108.85 116.58 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.246 176.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 30' ' ' TYR . . . -140.41 139.96 10.18 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.394 -0.431 . . . . 0.0 112.667 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -76.26 74.85 3.07 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 122.133 -0.628 . . . . 0.0 111.562 -177.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 103' ' ' VAL . 16.1 t 54.65 37.01 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-O 122.197 0.999 . . . . 0.0 110.129 -178.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.9 m -76.42 -15.18 59.99 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.657 -173.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -62.59 122.9 16.97 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -175.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 32.7 mtp180 57.26 32.07 21.13 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.985 176.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.6 p 59.16 -74.22 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.987 0.915 . . . . 0.0 112.85 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.3 t70 . . . . . 0 C--O 1.255 1.356 0 CA-C-O 119.086 -0.483 . . . . 0.0 111.276 -179.818 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ttt . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 3' ' ' HIS . . . 80.64 -67.35 3.55 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 114.381 0.512 . . . . 0.0 114.381 172.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 2' ' ' GLY . 14.1 m170 73.31 -56.12 0.66 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.2 p-80 -56.65 91.4 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -173.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -132.67 98.61 4.38 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -168.24 66.81 0.07 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.21 0.529 . . . . 0.0 111.012 172.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 41.2 m80 55.91 26.91 10.33 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.101 -175.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 63.82 -72.52 0.05 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.666 -169.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.5 m 48.76 26.98 1.41 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.219 0.533 . . . . 0.0 112.013 177.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.4 t60 -70.75 136.01 48.61 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.557 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.438 ' N ' ' SD ' ' A' ' 11' ' ' MET . 0.0 OUTLIER -56.56 133.32 53.42 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.066 0.46 . . . . 0.0 111.698 -177.935 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.1 -153.05 0.45 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.742 -177.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.5 13.21 3.16 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 177.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.75 146.56 28.05 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.763 0.316 . . . . 0.0 110.9 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.507 ' SD ' HD22 ' A' ' 19' ' ' LEU . 68.1 mtm -92.36 -79.36 0.39 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -172.54 -176.73 1.59 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.407 -176.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 58.9 m-20 -75.55 -37.85 59.71 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.208 0.528 . . . . 0.0 110.461 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.35 132.23 37.37 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.12 176.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.507 HD22 ' SD ' ' A' ' 15' ' ' MET . 57.4 tp -116.36 -56.42 2.3 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.124 0.487 . . . . 0.0 112.306 -174.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -76.7 -44.73 32.36 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.933 0.396 . . . . 0.0 111.745 -175.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -117.25 107.13 14.04 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.096 0.475 . . . . 0.0 111.126 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -133.7 -82.35 0.19 Allowed Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.145 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.1 t 57.0 17.23 3.25 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 175.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.14 25.94 3.07 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.104 -0.373 . . . . 0.0 111.849 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -110.12 101.04 1.36 Allowed Glycine 0 CA--C 1.531 1.09 0 C-N-CA 121.34 -0.457 . . . . 0.0 113.47 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -82.72 168.09 14.38 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.674 2.249 . . . . 0.0 112.222 174.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 28.2 ttt -123.59 122.81 39.12 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.913 0.387 . . . . 0.0 111.317 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 74' ' ' THR . 36.4 ttp-105 -104.34 133.44 49.24 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.106 0.479 . . . . 0.0 111.64 -178.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.541 HD22 HD12 ' A' ' 85' ' ' LEU . 67.2 mt -107.33 140.53 40.1 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.148 0.499 . . . . 0.0 111.817 -177.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -99.02 116.92 32.36 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.805 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.3 t -115.69 130.83 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 120.744 0.307 . . . . 0.0 111.611 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.06 105.52 0.61 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 121.229 -0.51 . . . . 0.0 113.733 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.3 t -175.05 16.27 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.228 0.537 . . . . 0.0 111.689 175.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.526 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 10.7 mt -87.03 87.3 7.42 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.962 -0.461 . . . . 0.0 111.692 -170.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -80.65 60.94 4.16 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.361 0.601 . . . . 0.0 112.075 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.491 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 46.6 t80 57.48 8.96 0.69 Allowed 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 177.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -126.88 -2.8 6.54 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.704 -0.622 . . . . 0.0 111.858 -176.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.524 HD11 ' HB2' ' A' ' 94' ' ' ALA . 17.7 mm -108.76 122.38 63.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 122.185 -0.322 . . . . 0.0 110.636 -178.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.2 p -98.08 161.91 13.48 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.826 0.346 . . . . 0.0 111.886 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 1.8 mp0 -56.28 -35.16 67.16 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.441 0.639 . . . . 0.0 110.033 173.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.93 -39.53 93.65 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.374 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.3 mmt -68.88 -43.87 74.43 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.103 0.478 . . . . 0.0 110.857 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.438 ' HB3' HD11 ' A' ' 73' ' ' ILE . 78.7 mt -56.29 -42.64 77.84 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.141 0.496 . . . . 0.0 110.661 174.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 66.6 ttp85 -60.62 -49.87 75.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.089 176.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.89 -33.53 63.77 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 121.375 -0.44 . . . . 0.0 113.404 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.9 mm -80.6 -40.69 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.456 ' HB2' HD11 ' A' ' 53' ' ' ILE . 26.5 m-85 -85.5 -26.42 26.26 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -175.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 44' ' ' ARG . 1.8 mt-10 -59.2 -38.2 60.92 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -45.88 -20.67 0.78 Allowed 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.171 1.914 . . . . 0.0 113.852 172.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -96.17 -29.56 13.99 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.49 -142.1 3.31 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.831 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 57.8 ttm-85 -103.47 -38.71 7.05 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -177.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.456 HD11 ' HB2' ' A' ' 47' ' ' PHE . 66.1 mt 69.18 107.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.12 0.568 . . . . 0.0 111.351 -172.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -80.89 -41.09 23.62 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.992 0.425 . . . . 0.0 111.379 -176.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 93.3 p -151.34 142.2 22.92 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.866 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.0 mt -123.58 106.19 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 120.873 0.368 . . . . 0.0 110.782 172.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -99.72 110.97 23.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.849 0.356 . . . . 0.0 110.559 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 59' ' ' MET . 6.7 tt -97.99 133.73 42.07 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.43 ' N ' HD23 ' A' ' 58' ' ' LEU . 55.0 mtp -91.93 113.38 25.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.363 0.601 . . . . 0.0 110.566 -176.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -138.44 139.09 38.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.816 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -72.54 83.9 1.12 Allowed 'General case' 0 C--O 1.237 0.435 0 CA-C-O 120.839 0.352 . . . . 0.0 110.41 174.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.7 m -56.2 -15.71 4.22 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -175.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.46 ' O ' ' HB ' ' A' ' 64' ' ' THR . 31.2 mm-40 -53.16 -48.5 67.92 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.234 0.54 . . . . 0.0 109.817 172.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 63' ' ' GLU . 14.0 t 164.4 -4.82 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.768 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.25 -24.39 75.51 Favored Glycine 0 C--N 1.34 0.8 0 C-N-CA 121.24 -0.505 . . . . 0.0 111.985 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 46.9 mtt180 70.43 -158.8 0.14 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 122.723 0.409 . . . . 0.0 112.081 170.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.491 ' HB3' ' HA ' ' A' ' 36' ' ' PHE . 36.0 t -50.68 115.55 1.54 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -174.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -71.36 -30.81 66.6 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.065 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 124.84 -7.4 8.26 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 120.929 -0.653 . . . . 0.0 114.355 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -140.23 152.13 45.72 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 117.45 0.625 . . . . 0.0 112.603 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.02 160.35 28.6 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.812 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -110.7 121.74 46.09 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.547 -0.384 . . . . 0.0 111.477 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.438 HD11 ' HB3' ' A' ' 43' ' ' LEU . 71.8 mt -110.09 119.94 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.966 0.412 . . . . 0.0 111.317 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 45.6 m -100.19 125.55 46.35 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -174.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.42 ' HZ ' ' HB3' ' A' ' 47' ' ' PHE . 82.8 m-85 -106.24 144.86 32.33 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.033 173.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.7 t -69.14 -32.66 72.18 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.103 0.478 . . . . 0.0 110.806 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -108.28 132.52 53.6 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.36 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.4 t -71.21 -35.42 71.52 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -67.29 -44.82 78.31 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.096 0.474 . . . . 0.0 110.832 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 67.4 m -60.46 -36.3 77.92 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.029 0.443 . . . . 0.0 110.751 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.49 -44.63 82.11 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.505 176.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -60.64 -47.27 86.97 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.878 0.37 . . . . 0.0 111.514 176.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.32 -43.08 88.02 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.205 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.6 -53.2 55.39 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.018 0.437 . . . . 0.0 111.112 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.56 ' HA ' HG11 ' A' ' 100' ' ' VAL . 9.8 tt -53.47 -53.5 50.59 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.456 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.56 -34.64 78.34 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -174.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -88.12 -24.76 23.28 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 89.8 mt -95.36 -13.8 24.42 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -56.52 101.88 0.07 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.241 0.543 . . . . 0.0 110.582 168.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.77 30.56 11.32 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.027 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.422 ' H ' ' HB3' ' A' ' 98' ' ' MET . 84.5 t80 -92.44 103.98 16.35 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.752 0.31 . . . . 0.0 110.484 173.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -71.01 85.57 0.71 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.395 0.617 . . . . 0.0 111.571 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 61.1 tp -74.57 -68.29 0.55 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.3 0.571 . . . . 0.0 110.907 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.524 ' HB2' HD11 ' A' ' 38' ' ' ILE . . . -86.56 38.17 0.77 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.336 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.19 21.81 66.5 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.22 -173.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 28.4 mtp-105 -139.28 141.74 30.26 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 122.86 0.464 . . . . 0.0 110.553 -175.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -52.97 142.01 54.59 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.265 2.644 . . . . 0.0 113.823 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.422 ' HB3' ' H ' ' A' ' 91' ' ' PHE . 52.0 tpp -98.9 123.02 42.89 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.984 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -99.92 102.21 13.54 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 122.398 -0.189 . . . . 0.0 110.661 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.56 HG11 ' HA ' ' A' ' 85' ' ' LEU . 26.5 t -118.66 108.24 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.011 0.434 . . . . 0.0 111.626 -178.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -129.06 154.18 20.15 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.005 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -70.48 147.32 49.53 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 122.213 -0.58 . . . . 0.0 110.902 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 28.1 m -62.38 137.65 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 120.95 0.405 . . . . 0.0 111.027 175.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 56.4 p -78.77 138.9 38.44 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.686 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -162.26 -90.13 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 106' ' ' ARG . 14.3 ttt-85 -139.34 8.44 2.44 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.443 0.64 . . . . 0.0 110.5 176.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.7 p -84.94 -20.12 31.14 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.911 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 C--O 1.252 1.2 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.4 -176.286 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.545 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.747 0.308 . . . . 0.0 111.064 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 135.84 -139.0 10.36 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.505 -0.378 . . . . 0.0 112.293 -178.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.53 134.27 54.08 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.997 0.427 . . . . 0.0 112.083 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -91.3 154.58 19.15 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.009 0.433 . . . . 0.0 111.08 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -78.69 134.38 37.11 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -173.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -167.1 140.89 3.71 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.68 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -70.51 8.33 0.85 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.2 t60 65.44 48.49 2.05 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.245 0.545 . . . . 0.0 111.32 175.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.5 t -79.62 104.26 10.09 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 175.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -67.71 88.04 0.23 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.5 mmt -128.87 22.19 5.82 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.114 177.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.57 52.09 2.0 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -176.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.8 -17.41 23.14 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.71 -21.47 66.53 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 178.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.1 mmt 64.98 -77.55 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.278 0.631 . . . . 0.0 112.488 177.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.73 133.3 51.79 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -159.61 155.01 25.49 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.886 0.374 . . . . 0.0 111.235 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -91.59 95.23 9.81 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.736 0.303 . . . . 0.0 111.021 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 47.0 tp -76.2 -45.35 33.62 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.374 0.607 . . . . 0.0 110.26 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -97.65 54.68 1.18 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.4 0.619 . . . . 0.0 110.802 176.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -57.61 102.3 0.09 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.577 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.08 -7.92 75.82 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.378 -0.439 . . . . 0.0 113.322 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 63.8 m 64.28 134.25 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.413 0.625 . . . . 0.0 112.565 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.11 -27.74 29.96 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.019 0.437 . . . . 0.0 110.774 172.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -129.55 160.75 22.76 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.695 176.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.54 146.01 30.3 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.825 2.35 . . . . 0.0 113.554 -178.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 14.2 tpt -104.08 122.57 45.55 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.256 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -99.47 139.87 34.49 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.81 0.338 . . . . 0.0 111.358 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.0 mt -121.0 129.65 53.48 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.135 0.493 . . . . 0.0 111.406 176.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -91.58 112.83 24.9 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.393 175.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.7 t -103.67 99.76 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.011 0.434 . . . . 0.0 110.745 176.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.8 89.2 0.6 Allowed Glycine 0 CA--C 1.521 0.426 0 C-N-CA 121.003 -0.618 . . . . 0.0 113.107 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.42 ' CB ' ' HA ' ' A' ' 98' ' ' MET . 25.0 t -175.08 25.79 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.464 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 41.9 mt -69.41 107.4 3.31 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.362 -0.836 . . . . 0.0 109.499 176.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.538 ' CE1' ' HB3' ' A' ' 96' ' ' ARG . 14.0 m80 -78.5 44.78 0.53 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -173.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.54 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 94.4 m-85 60.83 16.79 7.13 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.786 0.434 . . . . 0.0 111.988 -177.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -146.09 -33.52 0.32 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.6 mm -60.9 131.81 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.985 0.422 . . . . 0.0 111.788 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 74.7 p -116.63 169.57 9.25 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.048 0.452 . . . . 0.0 111.756 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.494 ' H ' HD11 ' A' ' 58' ' ' LEU . 2.3 pt-20 -61.73 -28.12 69.2 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.852 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -60.84 -40.0 91.17 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.937 0.399 . . . . 0.0 111.53 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.8 mtt -65.66 -53.66 38.18 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.255 0.55 . . . . 0.0 110.417 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.43 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 43.6 mt -56.15 -55.06 37.68 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.052 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 80.0 ttt180 -49.01 -46.78 44.54 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.576 176.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.46 -33.39 81.14 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 121.325 -0.464 . . . . 0.0 113.844 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 59.6 mt -86.3 -40.16 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.43 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 54.1 m-85 -77.73 -31.78 52.4 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.504 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 2.8 tm-20 -52.18 -48.6 88.42 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 90.5 Cg_exo -45.6 -28.81 4.64 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 122.538 2.159 . . . . 0.0 113.963 175.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -83.72 -47.97 10.63 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.907 0.384 . . . . 0.0 111.365 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.32 149.0 13.25 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 112.043 -0.423 . . . . 0.0 112.043 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.73 115.38 5.82 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.856 0.36 . . . . 0.0 110.793 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.513 ' H ' HD12 ' A' ' 53' ' ' ILE . 3.6 mp -66.97 138.55 22.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 120.939 0.399 . . . . 0.0 112.03 -178.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -80.3 -55.65 4.76 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.09 0.472 . . . . 0.0 110.817 173.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.5 p -151.33 140.72 21.47 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.78 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.484 HG13 HG21 ' A' ' 53' ' ' ILE . 49.2 mt -116.77 140.48 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 120.948 0.404 . . . . 0.0 110.511 172.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -129.37 121.22 26.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.185 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.494 HD11 ' H ' ' A' ' 40' ' ' GLU . 70.4 mt -96.68 130.49 43.9 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.724 0.297 . . . . 0.0 110.292 173.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 92.3 mmm -93.13 101.37 13.67 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.275 0.56 . . . . 0.0 111.068 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 62.9 mtt -97.83 156.38 16.61 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.715 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.694 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 9.2 m-20 -73.98 107.4 6.17 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.614 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 99.5 p -60.96 -14.41 22.51 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.038 0.447 . . . . 0.0 111.542 177.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -68.77 -32.43 72.17 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.43 0.633 . . . . 0.0 111.083 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.472 ' OG1' ' HG2' ' A' ' 66' ' ' ARG . 51.2 p -142.68 -50.67 0.36 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.988 -174.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.45 21.73 1.42 Allowed Glycine 0 CA--C 1.525 0.714 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.402 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.472 ' HG2' ' OG1' ' A' ' 64' ' ' THR . 28.0 mmm180 -86.6 -161.46 0.66 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.352 0.261 . . . . 0.0 110.927 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.54 ' HB3' ' HA ' ' A' ' 36' ' ' PHE . 37.6 t -113.07 130.56 56.12 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 121.814 -0.553 . . . . 0.0 111.516 178.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.694 ' HE3' ' HA ' ' A' ' 61' ' ' ASP . 97.4 mttt -81.88 -7.16 59.58 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 95.56 6.25 59.77 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 114.855 0.702 . . . . 0.0 114.855 173.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -149.94 156.52 41.88 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.312 1.056 . . . . 0.0 112.907 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.64 161.12 28.89 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.73 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -115.06 139.04 50.2 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 122.461 -0.435 . . . . 0.0 111.656 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.41 HG12 HG23 ' A' ' 56' ' ' ILE . 60.4 mt -122.65 144.26 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.723 0.297 . . . . 0.0 111.185 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.6 m -115.76 134.05 55.41 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -126.08 147.83 49.49 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.839 0.352 . . . . 0.0 111.331 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.0 m -93.38 13.26 22.08 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 120.899 0.38 . . . . 0.0 111.31 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.598 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 15.6 t70 -142.82 109.14 5.29 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.929 0.395 . . . . 0.0 110.698 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.0 m -66.32 -31.51 72.34 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -176.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -65.72 -57.73 7.34 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.788 0.328 . . . . 0.0 111.322 -176.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.598 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 31.2 p -58.06 -38.51 76.47 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.927 0.394 . . . . 0.0 111.144 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.52 -41.16 98.5 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.555 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -60.41 -44.18 95.98 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.944 0.402 . . . . 0.0 110.699 176.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -65.14 -47.46 77.0 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.349 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.15 -51.82 55.6 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.13 0.491 . . . . 0.0 110.934 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.3 tt -55.51 -53.48 55.83 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.92 176.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -62.62 -28.44 69.9 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -174.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.641 ' N ' HE21 ' A' ' 87' ' ' GLN . 0.0 OUTLIER -89.96 -38.26 13.78 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.011 -0.431 . . . . 0.0 111.944 -179.008 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 73.5 mt -92.24 -23.3 19.38 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -172.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -69.83 101.02 1.63 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.133 0.492 . . . . 0.0 110.837 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 117.25 -14.81 13.43 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 -173.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -70.57 125.5 27.0 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.835 0.35 . . . . 0.0 110.679 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -77.95 90.43 4.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.204 0.526 . . . . 0.0 112.046 -177.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.5 tp -81.14 132.1 35.34 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.727 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 62.13 25.1 15.01 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.074 0.464 . . . . 0.0 111.372 -176.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.8 32.66 53.22 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.12 -0.491 . . . . 0.0 113.221 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.538 ' HB3' ' CE1' ' A' ' 35' ' ' HIS . 55.7 ttt180 -159.09 131.62 4.41 Favored Pre-proline 0 CA--C 1.545 0.763 0 O-C-N 122.619 -0.342 . . . . 0.0 110.472 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 96' ' ' ARG . 77.9 Cg_exo -48.96 127.73 17.67 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 C-N-CA 123.557 2.838 . . . . 0.0 115.095 -172.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.42 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 50.1 ttp -99.56 117.88 34.92 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.723 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.4 ' H ' ' HB2' ' A' ' 33' ' ' SER . 92.5 mttt -89.49 105.7 17.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.908 0.385 . . . . 0.0 111.787 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.8 t -106.99 99.18 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 121.029 0.442 . . . . 0.0 111.159 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -107.89 162.4 13.2 Favored Glycine 0 C--O 1.223 -0.558 0 N-CA-C 112.136 -0.386 . . . . 0.0 112.136 178.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 -52.75 -84.76 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 117.78 0.79 . . . . 0.0 110.616 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.2 t -139.44 47.3 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 170.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.766 HG22 ' H ' ' A' ' 105' ' ' GLU . 4.3 m 64.35 -171.92 0.18 Allowed 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.415 -169.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.766 ' H ' HG22 ' A' ' 104' ' ' THR . 39.8 mm-40 72.77 -84.91 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 170.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -94.28 99.91 12.06 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -168.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 89.9 m -123.66 -59.26 1.54 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.954 168.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 . . . . . 0 C--O 1.251 1.132 0 CA-C-O 119.14 -0.457 . . . . 0.0 111.531 176.113 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.784 0.326 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -67.33 78.69 0.17 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.376 -0.44 . . . . 0.0 112.784 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -73.85 130.75 40.55 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.129 0.49 . . . . 0.0 111.935 -177.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -125.93 91.43 3.39 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.227 0.536 . . . . 0.0 111.886 -177.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -102.19 153.72 19.69 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.52 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -80.97 -17.78 49.23 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -171.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -63.15 91.69 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.434 0.635 . . . . 0.0 112.421 -176.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -145.22 16.84 1.53 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.316 176.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.4 m -85.45 19.85 2.22 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -173.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 9.8 t60 72.77 -48.71 0.69 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.103 0.561 . . . . 0.0 112.417 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 65.3 mtt -59.9 115.06 3.14 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.217 0.532 . . . . 0.0 111.962 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.35 -171.93 3.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.65 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.7 74.09 10.19 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.083 0.468 . . . . 0.0 110.912 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.39 -45.43 46.03 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -175.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.8 ttt -62.67 -51.69 66.26 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.849 0.357 . . . . 0.0 111.497 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -170.06 -83.47 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.938 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -167.88 -74.78 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 174.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 59.59 -76.98 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.51 0.724 . . . . 0.0 112.901 172.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 66.2 mt -89.84 88.98 7.55 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.933 0.396 . . . . 0.0 111.36 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -85.77 93.23 8.83 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.246 0.546 . . . . 0.0 111.855 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -112.72 -49.53 2.94 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.577 171.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.86 77.73 0.4 Allowed Glycine 0 CA--C 1.528 0.903 0 CA-C-N 116.247 -0.433 . . . . 0.0 113.516 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.6 t -66.3 -59.79 3.38 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.147 0.498 . . . . 0.0 110.935 176.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -95.02 -73.76 0.57 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.029 0.442 . . . . 0.0 110.88 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 155.39 97.13 0.13 Allowed Glycine 0 CA--C 1.527 0.826 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.06 178.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.78 120.64 7.85 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.232 1.955 . . . . 0.0 111.997 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 13.4 tpt -98.96 128.98 45.24 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.81 0.338 . . . . 0.0 110.809 -176.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -109.45 128.46 55.17 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.887 0.375 . . . . 0.0 111.28 -173.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.4 mt -100.06 144.94 28.51 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.223 0.535 . . . . 0.0 111.555 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -108.71 105.9 15.7 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.049 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.603 HG22 HG22 ' A' ' 100' ' ' VAL . 46.5 t -99.77 98.15 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.716 176.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.97 88.95 0.47 Allowed Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.761 -176.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.4 p -175.99 29.22 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.124 0.488 . . . . 0.0 110.991 176.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 30.9 mt -86.9 130.45 34.46 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.429 -174.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -83.24 63.1 7.03 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.289 0.566 . . . . 0.0 112.161 -174.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 55.29 8.92 0.31 Allowed 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -163.52 69.32 0.21 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.137 0.494 . . . . 0.0 112.043 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.0 mm -130.67 118.7 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 169.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.513 ' OG1' ' SD ' ' A' ' 42' ' ' MET . 14.6 p -91.08 163.35 14.33 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.312 0.577 . . . . 0.0 112.464 -172.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -61.07 -30.05 70.11 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.635 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.64 -47.66 71.86 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.378 -177.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.513 ' SD ' ' OG1' ' A' ' 39' ' ' THR . 1.3 mpt? -61.64 -48.39 81.08 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.101 0.477 . . . . 0.0 110.825 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.412 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 77.9 mt -54.62 -50.65 67.57 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.308 177.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.475 ' HG2' ' HG3' ' A' ' 48' ' ' GLU . 30.1 ttp-105 -52.63 -52.82 53.74 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.839 0.352 . . . . 0.0 110.887 178.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -54.81 -31.07 54.04 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 116.102 -0.499 . . . . 0.0 113.712 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.6 mt -79.68 -41.62 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 O-C-N 122.514 -0.404 . . . . 0.0 111.818 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.412 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 19.0 m-85 -82.66 -26.25 32.32 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -175.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.475 ' HG3' ' HG2' ' A' ' 44' ' ' ARG . 32.4 mt-10 -54.79 -47.57 97.85 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -178.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -48.79 -20.85 3.12 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.692 2.262 . . . . 0.0 114.686 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -82.12 -38.43 24.79 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.918 -0.489 . . . . 0.0 111.413 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -162.96 -99.89 0.14 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.681 -0.567 . . . . 0.0 111.681 176.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.7 ttp180 -162.76 153.7 17.18 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.768 0.318 . . . . 0.0 110.144 171.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.49 HG21 HG13 ' A' ' 56' ' ' ILE . 1.7 mp -84.12 139.94 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.126 0.488 . . . . 0.0 111.997 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -96.01 -60.51 1.62 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 174.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.3 t -150.63 126.62 10.47 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.251 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.548 HG23 HG12 ' A' ' 73' ' ' ILE . 54.8 mt -99.66 150.36 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 120.833 0.349 . . . . 0.0 111.284 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -149.82 134.8 17.9 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.683 0.278 . . . . 0.0 110.695 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.2 mt -97.28 142.68 28.87 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.739 0.304 . . . . 0.0 110.512 173.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.498 ' HB3' ' HB2' ' A' ' 70' ' ' TYR . 13.0 tpt -93.48 91.96 7.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.306 0.574 . . . . 0.0 109.788 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.563 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 21.6 ptp -111.78 177.07 4.77 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.001 -175.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -89.79 142.69 27.45 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.472 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 79.8 p -80.02 3.47 20.08 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -91.39 -66.79 0.9 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.286 0.565 . . . . 0.0 111.097 -178.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.448 ' OG1' ' HG3' ' A' ' 66' ' ' ARG . 32.8 p -102.39 -10.53 19.36 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.647 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.65 50.43 48.64 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.362 -0.447 . . . . 0.0 113.077 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.448 ' HG3' ' OG1' ' A' ' 64' ' ' THR . 64.3 mtt-85 -109.4 -79.63 0.58 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 122.424 -0.457 . . . . 0.0 111.862 -177.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 60' ' ' MET . 42.5 t 179.14 140.39 0.11 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -90.95 -2.37 57.72 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.455 169.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.23 15.29 48.45 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 116.165 -0.47 . . . . 0.0 113.732 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.498 ' HB2' ' HB3' ' A' ' 59' ' ' MET . 4.3 m-85 -130.79 160.85 33.15 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 122.475 -0.426 . . . . 0.0 111.546 -178.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.4 135.73 5.34 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 121.439 -0.41 . . . . 0.0 112.901 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -106.94 115.11 29.62 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 122.347 -0.502 . . . . 0.0 111.581 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.548 HG12 HG23 ' A' ' 56' ' ' ILE . 58.7 mt -111.27 123.79 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.868 0.366 . . . . 0.0 111.344 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.5 m -99.68 131.32 45.75 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -176.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.437 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 80.9 m-85 -117.11 151.5 36.71 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.941 0.496 . . . . 0.0 111.327 177.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.6 t -73.72 -34.92 65.0 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.101 0.477 . . . . 0.0 110.924 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -100.28 124.98 46.41 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.825 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 63.3 m -60.42 -37.11 79.81 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.316 176.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -71.2 -50.47 32.78 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.886 -177.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 96.2 m -54.35 -41.4 69.07 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 120.915 0.388 . . . . 0.0 111.144 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -61.66 -47.58 84.72 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.159 175.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.405 ' HB3' ' NZ ' ' A' ' 82' ' ' LYS . 6.8 ttpm? -63.56 -32.8 74.37 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.534 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -68.67 -48.4 64.03 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.734 0.302 . . . . 0.0 110.635 176.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.79 -46.96 67.86 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.202 0.525 . . . . 0.0 110.499 174.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.41 HD23 ' C ' ' A' ' 85' ' ' LEU . 7.8 tt -57.96 -54.37 47.66 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.946 174.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -57.87 -31.64 66.9 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.378 -174.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.663 ' N ' HE21 ' A' ' 87' ' ' GLN . 0.0 OUTLIER -92.52 -43.46 9.15 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.147 -0.346 . . . . 0.0 111.931 -178.465 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 84.5 mt -85.1 -22.39 28.92 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -171.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -63.41 104.29 0.61 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.085 0.469 . . . . 0.0 110.174 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 110.11 -11.93 31.57 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.881 -177.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -65.69 127.47 32.06 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.856 0.36 . . . . 0.0 111.819 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -89.23 100.85 13.55 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.996 0.427 . . . . 0.0 110.935 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 60.1 tp -86.28 -81.33 0.22 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.937 0.399 . . . . 0.0 111.732 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.86 52.33 2.44 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.866 0.365 . . . . 0.0 111.124 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.11 15.56 58.67 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.453 -174.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -135.68 140.56 34.15 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 122.945 0.498 . . . . 0.0 110.591 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.23 145.35 98.73 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.829 2.352 . . . . 0.0 113.081 176.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.43 ' HG2' HG23 ' A' ' 100' ' ' VAL . 46.9 ttm -99.09 108.76 21.48 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.287 175.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -89.09 93.13 9.48 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.857 0.36 . . . . 0.0 111.276 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.603 HG22 HG22 ' A' ' 31' ' ' VAL . 44.8 t -105.38 105.74 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.706 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -115.61 154.47 16.9 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.367 -0.444 . . . . 0.0 112.231 176.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -79.54 56.26 2.15 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 117.755 0.777 . . . . 0.0 111.83 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 50.3 t 50.07 87.93 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 121.432 0.634 . . . . 0.0 111.989 -177.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 51.9 m -149.08 86.94 1.51 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.529 0.68 . . . . 0.0 110.492 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -152.02 11.35 0.56 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.571 -175.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 106' ' ' ARG . 31.0 ttt180 -168.66 16.82 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.046 -166.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.1 p -103.23 -41.39 6.07 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.953 -174.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 35.6 t70 . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.427 -0.797 . . . . 0.0 111.14 -179.452 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.795 0.331 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.37 -172.27 18.79 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.754 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -75.95 74.33 2.86 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.421 0.629 . . . . 0.0 111.428 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -119.18 80.25 1.53 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.983 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -112.63 -1.85 14.71 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.406 0.622 . . . . 0.0 110.106 172.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -161.6 132.22 5.09 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.281 173.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.05 11.57 13.38 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -148.42 152.56 37.18 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.158 0.583 . . . . 0.0 109.843 170.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.8 p -156.29 136.23 12.7 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.22 0.533 . . . . 0.0 112.234 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -131.98 18.07 4.6 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.584 0.707 . . . . 0.0 110.014 173.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.7 ptm -81.73 29.62 0.38 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.604 -173.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -125.17 21.76 8.0 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.09 -49.49 13.83 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.054 0.454 . . . . 0.0 111.123 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.9 96.39 9.78 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.388 178.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.499 ' C ' ' SD ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -85.13 106.13 16.36 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.092 0.472 . . . . 0.0 111.037 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.47 -62.69 0.65 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.396 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 65.53 -14.14 0.13 Allowed 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 175.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -57.02 105.18 0.2 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.132 0.424 . . . . 0.0 110.263 174.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.7 mt 61.73 77.24 0.34 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.713 0.768 . . . . 0.0 109.933 -168.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.6 pm0 -68.83 -20.85 64.32 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.302 -172.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -117.16 94.56 4.62 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.053 0.454 . . . . 0.0 110.381 175.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 161.86 -146.39 12.03 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 121.19 -0.529 . . . . 0.0 112.833 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.494 ' HA ' ' HB3' ' A' ' 78' ' ' SER . 42.7 t 68.51 -65.42 0.27 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.086 0.554 . . . . 0.0 112.156 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.64 71.9 1.01 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.189 0.519 . . . . 0.0 111.297 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -172.66 168.83 41.96 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.541 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.21 126.0 11.93 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.75 2.3 . . . . 0.0 113.262 -175.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 26.9 ttt -126.65 125.51 42.02 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.847 0.356 . . . . 0.0 111.558 -178.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 74' ' ' THR . 11.1 ttp180 -98.85 138.14 36.41 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.153 0.501 . . . . 0.0 111.373 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.654 HD22 HD12 ' A' ' 85' ' ' LEU . 23.6 mt -117.04 146.83 42.83 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.247 -172.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 55.7 t80 -89.85 115.6 27.3 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 122.781 0.432 . . . . 0.0 110.961 175.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.6 t -111.6 98.84 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.107 0.48 . . . . 0.0 110.943 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.88 96.15 1.14 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.406 -0.426 . . . . 0.0 113.76 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.4 t -174.73 9.85 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.3 mt -69.12 93.33 0.59 Allowed 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.728 -0.607 . . . . 0.0 111.19 -172.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.67 69.09 3.02 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -175.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 47.0 t80 53.15 39.86 30.31 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 172.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -171.03 -31.58 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.3 mm -64.66 95.28 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.13 0.49 . . . . 0.0 111.327 -178.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.8 p -92.47 -178.37 4.89 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.49 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.533 ' HG3' HD13 ' A' ' 58' ' ' LEU . 2.1 mp0 -52.57 -40.52 62.7 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.065 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.65 -52.32 62.68 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.583 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 20.8 mmt -62.29 -52.51 63.39 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.438 0.637 . . . . 0.0 110.676 -177.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.469 ' HB3' HD11 ' A' ' 73' ' ' ILE . 61.7 mt -55.34 -49.96 70.88 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.613 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -57.21 -50.57 72.44 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.392 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.26 -31.12 62.0 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.369 -0.444 . . . . 0.0 113.857 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.7 mt -85.15 -37.56 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -85.08 -32.3 22.91 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -173.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -59.64 -36.98 45.49 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -46.76 -19.48 0.77 Allowed 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 122.144 1.896 . . . . 0.0 113.847 171.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -90.83 -35.44 14.81 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.781 0.324 . . . . 0.0 111.262 174.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.413 ' HA3' ' SG ' ' A' ' 80' ' ' CYS . . . -172.85 -123.08 0.7 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.413 -0.422 . . . . 0.0 112.742 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -149.54 128.22 12.43 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 122.282 -0.54 . . . . 0.0 110.681 177.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.491 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.7 mp -87.33 138.98 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.765 -176.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -81.42 -48.57 11.73 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.048 0.452 . . . . 0.0 111.104 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 96.0 p -148.98 143.4 26.11 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.356 -178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.527 HG23 HG12 ' A' ' 73' ' ' ILE . 52.1 mt -121.3 104.74 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 120.997 0.427 . . . . 0.0 110.709 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -102.75 111.76 24.22 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -175.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.533 HD13 ' HG3' ' A' ' 40' ' ' GLU . 7.8 mp -98.51 139.68 33.87 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.919 -0.488 . . . . 0.0 110.89 177.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.533 ' HG3' ' CE2' ' A' ' 70' ' ' TYR . 18.2 mmt -94.12 100.41 12.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.072 0.463 . . . . 0.0 111.03 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -148.95 112.71 5.09 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.301 0.572 . . . . 0.0 111.408 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.553 ' HB2' ' HA3' ' A' ' 65' ' ' GLY . 9.1 m-20 -80.11 77.66 6.8 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.129 0.49 . . . . 0.0 110.697 178.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.3 m -47.62 -28.78 2.51 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -170.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -56.13 -46.11 79.3 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.421 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 7.6 t -168.04 -23.7 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -175.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.553 ' HA3' ' HB2' ' A' ' 61' ' ' ASP . . . -72.84 -29.52 65.04 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.957 -0.639 . . . . 0.0 111.546 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 64' ' ' THR . 47.6 mtm-85 63.46 -170.33 0.18 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.052 0.541 . . . . 0.0 112.263 172.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.8 t -57.64 114.26 2.18 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.419 ' NZ ' ' HB3' ' A' ' 68' ' ' LYS . 8.0 mtpm? -77.72 -9.11 58.83 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.804 0.335 . . . . 0.0 111.58 177.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.48 2.29 61.83 Favored Glycine 0 CA--C 1.531 1.094 0 N-CA-C 115.108 0.803 . . . . 0.0 115.108 173.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.533 ' CE2' ' HG3' ' A' ' 59' ' ' MET . 34.1 p90 -143.11 148.98 37.5 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.122 0.961 . . . . 0.0 112.542 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -138.3 146.76 18.62 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.48 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 95.2 m-85 -100.18 121.76 41.95 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 122.594 -0.356 . . . . 0.0 111.523 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 56' ' ' ILE . 77.8 mt -110.36 125.03 67.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 120.794 0.331 . . . . 0.0 111.596 -178.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 27.2 m -101.35 120.6 40.51 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -175.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.471 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 70.3 m-85 -100.08 152.05 20.68 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.325 173.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.7 t -75.46 -14.4 60.43 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.891 0.377 . . . . 0.0 111.685 -177.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -136.46 138.85 41.88 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.689 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.494 ' HB3' ' HA ' ' A' ' 23' ' ' SER . 28.9 t -70.02 -27.34 64.59 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -80.97 -40.94 23.62 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.772 -0.58 . . . . 0.0 110.509 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.413 ' SG ' ' HA3' ' A' ' 51' ' ' GLY . 50.4 t -61.46 -39.26 90.21 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.123 0.487 . . . . 0.0 110.349 169.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.471 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -60.49 -48.69 80.67 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.228 174.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -68.39 -24.98 64.83 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 111.625 0.232 . . . . 0.0 111.625 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -63.6 -55.57 22.69 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.295 0.569 . . . . 0.0 110.104 175.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.67 -51.83 67.72 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.828 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.654 HD12 HD22 ' A' ' 29' ' ' LEU . 6.4 tt -49.11 -63.85 0.98 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.444 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -67.01 -20.92 65.95 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -172.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -94.95 -14.71 24.18 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 94.1 mt -110.21 -14.71 14.14 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -176.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.3 97.13 0.92 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.876 0.846 . . . . 0.0 111.178 176.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.96 -2.1 22.84 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.168 -174.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -64.97 127.31 31.06 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 122.592 0.357 . . . . 0.0 111.147 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -76.88 96.26 4.28 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.33 0.586 . . . . 0.0 110.987 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.8 tp -98.34 120.71 39.23 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.463 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 58.35 20.24 7.12 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.03 0.443 . . . . 0.0 112.116 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.87 8.13 58.29 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 116.203 -0.453 . . . . 0.0 113.436 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -130.88 132.23 23.76 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.592 -0.357 . . . . 0.0 110.906 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.53 133.09 49.66 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 122.341 2.028 . . . . 0.0 112.793 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.0 ttp -99.06 116.91 32.38 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.099 0.476 . . . . 0.0 111.538 -177.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -89.98 103.72 16.36 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.896 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.501 HG12 ' HG ' ' A' ' 85' ' ' LEU . 21.6 t -113.93 112.83 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.596 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -151.47 78.24 0.21 Allowed Glycine 0 CA--C 1.534 1.225 0 C-N-CA 119.951 -1.119 . . . . 0.0 115.169 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 27.0 p80 39.13 -162.19 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 174.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.9 t -80.49 116.07 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 170.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 65.9 p -50.66 -87.06 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -166.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -78.92 155.61 28.93 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -166.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 35.5 ptt-85 -138.12 -166.01 1.9 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.701 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.0 m -76.99 87.52 3.51 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 122.179 -0.325 . . . . 0.0 111.761 177.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.6 t70 . . . . . 0 C--O 1.259 1.569 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 175.392 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ptp . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.737 0.303 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.39 81.38 0.6 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.505 172.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -63.32 87.17 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 121.39 0.614 . . . . 0.0 112.513 -175.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -95.01 -59.8 1.82 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.814 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.6 m80 64.18 -13.17 0.1 Allowed 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -83.48 63.12 7.16 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.268 0.556 . . . . 0.0 111.706 -171.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -100.63 123.03 44.27 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -82.58 91.8 7.0 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.306 0.574 . . . . 0.0 111.274 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.7 m -66.45 86.63 0.11 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.303 0.573 . . . . 0.0 111.236 178.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -154.91 151.63 28.79 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.16 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 51.7 ttm -49.87 -37.35 30.66 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.57 83.39 2.61 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.226 0.536 . . . . 0.0 111.576 176.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -128.59 82.07 2.06 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.017 0.437 . . . . 0.0 110.897 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -178.66 -36.94 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.28 -177.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 56.3 ttp 66.86 -72.36 0.09 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.979 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.75 42.14 1.1 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.946 0.403 . . . . 0.0 111.428 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.0 m120 60.08 -170.81 0.14 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.666 -176.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -103.74 -26.76 12.62 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -177.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp -133.0 11.68 4.27 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -76.32 117.69 18.25 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 122.144 -0.348 . . . . 0.0 111.161 178.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -87.31 120.69 28.86 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.301 0.572 . . . . 0.0 111.458 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.87 169.75 17.08 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.145 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.3 m -110.19 -22.34 11.81 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -162.69 133.31 4.74 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.815 0.34 . . . . 0.0 111.413 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -163.16 -78.46 0.03 OUTLIER Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.826 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 37.9 Cg_endo -64.69 101.12 0.36 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.662 2.241 . . . . 0.0 112.946 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -99.77 142.68 30.93 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.586 -178.641 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.548 ' N ' ' SD ' ' A' ' 27' ' ' MET . 34.2 ttm105 -118.58 116.54 26.83 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.997 0.427 . . . . 0.0 112.026 -175.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.558 HD22 HD12 ' A' ' 85' ' ' LEU . 73.3 mt -99.45 128.38 45.56 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.562 178.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -91.49 114.9 27.55 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.131 0.491 . . . . 0.0 111.13 175.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.1 t -107.21 107.83 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.246 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.7 89.53 0.54 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.613 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.5 p -175.09 18.02 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 120.923 0.392 . . . . 0.0 111.976 176.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.544 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 17.8 mt -83.3 81.22 8.8 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.986 -0.447 . . . . 0.0 111.372 -173.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -78.14 75.7 4.67 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 121.188 0.518 . . . . 0.0 112.313 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.437 ' HB3' ' OG ' ' A' ' 67' ' ' SER . 16.3 p90 39.25 26.53 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 176.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -140.28 8.89 2.26 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 122.0 -0.437 . . . . 0.0 111.501 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 38' ' ' ILE . 3.7 mp -118.48 123.91 72.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.596 -177.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 57.3 p -105.83 175.55 5.46 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -54.55 -49.2 70.86 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.729 176.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -73.15 -19.0 61.22 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -174.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.4 tpt -70.51 -54.77 10.9 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 172.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.3 mt -59.21 -55.76 30.78 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.781 175.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -53.89 -35.27 61.42 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.498 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.32 -35.71 92.3 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.137 -0.554 . . . . 0.0 113.073 177.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.8 mt -86.21 -38.5 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-O 120.998 0.428 . . . . 0.0 111.985 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.414 ' HB3' ' HZ ' ' A' ' 75' ' ' PHE . 35.0 m-85 -79.59 -44.63 20.69 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -173.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.414 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 27.1 tt0 -64.84 -32.35 6.68 Favored Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -172.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 48' ' ' GLU . 89.1 Cg_exo -47.89 -22.86 3.65 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.124 1.883 . . . . 0.0 113.629 169.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -77.26 -23.37 51.22 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 122.149 -0.345 . . . . 0.0 111.698 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.761 ' HA3' ' SG ' ' A' ' 80' ' ' CYS . . . -177.89 -100.06 0.13 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.46 175.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.66 130.4 6.59 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.097 0.475 . . . . 0.0 111.481 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.3 mt -111.04 140.82 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.699 -174.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -90.77 -62.36 1.47 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.847 0.356 . . . . 0.0 111.787 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.5 t -145.7 147.65 32.18 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.874 0.369 . . . . 0.0 111.623 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.554 HG12 HG23 ' A' ' 73' ' ' ILE . 55.2 mt -123.88 125.23 70.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.076 0.465 . . . . 0.0 110.852 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -108.89 117.39 34.07 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.879 0.371 . . . . 0.0 110.952 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 82.1 mt -98.42 136.63 38.29 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.75 0.309 . . . . 0.0 110.665 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 22.4 mmt -93.39 120.99 34.31 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.738 0.78 . . . . 0.0 112.196 -175.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.6 mtt -121.16 177.27 5.21 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.298 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.432 ' HB3' ' N ' ' A' ' 66' ' ' ARG . 15.9 t70 -82.42 137.48 34.69 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.893 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 90.3 p -89.11 -2.59 58.6 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -173.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.21 -75.75 0.59 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.206 0.527 . . . . 0.0 110.894 -177.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.563 HG23 ' HG3' ' A' ' 66' ' ' ARG . 1.8 t -93.06 -15.91 25.58 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.044 -177.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.93 26.27 13.05 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.067 -0.587 . . . . 0.0 114.437 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.563 ' HG3' HG23 ' A' ' 64' ' ' THR . 20.1 mtm180 -76.82 -166.19 0.65 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 117.268 0.534 . . . . 0.0 111.241 176.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.437 ' OG ' ' HB3' ' A' ' 36' ' ' PHE . 88.7 p -105.5 152.73 22.67 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.854 -0.529 . . . . 0.0 111.275 178.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -96.22 -37.71 10.43 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.947 0.403 . . . . 0.0 111.488 175.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 111.05 13.06 14.23 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.818 -0.705 . . . . 0.0 114.555 175.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -149.82 156.11 41.24 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.59 0.695 . . . . 0.0 111.757 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.91 160.54 28.67 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.418 -0.42 . . . . 0.0 113.064 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -112.61 121.35 44.53 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.768 0.318 . . . . 0.0 111.402 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.554 HG23 HG12 ' A' ' 56' ' ' ILE . 67.3 mt -103.69 133.92 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.811 0.338 . . . . 0.0 111.323 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 68.1 m -110.14 118.37 36.21 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.481 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 31.3 m-85 -99.09 150.72 21.73 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.163 175.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.2 t -82.67 1.78 36.77 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.012 0.434 . . . . 0.0 111.565 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -142.28 135.85 29.18 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.041 0.448 . . . . 0.0 111.35 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.8 t -65.72 -47.84 73.96 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -71.7 -35.42 70.22 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.246 -0.284 . . . . 0.0 111.495 -176.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.761 ' SG ' ' HA3' ' A' ' 51' ' ' GLY . 43.9 t -59.38 -44.65 92.74 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.118 0.485 . . . . 0.0 110.918 173.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.481 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -65.53 -47.53 75.59 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.678 177.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.8 ttpp -60.76 -34.21 74.11 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.823 0.344 . . . . 0.0 111.349 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -66.43 -49.25 67.39 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.912 0.387 . . . . 0.0 110.919 176.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.02 -44.7 87.45 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.127 0.489 . . . . 0.0 111.169 176.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.558 HD12 HD22 ' A' ' 29' ' ' LEU . 8.6 tt -56.76 -59.08 5.55 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.987 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.93 -25.18 67.43 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -173.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -89.68 -31.12 17.64 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 122.032 -0.418 . . . . 0.0 112.056 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.0 mt -103.24 -6.74 21.78 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -66.07 92.37 0.17 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.221 0.534 . . . . 0.0 110.614 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 115.07 3.18 21.66 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.943 -176.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -64.63 135.79 56.31 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.589 0.355 . . . . 0.0 111.709 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -70.13 79.87 0.51 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.177 0.513 . . . . 0.0 111.383 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.572 HD22 ' SD ' ' A' ' 98' ' ' MET . 56.8 tp -84.33 118.49 24.25 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.907 0.384 . . . . 0.0 111.657 -177.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 57.15 26.86 12.63 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 176.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.44 11.39 59.61 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 116.075 -0.512 . . . . 0.0 113.4 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -145.49 139.81 15.27 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 122.478 0.311 . . . . 0.0 110.807 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -55.41 136.73 75.07 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.491 2.127 . . . . 0.0 112.887 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.572 ' SD ' HD22 ' A' ' 93' ' ' LEU . 44.8 ttp -98.67 118.45 35.42 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.229 0.538 . . . . 0.0 111.395 -176.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -88.98 96.31 10.67 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.333 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 18.7 t -104.71 105.91 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.993 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -133.22 151.8 20.19 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.451 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.5 p80 -69.58 173.2 6.29 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 122.29 -0.535 . . . . 0.0 110.904 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.477 HG21 HH11 ' A' ' 28' ' ' ARG . 41.9 t -63.86 136.68 25.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.647 0.261 . . . . 0.0 110.633 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 40.8 p -67.9 0.38 3.5 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -172.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -73.52 109.74 7.27 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.118 0.485 . . . . 0.0 111.103 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -135.51 130.98 35.46 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.313 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.2 m -122.38 89.15 3.06 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.084 0.469 . . . . 0.0 110.606 172.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.0 t70 . . . . . 0 C--O 1.253 1.25 0 CA-C-O 119.023 -0.513 . . . . 0.0 110.699 -178.66 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttt . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 120.815 0.34 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.1 73.8 1.71 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.375 -0.441 . . . . 0.0 113.885 -176.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -151.42 -177.27 5.97 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.76 0.424 . . . . 0.0 110.857 175.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -76.13 72.41 2.94 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.4 m80 58.61 -79.16 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 171.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -71.06 88.38 0.78 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.49 0.662 . . . . 0.0 111.654 -175.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -73.11 98.98 2.68 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.92 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -86.18 114.42 23.0 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.97 0.414 . . . . 0.0 110.757 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.4 t -80.06 -176.82 5.72 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.088 0.47 . . . . 0.0 111.67 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -147.54 168.98 20.57 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.736 0.303 . . . . 0.0 111.56 -177.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.3 mmt -60.71 127.53 32.11 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.028 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.65 24.09 10.46 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -174.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 63.26 53.87 2.15 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.966 0.412 . . . . 0.0 111.529 -177.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 68.11 115.31 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.577 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.568 ' N ' ' SD ' ' A' ' 15' ' ' MET . 1.1 mpt? -77.22 144.65 38.11 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.53 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.08 105.6 17.92 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.129 0.49 . . . . 0.0 111.759 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -85.54 157.92 20.28 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.128 176.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.5 t30 56.51 59.36 3.64 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.444 0.64 . . . . 0.0 111.035 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 19' ' ' LEU . 8.5 tt -84.65 -34.04 23.12 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.2 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.31 -160.8 0.82 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.275 177.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -69.35 103.05 1.89 Allowed 'General case' 0 CA--C 1.539 0.526 0 O-C-N 122.307 -0.246 . . . . 0.0 111.563 177.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.65 91.49 0.03 OUTLIER Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.347 -0.454 . . . . 0.0 113.006 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.5 p -139.83 108.84 6.02 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.045 0.45 . . . . 0.0 111.595 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -153.87 -75.38 0.12 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.326 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 59.86 -114.47 6.37 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 116.443 -0.344 . . . . 0.0 113.069 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.67 127.13 12.76 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.321 2.014 . . . . 0.0 111.969 176.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 14.3 tpt -102.9 131.64 49.67 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.887 0.375 . . . . 0.0 111.922 -172.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.8 ttm-85 -102.72 118.46 36.89 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.856 0.36 . . . . 0.0 110.896 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 76.0 mt -102.68 150.57 23.31 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.281 0.562 . . . . 0.0 111.829 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -105.59 131.43 52.99 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.299 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.6 t -125.94 106.44 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.569 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -125.38 88.52 0.37 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.829 -176.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.497 ' HG ' ' HA ' ' A' ' 98' ' ' MET . 89.6 p -175.79 23.71 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.97 0.414 . . . . 0.0 111.41 178.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.557 ' HB3' HG13 ' A' ' 38' ' ' ILE . 53.4 mt -83.64 166.86 17.8 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.198 -176.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.426 ' O ' ' ND1' ' A' ' 35' ' ' HIS . 33.6 p80 -141.85 80.44 1.72 Allowed 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 60.1 t80 50.61 8.34 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.407 ' O ' HD13 ' A' ' 38' ' ' ILE . 4.8 t30 -143.34 52.59 1.35 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.091 -1.005 . . . . 0.0 110.535 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.557 HG13 ' HB3' ' A' ' 34' ' ' LEU . 30.1 mm -133.24 125.08 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.625 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.417 ' OG1' ' HG3' ' A' ' 42' ' ' MET . 41.8 p -108.03 158.88 17.01 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.861 0.362 . . . . 0.0 111.835 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -54.9 -32.04 60.62 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.108 0.48 . . . . 0.0 110.742 172.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -62.64 -42.41 99.58 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.527 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.427 ' SD ' ' HA ' ' A' ' 38' ' ' ILE . 59.0 mtt -64.06 -55.41 22.37 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.538 0.685 . . . . 0.0 110.686 179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.435 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 45.6 mt -56.72 -54.83 41.7 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.357 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -53.13 -47.88 68.34 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.314 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.09 -30.22 75.01 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 121.305 -0.474 . . . . 0.0 113.741 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 74.1 mt -82.98 -40.46 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 O-C-N 122.377 -0.484 . . . . 0.0 112.23 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.485 ' HB3' ' HE2' ' A' ' 75' ' ' PHE . 77.2 m-85 -85.77 -30.78 22.78 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -173.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.413 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 30.1 mt-10 -55.32 -41.63 91.75 Favored Pre-proline 0 N--CA 1.484 1.226 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 48' ' ' GLU . 51.7 Cg_exo -41.09 -39.29 3.5 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 122.378 2.052 . . . . 0.0 113.058 172.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -76.65 -57.67 3.72 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.067 0.46 . . . . 0.0 110.881 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -157.98 135.01 4.12 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.017 -175.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -56.3 122.26 11.41 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 122.6 0.36 . . . . 0.0 111.236 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 53' ' ' ILE . 2.9 mp -79.6 135.27 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.148 0.499 . . . . 0.0 111.911 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -87.74 -51.05 6.08 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.148 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.8 m -150.41 140.34 21.92 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.812 0.339 . . . . 0.0 111.877 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.537 HG23 HG12 ' A' ' 73' ' ' ILE . 53.8 mt -116.66 140.58 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.911 177.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -136.86 110.19 7.88 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.716 0.293 . . . . 0.0 111.764 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 58' ' ' LEU . 5.1 mp -99.57 150.66 22.01 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.648 0.261 . . . . 0.0 110.391 175.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.445 ' HG3' ' CE2' ' A' ' 70' ' ' TYR . 20.4 mmt -94.6 122.01 36.75 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.569 0.699 . . . . 0.0 112.747 -177.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -152.5 145.82 24.76 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.821 -1.082 . . . . 0.0 111.121 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.543 ' HB3' ' HA3' ' A' ' 65' ' ' GLY . 22.0 t70 -117.02 118.67 33.03 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.749 0.309 . . . . 0.0 110.801 176.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.4 t -73.73 -15.82 61.2 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -174.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -73.26 -70.06 0.39 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.207 0.527 . . . . 0.0 110.687 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.7 t -160.05 16.25 0.14 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.243 0.544 . . . . 0.0 111.909 178.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.543 ' HA3' ' HB3' ' A' ' 61' ' ' ASP . . . -89.42 -30.91 12.43 Favored Glycine 0 CA--C 1.517 0.182 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.433 175.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 57.1 mtp85 60.69 -168.92 0.16 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 122.971 0.508 . . . . 0.0 111.904 176.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.0 m -69.01 105.44 2.41 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.196 -0.315 . . . . 0.0 111.442 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -62.14 -37.91 86.96 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.81 6.62 18.91 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.502 -0.856 . . . . 0.0 115.018 174.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.445 ' CE2' ' HG3' ' A' ' 59' ' ' MET . 35.3 p90 -130.24 147.84 52.01 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.156 0.978 . . . . 0.0 111.824 176.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -149.52 160.24 28.38 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 116.097 -0.501 . . . . 0.0 113.315 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -113.68 139.05 49.38 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.659 0.383 . . . . 0.0 110.999 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.537 HG12 HG23 ' A' ' 56' ' ' ILE . 75.0 mt -124.11 125.67 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.795 0.331 . . . . 0.0 111.447 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.9 m -99.53 118.24 35.66 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.885 0.374 . . . . 0.0 111.549 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.485 ' HE2' ' HB3' ' A' ' 47' ' ' PHE . 43.8 m-85 -99.64 150.08 22.64 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.313 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.1 t -75.77 -18.74 59.42 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.113 0.482 . . . . 0.0 111.067 173.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -110.06 152.81 25.49 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.076 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.1 p -100.41 -59.86 1.63 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 120.967 0.413 . . . . 0.0 112.081 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -65.36 -39.87 92.88 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -175.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 77.9 m -61.6 -31.03 71.08 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.08 0.467 . . . . 0.0 110.541 174.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.32 -33.93 67.71 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.845 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -54.6 -50.44 68.05 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.019 0.438 . . . . 0.0 110.181 172.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.494 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . 6.9 ttpm? -64.48 -40.95 96.64 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.033 177.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.4 -41.64 69.52 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.358 0.599 . . . . 0.0 110.934 176.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.431 HD23 ' C ' ' A' ' 85' ' ' LEU . 7.0 tt -63.91 -62.73 1.45 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.664 177.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.494 ' HG2' ' HA ' ' A' ' 83' ' ' LYS . 14.8 pt-20 -66.42 -18.37 65.32 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.497 -173.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -86.2 -40.97 15.06 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.746 0.308 . . . . 0.0 111.554 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 81.2 mt -97.38 -13.2 21.99 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -168.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.41 81.12 0.06 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 121.699 0.761 . . . . 0.0 111.705 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 141.88 -14.52 2.63 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.706 -175.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -65.72 135.03 54.41 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 122.939 0.496 . . . . 0.0 111.302 177.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -82.74 104.82 13.27 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.099 0.475 . . . . 0.0 112.073 -177.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.6 tp -101.63 128.25 48.0 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.277 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 61.05 22.78 13.01 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.051 0.453 . . . . 0.0 111.243 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 85.78 12.05 72.67 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 116.135 -0.484 . . . . 0.0 113.37 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.7 ttt85 -134.96 134.13 21.54 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 122.52 -0.4 . . . . 0.0 110.631 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -53.64 142.15 61.69 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.922 2.415 . . . . 0.0 113.38 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.497 ' HA ' ' HG ' ' A' ' 33' ' ' SER . 44.9 ttm -99.34 114.43 27.3 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.309 -177.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -89.69 97.82 11.42 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.959 0.409 . . . . 0.0 110.936 177.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.2 t -103.9 127.52 57.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.499 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -150.0 159.38 28.08 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.543 175.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.423 ' O ' HG23 ' A' ' 104' ' ' THR . 49.7 p-80 -72.44 155.02 40.56 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 122.208 -0.583 . . . . 0.0 111.002 177.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 52.1 t -58.02 95.9 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.122 0.487 . . . . 0.0 111.222 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 102' ' ' HIS . 81.4 p -84.31 -173.37 4.68 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.605 0.717 . . . . 0.0 112.636 -176.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -103.0 169.5 8.53 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.887 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 64.4 106.16 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 99.1 m -89.35 110.11 20.94 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 168.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.5 t70 . . . . . 0 C--O 1.252 1.224 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -172.143 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.737 0.303 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.64 -65.62 2.81 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.833 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.7 p-80 -106.42 112.87 26.07 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.241 0.543 . . . . 0.0 111.098 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -100.19 -13.85 18.75 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.254 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -138.49 154.94 48.82 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.033 0.533 . . . . 0.0 110.349 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -164.8 -32.13 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -68.14 -20.71 64.92 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.5 m80 66.95 -71.29 0.1 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.089 0.556 . . . . 0.0 111.9 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.3 m -136.47 -173.37 3.39 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.835 0.35 . . . . 0.0 111.109 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -67.58 -26.23 66.18 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.97 0.415 . . . . 0.0 110.542 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 12.8 tmm? -70.31 87.7 0.62 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.414 0.626 . . . . 0.0 109.864 172.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -178.8 -42.97 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.798 -177.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 14' ' ' ALA . . . -116.42 141.47 48.12 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.139 173.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 13' ' ' ALA . . . 72.31 -54.86 0.68 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.973 0.509 . . . . 0.0 112.108 -176.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 24.7 mmt -80.25 110.97 16.18 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.218 -0.301 . . . . 0.0 111.184 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.13 167.49 29.7 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.118 0.485 . . . . 0.0 111.979 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -92.04 100.86 13.43 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.443 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -127.95 -56.55 1.27 Allowed 'General case' 0 N--CA 1.471 0.608 0 O-C-N 122.025 -0.422 . . . . 0.0 111.964 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.0 tp -93.49 94.96 8.96 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.236 0.541 . . . . 0.0 110.802 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -97.26 -60.78 1.51 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.715 -178.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -144.4 93.49 2.44 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.462 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.76 -84.31 0.09 OUTLIER Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.488 -0.387 . . . . 0.0 113.577 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.4 m -147.65 156.4 42.75 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.343 -0.504 . . . . 0.0 111.654 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -140.79 165.4 27.59 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.731 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -156.24 -116.13 0.52 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.925 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 51.3 Cg_exo -54.06 122.27 11.12 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.156 2.57 . . . . 0.0 114.083 -173.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 28.1 ttt -100.66 133.83 44.52 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.319 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.3 ttm-85 -111.19 129.39 55.97 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.984 0.421 . . . . 0.0 111.873 -174.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 80.5 mt -103.8 142.7 33.92 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.497 0.665 . . . . 0.0 111.9 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -99.69 113.36 25.76 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.198 175.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -116.93 115.4 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -175.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.72 104.37 1.37 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.656 -0.307 . . . . 0.0 113.685 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.543 ' HB2' ' HA ' ' A' ' 98' ' ' MET . 23.9 t -174.82 20.99 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.357 0.599 . . . . 0.0 111.268 175.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.9 mt -93.49 91.85 7.33 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.805 -174.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -80.1 61.51 3.98 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -174.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 22.6 t80 50.29 41.23 24.07 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.641 0.734 . . . . 0.0 110.979 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -149.9 -50.8 0.14 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.754 -171.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.411 HD11 ' HB2' ' A' ' 94' ' ' ALA . 60.8 mt -78.96 133.97 28.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.239 -172.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.3 p -114.27 178.37 4.31 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.198 0.523 . . . . 0.0 112.087 -177.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.429 ' HG3' ' CD1' ' A' ' 58' ' ' LEU . 2.1 mp0 -50.41 -45.35 55.6 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.881 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -55.87 -44.6 78.27 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.577 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.436 ' O ' HG12 ' A' ' 46' ' ' ILE . 12.5 tpt -66.49 -49.9 65.06 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.185 0.517 . . . . 0.0 110.29 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.435 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 71.4 mt -54.25 -53.54 52.2 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.093 176.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.2 ttm105 -51.01 -43.21 60.79 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.536 176.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.96 -28.22 71.64 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.349 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 42' ' ' MET . 42.4 mm -85.17 -37.26 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 120.911 0.386 . . . . 0.0 111.929 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.435 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 46.8 m-85 -86.17 -28.03 24.18 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -174.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -57.7 -38.1 63.48 Favored Pre-proline 0 N--CA 1.484 1.268 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -47.92 -19.9 1.75 Allowed 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 122.086 1.857 . . . . 0.0 113.581 170.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -94.75 -46.66 6.82 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.808 0.337 . . . . 0.0 111.527 175.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.47 -133.5 1.49 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.595 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -129.77 143.8 50.99 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 122.089 -0.654 . . . . 0.0 111.427 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.533 HG21 HG13 ' A' ' 56' ' ' ILE . 2.4 mp -94.97 138.69 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.017 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -95.45 -45.33 7.15 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.911 0.386 . . . . 0.0 111.064 174.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.2 t -152.14 147.03 25.96 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.506 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.551 HG12 HG23 ' A' ' 73' ' ' ILE . 51.8 mt -130.46 106.62 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 120.81 0.338 . . . . 0.0 110.863 175.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -108.93 119.98 41.17 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.754 0.311 . . . . 0.0 111.323 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.43 ' N ' HD12 ' A' ' 58' ' ' LEU . 7.2 mp -98.22 141.55 30.99 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.064 0.459 . . . . 0.0 111.538 -177.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.595 ' SD ' ' HE2' ' A' ' 72' ' ' PHE . 56.8 mtp -101.45 101.36 11.95 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.432 0.634 . . . . 0.0 111.851 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.434 ' O ' ' N ' ' A' ' 62' ' ' SER . 14.1 ptt? -119.31 113.45 20.85 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 168.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.55 ' HB3' ' O ' ' A' ' 66' ' ' ARG . 5.1 p-10 32.94 -76.31 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -166.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 60' ' ' MET . 28.2 t 45.73 37.38 3.34 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.903 0.858 . . . . 0.0 109.839 -168.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -162.39 -50.71 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.75 -169.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.448 ' H ' ' HB2' ' A' ' 61' ' ' ASP . 8.4 t -126.72 -33.29 2.52 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -172.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.427 ' H ' ' CB ' ' A' ' 61' ' ' ASP . . . 108.47 22.03 7.3 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 120.47 -0.871 . . . . 0.0 113.327 -173.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.55 ' O ' ' HB3' ' A' ' 61' ' ' ASP . 68.0 mtm-85 -119.41 -175.83 3.02 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 122.432 -0.452 . . . . 0.0 111.147 176.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.7 p -106.28 130.41 54.13 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.609 -0.682 . . . . 0.0 112.167 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.579 ' HB2' ' O ' ' A' ' 59' ' ' MET . 57.8 mttp -89.39 -59.22 2.27 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.887 0.375 . . . . 0.0 110.776 173.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.44 23.22 8.53 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 114.863 0.705 . . . . 0.0 114.863 172.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.535 ' HE1' ' SD ' ' A' ' 59' ' ' MET . 27.6 p90 -143.49 152.06 41.04 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.775 0.788 . . . . 0.0 112.088 177.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.8 158.13 23.66 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.945 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.595 ' HE2' ' SD ' ' A' ' 59' ' ' MET . 98.2 m-85 -110.02 125.08 52.53 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.831 0.348 . . . . 0.0 111.17 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.551 HG23 HG12 ' A' ' 56' ' ' ILE . 59.9 mt -113.43 135.14 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.593 -178.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.2 m -100.01 133.97 43.62 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.492 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 96.1 m-85 -125.14 143.86 50.72 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.509 0.324 . . . . 0.0 111.27 177.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.2 m -81.48 -5.63 58.14 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 120.745 0.307 . . . . 0.0 111.708 176.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 80' ' ' CYS . 8.4 t0 -124.18 115.84 21.75 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.939 0.399 . . . . 0.0 110.842 -178.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 48.8 m -71.76 -22.27 61.62 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.75 -36.65 15.04 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 72.6 m -66.13 -39.99 90.31 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.963 0.411 . . . . 0.0 110.591 174.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.14 -40.49 82.43 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.033 0.444 . . . . 0.0 110.958 174.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.565 ' HZ2' ' HB2' ' A' ' 82' ' ' LYS . 4.7 ttmp? -62.23 -42.69 99.54 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.081 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 86.6 tttt -61.45 -50.89 70.96 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.61 0.243 . . . . 0.0 110.478 173.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.12 -40.99 47.73 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.19 0.519 . . . . 0.0 111.055 177.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.3 tt -61.46 -48.34 81.59 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.24 175.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -67.62 -34.2 76.5 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -177.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 83' ' ' LYS . 48.0 mm-40 -90.8 -32.84 15.94 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -173.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.0 mt -99.52 -11.26 21.2 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -172.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -65.93 94.89 0.24 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.316 0.579 . . . . 0.0 110.246 176.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 106.8 22.43 7.65 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.177 -173.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -80.92 142.83 33.13 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 122.732 -0.276 . . . . 0.0 111.715 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -75.06 85.06 2.31 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.852 0.358 . . . . 0.0 111.263 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.559 HD22 ' SD ' ' A' ' 98' ' ' MET . 54.9 tp -103.02 124.84 49.28 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.724 0.297 . . . . 0.0 111.292 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.411 ' HB2' HD11 ' A' ' 38' ' ' ILE . . . 59.82 16.19 5.44 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.85 11.12 59.35 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.42 -0.419 . . . . 0.0 113.309 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 96' ' ' ARG . 16.3 mtp180 -133.7 154.97 80.85 Favored Pre-proline 0 N--CA 1.47 0.57 0 O-C-N 122.474 -0.427 . . . . 0.0 111.877 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.57 130.32 23.3 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.779 2.319 . . . . 0.0 112.26 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.559 ' SD ' HD22 ' A' ' 93' ' ' LEU . 48.6 ttp -97.84 125.67 42.82 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.299 0.571 . . . . 0.0 111.851 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -89.1 108.35 19.55 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.489 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.1 t -116.18 122.28 69.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 121.285 0.564 . . . . 0.0 112.053 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -146.1 146.8 17.26 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.959 175.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -76.26 142.09 41.49 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.268 1.034 . . . . 0.0 110.93 -176.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.1 m -59.54 122.93 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 121.299 0.571 . . . . 0.0 111.412 -177.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.2 t -161.03 61.17 0.29 Allowed 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.892 0.854 . . . . 0.0 110.802 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -78.0 74.81 4.55 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.59 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 106' ' ' ARG . 12.0 ptm180 -142.48 173.69 11.31 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.587 -176.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 50.9 m -100.96 146.36 27.5 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.466 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.1 t70 . . . . . 0 C--O 1.252 1.205 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.319 177.324 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 120.538 0.208 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -56.62 -34.55 64.48 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.428 -0.415 . . . . 0.0 113.986 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -64.36 -29.57 70.64 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -118.32 106.37 12.69 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.869 0.366 . . . . 0.0 110.991 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -89.77 -48.63 7.13 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.546 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -147.08 -110.41 0.09 Allowed 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 111.722 0.267 . . . . 0.0 111.722 176.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.0 m80 58.2 111.61 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.374 0.607 . . . . 0.0 111.962 -172.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -66.36 103.55 1.05 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.555 -178.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 81.1 p -62.91 112.34 2.53 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.785 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -112.57 13.08 19.98 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 177.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.441 ' C ' ' SD ' ' A' ' 11' ' ' MET . 0.2 OUTLIER 74.49 -53.19 0.68 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.589 0.756 . . . . 0.0 113.001 176.076 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.07 25.38 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -172.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.71 -15.63 29.95 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.887 -0.508 . . . . 0.0 111.955 177.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.45 111.6 2.39 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.3 mpt? 56.91 21.76 6.48 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.93 95.79 3.03 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.886 0.374 . . . . 0.0 111.636 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -93.25 -68.87 0.78 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.279 177.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 61.6 t30 48.57 95.26 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 176.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 84.5 mt -77.55 76.07 4.09 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.271 0.557 . . . . 0.0 110.469 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.573 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 17.8 pt20 -84.07 167.65 16.62 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.116 -177.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.573 ' HG2' ' O ' ' A' ' 20' ' ' GLN . 0.0 OUTLIER 64.6 -32.31 0.14 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 125.362 1.465 . . . . 0.0 114.362 177.022 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.88 -27.74 59.75 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.195 -0.526 . . . . 0.0 114.297 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.6 m -128.32 12.99 6.58 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 122.544 -0.386 . . . . 0.0 111.916 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -127.27 162.0 27.25 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -173.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -120.56 90.84 0.47 Allowed Glycine 0 CA--C 1.53 1.004 0 CA-C-N 116.218 -0.447 . . . . 0.0 113.096 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -88.54 169.69 5.71 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.13 2.553 . . . . 0.0 112.729 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.2 ttt -124.05 145.73 49.03 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.003 0.43 . . . . 0.0 111.547 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -116.62 119.39 35.39 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.677 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.591 HD22 HD12 ' A' ' 85' ' ' LEU . 60.7 mt -99.25 138.41 36.38 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.087 0.47 . . . . 0.0 112.202 -178.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -92.8 107.26 19.08 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.539 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.7 t -101.06 97.91 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.004 0.431 . . . . 0.0 111.14 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.76 88.99 0.83 Allowed Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.629 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.3 t -175.49 24.18 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.993 0.425 . . . . 0.0 111.359 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 43.0 mt -73.79 92.66 2.05 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.879 -0.513 . . . . 0.0 110.517 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -78.98 65.56 4.19 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -174.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 55.23 8.74 0.29 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.919 1.452 . . . . 0.0 114.919 170.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -155.16 8.73 0.29 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.411 0.55 . . . . 0.0 112.244 178.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.6 mm -78.06 131.41 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 121.946 -0.471 . . . . 0.0 110.811 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.453 ' OG1' ' HG3' ' A' ' 42' ' ' MET . 49.4 p -106.01 160.49 15.25 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -177.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -55.09 -38.49 68.17 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.319 0.58 . . . . 0.0 110.556 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -61.04 -41.41 96.53 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.107 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.453 ' HG3' ' OG1' ' A' ' 39' ' ' THR . 66.8 mtt -62.77 -55.52 25.77 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.251 0.548 . . . . 0.0 110.529 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.1 mt -54.59 -46.58 73.81 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.104 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 50.9 ttt85 -60.22 -46.48 89.62 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.502 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.07 -29.71 59.82 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.117 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.7 mm -86.54 -53.16 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 75' ' ' PHE . 34.0 m-85 -79.83 -36.71 36.46 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -171.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.473 ' HA ' HG13 ' A' ' 53' ' ' ILE . 0.6 OUTLIER -56.43 -48.06 97.75 Favored Pre-proline 0 N--CA 1.482 1.134 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -172.92 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -47.07 -20.93 1.41 Allowed 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.649 2.232 . . . . 0.0 114.248 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -70.91 -51.6 25.1 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 178.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 52' ' ' ARG . . . -173.52 45.77 0.16 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 119.652 -1.261 . . . . 0.0 115.176 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 73.1 ttt180 72.19 137.19 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 172.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.473 HG13 ' HA ' ' A' ' 48' ' ' GLU . 66.0 mt -128.06 133.18 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.316 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -108.15 -48.09 3.43 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -176.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.7 m -126.94 122.06 33.5 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -176.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 51.8 mt -115.65 106.23 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.853 0.359 . . . . 0.0 110.808 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -99.34 116.3 31.2 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.716 0.293 . . . . 0.0 111.524 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.7 mt -99.0 130.73 45.36 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 173.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 85.0 mmm -93.53 113.41 25.52 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.34 0.591 . . . . 0.0 111.551 -174.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 23.9 ptp -128.95 153.58 47.39 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.895 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.97 103.65 2.74 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.827 0.346 . . . . 0.0 110.667 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.5 t -73.36 70.68 1.22 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.345 0.593 . . . . 0.0 110.844 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -179.24 -59.51 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.8 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.2 p -94.05 -20.24 20.12 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.612 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.78 21.22 66.58 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.202 -0.523 . . . . 0.0 113.536 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -88.84 144.84 25.95 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.059 0.456 . . . . 0.0 111.546 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.7 m -80.92 125.56 30.28 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.276 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.404 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 34.2 mmtp -68.94 -38.1 79.28 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.95 4.16 31.53 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.718 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 68' ' ' LYS . 4.4 p90 -141.14 154.34 45.83 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.322 0.561 . . . . 0.0 112.072 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.32 161.15 28.85 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.839 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -116.17 122.1 44.06 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.523 -0.398 . . . . 0.0 111.828 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.5 mt -108.75 133.09 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 120.96 0.41 . . . . 0.0 111.592 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.4 m -109.52 123.98 50.32 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.735 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.434 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 7.0 m-85 -106.1 150.62 25.62 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.26 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.6 m -70.86 -11.62 61.06 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.081 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -136.76 122.97 20.48 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.031 0.443 . . . . 0.0 111.518 -178.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.8 m -65.1 -41.72 94.7 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.151 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -64.21 -46.49 83.65 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.024 0.44 . . . . 0.0 111.535 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.9 m -64.3 -38.52 91.34 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.211 177.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.434 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -64.53 -42.69 95.61 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.149 0.499 . . . . 0.0 111.386 176.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.433 ' HE3' ' HB2' ' A' ' 82' ' ' LYS . 37.8 ttmt -60.61 -40.93 93.63 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.943 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.46 -45.47 83.61 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.232 174.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.47 -48.63 68.72 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.203 0.525 . . . . 0.0 110.992 176.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.591 HD12 HD22 ' A' ' 29' ' ' LEU . 9.0 tt -54.49 -56.81 15.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.199 175.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -61.17 -36.43 79.79 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -175.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -79.98 -30.57 39.74 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.191 0.519 . . . . 0.0 111.17 -175.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 64.9 mt -103.31 -4.18 24.58 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -176.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -64.81 98.19 0.26 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.878 0.37 . . . . 0.0 110.548 175.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.27 0.18 40.83 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.012 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -68.03 125.44 26.33 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 122.618 -0.342 . . . . 0.0 110.739 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -79.62 91.58 5.24 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.224 0.535 . . . . 0.0 110.472 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.5 tp -77.61 -70.62 0.46 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.713 -174.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.79 45.67 1.31 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.2 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.92 8.68 64.71 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.925 -174.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -141.72 144.1 31.65 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 122.794 0.437 . . . . 0.0 110.332 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.95 135.8 51.41 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.227 2.618 . . . . 0.0 113.637 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.6 ttp -103.23 121.01 41.8 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.387 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -89.05 105.12 17.58 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.767 0.318 . . . . 0.0 111.627 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 85' ' ' LEU . 11.1 t -106.06 105.37 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.737 0.303 . . . . 0.0 110.421 175.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.69 161.65 12.68 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.346 -0.454 . . . . 0.0 113.616 -176.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -72.17 21.34 0.06 Allowed 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 86.4 t 69.47 120.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.208 0.603 . . . . 0.0 111.799 -177.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.3 t -51.12 160.55 0.5 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -50.73 -32.22 18.93 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.584 ' HG3' HG22 ' A' ' 107' ' ' THR . 10.4 ptp180 -155.12 -49.59 0.09 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.956 0.408 . . . . 0.0 110.907 -178.044 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.584 HG22 ' HG3' ' A' ' 106' ' ' ARG . 8.8 t 177.23 22.0 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.737 0.779 . . . . 0.0 109.788 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.7 t70 . . . . . 0 C--O 1.254 1.318 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.952 -167.733 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 120.705 0.288 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 56.33 -154.04 16.7 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 116.324 -0.398 . . . . 0.0 113.93 178.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -144.19 -89.78 0.11 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 122.738 0.415 . . . . 0.0 109.929 175.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 50.73 18.65 0.51 Allowed 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 169.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 60.17 107.18 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 O-C-N 122.248 -0.282 . . . . 0.0 111.115 -174.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -65.37 -21.06 66.64 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -176.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 64.09 2.19 1.38 Allowed 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 166.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -90.83 118.75 30.48 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -176.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.5 m -111.77 119.96 40.36 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.55 169.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -59.13 -19.27 43.3 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 16.2 tpt 59.05 97.33 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.131 0.491 . . . . 0.0 112.077 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.98 -25.16 0.74 Allowed 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.27 103.93 0.08 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -174.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -173.94 3.58 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 177.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.0 mtt 64.86 -71.86 0.07 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.096 0.558 . . . . 0.0 111.695 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 51.23 85.43 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 176.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -98.76 -5.17 31.82 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.947 0.404 . . . . 0.0 111.381 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -112.32 123.81 51.09 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.551 -176.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.9 tp -141.38 -58.22 0.49 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.266 0.555 . . . . 0.0 110.17 175.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -158.37 96.76 1.44 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.919 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -48.7 109.33 0.24 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.465 0.65 . . . . 0.0 112.235 -176.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.9 -25.85 7.39 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.219 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.3 p 52.56 110.9 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.506 0.723 . . . . 0.0 112.413 -177.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -42.72 -54.47 4.04 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -173.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.85 72.85 0.04 OUTLIER Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.182 -0.533 . . . . 0.0 112.702 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 56.5 Cg_endo -69.29 124.67 11.51 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.561 2.174 . . . . 0.0 113.21 -176.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 13.3 tpt -122.51 138.44 54.56 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.616 176.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.431 ' HD3' ' HB3' ' A' ' 72' ' ' PHE . 36.5 ttm180 -110.94 135.21 51.8 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.07 0.462 . . . . 0.0 111.955 -173.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.9 mt -109.91 137.7 47.33 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.204 0.526 . . . . 0.0 111.945 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -89.94 110.31 21.28 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.524 172.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.7 t -110.71 101.76 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.815 0.34 . . . . 0.0 111.046 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 70' ' ' TYR . . . -113.62 89.72 0.52 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.72 -178.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.43 ' HB2' ' HA ' ' A' ' 98' ' ' MET . 22.6 t -166.39 21.22 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.576 0.703 . . . . 0.0 110.852 176.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.46 ' HB3' ' HB ' ' A' ' 38' ' ' ILE . 18.8 mt -85.72 99.77 11.55 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.704 -176.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.439 ' O ' ' CG ' ' A' ' 35' ' ' HIS . 12.3 p80 -70.01 76.04 0.49 Allowed 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.547 0.689 . . . . 0.0 112.383 -175.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 50.41 16.25 0.26 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 171.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.81 -44.01 0.27 Allowed 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.799 -0.563 . . . . 0.0 112.036 -174.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.582 HD12 ' SD ' ' A' ' 42' ' ' MET . 37.8 mm -49.32 130.86 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -174.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 54.2 p -97.35 170.45 9.06 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.218 0.533 . . . . 0.0 112.158 -176.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.542 ' HG3' HD23 ' A' ' 58' ' ' LEU . 2.6 mp0 -62.59 -38.03 88.54 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.432 175.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.37 -37.81 88.83 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.487 -177.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.582 ' SD ' HD12 ' A' ' 38' ' ' ILE . 28.0 ttt -63.34 -50.5 69.75 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.426 0.632 . . . . 0.0 110.1 177.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.457 ' HB3' HD11 ' A' ' 73' ' ' ILE . 64.4 mt -56.16 -53.24 59.51 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.257 176.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -52.62 -40.63 62.94 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.383 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.41 -33.96 78.61 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.291 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 63.2 mt -85.08 -44.04 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.471 ' HD2' ' HZ ' ' A' ' 75' ' ' PHE . 36.8 m-85 -80.81 -31.54 35.6 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -173.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.504 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 25.2 tp10 -54.73 -46.75 99.31 Favored Pre-proline 0 N--CA 1.481 1.105 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 73.0 Cg_exo -52.13 -18.68 7.68 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 122.736 2.29 . . . . 0.0 114.318 176.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -82.61 -29.8 29.91 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.079 -0.388 . . . . 0.0 112.029 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.428 ' HA3' ' HB3' ' A' ' 80' ' ' CYS . . . -169.83 -99.25 0.12 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.316 -0.469 . . . . 0.0 112.447 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -166.43 136.98 3.36 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.143 0.497 . . . . 0.0 111.784 173.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.457 HG21 HG13 ' A' ' 56' ' ' ILE . 3.5 mp -96.89 129.26 47.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.311 177.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -77.61 -55.37 5.41 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.455 0.645 . . . . 0.0 110.345 173.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 95.9 p -150.67 150.55 31.25 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.13 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.457 HG13 HG21 ' A' ' 53' ' ' ILE . 60.9 mt -119.77 126.97 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 121.004 0.43 . . . . 0.0 111.212 176.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -101.79 118.4 36.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.981 0.42 . . . . 0.0 110.276 173.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.542 HD23 ' HG3' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -98.34 131.19 44.85 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.5 tpt -92.01 93.47 8.78 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.643 0.735 . . . . 0.0 111.047 -171.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 22.1 ptp -132.94 166.32 22.62 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.622 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -99.73 104.83 16.58 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.874 0.368 . . . . 0.0 110.931 -177.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.7 p -80.78 5.19 16.59 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -175.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -96.7 -55.09 3.01 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.364 0.602 . . . . 0.0 110.812 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.6 p -87.82 -22.06 24.71 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.913 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.39 46.62 5.19 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.433 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -128.07 179.5 5.56 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.734 0.414 . . . . 0.0 111.197 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.8 m -124.69 140.07 53.28 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.597 0.237 . . . . 0.0 111.246 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -85.5 -31.3 22.83 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.801 0.334 . . . . 0.0 111.48 178.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.98 12.64 33.78 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.803 175.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.423 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 2.7 m-85 -121.87 160.56 24.48 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.397 -0.473 . . . . 0.0 110.734 178.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.36 130.51 3.27 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.456 -0.402 . . . . 0.0 112.372 175.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.431 ' HB3' ' HD3' ' A' ' 28' ' ' ARG . 89.4 m-85 -98.99 107.2 19.57 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.06 0.457 . . . . 0.0 111.078 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' A' ' 43' ' ' LEU . 69.5 mt -99.49 127.92 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.689 -176.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.9 m -103.25 122.82 45.55 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.007 0.432 . . . . 0.0 111.711 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.503 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 44.3 m-85 -99.31 151.45 21.04 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.453 177.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.1 t -76.91 -5.67 49.4 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.735 0.302 . . . . 0.0 111.205 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.505 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 29.0 t70 -142.6 147.62 36.13 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.021 0.439 . . . . 0.0 111.488 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.6 p -72.26 -42.71 65.31 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.054 -178.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -69.13 -38.12 78.69 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.641 0.258 . . . . 0.0 111.359 -177.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.505 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 83.7 m -55.4 -45.5 76.65 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.205 0.526 . . . . 0.0 111.178 175.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.08 -40.99 82.58 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.292 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -58.29 -44.5 88.52 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.072 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -65.23 -49.44 69.66 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.625 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.27 -47.47 72.28 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.945 0.403 . . . . 0.0 111.228 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 85' ' ' LEU . 8.8 tt -57.51 -50.7 72.2 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.79 174.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -54.02 -35.09 61.55 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.912 -175.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -93.31 -42.85 9.09 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.7 mt -87.61 -17.21 32.44 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -169.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -71.0 107.98 4.35 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.116 0.484 . . . . 0.0 110.616 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.93 -13.78 37.82 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.245 -174.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -65.67 135.11 54.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.957 0.408 . . . . 0.0 111.885 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 92' ' ' GLU . 9.0 pt-20 -73.73 95.0 2.3 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.195 0.521 . . . . 0.0 111.105 177.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 67.2 tp -67.4 -77.21 0.07 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.28 0.562 . . . . 0.0 111.787 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -108.08 46.41 0.96 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.247 0.546 . . . . 0.0 110.895 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.94 3.42 89.21 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.098 -174.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -128.69 139.68 36.29 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 123.138 0.575 . . . . 0.0 110.255 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.23 134.43 63.97 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.536 2.157 . . . . 0.0 112.048 175.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.43 ' HA ' ' HB2' ' A' ' 33' ' ' SER . 39.3 ttp -98.44 121.73 40.74 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.106 0.479 . . . . 0.0 111.465 -174.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -87.63 100.58 12.91 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.891 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 28.1 t -111.65 102.21 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.829 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -120.18 138.82 13.29 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.725 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -76.33 53.1 0.81 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 122.379 -0.483 . . . . 0.0 111.724 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.2 t 45.07 77.22 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.445 0.641 . . . . 0.0 111.23 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 77.4 p -67.52 149.21 50.46 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.208 -174.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -34.64 62.48 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.565 178.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -86.88 -16.14 36.92 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.777 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.5 m 72.33 -55.56 0.67 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.609 0.764 . . . . 0.0 112.117 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 . . . . . 0 C--O 1.253 1.285 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 174.31 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo . . . . . 0 CA--C 1.54 0.824 0 N-CA-C 113.199 0.423 . . . . 0.0 113.199 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.7 ttt -148.55 140.87 24.17 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.354 -177.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 28' ' ' ARG . 41.9 ttp180 -115.25 128.33 56.07 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.831 0.348 . . . . 0.0 111.124 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.2 mt -103.5 150.05 24.26 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.168 0.509 . . . . 0.0 112.063 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 78.3 t80 -107.25 106.8 17.43 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.537 176.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.422 HG22 HG22 ' A' ' 100' ' ' VAL . 51.4 t -105.72 125.18 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 120.799 0.333 . . . . 0.0 111.826 -177.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -127.64 96.91 0.45 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 121.248 -0.501 . . . . 0.0 113.7 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 96.6 p -163.96 11.2 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.054 0.454 . . . . 0.0 111.671 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.436 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 8.3 mt -83.06 81.46 8.67 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -171.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.414 ' O ' ' CD2' ' A' ' 35' ' ' HIS . 1.1 p-80 -80.38 71.35 7.19 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.738 0.78 . . . . 0.0 112.319 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 61.47 9.36 2.63 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 172.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -143.3 -8.81 0.77 Allowed 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.246 -0.909 . . . . 0.0 113.364 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.534 ' N ' HD12 ' A' ' 38' ' ' ILE . 2.5 mp -90.59 113.34 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 O-C-N 121.709 -0.62 . . . . 0.0 110.308 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.3 p -95.94 170.42 9.3 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -174.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -53.17 -44.14 67.64 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.683 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -64.13 -39.52 94.21 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.135 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.0 mmt -62.4 -53.05 60.64 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.329 0.585 . . . . 0.0 110.482 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.417 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 54.8 mt -54.67 -55.17 32.52 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.927 176.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.48 ' HB2' HD11 ' A' ' 56' ' ' ILE . 25.4 ttt85 -55.13 -44.1 74.74 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.6 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.12 -29.7 68.92 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.438 -0.41 . . . . 0.0 113.5 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.9 mt -83.46 -34.46 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 O-C-N 122.475 -0.426 . . . . 0.0 112.09 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.428 ' HD2' ' HZ ' ' A' ' 75' ' ' PHE . 6.9 m-85 -85.28 -32.16 22.69 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -174.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.15 -35.51 21.48 Favored Pre-proline 0 N--CA 1.479 1.0 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -45.47 -26.65 2.87 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.205 1.937 . . . . 0.0 113.117 170.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -80.18 -47.74 14.23 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.932 0.396 . . . . 0.0 111.027 174.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.424 ' HA3' ' SG ' ' A' ' 80' ' ' CYS . . . -161.44 -101.5 0.17 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.208 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 52' ' ' ARG . 38.3 ttt180 -164.66 146.13 8.1 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 122.569 -0.371 . . . . 0.0 111.015 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.448 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.3 mp -108.79 130.62 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.835 0.35 . . . . 0.0 111.549 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -79.7 -49.4 12.14 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.853 0.359 . . . . 0.0 111.477 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.5 p -150.79 144.17 24.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.088 0.47 . . . . 0.0 111.57 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.48 HD11 ' HB2' ' A' ' 44' ' ' ARG . 61.9 mt -115.7 115.44 49.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 177.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -110.2 105.69 14.84 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.805 0.336 . . . . 0.0 111.082 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 72.1 mt -98.07 146.78 25.2 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.914 0.388 . . . . 0.0 111.087 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 66.6 mmm . . . . . 0 C--O 1.236 0.361 0 CA-C-O 120.975 0.417 . . . . 0.0 110.026 178.747 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 134.44 -15.41 4.43 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.601 -0.809 . . . . 0.0 114.123 177.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -137.36 150.66 47.86 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.399 0.599 . . . . 0.0 112.453 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.37 158.51 27.76 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 116.182 -0.463 . . . . 0.0 113.018 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -102.08 125.24 48.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.03 0.443 . . . . 0.0 111.352 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.41 HG12 HG23 ' A' ' 56' ' ' ILE . 73.4 mt -111.53 123.22 67.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.165 0.507 . . . . 0.0 111.249 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.4 m -99.54 119.26 37.76 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.458 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 49.1 m-85 -100.95 150.63 22.67 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.424 175.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.3 t -78.36 -30.01 47.8 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.994 0.426 . . . . 0.0 110.942 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -106.91 117.25 33.57 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.827 0.346 . . . . 0.0 111.434 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.9 p -59.5 -52.93 63.48 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.6 tp10 -55.15 -43.91 74.65 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.835 0.35 . . . . 0.0 111.481 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.424 ' SG ' ' HA3' ' A' ' 51' ' ' GLY . 52.6 t -62.9 -45.1 94.12 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.247 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -60.86 -44.04 97.56 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.251 0.548 . . . . 0.0 111.225 176.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.435 ' HB3' ' HE2' ' A' ' 82' ' ' LYS . 35.7 ttpt -61.71 -38.52 88.19 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.85 177.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -65.23 -46.78 79.24 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.163 176.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.59 -48.05 78.26 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.007 0.432 . . . . 0.0 110.634 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.428 ' C ' HD23 ' A' ' 85' ' ' LEU . 8.2 tt -55.58 -50.76 69.23 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.293 0.568 . . . . 0.0 110.668 174.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -62.26 -32.08 72.73 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.913 -173.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -94.88 -36.76 11.5 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.439 ' O ' ' HB3' ' A' ' 98' ' ' MET . 91.4 mt -87.97 -20.1 26.34 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -172.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -64.25 105.67 0.95 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.225 0.536 . . . . 0.0 110.411 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.49 -9.1 26.3 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.098 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -69.34 130.87 43.79 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 122.646 0.378 . . . . 0.0 112.005 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -89.22 103.95 16.53 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.208 0.528 . . . . 0.0 111.536 176.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.2 tp -87.79 -68.62 0.75 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.291 0.567 . . . . 0.0 111.386 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.53 45.36 1.01 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.434 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.0 26.31 74.8 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.211 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -151.85 133.15 7.87 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 123.11 0.564 . . . . 0.0 110.225 -175.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -54.43 150.77 32.76 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.894 2.396 . . . . 0.0 113.921 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.497 ' HG3' HG23 ' A' ' 100' ' ' VAL . 44.0 tpp -98.41 108.27 20.93 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.869 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -88.63 100.1 12.84 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 122.171 -0.331 . . . . 0.0 111.211 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.497 HG23 ' HG3' ' A' ' 98' ' ' MET . 59.9 t -117.54 107.96 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.938 0.399 . . . . 0.0 111.599 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -120.75 155.47 16.24 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.981 177.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 20.3 p80 . . . . . 0 N--CA 1.474 0.731 0 O-C-N 122.081 -0.658 . . . . 0.0 112.453 -177.955 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 38.6 Cg_exo . . . . . 0 CA--C 1.544 1.011 0 N-CA-C 113.216 0.429 . . . . 0.0 113.216 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 11.0 tpt -102.74 145.74 29.27 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.977 0.418 . . . . 0.0 111.689 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -114.52 127.56 55.87 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.043 0.449 . . . . 0.0 111.751 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.4 mt -104.31 149.89 24.94 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.188 0.518 . . . . 0.0 111.546 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.409 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 59.4 t80 -103.45 109.87 21.68 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.539 176.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -110.93 108.16 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 120.743 0.306 . . . . 0.0 111.047 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -121.77 88.59 0.42 Allowed Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.823 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.3 m -164.42 24.98 0.07 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 120.939 0.4 . . . . 0.0 111.283 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 34.2 mt -85.23 143.97 28.42 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.891 0.377 . . . . 0.0 111.661 -174.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.438 ' CE1' ' HB3' ' A' ' 37' ' ' ASN . 33.1 p80 -108.83 48.65 0.85 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.079 0.466 . . . . 0.0 111.708 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 50.1 t80 61.54 9.18 2.58 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.438 ' HB3' ' CE1' ' A' ' 35' ' ' HIS . 3.3 t-20 -142.5 37.06 1.49 Allowed 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.539 -0.725 . . . . 0.0 111.669 -178.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.3 mm -125.76 106.62 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 O-C-N 122.023 -0.423 . . . . 0.0 110.407 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.3 p -93.26 175.66 6.68 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.154 0.502 . . . . 0.0 112.304 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.468 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 2.7 mp0 -53.09 -36.01 60.22 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.214 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -56.45 -52.09 65.98 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.847 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.6 tpt -65.34 -47.9 74.9 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.188 0.518 . . . . 0.0 110.711 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.0 mt -56.11 -44.11 78.78 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.248 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -65.15 -44.65 87.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.217 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.99 -31.89 65.72 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.267 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 58.2 mt -86.0 -45.03 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 75' ' ' PHE . 37.5 m-85 -85.14 -43.7 13.61 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -172.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.466 ' CD ' HH11 ' A' ' 52' ' ' ARG . 36.1 tt0 -59.56 -35.1 26.57 Favored Pre-proline 0 N--CA 1.48 1.028 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -172.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 48' ' ' GLU . 60.3 Cg_exo -43.01 -29.39 1.55 Allowed 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 122.081 1.854 . . . . 0.0 113.523 172.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -82.11 -31.18 30.81 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.933 0.397 . . . . 0.0 111.482 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.564 ' HA3' ' HB3' ' A' ' 80' ' ' CYS . . . -175.89 134.47 2.66 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.279 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.466 HH11 ' CD ' ' A' ' 48' ' ' GLU . 14.1 tpt180 -48.22 125.14 8.85 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 122.946 0.498 . . . . 0.0 111.941 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 73.8 mt -94.73 133.95 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.171 0.51 . . . . 0.0 111.831 -175.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -83.92 -51.34 7.24 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.862 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.6 m -150.48 132.95 15.64 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.896 0.379 . . . . 0.0 111.694 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.541 HG23 HG12 ' A' ' 73' ' ' ILE . 58.4 mt -108.84 107.6 23.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.821 176.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -102.19 118.59 37.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.363 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.4 HD13 ' HG3' ' A' ' 40' ' ' GLU . 9.4 mp -98.43 139.63 33.9 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.078 0.466 . . . . 0.0 110.577 175.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.701 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 45.0 tpp . . . . . 0 C--O 1.238 0.449 0 CA-C-O 121.405 0.622 . . . . 0.0 111.387 -173.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.701 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 68.8 mttm . . . . . 0 N--CA 1.471 0.614 0 CA-C-O 120.677 0.275 . . . . 0.0 111.538 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.99 -6.55 8.86 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.992 -0.623 . . . . 0.0 114.31 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -138.01 160.0 40.53 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 117.719 0.76 . . . . 0.0 112.571 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -142.63 151.71 23.27 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.802 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -105.26 115.59 30.51 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.804 0.442 . . . . 0.0 111.448 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.541 HG12 HG23 ' A' ' 56' ' ' ILE . 68.5 mt -104.78 128.37 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 122.222 -0.299 . . . . 0.0 111.546 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.3 m -108.21 121.35 44.68 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 18.2 m-85 -98.5 151.61 20.43 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.294 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.3 t -69.09 -13.04 62.2 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.833 0.349 . . . . 0.0 111.737 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.627 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 16.4 t70 -133.59 153.29 51.78 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.049 0.452 . . . . 0.0 111.361 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 68.7 p -73.12 -51.96 16.03 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.199 -176.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -74.36 -23.05 58.95 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 92.3 m -60.72 -42.84 98.06 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.221 0.534 . . . . 0.0 109.942 170.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.91 -46.94 73.28 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.958 174.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -53.41 -47.71 69.33 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.647 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -60.33 -44.88 95.08 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.184 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.98 -40.14 83.9 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.143 0.497 . . . . 0.0 110.937 175.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.8 -57.98 9.76 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.826 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.401 ' HG3' ' NE2' ' A' ' 87' ' ' GLN . 11.2 pt-20 -61.72 -26.85 68.31 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -174.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.401 ' NE2' ' HG3' ' A' ' 86' ' ' GLU . 2.7 mp0 -90.54 -34.7 15.43 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.4 mt -97.84 -14.22 20.85 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -173.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -70.85 80.8 0.63 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.584 0.707 . . . . 0.0 110.702 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.64 -4.71 5.13 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.169 -174.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -59.61 140.08 56.65 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -73.37 84.9 1.46 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.953 0.406 . . . . 0.0 111.524 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 67.0 tp -90.59 116.01 28.15 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.291 -0.256 . . . . 0.0 110.854 176.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 59.49 16.9 5.58 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.89 11.85 48.6 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.512 -0.375 . . . . 0.0 112.903 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -132.27 138.46 32.31 Favored Pre-proline 0 N--CA 1.468 0.467 0 O-C-N 122.65 -0.324 . . . . 0.0 111.306 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.19 131.44 38.89 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.326 2.018 . . . . 0.0 112.169 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.4 ttp -97.01 118.99 34.63 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.289 0.566 . . . . 0.0 111.398 -175.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -88.38 104.91 17.21 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.72 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.9 t -111.6 111.44 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.11 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 30' ' ' TYR . . . -133.77 150.8 20.01 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.324 177.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 21.1 p80 . . . . . 0 CA--C 1.54 0.594 0 CA-C-N 117.788 0.794 . . . . 0.0 111.017 -179.964 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo . . . . . 0 CA--C 1.542 0.899 0 N-CA-C 113.687 0.61 . . . . 0.0 113.687 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.3 ttt -102.08 135.82 42.98 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.857 0.36 . . . . 0.0 111.08 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.449 ' HD3' ' HB3' ' A' ' 72' ' ' PHE . 33.7 ttm180 -106.55 134.52 49.55 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -176.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.516 HD22 HD12 ' A' ' 85' ' ' LEU . 75.2 mt -113.11 147.68 36.83 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.191 0.519 . . . . 0.0 111.784 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -94.77 123.17 38.07 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.572 174.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.2 t -116.97 123.2 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 120.733 0.302 . . . . 0.0 111.245 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.3 96.84 0.53 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.277 -0.487 . . . . 0.0 113.345 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.442 ' HB3' ' HA ' ' A' ' 98' ' ' MET . 78.3 p -174.72 15.46 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 177.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.432 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 20.8 mt -82.55 83.31 7.62 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.88 -0.513 . . . . 0.0 111.102 -173.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.415 ' O ' ' CG ' ' A' ' 35' ' ' HIS . 14.4 p80 -78.15 65.08 3.45 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.429 0.633 . . . . 0.0 112.012 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 56.5 t80 55.37 9.73 0.4 Allowed 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 176.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -139.64 1.63 1.94 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.343 -0.848 . . . . 0.0 112.762 -176.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.478 HD12 ' SD ' ' A' ' 42' ' ' MET . 31.6 mm -103.53 118.05 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 O-C-N 121.874 -0.516 . . . . 0.0 110.753 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 34.4 p -103.65 176.59 5.1 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.22 0.534 . . . . 0.0 112.138 -175.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -53.17 -48.58 67.88 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.463 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -59.12 -40.32 85.07 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.792 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.511 ' SD ' HD11 ' A' ' 93' ' ' LEU . 46.3 ttm -65.21 -46.56 80.16 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.256 0.551 . . . . 0.0 110.442 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.3 mt -57.95 -44.46 87.02 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.697 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 44' ' ' ARG . 43.5 ttm180 -56.65 -44.74 81.61 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.164 0.506 . . . . 0.0 110.817 175.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.72 -35.45 81.64 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.129 -0.558 . . . . 0.0 113.638 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.45 HD11 HD13 ' A' ' 93' ' ' LEU . 63.3 mt -84.72 -45.13 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -85.25 -34.04 22.05 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -173.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.619 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 36.4 tt0 -56.84 -41.48 91.53 Favored Pre-proline 0 N--CA 1.477 0.921 0 N-CA-C 113.682 0.994 . . . . 0.0 113.682 -172.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 48' ' ' GLU . 5.1 Cg_endo -47.3 -33.15 15.83 Favored 'Trans proline' 0 C--N 1.363 1.292 0 C-N-CA 122.232 1.954 . . . . 0.0 112.934 175.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -77.1 -47.8 19.5 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.164 0.507 . . . . 0.0 110.876 175.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -162.6 136.52 4.37 Favored Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.845 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 -54.98 134.57 48.95 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.007 0.432 . . . . 0.0 112.057 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.491 HG21 HG13 ' A' ' 56' ' ' ILE . 1.8 mp -81.82 129.38 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.103 0.478 . . . . 0.0 111.813 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -90.43 -43.52 10.22 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.334 176.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.0 p -151.98 148.21 27.47 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.715 0.293 . . . . 0.0 111.64 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.491 HG13 HG21 ' A' ' 53' ' ' ILE . 59.4 mt -127.53 106.61 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.891 0.377 . . . . 0.0 110.895 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -99.45 115.22 28.78 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.614 0.245 . . . . 0.0 110.936 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 80.4 mt -98.01 132.16 43.81 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.037 0.446 . . . . 0.0 110.99 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 89.1 mmm . . . . . 0 CA--C 1.536 0.405 0 CA-C-O 121.343 0.592 . . . . 0.0 111.295 -178.312 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.6 mttm . . . . . 0 N--CA 1.472 0.675 0 CA-C-O 120.871 0.367 . . . . 0.0 111.736 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 104.1 4.44 44.58 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 120.936 -0.649 . . . . 0.0 114.588 174.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -144.84 156.12 43.85 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 117.643 0.722 . . . . 0.0 112.649 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.94 160.73 28.76 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.793 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.449 ' HB3' ' HD3' ' A' ' 28' ' ' ARG . 90.7 m-85 -111.42 124.07 51.5 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 122.569 -0.371 . . . . 0.0 111.511 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.5 mt -112.85 132.98 60.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 120.914 0.388 . . . . 0.0 111.703 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.3 m -101.65 125.41 48.31 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.705 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.469 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 88.3 m-85 -108.99 151.21 26.64 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.811 0.445 . . . . 0.0 111.167 177.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.9 m -62.88 -31.19 72.19 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -177.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.62 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 25.3 t70 -126.88 148.04 50.03 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.073 0.464 . . . . 0.0 111.612 -172.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.1 t -76.17 -34.46 59.34 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -77.24 -36.54 54.51 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.726 0.298 . . . . 0.0 111.114 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.62 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 17.5 p -63.67 -44.17 94.54 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.086 0.47 . . . . 0.0 110.257 175.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -64.63 -46.66 81.59 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.113 175.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -54.56 -43.72 72.3 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.627 175.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.86 -42.62 94.71 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.831 0.348 . . . . 0.0 111.285 177.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.56 -55.25 36.84 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.006 0.431 . . . . 0.0 111.071 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.516 HD12 HD22 ' A' ' 29' ' ' LEU . 8.6 tt -51.57 -55.89 16.63 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.826 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -54.15 -34.03 59.39 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.562 -175.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -97.39 -24.21 15.73 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 97.7 mt -101.65 -11.21 19.37 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -173.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -68.54 85.9 0.3 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.966 0.889 . . . . 0.0 111.225 177.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 127.73 -2.13 6.94 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.309 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -59.69 134.92 57.47 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.459 0.304 . . . . 0.0 111.357 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.34 91.38 1.72 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.23 0.538 . . . . 0.0 111.728 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.511 HD11 ' SD ' ' A' ' 42' ' ' MET . 55.0 tp -99.89 122.05 42.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.596 177.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 59.15 18.67 6.69 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.042 0.448 . . . . 0.0 111.812 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.3 -20.25 30.71 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 116.213 -0.448 . . . . 0.0 113.128 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -115.21 153.81 47.35 Favored Pre-proline 0 CA--C 1.537 0.475 0 O-C-N 122.768 -0.254 . . . . 0.0 111.614 -174.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -63.65 139.02 67.42 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.216 1.944 . . . . 0.0 112.772 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.442 ' HA ' ' HB3' ' A' ' 33' ' ' SER . 44.3 ttp -97.84 120.37 38.11 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.04 -178.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -88.26 99.88 12.57 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.057 0.456 . . . . 0.0 112.155 -174.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 18.3 t -106.03 126.83 61.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.035 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -149.95 160.59 28.57 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.263 -0.494 . . . . 0.0 113.132 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.8 p80 . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 121.104 0.478 . . . . 0.0 112.162 175.161 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 CA--C 1.544 0.992 0 N-CA-C 111.187 -0.351 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.2 ttt -100.0 122.67 43.26 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.861 -0.525 . . . . 0.0 111.293 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -98.99 125.76 44.52 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.769 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.45 HD22 HD12 ' A' ' 85' ' ' LEU . 76.8 mt -110.9 133.54 53.29 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.391 0.615 . . . . 0.0 111.74 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -89.78 109.36 20.36 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.331 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.8 t -109.73 123.21 65.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.78 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -123.73 97.29 0.56 Allowed Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.522 -0.371 . . . . 0.0 113.154 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.494 ' HB3' ' HA ' ' A' ' 98' ' ' MET . 99.7 p -161.02 9.74 0.09 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.089 0.471 . . . . 0.0 111.494 176.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.472 HD21 HD21 ' A' ' 43' ' ' LEU . 10.6 mt -87.16 87.71 7.51 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 122.2 -0.312 . . . . 0.0 111.595 -170.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -73.48 72.8 1.39 Allowed 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 56.07 20.62 4.48 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 173.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -153.78 -37.24 0.1 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -175.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.4 mm -59.98 128.72 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 120.778 0.323 . . . . 0.0 111.517 -175.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 62.7 p -113.45 178.16 4.38 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -173.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -48.67 -46.1 39.76 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.964 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.66 -44.87 63.19 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.488 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.7 mmt -66.89 -47.06 72.97 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.461 0.648 . . . . 0.0 110.576 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.472 HD21 HD21 ' A' ' 34' ' ' LEU . 70.6 mt -59.46 -50.67 73.05 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.735 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 44' ' ' ARG . 8.2 ttm180 -58.56 -44.7 89.79 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 122.27 -0.268 . . . . 0.0 111.657 177.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.36 -38.36 68.81 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.579 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.489 HD11 HD13 ' A' ' 93' ' ' LEU . 59.6 mt -86.8 -49.18 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 75' ' ' PHE . 51.6 m-85 -77.18 -41.76 40.28 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -170.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.413 ' HB2' HD12 ' A' ' 53' ' ' ILE . 29.6 tt0 -62.85 -37.88 38.15 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -173.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -46.06 -18.06 0.37 Allowed 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.447 2.098 . . . . 0.0 114.112 172.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -82.23 -42.97 18.21 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.801 0.334 . . . . 0.0 111.417 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.17 -122.87 1.06 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.791 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.401 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 29.8 mmt180 -140.29 129.77 24.08 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.387 0.613 . . . . 0.0 111.449 175.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.413 HD12 ' HB2' ' A' ' 48' ' ' GLU . 74.9 mt -100.35 120.81 50.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.822 -175.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -73.45 -53.88 9.59 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.956 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.8 t -150.55 150.2 30.92 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.032 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.1 mt -120.65 116.7 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.372 175.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -118.01 129.18 55.43 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.722 0.296 . . . . 0.0 111.263 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 58' ' ' LEU . 6.0 mp -99.78 141.85 32.04 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.974 0.416 . . . . 0.0 111.075 177.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.462 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 31.0 tpp . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 121.767 0.794 . . . . 0.0 111.675 -176.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.462 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 57.2 mttp . . . . . 0 N--CA 1.473 0.719 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 112.7 3.12 25.4 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 120.937 -0.649 . . . . 0.0 114.495 177.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -140.76 158.77 43.48 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.818 0.809 . . . . 0.0 112.423 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -144.37 159.95 27.8 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.629 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -107.4 124.9 50.52 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 122.624 -0.339 . . . . 0.0 111.256 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 64.7 mt -110.21 130.82 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 120.896 0.379 . . . . 0.0 111.145 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.0 m -106.35 114.25 28.26 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.417 ' CZ ' ' HB3' ' A' ' 47' ' ' PHE . 38.5 m-85 -99.46 152.42 20.01 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.14 0.576 . . . . 0.0 110.763 177.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.8 t -93.65 -5.55 48.41 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.662 0.744 . . . . 0.0 110.002 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -119.8 101.81 8.15 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.186 -175.395 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.7 p -56.9 -55.21 37.5 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -176.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -58.23 -47.36 83.78 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 82.5 m -62.09 -40.86 97.26 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.846 0.355 . . . . 0.0 111.572 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.89 -42.68 89.96 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.064 0.459 . . . . 0.0 111.452 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -62.67 -36.38 82.71 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.093 0.473 . . . . 0.0 110.729 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -63.31 -52.05 63.54 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.086 0.47 . . . . 0.0 110.359 172.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.66 -43.69 57.4 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.201 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.45 HD12 HD22 ' A' ' 29' ' ' LEU . 9.5 tt -54.01 -62.76 1.44 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.185 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -74.9 -4.8 40.16 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -172.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -98.32 -29.72 13.0 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.95 -0.469 . . . . 0.0 111.495 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 88.1 mt -106.71 -13.27 15.32 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -175.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -70.17 91.41 0.71 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.28 0.562 . . . . 0.0 110.247 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 125.98 -15.51 6.95 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.992 -172.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -59.73 133.9 56.53 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.072 0.549 . . . . 0.0 111.457 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 30.8 mt-10 -89.08 90.22 8.3 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.238 0.542 . . . . 0.0 111.923 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.489 HD13 HD11 ' A' ' 46' ' ' ILE . 36.2 tp -85.31 -65.5 1.0 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.41 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.04 38.56 0.66 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.879 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.89 17.27 75.19 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 121.241 -0.504 . . . . 0.0 111.954 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 9.7 ptm85 -157.68 151.59 19.67 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 115.505 -0.347 . . . . 0.0 110.349 -174.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.51 141.48 62.3 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.005 2.47 . . . . 0.0 113.039 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.494 ' HA ' ' HB3' ' A' ' 33' ' ' SER . 36.5 ttp -99.31 128.12 45.4 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.119 0.485 . . . . 0.0 111.48 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -89.12 101.46 14.12 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.533 -178.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.7 t -114.24 111.38 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 120.789 0.328 . . . . 0.0 111.321 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -127.38 151.11 18.33 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.298 -0.477 . . . . 0.0 113.272 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.1 p80 . . . . . 0 N--CA 1.473 0.68 0 O-C-N 122.32 -0.518 . . . . 0.0 111.705 178.955 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo . . . . . 0 CA--C 1.541 0.867 0 CA-C-O 120.752 0.23 . . . . 0.0 112.292 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.8 ttt -99.6 136.4 39.58 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.091 0.472 . . . . 0.0 111.471 -176.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -112.48 118.98 36.64 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.349 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.9 mt -102.4 145.65 29.22 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.347 0.594 . . . . 0.0 112.126 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -102.08 120.48 40.51 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.616 173.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.3 t -118.98 115.94 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.672 0.272 . . . . 0.0 110.997 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.55 87.51 0.38 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.334 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.4 m -166.13 28.72 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.164 0.585 . . . . 0.0 110.61 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.493 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 15.0 mt -95.25 103.09 14.94 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.768 -176.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -74.21 67.1 1.34 Allowed 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -176.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 50.72 20.83 0.8 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 174.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.16 -38.2 0.27 Allowed 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.99 -0.444 . . . . 0.0 111.784 -174.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.7 mm -60.38 109.63 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 120.824 0.345 . . . . 0.0 111.149 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 61.0 p -92.93 172.57 8.24 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -54.79 -42.72 72.13 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.726 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -63.38 -38.04 89.61 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.703 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.1 mmt -65.51 -52.73 50.58 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.408 0.623 . . . . 0.0 110.197 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 65.5 mt -55.2 -40.33 70.65 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.925 174.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 44' ' ' ARG . 45.0 ttm180 -61.5 -46.76 88.64 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.876 0.37 . . . . 0.0 110.957 177.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.31 -32.03 60.09 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.139 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 58.1 mt -85.68 -50.12 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -82.48 -27.69 31.65 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -172.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.632 ' HG3' ' O ' ' A' ' 52' ' ' ARG . 22.1 tt0 -57.33 -48.23 97.68 Favored Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -173.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 80.3 Cg_exo -47.89 -18.88 1.23 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 122.621 2.214 . . . . 0.0 114.013 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -78.45 -40.31 36.05 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.42 ' HA3' ' HB3' ' A' ' 80' ' ' CYS . . . -169.8 37.93 0.19 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 119.838 -1.173 . . . . 0.0 115.438 -178.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.632 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 0.0 OUTLIER 72.67 -53.79 0.7 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.366 0.666 . . . . 0.0 112.541 174.593 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.447 ' HB ' ' O ' ' A' ' 52' ' ' ARG . 68.7 mt 79.82 137.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.756 0.823 . . . . 0.0 111.672 -177.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -85.01 -64.96 1.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.196 0.522 . . . . 0.0 110.151 174.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.2 t -147.59 146.36 29.36 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.046 0.451 . . . . 0.0 111.865 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.527 HG23 HG12 ' A' ' 73' ' ' ILE . 60.4 mt -115.36 130.19 70.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.894 174.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -125.07 122.45 37.26 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.924 0.393 . . . . 0.0 111.547 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.8 mt -99.13 149.73 22.75 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.657 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 82.8 mmm . . . . . 0 CA--C 1.537 0.458 0 CA-C-O 120.699 0.285 . . . . 0.0 110.727 179.898 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.2 mttm . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 145.27 -11.01 1.79 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.929 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -128.55 145.26 51.18 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 117.23 0.515 . . . . 0.0 111.858 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.33 160.87 28.75 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.651 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -113.25 127.25 56.1 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.007 0.432 . . . . 0.0 111.72 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 56' ' ' ILE . 67.1 mt -110.12 134.71 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.771 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 38.8 m -116.25 123.3 47.39 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.025 0.44 . . . . 0.0 111.926 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -100.22 149.66 23.34 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.511 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.8 m -72.06 -9.46 58.42 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.066 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.632 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 19.8 t70 -138.12 150.23 46.65 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.874 0.369 . . . . 0.0 111.47 -177.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 71.2 p -68.72 -53.19 23.5 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -68.54 -30.17 68.9 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 93.8 m -58.03 -41.45 83.25 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.16 0.505 . . . . 0.0 111.183 174.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.39 -38.67 29.85 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.237 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -54.93 -48.94 72.48 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.308 0.575 . . . . 0.0 110.688 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -70.02 -41.97 73.59 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.566 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.06 -44.02 67.14 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.273 0.558 . . . . 0.0 110.873 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 tt -62.29 -62.25 1.89 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.521 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -56.54 -29.73 62.29 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -176.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -87.95 -38.6 15.42 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 122.09 -0.381 . . . . 0.0 111.728 -175.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 76.5 mt -96.16 -23.4 16.76 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -172.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -65.69 100.13 0.51 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.068 0.461 . . . . 0.0 110.641 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.47 -9.67 13.1 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.738 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -73.22 126.97 31.3 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 122.535 -0.391 . . . . 0.0 111.938 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 45.3 mt-10 -80.04 102.54 9.35 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.866 0.365 . . . . 0.0 111.143 176.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 65.8 tp -89.53 -66.74 0.89 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.034 0.445 . . . . 0.0 111.516 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -92.15 32.4 1.17 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.955 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.61 4.99 79.2 Favored Glycine 0 C--N 1.332 0.343 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 -174.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 1.5 ptm85 -143.44 152.37 56.81 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 122.927 0.491 . . . . 0.0 110.695 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -61.16 155.59 50.12 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.118 2.545 . . . . 0.0 114.384 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 31.9 tpp -99.46 117.72 34.49 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.728 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.587 ' NZ ' ' HB3' ' A' ' 99' ' ' LYS . 7.7 mtpm? -89.32 101.97 14.64 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.121 -0.362 . . . . 0.0 111.419 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.6 t -120.52 118.1 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.886 0.374 . . . . 0.0 111.666 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -139.24 147.49 19.25 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.176 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 11.3 p80 . . . . . 0 N--CA 1.47 0.574 0 CA-C-N 117.663 0.732 . . . . 0.0 110.769 -179.675 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo . . . . . 0 CA--C 1.539 0.738 0 CA-C-O 121.014 0.339 . . . . 0.0 112.67 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.505 ' HB2' ' HA ' ' A' ' 78' ' ' SER . 27.0 ttt -113.11 133.15 55.15 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.972 0.415 . . . . 0.0 111.558 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -99.78 116.28 31.5 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.159 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.2 mt -99.55 143.06 30.23 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.13 0.491 . . . . 0.0 111.665 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -97.73 120.11 37.54 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.602 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 99' ' ' LYS . 58.4 t -115.17 112.55 40.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.478 176.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.56 93.35 0.22 Allowed Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.527 -0.844 . . . . 0.0 114.645 -174.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.645 ' OG ' ' HA ' ' A' ' 98' ' ' MET . 90.9 p -176.08 19.89 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 28.8 mt -84.88 150.33 25.06 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 122.279 -0.263 . . . . 0.0 111.43 -175.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.4 ' O ' ' ND1' ' A' ' 35' ' ' HIS . 24.9 p80 -122.49 76.61 1.34 Allowed 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -176.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 23.7 t80 42.94 41.86 2.81 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.312 0.645 . . . . 0.0 112.616 173.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -152.99 -51.32 0.1 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.998 0.428 . . . . 0.0 111.374 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.64 ' HA ' ' SD ' ' A' ' 42' ' ' MET . 3.2 mp -62.59 127.9 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.137 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.437 ' OG1' ' HG3' ' A' ' 42' ' ' MET . 35.3 p -106.51 171.93 7.09 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.329 0.585 . . . . 0.0 112.078 -175.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.522 ' HG2' ' HG ' ' A' ' 58' ' ' LEU . 79.6 mt-10 -67.08 -32.88 74.35 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.793 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -64.17 -39.2 93.51 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.075 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.64 ' SD ' ' HA ' ' A' ' 38' ' ' ILE . 64.4 mtt -62.88 -52.4 63.23 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.442 0.639 . . . . 0.0 110.273 176.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.503 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 63.1 mt -54.47 -51.39 65.19 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.106 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -50.2 -50.1 50.58 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.888 0.375 . . . . 0.0 111.195 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.93 -28.77 66.57 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.656 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.8 mm -82.84 -38.33 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 O-C-N 122.453 -0.439 . . . . 0.0 111.97 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.503 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 44.5 m-85 -85.89 -30.83 22.56 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -174.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -56.7 -38.68 71.17 Favored Pre-proline 0 N--CA 1.483 1.197 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -47.18 -22.83 2.52 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.245 1.964 . . . . 0.0 113.408 171.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.429 ' HE1' ' HG3' ' A' ' 87' ' ' GLN . 81.5 m-85 -93.69 -44.9 7.94 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.087 0.47 . . . . 0.0 111.096 175.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -174.32 140.58 5.49 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.844 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.0 ttp85 -58.34 134.5 56.64 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.242 0.544 . . . . 0.0 112.082 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.4 mp -94.01 137.9 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.144 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -87.99 -40.67 13.69 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.833 0.349 . . . . 0.0 111.806 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.9 t -150.96 132.36 14.64 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.117 0.484 . . . . 0.0 112.238 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.534 HG23 HG12 ' A' ' 73' ' ' ILE . 47.9 mt -117.64 133.2 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.211 173.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -137.89 118.83 14.27 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.844 0.355 . . . . 0.0 111.404 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.605 HD23 ' HA3' ' A' ' 71' ' ' GLY . 91.7 mt -96.48 149.81 21.32 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 174.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.564 ' SD ' ' CE2' ' A' ' 70' ' ' TYR . 60.9 mtp . . . . . 0 C--O 1.237 0.435 0 CA-C-O 121.798 0.808 . . . . 0.0 111.349 -177.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.3 mttt . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.03 3.57 87.62 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 114.963 0.745 . . . . 0.0 114.963 169.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.564 ' CE2' ' SD ' ' A' ' 59' ' ' MET . 49.4 p90 -133.09 145.98 51.24 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 117.805 0.802 . . . . 0.0 111.993 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.605 ' HA3' HD23 ' A' ' 58' ' ' LEU . . . -151.2 161.9 29.28 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 115.816 -0.629 . . . . 0.0 113.239 -177.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -105.2 129.04 53.67 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.914 0.388 . . . . 0.0 111.768 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.534 HG12 HG23 ' A' ' 56' ' ' ILE . 66.8 mt -111.76 132.69 59.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.025 178.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.7 m -112.57 118.54 35.39 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.441 ' HZ ' ' HD2' ' A' ' 47' ' ' PHE . 45.0 m-85 -99.12 152.13 20.21 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.792 0.437 . . . . 0.0 111.841 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.1 m -68.09 -10.81 56.83 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.624 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -139.64 161.04 38.49 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.081 0.467 . . . . 0.0 112.096 -176.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.505 ' HA ' ' HB2' ' A' ' 27' ' ' MET . 51.7 m -91.33 -37.31 13.33 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -79.4 -40.01 31.06 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.015 -0.428 . . . . 0.0 112.023 -177.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 76.5 m -58.13 -41.86 84.57 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.329 0.585 . . . . 0.0 110.765 174.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.6 -45.37 68.73 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.984 176.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.518 ' HB2' ' NZ ' ' A' ' 82' ' ' LYS . 5.0 ttmp? -57.25 -34.98 69.16 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.405 178.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 46.0 tttm -75.23 -37.74 60.93 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.965 0.412 . . . . 0.0 111.01 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.89 -33.19 64.38 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.501 0.667 . . . . 0.0 110.475 172.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 100' ' ' VAL . 7.6 tt -65.85 -55.38 17.34 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.766 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 83' ' ' LYS . 2.6 pp20? -64.74 -19.28 65.7 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -174.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.429 ' HG3' ' HE1' ' A' ' 50' ' ' PHE . 85.9 mm-40 -94.6 -46.46 6.94 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.871 -0.518 . . . . 0.0 111.893 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 71.6 mt -89.61 -17.3 28.74 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -170.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -71.01 91.4 0.88 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.464 0.65 . . . . 0.0 110.187 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.42 -14.13 8.78 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.943 -173.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -61.77 120.26 10.34 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.703 0.401 . . . . 0.0 110.958 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 43.0 mt-10 -79.0 93.71 5.15 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.158 0.504 . . . . 0.0 111.67 -177.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.5 tp -96.51 135.88 37.79 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.995 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 59.76 24.07 13.0 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.206 0.527 . . . . 0.0 111.146 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.33 3.67 89.91 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.121 -0.491 . . . . 0.0 113.526 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 44.9 mtp180 -121.13 136.5 25.75 Favored Pre-proline 0 N--CA 1.473 0.676 0 CA-C-N 117.306 0.553 . . . . 0.0 111.731 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -59.99 129.31 29.81 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.473 2.115 . . . . 0.0 111.82 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.645 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 40.9 ttp -97.62 124.88 42.07 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.174 0.511 . . . . 0.0 111.781 -174.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 68.2 mttm -88.41 101.91 14.36 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.148 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.515 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 44.0 t -114.45 99.51 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.632 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -135.62 160.24 24.44 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.747 -0.739 . . . . 0.0 113.062 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 15.0 p80 . . . . . 0 CA--C 1.537 0.479 0 O-C-N 122.514 -0.403 . . . . 0.0 110.598 177.209 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo . . . . . 0 CA--C 1.541 0.874 0 N-CA-C 113.116 0.391 . . . . 0.0 113.116 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 26.3 ttt -99.12 141.27 32.09 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.677 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.489 ' HD3' ' HB3' ' A' ' 72' ' ' PHE . 42.4 ttm180 -115.71 130.95 57.05 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.171 0.51 . . . . 0.0 112.288 -171.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.427 HD11 ' O ' ' A' ' 81' ' ' ALA . 85.5 mt -107.66 145.39 33.43 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.195 0.522 . . . . 0.0 111.831 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.51 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 39.0 t80 -97.32 111.79 23.89 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.961 173.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -106.23 107.44 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 120.805 0.336 . . . . 0.0 111.35 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.592 ' HA2' ' HB3' ' A' ' 70' ' ' TYR . . . -113.39 97.57 0.87 Allowed Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.244 -0.503 . . . . 0.0 113.831 -176.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.73 ' HB2' ' HA ' ' A' ' 98' ' ' MET . 30.7 t -174.81 15.25 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.39 0.614 . . . . 0.0 111.183 172.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.725 ' HA ' HD12 ' A' ' 38' ' ' ILE . 11.1 mt -85.59 88.62 7.55 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 122.029 -0.42 . . . . 0.0 110.405 -171.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -78.49 69.29 4.65 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.579 0.704 . . . . 0.0 112.377 -172.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 48.3 t80 57.68 9.62 0.87 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 175.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -124.18 -38.91 2.4 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.609 -0.682 . . . . 0.0 112.596 -177.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.725 HD12 ' HA ' ' A' ' 34' ' ' LEU . 58.8 mt -67.61 134.06 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.938 0.399 . . . . 0.0 111.978 -176.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 56.6 p -110.02 166.21 11.12 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.066 0.46 . . . . 0.0 112.205 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.493 ' HA ' HD12 ' A' ' 43' ' ' LEU . 2.5 mp0 -63.07 -36.54 83.93 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.248 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -66.67 -33.56 75.92 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.909 0.385 . . . . 0.0 111.277 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.47 ' SD ' HG23 ' A' ' 38' ' ' ILE . 27.1 ttt -68.18 -44.66 75.41 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.562 0.696 . . . . 0.0 110.107 174.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 40' ' ' GLU . 92.2 mt -55.09 -55.26 33.0 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.722 178.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.534 ' HB3' HD11 ' A' ' 56' ' ' ILE . 14.2 ptm180 -61.78 -33.22 73.72 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.385 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.19 -36.8 69.81 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.63 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 63.2 mt -85.45 -49.21 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 177.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -82.31 -32.52 29.41 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -169.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.749 ' HG3' ' HA ' ' A' ' 52' ' ' ARG . 22.2 tt0 -62.07 -42.49 81.98 Favored Pre-proline 0 N--CA 1.48 1.056 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -174.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -47.78 -18.29 0.98 Allowed 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 122.529 2.152 . . . . 0.0 114.316 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -71.38 -51.9 21.58 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.525 ' N ' ' SG ' ' A' ' 80' ' ' CYS . . . -170.91 43.76 0.19 Allowed Glycine 0 N--CA 1.468 0.77 0 C-N-CA 120.079 -1.058 . . . . 0.0 114.092 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.749 ' HA ' ' HG3' ' A' ' 48' ' ' GLU . 0.3 OUTLIER 63.31 143.91 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.974 0.892 . . . . 0.0 113.39 178.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.41 HG13 ' HA ' ' A' ' 48' ' ' GLU . 89.2 mt -119.09 133.69 65.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.16 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -82.68 -56.48 3.83 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.674 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.7 p -150.12 138.34 20.39 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.255 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 44' ' ' ARG . 46.0 mt -107.67 116.31 50.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.343 0.592 . . . . 0.0 111.113 177.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -99.36 115.72 29.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.993 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 27.9 tp -97.16 133.35 41.92 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.551 -0.718 . . . . 0.0 110.516 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.6 ' HG3' ' HD3' ' A' ' 68' ' ' LYS . 14.3 tpt . . . . . 0 C--O 1.235 0.302 0 CA-C-O 121.889 0.852 . . . . 0.0 111.142 -171.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.6 ' HD3' ' HG3' ' A' ' 59' ' ' MET . 26.0 mtpp . . . . . 0 CA--C 1.542 0.643 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 101.03 7.05 51.02 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 120.969 -0.634 . . . . 0.0 114.486 175.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.592 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -145.26 160.07 42.05 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 117.476 0.638 . . . . 0.0 112.567 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -145.29 147.57 18.77 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.955 -0.566 . . . . 0.0 113.147 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.489 ' HB3' ' HD3' ' A' ' 28' ' ' ARG . 95.8 m-85 -99.57 112.67 24.85 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.935 0.398 . . . . 0.0 111.266 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.529 HG23 HG12 ' A' ' 56' ' ' ILE . 67.8 mt -99.41 126.18 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.956 0.408 . . . . 0.0 111.586 -178.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 36.7 m -101.54 118.41 36.9 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.517 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -98.53 151.53 20.54 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.109 0.481 . . . . 0.0 112.17 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.0 t -72.19 -28.83 63.46 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.148 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -116.3 133.0 56.51 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.972 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.6 t -67.04 -51.17 58.09 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.941 0.401 . . . . 0.0 111.891 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -57.77 -34.37 69.5 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.098 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 51' ' ' GLY . 7.7 t -57.97 -46.3 85.38 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.824 175.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.427 ' O ' HD11 ' A' ' 29' ' ' LEU . . . -65.16 -41.77 94.35 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.07 0.462 . . . . 0.0 111.15 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -64.93 -35.67 81.91 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.564 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 85.6 tttt -72.35 -50.41 26.95 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.741 0.305 . . . . 0.0 111.318 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.15 -42.77 61.01 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.11 0.481 . . . . 0.0 110.954 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.409 HD23 ' C ' ' A' ' 85' ' ' LEU . 7.8 tt -57.19 -55.9 28.7 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.511 173.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -53.67 -34.85 60.06 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.132 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 83' ' ' LYS . 11.1 mm100 -86.8 -35.43 19.12 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.911 -174.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 73.8 mt -104.79 -7.02 19.76 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -171.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -62.91 99.71 0.17 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.028 0.442 . . . . 0.0 111.134 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.05 -2.42 44.31 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 116.264 -0.426 . . . . 0.0 113.342 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -67.15 131.69 46.31 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 122.607 -0.349 . . . . 0.0 111.578 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.82 103.34 1.41 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.987 0.423 . . . . 0.0 111.153 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 56.6 tp -113.17 127.33 56.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.433 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 58.26 23.73 10.7 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.148 0.499 . . . . 0.0 111.754 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.99 -18.27 54.99 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.82 -0.627 . . . . 0.0 114.018 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 31.7 mtt85 -116.59 140.01 26.19 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 117.378 0.589 . . . . 0.0 111.997 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.23 132.12 48.74 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.778 2.318 . . . . 0.0 112.098 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.73 ' HA ' ' HB2' ' A' ' 33' ' ' SER . 38.5 ttp -96.75 119.35 35.07 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.361 0.6 . . . . 0.0 111.738 -171.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -87.8 94.19 9.68 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.64 -176.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.05 113.57 38.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.461 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.51 ' O ' ' HB3' ' A' ' 30' ' ' TYR . . . -142.08 131.59 4.8 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.25 -0.5 . . . . 0.0 112.548 176.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 25.9 p80 . . . . . 0 N--CA 1.477 0.881 0 CA-C-N 117.655 0.727 . . . . 0.0 112.128 -177.848 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo . . . . . 0 CA--C 1.543 0.958 0 N-CA-C 113.551 0.558 . . . . 0.0 113.551 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 11.7 tpt -126.23 147.51 49.66 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.763 0.315 . . . . 0.0 111.474 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 36.7 ttt85 -120.81 121.22 37.69 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.854 0.359 . . . . 0.0 111.308 -174.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 81.6 mt -106.01 143.66 33.82 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 55.2 t80 -91.66 116.06 28.57 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.495 172.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.465 HG21 HD12 ' A' ' 73' ' ' ILE . 60.0 t -118.73 109.14 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-O 121.093 0.473 . . . . 0.0 111.789 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.5 104.76 1.84 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.576 -0.345 . . . . 0.0 112.937 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.555 ' HB2' ' HA ' ' A' ' 98' ' ' MET . 39.7 t -171.64 14.61 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.248 0.547 . . . . 0.0 111.823 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.494 HD11 HD22 ' A' ' 58' ' ' LEU . 12.1 mt -86.16 85.44 7.35 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.722 -0.611 . . . . 0.0 111.529 -172.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.401 ' O ' ' ND1' ' A' ' 35' ' ' HIS . 33.8 p80 -78.64 66.58 4.18 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.672 0.748 . . . . 0.0 112.046 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 47.0 t80 60.18 9.24 1.8 Allowed 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.55 -34.95 1.53 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.584 -0.697 . . . . 0.0 111.483 -178.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.427 ' HB ' HD22 ' A' ' 34' ' ' LEU . 11.6 mm -73.21 107.36 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.931 0.396 . . . . 0.0 111.329 -175.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.5 p -99.54 179.23 4.62 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.957 0.408 . . . . 0.0 112.014 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -60.48 -43.13 97.28 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.275 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.31 -37.21 82.43 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.129 0.49 . . . . 0.0 110.959 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.403 ' SD ' HG23 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -67.54 -55.02 15.16 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.334 0.588 . . . . 0.0 110.246 178.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.4 mt -55.18 -44.12 74.94 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.444 176.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.511 HH21 ' NH1' ' A' ' 52' ' ' ARG . 53.9 ttt180 -58.7 -47.34 84.89 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.232 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.44 -31.59 60.05 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.998 177.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.8 mt -80.28 -54.48 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -79.76 -33.91 40.29 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -172.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.858 ' HG3' ' HA ' ' A' ' 52' ' ' ARG . 10.1 tt0 -60.78 -38.67 58.54 Favored Pre-proline 0 N--CA 1.476 0.867 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -172.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -46.3 -26.52 3.98 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.535 2.157 . . . . 0.0 113.798 172.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -66.91 -63.74 1.0 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.653 0.263 . . . . 0.0 111.595 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.465 ' HA3' ' SG ' ' A' ' 80' ' ' CYS . . . -165.65 40.02 0.28 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.472 -0.87 . . . . 0.0 114.314 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.858 ' HA ' ' HG3' ' A' ' 48' ' ' GLU . 43.7 tpt85 71.26 127.18 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 172.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.481 HG21 HG13 ' A' ' 56' ' ' ILE . 1.7 mp -82.89 141.31 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.038 0.447 . . . . 0.0 111.432 175.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -90.29 -56.22 3.3 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.309 0.576 . . . . 0.0 109.656 173.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.6 m -150.6 144.02 25.0 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.46 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.512 HG23 HG12 ' A' ' 73' ' ' ILE . 57.3 mt -122.29 109.87 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.023 0.44 . . . . 0.0 110.776 175.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -108.83 112.26 24.42 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.314 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.494 HD22 HD11 ' A' ' 34' ' ' LEU . 32.7 mt -98.69 141.91 30.92 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.81 0.338 . . . . 0.0 110.921 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 64.7 mtp . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 121.167 0.508 . . . . 0.0 111.488 -176.279 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.2 mttp . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.2 -6.63 19.17 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 120.917 -0.659 . . . . 0.0 114.439 174.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -135.56 151.72 50.58 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 117.376 0.588 . . . . 0.0 112.364 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.7 158.76 27.83 Favored Glycine 0 CA--C 1.527 0.844 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.734 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -101.51 120.44 40.3 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.601 -0.352 . . . . 0.0 111.603 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.512 HG12 HG23 ' A' ' 56' ' ' ILE . 70.9 mt -103.9 117.11 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.278 0.561 . . . . 0.0 111.249 178.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 51.9 m -99.85 125.71 45.85 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.68 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -103.3 150.44 23.75 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.782 175.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.8 t -72.92 -11.87 60.74 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.683 0.278 . . . . 0.0 111.65 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -126.24 144.38 50.8 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.852 0.358 . . . . 0.0 110.986 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 54.5 m -78.78 -43.67 24.94 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -69.69 -34.9 74.58 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.826 0.346 . . . . 0.0 111.508 -175.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.465 ' SG ' ' HA3' ' A' ' 51' ' ' GLY . 35.8 t -60.04 -43.39 95.36 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.068 0.461 . . . . 0.0 111.081 174.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.39 -40.97 96.84 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.01 176.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -56.67 -46.44 81.1 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.965 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 86.8 tttt -62.03 -54.04 47.06 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.288 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.92 -52.12 61.58 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.894 0.378 . . . . 0.0 111.836 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.9 tt -53.87 -54.6 36.29 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.621 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -64.67 -25.14 67.82 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -173.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 83' ' ' LYS . 8.3 mm-40 -95.72 -17.79 20.98 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.473 ' HB3' ' SD ' ' A' ' 98' ' ' MET . 90.2 mt -112.2 -24.53 9.79 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -175.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -60.03 101.41 0.12 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.169 0.509 . . . . 0.0 111.534 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.65 -15.98 9.69 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 116.063 -0.517 . . . . 0.0 113.013 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -63.41 129.98 42.53 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 122.658 -0.319 . . . . 0.0 111.784 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -65.86 94.31 0.21 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.993 0.425 . . . . 0.0 111.18 175.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 66.9 tp -86.75 115.25 24.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.426 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 55.92 22.35 5.65 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 109.26 -9.41 33.32 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 114.098 0.399 . . . . 0.0 114.098 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -130.93 134.89 26.51 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 117.405 0.603 . . . . 0.0 110.78 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.66 149.42 13.87 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.819 2.346 . . . . 0.0 113.26 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.555 ' HA ' ' HB2' ' A' ' 33' ' ' SER . 43.9 ttm -96.85 104.78 16.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.234 0.54 . . . . 0.0 109.906 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.414 ' NZ ' ' HB3' ' A' ' 99' ' ' LYS . 2.0 mmmp? -87.84 89.9 8.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.708 -175.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 20.4 t -105.2 117.82 51.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.089 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -148.14 162.15 28.73 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.208 -0.52 . . . . 0.0 113.053 -176.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 . . . . . 0 CA--C 1.539 0.547 0 CA-C-O 121.305 0.574 . . . . 0.0 111.552 177.319 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.701 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 14.4 Cg_exo . . . . . 0 CA--C 1.548 1.186 0 N-CA-C 116.619 1.738 . . . . 0.0 116.619 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.9 ttt -139.46 138.22 36.24 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.46 170.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 28' ' ' ARG . 62.8 mtt-85 -99.74 143.6 29.78 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.422 0.629 . . . . 0.0 112.483 -177.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.0 mt -112.44 139.16 48.24 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.28 177.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -90.71 108.8 20.06 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.769 176.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.35 104.41 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.674 0.273 . . . . 0.0 111.201 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.533 ' HA2' ' HB3' ' A' ' 70' ' ' TYR . . . -114.64 91.68 0.57 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.201 -0.523 . . . . 0.0 113.945 -177.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 t -175.15 21.13 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.433 0.635 . . . . 0.0 111.174 175.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.485 HD22 HG21 ' A' ' 38' ' ' ILE . 13.1 mt -85.02 93.13 8.52 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.869 -0.52 . . . . 0.0 110.945 -173.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -81.44 62.1 5.18 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.293 0.568 . . . . 0.0 112.531 -174.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 62.0 t80 59.61 9.22 1.49 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 173.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -130.95 4.95 4.51 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.61 -0.681 . . . . 0.0 111.502 -178.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.55 HG23 ' SD ' ' A' ' 42' ' ' MET . 27.1 mm -105.25 127.98 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 122.111 -0.368 . . . . 0.0 110.81 -177.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.6 p -107.23 167.3 10.01 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.936 0.398 . . . . 0.0 111.788 -176.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -55.21 -44.5 75.42 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.125 0.488 . . . . 0.0 110.878 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -68.03 -31.63 71.43 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.184 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.55 ' SD ' HG23 ' A' ' 38' ' ' ILE . 52.5 ttm -62.14 -50.21 72.77 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.406 0.622 . . . . 0.0 109.887 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.42 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 48.9 mt -57.14 -44.15 83.13 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.495 173.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -53.27 -47.35 69.21 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.078 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.74 -29.49 74.06 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.306 -0.473 . . . . 0.0 113.387 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.1 mt -84.59 -44.06 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 O-C-N 122.386 -0.479 . . . . 0.0 112.158 178.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.42 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 38.9 m-85 -85.64 -29.12 24.29 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -171.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -52.81 -47.33 95.21 Favored Pre-proline 0 N--CA 1.486 1.334 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -49.93 -18.22 2.83 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 122.801 2.334 . . . . 0.0 114.919 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.489 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 79.3 m-85 -78.69 -70.48 0.49 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.431 ' N ' ' SG ' ' A' ' 80' ' ' CYS . . . -157.95 24.25 0.4 Allowed Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.713 -177.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 68.88 144.9 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.502 ' N ' HD12 ' A' ' 53' ' ' ILE . 4.0 mp -107.22 139.72 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.45 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -78.32 -48.37 15.78 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.434 0.635 . . . . 0.0 110.937 175.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 61.3 m -151.2 132.28 14.35 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.66 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.477 HG23 HG12 ' A' ' 73' ' ' ILE . 54.6 mt -106.45 129.05 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 173.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -130.41 134.44 47.14 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.851 0.358 . . . . 0.0 111.658 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 76.1 mt -98.72 144.02 28.44 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.81 0.338 . . . . 0.0 110.623 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 10.0 tpt . . . . . 0 CA--C 1.538 0.519 0 CA-C-O 121.315 0.579 . . . . 0.0 111.227 -176.839 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 73.6 mmtt . . . . . 0 CA--C 1.537 0.477 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.76 5.24 63.05 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.589 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.533 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 2.2 p90 -141.45 158.98 43.16 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.034 0.445 . . . . 0.0 111.851 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.47 161.25 28.9 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 116.256 -0.429 . . . . 0.0 113.04 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -109.15 123.08 48.63 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.169 0.509 . . . . 0.0 111.738 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.477 HG12 HG23 ' A' ' 56' ' ' ILE . 78.4 mt -107.69 122.27 61.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 178.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.452 ' O ' HG23 ' A' ' 53' ' ' ILE . 28.2 m -99.57 115.38 29.24 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -175.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.701 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 40.9 m-85 -97.66 141.41 30.72 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.59 0.233 . . . . 0.0 111.437 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.9 t -73.75 -3.3 27.58 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.377 176.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' A' ' 80' ' ' CYS . 11.2 t70 -132.95 121.03 22.2 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.787 0.327 . . . . 0.0 110.687 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.2 p -60.19 -51.81 67.98 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.12 -36.77 85.11 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.773 0.32 . . . . 0.0 110.993 -177.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.575 ' HB3' ' HB3' ' A' ' 77' ' ' ASP . 25.0 t -63.08 -40.75 98.57 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.797 0.332 . . . . 0.0 111.362 175.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.517 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -63.86 -47.6 80.07 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.317 0.58 . . . . 0.0 110.551 175.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -57.44 -42.11 81.8 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.655 176.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -66.87 -49.58 65.23 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.817 0.341 . . . . 0.0 111.182 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.66 -44.45 69.66 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.204 0.526 . . . . 0.0 110.662 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.431 ' C ' HD23 ' A' ' 85' ' ' LEU . 7.1 tt -56.96 -58.5 7.87 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.686 175.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -61.31 -25.88 67.42 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -174.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.64 ' N ' HE21 ' A' ' 87' ' ' GLN . 0.0 OUTLIER -89.16 -46.16 9.02 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.805 0.336 . . . . 0.0 111.754 -179.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 70.7 mt -89.81 -9.3 49.7 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -169.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -67.78 82.27 0.19 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.446 0.641 . . . . 0.0 110.826 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 142.7 -21.2 2.36 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.606 -175.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -48.92 119.51 3.24 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.221 0.608 . . . . 0.0 111.52 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -69.37 93.6 0.66 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.27 0.557 . . . . 0.0 110.995 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.438 HD21 HG21 ' A' ' 38' ' ' ILE . 51.2 tp -85.46 111.59 20.11 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.223 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 63.02 2.78 1.09 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 126.69 -7.82 7.36 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.524 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -122.79 130.29 24.68 Favored Pre-proline 0 N--CA 1.47 0.555 0 CA-C-N 117.01 0.405 . . . . 0.0 110.906 176.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.55 136.51 41.07 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.427 2.085 . . . . 0.0 112.016 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 51.3 ttp -95.96 116.42 28.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.43 0.633 . . . . 0.0 111.077 -172.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -88.29 92.51 9.19 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.079 -176.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.7 t -99.83 107.31 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.642 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -134.95 161.22 24.53 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.569 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.8 p80 . . . . . 0 CA--C 1.541 0.613 0 O-C-N 122.479 -0.424 . . . . 0.0 111.908 175.914 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo . . . . . 0 CA--C 1.538 0.676 0 CA-C-O 120.947 0.311 . . . . 0.0 112.646 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 28.1 ttt -112.9 123.11 49.57 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.039 0.447 . . . . 0.0 111.268 -173.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.471 ' HD2' ' HB3' ' A' ' 72' ' ' PHE . 47.7 ttp180 -102.82 136.61 42.31 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.032 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.0 mt -107.51 148.59 29.01 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.233 0.54 . . . . 0.0 112.299 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -95.64 112.33 24.07 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.769 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.4 t -108.91 99.47 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.092 0.472 . . . . 0.0 111.207 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.78 89.13 0.84 Allowed Glycine 0 CA--C 1.524 0.642 0 C-N-CA 121.186 -0.53 . . . . 0.0 113.129 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.0 t -172.44 25.84 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.158 0.504 . . . . 0.0 111.107 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.407 HD22 ' HB ' ' A' ' 38' ' ' ILE . 62.4 mt -72.26 103.56 3.41 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.776 -0.578 . . . . 0.0 110.522 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -79.38 35.9 0.29 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 63.58 13.67 7.46 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 176.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -148.52 11.05 0.87 Allowed 'General case' 0 N--CA 1.473 0.725 0 O-C-N 122.065 -0.397 . . . . 0.0 111.692 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.545 HG23 ' SD ' ' A' ' 42' ' ' MET . 30.8 mm -83.33 140.11 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.639 0.256 . . . . 0.0 110.749 -178.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 79.1 p -116.8 161.27 19.54 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -55.41 -40.34 71.34 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.216 177.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -65.04 -39.55 93.49 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.533 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.545 ' SD ' HG23 ' A' ' 38' ' ' ILE . 50.5 ttm -61.83 -52.29 64.76 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.326 0.584 . . . . 0.0 110.525 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.448 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 55.8 mt -55.47 -53.64 53.75 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.2 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.504 ' HB2' HD11 ' A' ' 56' ' ' ILE . 53.0 ttt180 -54.36 -46.88 73.09 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.404 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.61 -31.02 69.84 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 116.288 -0.414 . . . . 0.0 113.447 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 68.7 mt -85.18 -37.6 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 O-C-N 122.504 -0.41 . . . . 0.0 112.08 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.448 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 37.8 m-85 -85.38 -30.1 23.9 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -174.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -58.27 -39.89 78.86 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -45.69 -15.34 0.13 Allowed 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 122.112 1.875 . . . . 0.0 114.253 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -103.97 -23.11 13.37 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.438 ' HA3' ' HB2' ' A' ' 80' ' ' CYS . . . -174.57 -128.6 1.1 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.275 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -151.82 124.94 8.67 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 122.402 -0.47 . . . . 0.0 110.358 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.505 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.5 mp -86.7 138.5 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.412 -178.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -83.98 -54.74 4.64 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.895 0.379 . . . . 0.0 111.186 175.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.4 m -141.92 138.53 32.08 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.88 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.533 HG23 HG12 ' A' ' 73' ' ' ILE . 65.3 mt -108.11 112.2 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.807 0.337 . . . . 0.0 110.918 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -105.81 129.02 54.08 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.924 0.392 . . . . 0.0 110.758 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 58' ' ' LEU . 6.6 mp -111.33 148.72 32.35 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.149 -0.345 . . . . 0.0 110.505 175.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 96.0 mmm . . . . . 0 C--N 1.326 -0.439 0 CA-C-O 121.292 0.568 . . . . 0.0 110.145 -179.782 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp . . . . . 0 CA--C 1.538 0.504 0 CA-C-O 120.886 0.374 . . . . 0.0 111.341 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.49 -6.13 65.26 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.044 -0.598 . . . . 0.0 114.552 175.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -143.9 155.97 44.28 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 117.453 0.627 . . . . 0.0 112.054 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -145.46 160.77 28.14 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.23 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.471 ' HB3' ' HD2' ' A' ' 28' ' ' ARG . 96.9 m-85 -119.12 116.54 26.58 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.26 0.552 . . . . 0.0 111.888 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.533 HG12 HG23 ' A' ' 56' ' ' ILE . 70.5 mt -104.13 126.7 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.669 -177.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.7 m -99.27 117.47 33.8 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -99.03 150.52 21.91 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.991 0.424 . . . . 0.0 111.569 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.2 t -80.92 -2.35 47.28 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.145 0.498 . . . . 0.0 111.458 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.547 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 29.3 t70 -142.52 143.86 32.7 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.12 0.486 . . . . 0.0 111.219 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.8 t -75.15 -42.93 55.07 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.849 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.51 -47.53 85.18 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -177.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.547 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 30.8 p -60.04 -40.81 90.67 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.996 0.427 . . . . 0.0 111.333 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.09 -45.94 83.14 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.253 0.549 . . . . 0.0 111.003 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -60.47 -38.64 84.86 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.053 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -67.86 -42.06 81.92 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.536 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.22 -49.71 76.52 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.106 176.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.48 ' C ' HD23 ' A' ' 85' ' ' LEU . 7.0 tt -53.89 -54.9 32.21 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.211 0.529 . . . . 0.0 110.205 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -47.15 -39.74 14.25 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.482 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -97.62 -33.48 11.31 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -174.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 92.6 mt -92.83 -15.54 26.37 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -173.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -67.0 93.64 0.29 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.23 0.538 . . . . 0.0 109.974 176.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.9 10.78 15.39 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.334 -174.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -77.54 133.76 38.44 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.518 0.327 . . . . 0.0 111.306 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -75.76 88.17 2.8 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.156 0.503 . . . . 0.0 111.762 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.1 tp -90.42 125.9 35.71 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.58 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 55.75 26.79 9.87 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.157 0.503 . . . . 0.0 111.541 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.8 15.59 72.56 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 116.128 -0.487 . . . . 0.0 113.38 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 30.5 mtp180 -139.13 144.31 40.25 Favored Pre-proline 0 N--CA 1.472 0.641 0 O-C-N 122.604 -0.35 . . . . 0.0 111.743 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.67 138.0 83.99 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.379 2.719 . . . . 0.0 114.118 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 47.0 ttm -99.37 114.84 27.96 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.031 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -89.25 101.34 14.01 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 122.068 -0.395 . . . . 0.0 111.409 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.6 t -108.04 117.27 53.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.071 0.463 . . . . 0.0 112.064 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.55 160.87 12.91 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.523 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 21.0 p80 . . . . . 0 N--CA 1.479 0.978 0 O-C-N 122.147 -0.62 . . . . 0.0 112.327 -174.645 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo . . . . . 0 CA--C 1.542 0.886 0 CA-C-O 120.984 0.327 . . . . 0.0 112.217 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.489 ' HB2' ' HA ' ' A' ' 78' ' ' SER . 21.6 ttt -104.92 138.93 40.41 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.79 0.329 . . . . 0.0 111.226 -176.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -108.13 126.99 53.4 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.881 0.372 . . . . 0.0 111.524 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 75.2 mt -105.5 140.8 38.04 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.196 0.522 . . . . 0.0 111.779 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.405 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 48.4 t80 -95.17 115.21 27.13 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.152 173.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.7 t -109.26 101.22 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.054 0.454 . . . . 0.0 111.595 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 70' ' ' TYR . . . -101.62 89.06 0.74 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.77 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.8 t -174.69 22.08 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.112 0.482 . . . . 0.0 111.353 178.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.495 HD21 HD21 ' A' ' 43' ' ' LEU . 14.6 mt -77.93 70.5 4.31 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.765 0.793 . . . . 0.0 110.222 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -66.06 78.97 0.09 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.014 -0.994 . . . . 0.0 113.036 -175.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.6 t80 45.99 38.71 4.87 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 121.287 0.565 . . . . 0.0 112.443 171.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -166.62 -41.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.7 mm -73.69 103.21 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 121.073 0.463 . . . . 0.0 112.059 -173.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.8 p -93.23 173.89 7.49 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.43 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.473 ' HA ' HD12 ' A' ' 43' ' ' LEU . 25.3 mt-10 -51.1 -39.45 56.16 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.695 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.06 -48.73 80.5 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.553 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.4 mmt -63.42 -40.68 97.83 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.961 0.41 . . . . 0.0 110.762 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.495 HD21 HD21 ' A' ' 34' ' ' LEU . 77.0 mt -57.04 -44.68 83.17 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.429 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -60.93 -47.12 87.88 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.999 0.428 . . . . 0.0 111.099 174.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.42 -32.32 64.13 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.579 -178.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.7 mt -86.49 -50.93 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 121.099 0.475 . . . . 0.0 112.208 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 75' ' ' PHE . 42.5 m-85 -85.29 -40.55 16.45 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -171.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -58.6 -37.57 55.76 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -175.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -51.98 -12.7 1.43 Allowed 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 122.217 1.945 . . . . 0.0 114.088 171.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -91.49 -31.26 16.03 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.108 0.48 . . . . 0.0 111.052 173.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.433 ' HA3' ' HB3' ' A' ' 80' ' ' CYS . . . -178.85 134.66 2.39 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.461 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.04 129.97 18.14 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.095 0.474 . . . . 0.0 111.698 -178.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.9 mt -95.34 128.72 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.076 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.425 ' HG2' ' OG ' ' A' ' 76' ' ' SER . 14.7 mm-40 -73.11 -57.43 4.03 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.972 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.9 t -151.76 148.99 28.53 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.716 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.433 HG12 HG23 ' A' ' 73' ' ' ILE . 45.6 mt -120.84 140.46 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.599 175.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -122.65 110.07 15.07 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.447 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.421 HD23 ' N ' ' A' ' 59' ' ' MET . 3.4 tt -98.39 129.51 45.03 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -177.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.421 ' N ' HD23 ' A' ' 58' ' ' LEU . 55.0 mtp . . . . . 0 CA--C 1.537 0.446 0 CA-C-O 121.676 0.75 . . . . 0.0 112.452 -174.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.9 mttp . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.24 15.17 57.81 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.454 0.942 . . . . 0.0 115.454 169.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.439 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 3.2 p90 -147.36 152.75 38.71 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.167 0.984 . . . . 0.0 112.754 177.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.81 160.58 28.68 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 115.496 -0.775 . . . . 0.0 113.059 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -108.77 126.41 52.99 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 122.579 -0.365 . . . . 0.0 111.463 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.433 HG23 HG12 ' A' ' 56' ' ' ILE . 69.9 mt -112.31 131.36 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.806 0.336 . . . . 0.0 111.598 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 91.9 m -108.36 120.06 41.29 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 120.683 0.278 . . . . 0.0 111.537 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 47' ' ' PHE . 34.4 m-85 -98.94 150.19 22.19 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.731 0.301 . . . . 0.0 111.261 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.425 ' OG ' ' HG2' ' A' ' 54' ' ' GLU . 13.3 m -75.98 10.8 1.69 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -153.79 146.01 23.82 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.815 0.341 . . . . 0.0 110.779 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.489 ' HA ' ' HB2' ' A' ' 27' ' ' MET . 31.3 t -75.07 -48.09 25.62 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.866 0.365 . . . . 0.0 111.984 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -71.1 -31.16 67.44 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 122.274 -0.266 . . . . 0.0 111.49 -175.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.433 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . 93.2 m -59.85 -46.57 88.86 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.851 0.357 . . . . 0.0 111.2 174.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.69 -44.49 77.62 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.038 0.447 . . . . 0.0 110.868 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 39.4 ttmt -54.28 -47.03 72.82 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.304 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -67.58 -42.95 81.72 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.491 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.07 -45.43 71.73 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.079 0.466 . . . . 0.0 110.988 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 tt -57.48 -52.81 63.88 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.624 176.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 82' ' ' LYS . 47.8 mm-40 -56.07 -35.84 67.43 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -177.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -87.7 -36.4 17.42 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -174.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 80.7 mt -95.88 -15.1 22.66 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -173.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -64.01 104.91 0.77 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.943 0.401 . . . . 0.0 110.127 174.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.95 16.91 42.79 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.88 -176.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -77.28 133.92 38.69 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.428 0.291 . . . . 0.0 111.201 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.32 92.88 5.21 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.5 tp -100.03 126.39 46.22 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 122.276 -0.265 . . . . 0.0 110.327 175.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 64.75 12.15 7.42 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.859 0.362 . . . . 0.0 111.773 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.89 2.66 58.3 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.515 -0.374 . . . . 0.0 113.409 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -130.77 154.17 81.78 Favored Pre-proline 0 CA--C 1.543 0.708 0 O-C-N 122.46 -0.435 . . . . 0.0 111.032 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.2 151.63 84.82 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.878 2.385 . . . . 0.0 114.414 -174.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 46.2 ttm -109.47 120.45 42.53 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.216 177.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -89.33 99.19 12.23 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.914 0.388 . . . . 0.0 111.668 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.1 t -108.85 116.58 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.246 176.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 30' ' ' TYR . . . -140.41 139.96 10.18 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.394 -0.431 . . . . 0.0 112.667 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 29.2 p80 . . . . . 0 N--CA 1.472 0.66 0 O-C-N 122.133 -0.628 . . . . 0.0 111.562 -177.282 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 CA--C 1.54 0.817 0 CA-C-O 120.759 0.233 . . . . 0.0 112.222 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 28.2 ttt -123.59 122.81 39.12 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.913 0.387 . . . . 0.0 111.317 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 74' ' ' THR . 36.4 ttp-105 -104.34 133.44 49.24 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.106 0.479 . . . . 0.0 111.64 -178.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.541 HD22 HD12 ' A' ' 85' ' ' LEU . 67.2 mt -107.33 140.53 40.1 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.148 0.499 . . . . 0.0 111.817 -177.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -99.02 116.92 32.36 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.805 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.3 t -115.69 130.83 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 120.744 0.307 . . . . 0.0 111.611 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.06 105.52 0.61 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 121.229 -0.51 . . . . 0.0 113.733 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.3 t -175.05 16.27 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.228 0.537 . . . . 0.0 111.689 175.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.526 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 10.7 mt -87.03 87.3 7.42 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.962 -0.461 . . . . 0.0 111.692 -170.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -80.65 60.94 4.16 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.361 0.601 . . . . 0.0 112.075 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 46.6 t80 57.48 8.96 0.69 Allowed 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -126.88 -2.8 6.54 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.704 -0.622 . . . . 0.0 111.858 -176.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.524 HD11 ' HB2' ' A' ' 94' ' ' ALA . 17.7 mm -108.76 122.38 63.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 122.185 -0.322 . . . . 0.0 110.636 -178.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.2 p -98.08 161.91 13.48 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.826 0.346 . . . . 0.0 111.886 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 1.8 mp0 -56.28 -35.16 67.16 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.441 0.639 . . . . 0.0 110.033 173.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.93 -39.53 93.65 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.374 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.3 mmt -68.88 -43.87 74.43 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.103 0.478 . . . . 0.0 110.857 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.438 ' HB3' HD11 ' A' ' 73' ' ' ILE . 78.7 mt -56.29 -42.64 77.84 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.141 0.496 . . . . 0.0 110.661 174.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 66.6 ttp85 -60.62 -49.87 75.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.089 176.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.89 -33.53 63.77 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 121.375 -0.44 . . . . 0.0 113.404 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.9 mm -80.6 -40.69 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.456 ' HB2' HD11 ' A' ' 53' ' ' ILE . 26.5 m-85 -85.5 -26.42 26.26 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -175.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 44' ' ' ARG . 1.8 mt-10 -59.2 -38.2 60.92 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -45.88 -20.67 0.78 Allowed 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.171 1.914 . . . . 0.0 113.852 172.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -96.17 -29.56 13.99 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.49 -142.1 3.31 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.831 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 57.8 ttm-85 -103.47 -38.71 7.05 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -177.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.456 HD11 ' HB2' ' A' ' 47' ' ' PHE . 66.1 mt 69.18 107.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.12 0.568 . . . . 0.0 111.351 -172.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -80.89 -41.09 23.62 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.992 0.425 . . . . 0.0 111.379 -176.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 93.3 p -151.34 142.2 22.92 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.866 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.0 mt -123.58 106.19 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 120.873 0.368 . . . . 0.0 110.782 172.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -99.72 110.97 23.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.849 0.356 . . . . 0.0 110.559 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 59' ' ' MET . 6.7 tt -97.99 133.73 42.07 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.43 ' N ' HD23 ' A' ' 58' ' ' LEU . 55.0 mtp . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 121.363 0.601 . . . . 0.0 110.566 -176.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.7 mttm . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 124.84 -7.4 8.26 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 120.929 -0.653 . . . . 0.0 114.355 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -140.23 152.13 45.72 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 117.45 0.625 . . . . 0.0 112.603 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.02 160.35 28.6 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.812 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -110.7 121.74 46.09 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.547 -0.384 . . . . 0.0 111.477 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.438 HD11 ' HB3' ' A' ' 43' ' ' LEU . 71.8 mt -110.09 119.94 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.966 0.412 . . . . 0.0 111.317 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 45.6 m -100.19 125.55 46.35 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -174.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.42 ' HZ ' ' HB3' ' A' ' 47' ' ' PHE . 82.8 m-85 -106.24 144.86 32.33 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.033 173.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.7 t -69.14 -32.66 72.18 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.103 0.478 . . . . 0.0 110.806 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -108.28 132.52 53.6 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.36 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.4 t -71.21 -35.42 71.52 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -67.29 -44.82 78.31 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.096 0.474 . . . . 0.0 110.832 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 67.4 m -60.46 -36.3 77.92 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.029 0.443 . . . . 0.0 110.751 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.49 -44.63 82.11 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.505 176.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -60.64 -47.27 86.97 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.878 0.37 . . . . 0.0 111.514 176.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.32 -43.08 88.02 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.205 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.6 -53.2 55.39 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.018 0.437 . . . . 0.0 111.112 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.56 ' HA ' HG11 ' A' ' 100' ' ' VAL . 9.8 tt -53.47 -53.5 50.59 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.456 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.56 -34.64 78.34 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -174.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -88.12 -24.76 23.28 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 89.8 mt -95.36 -13.8 24.42 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -56.52 101.88 0.07 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.241 0.543 . . . . 0.0 110.582 168.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.77 30.56 11.32 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.027 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.422 ' H ' ' HB3' ' A' ' 98' ' ' MET . 84.5 t80 -92.44 103.98 16.35 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.752 0.31 . . . . 0.0 110.484 173.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -71.01 85.57 0.71 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.395 0.617 . . . . 0.0 111.571 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 61.1 tp -74.57 -68.29 0.55 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.3 0.571 . . . . 0.0 110.907 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.524 ' HB2' HD11 ' A' ' 38' ' ' ILE . . . -86.56 38.17 0.77 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.336 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.19 21.81 66.5 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.22 -173.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 28.4 mtp-105 -139.28 141.74 30.26 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 122.86 0.464 . . . . 0.0 110.553 -175.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -52.97 142.01 54.59 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.265 2.644 . . . . 0.0 113.823 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.422 ' HB3' ' H ' ' A' ' 91' ' ' PHE . 52.0 tpp -98.9 123.02 42.89 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.984 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -99.92 102.21 13.54 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 122.398 -0.189 . . . . 0.0 110.661 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.56 HG11 ' HA ' ' A' ' 85' ' ' LEU . 26.5 t -118.66 108.24 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.011 0.434 . . . . 0.0 111.626 -178.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -129.06 154.18 20.15 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.005 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 21.8 p80 . . . . . 0 N--CA 1.47 0.55 0 O-C-N 122.213 -0.58 . . . . 0.0 110.902 178.671 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 CA--C 1.543 0.951 0 N-CA-C 113.554 0.559 . . . . 0.0 113.554 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 14.2 tpt -104.08 122.57 45.55 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.256 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -99.47 139.87 34.49 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.81 0.338 . . . . 0.0 111.358 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.0 mt -121.0 129.65 53.48 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.135 0.493 . . . . 0.0 111.406 176.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -91.58 112.83 24.9 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.393 175.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.7 t -103.67 99.76 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.011 0.434 . . . . 0.0 110.745 176.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.8 89.2 0.6 Allowed Glycine 0 CA--C 1.521 0.426 0 C-N-CA 121.003 -0.618 . . . . 0.0 113.107 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.42 ' CB ' ' HA ' ' A' ' 98' ' ' MET . 25.0 t -175.08 25.79 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.464 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 41.9 mt -69.41 107.4 3.31 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.362 -0.836 . . . . 0.0 109.499 176.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.492 ' CE1' ' HB3' ' A' ' 96' ' ' ARG . 29.3 m-70 -78.5 44.78 0.53 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -173.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 60.83 16.79 7.13 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.786 0.434 . . . . 0.0 111.988 -177.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -146.09 -33.52 0.32 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.6 mm -60.9 131.81 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.985 0.422 . . . . 0.0 111.788 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 74.7 p -116.63 169.57 9.25 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.048 0.452 . . . . 0.0 111.756 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.494 ' H ' HD11 ' A' ' 58' ' ' LEU . 2.3 pt-20 -61.73 -28.12 69.2 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.852 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -60.84 -40.0 91.17 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.937 0.399 . . . . 0.0 111.53 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.8 mtt -65.66 -53.66 38.18 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.255 0.55 . . . . 0.0 110.417 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.43 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 43.6 mt -56.15 -55.06 37.68 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.052 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 80.0 ttt180 -49.01 -46.78 44.54 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.576 176.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.46 -33.39 81.14 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 121.325 -0.464 . . . . 0.0 113.844 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 59.6 mt -86.3 -40.16 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.43 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 54.1 m-85 -77.73 -31.78 52.4 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.504 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 2.8 tm-20 -52.18 -48.6 88.42 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 90.5 Cg_exo -45.6 -28.81 4.64 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 122.538 2.159 . . . . 0.0 113.963 175.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -83.72 -47.97 10.63 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.907 0.384 . . . . 0.0 111.365 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.32 149.0 13.25 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 112.043 -0.423 . . . . 0.0 112.043 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.73 115.38 5.82 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.856 0.36 . . . . 0.0 110.793 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.513 HD12 ' H ' ' A' ' 53' ' ' ILE . 3.6 mp -66.97 138.55 22.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 120.939 0.399 . . . . 0.0 112.03 -178.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -80.3 -55.65 4.76 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.09 0.472 . . . . 0.0 110.817 173.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.5 p -151.33 140.72 21.47 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.78 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.484 HG13 HG21 ' A' ' 53' ' ' ILE . 49.2 mt -116.77 140.48 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 120.948 0.404 . . . . 0.0 110.511 172.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.453 ' HA ' HE21 ' A' ' 57' ' ' GLN . 0.1 OUTLIER -129.37 121.22 26.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.185 -179.113 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.494 HD11 ' H ' ' A' ' 40' ' ' GLU . 70.4 mt -96.68 130.49 43.9 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.724 0.297 . . . . 0.0 110.292 173.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 92.3 mmm . . . . . 0 CA--C 1.536 0.415 0 CA-C-O 121.275 0.56 . . . . 0.0 111.068 -177.921 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.4 mttt . . . . . 0 N--CA 1.469 0.492 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 95.56 6.25 59.77 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 114.855 0.702 . . . . 0.0 114.855 173.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -149.94 156.52 41.88 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.312 1.056 . . . . 0.0 112.907 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.64 161.12 28.89 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.73 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -115.06 139.04 50.2 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 122.461 -0.435 . . . . 0.0 111.656 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.41 HG12 HG23 ' A' ' 56' ' ' ILE . 60.4 mt -122.65 144.26 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.723 0.297 . . . . 0.0 111.185 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.6 m -115.76 134.05 55.41 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -126.08 147.83 49.49 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.839 0.352 . . . . 0.0 111.331 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.0 m -93.38 13.26 22.08 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 120.899 0.38 . . . . 0.0 111.31 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.598 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 15.6 t70 -142.82 109.14 5.29 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.929 0.395 . . . . 0.0 110.698 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.0 m -66.32 -31.51 72.34 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -176.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -65.72 -57.73 7.34 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.788 0.328 . . . . 0.0 111.322 -176.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.598 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 31.2 p -58.06 -38.51 76.47 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.927 0.394 . . . . 0.0 111.144 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.52 -41.16 98.5 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.555 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -60.41 -44.18 95.98 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.944 0.402 . . . . 0.0 110.699 176.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -65.14 -47.46 77.0 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.349 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.15 -51.82 55.6 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.13 0.491 . . . . 0.0 110.934 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.3 tt -55.51 -53.48 55.83 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.92 176.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -62.62 -28.44 69.9 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -174.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.641 ' N ' HE21 ' A' ' 87' ' ' GLN . 0.0 OUTLIER -89.96 -38.26 13.78 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.011 -0.431 . . . . 0.0 111.944 -179.008 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 73.5 mt -92.24 -23.3 19.38 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -172.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -69.83 101.02 1.63 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.133 0.492 . . . . 0.0 110.837 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 117.25 -14.81 13.43 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 -173.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -70.57 125.5 27.0 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.835 0.35 . . . . 0.0 110.679 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -77.95 90.43 4.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.204 0.526 . . . . 0.0 112.046 -177.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.5 tp -81.14 132.1 35.34 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.727 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 62.13 25.1 15.01 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.074 0.464 . . . . 0.0 111.372 -176.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.8 32.66 53.22 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.12 -0.491 . . . . 0.0 113.221 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.492 ' HB3' ' CE1' ' A' ' 35' ' ' HIS . 55.7 ttt180 -159.09 131.62 4.41 Favored Pre-proline 0 CA--C 1.545 0.763 0 O-C-N 122.619 -0.342 . . . . 0.0 110.472 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 96' ' ' ARG . 77.9 Cg_exo -48.96 127.73 17.67 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 C-N-CA 123.557 2.838 . . . . 0.0 115.095 -172.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.42 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 50.1 ttp -99.56 117.88 34.92 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.723 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.4 ' H ' ' HB2' ' A' ' 33' ' ' SER . 92.5 mttt -89.49 105.7 17.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.908 0.385 . . . . 0.0 111.787 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.8 t -106.99 99.18 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 121.029 0.442 . . . . 0.0 111.159 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -107.89 162.4 13.2 Favored Glycine 0 C--O 1.223 -0.558 0 N-CA-C 112.136 -0.386 . . . . 0.0 112.136 178.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 . . . . . 0 N--CA 1.475 0.779 0 CA-C-N 117.78 0.79 . . . . 0.0 110.616 177.307 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo . . . . . 0 CA--C 1.541 0.859 0 CA-C-O 120.963 0.318 . . . . 0.0 111.997 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 13.4 tpt -98.96 128.98 45.24 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.81 0.338 . . . . 0.0 110.809 -176.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -109.45 128.46 55.17 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.887 0.375 . . . . 0.0 111.28 -173.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.4 mt -100.06 144.94 28.51 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.223 0.535 . . . . 0.0 111.555 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -108.71 105.9 15.7 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.049 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.603 HG22 HG22 ' A' ' 100' ' ' VAL . 46.5 t -99.77 98.15 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.716 176.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.97 88.95 0.47 Allowed Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.761 -176.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.4 p -175.99 29.22 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.124 0.488 . . . . 0.0 110.991 176.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 30.9 mt -86.9 130.45 34.46 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.429 -174.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -83.24 63.1 7.03 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.289 0.566 . . . . 0.0 112.161 -174.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 55.29 8.92 0.31 Allowed 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -163.52 69.32 0.21 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.137 0.494 . . . . 0.0 112.043 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.0 mm -130.67 118.7 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 169.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.513 ' OG1' ' SD ' ' A' ' 42' ' ' MET . 14.6 p -91.08 163.35 14.33 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.312 0.577 . . . . 0.0 112.464 -172.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -61.07 -30.05 70.11 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.635 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.64 -47.66 71.86 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.378 -177.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.513 ' SD ' ' OG1' ' A' ' 39' ' ' THR . 1.3 mpt? -61.64 -48.39 81.08 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.101 0.477 . . . . 0.0 110.825 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.412 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 77.9 mt -54.62 -50.65 67.57 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.308 177.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.475 ' HG2' ' HG3' ' A' ' 48' ' ' GLU . 30.1 ttp-105 -52.63 -52.82 53.74 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.839 0.352 . . . . 0.0 110.887 178.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -54.81 -31.07 54.04 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 116.102 -0.499 . . . . 0.0 113.712 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.6 mt -79.68 -41.62 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 O-C-N 122.514 -0.404 . . . . 0.0 111.818 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.412 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 19.0 m-85 -82.66 -26.25 32.32 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -175.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.475 ' HG3' ' HG2' ' A' ' 44' ' ' ARG . 32.4 mt-10 -54.79 -47.57 97.85 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -178.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -48.79 -20.85 3.12 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.692 2.262 . . . . 0.0 114.686 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -82.12 -38.43 24.79 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.918 -0.489 . . . . 0.0 111.413 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -162.96 -99.89 0.14 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.681 -0.567 . . . . 0.0 111.681 176.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.7 ttp180 -162.76 153.7 17.18 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.768 0.318 . . . . 0.0 110.144 171.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.49 HG21 HG13 ' A' ' 56' ' ' ILE . 1.7 mp -84.12 139.94 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.126 0.488 . . . . 0.0 111.997 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -96.01 -60.51 1.62 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 174.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.3 t -150.63 126.62 10.47 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.251 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.548 HG23 HG12 ' A' ' 73' ' ' ILE . 54.8 mt -99.66 150.36 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 120.833 0.349 . . . . 0.0 111.284 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.448 HE21 ' N ' ' A' ' 58' ' ' LEU . 29.9 tp60 -149.82 134.8 17.9 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.683 0.278 . . . . 0.0 110.695 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.448 ' N ' HE21 ' A' ' 57' ' ' GLN . 95.2 mt -97.28 142.68 28.87 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.739 0.304 . . . . 0.0 110.512 173.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.498 ' HB3' ' HB2' ' A' ' 70' ' ' TYR . 13.0 tpt . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 121.306 0.574 . . . . 0.0 109.788 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp . . . . . 0 CA--C 1.54 0.594 0 CA-C-O 121.032 0.444 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.23 15.29 48.45 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 116.165 -0.47 . . . . 0.0 113.732 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.498 ' HB2' ' HB3' ' A' ' 59' ' ' MET . 4.3 m-85 -130.79 160.85 33.15 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 122.475 -0.426 . . . . 0.0 111.546 -178.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.4 135.73 5.34 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 121.439 -0.41 . . . . 0.0 112.901 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -106.94 115.11 29.62 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 122.347 -0.502 . . . . 0.0 111.581 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.548 HG12 HG23 ' A' ' 56' ' ' ILE . 58.7 mt -111.27 123.79 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.868 0.366 . . . . 0.0 111.344 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.5 m -99.68 131.32 45.75 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -176.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.437 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 80.9 m-85 -117.11 151.5 36.71 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.941 0.496 . . . . 0.0 111.327 177.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.6 t -73.72 -34.92 65.0 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.101 0.477 . . . . 0.0 110.924 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -100.28 124.98 46.41 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.825 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 63.3 m -60.42 -37.11 79.81 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.316 176.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -71.2 -50.47 32.78 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.886 -177.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 96.2 m -54.35 -41.4 69.07 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 120.915 0.388 . . . . 0.0 111.144 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -61.66 -47.58 84.72 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.159 175.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.405 ' HB3' ' NZ ' ' A' ' 82' ' ' LYS . 6.8 ttpm? -63.56 -32.8 74.37 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.534 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -68.67 -48.4 64.03 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.734 0.302 . . . . 0.0 110.635 176.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.79 -46.96 67.86 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.202 0.525 . . . . 0.0 110.499 174.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.41 ' C ' HD23 ' A' ' 85' ' ' LEU . 7.8 tt -57.96 -54.37 47.66 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.946 174.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -57.87 -31.64 66.9 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.378 -174.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.663 ' N ' HE21 ' A' ' 87' ' ' GLN . 0.0 OUTLIER -92.52 -43.46 9.15 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.147 -0.346 . . . . 0.0 111.931 -178.465 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 84.5 mt -85.1 -22.39 28.92 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -171.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -63.41 104.29 0.61 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.085 0.469 . . . . 0.0 110.174 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 110.11 -11.93 31.57 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.881 -177.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -65.69 127.47 32.06 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.856 0.36 . . . . 0.0 111.819 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -89.23 100.85 13.55 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.996 0.427 . . . . 0.0 110.935 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 60.1 tp -86.28 -81.33 0.22 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.937 0.399 . . . . 0.0 111.732 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.86 52.33 2.44 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.866 0.365 . . . . 0.0 111.124 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.11 15.56 58.67 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.453 -174.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -135.68 140.56 34.15 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 122.945 0.498 . . . . 0.0 110.591 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.23 145.35 98.73 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.829 2.352 . . . . 0.0 113.081 176.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.43 ' HG2' HG23 ' A' ' 100' ' ' VAL . 46.9 ttm -99.09 108.76 21.48 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.287 175.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -89.09 93.13 9.48 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.857 0.36 . . . . 0.0 111.276 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.603 HG22 HG22 ' A' ' 31' ' ' VAL . 44.8 t -105.38 105.74 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.706 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -115.61 154.47 16.9 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.367 -0.444 . . . . 0.0 112.231 176.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 14.6 p80 . . . . . 0 N--CA 1.475 0.775 0 CA-C-N 117.755 0.777 . . . . 0.0 111.83 -179.623 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo . . . . . 0 CA--C 1.541 0.853 0 N-CA-C 113.262 0.447 . . . . 0.0 113.262 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 26.9 ttt -126.65 125.51 42.02 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.847 0.356 . . . . 0.0 111.558 -178.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 74' ' ' THR . 11.1 ttp180 -98.85 138.14 36.41 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.153 0.501 . . . . 0.0 111.373 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.654 HD22 HD12 ' A' ' 85' ' ' LEU . 23.6 mt -117.04 146.83 42.83 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.247 -172.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 55.7 t80 -89.85 115.6 27.3 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 122.781 0.432 . . . . 0.0 110.961 175.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.6 t -111.6 98.84 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.107 0.48 . . . . 0.0 110.943 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.88 96.15 1.14 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.406 -0.426 . . . . 0.0 113.76 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.4 t -174.73 9.85 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.3 mt -69.12 93.33 0.59 Allowed 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.728 -0.607 . . . . 0.0 111.19 -172.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -76.67 69.09 3.02 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -175.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 47.0 t80 53.15 39.86 30.31 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 172.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -171.03 -31.58 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.3 mm -64.66 95.28 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.13 0.49 . . . . 0.0 111.327 -178.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.8 p -92.47 -178.37 4.89 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.49 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.533 ' HG3' HD13 ' A' ' 58' ' ' LEU . 2.1 mp0 -52.57 -40.52 62.7 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.065 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.65 -52.32 62.68 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.583 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 20.8 mmt -62.29 -52.51 63.39 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.438 0.637 . . . . 0.0 110.676 -177.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.469 ' HB3' HD11 ' A' ' 73' ' ' ILE . 61.7 mt -55.34 -49.96 70.88 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.613 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -57.21 -50.57 72.44 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.392 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.26 -31.12 62.0 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.369 -0.444 . . . . 0.0 113.857 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.7 mt -85.15 -37.56 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -85.08 -32.3 22.91 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -173.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -59.64 -36.98 45.49 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -46.76 -19.48 0.77 Allowed 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 122.144 1.896 . . . . 0.0 113.847 171.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -90.83 -35.44 14.81 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.781 0.324 . . . . 0.0 111.262 174.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.413 ' HA3' ' SG ' ' A' ' 80' ' ' CYS . . . -172.85 -123.08 0.7 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.413 -0.422 . . . . 0.0 112.742 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -149.54 128.22 12.43 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 122.282 -0.54 . . . . 0.0 110.681 177.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.491 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.7 mp -87.33 138.98 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.765 -176.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -81.42 -48.57 11.73 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.048 0.452 . . . . 0.0 111.104 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 96.0 p -148.98 143.4 26.11 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.356 -178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.527 HG23 HG12 ' A' ' 73' ' ' ILE . 52.1 mt -121.3 104.74 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 120.997 0.427 . . . . 0.0 110.709 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -102.75 111.76 24.22 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -175.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.533 HD13 ' HG3' ' A' ' 40' ' ' GLU . 7.8 mp -98.51 139.68 33.87 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.919 -0.488 . . . . 0.0 110.89 177.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.533 ' HG3' ' CE2' ' A' ' 70' ' ' TYR . 18.2 mmt . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 121.072 0.463 . . . . 0.0 111.03 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.419 ' NZ ' ' HB3' ' A' ' 68' ' ' LYS . 8.0 mtpm? . . . . . 0 CA--C 1.54 0.584 0 CA-C-O 120.804 0.335 . . . . 0.0 111.58 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.48 2.29 61.83 Favored Glycine 0 CA--C 1.531 1.094 0 N-CA-C 115.108 0.803 . . . . 0.0 115.108 173.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.533 ' CE2' ' HG3' ' A' ' 59' ' ' MET . 34.1 p90 -143.11 148.98 37.5 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.122 0.961 . . . . 0.0 112.542 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -138.3 146.76 18.62 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.48 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 95.2 m-85 -100.18 121.76 41.95 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 122.594 -0.356 . . . . 0.0 111.523 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 56' ' ' ILE . 77.8 mt -110.36 125.03 67.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 120.794 0.331 . . . . 0.0 111.596 -178.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 27.2 m -101.35 120.6 40.51 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -175.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.471 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 70.3 m-85 -100.08 152.05 20.68 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.325 173.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.7 t -75.46 -14.4 60.43 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.891 0.377 . . . . 0.0 111.685 -177.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -136.46 138.85 41.88 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.689 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.9 t -70.02 -27.34 64.59 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -80.97 -40.94 23.62 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.772 -0.58 . . . . 0.0 110.509 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.413 ' SG ' ' HA3' ' A' ' 51' ' ' GLY . 50.4 t -61.46 -39.26 90.21 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.123 0.487 . . . . 0.0 110.349 169.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.471 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -60.49 -48.69 80.67 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.228 174.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -68.39 -24.98 64.83 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 111.625 0.232 . . . . 0.0 111.625 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -63.6 -55.57 22.69 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.295 0.569 . . . . 0.0 110.104 175.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.67 -51.83 67.72 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.828 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.654 HD12 HD22 ' A' ' 29' ' ' LEU . 6.4 tt -49.11 -63.85 0.98 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.444 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.432 ' HA ' HD21 ' A' ' 89' ' ' ASN . 6.7 mm-40 -67.01 -20.92 65.95 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -172.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -94.95 -14.71 24.18 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 94.1 mt -110.21 -14.71 14.14 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -176.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.463 ' ND2' HD23 ' A' ' 85' ' ' LEU . 10.0 p30 -69.3 97.13 0.92 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.876 0.846 . . . . 0.0 111.178 176.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.96 -2.1 22.84 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.168 -174.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -64.97 127.31 31.06 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 122.592 0.357 . . . . 0.0 111.147 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -76.88 96.26 4.28 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.33 0.586 . . . . 0.0 110.987 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.8 tp -98.34 120.71 39.23 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.463 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 58.35 20.24 7.12 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.03 0.443 . . . . 0.0 112.116 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.87 8.13 58.29 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 116.203 -0.453 . . . . 0.0 113.436 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -130.88 132.23 23.76 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.592 -0.357 . . . . 0.0 110.906 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.53 133.09 49.66 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 122.341 2.028 . . . . 0.0 112.793 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.0 ttp -99.06 116.91 32.38 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.099 0.476 . . . . 0.0 111.538 -177.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -89.98 103.72 16.36 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.896 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.501 HG12 ' HG ' ' A' ' 85' ' ' LEU . 21.6 t -113.93 112.83 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.596 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -151.47 78.24 0.21 Allowed Glycine 0 CA--C 1.534 1.225 0 C-N-CA 119.951 -1.119 . . . . 0.0 115.169 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 27.0 p80 . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 174.658 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 37.9 Cg_endo . . . . . 0 CA--C 1.542 0.886 0 CA-C-O 121.4 0.5 . . . . 0.0 112.946 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -99.77 142.68 30.93 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.586 -178.641 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.548 ' N ' ' SD ' ' A' ' 27' ' ' MET . 34.2 ttm105 -118.58 116.54 26.83 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.997 0.427 . . . . 0.0 112.026 -175.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.558 HD22 HD12 ' A' ' 85' ' ' LEU . 73.3 mt -99.45 128.38 45.56 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.562 178.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -91.49 114.9 27.55 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.131 0.491 . . . . 0.0 111.13 175.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.1 t -107.21 107.83 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.246 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.7 89.53 0.54 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.613 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.5 p -175.09 18.02 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 120.923 0.392 . . . . 0.0 111.976 176.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.544 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 17.8 mt -83.3 81.22 8.8 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.986 -0.447 . . . . 0.0 111.372 -173.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -78.14 75.7 4.67 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 121.188 0.518 . . . . 0.0 112.313 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 16.3 p90 39.25 26.53 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 176.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -140.28 8.89 2.26 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 122.0 -0.437 . . . . 0.0 111.501 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 38' ' ' ILE . 3.7 mp -118.48 123.91 72.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.596 -177.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 57.3 p -105.83 175.55 5.46 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -54.55 -49.2 70.86 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.729 176.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -73.15 -19.0 61.22 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -174.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.4 tpt -70.51 -54.77 10.9 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 172.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.3 mt -59.21 -55.76 30.78 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.781 175.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -53.89 -35.27 61.42 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.498 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.32 -35.71 92.3 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.137 -0.554 . . . . 0.0 113.073 177.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.8 mt -86.21 -38.5 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-O 120.998 0.428 . . . . 0.0 111.985 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.414 ' HB3' ' HZ ' ' A' ' 75' ' ' PHE . 35.0 m-85 -79.59 -44.63 20.69 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -173.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.414 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 27.1 tt0 -64.84 -32.35 6.68 Favored Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -172.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 48' ' ' GLU . 89.1 Cg_exo -47.89 -22.86 3.65 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.124 1.883 . . . . 0.0 113.629 169.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -77.26 -23.37 51.22 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 122.149 -0.345 . . . . 0.0 111.698 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.761 ' HA3' ' SG ' ' A' ' 80' ' ' CYS . . . -177.89 -100.06 0.13 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.46 175.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.66 130.4 6.59 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.097 0.475 . . . . 0.0 111.481 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.3 mt -111.04 140.82 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.699 -174.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -90.77 -62.36 1.47 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.847 0.356 . . . . 0.0 111.787 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.5 t -145.7 147.65 32.18 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.874 0.369 . . . . 0.0 111.623 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.554 HG12 HG23 ' A' ' 73' ' ' ILE . 55.2 mt -123.88 125.23 70.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.076 0.465 . . . . 0.0 110.852 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -108.89 117.39 34.07 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.879 0.371 . . . . 0.0 110.952 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 82.1 mt -98.42 136.63 38.29 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.75 0.309 . . . . 0.0 110.665 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 22.4 mmt . . . . . 0 C--O 1.236 0.383 0 CA-C-O 121.738 0.78 . . . . 0.0 112.196 -175.813 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm . . . . . 0 N--CA 1.471 0.624 0 CA-C-O 120.947 0.403 . . . . 0.0 111.488 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 111.05 13.06 14.23 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.818 -0.705 . . . . 0.0 114.555 175.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -149.82 156.11 41.24 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.59 0.695 . . . . 0.0 111.757 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.91 160.54 28.67 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.418 -0.42 . . . . 0.0 113.064 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -112.61 121.35 44.53 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.768 0.318 . . . . 0.0 111.402 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.554 HG23 HG12 ' A' ' 56' ' ' ILE . 67.3 mt -103.69 133.92 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.811 0.338 . . . . 0.0 111.323 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 68.1 m -110.14 118.37 36.21 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.481 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 31.3 m-85 -99.09 150.72 21.73 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.163 175.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.2 t -82.67 1.78 36.77 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.012 0.434 . . . . 0.0 111.565 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -142.28 135.85 29.18 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.041 0.448 . . . . 0.0 111.35 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.8 t -65.72 -47.84 73.96 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -71.7 -35.42 70.22 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.246 -0.284 . . . . 0.0 111.495 -176.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.761 ' SG ' ' HA3' ' A' ' 51' ' ' GLY . 43.9 t -59.38 -44.65 92.74 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.118 0.485 . . . . 0.0 110.918 173.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.481 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -65.53 -47.53 75.59 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.678 177.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.8 ttpp -60.76 -34.21 74.11 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.823 0.344 . . . . 0.0 111.349 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -66.43 -49.25 67.39 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.912 0.387 . . . . 0.0 110.919 176.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.02 -44.7 87.45 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.127 0.489 . . . . 0.0 111.169 176.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.558 HD12 HD22 ' A' ' 29' ' ' LEU . 8.6 tt -56.76 -59.08 5.55 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.987 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.93 -25.18 67.43 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -173.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -89.68 -31.12 17.64 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 122.032 -0.418 . . . . 0.0 112.056 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.0 mt -103.24 -6.74 21.78 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -66.07 92.37 0.17 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.221 0.534 . . . . 0.0 110.614 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 115.07 3.18 21.66 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.943 -176.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -64.63 135.79 56.31 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.589 0.355 . . . . 0.0 111.709 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -70.13 79.87 0.51 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.177 0.513 . . . . 0.0 111.383 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.572 HD22 ' SD ' ' A' ' 98' ' ' MET . 56.8 tp -84.33 118.49 24.25 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.907 0.384 . . . . 0.0 111.657 -177.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 57.15 26.86 12.63 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 176.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.44 11.39 59.61 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 116.075 -0.512 . . . . 0.0 113.4 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -145.49 139.81 15.27 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 122.478 0.311 . . . . 0.0 110.807 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -55.41 136.73 75.07 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.491 2.127 . . . . 0.0 112.887 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.572 ' SD ' HD22 ' A' ' 93' ' ' LEU . 44.8 ttp -98.67 118.45 35.42 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.229 0.538 . . . . 0.0 111.395 -176.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -88.98 96.31 10.67 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.333 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 18.7 t -104.71 105.91 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.993 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -133.22 151.8 20.19 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.451 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.5 p80 . . . . . 0 N--CA 1.47 0.556 0 O-C-N 122.29 -0.535 . . . . 0.0 110.904 177.717 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 CA--C 1.539 0.735 0 CA-C-O 120.95 0.312 . . . . 0.0 111.969 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 14.3 tpt -102.9 131.64 49.67 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.887 0.375 . . . . 0.0 111.922 -172.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.8 ttm-85 -102.72 118.46 36.89 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.856 0.36 . . . . 0.0 110.896 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 76.0 mt -102.68 150.57 23.31 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.281 0.562 . . . . 0.0 111.829 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -105.59 131.43 52.99 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.299 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.6 t -125.94 106.44 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.569 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -125.38 88.52 0.37 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.829 -176.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.497 ' HG ' ' HA ' ' A' ' 98' ' ' MET . 89.6 p -175.79 23.71 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.97 0.414 . . . . 0.0 111.41 178.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.557 ' HB3' HG13 ' A' ' 38' ' ' ILE . 53.4 mt -83.64 166.86 17.8 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.198 -176.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.426 ' ND1' ' O ' ' A' ' 35' ' ' HIS . 33.6 p80 -141.85 80.44 1.72 Allowed 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 60.1 t80 50.61 8.34 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.407 ' O ' HD13 ' A' ' 38' ' ' ILE . 4.8 t30 -143.34 52.59 1.35 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.091 -1.005 . . . . 0.0 110.535 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.557 HG13 ' HB3' ' A' ' 34' ' ' LEU . 30.1 mm -133.24 125.08 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.625 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.417 ' OG1' ' HG3' ' A' ' 42' ' ' MET . 41.8 p -108.03 158.88 17.01 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.861 0.362 . . . . 0.0 111.835 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -54.9 -32.04 60.62 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.108 0.48 . . . . 0.0 110.742 172.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -62.64 -42.41 99.58 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.527 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.427 ' SD ' ' HA ' ' A' ' 38' ' ' ILE . 59.0 mtt -64.06 -55.41 22.37 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.538 0.685 . . . . 0.0 110.686 179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.435 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 45.6 mt -56.72 -54.83 41.7 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.357 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -53.13 -47.88 68.34 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.314 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.09 -30.22 75.01 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 121.305 -0.474 . . . . 0.0 113.741 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 74.1 mt -82.98 -40.46 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 O-C-N 122.377 -0.484 . . . . 0.0 112.23 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.485 ' HB3' ' HE2' ' A' ' 75' ' ' PHE . 77.2 m-85 -85.77 -30.78 22.78 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -173.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.413 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 30.1 mt-10 -55.32 -41.63 91.75 Favored Pre-proline 0 N--CA 1.484 1.226 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 48' ' ' GLU . 51.7 Cg_exo -41.09 -39.29 3.5 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 122.378 2.052 . . . . 0.0 113.058 172.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -76.65 -57.67 3.72 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.067 0.46 . . . . 0.0 110.881 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -157.98 135.01 4.12 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.017 -175.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -56.3 122.26 11.41 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 122.6 0.36 . . . . 0.0 111.236 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 53' ' ' ILE . 2.9 mp -79.6 135.27 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.148 0.499 . . . . 0.0 111.911 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -87.74 -51.05 6.08 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.148 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.8 m -150.41 140.34 21.92 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.812 0.339 . . . . 0.0 111.877 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.537 HG23 HG12 ' A' ' 73' ' ' ILE . 53.8 mt -116.66 140.58 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.911 177.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -136.86 110.19 7.88 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.716 0.293 . . . . 0.0 111.764 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.429 HD12 ' N ' ' A' ' 58' ' ' LEU . 5.1 mp -99.57 150.66 22.01 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.648 0.261 . . . . 0.0 110.391 175.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.445 ' HG3' ' CE2' ' A' ' 70' ' ' TYR . 20.4 mmt . . . . . 0 N--CA 1.467 0.382 0 CA-C-O 121.569 0.699 . . . . 0.0 112.747 -177.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.4 mttp . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.81 6.62 18.91 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.502 -0.856 . . . . 0.0 115.018 174.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.445 ' CE2' ' HG3' ' A' ' 59' ' ' MET . 35.3 p90 -130.24 147.84 52.01 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.156 0.978 . . . . 0.0 111.824 176.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -149.52 160.24 28.38 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 116.097 -0.501 . . . . 0.0 113.315 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -113.68 139.05 49.38 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.659 0.383 . . . . 0.0 110.999 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.537 HG12 HG23 ' A' ' 56' ' ' ILE . 75.0 mt -124.11 125.67 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.795 0.331 . . . . 0.0 111.447 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.9 m -99.53 118.24 35.66 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.885 0.374 . . . . 0.0 111.549 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.485 ' HE2' ' HB3' ' A' ' 47' ' ' PHE . 43.8 m-85 -99.64 150.08 22.64 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.313 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.1 t -75.77 -18.74 59.42 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.113 0.482 . . . . 0.0 111.067 173.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -110.06 152.81 25.49 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.076 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.1 p -100.41 -59.86 1.63 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 120.967 0.413 . . . . 0.0 112.081 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -65.36 -39.87 92.88 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -175.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 77.9 m -61.6 -31.03 71.08 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.08 0.467 . . . . 0.0 110.541 174.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.32 -33.93 67.71 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.845 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -54.6 -50.44 68.05 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.019 0.438 . . . . 0.0 110.181 172.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.494 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . 6.9 ttpm? -64.48 -40.95 96.64 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.033 177.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.4 -41.64 69.52 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.358 0.599 . . . . 0.0 110.934 176.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.431 HD23 ' C ' ' A' ' 85' ' ' LEU . 7.0 tt -63.91 -62.73 1.45 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.664 177.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.494 ' HG2' ' HA ' ' A' ' 83' ' ' LYS . 14.8 pt-20 -66.42 -18.37 65.32 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.497 -173.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -86.2 -40.97 15.06 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.746 0.308 . . . . 0.0 111.554 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 81.2 mt -97.38 -13.2 21.99 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -168.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.427 HD21 ' HA ' ' A' ' 86' ' ' GLU . 10.7 p30 -65.41 81.12 0.06 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 121.699 0.761 . . . . 0.0 111.705 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 141.88 -14.52 2.63 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.706 -175.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -65.72 135.03 54.41 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 122.939 0.496 . . . . 0.0 111.302 177.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -82.74 104.82 13.27 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.099 0.475 . . . . 0.0 112.073 -177.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.6 tp -101.63 128.25 48.0 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.277 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 61.05 22.78 13.01 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.051 0.453 . . . . 0.0 111.243 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 85.78 12.05 72.67 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 116.135 -0.484 . . . . 0.0 113.37 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.7 ttt85 -134.96 134.13 21.54 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 122.52 -0.4 . . . . 0.0 110.631 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -53.64 142.15 61.69 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.922 2.415 . . . . 0.0 113.38 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.497 ' HA ' ' HG ' ' A' ' 33' ' ' SER . 44.9 ttm -99.34 114.43 27.3 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.309 -177.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -89.69 97.82 11.42 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.959 0.409 . . . . 0.0 110.936 177.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.2 t -103.9 127.52 57.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.499 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -150.0 159.38 28.08 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.543 175.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 11.0 p80 . . . . . 0 N--CA 1.472 0.651 0 O-C-N 122.208 -0.583 . . . . 0.0 111.002 177.152 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 51.3 Cg_exo . . . . . 0 CA--C 1.544 1.018 0 N-CA-C 114.083 0.763 . . . . 0.0 114.083 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 28.1 ttt -100.66 133.83 44.52 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.319 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.3 ttm-85 -111.19 129.39 55.97 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.984 0.421 . . . . 0.0 111.873 -174.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 80.5 mt -103.8 142.7 33.92 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.497 0.665 . . . . 0.0 111.9 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -99.69 113.36 25.76 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.198 175.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -116.93 115.4 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -175.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.72 104.37 1.37 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.656 -0.307 . . . . 0.0 113.685 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.543 ' HB2' ' HA ' ' A' ' 98' ' ' MET . 23.9 t -174.82 20.99 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.357 0.599 . . . . 0.0 111.268 175.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.9 mt -93.49 91.85 7.33 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.805 -174.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -80.1 61.51 3.98 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -174.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 22.6 t80 50.29 41.23 24.07 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.641 0.734 . . . . 0.0 110.979 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -149.9 -50.8 0.14 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.754 -171.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.411 HD11 ' HB2' ' A' ' 94' ' ' ALA . 60.8 mt -78.96 133.97 28.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.239 -172.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.3 p -114.27 178.37 4.31 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.198 0.523 . . . . 0.0 112.087 -177.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.429 ' HG3' ' CD1' ' A' ' 58' ' ' LEU . 2.1 mp0 -50.41 -45.35 55.6 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.881 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -55.87 -44.6 78.27 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.577 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.436 ' O ' HG12 ' A' ' 46' ' ' ILE . 12.5 tpt -66.49 -49.9 65.06 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.185 0.517 . . . . 0.0 110.29 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.435 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 71.4 mt -54.25 -53.54 52.2 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.093 176.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.2 ttm105 -51.01 -43.21 60.79 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.536 176.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.96 -28.22 71.64 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.349 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 42' ' ' MET . 42.4 mm -85.17 -37.26 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 120.911 0.386 . . . . 0.0 111.929 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.435 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 46.8 m-85 -86.17 -28.03 24.18 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -174.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -57.7 -38.1 63.48 Favored Pre-proline 0 N--CA 1.484 1.268 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -47.92 -19.9 1.75 Allowed 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 122.086 1.857 . . . . 0.0 113.581 170.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -94.75 -46.66 6.82 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.808 0.337 . . . . 0.0 111.527 175.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.47 -133.5 1.49 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.595 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -129.77 143.8 50.99 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 122.089 -0.654 . . . . 0.0 111.427 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.533 HG21 HG13 ' A' ' 56' ' ' ILE . 2.4 mp -94.97 138.69 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.017 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -95.45 -45.33 7.15 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.911 0.386 . . . . 0.0 111.064 174.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.2 t -152.14 147.03 25.96 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.506 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.551 HG12 HG23 ' A' ' 73' ' ' ILE . 51.8 mt -130.46 106.62 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 120.81 0.338 . . . . 0.0 110.863 175.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -108.93 119.98 41.17 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.754 0.311 . . . . 0.0 111.323 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.43 HD12 ' N ' ' A' ' 58' ' ' LEU . 7.2 mp -98.22 141.55 30.99 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.064 0.459 . . . . 0.0 111.538 -177.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.595 ' SD ' ' HE2' ' A' ' 72' ' ' PHE . 56.8 mtp . . . . . 0 CA--C 1.536 0.432 0 CA-C-O 121.432 0.634 . . . . 0.0 111.851 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.579 ' HB2' ' O ' ' A' ' 59' ' ' MET . 57.8 mttp . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 120.887 0.375 . . . . 0.0 110.776 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.44 23.22 8.53 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 114.863 0.705 . . . . 0.0 114.863 172.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.535 ' HE1' ' SD ' ' A' ' 59' ' ' MET . 27.6 p90 -143.49 152.06 41.04 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.775 0.788 . . . . 0.0 112.088 177.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.8 158.13 23.66 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.945 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.595 ' HE2' ' SD ' ' A' ' 59' ' ' MET . 98.2 m-85 -110.02 125.08 52.53 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.831 0.348 . . . . 0.0 111.17 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.551 HG23 HG12 ' A' ' 56' ' ' ILE . 59.9 mt -113.43 135.14 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.593 -178.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.2 m -100.01 133.97 43.62 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.492 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 96.1 m-85 -125.14 143.86 50.72 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.509 0.324 . . . . 0.0 111.27 177.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.2 m -81.48 -5.63 58.14 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 120.745 0.307 . . . . 0.0 111.708 176.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 80' ' ' CYS . 8.4 t0 -124.18 115.84 21.75 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.939 0.399 . . . . 0.0 110.842 -178.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 48.8 m -71.76 -22.27 61.62 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.75 -36.65 15.04 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 72.6 m -66.13 -39.99 90.31 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.963 0.411 . . . . 0.0 110.591 174.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.14 -40.49 82.43 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.033 0.444 . . . . 0.0 110.958 174.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.565 ' HZ2' ' HB2' ' A' ' 82' ' ' LYS . 4.7 ttmp? -62.23 -42.69 99.54 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.081 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 86.6 tttt -61.45 -50.89 70.96 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.61 0.243 . . . . 0.0 110.478 173.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.12 -40.99 47.73 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.19 0.519 . . . . 0.0 111.055 177.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.3 tt -61.46 -48.34 81.59 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.24 175.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -67.62 -34.2 76.5 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -177.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 83' ' ' LYS . 7.9 mm100 -90.8 -32.84 15.94 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -173.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.0 mt -99.52 -11.26 21.2 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -172.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -65.93 94.89 0.24 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.316 0.579 . . . . 0.0 110.246 176.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 106.8 22.43 7.65 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.177 -173.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -80.92 142.83 33.13 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 122.732 -0.276 . . . . 0.0 111.715 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -75.06 85.06 2.31 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.852 0.358 . . . . 0.0 111.263 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.559 HD22 ' SD ' ' A' ' 98' ' ' MET . 54.9 tp -103.02 124.84 49.28 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.724 0.297 . . . . 0.0 111.292 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.411 ' HB2' HD11 ' A' ' 38' ' ' ILE . . . 59.82 16.19 5.44 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.85 11.12 59.35 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.42 -0.419 . . . . 0.0 113.309 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 96' ' ' ARG . 16.3 mtp180 -133.7 154.97 80.85 Favored Pre-proline 0 N--CA 1.47 0.57 0 O-C-N 122.474 -0.427 . . . . 0.0 111.877 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.57 130.32 23.3 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.779 2.319 . . . . 0.0 112.26 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.559 ' SD ' HD22 ' A' ' 93' ' ' LEU . 48.6 ttp -97.84 125.67 42.82 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.299 0.571 . . . . 0.0 111.851 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -89.1 108.35 19.55 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.489 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.1 t -116.18 122.28 69.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 121.285 0.564 . . . . 0.0 112.053 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -146.1 146.8 17.26 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.959 175.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.3 p80 . . . . . 0 N--CA 1.47 0.554 0 CA-C-N 118.268 1.034 . . . . 0.0 110.93 -176.748 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo . . . . . 0 CA--C 1.541 0.851 0 CA-C-O 120.796 0.248 . . . . 0.0 112.729 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.2 ttt -124.05 145.73 49.03 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.003 0.43 . . . . 0.0 111.547 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -116.62 119.39 35.39 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.677 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.591 HD22 HD12 ' A' ' 85' ' ' LEU . 60.7 mt -99.25 138.41 36.38 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.087 0.47 . . . . 0.0 112.202 -178.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -92.8 107.26 19.08 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.539 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.7 t -101.06 97.91 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.004 0.431 . . . . 0.0 111.14 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.76 88.99 0.83 Allowed Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.629 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.3 t -175.49 24.18 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.993 0.425 . . . . 0.0 111.359 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 43.0 mt -73.79 92.66 2.05 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.879 -0.513 . . . . 0.0 110.517 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -78.98 65.56 4.19 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -174.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 55.23 8.74 0.29 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.919 1.452 . . . . 0.0 114.919 170.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -155.16 8.73 0.29 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.411 0.55 . . . . 0.0 112.244 178.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.6 mm -78.06 131.41 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 121.946 -0.471 . . . . 0.0 110.811 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.453 ' OG1' ' HG3' ' A' ' 42' ' ' MET . 49.4 p -106.01 160.49 15.25 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -177.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -55.09 -38.49 68.17 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.319 0.58 . . . . 0.0 110.556 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -61.04 -41.41 96.53 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.107 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.453 ' HG3' ' OG1' ' A' ' 39' ' ' THR . 66.8 mtt -62.77 -55.52 25.77 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.251 0.548 . . . . 0.0 110.529 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.1 mt -54.59 -46.58 73.81 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.104 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 50.9 ttt85 -60.22 -46.48 89.62 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.502 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.07 -29.71 59.82 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.117 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.7 mm -86.54 -53.16 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 75' ' ' PHE . 34.0 m-85 -79.83 -36.71 36.46 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -171.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.473 ' HA ' HG13 ' A' ' 53' ' ' ILE . 0.6 OUTLIER -56.43 -48.06 97.75 Favored Pre-proline 0 N--CA 1.482 1.134 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -172.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -47.07 -20.93 1.41 Allowed 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.649 2.232 . . . . 0.0 114.248 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -70.91 -51.6 25.1 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 178.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 52' ' ' ARG . . . -173.52 45.77 0.16 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 119.652 -1.261 . . . . 0.0 115.176 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 73.1 ttt180 72.19 137.19 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 172.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.473 HG13 ' HA ' ' A' ' 48' ' ' GLU . 66.0 mt -128.06 133.18 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.316 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -108.15 -48.09 3.43 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -176.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.7 m -126.94 122.06 33.5 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -176.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 51.8 mt -115.65 106.23 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.853 0.359 . . . . 0.0 110.808 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -99.34 116.3 31.2 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.716 0.293 . . . . 0.0 111.524 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.7 mt -99.0 130.73 45.36 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 173.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 85.0 mmm . . . . . 0 CA--C 1.535 0.39 0 CA-C-O 121.34 0.591 . . . . 0.0 111.551 -174.385 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.404 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 34.2 mmtp . . . . . 0 N--CA 1.471 0.578 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.95 4.16 31.53 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.718 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 68' ' ' LYS . 4.4 p90 -141.14 154.34 45.83 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.322 0.561 . . . . 0.0 112.072 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.32 161.15 28.85 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.839 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -116.17 122.1 44.06 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.523 -0.398 . . . . 0.0 111.828 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.5 mt -108.75 133.09 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 120.96 0.41 . . . . 0.0 111.592 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.4 m -109.52 123.98 50.32 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.735 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.434 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 7.0 m-85 -106.1 150.62 25.62 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.26 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.6 m -70.86 -11.62 61.06 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.081 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -136.76 122.97 20.48 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.031 0.443 . . . . 0.0 111.518 -178.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.8 m -65.1 -41.72 94.7 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.151 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -64.21 -46.49 83.65 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.024 0.44 . . . . 0.0 111.535 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.9 m -64.3 -38.52 91.34 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.211 177.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.434 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -64.53 -42.69 95.61 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.149 0.499 . . . . 0.0 111.386 176.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.433 ' HE3' ' HB2' ' A' ' 82' ' ' LYS . 37.8 ttmt -60.61 -40.93 93.63 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.943 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.46 -45.47 83.61 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.232 174.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.47 -48.63 68.72 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.203 0.525 . . . . 0.0 110.992 176.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.591 HD12 HD22 ' A' ' 29' ' ' LEU . 9.0 tt -54.49 -56.81 15.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.199 175.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -61.17 -36.43 79.79 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -175.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -79.98 -30.57 39.74 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.191 0.519 . . . . 0.0 111.17 -175.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 64.9 mt -103.31 -4.18 24.58 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -176.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -64.81 98.19 0.26 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.878 0.37 . . . . 0.0 110.548 175.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.27 0.18 40.83 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.012 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -68.03 125.44 26.33 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 122.618 -0.342 . . . . 0.0 110.739 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -79.62 91.58 5.24 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.224 0.535 . . . . 0.0 110.472 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.5 tp -77.61 -70.62 0.46 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.713 -174.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.79 45.67 1.31 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.2 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.92 8.68 64.71 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.925 -174.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -141.72 144.1 31.65 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 122.794 0.437 . . . . 0.0 110.332 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.95 135.8 51.41 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.227 2.618 . . . . 0.0 113.637 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.6 ttp -103.23 121.01 41.8 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.387 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -89.05 105.12 17.58 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.767 0.318 . . . . 0.0 111.627 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 85' ' ' LEU . 11.1 t -106.06 105.37 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.737 0.303 . . . . 0.0 110.421 175.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.69 161.65 12.68 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.346 -0.454 . . . . 0.0 113.616 -176.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 179.012 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 56.5 Cg_endo . . . . . 0 CA--C 1.538 0.701 0 N-CA-C 113.21 0.427 . . . . 0.0 113.21 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 13.3 tpt -122.51 138.44 54.56 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.616 176.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.431 ' HD3' ' HB3' ' A' ' 72' ' ' PHE . 36.5 ttm180 -110.94 135.21 51.8 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.07 0.462 . . . . 0.0 111.955 -173.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.9 mt -109.91 137.7 47.33 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.204 0.526 . . . . 0.0 111.945 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -89.94 110.31 21.28 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.524 172.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.7 t -110.71 101.76 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.815 0.34 . . . . 0.0 111.046 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 70' ' ' TYR . . . -113.62 89.72 0.52 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.72 -178.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.43 ' HB2' ' HA ' ' A' ' 98' ' ' MET . 22.6 t -166.39 21.22 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.576 0.703 . . . . 0.0 110.852 176.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.46 ' HB3' ' HB ' ' A' ' 38' ' ' ILE . 18.8 mt -85.72 99.77 11.55 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.704 -176.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.439 ' CG ' ' O ' ' A' ' 35' ' ' HIS . 12.3 p80 -70.01 76.04 0.49 Allowed 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.547 0.689 . . . . 0.0 112.383 -175.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 50.41 16.25 0.26 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 171.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.81 -44.01 0.27 Allowed 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.799 -0.563 . . . . 0.0 112.036 -174.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.582 HD12 ' SD ' ' A' ' 42' ' ' MET . 37.8 mm -49.32 130.86 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -174.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 54.2 p -97.35 170.45 9.06 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.218 0.533 . . . . 0.0 112.158 -176.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.542 ' HG3' HD23 ' A' ' 58' ' ' LEU . 2.6 mp0 -62.59 -38.03 88.54 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.432 175.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.37 -37.81 88.83 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.487 -177.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.582 ' SD ' HD12 ' A' ' 38' ' ' ILE . 28.0 ttt -63.34 -50.5 69.75 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.426 0.632 . . . . 0.0 110.1 177.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.457 ' HB3' HD11 ' A' ' 73' ' ' ILE . 64.4 mt -56.16 -53.24 59.51 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.257 176.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -52.62 -40.63 62.94 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.383 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.41 -33.96 78.61 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.291 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 63.2 mt -85.08 -44.04 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.471 ' HD2' ' HZ ' ' A' ' 75' ' ' PHE . 36.8 m-85 -80.81 -31.54 35.6 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -173.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.504 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 25.2 tp10 -54.73 -46.75 99.31 Favored Pre-proline 0 N--CA 1.481 1.105 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 73.0 Cg_exo -52.13 -18.68 7.68 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 122.736 2.29 . . . . 0.0 114.318 176.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -82.61 -29.8 29.91 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.079 -0.388 . . . . 0.0 112.029 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.428 ' HA3' ' HB3' ' A' ' 80' ' ' CYS . . . -169.83 -99.25 0.12 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.316 -0.469 . . . . 0.0 112.447 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -166.43 136.98 3.36 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.143 0.497 . . . . 0.0 111.784 173.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.457 HG21 HG13 ' A' ' 56' ' ' ILE . 3.5 mp -96.89 129.26 47.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.311 177.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -77.61 -55.37 5.41 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.455 0.645 . . . . 0.0 110.345 173.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 95.9 p -150.67 150.55 31.25 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.13 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.457 HG13 HG21 ' A' ' 53' ' ' ILE . 60.9 mt -119.77 126.97 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 121.004 0.43 . . . . 0.0 111.212 176.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -101.79 118.4 36.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.981 0.42 . . . . 0.0 110.276 173.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.542 HD23 ' HG3' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -98.34 131.19 44.85 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.5 tpt . . . . . 0 CA--C 1.537 0.45 0 CA-C-O 121.643 0.735 . . . . 0.0 111.047 -171.367 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 120.801 0.334 . . . . 0.0 111.48 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.98 12.64 33.78 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.803 175.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.423 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 2.7 m-85 -121.87 160.56 24.48 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.397 -0.473 . . . . 0.0 110.734 178.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.36 130.51 3.27 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.456 -0.402 . . . . 0.0 112.372 175.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.431 ' HB3' ' HD3' ' A' ' 28' ' ' ARG . 89.4 m-85 -98.99 107.2 19.57 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.06 0.457 . . . . 0.0 111.078 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' A' ' 43' ' ' LEU . 69.5 mt -99.49 127.92 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.689 -176.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.9 m -103.25 122.82 45.55 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.007 0.432 . . . . 0.0 111.711 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.503 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 44.3 m-85 -99.31 151.45 21.04 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.453 177.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.1 t -76.91 -5.67 49.4 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.735 0.302 . . . . 0.0 111.205 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.505 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 29.0 t70 -142.6 147.62 36.13 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.021 0.439 . . . . 0.0 111.488 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.6 p -72.26 -42.71 65.31 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.054 -178.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -69.13 -38.12 78.69 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.641 0.258 . . . . 0.0 111.359 -177.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.505 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 83.7 m -55.4 -45.5 76.65 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.205 0.526 . . . . 0.0 111.178 175.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.08 -40.99 82.58 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.292 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -58.29 -44.5 88.52 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.072 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -65.23 -49.44 69.66 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.625 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.27 -47.47 72.28 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.945 0.403 . . . . 0.0 111.228 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 85' ' ' LEU . 8.8 tt -57.51 -50.7 72.2 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.79 174.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -54.02 -35.09 61.55 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.912 -175.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -93.31 -42.85 9.09 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.7 mt -87.61 -17.21 32.44 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -169.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -71.0 107.98 4.35 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.116 0.484 . . . . 0.0 110.616 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.93 -13.78 37.82 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.245 -174.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -65.67 135.11 54.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.957 0.408 . . . . 0.0 111.885 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 92' ' ' GLU . 9.0 pt-20 -73.73 95.0 2.3 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.195 0.521 . . . . 0.0 111.105 177.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 67.2 tp -67.4 -77.21 0.07 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.28 0.562 . . . . 0.0 111.787 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -108.08 46.41 0.96 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.247 0.546 . . . . 0.0 110.895 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.94 3.42 89.21 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.098 -174.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -128.69 139.68 36.29 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 123.138 0.575 . . . . 0.0 110.255 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.23 134.43 63.97 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.536 2.157 . . . . 0.0 112.048 175.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.43 ' HA ' ' HB2' ' A' ' 33' ' ' SER . 39.3 ttp -98.44 121.73 40.74 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.106 0.479 . . . . 0.0 111.465 -174.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -87.63 100.58 12.91 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.891 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 28.1 t -111.65 102.21 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.829 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -120.18 138.82 13.29 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.725 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 19.9 p80 . . . . . 0 N--CA 1.473 0.698 0 O-C-N 122.379 -0.483 . . . . 0.0 111.724 -179.514 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.626 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 120.81 0.338 . . . . 0.0 111.068 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -86.16 -135.45 3.94 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.511 175.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.9 t60 61.09 88.88 0.08 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.277 0.561 . . . . 0.0 112.06 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -70.62 125.82 27.87 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.285 0.564 . . . . 0.0 112.385 -177.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -113.84 109.25 18.23 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.458 175.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.411 ' CE1' ' HB3' ' A' ' 8' ' ' HIS . 77.8 t60 -160.68 110.21 1.71 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.958 0.408 . . . . 0.0 111.367 -176.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -120.89 6.72 10.39 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.808 0.337 . . . . 0.0 111.04 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.411 ' HB3' ' CE1' ' A' ' 6' ' ' HIS . 54.0 t60 -59.85 -20.12 55.17 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.301 0.572 . . . . 0.0 110.912 176.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.0 m -68.84 98.52 0.93 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.159 172.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -56.02 96.05 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.801 -177.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 62.1 mtt 69.64 179.68 0.24 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.441 0.696 . . . . 0.0 112.231 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 73.0 -52.44 0.71 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.404 0.682 . . . . 0.0 112.554 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.62 -36.26 71.56 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.44 -61.44 1.79 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.07 0.462 . . . . 0.0 111.716 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 28.3 ttt -87.26 85.53 7.19 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.207 0.527 . . . . 0.0 110.484 177.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.4 -29.74 5.06 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.839 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -79.47 126.1 30.41 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.61 0.243 . . . . 0.0 110.99 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -61.86 -25.97 67.86 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -176.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 76.2 mt -95.95 -18.1 20.53 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 57.68 90.25 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.292 0.568 . . . . 0.0 110.961 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -61.06 -35.2 76.32 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -171.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -145.72 -160.26 8.56 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.86 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.5 t 68.77 -166.64 0.18 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.777 0.431 . . . . 0.0 111.695 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 72.4 -11.57 0.8 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 176.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.14 -100.63 0.52 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.129 -0.557 . . . . 0.0 113.322 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -77.36 163.29 30.16 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.659 2.239 . . . . 0.0 113.199 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.7 ttt -148.55 140.87 24.17 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.354 -177.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 28' ' ' ARG . 41.9 ttp180 -115.25 128.33 56.07 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.831 0.348 . . . . 0.0 111.124 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.2 mt -103.5 150.05 24.26 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.168 0.509 . . . . 0.0 112.063 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 78.3 t80 -107.25 106.8 17.43 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.537 176.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.422 HG22 HG22 ' A' ' 100' ' ' VAL . 51.4 t -105.72 125.18 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 120.799 0.333 . . . . 0.0 111.826 -177.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -127.64 96.91 0.45 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 121.248 -0.501 . . . . 0.0 113.7 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 96.6 p -163.96 11.2 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.054 0.454 . . . . 0.0 111.671 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.436 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 8.3 mt -83.06 81.46 8.67 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -171.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.414 ' O ' ' CD2' ' A' ' 35' ' ' HIS . 1.1 p-80 -80.38 71.35 7.19 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.738 0.78 . . . . 0.0 112.319 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 61.47 9.36 2.63 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 172.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -143.3 -8.81 0.77 Allowed 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.246 -0.909 . . . . 0.0 113.364 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.534 ' N ' HD12 ' A' ' 38' ' ' ILE . 2.5 mp -90.59 113.34 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 O-C-N 121.709 -0.62 . . . . 0.0 110.308 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.3 p -95.94 170.42 9.3 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -174.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -53.17 -44.14 67.64 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.683 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -64.13 -39.52 94.21 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.135 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.0 mmt -62.4 -53.05 60.64 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.329 0.585 . . . . 0.0 110.482 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.417 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 54.8 mt -54.67 -55.17 32.52 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.927 176.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.48 ' HB2' HD11 ' A' ' 56' ' ' ILE . 25.4 ttt85 -55.13 -44.1 74.74 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.6 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.12 -29.7 68.92 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.438 -0.41 . . . . 0.0 113.5 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.9 mt -83.46 -34.46 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 O-C-N 122.475 -0.426 . . . . 0.0 112.09 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.428 ' HD2' ' HZ ' ' A' ' 75' ' ' PHE . 6.9 m-85 -85.28 -32.16 22.69 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -174.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.15 -35.51 21.48 Favored Pre-proline 0 N--CA 1.479 1.0 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -45.47 -26.65 2.87 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.205 1.937 . . . . 0.0 113.117 170.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -80.18 -47.74 14.23 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.932 0.396 . . . . 0.0 111.027 174.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.424 ' HA3' ' SG ' ' A' ' 80' ' ' CYS . . . -161.44 -101.5 0.17 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.208 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 52' ' ' ARG . 38.3 ttt180 -164.66 146.13 8.1 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 122.569 -0.371 . . . . 0.0 111.015 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.448 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.3 mp -108.79 130.62 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.835 0.35 . . . . 0.0 111.549 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -79.7 -49.4 12.14 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.853 0.359 . . . . 0.0 111.477 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.5 p -150.79 144.17 24.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.088 0.47 . . . . 0.0 111.57 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.48 HD11 ' HB2' ' A' ' 44' ' ' ARG . 61.9 mt -115.7 115.44 49.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 177.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -110.2 105.69 14.84 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.805 0.336 . . . . 0.0 111.082 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 72.1 mt -98.07 146.78 25.2 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.914 0.388 . . . . 0.0 111.087 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 66.6 mmm -93.87 110.07 21.74 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.975 0.417 . . . . 0.0 110.026 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.3 ptt? -128.5 143.47 50.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.087 0.47 . . . . 0.0 111.802 -174.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -66.61 88.45 0.14 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.033 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.6 t -59.39 -13.67 9.28 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.414 0.626 . . . . 0.0 110.797 175.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -60.81 -41.05 94.94 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.524 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.442 HG23 ' HG3' ' A' ' 66' ' ' ARG . 11.1 t -132.27 -7.05 3.39 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -177.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.94 53.03 3.63 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.417 -0.421 . . . . 0.0 113.332 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.442 ' HG3' HG23 ' A' ' 64' ' ' THR . 71.7 mtt-85 -137.08 162.0 34.58 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 122.502 -0.411 . . . . 0.0 111.417 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 54.3 m -85.13 128.07 34.51 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 122.314 -0.241 . . . . 0.0 111.378 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -71.04 -31.57 68.06 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 134.44 -15.41 4.43 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.601 -0.809 . . . . 0.0 114.123 177.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -137.36 150.66 47.86 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.399 0.599 . . . . 0.0 112.453 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.37 158.51 27.76 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 116.182 -0.463 . . . . 0.0 113.018 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -102.08 125.24 48.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.03 0.443 . . . . 0.0 111.352 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.41 HG12 HG23 ' A' ' 56' ' ' ILE . 73.4 mt -111.53 123.22 67.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.165 0.507 . . . . 0.0 111.249 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.4 m -99.54 119.26 37.76 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.458 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 49.1 m-85 -100.95 150.63 22.67 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.424 175.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.3 t -78.36 -30.01 47.8 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.994 0.426 . . . . 0.0 110.942 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -106.91 117.25 33.57 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.827 0.346 . . . . 0.0 111.434 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.9 p -59.5 -52.93 63.48 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.6 tp10 -55.15 -43.91 74.65 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.835 0.35 . . . . 0.0 111.481 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.424 ' SG ' ' HA3' ' A' ' 51' ' ' GLY . 52.6 t -62.9 -45.1 94.12 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.247 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -60.86 -44.04 97.56 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.251 0.548 . . . . 0.0 111.225 176.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.435 ' HB3' ' HE2' ' A' ' 82' ' ' LYS . 35.7 ttpt -61.71 -38.52 88.19 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.85 177.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -65.23 -46.78 79.24 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.163 176.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.59 -48.05 78.26 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.007 0.432 . . . . 0.0 110.634 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.428 HD23 ' C ' ' A' ' 85' ' ' LEU . 8.2 tt -55.58 -50.76 69.23 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.293 0.568 . . . . 0.0 110.668 174.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -62.26 -32.08 72.73 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.913 -173.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -94.88 -36.76 11.5 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.439 ' O ' ' HB3' ' A' ' 98' ' ' MET . 91.4 mt -87.97 -20.1 26.34 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -172.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -64.25 105.67 0.95 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.225 0.536 . . . . 0.0 110.411 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.49 -9.1 26.3 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.098 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -69.34 130.87 43.79 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 122.646 0.378 . . . . 0.0 112.005 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -89.22 103.95 16.53 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.208 0.528 . . . . 0.0 111.536 176.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.2 tp -87.79 -68.62 0.75 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.291 0.567 . . . . 0.0 111.386 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.53 45.36 1.01 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.434 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.0 26.31 74.8 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.211 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -151.85 133.15 7.87 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 123.11 0.564 . . . . 0.0 110.225 -175.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -54.43 150.77 32.76 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.894 2.396 . . . . 0.0 113.921 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.497 ' HG3' HG23 ' A' ' 100' ' ' VAL . 44.0 tpp -98.41 108.27 20.93 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.869 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -88.63 100.1 12.84 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 122.171 -0.331 . . . . 0.0 111.211 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.497 HG23 ' HG3' ' A' ' 98' ' ' MET . 59.9 t -117.54 107.96 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.938 0.399 . . . . 0.0 111.599 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -120.75 155.47 16.24 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.981 177.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.52 ' CE1' ' HG2' ' A' ' 105' ' ' GLU . 20.3 p80 -82.0 46.64 1.03 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 122.081 -0.658 . . . . 0.0 112.453 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.2 t 56.69 -78.6 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.9 t -87.92 129.65 35.17 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -173.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.52 ' HG2' ' CE1' ' A' ' 102' ' ' HIS . 79.1 mt-10 -142.65 -50.47 0.36 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.903 174.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -131.51 47.56 2.52 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.159 0.504 . . . . 0.0 111.225 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.2 p -56.09 -64.87 0.72 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.2 t0 . . . . . 0 C--O 1.252 1.187 0 CA-C-O 118.743 -0.646 . . . . 0.0 111.552 -178.325 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.544 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.79 0.329 . . . . 0.0 111.285 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.89 37.57 94.46 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.346 -0.454 . . . . 0.0 113.47 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 72.3 m80 63.54 161.88 0.1 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.145 0.497 . . . . 0.0 111.85 -175.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -141.3 36.45 1.7 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.173 0.511 . . . . 0.0 110.906 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -74.34 71.97 1.78 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.998 0.428 . . . . 0.0 111.077 -176.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -133.58 22.88 3.99 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.058 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 21.6 p80 55.0 130.98 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.671 1.189 . . . . 0.0 113.995 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -158.26 -171.02 3.32 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.63 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.0 m -52.21 116.26 2.13 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -177.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -105.33 162.87 13.06 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.939 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 51.2 mtm 68.31 1.31 2.83 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 176.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.16 116.71 22.48 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.107 0.163 . . . . 0.0 111.091 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 66.81 124.14 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.09 16.67 0.95 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.834 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.602 ' SD ' ' N ' ' A' ' 15' ' ' MET . 1.0 OUTLIER -80.72 137.07 36.26 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -176.325 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 61.2 78.46 0.29 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.406 0.622 . . . . 0.0 111.667 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -84.42 75.05 10.28 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.172 0.511 . . . . 0.0 111.882 -176.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -79.86 44.73 0.66 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.261 0.553 . . . . 0.0 111.437 177.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.473 HD12 ' N ' ' A' ' 20' ' ' GLN . 2.5 pp -78.86 -17.28 55.88 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.098 0.475 . . . . 0.0 111.116 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.473 ' N ' HD12 ' A' ' 19' ' ' LEU . 17.1 pt20 -94.12 99.53 11.79 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.775 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -67.21 -44.32 79.85 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.226 0.536 . . . . 0.0 110.227 176.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -156.97 143.71 9.91 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.021 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 85.5 p -68.31 -18.58 64.54 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 117.207 0.504 . . . . 0.0 111.449 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -113.42 101.44 9.37 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.348 172.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -176.81 -165.24 31.99 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.473 -0.394 . . . . 0.0 112.413 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 38.6 Cg_exo -57.64 101.77 0.11 Allowed 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.598 2.199 . . . . 0.0 113.216 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 11.0 tpt -102.74 145.74 29.27 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.977 0.418 . . . . 0.0 111.689 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -114.52 127.56 55.87 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.043 0.449 . . . . 0.0 111.751 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.4 mt -104.31 149.89 24.94 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.188 0.518 . . . . 0.0 111.546 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.409 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 59.4 t80 -103.45 109.87 21.68 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.539 176.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -110.93 108.16 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 120.743 0.306 . . . . 0.0 111.047 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -121.77 88.59 0.42 Allowed Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.823 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.3 m -164.42 24.98 0.07 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 120.939 0.4 . . . . 0.0 111.283 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 34.2 mt -85.23 143.97 28.42 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.891 0.377 . . . . 0.0 111.661 -174.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.438 ' CE1' ' HB3' ' A' ' 37' ' ' ASN . 33.1 p80 -108.83 48.65 0.85 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.079 0.466 . . . . 0.0 111.708 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 50.1 t80 61.54 9.18 2.58 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.438 ' HB3' ' CE1' ' A' ' 35' ' ' HIS . 3.3 t-20 -142.5 37.06 1.49 Allowed 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.539 -0.725 . . . . 0.0 111.669 -178.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.3 mm -125.76 106.62 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 O-C-N 122.023 -0.423 . . . . 0.0 110.407 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.3 p -93.26 175.66 6.68 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.154 0.502 . . . . 0.0 112.304 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.468 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 2.7 mp0 -53.09 -36.01 60.22 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.214 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -56.45 -52.09 65.98 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.847 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.6 tpt -65.34 -47.9 74.9 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.188 0.518 . . . . 0.0 110.711 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.0 mt -56.11 -44.11 78.78 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.248 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -65.15 -44.65 87.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.217 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.99 -31.89 65.72 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.267 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 58.2 mt -86.0 -45.03 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 75' ' ' PHE . 37.5 m-85 -85.14 -43.7 13.61 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -172.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.466 ' CD ' HH11 ' A' ' 52' ' ' ARG . 36.1 tt0 -59.56 -35.1 26.57 Favored Pre-proline 0 N--CA 1.48 1.028 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -172.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 48' ' ' GLU . 60.3 Cg_exo -43.01 -29.39 1.55 Allowed 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 122.081 1.854 . . . . 0.0 113.523 172.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -82.11 -31.18 30.81 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.933 0.397 . . . . 0.0 111.482 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.564 ' HA3' ' HB3' ' A' ' 80' ' ' CYS . . . -175.89 134.47 2.66 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.279 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.466 HH11 ' CD ' ' A' ' 48' ' ' GLU . 14.1 tpt180 -48.22 125.14 8.85 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 122.946 0.498 . . . . 0.0 111.941 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 73.8 mt -94.73 133.95 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.171 0.51 . . . . 0.0 111.831 -175.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -83.92 -51.34 7.24 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.862 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.6 m -150.48 132.95 15.64 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.896 0.379 . . . . 0.0 111.694 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.541 HG23 HG12 ' A' ' 73' ' ' ILE . 58.4 mt -108.84 107.6 23.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.821 176.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -102.19 118.59 37.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.363 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.4 HD13 ' HG3' ' A' ' 40' ' ' GLU . 9.4 mp -98.43 139.63 33.9 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.078 0.466 . . . . 0.0 110.577 175.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.701 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 45.0 tpp -93.1 99.69 12.24 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.405 0.622 . . . . 0.0 111.387 -173.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.495 ' O ' ' HE2' ' A' ' 68' ' ' LYS . 65.5 mtt -85.84 -177.44 6.35 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.391 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.1 p-10 -79.55 -13.54 59.47 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.607 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.8 p 59.28 17.43 5.77 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.604 0.762 . . . . 0.0 111.717 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -118.6 -61.18 1.69 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.147 -175.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.1 p -112.66 -29.5 7.42 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.543 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 117.19 38.22 0.88 Allowed Glycine 0 CA--C 1.529 0.925 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.551 -177.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -110.22 159.46 17.37 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.587 -0.36 . . . . 0.0 111.01 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.9 m -92.76 128.41 38.61 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.684 -175.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.701 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 68.8 mttm -71.2 -25.95 62.73 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.677 0.275 . . . . 0.0 111.538 177.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.99 -6.55 8.86 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.992 -0.623 . . . . 0.0 114.31 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -138.01 160.0 40.53 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 117.719 0.76 . . . . 0.0 112.571 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -142.63 151.71 23.27 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.802 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -105.26 115.59 30.51 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.804 0.442 . . . . 0.0 111.448 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.541 HG12 HG23 ' A' ' 56' ' ' ILE . 68.5 mt -104.78 128.37 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 122.222 -0.299 . . . . 0.0 111.546 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.3 m -108.21 121.35 44.68 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 18.2 m-85 -98.5 151.61 20.43 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.294 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.3 t -69.09 -13.04 62.2 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.833 0.349 . . . . 0.0 111.737 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.627 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 16.4 t70 -133.59 153.29 51.78 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.049 0.452 . . . . 0.0 111.361 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 68.7 p -73.12 -51.96 16.03 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.199 -176.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -74.36 -23.05 58.95 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 92.3 m -60.72 -42.84 98.06 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.221 0.534 . . . . 0.0 109.942 170.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.91 -46.94 73.28 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.958 174.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -53.41 -47.71 69.33 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.647 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -60.33 -44.88 95.08 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.184 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.98 -40.14 83.9 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.143 0.497 . . . . 0.0 110.937 175.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.8 -57.98 9.76 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.826 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.401 ' HG3' ' NE2' ' A' ' 87' ' ' GLN . 11.2 pt-20 -61.72 -26.85 68.31 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -174.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.401 ' NE2' ' HG3' ' A' ' 86' ' ' GLU . 2.7 mp0 -90.54 -34.7 15.43 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.4 mt -97.84 -14.22 20.85 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -173.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -70.85 80.8 0.63 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.584 0.707 . . . . 0.0 110.702 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.64 -4.71 5.13 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.169 -174.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -59.61 140.08 56.65 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -73.37 84.9 1.46 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.953 0.406 . . . . 0.0 111.524 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 67.0 tp -90.59 116.01 28.15 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.291 -0.256 . . . . 0.0 110.854 176.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 59.49 16.9 5.58 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.89 11.85 48.6 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.512 -0.375 . . . . 0.0 112.903 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -132.27 138.46 32.31 Favored Pre-proline 0 N--CA 1.468 0.467 0 O-C-N 122.65 -0.324 . . . . 0.0 111.306 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.19 131.44 38.89 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.326 2.018 . . . . 0.0 112.169 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.4 ttp -97.01 118.99 34.63 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.289 0.566 . . . . 0.0 111.398 -175.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -88.38 104.91 17.21 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.72 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.9 t -111.6 111.44 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.11 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 30' ' ' TYR . . . -133.77 150.8 20.01 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.324 177.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -66.99 143.92 56.5 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 117.788 0.794 . . . . 0.0 111.017 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.7 t -68.37 147.12 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.089 0.471 . . . . 0.0 111.895 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 45.1 m -74.65 150.26 39.66 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 174.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -53.99 -50.04 67.47 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -177.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -81.29 83.39 6.89 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.973 -0.454 . . . . 0.0 111.774 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.1 t -94.4 -28.51 15.47 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.751 175.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.7 t70 . . . . . 0 C--O 1.252 1.224 0 CA-C-O 118.236 -0.888 . . . . 0.0 112.185 -177.918 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptp . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 120.663 0.268 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 161.41 154.01 7.28 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 120.753 -0.737 . . . . 0.0 113.622 176.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -88.24 -22.53 23.91 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.904 0.383 . . . . 0.0 111.12 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -165.01 118.23 1.24 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.331 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -109.25 138.32 45.78 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -75.51 142.97 42.74 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.773 0.321 . . . . 0.0 110.361 173.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -83.44 97.62 9.07 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -168.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -116.68 -27.69 6.6 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.262 163.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 10' ' ' HIS . 22.4 m -57.43 124.57 19.4 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.14 173.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' HB3' ' O ' ' A' ' 9' ' ' SER . 70.6 t60 72.12 -41.93 0.52 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.349 0.66 . . . . 0.0 112.593 -177.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.6 ttt -70.31 79.03 0.54 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.253 0.549 . . . . 0.0 111.948 -176.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.74 74.9 1.02 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.962 172.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 64.25 -70.64 0.08 Allowed 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.699 -173.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -176.26 177.43 1.53 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.118 0.567 . . . . 0.0 110.856 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.483 ' N ' ' SD ' ' A' ' 15' ' ' MET . 3.4 mpp? -59.46 150.47 26.6 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.519 0.2 . . . . 0.0 111.326 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 67.17 99.86 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.25 0.548 . . . . 0.0 112.153 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.01 114.6 11.86 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.015 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.7 t30 66.61 138.89 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.5 0.667 . . . . 0.0 111.931 -172.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.691 ' H ' HD23 ' A' ' 19' ' ' LEU . 2.1 pt? -128.36 -0.13 5.68 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.32 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.417 ' HA ' ' OE1' ' A' ' 20' ' ' GLN . 6.1 tp60 -107.02 152.93 23.33 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.092 0.473 . . . . 0.0 111.505 -176.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -84.75 129.02 34.88 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.484 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.16 108.62 2.25 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 121.164 -0.541 . . . . 0.0 113.066 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.3 t -89.54 21.9 3.22 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 122.455 -0.438 . . . . 0.0 111.784 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 73.34 -35.31 0.31 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.71 -175.57 23.45 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.509 -0.377 . . . . 0.0 112.905 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.37 130.62 29.61 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.163 2.576 . . . . 0.0 113.687 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.3 ttt -102.08 135.82 42.98 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.857 0.36 . . . . 0.0 111.08 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.449 ' HD3' ' HB3' ' A' ' 72' ' ' PHE . 33.7 ttm180 -106.55 134.52 49.55 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -176.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.516 HD22 HD12 ' A' ' 85' ' ' LEU . 75.2 mt -113.11 147.68 36.83 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.191 0.519 . . . . 0.0 111.784 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -94.77 123.17 38.07 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.572 174.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.2 t -116.97 123.2 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 120.733 0.302 . . . . 0.0 111.245 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.3 96.84 0.53 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.277 -0.487 . . . . 0.0 113.345 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.442 ' HB3' ' HA ' ' A' ' 98' ' ' MET . 78.3 p -174.72 15.46 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 177.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.432 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 20.8 mt -82.55 83.31 7.62 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.88 -0.513 . . . . 0.0 111.102 -173.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.415 ' O ' ' CG ' ' A' ' 35' ' ' HIS . 14.4 p80 -78.15 65.08 3.45 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.429 0.633 . . . . 0.0 112.012 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 56.5 t80 55.37 9.73 0.4 Allowed 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 176.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -139.64 1.63 1.94 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.343 -0.848 . . . . 0.0 112.762 -176.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.478 HD12 ' SD ' ' A' ' 42' ' ' MET . 31.6 mm -103.53 118.05 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 O-C-N 121.874 -0.516 . . . . 0.0 110.753 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 34.4 p -103.65 176.59 5.1 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.22 0.534 . . . . 0.0 112.138 -175.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -53.17 -48.58 67.88 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.463 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -59.12 -40.32 85.07 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.792 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.511 ' SD ' HD11 ' A' ' 93' ' ' LEU . 46.3 ttm -65.21 -46.56 80.16 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.256 0.551 . . . . 0.0 110.442 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.3 mt -57.95 -44.46 87.02 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.697 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 44' ' ' ARG . 43.5 ttm180 -56.65 -44.74 81.61 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.164 0.506 . . . . 0.0 110.817 175.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.72 -35.45 81.64 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.129 -0.558 . . . . 0.0 113.638 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.45 HD11 HD13 ' A' ' 93' ' ' LEU . 63.3 mt -84.72 -45.13 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -85.25 -34.04 22.05 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -173.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.619 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 36.4 tt0 -56.84 -41.48 91.53 Favored Pre-proline 0 N--CA 1.477 0.921 0 N-CA-C 113.682 0.994 . . . . 0.0 113.682 -172.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 48' ' ' GLU . 5.1 Cg_endo -47.3 -33.15 15.83 Favored 'Trans proline' 0 C--N 1.363 1.292 0 C-N-CA 122.232 1.954 . . . . 0.0 112.934 175.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -77.1 -47.8 19.5 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.164 0.507 . . . . 0.0 110.876 175.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -162.6 136.52 4.37 Favored Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.845 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 -54.98 134.57 48.95 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.007 0.432 . . . . 0.0 112.057 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.491 HG21 HG13 ' A' ' 56' ' ' ILE . 1.8 mp -81.82 129.38 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.103 0.478 . . . . 0.0 111.813 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -90.43 -43.52 10.22 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.334 176.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.0 p -151.98 148.21 27.47 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.715 0.293 . . . . 0.0 111.64 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.491 HG13 HG21 ' A' ' 53' ' ' ILE . 59.4 mt -127.53 106.61 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.891 0.377 . . . . 0.0 110.895 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -99.45 115.22 28.78 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.614 0.245 . . . . 0.0 110.936 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 80.4 mt -98.01 132.16 43.81 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.037 0.446 . . . . 0.0 110.99 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 89.1 mmm -94.49 98.9 11.18 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.343 0.592 . . . . 0.0 111.295 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 22.9 ptp -117.4 152.41 35.03 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.562 176.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -79.83 113.38 17.95 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.8 t -74.25 -12.98 60.71 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.838 0.827 . . . . 0.0 109.256 167.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -68.04 -53.85 22.7 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.066 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 74.8 p -108.84 -9.13 15.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.157 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.34 18.24 80.0 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.602 -176.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -112.99 -163.9 0.88 Allowed 'General case' 0 CA--C 1.544 0.726 0 O-C-N 122.452 -0.44 . . . . 0.0 111.065 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.1 m -111.7 137.14 49.99 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 122.071 -0.393 . . . . 0.0 111.927 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -78.83 -25.59 44.15 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.871 0.367 . . . . 0.0 111.736 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 104.1 4.44 44.58 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 120.936 -0.649 . . . . 0.0 114.588 174.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -144.84 156.12 43.85 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 117.643 0.722 . . . . 0.0 112.649 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.94 160.73 28.76 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.793 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.449 ' HB3' ' HD3' ' A' ' 28' ' ' ARG . 90.7 m-85 -111.42 124.07 51.5 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 122.569 -0.371 . . . . 0.0 111.511 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.5 mt -112.85 132.98 60.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 120.914 0.388 . . . . 0.0 111.703 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.3 m -101.65 125.41 48.31 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.705 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.469 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 88.3 m-85 -108.99 151.21 26.64 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.811 0.445 . . . . 0.0 111.167 177.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.9 m -62.88 -31.19 72.19 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -177.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.62 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 25.3 t70 -126.88 148.04 50.03 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.073 0.464 . . . . 0.0 111.612 -172.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.1 t -76.17 -34.46 59.34 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -77.24 -36.54 54.51 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.726 0.298 . . . . 0.0 111.114 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.62 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 17.5 p -63.67 -44.17 94.54 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.086 0.47 . . . . 0.0 110.257 175.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -64.63 -46.66 81.59 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.113 175.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -54.56 -43.72 72.3 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.627 175.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.86 -42.62 94.71 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.831 0.348 . . . . 0.0 111.285 177.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.56 -55.25 36.84 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.006 0.431 . . . . 0.0 111.071 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.516 HD12 HD22 ' A' ' 29' ' ' LEU . 8.6 tt -51.57 -55.89 16.63 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.826 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -54.15 -34.03 59.39 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.562 -175.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -97.39 -24.21 15.73 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 97.7 mt -101.65 -11.21 19.37 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -173.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -68.54 85.9 0.3 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.966 0.889 . . . . 0.0 111.225 177.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 127.73 -2.13 6.94 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.309 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -59.69 134.92 57.47 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.459 0.304 . . . . 0.0 111.357 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.34 91.38 1.72 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.23 0.538 . . . . 0.0 111.728 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.511 HD11 ' SD ' ' A' ' 42' ' ' MET . 55.0 tp -99.89 122.05 42.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.596 177.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 59.15 18.67 6.69 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.042 0.448 . . . . 0.0 111.812 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.3 -20.25 30.71 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 116.213 -0.448 . . . . 0.0 113.128 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -115.21 153.81 47.35 Favored Pre-proline 0 CA--C 1.537 0.475 0 O-C-N 122.768 -0.254 . . . . 0.0 111.614 -174.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -63.65 139.02 67.42 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.216 1.944 . . . . 0.0 112.772 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.442 ' HA ' ' HB3' ' A' ' 33' ' ' SER . 44.3 ttp -97.84 120.37 38.11 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.04 -178.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -88.26 99.88 12.57 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.057 0.456 . . . . 0.0 112.155 -174.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 18.3 t -106.03 126.83 61.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.035 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -149.95 160.59 28.57 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.263 -0.494 . . . . 0.0 113.132 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -65.33 176.74 1.28 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.104 0.478 . . . . 0.0 112.162 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.762 HG12 ' H ' ' A' ' 104' ' ' THR . 6.0 t -71.46 -179.75 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.508 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.762 ' H ' HG12 ' A' ' 103' ' ' VAL . 75.3 p -43.34 -55.78 3.89 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -175.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 103' ' ' VAL . 12.7 mm-40 74.82 -40.87 0.45 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 178.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.411 ' HB3' ' OD1' ' A' ' 108' ' ' ASP . 48.2 mtm105 -52.97 143.2 17.7 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.745 1.016 . . . . 0.0 113.745 -174.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.4 t -80.43 6.39 12.41 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.411 ' OD1' ' HB3' ' A' ' 106' ' ' ARG . 3.6 m-20 . . . . . 0 C--O 1.252 1.216 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 120.719 0.295 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 59.08 -154.3 29.15 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.163 -0.541 . . . . 0.0 113.467 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 72.1 m80 66.95 121.25 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.313 0.578 . . . . 0.0 111.926 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -68.14 85.99 0.25 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.415 0.626 . . . . 0.0 111.244 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -126.3 126.13 43.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.432 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -67.44 -179.18 0.99 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.796 0.332 . . . . 0.0 111.532 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -69.95 -75.52 0.11 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 122.299 -0.251 . . . . 0.0 111.182 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 81.1 t60 62.96 142.64 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.4 m 67.19 170.84 0.26 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.711 0.767 . . . . 0.0 112.531 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -154.61 76.42 1.02 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.56 172.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 62.9 mtm -86.66 103.51 15.2 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.726 -175.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.83 -175.37 2.65 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.477 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -118.24 146.42 44.28 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.761 0.315 . . . . 0.0 111.465 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.34 122.63 17.57 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.233 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.4 mmt -55.65 104.97 0.15 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.213 0.53 . . . . 0.0 111.689 -178.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.78 -3.53 54.1 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -64.98 82.88 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.492 0.663 . . . . 0.0 111.011 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -174.91 -45.8 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.32 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 73.6 mt -83.84 47.56 1.32 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.745 0.783 . . . . 0.0 109.802 173.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.4 ' NE2' ' OG1' ' A' ' 104' ' ' THR . 16.5 tp60 -93.45 90.7 6.82 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.791 -169.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -156.26 138.69 14.87 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.84 165.63 31.63 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.983 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.3 p -141.02 155.82 46.13 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.867 0.365 . . . . 0.0 110.362 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.471 ' O ' ' HD2' ' A' ' 26' ' ' PRO . . . -77.91 8.66 4.36 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.6 -74.5 0.21 Allowed Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 -172.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' A' ' 24' ' ' ALA . 47.1 Cg_endo -68.54 153.78 72.99 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 122.269 1.98 . . . . 0.0 111.187 166.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.2 ttt -100.0 122.67 43.26 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.861 -0.525 . . . . 0.0 111.293 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -98.99 125.76 44.52 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.769 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.45 HD22 HD12 ' A' ' 85' ' ' LEU . 76.8 mt -110.9 133.54 53.29 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.391 0.615 . . . . 0.0 111.74 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -89.78 109.36 20.36 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.331 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.8 t -109.73 123.21 65.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.78 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -123.73 97.29 0.56 Allowed Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.522 -0.371 . . . . 0.0 113.154 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.494 ' HB3' ' HA ' ' A' ' 98' ' ' MET . 99.7 p -161.02 9.74 0.09 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.089 0.471 . . . . 0.0 111.494 176.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.472 HD21 HD21 ' A' ' 43' ' ' LEU . 10.6 mt -87.16 87.71 7.51 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 122.2 -0.312 . . . . 0.0 111.595 -170.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -73.48 72.8 1.39 Allowed 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 56.07 20.62 4.48 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 173.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -153.78 -37.24 0.1 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -175.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.4 mm -59.98 128.72 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 120.778 0.323 . . . . 0.0 111.517 -175.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 62.7 p -113.45 178.16 4.38 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -173.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -48.67 -46.1 39.76 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.964 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.66 -44.87 63.19 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.488 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.7 mmt -66.89 -47.06 72.97 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.461 0.648 . . . . 0.0 110.576 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.472 HD21 HD21 ' A' ' 34' ' ' LEU . 70.6 mt -59.46 -50.67 73.05 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.735 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 44' ' ' ARG . 8.2 ttm180 -58.56 -44.7 89.79 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 122.27 -0.268 . . . . 0.0 111.657 177.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.36 -38.36 68.81 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.579 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.489 HD11 HD13 ' A' ' 93' ' ' LEU . 59.6 mt -86.8 -49.18 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 75' ' ' PHE . 51.6 m-85 -77.18 -41.76 40.28 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -170.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.413 ' HB2' HD12 ' A' ' 53' ' ' ILE . 29.6 tt0 -62.85 -37.88 38.15 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -173.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -46.06 -18.06 0.37 Allowed 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.447 2.098 . . . . 0.0 114.112 172.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -82.23 -42.97 18.21 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.801 0.334 . . . . 0.0 111.417 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.17 -122.87 1.06 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.791 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.401 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 29.8 mmt180 -140.29 129.77 24.08 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.387 0.613 . . . . 0.0 111.449 175.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.413 HD12 ' HB2' ' A' ' 48' ' ' GLU . 74.9 mt -100.35 120.81 50.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.822 -175.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -73.45 -53.88 9.59 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.956 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.8 t -150.55 150.2 30.92 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.032 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.1 mt -120.65 116.7 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.372 175.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -118.01 129.18 55.43 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.722 0.296 . . . . 0.0 111.263 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 58' ' ' LEU . 6.0 mp -99.78 141.85 32.04 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.974 0.416 . . . . 0.0 111.075 177.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.462 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 31.0 tpp -93.6 101.42 13.58 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.767 0.794 . . . . 0.0 111.675 -176.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -130.6 131.74 45.13 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.55 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -81.25 106.59 13.35 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.93 0.395 . . . . 0.0 110.992 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 62.9 p -74.56 -12.97 60.6 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -62.32 -54.33 42.08 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.898 0.38 . . . . 0.0 110.299 174.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.5 t -175.15 -10.72 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.25 -24.34 73.58 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.895 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 79.6 mtm-85 61.01 -157.68 0.34 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 122.883 0.473 . . . . 0.0 111.729 175.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.9 m -54.52 111.68 0.85 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.462 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 57.2 mttp -77.98 -25.21 47.96 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 112.7 3.12 25.4 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 120.937 -0.649 . . . . 0.0 114.495 177.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -140.76 158.77 43.48 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.818 0.809 . . . . 0.0 112.423 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -144.37 159.95 27.8 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.629 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -107.4 124.9 50.52 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 122.624 -0.339 . . . . 0.0 111.256 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 64.7 mt -110.21 130.82 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 120.896 0.379 . . . . 0.0 111.145 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.0 m -106.35 114.25 28.26 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.417 ' CZ ' ' HB3' ' A' ' 47' ' ' PHE . 38.5 m-85 -99.46 152.42 20.01 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.14 0.576 . . . . 0.0 110.763 177.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.8 t -93.65 -5.55 48.41 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.662 0.744 . . . . 0.0 110.002 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -119.8 101.81 8.15 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.186 -175.395 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.7 p -56.9 -55.21 37.5 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -176.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -58.23 -47.36 83.78 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 82.5 m -62.09 -40.86 97.26 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.846 0.355 . . . . 0.0 111.572 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.89 -42.68 89.96 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.064 0.459 . . . . 0.0 111.452 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -62.67 -36.38 82.71 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.093 0.473 . . . . 0.0 110.729 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -63.31 -52.05 63.54 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.086 0.47 . . . . 0.0 110.359 172.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.66 -43.69 57.4 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.201 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.45 HD12 HD22 ' A' ' 29' ' ' LEU . 9.5 tt -54.01 -62.76 1.44 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.185 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -74.9 -4.8 40.16 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -172.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -98.32 -29.72 13.0 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.95 -0.469 . . . . 0.0 111.495 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 88.1 mt -106.71 -13.27 15.32 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -175.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -70.17 91.41 0.71 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.28 0.562 . . . . 0.0 110.247 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 125.98 -15.51 6.95 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.992 -172.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -59.73 133.9 56.53 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.072 0.549 . . . . 0.0 111.457 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 30.8 mt-10 -89.08 90.22 8.3 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.238 0.542 . . . . 0.0 111.923 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.489 HD13 HD11 ' A' ' 46' ' ' ILE . 36.2 tp -85.31 -65.5 1.0 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.41 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.04 38.56 0.66 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.879 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.89 17.27 75.19 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 121.241 -0.504 . . . . 0.0 111.954 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 9.7 ptm85 -157.68 151.59 19.67 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 115.505 -0.347 . . . . 0.0 110.349 -174.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.51 141.48 62.3 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.005 2.47 . . . . 0.0 113.039 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.494 ' HA ' ' HB3' ' A' ' 33' ' ' SER . 36.5 ttp -99.31 128.12 45.4 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.119 0.485 . . . . 0.0 111.48 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -89.12 101.46 14.12 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.533 -178.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.7 t -114.24 111.38 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 120.789 0.328 . . . . 0.0 111.321 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -127.38 151.11 18.33 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.298 -0.477 . . . . 0.0 113.272 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -71.02 122.95 20.98 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 122.32 -0.518 . . . . 0.0 111.705 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 90.8 t -74.79 -59.3 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.4 ' OG1' ' NE2' ' A' ' 20' ' ' GLN . 72.5 p 51.21 92.44 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.43 0.692 . . . . 0.0 111.901 -176.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.46 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -92.96 -41.73 9.86 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -170.143 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -135.53 148.55 49.19 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -176.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.1 t -110.21 126.21 53.89 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.236 173.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.5 t70 . . . . . 0 C--O 1.254 1.304 0 CA-C-O 118.877 -0.582 . . . . 0.0 112.045 -174.68 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -85.09 -55.26 2.67 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.968 -175.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -131.21 135.62 47.54 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -172.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -156.88 126.83 6.32 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.993 173.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -70.96 92.65 0.94 Allowed 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.698 0.761 . . . . 0.0 112.882 -172.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -142.05 -36.77 0.41 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.808 172.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 -79.34 110.5 14.68 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.234 0.54 . . . . 0.0 110.226 174.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -77.04 116.87 18.07 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.005 0.431 . . . . 0.0 110.981 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 75.6 p -123.33 -71.58 0.72 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.987 0.422 . . . . 0.0 111.534 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.8 m80 -140.16 -45.53 0.42 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.975 0.417 . . . . 0.0 111.2 175.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.6 mtt -72.75 92.65 1.58 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.998 0.428 . . . . 0.0 111.533 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.17 -47.79 0.13 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.669 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.64 -74.72 0.14 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 177.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -163.96 145.88 9.09 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.835 0.35 . . . . 0.0 111.347 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 15.0 tpt -93.07 -8.84 41.64 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.213 0.53 . . . . 0.0 110.968 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.96 -9.48 52.36 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -174.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -93.12 2.13 56.86 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.003 0.43 . . . . 0.0 111.602 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -67.0 118.72 10.84 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.9 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.6 tp -73.29 87.98 1.51 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.864 0.84 . . . . 0.0 110.277 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -88.76 160.39 17.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.903 -176.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.2 tttt -81.06 136.81 36.01 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.819 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.08 91.0 0.03 OUTLIER Glycine 0 CA--C 1.53 0.987 0 N-CA-C 114.181 0.432 . . . . 0.0 114.181 -174.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.3 t -78.05 -57.05 4.0 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.948 0.404 . . . . 0.0 111.172 176.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -141.92 -50.67 0.4 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.951 0.405 . . . . 0.0 111.673 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.73 78.79 1.3 Allowed Glycine 0 CA--C 1.531 1.072 0 CA-C-N 116.275 -0.421 . . . . 0.0 113.978 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.49 137.69 56.32 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.635 2.223 . . . . 0.0 112.292 174.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.8 ttt -99.6 136.4 39.58 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.091 0.472 . . . . 0.0 111.471 -176.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -112.48 118.98 36.64 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.349 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.9 mt -102.4 145.65 29.22 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.347 0.594 . . . . 0.0 112.126 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -102.08 120.48 40.51 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.616 173.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.3 t -118.98 115.94 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.672 0.272 . . . . 0.0 110.997 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.55 87.51 0.38 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.334 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.4 m -166.13 28.72 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.164 0.585 . . . . 0.0 110.61 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.493 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 15.0 mt -95.25 103.09 14.94 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.768 -176.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -74.21 67.1 1.34 Allowed 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -176.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 50.72 20.83 0.8 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 174.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.16 -38.2 0.27 Allowed 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.99 -0.444 . . . . 0.0 111.784 -174.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.7 mm -60.38 109.63 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 120.824 0.345 . . . . 0.0 111.149 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 61.0 p -92.93 172.57 8.24 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -54.79 -42.72 72.13 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.726 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -63.38 -38.04 89.61 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.703 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.1 mmt -65.51 -52.73 50.58 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.408 0.623 . . . . 0.0 110.197 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 65.5 mt -55.2 -40.33 70.65 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.925 174.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 44' ' ' ARG . 45.0 ttm180 -61.5 -46.76 88.64 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.876 0.37 . . . . 0.0 110.957 177.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.31 -32.03 60.09 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.139 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 58.1 mt -85.68 -50.12 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -82.48 -27.69 31.65 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -172.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.632 ' HG3' ' O ' ' A' ' 52' ' ' ARG . 22.1 tt0 -57.33 -48.23 97.68 Favored Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -173.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 80.3 Cg_exo -47.89 -18.88 1.23 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 122.621 2.214 . . . . 0.0 114.013 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -78.45 -40.31 36.05 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.42 ' HA3' ' HB3' ' A' ' 80' ' ' CYS . . . -169.8 37.93 0.19 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 119.838 -1.173 . . . . 0.0 115.438 -178.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.632 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 0.0 OUTLIER 72.67 -53.79 0.7 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.366 0.666 . . . . 0.0 112.541 174.593 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.447 ' HB ' ' O ' ' A' ' 52' ' ' ARG . 68.7 mt 79.82 137.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.756 0.823 . . . . 0.0 111.672 -177.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -85.01 -64.96 1.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.196 0.522 . . . . 0.0 110.151 174.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.2 t -147.59 146.36 29.36 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.046 0.451 . . . . 0.0 111.865 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.527 HG23 HG12 ' A' ' 73' ' ' ILE . 60.4 mt -115.36 130.19 70.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.894 174.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -125.07 122.45 37.26 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.924 0.393 . . . . 0.0 111.547 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.8 mt -99.13 149.73 22.75 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.657 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 82.8 mmm -97.13 111.24 23.56 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.699 0.285 . . . . 0.0 110.727 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -115.8 148.9 39.36 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.159 0.504 . . . . 0.0 111.925 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -75.47 151.79 37.99 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.498 173.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.6 t -108.53 20.75 18.19 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -173.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -116.67 -67.18 1.01 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.184 0.516 . . . . 0.0 109.866 172.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.0 t -161.79 13.99 0.09 Allowed 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.361 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.92 -27.59 45.23 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.817 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.491 ' NE ' ' HA ' ' A' ' 66' ' ' ARG . 3.5 mmp_? 59.33 -154.5 0.37 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.534 0.334 . . . . 0.0 111.84 176.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.5 m -52.92 99.46 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -54.24 -49.88 68.45 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -174.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 145.27 -11.01 1.79 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.929 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -128.55 145.26 51.18 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 117.23 0.515 . . . . 0.0 111.858 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.33 160.87 28.75 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.651 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -113.25 127.25 56.1 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.007 0.432 . . . . 0.0 111.72 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 56' ' ' ILE . 67.1 mt -110.12 134.71 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.771 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 38.8 m -116.25 123.3 47.39 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.025 0.44 . . . . 0.0 111.926 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -100.22 149.66 23.34 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.511 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.8 m -72.06 -9.46 58.42 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.066 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.632 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 19.8 t70 -138.12 150.23 46.65 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.874 0.369 . . . . 0.0 111.47 -177.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 71.2 p -68.72 -53.19 23.5 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -68.54 -30.17 68.9 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 93.8 m -58.03 -41.45 83.25 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.16 0.505 . . . . 0.0 111.183 174.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.39 -38.67 29.85 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.237 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -54.93 -48.94 72.48 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.308 0.575 . . . . 0.0 110.688 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -70.02 -41.97 73.59 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.566 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.06 -44.02 67.14 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.273 0.558 . . . . 0.0 110.873 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 tt -62.29 -62.25 1.89 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.521 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -56.54 -29.73 62.29 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -176.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -87.95 -38.6 15.42 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 122.09 -0.381 . . . . 0.0 111.728 -175.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 76.5 mt -96.16 -23.4 16.76 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -172.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -65.69 100.13 0.51 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.068 0.461 . . . . 0.0 110.641 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.47 -9.67 13.1 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.738 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -73.22 126.97 31.3 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 122.535 -0.391 . . . . 0.0 111.938 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 45.3 mt-10 -80.04 102.54 9.35 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.866 0.365 . . . . 0.0 111.143 176.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 65.8 tp -89.53 -66.74 0.89 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.034 0.445 . . . . 0.0 111.516 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -92.15 32.4 1.17 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.955 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.61 4.99 79.2 Favored Glycine 0 C--N 1.332 0.343 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 -174.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 1.5 ptm85 -143.44 152.37 56.81 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 122.927 0.491 . . . . 0.0 110.695 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -61.16 155.59 50.12 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.118 2.545 . . . . 0.0 114.384 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 31.9 tpp -99.46 117.72 34.49 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.728 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.587 ' NZ ' ' HB3' ' A' ' 99' ' ' LYS . 7.7 mtpm? -89.32 101.97 14.64 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.121 -0.362 . . . . 0.0 111.419 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.6 t -120.52 118.1 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.886 0.374 . . . . 0.0 111.666 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -139.24 147.49 19.25 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.176 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -66.73 150.34 49.24 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 117.663 0.732 . . . . 0.0 110.769 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.1 m -72.53 178.01 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.051 0.453 . . . . 0.0 111.623 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 74.1 p -82.09 86.23 6.63 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 122.018 -0.426 . . . . 0.0 111.734 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -84.99 94.9 8.92 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 172.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -135.35 148.67 49.5 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.215 0.531 . . . . 0.0 111.926 -177.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 97.7 m -100.25 -43.89 6.13 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.103 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--O 1.253 1.284 0 CA-C-O 118.343 -0.837 . . . . 0.0 112.383 -179.131 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 120.62 0.247 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.96 -70.76 1.19 Allowed Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.752 -174.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.452 ' O ' ' HB2' ' A' ' 4' ' ' HIS . 16.3 m-70 -84.93 139.74 31.61 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 169.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 9.1 m-70 68.98 97.44 0.06 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.185 0.517 . . . . 0.0 111.853 -173.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -84.09 -19.85 33.6 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.177 0.513 . . . . 0.0 110.505 174.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -103.24 103.5 13.54 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.304 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -83.45 -9.47 58.98 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.846 0.355 . . . . 0.0 111.132 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -119.24 112.29 19.29 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.884 0.373 . . . . 0.0 110.778 173.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.4 t -94.86 -178.65 4.58 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.827 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 68.31 32.64 4.57 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.511 176.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.3 ttt 58.73 94.31 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.197 0.523 . . . . 0.0 111.211 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.707 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -86.5 -79.3 0.26 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -175.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 55.86 -83.96 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -177.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -95.17 -24.96 16.59 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.879 0.371 . . . . 0.0 111.45 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.507 ' N ' ' SD ' ' A' ' 15' ' ' MET . 1.3 mpt? -86.39 8.47 21.49 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.707 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . . . -81.49 87.6 6.21 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.706 0.289 . . . . 0.0 110.731 176.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 64.41 86.55 0.12 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.646 -172.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -78.0 126.7 31.23 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.091 0.472 . . . . 0.0 112.238 -176.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 58.1 tp -90.02 -44.56 9.77 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.295 0.569 . . . . 0.0 110.644 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 22.4 tm0? -84.96 90.8 7.9 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.827 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.41 ' HE3' ' HB2' ' A' ' 21' ' ' LYS . 35.8 ttmt -178.43 155.41 0.87 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.665 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.62 81.91 0.06 OUTLIER Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.428 -0.415 . . . . 0.0 113.822 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.3 t -96.84 119.64 35.69 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.614 -0.345 . . . . 0.0 111.061 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.53 138.27 33.49 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.854 0.359 . . . . 0.0 111.251 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.66 -74.85 0.4 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.795 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.53 134.67 29.05 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.834 2.356 . . . . 0.0 112.67 176.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.505 ' HB2' ' HA ' ' A' ' 78' ' ' SER . 27.0 ttt -113.11 133.15 55.15 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.972 0.415 . . . . 0.0 111.558 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -99.78 116.28 31.5 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.159 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.2 mt -99.55 143.06 30.23 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.13 0.491 . . . . 0.0 111.665 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -97.73 120.11 37.54 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.602 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 99' ' ' LYS . 58.4 t -115.17 112.55 40.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.478 176.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.56 93.35 0.22 Allowed Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.527 -0.844 . . . . 0.0 114.645 -174.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.645 ' OG ' ' HA ' ' A' ' 98' ' ' MET . 90.9 p -176.08 19.89 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 28.8 mt -84.88 150.33 25.06 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 122.279 -0.263 . . . . 0.0 111.43 -175.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.4 ' O ' ' ND1' ' A' ' 35' ' ' HIS . 24.9 p80 -122.49 76.61 1.34 Allowed 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -176.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.422 ' HD1' ' HB3' ' A' ' 67' ' ' SER . 23.7 t80 42.94 41.86 2.81 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.312 0.645 . . . . 0.0 112.616 173.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -152.99 -51.32 0.1 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.998 0.428 . . . . 0.0 111.374 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.64 ' HA ' ' SD ' ' A' ' 42' ' ' MET . 3.2 mp -62.59 127.9 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.137 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.437 ' OG1' ' HG3' ' A' ' 42' ' ' MET . 35.3 p -106.51 171.93 7.09 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.329 0.585 . . . . 0.0 112.078 -175.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.522 ' HG2' ' HG ' ' A' ' 58' ' ' LEU . 79.6 mt-10 -67.08 -32.88 74.35 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.793 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -64.17 -39.2 93.51 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.075 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.64 ' SD ' ' HA ' ' A' ' 38' ' ' ILE . 64.4 mtt -62.88 -52.4 63.23 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.442 0.639 . . . . 0.0 110.273 176.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.503 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 63.1 mt -54.47 -51.39 65.19 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.106 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -50.2 -50.1 50.58 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.888 0.375 . . . . 0.0 111.195 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.93 -28.77 66.57 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.656 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.8 mm -82.84 -38.33 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 O-C-N 122.453 -0.439 . . . . 0.0 111.97 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.503 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 44.5 m-85 -85.89 -30.83 22.56 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -174.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -56.7 -38.68 71.17 Favored Pre-proline 0 N--CA 1.483 1.197 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -47.18 -22.83 2.52 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.245 1.964 . . . . 0.0 113.408 171.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.429 ' HE1' ' HG3' ' A' ' 87' ' ' GLN . 81.5 m-85 -93.69 -44.9 7.94 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.087 0.47 . . . . 0.0 111.096 175.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -174.32 140.58 5.49 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.844 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.0 ttp85 -58.34 134.5 56.64 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.242 0.544 . . . . 0.0 112.082 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.4 mp -94.01 137.9 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.144 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -87.99 -40.67 13.69 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.833 0.349 . . . . 0.0 111.806 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.9 t -150.96 132.36 14.64 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.117 0.484 . . . . 0.0 112.238 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.534 HG23 HG12 ' A' ' 73' ' ' ILE . 47.9 mt -117.64 133.2 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.211 173.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -137.89 118.83 14.27 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.844 0.355 . . . . 0.0 111.404 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.605 HD23 ' HA3' ' A' ' 71' ' ' GLY . 91.7 mt -96.48 149.81 21.32 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 174.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.564 ' SD ' ' CE2' ' A' ' 70' ' ' TYR . 60.9 mtp -92.48 112.93 25.06 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.798 0.808 . . . . 0.0 111.349 -177.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.1 ptm -147.01 145.71 29.81 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.031 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.783 ' HB2' ' HA3' ' A' ' 65' ' ' GLY . 45.4 m-20 -121.68 109.35 14.64 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.801 0.334 . . . . 0.0 111.833 -174.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.8 t -55.24 -33.88 63.52 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -57.62 -39.04 76.0 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.2 t 175.42 -14.08 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -177.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.783 ' HA3' ' HB2' ' A' ' 61' ' ' ASP . . . -63.3 -31.84 82.11 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.327 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 66.89 -68.45 0.14 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 171.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.422 ' HB3' ' HD1' ' A' ' 36' ' ' PHE . 46.6 t -167.05 116.46 0.85 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.88 0.371 . . . . 0.0 111.059 177.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -85.94 -5.15 59.28 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.03 3.57 87.62 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 114.963 0.745 . . . . 0.0 114.963 169.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.564 ' CE2' ' SD ' ' A' ' 59' ' ' MET . 49.4 p90 -133.09 145.98 51.24 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 117.805 0.802 . . . . 0.0 111.993 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.605 ' HA3' HD23 ' A' ' 58' ' ' LEU . . . -151.2 161.9 29.28 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 115.816 -0.629 . . . . 0.0 113.239 -177.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -105.2 129.04 53.67 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.914 0.388 . . . . 0.0 111.768 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.534 HG12 HG23 ' A' ' 56' ' ' ILE . 66.8 mt -111.76 132.69 59.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.025 178.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.7 m -112.57 118.54 35.39 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.441 ' HZ ' ' HD2' ' A' ' 47' ' ' PHE . 45.0 m-85 -99.12 152.13 20.21 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.792 0.437 . . . . 0.0 111.841 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.1 m -68.09 -10.81 56.83 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.624 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -139.64 161.04 38.49 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.081 0.467 . . . . 0.0 112.096 -176.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.505 ' HA ' ' HB2' ' A' ' 27' ' ' MET . 51.7 m -91.33 -37.31 13.33 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -79.4 -40.01 31.06 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.015 -0.428 . . . . 0.0 112.023 -177.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 76.5 m -58.13 -41.86 84.57 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.329 0.585 . . . . 0.0 110.765 174.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.6 -45.37 68.73 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.984 176.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.518 ' HB2' ' NZ ' ' A' ' 82' ' ' LYS . 5.0 ttmp? -57.25 -34.98 69.16 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.405 178.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 46.0 tttm -75.23 -37.74 60.93 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.965 0.412 . . . . 0.0 111.01 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.89 -33.19 64.38 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.501 0.667 . . . . 0.0 110.475 172.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 100' ' ' VAL . 7.6 tt -65.85 -55.38 17.34 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.766 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 83' ' ' LYS . 2.6 pp20? -64.74 -19.28 65.7 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -174.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.429 ' HG3' ' HE1' ' A' ' 50' ' ' PHE . 85.9 mm-40 -94.6 -46.46 6.94 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.871 -0.518 . . . . 0.0 111.893 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 71.6 mt -89.61 -17.3 28.74 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -170.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -71.01 91.4 0.88 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.464 0.65 . . . . 0.0 110.187 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.42 -14.13 8.78 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.943 -173.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -61.77 120.26 10.34 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.703 0.401 . . . . 0.0 110.958 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 43.0 mt-10 -79.0 93.71 5.15 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.158 0.504 . . . . 0.0 111.67 -177.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.5 tp -96.51 135.88 37.79 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.995 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 59.76 24.07 13.0 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.206 0.527 . . . . 0.0 111.146 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.33 3.67 89.91 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.121 -0.491 . . . . 0.0 113.526 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 44.9 mtp180 -121.13 136.5 25.75 Favored Pre-proline 0 N--CA 1.473 0.676 0 CA-C-N 117.306 0.553 . . . . 0.0 111.731 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -59.99 129.31 29.81 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.473 2.115 . . . . 0.0 111.82 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.645 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 40.9 ttp -97.62 124.88 42.07 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.174 0.511 . . . . 0.0 111.781 -174.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 68.2 mttm -88.41 101.91 14.36 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.148 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.515 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 44.0 t -114.45 99.51 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.632 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -135.62 160.24 24.44 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.747 -0.739 . . . . 0.0 113.062 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -72.68 151.94 41.97 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 122.514 -0.403 . . . . 0.0 110.598 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.5 t -62.79 85.07 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.318 0.58 . . . . 0.0 112.423 -173.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 57.6 m -124.49 85.79 2.47 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.463 0.649 . . . . 0.0 110.141 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -82.09 -33.13 29.94 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.409 -174.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -98.3 114.1 26.27 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -173.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 68.3 p -94.9 -66.48 0.91 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 167.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.5 t70 . . . . . 0 C--O 1.254 1.34 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 172.021 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.438 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 120.592 0.234 . . . . 0.0 111.211 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -61.78 83.06 0.03 OUTLIER Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.364 -0.446 . . . . 0.0 113.356 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 51.53 -110.17 0.48 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.107 0.563 . . . . 0.0 111.664 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -147.61 99.8 3.16 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.964 0.412 . . . . 0.0 110.517 176.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -80.42 65.38 5.55 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.117 0.484 . . . . 0.0 111.307 -177.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -81.78 39.05 0.53 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.484 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -70.4 86.49 0.61 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.913 -176.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.1 p80 -154.83 9.93 0.33 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.6 m 63.09 172.19 0.15 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -73.81 85.23 1.69 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.273 0.558 . . . . 0.0 111.781 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.7 ttt -59.13 -48.94 79.77 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.878 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.29 -71.66 0.19 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 58.68 17.62 5.24 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -105.29 147.4 28.15 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.904 0.383 . . . . 0.0 111.438 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 83.5 mtp -96.43 131.85 42.57 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.92 0.391 . . . . 0.0 111.397 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.09 80.27 8.87 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.075 0.464 . . . . 0.0 111.445 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -134.92 94.09 3.11 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.407 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -77.83 -69.34 0.55 Allowed 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.2 tp 63.44 -76.92 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.191 0.597 . . . . 0.0 111.623 175.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -148.89 3.33 0.62 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 176.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -74.76 -44.75 48.11 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.145 0.498 . . . . 0.0 111.198 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.9 59.23 4.75 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.385 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.8 p 49.49 -83.23 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.537 0.735 . . . . 0.0 112.8 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.22 140.82 51.69 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.511 0.325 . . . . 0.0 110.972 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -139.78 -174.02 13.5 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.518 -177.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.07 128.22 29.61 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.904 2.403 . . . . 0.0 113.116 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 26.3 ttt -99.12 141.27 32.09 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.677 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.489 ' HD3' ' HB3' ' A' ' 72' ' ' PHE . 42.4 ttm180 -115.71 130.95 57.05 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.171 0.51 . . . . 0.0 112.288 -171.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.427 HD11 ' O ' ' A' ' 81' ' ' ALA . 85.5 mt -107.66 145.39 33.43 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.195 0.522 . . . . 0.0 111.831 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.51 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 39.0 t80 -97.32 111.79 23.89 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.961 173.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -106.23 107.44 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 120.805 0.336 . . . . 0.0 111.35 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.592 ' HA2' ' HB3' ' A' ' 70' ' ' TYR . . . -113.39 97.57 0.87 Allowed Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.244 -0.503 . . . . 0.0 113.831 -176.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.73 ' HB2' ' HA ' ' A' ' 98' ' ' MET . 30.7 t -174.81 15.25 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.39 0.614 . . . . 0.0 111.183 172.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.725 ' HA ' HD12 ' A' ' 38' ' ' ILE . 11.1 mt -85.59 88.62 7.55 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 122.029 -0.42 . . . . 0.0 110.405 -171.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -78.49 69.29 4.65 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.579 0.704 . . . . 0.0 112.377 -172.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 48.3 t80 57.68 9.62 0.87 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 175.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -124.18 -38.91 2.4 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.609 -0.682 . . . . 0.0 112.596 -177.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.725 HD12 ' HA ' ' A' ' 34' ' ' LEU . 58.8 mt -67.61 134.06 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.938 0.399 . . . . 0.0 111.978 -176.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 56.6 p -110.02 166.21 11.12 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.066 0.46 . . . . 0.0 112.205 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.493 ' HA ' HD12 ' A' ' 43' ' ' LEU . 2.5 mp0 -63.07 -36.54 83.93 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.248 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -66.67 -33.56 75.92 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.909 0.385 . . . . 0.0 111.277 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.47 ' SD ' HG23 ' A' ' 38' ' ' ILE . 27.1 ttt -68.18 -44.66 75.41 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.562 0.696 . . . . 0.0 110.107 174.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 40' ' ' GLU . 92.2 mt -55.09 -55.26 33.0 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.722 178.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.534 ' HB3' HD11 ' A' ' 56' ' ' ILE . 14.2 ptm180 -61.78 -33.22 73.72 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.385 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.19 -36.8 69.81 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.63 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 63.2 mt -85.45 -49.21 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 177.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -82.31 -32.52 29.41 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -169.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.749 ' HG3' ' HA ' ' A' ' 52' ' ' ARG . 22.2 tt0 -62.07 -42.49 81.98 Favored Pre-proline 0 N--CA 1.48 1.056 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -174.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -47.78 -18.29 0.98 Allowed 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 122.529 2.152 . . . . 0.0 114.316 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -71.38 -51.9 21.58 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.525 ' N ' ' SG ' ' A' ' 80' ' ' CYS . . . -170.91 43.76 0.19 Allowed Glycine 0 N--CA 1.468 0.77 0 C-N-CA 120.079 -1.058 . . . . 0.0 114.092 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.749 ' HA ' ' HG3' ' A' ' 48' ' ' GLU . 0.3 OUTLIER 63.31 143.91 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.974 0.892 . . . . 0.0 113.39 178.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.41 HG13 ' HA ' ' A' ' 48' ' ' GLU . 89.2 mt -119.09 133.69 65.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.16 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -82.68 -56.48 3.83 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.674 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.7 p -150.12 138.34 20.39 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.255 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 44' ' ' ARG . 46.0 mt -107.67 116.31 50.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.343 0.592 . . . . 0.0 111.113 177.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -99.36 115.72 29.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.993 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 27.9 tp -97.16 133.35 41.92 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.551 -0.718 . . . . 0.0 110.516 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.6 ' HG3' ' HD3' ' A' ' 68' ' ' LYS . 14.3 tpt -92.28 99.29 12.09 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.889 0.852 . . . . 0.0 111.142 -171.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.509 ' HA ' ' HG3' ' A' ' 68' ' ' LYS . 19.5 ptp -132.0 149.28 52.47 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.069 177.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -66.94 92.2 0.23 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.302 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.2 m -56.8 -9.07 0.7 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.303 0.573 . . . . 0.0 111.496 175.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -76.5 -43.01 41.42 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.18 177.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 77.5 p -121.63 0.72 9.94 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -175.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.02 20.73 76.54 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 121.548 -0.358 . . . . 0.0 113.7 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.1 mmt85 -100.08 148.31 24.7 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.23 -0.57 . . . . 0.0 112.044 -176.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.5 m -85.88 128.97 34.95 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.122 -178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.6 ' HD3' ' HG3' ' A' ' 59' ' ' MET . 26.0 mtpp -86.94 -15.02 40.13 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 101.03 7.05 51.02 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 120.969 -0.634 . . . . 0.0 114.486 175.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.592 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -145.26 160.07 42.05 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 117.476 0.638 . . . . 0.0 112.567 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -145.29 147.57 18.77 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.955 -0.566 . . . . 0.0 113.147 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.489 ' HB3' ' HD3' ' A' ' 28' ' ' ARG . 95.8 m-85 -99.57 112.67 24.85 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.935 0.398 . . . . 0.0 111.266 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.529 HG23 HG12 ' A' ' 56' ' ' ILE . 67.8 mt -99.41 126.18 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.956 0.408 . . . . 0.0 111.586 -178.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 36.7 m -101.54 118.41 36.9 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.517 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -98.53 151.53 20.54 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.109 0.481 . . . . 0.0 112.17 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.0 t -72.19 -28.83 63.46 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.148 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -116.3 133.0 56.51 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.972 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.6 t -67.04 -51.17 58.09 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.941 0.401 . . . . 0.0 111.891 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -57.77 -34.37 69.5 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.098 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 51' ' ' GLY . 7.7 t -57.97 -46.3 85.38 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.824 175.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.427 ' O ' HD11 ' A' ' 29' ' ' LEU . . . -65.16 -41.77 94.35 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.07 0.462 . . . . 0.0 111.15 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -64.93 -35.67 81.91 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.564 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 85.6 tttt -72.35 -50.41 26.95 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.741 0.305 . . . . 0.0 111.318 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.15 -42.77 61.01 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.11 0.481 . . . . 0.0 110.954 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.409 HD23 ' C ' ' A' ' 85' ' ' LEU . 7.8 tt -57.19 -55.9 28.7 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.511 173.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -53.67 -34.85 60.06 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.132 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 83' ' ' LYS . 11.1 mm100 -86.8 -35.43 19.12 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.911 -174.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 73.8 mt -104.79 -7.02 19.76 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -171.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -62.91 99.71 0.17 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.028 0.442 . . . . 0.0 111.134 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.05 -2.42 44.31 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 116.264 -0.426 . . . . 0.0 113.342 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -67.15 131.69 46.31 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 122.607 -0.349 . . . . 0.0 111.578 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.82 103.34 1.41 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.987 0.423 . . . . 0.0 111.153 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 56.6 tp -113.17 127.33 56.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.433 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 58.26 23.73 10.7 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.148 0.499 . . . . 0.0 111.754 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.99 -18.27 54.99 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.82 -0.627 . . . . 0.0 114.018 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 31.7 mtt85 -116.59 140.01 26.19 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 117.378 0.589 . . . . 0.0 111.997 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.23 132.12 48.74 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.778 2.318 . . . . 0.0 112.098 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.73 ' HA ' ' HB2' ' A' ' 33' ' ' SER . 38.5 ttp -96.75 119.35 35.07 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.361 0.6 . . . . 0.0 111.738 -171.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -87.8 94.19 9.68 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.64 -176.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.05 113.57 38.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.461 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.51 ' O ' ' HB3' ' A' ' 30' ' ' TYR . . . -142.08 131.59 4.8 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.25 -0.5 . . . . 0.0 112.548 176.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -63.2 94.98 0.08 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 117.655 0.727 . . . . 0.0 112.128 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.538 HG12 ' HG2' ' A' ' 105' ' ' GLU . 43.0 t 49.93 86.92 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.832 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.7 t -73.37 82.3 1.41 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.653 0.74 . . . . 0.0 112.61 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.538 ' HG2' HG12 ' A' ' 103' ' ' VAL . 19.8 mm-40 -94.55 -69.37 0.75 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.121 173.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.7 tpm_? 71.5 -57.56 0.6 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.166 0.586 . . . . 0.0 112.454 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.2 m -53.36 119.86 5.32 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.984 0.421 . . . . 0.0 111.986 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.5 t70 . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.903 -0.57 . . . . 0.0 111.875 -179.999 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.9 ttm . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.875 0.369 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -96.78 -159.71 31.73 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.316 174.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -129.61 97.01 4.4 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 117.28 0.54 . . . . 0.0 111.829 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -130.85 128.92 41.61 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.783 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -80.69 144.53 32.17 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.036 0.446 . . . . 0.0 111.263 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -118.31 11.68 13.17 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.065 0.46 . . . . 0.0 111.321 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -76.88 131.84 38.8 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.847 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 76.9 t60 63.89 98.86 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.8 m -130.83 -68.7 0.67 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.803 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.3 t60 53.87 30.7 11.91 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.107 0.563 . . . . 0.0 111.831 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.0 tpt 61.11 -72.47 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.487 0.715 . . . . 0.0 112.054 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.15 104.48 4.64 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.855 0.359 . . . . 0.0 111.489 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.1 175.78 10.06 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 68.54 4.91 4.53 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.0 mmt -101.35 118.4 36.89 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 122.489 0.316 . . . . 0.0 110.582 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -159.79 -168.09 2.16 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.224 0.535 . . . . 0.0 111.784 -176.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -77.47 2.53 15.94 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.286 -0.416 . . . . 0.0 112.08 176.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -137.9 -179.99 6.09 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 122.359 0.264 . . . . 0.0 110.882 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.431 ' O ' ' HB3' ' A' ' 20' ' ' GLN . 87.2 mt -92.89 43.81 1.13 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.907 0.384 . . . . 0.0 110.664 -176.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.691 ' HA ' HE21 ' A' ' 20' ' ' GLN . 0.0 OUTLIER 75.28 -23.63 0.23 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.435 0.694 . . . . 0.0 112.359 -178.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 70.83 -66.34 0.3 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.189 0.596 . . . . 0.0 112.001 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.02 138.02 4.91 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.481 -0.39 . . . . 0.0 112.593 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 79.7 p -99.77 13.01 35.16 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -177.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 69.89 -167.9 0.17 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.878 0.471 . . . . 0.0 112.073 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -163.5 -59.85 0.02 OUTLIER Glycine 0 CA--C 1.531 1.075 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.486 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.16 155.86 43.17 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.689 2.26 . . . . 0.0 113.551 176.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 11.7 tpt -126.23 147.51 49.66 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.763 0.315 . . . . 0.0 111.474 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 36.7 ttt85 -120.81 121.22 37.69 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.854 0.359 . . . . 0.0 111.308 -174.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 81.6 mt -106.01 143.66 33.82 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 55.2 t80 -91.66 116.06 28.57 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.495 172.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.465 HG21 HD12 ' A' ' 73' ' ' ILE . 60.0 t -118.73 109.14 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-O 121.093 0.473 . . . . 0.0 111.789 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.5 104.76 1.84 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.576 -0.345 . . . . 0.0 112.937 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.555 ' HB2' ' HA ' ' A' ' 98' ' ' MET . 39.7 t -171.64 14.61 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.248 0.547 . . . . 0.0 111.823 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.494 HD11 HD22 ' A' ' 58' ' ' LEU . 12.1 mt -86.16 85.44 7.35 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.722 -0.611 . . . . 0.0 111.529 -172.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.401 ' ND1' ' O ' ' A' ' 35' ' ' HIS . 33.8 p80 -78.64 66.58 4.18 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.672 0.748 . . . . 0.0 112.046 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 47.0 t80 60.18 9.24 1.8 Allowed 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.55 -34.95 1.53 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.584 -0.697 . . . . 0.0 111.483 -178.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.427 ' HB ' HD22 ' A' ' 34' ' ' LEU . 11.6 mm -73.21 107.36 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.931 0.396 . . . . 0.0 111.329 -175.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.5 p -99.54 179.23 4.62 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.957 0.408 . . . . 0.0 112.014 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -60.48 -43.13 97.28 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.275 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.31 -37.21 82.43 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.129 0.49 . . . . 0.0 110.959 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.403 ' SD ' HG23 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -67.54 -55.02 15.16 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.334 0.588 . . . . 0.0 110.246 178.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.4 mt -55.18 -44.12 74.94 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.444 176.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.511 HH21 ' NH1' ' A' ' 52' ' ' ARG . 53.9 ttt180 -58.7 -47.34 84.89 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.232 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.44 -31.59 60.05 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.998 177.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.8 mt -80.28 -54.48 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -79.76 -33.91 40.29 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -172.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.858 ' HG3' ' HA ' ' A' ' 52' ' ' ARG . 10.1 tt0 -60.78 -38.67 58.54 Favored Pre-proline 0 N--CA 1.476 0.867 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -172.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -46.3 -26.52 3.98 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.535 2.157 . . . . 0.0 113.798 172.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -66.91 -63.74 1.0 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.653 0.263 . . . . 0.0 111.595 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.465 ' HA3' ' SG ' ' A' ' 80' ' ' CYS . . . -165.65 40.02 0.28 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.472 -0.87 . . . . 0.0 114.314 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.858 ' HA ' ' HG3' ' A' ' 48' ' ' GLU . 43.7 tpt85 71.26 127.18 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 172.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.481 HG21 HG13 ' A' ' 56' ' ' ILE . 1.7 mp -82.89 141.31 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.038 0.447 . . . . 0.0 111.432 175.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -90.29 -56.22 3.3 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.309 0.576 . . . . 0.0 109.656 173.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.6 m -150.6 144.02 25.0 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.46 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.512 HG23 HG12 ' A' ' 73' ' ' ILE . 57.3 mt -122.29 109.87 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.023 0.44 . . . . 0.0 110.776 175.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -108.83 112.26 24.42 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.314 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.494 HD22 HD11 ' A' ' 34' ' ' LEU . 32.7 mt -98.69 141.91 30.92 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.81 0.338 . . . . 0.0 110.921 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 64.7 mtp -93.66 103.38 15.54 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.167 0.508 . . . . 0.0 111.488 -176.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.582 ' HG2' ' HA ' ' A' ' 67' ' ' SER . 65.4 mtm -124.57 152.88 42.96 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.984 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.448 ' HB3' ' CA ' ' A' ' 65' ' ' GLY . 11.4 t70 -98.83 114.46 27.05 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 174.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.2 p -75.09 -19.69 59.83 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -172.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -71.04 -68.29 0.45 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.152 0.501 . . . . 0.0 110.713 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.3 t -162.51 11.87 0.07 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.322 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.448 ' CA ' ' HB3' ' A' ' 61' ' ' ASP . . . -89.82 -27.73 20.78 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.558 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.7 mtt-85 61.49 -160.42 0.31 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.981 0.513 . . . . 0.0 111.729 174.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.582 ' HA ' ' HG2' ' A' ' 60' ' ' MET . 60.6 m -56.07 113.13 1.4 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -70.23 -27.05 64.16 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.2 -6.63 19.17 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 120.917 -0.659 . . . . 0.0 114.439 174.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -135.56 151.72 50.58 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 117.376 0.588 . . . . 0.0 112.364 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.7 158.76 27.83 Favored Glycine 0 CA--C 1.527 0.844 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.734 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -101.51 120.44 40.3 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.601 -0.352 . . . . 0.0 111.603 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.512 HG12 HG23 ' A' ' 56' ' ' ILE . 70.9 mt -103.9 117.11 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.278 0.561 . . . . 0.0 111.249 178.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 51.9 m -99.85 125.71 45.85 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.68 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -103.3 150.44 23.75 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.782 175.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.8 t -72.92 -11.87 60.74 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.683 0.278 . . . . 0.0 111.65 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -126.24 144.38 50.8 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.852 0.358 . . . . 0.0 110.986 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 54.5 m -78.78 -43.67 24.94 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -69.69 -34.9 74.58 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.826 0.346 . . . . 0.0 111.508 -175.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.465 ' SG ' ' HA3' ' A' ' 51' ' ' GLY . 35.8 t -60.04 -43.39 95.36 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.068 0.461 . . . . 0.0 111.081 174.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.39 -40.97 96.84 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.01 176.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -56.67 -46.44 81.1 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.965 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 86.8 tttt -62.03 -54.04 47.06 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.288 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.92 -52.12 61.58 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.894 0.378 . . . . 0.0 111.836 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.9 tt -53.87 -54.6 36.29 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.621 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -64.67 -25.14 67.82 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -173.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 83' ' ' LYS . 8.3 mm-40 -95.72 -17.79 20.98 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.473 ' HB3' ' SD ' ' A' ' 98' ' ' MET . 90.2 mt -112.2 -24.53 9.79 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -175.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -60.03 101.41 0.12 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.169 0.509 . . . . 0.0 111.534 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.65 -15.98 9.69 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 116.063 -0.517 . . . . 0.0 113.013 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -63.41 129.98 42.53 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 122.658 -0.319 . . . . 0.0 111.784 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -65.86 94.31 0.21 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.993 0.425 . . . . 0.0 111.18 175.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 66.9 tp -86.75 115.25 24.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.426 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 55.92 22.35 5.65 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 109.26 -9.41 33.32 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 114.098 0.399 . . . . 0.0 114.098 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -130.93 134.89 26.51 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 117.405 0.603 . . . . 0.0 110.78 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.66 149.42 13.87 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.819 2.346 . . . . 0.0 113.26 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.555 ' HA ' ' HB2' ' A' ' 33' ' ' SER . 43.9 ttm -96.85 104.78 16.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.234 0.54 . . . . 0.0 109.906 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.414 ' NZ ' ' HB3' ' A' ' 99' ' ' LYS . 2.0 mmmp? -87.84 89.9 8.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.708 -175.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 20.4 t -105.2 117.82 51.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.089 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -148.14 162.15 28.73 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.208 -0.52 . . . . 0.0 113.053 -176.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -64.18 158.9 21.82 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.305 0.574 . . . . 0.0 111.552 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 103' ' ' VAL . 12.1 t -91.12 11.39 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 121.668 0.747 . . . . 0.0 109.846 177.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 34.4 m 78.1 -19.7 0.42 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.032 0.933 . . . . 0.0 111.281 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 61.68 136.74 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.699 0.8 . . . . 0.0 112.961 176.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -76.3 65.92 2.3 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.337 0.589 . . . . 0.0 112.123 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.7 m -157.18 132.52 9.11 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.101 175.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 C--O 1.254 1.333 0 CA-C-O 118.572 -0.728 . . . . 0.0 112.342 -179.402 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.465 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.575 0.226 . . . . 0.0 111.124 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -114.56 -52.93 0.43 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.326 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -62.26 105.17 0.57 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.784 0.326 . . . . 0.0 110.619 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -75.36 -61.36 1.93 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -173.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -161.47 -56.15 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -77.46 98.65 5.37 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.053 0.454 . . . . 0.0 111.475 -175.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -135.35 15.74 3.45 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.507 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -98.81 24.32 7.77 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 120.857 0.36 . . . . 0.0 111.265 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.9 p -130.39 -83.68 0.54 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 55.44 38.63 30.54 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 121.557 0.694 . . . . 0.0 111.158 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 83.2 mtp -96.63 99.18 10.82 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.563 -176.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.04 -29.54 15.15 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.059 0.456 . . . . 0.0 111.393 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.39 25.43 0.74 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.163 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -119.82 131.13 55.21 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.657 0.265 . . . . 0.0 111.158 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.2 mtt -85.27 -99.37 0.06 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.231 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 67.87 -24.9 0.12 Allowed 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 175.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -54.76 127.87 30.27 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.399 0.619 . . . . 0.0 112.237 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -81.34 21.49 0.76 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.609 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.0 tp -67.51 -22.87 65.42 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.411 0.624 . . . . 0.0 110.651 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -95.11 12.34 29.03 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.491 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 84.4 tttt 63.97 109.09 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.076 0.551 . . . . 0.0 111.23 -174.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.4 173.47 22.66 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.959 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.9 p -90.32 163.62 14.66 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.196 0.522 . . . . 0.0 111.674 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.35 -58.41 3.29 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.178 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.587 ' N ' ' HD2' ' A' ' 26' ' ' PRO . . . 143.47 -43.36 1.02 Allowed Glycine 0 CA--C 1.543 1.798 0 CA-C-O 119.074 -0.848 . . . . 0.0 115.198 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.701 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 14.4 Cg_exo -26.29 112.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.363 1.317 0 C-N-CA 124.782 3.655 . . . . 0.0 116.619 -176.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.9 ttt -139.46 138.22 36.24 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.46 170.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 28' ' ' ARG . 62.8 mtt-85 -99.74 143.6 29.78 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.422 0.629 . . . . 0.0 112.483 -177.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.0 mt -112.44 139.16 48.24 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.28 177.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -90.71 108.8 20.06 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.769 176.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.35 104.41 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.674 0.273 . . . . 0.0 111.201 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.533 ' HA2' ' HB3' ' A' ' 70' ' ' TYR . . . -114.64 91.68 0.57 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.201 -0.523 . . . . 0.0 113.945 -177.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 t -175.15 21.13 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.433 0.635 . . . . 0.0 111.174 175.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.485 HD22 HG21 ' A' ' 38' ' ' ILE . 13.1 mt -85.02 93.13 8.52 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.869 -0.52 . . . . 0.0 110.945 -173.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -81.44 62.1 5.18 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.293 0.568 . . . . 0.0 112.531 -174.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 62.0 t80 59.61 9.22 1.49 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 173.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -130.95 4.95 4.51 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.61 -0.681 . . . . 0.0 111.502 -178.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.55 HG23 ' SD ' ' A' ' 42' ' ' MET . 27.1 mm -105.25 127.98 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 122.111 -0.368 . . . . 0.0 110.81 -177.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.6 p -107.23 167.3 10.01 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.936 0.398 . . . . 0.0 111.788 -176.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -55.21 -44.5 75.42 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.125 0.488 . . . . 0.0 110.878 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -68.03 -31.63 71.43 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.184 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.55 ' SD ' HG23 ' A' ' 38' ' ' ILE . 52.5 ttm -62.14 -50.21 72.77 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.406 0.622 . . . . 0.0 109.887 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.42 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 48.9 mt -57.14 -44.15 83.13 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.495 173.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -53.27 -47.35 69.21 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.078 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.74 -29.49 74.06 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.306 -0.473 . . . . 0.0 113.387 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.1 mt -84.59 -44.06 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 O-C-N 122.386 -0.479 . . . . 0.0 112.158 178.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.42 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 38.9 m-85 -85.64 -29.12 24.29 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -171.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -52.81 -47.33 95.21 Favored Pre-proline 0 N--CA 1.486 1.334 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -49.93 -18.22 2.83 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 122.801 2.334 . . . . 0.0 114.919 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.489 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 79.3 m-85 -78.69 -70.48 0.49 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.431 ' N ' ' SG ' ' A' ' 80' ' ' CYS . . . -157.95 24.25 0.4 Allowed Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.713 -177.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 68.88 144.9 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.502 ' N ' HD12 ' A' ' 53' ' ' ILE . 4.0 mp -107.22 139.72 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.45 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -78.32 -48.37 15.78 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.434 0.635 . . . . 0.0 110.937 175.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 61.3 m -151.2 132.28 14.35 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.66 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.477 HG23 HG12 ' A' ' 73' ' ' ILE . 54.6 mt -106.45 129.05 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 173.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -130.41 134.44 47.14 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.851 0.358 . . . . 0.0 111.658 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 76.1 mt -98.72 144.02 28.44 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.81 0.338 . . . . 0.0 110.623 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 10.0 tpt -94.08 116.15 28.54 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.315 0.579 . . . . 0.0 111.227 -176.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.0 mtt -111.61 173.83 6.16 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.375 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.498 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 23.6 t70 -81.47 118.76 22.98 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.79 0.328 . . . . 0.0 110.782 177.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.0 t -61.28 -9.78 5.74 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -174.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -102.52 -66.18 0.94 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.009 0.433 . . . . 0.0 111.698 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.472 ' OG1' ' HG2' ' A' ' 66' ' ' ARG . 57.2 p -96.18 -14.63 22.62 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -173.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.96 18.28 63.54 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 120.877 -0.678 . . . . 0.0 113.573 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.472 ' HG2' ' OG1' ' A' ' 64' ' ' THR . 11.1 mmm180 -68.21 170.03 9.35 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.255 0.55 . . . . 0.0 111.876 177.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.8 m -89.48 124.73 34.76 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.76 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.498 ' HE2' ' HA ' ' A' ' 61' ' ' ASP . 73.6 mmtt -79.99 -23.76 41.33 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 122.076 -0.39 . . . . 0.0 111.89 177.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.76 5.24 63.05 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.589 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.533 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 2.2 p90 -141.45 158.98 43.16 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.034 0.445 . . . . 0.0 111.851 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.47 161.25 28.9 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 116.256 -0.429 . . . . 0.0 113.04 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -109.15 123.08 48.63 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.169 0.509 . . . . 0.0 111.738 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.477 HG12 HG23 ' A' ' 56' ' ' ILE . 78.4 mt -107.69 122.27 61.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 178.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.452 ' O ' HG23 ' A' ' 53' ' ' ILE . 28.2 m -99.57 115.38 29.24 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -175.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.701 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 40.9 m-85 -97.66 141.41 30.72 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.59 0.233 . . . . 0.0 111.437 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.9 t -73.75 -3.3 27.58 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.377 176.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' A' ' 80' ' ' CYS . 11.2 t70 -132.95 121.03 22.2 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.787 0.327 . . . . 0.0 110.687 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.2 p -60.19 -51.81 67.98 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.12 -36.77 85.11 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.773 0.32 . . . . 0.0 110.993 -177.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.575 ' HB3' ' HB3' ' A' ' 77' ' ' ASP . 25.0 t -63.08 -40.75 98.57 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.797 0.332 . . . . 0.0 111.362 175.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.517 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -63.86 -47.6 80.07 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.317 0.58 . . . . 0.0 110.551 175.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -57.44 -42.11 81.8 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.655 176.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -66.87 -49.58 65.23 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.817 0.341 . . . . 0.0 111.182 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.66 -44.45 69.66 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.204 0.526 . . . . 0.0 110.662 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.431 HD23 ' C ' ' A' ' 85' ' ' LEU . 7.1 tt -56.96 -58.5 7.87 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.686 175.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -61.31 -25.88 67.42 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -174.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.64 HE21 ' N ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -89.16 -46.16 9.02 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.805 0.336 . . . . 0.0 111.754 -179.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 70.7 mt -89.81 -9.3 49.7 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -169.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -67.78 82.27 0.19 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.446 0.641 . . . . 0.0 110.826 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 142.7 -21.2 2.36 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.606 -175.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -48.92 119.51 3.24 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.221 0.608 . . . . 0.0 111.52 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -69.37 93.6 0.66 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.27 0.557 . . . . 0.0 110.995 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.438 HD21 HG21 ' A' ' 38' ' ' ILE . 51.2 tp -85.46 111.59 20.11 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.223 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 63.02 2.78 1.09 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 126.69 -7.82 7.36 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.524 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -122.79 130.29 24.68 Favored Pre-proline 0 N--CA 1.47 0.555 0 CA-C-N 117.01 0.405 . . . . 0.0 110.906 176.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.55 136.51 41.07 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.427 2.085 . . . . 0.0 112.016 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 51.3 ttp -95.96 116.42 28.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.43 0.633 . . . . 0.0 111.077 -172.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -88.29 92.51 9.19 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.079 -176.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.7 t -99.83 107.31 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.642 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -134.95 161.22 24.53 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.569 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -56.71 143.48 36.29 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.479 -0.424 . . . . 0.0 111.908 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 49.0 t -51.85 -31.81 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 120.961 0.41 . . . . 0.0 111.893 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 91.5 m -51.2 120.9 5.42 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.089 174.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -71.31 76.92 0.74 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.249 0.547 . . . . 0.0 111.926 -177.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 44.36 -102.03 0.05 Allowed 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.908 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.9 m 70.25 -35.45 0.32 Allowed 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -177.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 . . . . . 0 C--O 1.253 1.264 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.792 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.509 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 120.869 0.366 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -109.5 -97.72 2.48 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 116.396 -0.366 . . . . 0.0 113.288 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.7 p-80 49.36 101.85 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.11 0.964 . . . . 0.0 113.011 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 77.5 m80 61.03 31.11 19.87 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.133 0.492 . . . . 0.0 111.069 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -82.55 -3.13 55.51 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -171.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -106.45 -30.52 9.04 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.856 0.36 . . . . 0.0 111.598 176.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -78.76 129.4 34.6 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.999 0.428 . . . . 0.0 111.791 -175.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -66.61 91.49 0.19 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.047 0.451 . . . . 0.0 111.501 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.0 t -166.44 175.92 7.78 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -141.7 158.97 43.16 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.735 0.302 . . . . 0.0 111.086 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -65.37 -28.06 69.01 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -174.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.85 -57.88 3.23 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.713 0.292 . . . . 0.0 111.294 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 68.15 -68.27 0.17 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 176.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.51 -61.41 1.93 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.94 36.33 2.8 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -175.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.36 103.84 0.27 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 120.874 0.368 . . . . 0.0 111.979 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -110.57 -49.11 3.08 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -23.15 106.42 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -172.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.4 mt -80.06 9.69 5.2 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -175.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 64.55 -164.73 0.25 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.1 mttt 69.35 -71.44 0.12 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.587 0.755 . . . . 0.0 112.478 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.37 -120.7 0.61 Allowed Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.587 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 84.8 p 57.02 23.72 8.69 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.466 0.707 . . . . 0.0 112.787 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -147.2 175.82 10.45 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.55 -58.82 9.26 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 116.194 -0.457 . . . . 0.0 113.562 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -49.53 118.59 3.82 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.831 2.354 . . . . 0.0 112.646 176.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 28.1 ttt -112.9 123.11 49.57 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.039 0.447 . . . . 0.0 111.268 -173.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.471 ' HD2' ' HB3' ' A' ' 72' ' ' PHE . 47.7 ttp180 -102.82 136.61 42.31 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.032 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.0 mt -107.51 148.59 29.01 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.233 0.54 . . . . 0.0 112.299 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -95.64 112.33 24.07 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.769 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.4 t -108.91 99.47 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.092 0.472 . . . . 0.0 111.207 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.78 89.13 0.84 Allowed Glycine 0 CA--C 1.524 0.642 0 C-N-CA 121.186 -0.53 . . . . 0.0 113.129 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.0 t -172.44 25.84 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.158 0.504 . . . . 0.0 111.107 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.407 HD22 ' HB ' ' A' ' 38' ' ' ILE . 62.4 mt -72.26 103.56 3.41 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.776 -0.578 . . . . 0.0 110.522 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -79.38 35.9 0.29 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 63.58 13.67 7.46 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 176.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -148.52 11.05 0.87 Allowed 'General case' 0 N--CA 1.473 0.725 0 O-C-N 122.065 -0.397 . . . . 0.0 111.692 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.545 HG23 ' SD ' ' A' ' 42' ' ' MET . 30.8 mm -83.33 140.11 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.639 0.256 . . . . 0.0 110.749 -178.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 79.1 p -116.8 161.27 19.54 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -55.41 -40.34 71.34 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.216 177.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -65.04 -39.55 93.49 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.533 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.545 ' SD ' HG23 ' A' ' 38' ' ' ILE . 50.5 ttm -61.83 -52.29 64.76 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.326 0.584 . . . . 0.0 110.525 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.448 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 55.8 mt -55.47 -53.64 53.75 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.2 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.504 ' HB2' HD11 ' A' ' 56' ' ' ILE . 53.0 ttt180 -54.36 -46.88 73.09 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.404 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.61 -31.02 69.84 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 116.288 -0.414 . . . . 0.0 113.447 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 68.7 mt -85.18 -37.6 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 O-C-N 122.504 -0.41 . . . . 0.0 112.08 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.448 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 37.8 m-85 -85.38 -30.1 23.9 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -174.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -58.27 -39.89 78.86 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -45.69 -15.34 0.13 Allowed 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 122.112 1.875 . . . . 0.0 114.253 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -103.97 -23.11 13.37 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.438 ' HA3' ' HB2' ' A' ' 80' ' ' CYS . . . -174.57 -128.6 1.1 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.275 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -151.82 124.94 8.67 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 122.402 -0.47 . . . . 0.0 110.358 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.505 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.5 mp -86.7 138.5 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.412 -178.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -83.98 -54.74 4.64 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.895 0.379 . . . . 0.0 111.186 175.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.4 m -141.92 138.53 32.08 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.88 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.533 HG23 HG12 ' A' ' 73' ' ' ILE . 65.3 mt -108.11 112.2 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.807 0.337 . . . . 0.0 110.918 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -105.81 129.02 54.08 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.924 0.392 . . . . 0.0 110.758 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 58' ' ' LEU . 6.6 mp -111.33 148.72 32.35 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.149 -0.345 . . . . 0.0 110.505 175.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 96.0 mmm -92.14 104.53 16.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.292 0.568 . . . . 0.0 110.145 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 73.7 mtm -118.99 159.37 23.96 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.277 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -51.98 -21.82 3.42 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.223 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.3 m 75.24 -37.02 0.32 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 176.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -84.97 -67.64 0.78 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.198 0.523 . . . . 0.0 109.798 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.7 p -72.12 -33.78 68.08 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.419 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.45 23.28 26.91 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 115.524 -0.762 . . . . 0.0 113.378 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -85.86 161.29 19.16 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 122.709 -0.289 . . . . 0.0 110.993 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.3 t -82.94 141.49 32.11 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -176.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -91.53 -3.35 56.61 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.341 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.49 -6.13 65.26 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.044 -0.598 . . . . 0.0 114.552 175.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -143.9 155.97 44.28 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 117.453 0.627 . . . . 0.0 112.054 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -145.46 160.77 28.14 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.23 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.471 ' HB3' ' HD2' ' A' ' 28' ' ' ARG . 96.9 m-85 -119.12 116.54 26.58 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.26 0.552 . . . . 0.0 111.888 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.533 HG12 HG23 ' A' ' 56' ' ' ILE . 70.5 mt -104.13 126.7 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.669 -177.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.7 m -99.27 117.47 33.8 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -99.03 150.52 21.91 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.991 0.424 . . . . 0.0 111.569 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.2 t -80.92 -2.35 47.28 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.145 0.498 . . . . 0.0 111.458 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.547 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 29.3 t70 -142.52 143.86 32.7 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.12 0.486 . . . . 0.0 111.219 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.8 t -75.15 -42.93 55.07 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.849 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.51 -47.53 85.18 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -177.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.547 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 30.8 p -60.04 -40.81 90.67 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.996 0.427 . . . . 0.0 111.333 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.09 -45.94 83.14 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.253 0.549 . . . . 0.0 111.003 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -60.47 -38.64 84.86 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.053 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -67.86 -42.06 81.92 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.536 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.22 -49.71 76.52 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.106 176.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.48 ' C ' HD23 ' A' ' 85' ' ' LEU . 7.0 tt -53.89 -54.9 32.21 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.211 0.529 . . . . 0.0 110.205 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -47.15 -39.74 14.25 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.482 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -97.62 -33.48 11.31 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -174.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 92.6 mt -92.83 -15.54 26.37 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -173.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -67.0 93.64 0.29 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.23 0.538 . . . . 0.0 109.974 176.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.9 10.78 15.39 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.334 -174.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -77.54 133.76 38.44 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.518 0.327 . . . . 0.0 111.306 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -75.76 88.17 2.8 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.156 0.503 . . . . 0.0 111.762 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.1 tp -90.42 125.9 35.71 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.58 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 55.75 26.79 9.87 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.157 0.503 . . . . 0.0 111.541 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.8 15.59 72.56 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 116.128 -0.487 . . . . 0.0 113.38 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 30.5 mtp180 -139.13 144.31 40.25 Favored Pre-proline 0 N--CA 1.472 0.641 0 O-C-N 122.604 -0.35 . . . . 0.0 111.743 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.67 138.0 83.99 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.379 2.719 . . . . 0.0 114.118 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 47.0 ttm -99.37 114.84 27.96 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.031 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -89.25 101.34 14.01 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 122.068 -0.395 . . . . 0.0 111.409 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.6 t -108.04 117.27 53.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.071 0.463 . . . . 0.0 112.064 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.55 160.87 12.91 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.523 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -95.11 37.21 1.17 Allowed 'General case' 0 N--CA 1.479 0.978 0 O-C-N 122.147 -0.62 . . . . 0.0 112.327 -174.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.419 ' C ' ' H ' ' A' ' 105' ' ' GLU . 23.3 m 44.44 -174.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.639 0.776 . . . . 0.0 112.627 -172.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.8 m 71.66 -39.46 0.45 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 120.916 0.389 . . . . 0.0 110.823 -172.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.419 ' H ' ' C ' ' A' ' 103' ' ' VAL . 39.8 mt-10 -58.71 89.27 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.202 0.601 . . . . 0.0 111.51 176.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.26 -8.13 3.37 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.556 175.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 43.5 p -101.42 175.64 5.5 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.333 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.623 -0.703 . . . . 0.0 111.991 178.508 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mpp? . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.829 0.347 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.3 148.37 45.6 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.279 174.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -70.09 81.37 0.5 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.451 0.643 . . . . 0.0 111.384 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -66.51 108.94 2.58 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.883 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -98.33 -40.67 8.21 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.186 0.517 . . . . 0.0 110.786 176.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -102.4 159.55 15.32 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.573 -177.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 47.7 m80 -94.06 162.11 14.01 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.958 0.408 . . . . 0.0 111.741 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -76.89 -16.45 59.39 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -172.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 94.3 p -57.46 105.86 0.28 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.951 0.405 . . . . 0.0 111.995 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.62 ' HB3' ' SD ' ' A' ' 11' ' ' MET . 85.0 m-70 -138.53 -92.58 0.2 Allowed 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 177.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.62 ' SD ' ' HB3' ' A' ' 10' ' ' HIS . 2.1 mpt? -132.44 -175.15 3.66 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.171 0.51 . . . . 0.0 111.452 -177.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.67 118.83 11.47 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.018 176.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 59.51 29.35 18.91 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.454 ' HB2' ' HB2' ' A' ' 11' ' ' MET . . . -85.53 26.25 0.96 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.0 ttt -83.41 -1.68 54.02 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.277 0.561 . . . . 0.0 111.207 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.89 125.9 35.89 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.364 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -66.39 110.76 3.22 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.887 0.375 . . . . 0.0 111.437 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 17.1 m120 64.48 -86.54 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.832 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 7.3 tt 167.69 -56.44 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -176.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 44.17 104.61 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 177.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -71.83 90.6 1.11 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.884 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.59 -168.36 51.31 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.381 -0.438 . . . . 0.0 112.572 -176.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.2 t -65.03 128.11 34.4 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.462 -0.434 . . . . 0.0 111.077 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -151.47 134.3 15.69 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.117 0.484 . . . . 0.0 112.035 -177.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.7 65.44 0.83 Allowed Glycine 0 CA--C 1.532 1.139 0 CA-C-N 116.063 -0.517 . . . . 0.0 113.556 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -81.17 118.37 3.31 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.538 2.159 . . . . 0.0 112.217 176.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.489 ' HB2' ' HA ' ' A' ' 78' ' ' SER . 21.6 ttt -104.92 138.93 40.41 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.79 0.329 . . . . 0.0 111.226 -176.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -108.13 126.99 53.4 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.881 0.372 . . . . 0.0 111.524 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 75.2 mt -105.5 140.8 38.04 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.196 0.522 . . . . 0.0 111.779 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.405 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 48.4 t80 -95.17 115.21 27.13 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.152 173.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.7 t -109.26 101.22 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.054 0.454 . . . . 0.0 111.595 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 70' ' ' TYR . . . -101.62 89.06 0.74 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.77 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.8 t -174.69 22.08 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.112 0.482 . . . . 0.0 111.353 178.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.495 HD21 HD21 ' A' ' 43' ' ' LEU . 14.6 mt -77.93 70.5 4.31 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.765 0.793 . . . . 0.0 110.222 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -66.06 78.97 0.09 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.014 -0.994 . . . . 0.0 113.036 -175.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.6 t80 45.99 38.71 4.87 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 121.287 0.565 . . . . 0.0 112.443 171.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -166.62 -41.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.7 mm -73.69 103.21 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 121.073 0.463 . . . . 0.0 112.059 -173.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.8 p -93.23 173.89 7.49 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.43 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.473 ' HA ' HD12 ' A' ' 43' ' ' LEU . 25.3 mt-10 -51.1 -39.45 56.16 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.695 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.06 -48.73 80.5 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.553 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.4 mmt -63.42 -40.68 97.83 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.961 0.41 . . . . 0.0 110.762 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.495 HD21 HD21 ' A' ' 34' ' ' LEU . 77.0 mt -57.04 -44.68 83.17 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.429 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -60.93 -47.12 87.88 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.999 0.428 . . . . 0.0 111.099 174.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.42 -32.32 64.13 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.579 -178.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.7 mt -86.49 -50.93 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 121.099 0.475 . . . . 0.0 112.208 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 75' ' ' PHE . 42.5 m-85 -85.29 -40.55 16.45 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -171.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -58.6 -37.57 55.76 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -175.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -51.98 -12.7 1.43 Allowed 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 122.217 1.945 . . . . 0.0 114.088 171.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -91.49 -31.26 16.03 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.108 0.48 . . . . 0.0 111.052 173.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.433 ' HA3' ' HB3' ' A' ' 80' ' ' CYS . . . -178.85 134.66 2.39 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.461 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.04 129.97 18.14 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.095 0.474 . . . . 0.0 111.698 -178.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.9 mt -95.34 128.72 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.076 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.425 ' HG2' ' OG ' ' A' ' 76' ' ' SER . 14.7 mm-40 -73.11 -57.43 4.03 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.972 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.9 t -151.76 148.99 28.53 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.716 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.433 HG12 HG23 ' A' ' 73' ' ' ILE . 45.6 mt -120.84 140.46 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.599 175.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -122.65 110.07 15.07 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.447 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.54 HD22 ' HG3' ' A' ' 60' ' ' MET . 3.4 tt -98.39 129.51 45.03 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -177.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.421 ' N ' HD23 ' A' ' 58' ' ' LEU . 55.0 mtp -93.61 94.78 8.81 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.676 0.75 . . . . 0.0 112.452 -174.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.54 ' HG3' HD22 ' A' ' 58' ' ' LEU . 65.3 mtt -112.16 146.49 37.99 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.079 171.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -63.98 101.51 0.4 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.655 0.264 . . . . 0.0 111.403 176.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.8 m -63.29 -5.17 3.12 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.933 0.396 . . . . 0.0 111.751 176.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -81.49 -58.58 2.96 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.336 0.588 . . . . 0.0 111.081 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.6 p -102.65 -31.63 10.28 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.156 -176.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.67 26.93 8.26 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 116.301 -0.409 . . . . 0.0 112.698 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.0 mmm180 -98.06 156.5 16.62 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.089 0.471 . . . . 0.0 112.014 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.7 m -95.41 114.62 26.41 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.867 -177.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -76.06 -11.78 60.0 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 178.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.24 15.17 57.81 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.454 0.942 . . . . 0.0 115.454 169.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.439 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 3.2 p90 -147.36 152.75 38.71 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.167 0.984 . . . . 0.0 112.754 177.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.81 160.58 28.68 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 115.496 -0.775 . . . . 0.0 113.059 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -108.77 126.41 52.99 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 122.579 -0.365 . . . . 0.0 111.463 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.433 HG23 HG12 ' A' ' 56' ' ' ILE . 69.9 mt -112.31 131.36 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.806 0.336 . . . . 0.0 111.598 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 91.9 m -108.36 120.06 41.29 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 120.683 0.278 . . . . 0.0 111.537 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 47' ' ' PHE . 34.4 m-85 -98.94 150.19 22.19 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.731 0.301 . . . . 0.0 111.261 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.425 ' OG ' ' HG2' ' A' ' 54' ' ' GLU . 13.3 m -75.98 10.8 1.69 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -153.79 146.01 23.82 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.815 0.341 . . . . 0.0 110.779 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.489 ' HA ' ' HB2' ' A' ' 27' ' ' MET . 31.3 t -75.07 -48.09 25.62 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.866 0.365 . . . . 0.0 111.984 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -71.1 -31.16 67.44 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 122.274 -0.266 . . . . 0.0 111.49 -175.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.433 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . 93.2 m -59.85 -46.57 88.86 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.851 0.357 . . . . 0.0 111.2 174.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.69 -44.49 77.62 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.038 0.447 . . . . 0.0 110.868 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 39.4 ttmt -54.28 -47.03 72.82 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.304 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -67.58 -42.95 81.72 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.491 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.07 -45.43 71.73 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.079 0.466 . . . . 0.0 110.988 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 tt -57.48 -52.81 63.88 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.624 176.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 82' ' ' LYS . 47.8 mm-40 -56.07 -35.84 67.43 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -177.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -87.7 -36.4 17.42 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -174.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 80.7 mt -95.88 -15.1 22.66 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -173.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -64.01 104.91 0.77 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.943 0.401 . . . . 0.0 110.127 174.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.95 16.91 42.79 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.88 -176.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -77.28 133.92 38.69 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.428 0.291 . . . . 0.0 111.201 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.32 92.88 5.21 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.5 tp -100.03 126.39 46.22 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 122.276 -0.265 . . . . 0.0 110.327 175.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 64.75 12.15 7.42 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.859 0.362 . . . . 0.0 111.773 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.89 2.66 58.3 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.515 -0.374 . . . . 0.0 113.409 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -130.77 154.17 81.78 Favored Pre-proline 0 CA--C 1.543 0.708 0 O-C-N 122.46 -0.435 . . . . 0.0 111.032 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.2 151.63 84.82 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.878 2.385 . . . . 0.0 114.414 -174.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 46.2 ttm -109.47 120.45 42.53 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.216 177.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -89.33 99.19 12.23 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.914 0.388 . . . . 0.0 111.668 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.1 t -108.85 116.58 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.246 176.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 30' ' ' TYR . . . -140.41 139.96 10.18 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.394 -0.431 . . . . 0.0 112.667 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -76.26 74.85 3.07 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 122.133 -0.628 . . . . 0.0 111.562 -177.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 103' ' ' VAL . 16.1 t 54.65 37.01 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-O 122.197 0.999 . . . . 0.0 110.129 -178.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.9 m -76.42 -15.18 59.99 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.657 -173.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -62.59 122.9 16.97 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -175.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 32.7 mtp180 57.26 32.07 21.13 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.985 176.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.6 p 59.16 -74.22 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.987 0.915 . . . . 0.0 112.85 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.3 t70 . . . . . 0 C--O 1.255 1.356 0 CA-C-O 119.086 -0.483 . . . . 0.0 111.276 -179.818 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ttt . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 3' ' ' HIS . . . 80.64 -67.35 3.55 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 114.381 0.512 . . . . 0.0 114.381 172.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 2' ' ' GLY . 14.1 m170 73.31 -56.12 0.66 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.2 p-80 -56.65 91.4 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -173.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -132.67 98.61 4.38 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.534 ' HD2' ' HB2' ' A' ' 9' ' ' SER . 10.2 p-80 -168.24 66.81 0.07 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.21 0.529 . . . . 0.0 111.012 172.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 41.2 m80 55.91 26.91 10.33 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.101 -175.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 63.82 -72.52 0.05 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.666 -169.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.534 ' HB2' ' HD2' ' A' ' 6' ' ' HIS . 41.5 m 48.76 26.98 1.41 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.219 0.533 . . . . 0.0 112.013 177.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.4 t60 -70.75 136.01 48.61 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.557 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.438 ' N ' ' SD ' ' A' ' 11' ' ' MET . 0.0 OUTLIER -56.56 133.32 53.42 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.066 0.46 . . . . 0.0 111.698 -177.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.1 -153.05 0.45 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.742 -177.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.5 13.21 3.16 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 177.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.75 146.56 28.05 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.763 0.316 . . . . 0.0 110.9 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.507 ' SD ' HD22 ' A' ' 19' ' ' LEU . 68.1 mtm -92.36 -79.36 0.39 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -172.54 -176.73 1.59 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.407 -176.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 58.9 m-20 -75.55 -37.85 59.71 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.208 0.528 . . . . 0.0 110.461 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.35 132.23 37.37 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.12 176.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.507 HD22 ' SD ' ' A' ' 15' ' ' MET . 57.4 tp -116.36 -56.42 2.3 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.124 0.487 . . . . 0.0 112.306 -174.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -76.7 -44.73 32.36 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.933 0.396 . . . . 0.0 111.745 -175.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -117.25 107.13 14.04 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.096 0.475 . . . . 0.0 111.126 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -133.7 -82.35 0.19 Allowed Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.145 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.1 t 57.0 17.23 3.25 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 175.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.14 25.94 3.07 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.104 -0.373 . . . . 0.0 111.849 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -110.12 101.04 1.36 Allowed Glycine 0 CA--C 1.531 1.09 0 C-N-CA 121.34 -0.457 . . . . 0.0 113.47 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -82.72 168.09 14.38 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.674 2.249 . . . . 0.0 112.222 174.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 28.2 ttt -123.59 122.81 39.12 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.913 0.387 . . . . 0.0 111.317 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 74' ' ' THR . 36.4 ttp-105 -104.34 133.44 49.24 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.106 0.479 . . . . 0.0 111.64 -178.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.541 HD22 HD12 ' A' ' 85' ' ' LEU . 67.2 mt -107.33 140.53 40.1 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.148 0.499 . . . . 0.0 111.817 -177.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -99.02 116.92 32.36 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.805 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.3 t -115.69 130.83 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 120.744 0.307 . . . . 0.0 111.611 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.06 105.52 0.61 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 121.229 -0.51 . . . . 0.0 113.733 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.3 t -175.05 16.27 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.228 0.537 . . . . 0.0 111.689 175.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.526 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 10.7 mt -87.03 87.3 7.42 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.962 -0.461 . . . . 0.0 111.692 -170.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -80.65 60.94 4.16 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.361 0.601 . . . . 0.0 112.075 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.491 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 46.6 t80 57.48 8.96 0.69 Allowed 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 177.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -126.88 -2.8 6.54 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.704 -0.622 . . . . 0.0 111.858 -176.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.524 HD11 ' HB2' ' A' ' 94' ' ' ALA . 17.7 mm -108.76 122.38 63.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 122.185 -0.322 . . . . 0.0 110.636 -178.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.2 p -98.08 161.91 13.48 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.826 0.346 . . . . 0.0 111.886 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 1.8 mp0 -56.28 -35.16 67.16 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.441 0.639 . . . . 0.0 110.033 173.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.93 -39.53 93.65 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.374 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.3 mmt -68.88 -43.87 74.43 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.103 0.478 . . . . 0.0 110.857 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.438 ' HB3' HD11 ' A' ' 73' ' ' ILE . 78.7 mt -56.29 -42.64 77.84 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.141 0.496 . . . . 0.0 110.661 174.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 66.6 ttp85 -60.62 -49.87 75.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.089 176.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.89 -33.53 63.77 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 121.375 -0.44 . . . . 0.0 113.404 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.9 mm -80.6 -40.69 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.456 ' HB2' HD11 ' A' ' 53' ' ' ILE . 26.5 m-85 -85.5 -26.42 26.26 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -175.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 44' ' ' ARG . 1.8 mt-10 -59.2 -38.2 60.92 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -45.88 -20.67 0.78 Allowed 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.171 1.914 . . . . 0.0 113.852 172.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -96.17 -29.56 13.99 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.49 -142.1 3.31 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.831 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 57.8 ttm-85 -103.47 -38.71 7.05 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -177.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.456 HD11 ' HB2' ' A' ' 47' ' ' PHE . 66.1 mt 69.18 107.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.12 0.568 . . . . 0.0 111.351 -172.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -80.89 -41.09 23.62 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.992 0.425 . . . . 0.0 111.379 -176.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 93.3 p -151.34 142.2 22.92 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.866 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.0 mt -123.58 106.19 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 120.873 0.368 . . . . 0.0 110.782 172.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -99.72 110.97 23.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.849 0.356 . . . . 0.0 110.559 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 59' ' ' MET . 6.7 tt -97.99 133.73 42.07 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.43 ' N ' HD23 ' A' ' 58' ' ' LEU . 55.0 mtp -91.93 113.38 25.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.363 0.601 . . . . 0.0 110.566 -176.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -138.44 139.09 38.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.816 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -72.54 83.9 1.12 Allowed 'General case' 0 C--O 1.237 0.435 0 CA-C-O 120.839 0.352 . . . . 0.0 110.41 174.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.7 m -56.2 -15.71 4.22 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -175.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.46 ' O ' ' HB ' ' A' ' 64' ' ' THR . 31.2 mm-40 -53.16 -48.5 67.92 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.234 0.54 . . . . 0.0 109.817 172.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 63' ' ' GLU . 14.0 t 164.4 -4.82 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.768 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.25 -24.39 75.51 Favored Glycine 0 C--N 1.34 0.8 0 C-N-CA 121.24 -0.505 . . . . 0.0 111.985 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 46.9 mtt180 70.43 -158.8 0.14 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 122.723 0.409 . . . . 0.0 112.081 170.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.491 ' HB3' ' HA ' ' A' ' 36' ' ' PHE . 36.0 t -50.68 115.55 1.54 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -174.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -71.36 -30.81 66.6 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.065 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 124.84 -7.4 8.26 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 120.929 -0.653 . . . . 0.0 114.355 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -140.23 152.13 45.72 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 117.45 0.625 . . . . 0.0 112.603 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.02 160.35 28.6 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.812 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -110.7 121.74 46.09 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.547 -0.384 . . . . 0.0 111.477 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.438 HD11 ' HB3' ' A' ' 43' ' ' LEU . 71.8 mt -110.09 119.94 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.966 0.412 . . . . 0.0 111.317 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 45.6 m -100.19 125.55 46.35 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -174.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.42 ' HZ ' ' HB3' ' A' ' 47' ' ' PHE . 82.8 m-85 -106.24 144.86 32.33 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.033 173.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.7 t -69.14 -32.66 72.18 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.103 0.478 . . . . 0.0 110.806 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -108.28 132.52 53.6 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.36 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.4 t -71.21 -35.42 71.52 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -67.29 -44.82 78.31 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.096 0.474 . . . . 0.0 110.832 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 67.4 m -60.46 -36.3 77.92 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.029 0.443 . . . . 0.0 110.751 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.49 -44.63 82.11 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.505 176.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -60.64 -47.27 86.97 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.878 0.37 . . . . 0.0 111.514 176.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.32 -43.08 88.02 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.205 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.6 -53.2 55.39 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.018 0.437 . . . . 0.0 111.112 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.56 ' HA ' HG11 ' A' ' 100' ' ' VAL . 9.8 tt -53.47 -53.5 50.59 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.456 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.56 -34.64 78.34 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -174.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -88.12 -24.76 23.28 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 89.8 mt -95.36 -13.8 24.42 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -56.52 101.88 0.07 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.241 0.543 . . . . 0.0 110.582 168.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.77 30.56 11.32 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.027 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.422 ' H ' ' HB3' ' A' ' 98' ' ' MET . 84.5 t80 -92.44 103.98 16.35 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.752 0.31 . . . . 0.0 110.484 173.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -71.01 85.57 0.71 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.395 0.617 . . . . 0.0 111.571 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 61.1 tp -74.57 -68.29 0.55 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.3 0.571 . . . . 0.0 110.907 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.524 ' HB2' HD11 ' A' ' 38' ' ' ILE . . . -86.56 38.17 0.77 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.336 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.19 21.81 66.5 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.22 -173.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 28.4 mtp-105 -139.28 141.74 30.26 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 122.86 0.464 . . . . 0.0 110.553 -175.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -52.97 142.01 54.59 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.265 2.644 . . . . 0.0 113.823 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.422 ' HB3' ' H ' ' A' ' 91' ' ' PHE . 52.0 tpp -98.9 123.02 42.89 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.984 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -99.92 102.21 13.54 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 122.398 -0.189 . . . . 0.0 110.661 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.56 HG11 ' HA ' ' A' ' 85' ' ' LEU . 26.5 t -118.66 108.24 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.011 0.434 . . . . 0.0 111.626 -178.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -129.06 154.18 20.15 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.005 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -70.48 147.32 49.53 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 122.213 -0.58 . . . . 0.0 110.902 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 28.1 m -62.38 137.65 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 120.95 0.405 . . . . 0.0 111.027 175.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 56.4 p -78.77 138.9 38.44 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.686 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -162.26 -90.13 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 106' ' ' ARG . 14.3 ttt-85 -139.34 8.44 2.44 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.443 0.64 . . . . 0.0 110.5 176.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.7 p -84.94 -20.12 31.14 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.911 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 C--O 1.252 1.2 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.4 -176.286 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.545 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.747 0.308 . . . . 0.0 111.064 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 135.84 -139.0 10.36 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.505 -0.378 . . . . 0.0 112.293 -178.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.53 134.27 54.08 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.997 0.427 . . . . 0.0 112.083 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -91.3 154.58 19.15 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.009 0.433 . . . . 0.0 111.08 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -78.69 134.38 37.11 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -173.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -167.1 140.89 3.71 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.68 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -70.51 8.33 0.85 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.2 t60 65.44 48.49 2.05 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.245 0.545 . . . . 0.0 111.32 175.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.5 t -79.62 104.26 10.09 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 175.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -67.71 88.04 0.23 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.5 mmt -128.87 22.19 5.82 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.114 177.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.57 52.09 2.0 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -176.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.8 -17.41 23.14 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.71 -21.47 66.53 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 178.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.1 mmt 64.98 -77.55 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.278 0.631 . . . . 0.0 112.488 177.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.73 133.3 51.79 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -159.61 155.01 25.49 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.886 0.374 . . . . 0.0 111.235 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -91.59 95.23 9.81 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.736 0.303 . . . . 0.0 111.021 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 47.0 tp -76.2 -45.35 33.62 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.374 0.607 . . . . 0.0 110.26 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -97.65 54.68 1.18 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.4 0.619 . . . . 0.0 110.802 176.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -57.61 102.3 0.09 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.577 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.08 -7.92 75.82 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.378 -0.439 . . . . 0.0 113.322 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 63.8 m 64.28 134.25 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.413 0.625 . . . . 0.0 112.565 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.11 -27.74 29.96 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.019 0.437 . . . . 0.0 110.774 172.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -129.55 160.75 22.76 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.695 176.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.54 146.01 30.3 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.825 2.35 . . . . 0.0 113.554 -178.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 14.2 tpt -104.08 122.57 45.55 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.256 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -99.47 139.87 34.49 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.81 0.338 . . . . 0.0 111.358 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.0 mt -121.0 129.65 53.48 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.135 0.493 . . . . 0.0 111.406 176.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -91.58 112.83 24.9 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.393 175.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.7 t -103.67 99.76 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.011 0.434 . . . . 0.0 110.745 176.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.8 89.2 0.6 Allowed Glycine 0 CA--C 1.521 0.426 0 C-N-CA 121.003 -0.618 . . . . 0.0 113.107 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.42 ' CB ' ' HA ' ' A' ' 98' ' ' MET . 25.0 t -175.08 25.79 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.464 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 41.9 mt -69.41 107.4 3.31 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.362 -0.836 . . . . 0.0 109.499 176.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.492 ' CE1' ' HB3' ' A' ' 96' ' ' ARG . 29.3 m-70 -78.5 44.78 0.53 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -173.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.54 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 94.4 m-85 60.83 16.79 7.13 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.786 0.434 . . . . 0.0 111.988 -177.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -146.09 -33.52 0.32 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.6 mm -60.9 131.81 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.985 0.422 . . . . 0.0 111.788 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 74.7 p -116.63 169.57 9.25 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.048 0.452 . . . . 0.0 111.756 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.494 ' H ' HD11 ' A' ' 58' ' ' LEU . 2.3 pt-20 -61.73 -28.12 69.2 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.852 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -60.84 -40.0 91.17 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.937 0.399 . . . . 0.0 111.53 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.8 mtt -65.66 -53.66 38.18 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.255 0.55 . . . . 0.0 110.417 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.43 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 43.6 mt -56.15 -55.06 37.68 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.052 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 80.0 ttt180 -49.01 -46.78 44.54 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.576 176.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.46 -33.39 81.14 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 121.325 -0.464 . . . . 0.0 113.844 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 59.6 mt -86.3 -40.16 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.43 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 54.1 m-85 -77.73 -31.78 52.4 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.504 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 2.8 tm-20 -52.18 -48.6 88.42 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 90.5 Cg_exo -45.6 -28.81 4.64 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 122.538 2.159 . . . . 0.0 113.963 175.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -83.72 -47.97 10.63 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.907 0.384 . . . . 0.0 111.365 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.32 149.0 13.25 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 112.043 -0.423 . . . . 0.0 112.043 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.73 115.38 5.82 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.856 0.36 . . . . 0.0 110.793 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.513 ' H ' HD12 ' A' ' 53' ' ' ILE . 3.6 mp -66.97 138.55 22.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 120.939 0.399 . . . . 0.0 112.03 -178.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -80.3 -55.65 4.76 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.09 0.472 . . . . 0.0 110.817 173.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.5 p -151.33 140.72 21.47 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.78 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.484 HG13 HG21 ' A' ' 53' ' ' ILE . 49.2 mt -116.77 140.48 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 120.948 0.404 . . . . 0.0 110.511 172.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.453 ' HA ' HE21 ' A' ' 57' ' ' GLN . 0.1 OUTLIER -129.37 121.22 26.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.185 -179.113 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.494 HD11 ' H ' ' A' ' 40' ' ' GLU . 70.4 mt -96.68 130.49 43.9 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.724 0.297 . . . . 0.0 110.292 173.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 92.3 mmm -93.13 101.37 13.67 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.275 0.56 . . . . 0.0 111.068 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 62.9 mtt -97.83 156.38 16.61 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.715 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.694 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 9.2 m-20 -73.98 107.4 6.17 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.614 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 99.5 p -60.96 -14.41 22.51 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.038 0.447 . . . . 0.0 111.542 177.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -68.77 -32.43 72.17 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.43 0.633 . . . . 0.0 111.083 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.472 ' OG1' ' HG2' ' A' ' 66' ' ' ARG . 51.2 p -142.68 -50.67 0.36 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.988 -174.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.45 21.73 1.42 Allowed Glycine 0 CA--C 1.525 0.714 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.402 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.472 ' HG2' ' OG1' ' A' ' 64' ' ' THR . 28.0 mmm180 -86.6 -161.46 0.66 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.352 0.261 . . . . 0.0 110.927 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.54 ' HB3' ' HA ' ' A' ' 36' ' ' PHE . 37.6 t -113.07 130.56 56.12 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 121.814 -0.553 . . . . 0.0 111.516 178.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.694 ' HE3' ' HA ' ' A' ' 61' ' ' ASP . 97.4 mttt -81.88 -7.16 59.58 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 95.56 6.25 59.77 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 114.855 0.702 . . . . 0.0 114.855 173.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -149.94 156.52 41.88 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.312 1.056 . . . . 0.0 112.907 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.64 161.12 28.89 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.73 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -115.06 139.04 50.2 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 122.461 -0.435 . . . . 0.0 111.656 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.41 HG12 HG23 ' A' ' 56' ' ' ILE . 60.4 mt -122.65 144.26 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.723 0.297 . . . . 0.0 111.185 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.6 m -115.76 134.05 55.41 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -126.08 147.83 49.49 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.839 0.352 . . . . 0.0 111.331 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.0 m -93.38 13.26 22.08 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 120.899 0.38 . . . . 0.0 111.31 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.598 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 15.6 t70 -142.82 109.14 5.29 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.929 0.395 . . . . 0.0 110.698 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.0 m -66.32 -31.51 72.34 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -176.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -65.72 -57.73 7.34 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.788 0.328 . . . . 0.0 111.322 -176.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.598 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 31.2 p -58.06 -38.51 76.47 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.927 0.394 . . . . 0.0 111.144 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.52 -41.16 98.5 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.555 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -60.41 -44.18 95.98 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.944 0.402 . . . . 0.0 110.699 176.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -65.14 -47.46 77.0 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.349 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.15 -51.82 55.6 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.13 0.491 . . . . 0.0 110.934 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.3 tt -55.51 -53.48 55.83 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.92 176.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -62.62 -28.44 69.9 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -174.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.641 HE21 ' N ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -89.96 -38.26 13.78 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.011 -0.431 . . . . 0.0 111.944 -179.008 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 73.5 mt -92.24 -23.3 19.38 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -172.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -69.83 101.02 1.63 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.133 0.492 . . . . 0.0 110.837 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 117.25 -14.81 13.43 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 -173.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -70.57 125.5 27.0 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.835 0.35 . . . . 0.0 110.679 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -77.95 90.43 4.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.204 0.526 . . . . 0.0 112.046 -177.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.5 tp -81.14 132.1 35.34 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.727 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 62.13 25.1 15.01 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.074 0.464 . . . . 0.0 111.372 -176.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.8 32.66 53.22 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.12 -0.491 . . . . 0.0 113.221 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.492 ' HB3' ' CE1' ' A' ' 35' ' ' HIS . 55.7 ttt180 -159.09 131.62 4.41 Favored Pre-proline 0 CA--C 1.545 0.763 0 O-C-N 122.619 -0.342 . . . . 0.0 110.472 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 96' ' ' ARG . 77.9 Cg_exo -48.96 127.73 17.67 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 C-N-CA 123.557 2.838 . . . . 0.0 115.095 -172.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.42 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 50.1 ttp -99.56 117.88 34.92 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.723 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.4 ' H ' ' HB2' ' A' ' 33' ' ' SER . 92.5 mttt -89.49 105.7 17.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.908 0.385 . . . . 0.0 111.787 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.8 t -106.99 99.18 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 121.029 0.442 . . . . 0.0 111.159 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -107.89 162.4 13.2 Favored Glycine 0 C--O 1.223 -0.558 0 N-CA-C 112.136 -0.386 . . . . 0.0 112.136 178.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 -52.75 -84.76 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 117.78 0.79 . . . . 0.0 110.616 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.2 t -139.44 47.3 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 170.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.766 HG22 ' H ' ' A' ' 105' ' ' GLU . 4.3 m 64.35 -171.92 0.18 Allowed 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.415 -169.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.766 ' H ' HG22 ' A' ' 104' ' ' THR . 39.8 mm-40 72.77 -84.91 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 170.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -94.28 99.91 12.06 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -168.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 89.9 m -123.66 -59.26 1.54 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.954 168.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 . . . . . 0 C--O 1.251 1.132 0 CA-C-O 119.14 -0.457 . . . . 0.0 111.531 176.113 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.784 0.326 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -67.33 78.69 0.17 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.376 -0.44 . . . . 0.0 112.784 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -73.85 130.75 40.55 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.129 0.49 . . . . 0.0 111.935 -177.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -125.93 91.43 3.39 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.227 0.536 . . . . 0.0 111.886 -177.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -102.19 153.72 19.69 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.52 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -80.97 -17.78 49.23 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -171.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -63.15 91.69 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.434 0.635 . . . . 0.0 112.421 -176.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -145.22 16.84 1.53 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.316 176.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.4 m -85.45 19.85 2.22 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -173.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 9.8 t60 72.77 -48.71 0.69 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.103 0.561 . . . . 0.0 112.417 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 65.3 mtt -59.9 115.06 3.14 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.217 0.532 . . . . 0.0 111.962 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.35 -171.93 3.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.65 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.7 74.09 10.19 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.083 0.468 . . . . 0.0 110.912 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.39 -45.43 46.03 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -175.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.8 ttt -62.67 -51.69 66.26 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.849 0.357 . . . . 0.0 111.497 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -170.06 -83.47 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.938 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -167.88 -74.78 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 174.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 59.59 -76.98 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.51 0.724 . . . . 0.0 112.901 172.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 66.2 mt -89.84 88.98 7.55 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.933 0.396 . . . . 0.0 111.36 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -85.77 93.23 8.83 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.246 0.546 . . . . 0.0 111.855 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -112.72 -49.53 2.94 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.577 171.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.86 77.73 0.4 Allowed Glycine 0 CA--C 1.528 0.903 0 CA-C-N 116.247 -0.433 . . . . 0.0 113.516 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.6 t -66.3 -59.79 3.38 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.147 0.498 . . . . 0.0 110.935 176.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -95.02 -73.76 0.57 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.029 0.442 . . . . 0.0 110.88 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 155.39 97.13 0.13 Allowed Glycine 0 CA--C 1.527 0.826 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.06 178.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.78 120.64 7.85 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.232 1.955 . . . . 0.0 111.997 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 13.4 tpt -98.96 128.98 45.24 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.81 0.338 . . . . 0.0 110.809 -176.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -109.45 128.46 55.17 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.887 0.375 . . . . 0.0 111.28 -173.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.4 mt -100.06 144.94 28.51 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.223 0.535 . . . . 0.0 111.555 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -108.71 105.9 15.7 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.049 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.603 HG22 HG22 ' A' ' 100' ' ' VAL . 46.5 t -99.77 98.15 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.716 176.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.97 88.95 0.47 Allowed Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.761 -176.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.4 p -175.99 29.22 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.124 0.488 . . . . 0.0 110.991 176.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 30.9 mt -86.9 130.45 34.46 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.429 -174.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -83.24 63.1 7.03 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.289 0.566 . . . . 0.0 112.161 -174.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 55.29 8.92 0.31 Allowed 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -163.52 69.32 0.21 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.137 0.494 . . . . 0.0 112.043 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.0 mm -130.67 118.7 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 169.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.513 ' OG1' ' SD ' ' A' ' 42' ' ' MET . 14.6 p -91.08 163.35 14.33 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.312 0.577 . . . . 0.0 112.464 -172.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -61.07 -30.05 70.11 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.635 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.64 -47.66 71.86 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.378 -177.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.513 ' SD ' ' OG1' ' A' ' 39' ' ' THR . 1.3 mpt? -61.64 -48.39 81.08 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.101 0.477 . . . . 0.0 110.825 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.412 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 77.9 mt -54.62 -50.65 67.57 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.308 177.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.475 ' HG2' ' HG3' ' A' ' 48' ' ' GLU . 30.1 ttp-105 -52.63 -52.82 53.74 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.839 0.352 . . . . 0.0 110.887 178.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -54.81 -31.07 54.04 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 116.102 -0.499 . . . . 0.0 113.712 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.6 mt -79.68 -41.62 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 O-C-N 122.514 -0.404 . . . . 0.0 111.818 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.412 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 19.0 m-85 -82.66 -26.25 32.32 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -175.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.475 ' HG3' ' HG2' ' A' ' 44' ' ' ARG . 32.4 mt-10 -54.79 -47.57 97.85 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -178.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -48.79 -20.85 3.12 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.692 2.262 . . . . 0.0 114.686 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -82.12 -38.43 24.79 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.918 -0.489 . . . . 0.0 111.413 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -162.96 -99.89 0.14 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.681 -0.567 . . . . 0.0 111.681 176.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.7 ttp180 -162.76 153.7 17.18 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.768 0.318 . . . . 0.0 110.144 171.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.49 HG21 HG13 ' A' ' 56' ' ' ILE . 1.7 mp -84.12 139.94 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.126 0.488 . . . . 0.0 111.997 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -96.01 -60.51 1.62 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 174.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.3 t -150.63 126.62 10.47 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.251 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.548 HG23 HG12 ' A' ' 73' ' ' ILE . 54.8 mt -99.66 150.36 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 120.833 0.349 . . . . 0.0 111.284 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.448 HE21 ' N ' ' A' ' 58' ' ' LEU . 29.9 tp60 -149.82 134.8 17.9 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.683 0.278 . . . . 0.0 110.695 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.448 ' N ' HE21 ' A' ' 57' ' ' GLN . 95.2 mt -97.28 142.68 28.87 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.739 0.304 . . . . 0.0 110.512 173.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.498 ' HB3' ' HB2' ' A' ' 70' ' ' TYR . 13.0 tpt -93.48 91.96 7.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.306 0.574 . . . . 0.0 109.788 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.563 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 21.6 ptp -111.78 177.07 4.77 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.001 -175.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -89.79 142.69 27.45 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.472 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 79.8 p -80.02 3.47 20.08 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -91.39 -66.79 0.9 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.286 0.565 . . . . 0.0 111.097 -178.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.448 ' OG1' ' HG3' ' A' ' 66' ' ' ARG . 32.8 p -102.39 -10.53 19.36 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.647 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.65 50.43 48.64 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.362 -0.447 . . . . 0.0 113.077 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.448 ' HG3' ' OG1' ' A' ' 64' ' ' THR . 64.3 mtt-85 -109.4 -79.63 0.58 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 122.424 -0.457 . . . . 0.0 111.862 -177.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 60' ' ' MET . 42.5 t 179.14 140.39 0.11 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -90.95 -2.37 57.72 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.455 169.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.23 15.29 48.45 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 116.165 -0.47 . . . . 0.0 113.732 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.498 ' HB2' ' HB3' ' A' ' 59' ' ' MET . 4.3 m-85 -130.79 160.85 33.15 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 122.475 -0.426 . . . . 0.0 111.546 -178.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.4 135.73 5.34 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 121.439 -0.41 . . . . 0.0 112.901 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -106.94 115.11 29.62 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 122.347 -0.502 . . . . 0.0 111.581 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.548 HG12 HG23 ' A' ' 56' ' ' ILE . 58.7 mt -111.27 123.79 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.868 0.366 . . . . 0.0 111.344 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.5 m -99.68 131.32 45.75 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -176.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.437 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 80.9 m-85 -117.11 151.5 36.71 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.941 0.496 . . . . 0.0 111.327 177.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.6 t -73.72 -34.92 65.0 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.101 0.477 . . . . 0.0 110.924 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -100.28 124.98 46.41 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.825 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 63.3 m -60.42 -37.11 79.81 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.316 176.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -71.2 -50.47 32.78 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.886 -177.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 96.2 m -54.35 -41.4 69.07 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 120.915 0.388 . . . . 0.0 111.144 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -61.66 -47.58 84.72 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.159 175.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.405 ' HB3' ' NZ ' ' A' ' 82' ' ' LYS . 6.8 ttpm? -63.56 -32.8 74.37 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.534 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -68.67 -48.4 64.03 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.734 0.302 . . . . 0.0 110.635 176.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.79 -46.96 67.86 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.202 0.525 . . . . 0.0 110.499 174.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.41 ' C ' HD23 ' A' ' 85' ' ' LEU . 7.8 tt -57.96 -54.37 47.66 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.946 174.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -57.87 -31.64 66.9 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.378 -174.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.663 ' N ' HE21 ' A' ' 87' ' ' GLN . 0.0 OUTLIER -92.52 -43.46 9.15 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.147 -0.346 . . . . 0.0 111.931 -178.465 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 84.5 mt -85.1 -22.39 28.92 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -171.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -63.41 104.29 0.61 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.085 0.469 . . . . 0.0 110.174 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 110.11 -11.93 31.57 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.881 -177.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -65.69 127.47 32.06 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.856 0.36 . . . . 0.0 111.819 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -89.23 100.85 13.55 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.996 0.427 . . . . 0.0 110.935 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 60.1 tp -86.28 -81.33 0.22 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.937 0.399 . . . . 0.0 111.732 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.86 52.33 2.44 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.866 0.365 . . . . 0.0 111.124 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.11 15.56 58.67 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.453 -174.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -135.68 140.56 34.15 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 122.945 0.498 . . . . 0.0 110.591 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.23 145.35 98.73 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.829 2.352 . . . . 0.0 113.081 176.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.43 ' HG2' HG23 ' A' ' 100' ' ' VAL . 46.9 ttm -99.09 108.76 21.48 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.287 175.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -89.09 93.13 9.48 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.857 0.36 . . . . 0.0 111.276 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.603 HG22 HG22 ' A' ' 31' ' ' VAL . 44.8 t -105.38 105.74 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.706 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -115.61 154.47 16.9 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.367 -0.444 . . . . 0.0 112.231 176.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -79.54 56.26 2.15 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 117.755 0.777 . . . . 0.0 111.83 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 50.3 t 50.07 87.93 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 121.432 0.634 . . . . 0.0 111.989 -177.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 51.9 m -149.08 86.94 1.51 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.529 0.68 . . . . 0.0 110.492 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -152.02 11.35 0.56 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.571 -175.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 106' ' ' ARG . 31.0 ttt180 -168.66 16.82 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.046 -166.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.1 p -103.23 -41.39 6.07 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.953 -174.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 35.6 t70 . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.427 -0.797 . . . . 0.0 111.14 -179.452 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.795 0.331 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.37 -172.27 18.79 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.754 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -75.95 74.33 2.86 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.421 0.629 . . . . 0.0 111.428 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -119.18 80.25 1.53 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.983 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -112.63 -1.85 14.71 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.406 0.622 . . . . 0.0 110.106 172.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -161.6 132.22 5.09 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.281 173.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.422 ' H ' ' CD2' ' A' ' 7' ' ' HIS . 0.3 OUTLIER -118.05 11.57 13.38 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -179.261 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -148.42 152.56 37.18 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.158 0.583 . . . . 0.0 109.843 170.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.8 p -156.29 136.23 12.7 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.22 0.533 . . . . 0.0 112.234 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -131.98 18.07 4.6 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.584 0.707 . . . . 0.0 110.014 173.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.7 ptm -81.73 29.62 0.38 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.604 -173.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -125.17 21.76 8.0 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.09 -49.49 13.83 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.054 0.454 . . . . 0.0 111.123 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.9 96.39 9.78 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.388 178.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.499 ' SD ' ' C ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -85.13 106.13 16.36 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.092 0.472 . . . . 0.0 111.037 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.47 -62.69 0.65 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.396 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 65.53 -14.14 0.13 Allowed 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 175.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -57.02 105.18 0.2 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.132 0.424 . . . . 0.0 110.263 174.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.7 mt 61.73 77.24 0.34 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.713 0.768 . . . . 0.0 109.933 -168.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.602 ' NE2' ' H ' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -68.83 -20.85 64.32 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.302 -172.065 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -117.16 94.56 4.62 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.053 0.454 . . . . 0.0 110.381 175.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 161.86 -146.39 12.03 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 121.19 -0.529 . . . . 0.0 112.833 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.494 ' HA ' ' HB3' ' A' ' 78' ' ' SER . 42.7 t 68.51 -65.42 0.27 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.086 0.554 . . . . 0.0 112.156 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.64 71.9 1.01 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.189 0.519 . . . . 0.0 111.297 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -172.66 168.83 41.96 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.541 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.21 126.0 11.93 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.75 2.3 . . . . 0.0 113.262 -175.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 26.9 ttt -126.65 125.51 42.02 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.847 0.356 . . . . 0.0 111.558 -178.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 74' ' ' THR . 11.1 ttp180 -98.85 138.14 36.41 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.153 0.501 . . . . 0.0 111.373 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.654 HD22 HD12 ' A' ' 85' ' ' LEU . 23.6 mt -117.04 146.83 42.83 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.247 -172.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 55.7 t80 -89.85 115.6 27.3 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 122.781 0.432 . . . . 0.0 110.961 175.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.6 t -111.6 98.84 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.107 0.48 . . . . 0.0 110.943 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.88 96.15 1.14 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.406 -0.426 . . . . 0.0 113.76 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.4 t -174.73 9.85 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.3 mt -69.12 93.33 0.59 Allowed 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.728 -0.607 . . . . 0.0 111.19 -172.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -76.67 69.09 3.02 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -175.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 47.0 t80 53.15 39.86 30.31 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 172.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -171.03 -31.58 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.3 mm -64.66 95.28 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.13 0.49 . . . . 0.0 111.327 -178.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.8 p -92.47 -178.37 4.89 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.49 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.533 ' HG3' HD13 ' A' ' 58' ' ' LEU . 2.1 mp0 -52.57 -40.52 62.7 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.065 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.65 -52.32 62.68 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.583 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 20.8 mmt -62.29 -52.51 63.39 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.438 0.637 . . . . 0.0 110.676 -177.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.469 ' HB3' HD11 ' A' ' 73' ' ' ILE . 61.7 mt -55.34 -49.96 70.88 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.613 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -57.21 -50.57 72.44 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.392 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.26 -31.12 62.0 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.369 -0.444 . . . . 0.0 113.857 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.7 mt -85.15 -37.56 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -85.08 -32.3 22.91 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -173.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -59.64 -36.98 45.49 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -46.76 -19.48 0.77 Allowed 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 122.144 1.896 . . . . 0.0 113.847 171.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -90.83 -35.44 14.81 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.781 0.324 . . . . 0.0 111.262 174.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.413 ' HA3' ' SG ' ' A' ' 80' ' ' CYS . . . -172.85 -123.08 0.7 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.413 -0.422 . . . . 0.0 112.742 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -149.54 128.22 12.43 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 122.282 -0.54 . . . . 0.0 110.681 177.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.491 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.7 mp -87.33 138.98 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.765 -176.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -81.42 -48.57 11.73 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.048 0.452 . . . . 0.0 111.104 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 96.0 p -148.98 143.4 26.11 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.356 -178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.527 HG23 HG12 ' A' ' 73' ' ' ILE . 52.1 mt -121.3 104.74 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 120.997 0.427 . . . . 0.0 110.709 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -102.75 111.76 24.22 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -175.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.533 HD13 ' HG3' ' A' ' 40' ' ' GLU . 7.8 mp -98.51 139.68 33.87 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.919 -0.488 . . . . 0.0 110.89 177.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.533 ' HG3' ' CE2' ' A' ' 70' ' ' TYR . 18.2 mmt -94.12 100.41 12.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.072 0.463 . . . . 0.0 111.03 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -148.95 112.71 5.09 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.301 0.572 . . . . 0.0 111.408 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.553 ' HB2' ' HA3' ' A' ' 65' ' ' GLY . 9.1 m-20 -80.11 77.66 6.8 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.129 0.49 . . . . 0.0 110.697 178.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.3 m -47.62 -28.78 2.51 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -170.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -56.13 -46.11 79.3 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.421 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 7.6 t -168.04 -23.7 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -175.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.553 ' HA3' ' HB2' ' A' ' 61' ' ' ASP . . . -72.84 -29.52 65.04 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.957 -0.639 . . . . 0.0 111.546 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 64' ' ' THR . 47.6 mtm-85 63.46 -170.33 0.18 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.052 0.541 . . . . 0.0 112.263 172.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.8 t -57.64 114.26 2.18 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.419 ' NZ ' ' HB3' ' A' ' 68' ' ' LYS . 8.0 mtpm? -77.72 -9.11 58.83 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.804 0.335 . . . . 0.0 111.58 177.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.48 2.29 61.83 Favored Glycine 0 CA--C 1.531 1.094 0 N-CA-C 115.108 0.803 . . . . 0.0 115.108 173.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.533 ' CE2' ' HG3' ' A' ' 59' ' ' MET . 34.1 p90 -143.11 148.98 37.5 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.122 0.961 . . . . 0.0 112.542 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -138.3 146.76 18.62 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.48 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 95.2 m-85 -100.18 121.76 41.95 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 122.594 -0.356 . . . . 0.0 111.523 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 56' ' ' ILE . 77.8 mt -110.36 125.03 67.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 120.794 0.331 . . . . 0.0 111.596 -178.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 27.2 m -101.35 120.6 40.51 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -175.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.471 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 70.3 m-85 -100.08 152.05 20.68 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.325 173.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.7 t -75.46 -14.4 60.43 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.891 0.377 . . . . 0.0 111.685 -177.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -136.46 138.85 41.88 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.689 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.494 ' HB3' ' HA ' ' A' ' 23' ' ' SER . 28.9 t -70.02 -27.34 64.59 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -80.97 -40.94 23.62 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.772 -0.58 . . . . 0.0 110.509 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.413 ' SG ' ' HA3' ' A' ' 51' ' ' GLY . 50.4 t -61.46 -39.26 90.21 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.123 0.487 . . . . 0.0 110.349 169.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.471 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -60.49 -48.69 80.67 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.228 174.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -68.39 -24.98 64.83 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 111.625 0.232 . . . . 0.0 111.625 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -63.6 -55.57 22.69 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.295 0.569 . . . . 0.0 110.104 175.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.67 -51.83 67.72 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.828 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.654 HD12 HD22 ' A' ' 29' ' ' LEU . 6.4 tt -49.11 -63.85 0.98 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.444 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.432 ' HA ' HD21 ' A' ' 89' ' ' ASN . 6.7 mm-40 -67.01 -20.92 65.95 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -172.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -94.95 -14.71 24.18 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 94.1 mt -110.21 -14.71 14.14 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -176.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.463 ' ND2' HD23 ' A' ' 85' ' ' LEU . 10.0 p30 -69.3 97.13 0.92 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.876 0.846 . . . . 0.0 111.178 176.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.96 -2.1 22.84 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.168 -174.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -64.97 127.31 31.06 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 122.592 0.357 . . . . 0.0 111.147 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -76.88 96.26 4.28 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.33 0.586 . . . . 0.0 110.987 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.8 tp -98.34 120.71 39.23 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.463 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 58.35 20.24 7.12 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.03 0.443 . . . . 0.0 112.116 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.87 8.13 58.29 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 116.203 -0.453 . . . . 0.0 113.436 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -130.88 132.23 23.76 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.592 -0.357 . . . . 0.0 110.906 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.53 133.09 49.66 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 122.341 2.028 . . . . 0.0 112.793 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.0 ttp -99.06 116.91 32.38 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.099 0.476 . . . . 0.0 111.538 -177.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -89.98 103.72 16.36 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.896 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.501 HG12 ' HG ' ' A' ' 85' ' ' LEU . 21.6 t -113.93 112.83 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.596 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -151.47 78.24 0.21 Allowed Glycine 0 CA--C 1.534 1.225 0 C-N-CA 119.951 -1.119 . . . . 0.0 115.169 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 27.0 p80 39.13 -162.19 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 174.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.9 t -80.49 116.07 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 170.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 65.9 p -50.66 -87.06 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -166.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -78.92 155.61 28.93 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -166.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 35.5 ptt-85 -138.12 -166.01 1.9 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.701 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.0 m -76.99 87.52 3.51 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 122.179 -0.325 . . . . 0.0 111.761 177.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.6 t70 . . . . . 0 C--O 1.259 1.569 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 175.392 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ptp . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.737 0.303 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.39 81.38 0.6 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.505 172.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -63.32 87.17 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 121.39 0.614 . . . . 0.0 112.513 -175.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -95.01 -59.8 1.82 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.814 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.6 m80 64.18 -13.17 0.1 Allowed 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -83.48 63.12 7.16 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.268 0.556 . . . . 0.0 111.706 -171.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -100.63 123.03 44.27 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -82.58 91.8 7.0 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.306 0.574 . . . . 0.0 111.274 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.7 m -66.45 86.63 0.11 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.303 0.573 . . . . 0.0 111.236 178.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -154.91 151.63 28.79 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.16 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 51.7 ttm -49.87 -37.35 30.66 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.57 83.39 2.61 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.226 0.536 . . . . 0.0 111.576 176.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -128.59 82.07 2.06 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.017 0.437 . . . . 0.0 110.897 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -178.66 -36.94 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.28 -177.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 56.3 ttp 66.86 -72.36 0.09 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.979 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.75 42.14 1.1 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.946 0.403 . . . . 0.0 111.428 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.0 m120 60.08 -170.81 0.14 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.666 -176.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -103.74 -26.76 12.62 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -177.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp -133.0 11.68 4.27 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -76.32 117.69 18.25 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 122.144 -0.348 . . . . 0.0 111.161 178.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -87.31 120.69 28.86 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.301 0.572 . . . . 0.0 111.458 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.87 169.75 17.08 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.145 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.3 m -110.19 -22.34 11.81 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -162.69 133.31 4.74 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.815 0.34 . . . . 0.0 111.413 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -163.16 -78.46 0.03 OUTLIER Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.826 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 37.9 Cg_endo -64.69 101.12 0.36 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.662 2.241 . . . . 0.0 112.946 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -99.77 142.68 30.93 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.586 -178.641 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.548 ' N ' ' SD ' ' A' ' 27' ' ' MET . 34.2 ttm105 -118.58 116.54 26.83 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.997 0.427 . . . . 0.0 112.026 -175.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.558 HD22 HD12 ' A' ' 85' ' ' LEU . 73.3 mt -99.45 128.38 45.56 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.562 178.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -91.49 114.9 27.55 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.131 0.491 . . . . 0.0 111.13 175.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.1 t -107.21 107.83 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.246 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.7 89.53 0.54 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.613 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.5 p -175.09 18.02 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 120.923 0.392 . . . . 0.0 111.976 176.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.544 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 17.8 mt -83.3 81.22 8.8 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.986 -0.447 . . . . 0.0 111.372 -173.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -78.14 75.7 4.67 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 121.188 0.518 . . . . 0.0 112.313 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.437 ' HB3' ' OG ' ' A' ' 67' ' ' SER . 16.3 p90 39.25 26.53 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 176.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -140.28 8.89 2.26 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 122.0 -0.437 . . . . 0.0 111.501 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 38' ' ' ILE . 3.7 mp -118.48 123.91 72.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.596 -177.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 57.3 p -105.83 175.55 5.46 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -54.55 -49.2 70.86 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.729 176.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -73.15 -19.0 61.22 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -174.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.4 tpt -70.51 -54.77 10.9 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 172.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.3 mt -59.21 -55.76 30.78 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.781 175.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -53.89 -35.27 61.42 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.498 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.32 -35.71 92.3 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.137 -0.554 . . . . 0.0 113.073 177.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.8 mt -86.21 -38.5 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-O 120.998 0.428 . . . . 0.0 111.985 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.414 ' HB3' ' HZ ' ' A' ' 75' ' ' PHE . 35.0 m-85 -79.59 -44.63 20.69 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -173.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.414 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 27.1 tt0 -64.84 -32.35 6.68 Favored Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -172.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 48' ' ' GLU . 89.1 Cg_exo -47.89 -22.86 3.65 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.124 1.883 . . . . 0.0 113.629 169.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -77.26 -23.37 51.22 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 122.149 -0.345 . . . . 0.0 111.698 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.761 ' HA3' ' SG ' ' A' ' 80' ' ' CYS . . . -177.89 -100.06 0.13 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.46 175.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.66 130.4 6.59 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.097 0.475 . . . . 0.0 111.481 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.3 mt -111.04 140.82 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.699 -174.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -90.77 -62.36 1.47 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.847 0.356 . . . . 0.0 111.787 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.5 t -145.7 147.65 32.18 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.874 0.369 . . . . 0.0 111.623 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.554 HG12 HG23 ' A' ' 73' ' ' ILE . 55.2 mt -123.88 125.23 70.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.076 0.465 . . . . 0.0 110.852 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -108.89 117.39 34.07 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.879 0.371 . . . . 0.0 110.952 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 82.1 mt -98.42 136.63 38.29 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.75 0.309 . . . . 0.0 110.665 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 22.4 mmt -93.39 120.99 34.31 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.738 0.78 . . . . 0.0 112.196 -175.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.6 mtt -121.16 177.27 5.21 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.298 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.432 ' HB3' ' N ' ' A' ' 66' ' ' ARG . 15.9 t70 -82.42 137.48 34.69 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.893 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 90.3 p -89.11 -2.59 58.6 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -173.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.21 -75.75 0.59 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.206 0.527 . . . . 0.0 110.894 -177.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.563 HG23 ' HG3' ' A' ' 66' ' ' ARG . 1.8 t -93.06 -15.91 25.58 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.044 -177.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.93 26.27 13.05 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.067 -0.587 . . . . 0.0 114.437 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.563 ' HG3' HG23 ' A' ' 64' ' ' THR . 20.1 mtm180 -76.82 -166.19 0.65 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 117.268 0.534 . . . . 0.0 111.241 176.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.437 ' OG ' ' HB3' ' A' ' 36' ' ' PHE . 88.7 p -105.5 152.73 22.67 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.854 -0.529 . . . . 0.0 111.275 178.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -96.22 -37.71 10.43 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.947 0.403 . . . . 0.0 111.488 175.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 34' ' ' LEU . . . 111.05 13.06 14.23 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.818 -0.705 . . . . 0.0 114.555 175.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -149.82 156.11 41.24 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.59 0.695 . . . . 0.0 111.757 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.91 160.54 28.67 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.418 -0.42 . . . . 0.0 113.064 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -112.61 121.35 44.53 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.768 0.318 . . . . 0.0 111.402 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.554 HG23 HG12 ' A' ' 56' ' ' ILE . 67.3 mt -103.69 133.92 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.811 0.338 . . . . 0.0 111.323 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 68.1 m -110.14 118.37 36.21 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.481 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 31.3 m-85 -99.09 150.72 21.73 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.163 175.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.2 t -82.67 1.78 36.77 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.012 0.434 . . . . 0.0 111.565 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -142.28 135.85 29.18 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.041 0.448 . . . . 0.0 111.35 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.8 t -65.72 -47.84 73.96 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -71.7 -35.42 70.22 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.246 -0.284 . . . . 0.0 111.495 -176.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.761 ' SG ' ' HA3' ' A' ' 51' ' ' GLY . 43.9 t -59.38 -44.65 92.74 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.118 0.485 . . . . 0.0 110.918 173.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.481 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -65.53 -47.53 75.59 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.678 177.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.8 ttpp -60.76 -34.21 74.11 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.823 0.344 . . . . 0.0 111.349 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -66.43 -49.25 67.39 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.912 0.387 . . . . 0.0 110.919 176.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.02 -44.7 87.45 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.127 0.489 . . . . 0.0 111.169 176.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.558 HD12 HD22 ' A' ' 29' ' ' LEU . 8.6 tt -56.76 -59.08 5.55 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.987 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.93 -25.18 67.43 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -173.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -89.68 -31.12 17.64 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 122.032 -0.418 . . . . 0.0 112.056 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.0 mt -103.24 -6.74 21.78 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -66.07 92.37 0.17 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.221 0.534 . . . . 0.0 110.614 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 115.07 3.18 21.66 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.943 -176.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -64.63 135.79 56.31 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.589 0.355 . . . . 0.0 111.709 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -70.13 79.87 0.51 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.177 0.513 . . . . 0.0 111.383 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.572 HD22 ' SD ' ' A' ' 98' ' ' MET . 56.8 tp -84.33 118.49 24.25 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.907 0.384 . . . . 0.0 111.657 -177.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 57.15 26.86 12.63 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 176.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.44 11.39 59.61 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 116.075 -0.512 . . . . 0.0 113.4 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -145.49 139.81 15.27 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 122.478 0.311 . . . . 0.0 110.807 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -55.41 136.73 75.07 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.491 2.127 . . . . 0.0 112.887 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.572 ' SD ' HD22 ' A' ' 93' ' ' LEU . 44.8 ttp -98.67 118.45 35.42 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.229 0.538 . . . . 0.0 111.395 -176.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -88.98 96.31 10.67 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.333 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 18.7 t -104.71 105.91 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.993 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -133.22 151.8 20.19 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.451 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.5 p80 -69.58 173.2 6.29 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 122.29 -0.535 . . . . 0.0 110.904 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.477 HG21 HH11 ' A' ' 28' ' ' ARG . 41.9 t -63.86 136.68 25.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.647 0.261 . . . . 0.0 110.633 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 40.8 p -67.9 0.38 3.5 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -172.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -73.52 109.74 7.27 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.118 0.485 . . . . 0.0 111.103 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -135.51 130.98 35.46 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.313 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.2 m -122.38 89.15 3.06 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.084 0.469 . . . . 0.0 110.606 172.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.0 t70 . . . . . 0 C--O 1.253 1.25 0 CA-C-O 119.023 -0.513 . . . . 0.0 110.699 -178.66 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttt . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 120.815 0.34 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.1 73.8 1.71 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.375 -0.441 . . . . 0.0 113.885 -176.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -151.42 -177.27 5.97 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.76 0.424 . . . . 0.0 110.857 175.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -76.13 72.41 2.94 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.4 m80 58.61 -79.16 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 171.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -71.06 88.38 0.78 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.49 0.662 . . . . 0.0 111.654 -175.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -73.11 98.98 2.68 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.92 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -86.18 114.42 23.0 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.97 0.414 . . . . 0.0 110.757 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.4 t -80.06 -176.82 5.72 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.088 0.47 . . . . 0.0 111.67 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -147.54 168.98 20.57 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.736 0.303 . . . . 0.0 111.56 -177.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.3 mmt -60.71 127.53 32.11 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.028 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.65 24.09 10.46 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -174.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 63.26 53.87 2.15 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.966 0.412 . . . . 0.0 111.529 -177.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 68.11 115.31 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.577 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.568 ' N ' ' SD ' ' A' ' 15' ' ' MET . 1.1 mpt? -77.22 144.65 38.11 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.53 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.08 105.6 17.92 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.129 0.49 . . . . 0.0 111.759 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -85.54 157.92 20.28 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.128 176.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.5 t30 56.51 59.36 3.64 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.444 0.64 . . . . 0.0 111.035 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 19' ' ' LEU . 8.5 tt -84.65 -34.04 23.12 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.2 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.31 -160.8 0.82 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.275 177.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -69.35 103.05 1.89 Allowed 'General case' 0 CA--C 1.539 0.526 0 O-C-N 122.307 -0.246 . . . . 0.0 111.563 177.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.65 91.49 0.03 OUTLIER Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.347 -0.454 . . . . 0.0 113.006 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.5 p -139.83 108.84 6.02 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.045 0.45 . . . . 0.0 111.595 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -153.87 -75.38 0.12 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.326 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 59.86 -114.47 6.37 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 116.443 -0.344 . . . . 0.0 113.069 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.67 127.13 12.76 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.321 2.014 . . . . 0.0 111.969 176.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 14.3 tpt -102.9 131.64 49.67 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.887 0.375 . . . . 0.0 111.922 -172.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.8 ttm-85 -102.72 118.46 36.89 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.856 0.36 . . . . 0.0 110.896 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 76.0 mt -102.68 150.57 23.31 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.281 0.562 . . . . 0.0 111.829 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -105.59 131.43 52.99 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.299 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.6 t -125.94 106.44 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.569 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -125.38 88.52 0.37 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.829 -176.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.497 ' HG ' ' HA ' ' A' ' 98' ' ' MET . 89.6 p -175.79 23.71 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.97 0.414 . . . . 0.0 111.41 178.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.557 ' HB3' HG13 ' A' ' 38' ' ' ILE . 53.4 mt -83.64 166.86 17.8 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.198 -176.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.426 ' ND1' ' O ' ' A' ' 35' ' ' HIS . 33.6 p80 -141.85 80.44 1.72 Allowed 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 60.1 t80 50.61 8.34 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.407 ' O ' HD13 ' A' ' 38' ' ' ILE . 4.8 t30 -143.34 52.59 1.35 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.091 -1.005 . . . . 0.0 110.535 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.557 HG13 ' HB3' ' A' ' 34' ' ' LEU . 30.1 mm -133.24 125.08 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.625 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.417 ' OG1' ' HG3' ' A' ' 42' ' ' MET . 41.8 p -108.03 158.88 17.01 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.861 0.362 . . . . 0.0 111.835 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -54.9 -32.04 60.62 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.108 0.48 . . . . 0.0 110.742 172.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -62.64 -42.41 99.58 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.527 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.427 ' SD ' ' HA ' ' A' ' 38' ' ' ILE . 59.0 mtt -64.06 -55.41 22.37 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.538 0.685 . . . . 0.0 110.686 179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.435 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 45.6 mt -56.72 -54.83 41.7 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.357 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -53.13 -47.88 68.34 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.314 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.09 -30.22 75.01 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 121.305 -0.474 . . . . 0.0 113.741 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 74.1 mt -82.98 -40.46 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 O-C-N 122.377 -0.484 . . . . 0.0 112.23 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.485 ' HB3' ' HE2' ' A' ' 75' ' ' PHE . 77.2 m-85 -85.77 -30.78 22.78 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -173.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.413 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 30.1 mt-10 -55.32 -41.63 91.75 Favored Pre-proline 0 N--CA 1.484 1.226 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 48' ' ' GLU . 51.7 Cg_exo -41.09 -39.29 3.5 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 122.378 2.052 . . . . 0.0 113.058 172.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -76.65 -57.67 3.72 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.067 0.46 . . . . 0.0 110.881 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -157.98 135.01 4.12 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.017 -175.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -56.3 122.26 11.41 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 122.6 0.36 . . . . 0.0 111.236 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 53' ' ' ILE . 2.9 mp -79.6 135.27 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.148 0.499 . . . . 0.0 111.911 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -87.74 -51.05 6.08 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.148 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.8 m -150.41 140.34 21.92 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.812 0.339 . . . . 0.0 111.877 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.537 HG23 HG12 ' A' ' 73' ' ' ILE . 53.8 mt -116.66 140.58 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.911 177.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -136.86 110.19 7.88 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.716 0.293 . . . . 0.0 111.764 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.429 HD12 ' N ' ' A' ' 58' ' ' LEU . 5.1 mp -99.57 150.66 22.01 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.648 0.261 . . . . 0.0 110.391 175.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.445 ' HG3' ' CE2' ' A' ' 70' ' ' TYR . 20.4 mmt -94.6 122.01 36.75 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.569 0.699 . . . . 0.0 112.747 -177.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -152.5 145.82 24.76 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.821 -1.082 . . . . 0.0 111.121 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.543 ' HB3' ' HA3' ' A' ' 65' ' ' GLY . 22.0 t70 -117.02 118.67 33.03 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.749 0.309 . . . . 0.0 110.801 176.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.4 t -73.73 -15.82 61.2 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -174.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -73.26 -70.06 0.39 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.207 0.527 . . . . 0.0 110.687 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.7 t -160.05 16.25 0.14 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.243 0.544 . . . . 0.0 111.909 178.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.543 ' HA3' ' HB3' ' A' ' 61' ' ' ASP . . . -89.42 -30.91 12.43 Favored Glycine 0 CA--C 1.517 0.182 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.433 175.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 57.1 mtp85 60.69 -168.92 0.16 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 122.971 0.508 . . . . 0.0 111.904 176.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.0 m -69.01 105.44 2.41 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.196 -0.315 . . . . 0.0 111.442 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -62.14 -37.91 86.96 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.81 6.62 18.91 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.502 -0.856 . . . . 0.0 115.018 174.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.445 ' CE2' ' HG3' ' A' ' 59' ' ' MET . 35.3 p90 -130.24 147.84 52.01 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.156 0.978 . . . . 0.0 111.824 176.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -149.52 160.24 28.38 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 116.097 -0.501 . . . . 0.0 113.315 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -113.68 139.05 49.38 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.659 0.383 . . . . 0.0 110.999 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.537 HG12 HG23 ' A' ' 56' ' ' ILE . 75.0 mt -124.11 125.67 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.795 0.331 . . . . 0.0 111.447 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.9 m -99.53 118.24 35.66 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.885 0.374 . . . . 0.0 111.549 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.485 ' HE2' ' HB3' ' A' ' 47' ' ' PHE . 43.8 m-85 -99.64 150.08 22.64 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.313 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.1 t -75.77 -18.74 59.42 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.113 0.482 . . . . 0.0 111.067 173.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -110.06 152.81 25.49 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.076 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.1 p -100.41 -59.86 1.63 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 120.967 0.413 . . . . 0.0 112.081 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -65.36 -39.87 92.88 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -175.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 77.9 m -61.6 -31.03 71.08 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.08 0.467 . . . . 0.0 110.541 174.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.32 -33.93 67.71 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.845 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -54.6 -50.44 68.05 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.019 0.438 . . . . 0.0 110.181 172.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.494 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . 6.9 ttpm? -64.48 -40.95 96.64 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.033 177.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.4 -41.64 69.52 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.358 0.599 . . . . 0.0 110.934 176.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.431 HD23 ' C ' ' A' ' 85' ' ' LEU . 7.0 tt -63.91 -62.73 1.45 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.664 177.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.494 ' HG2' ' HA ' ' A' ' 83' ' ' LYS . 14.8 pt-20 -66.42 -18.37 65.32 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.497 -173.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -86.2 -40.97 15.06 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.746 0.308 . . . . 0.0 111.554 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 81.2 mt -97.38 -13.2 21.99 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -168.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.427 HD21 ' HA ' ' A' ' 86' ' ' GLU . 10.7 p30 -65.41 81.12 0.06 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 121.699 0.761 . . . . 0.0 111.705 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 141.88 -14.52 2.63 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.706 -175.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -65.72 135.03 54.41 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 122.939 0.496 . . . . 0.0 111.302 177.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -82.74 104.82 13.27 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.099 0.475 . . . . 0.0 112.073 -177.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.6 tp -101.63 128.25 48.0 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.277 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 61.05 22.78 13.01 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.051 0.453 . . . . 0.0 111.243 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 85.78 12.05 72.67 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 116.135 -0.484 . . . . 0.0 113.37 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.7 ttt85 -134.96 134.13 21.54 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 122.52 -0.4 . . . . 0.0 110.631 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -53.64 142.15 61.69 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.922 2.415 . . . . 0.0 113.38 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.497 ' HA ' ' HG ' ' A' ' 33' ' ' SER . 44.9 ttm -99.34 114.43 27.3 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.309 -177.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -89.69 97.82 11.42 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.959 0.409 . . . . 0.0 110.936 177.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.2 t -103.9 127.52 57.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.499 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -150.0 159.38 28.08 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.543 175.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.423 ' O ' HG23 ' A' ' 104' ' ' THR . 11.0 p80 -72.44 155.02 40.56 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 122.208 -0.583 . . . . 0.0 111.002 177.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 52.1 t -58.02 95.9 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.122 0.487 . . . . 0.0 111.222 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 102' ' ' HIS . 81.4 p -84.31 -173.37 4.68 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.605 0.717 . . . . 0.0 112.636 -176.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -103.0 169.5 8.53 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.887 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 64.4 106.16 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 99.1 m -89.35 110.11 20.94 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 168.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.5 t70 . . . . . 0 C--O 1.252 1.224 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -172.143 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.737 0.303 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.64 -65.62 2.81 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.833 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.7 p-80 -106.42 112.87 26.07 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.241 0.543 . . . . 0.0 111.098 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -100.19 -13.85 18.75 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.254 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -138.49 154.94 48.82 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.033 0.533 . . . . 0.0 110.349 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -164.8 -32.13 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 -68.14 -20.71 64.92 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.5 m80 66.95 -71.29 0.1 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.089 0.556 . . . . 0.0 111.9 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.3 m -136.47 -173.37 3.39 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.835 0.35 . . . . 0.0 111.109 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -67.58 -26.23 66.18 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.97 0.415 . . . . 0.0 110.542 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 12.8 tmm? -70.31 87.7 0.62 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.414 0.626 . . . . 0.0 109.864 172.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -178.8 -42.97 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.798 -177.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 14' ' ' ALA . . . -116.42 141.47 48.12 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.139 173.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 13' ' ' ALA . . . 72.31 -54.86 0.68 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.973 0.509 . . . . 0.0 112.108 -176.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 24.7 mmt -80.25 110.97 16.18 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.218 -0.301 . . . . 0.0 111.184 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.13 167.49 29.7 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.118 0.485 . . . . 0.0 111.979 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -92.04 100.86 13.43 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.443 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -127.95 -56.55 1.27 Allowed 'General case' 0 N--CA 1.471 0.608 0 O-C-N 122.025 -0.422 . . . . 0.0 111.964 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.0 tp -93.49 94.96 8.96 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.236 0.541 . . . . 0.0 110.802 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -97.26 -60.78 1.51 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.715 -178.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -144.4 93.49 2.44 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.462 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.76 -84.31 0.09 OUTLIER Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.488 -0.387 . . . . 0.0 113.577 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.4 m -147.65 156.4 42.75 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.343 -0.504 . . . . 0.0 111.654 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -140.79 165.4 27.59 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.731 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -156.24 -116.13 0.52 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.925 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 51.3 Cg_exo -54.06 122.27 11.12 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.156 2.57 . . . . 0.0 114.083 -173.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 28.1 ttt -100.66 133.83 44.52 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.319 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.3 ttm-85 -111.19 129.39 55.97 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.984 0.421 . . . . 0.0 111.873 -174.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 80.5 mt -103.8 142.7 33.92 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.497 0.665 . . . . 0.0 111.9 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -99.69 113.36 25.76 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.198 175.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -116.93 115.4 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -175.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.72 104.37 1.37 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.656 -0.307 . . . . 0.0 113.685 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.543 ' HB2' ' HA ' ' A' ' 98' ' ' MET . 23.9 t -174.82 20.99 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.357 0.599 . . . . 0.0 111.268 175.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.9 mt -93.49 91.85 7.33 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.805 -174.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -80.1 61.51 3.98 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -174.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 22.6 t80 50.29 41.23 24.07 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.641 0.734 . . . . 0.0 110.979 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -149.9 -50.8 0.14 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.754 -171.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.411 HD11 ' HB2' ' A' ' 94' ' ' ALA . 60.8 mt -78.96 133.97 28.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.239 -172.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.3 p -114.27 178.37 4.31 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.198 0.523 . . . . 0.0 112.087 -177.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.429 ' HG3' ' CD1' ' A' ' 58' ' ' LEU . 2.1 mp0 -50.41 -45.35 55.6 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.881 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -55.87 -44.6 78.27 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.577 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.436 ' O ' HG12 ' A' ' 46' ' ' ILE . 12.5 tpt -66.49 -49.9 65.06 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.185 0.517 . . . . 0.0 110.29 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.435 ' O ' ' HD1' ' A' ' 47' ' ' PHE . 71.4 mt -54.25 -53.54 52.2 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.093 176.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.2 ttm105 -51.01 -43.21 60.79 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.536 176.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.96 -28.22 71.64 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.349 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 42' ' ' MET . 42.4 mm -85.17 -37.26 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 120.911 0.386 . . . . 0.0 111.929 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.435 ' HD1' ' O ' ' A' ' 43' ' ' LEU . 46.8 m-85 -86.17 -28.03 24.18 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -174.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -57.7 -38.1 63.48 Favored Pre-proline 0 N--CA 1.484 1.268 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -47.92 -19.9 1.75 Allowed 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 122.086 1.857 . . . . 0.0 113.581 170.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -94.75 -46.66 6.82 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.808 0.337 . . . . 0.0 111.527 175.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.47 -133.5 1.49 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.595 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -129.77 143.8 50.99 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 122.089 -0.654 . . . . 0.0 111.427 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.533 HG21 HG13 ' A' ' 56' ' ' ILE . 2.4 mp -94.97 138.69 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.017 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -95.45 -45.33 7.15 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.911 0.386 . . . . 0.0 111.064 174.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.2 t -152.14 147.03 25.96 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.506 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.551 HG12 HG23 ' A' ' 73' ' ' ILE . 51.8 mt -130.46 106.62 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 120.81 0.338 . . . . 0.0 110.863 175.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -108.93 119.98 41.17 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.754 0.311 . . . . 0.0 111.323 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.43 HD12 ' N ' ' A' ' 58' ' ' LEU . 7.2 mp -98.22 141.55 30.99 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.064 0.459 . . . . 0.0 111.538 -177.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.595 ' SD ' ' HE2' ' A' ' 72' ' ' PHE . 56.8 mtp -101.45 101.36 11.95 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.432 0.634 . . . . 0.0 111.851 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.434 ' O ' ' N ' ' A' ' 62' ' ' SER . 14.1 ptt? -119.31 113.45 20.85 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 168.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.55 ' HB3' ' O ' ' A' ' 66' ' ' ARG . 5.1 p-10 32.94 -76.31 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -166.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 60' ' ' MET . 28.2 t 45.73 37.38 3.34 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.903 0.858 . . . . 0.0 109.839 -168.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -162.39 -50.71 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.75 -169.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.448 ' H ' ' HB2' ' A' ' 61' ' ' ASP . 8.4 t -126.72 -33.29 2.52 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -172.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.427 ' H ' ' CB ' ' A' ' 61' ' ' ASP . . . 108.47 22.03 7.3 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 120.47 -0.871 . . . . 0.0 113.327 -173.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.55 ' O ' ' HB3' ' A' ' 61' ' ' ASP . 68.0 mtm-85 -119.41 -175.83 3.02 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 122.432 -0.452 . . . . 0.0 111.147 176.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.7 p -106.28 130.41 54.13 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.609 -0.682 . . . . 0.0 112.167 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.579 ' HB2' ' O ' ' A' ' 59' ' ' MET . 57.8 mttp -89.39 -59.22 2.27 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.887 0.375 . . . . 0.0 110.776 173.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.44 23.22 8.53 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 114.863 0.705 . . . . 0.0 114.863 172.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.535 ' HE1' ' SD ' ' A' ' 59' ' ' MET . 27.6 p90 -143.49 152.06 41.04 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.775 0.788 . . . . 0.0 112.088 177.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.8 158.13 23.66 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.945 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.595 ' HE2' ' SD ' ' A' ' 59' ' ' MET . 98.2 m-85 -110.02 125.08 52.53 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.831 0.348 . . . . 0.0 111.17 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.551 HG23 HG12 ' A' ' 56' ' ' ILE . 59.9 mt -113.43 135.14 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.593 -178.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.2 m -100.01 133.97 43.62 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.492 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 96.1 m-85 -125.14 143.86 50.72 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.509 0.324 . . . . 0.0 111.27 177.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.2 m -81.48 -5.63 58.14 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 120.745 0.307 . . . . 0.0 111.708 176.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 80' ' ' CYS . 8.4 t0 -124.18 115.84 21.75 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.939 0.399 . . . . 0.0 110.842 -178.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 48.8 m -71.76 -22.27 61.62 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.75 -36.65 15.04 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 72.6 m -66.13 -39.99 90.31 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.963 0.411 . . . . 0.0 110.591 174.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.14 -40.49 82.43 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.033 0.444 . . . . 0.0 110.958 174.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.565 ' HZ2' ' HB2' ' A' ' 82' ' ' LYS . 4.7 ttmp? -62.23 -42.69 99.54 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.081 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 86.6 tttt -61.45 -50.89 70.96 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.61 0.243 . . . . 0.0 110.478 173.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.12 -40.99 47.73 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.19 0.519 . . . . 0.0 111.055 177.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.3 tt -61.46 -48.34 81.59 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.24 175.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -67.62 -34.2 76.5 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -177.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 83' ' ' LYS . 7.9 mm100 -90.8 -32.84 15.94 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -173.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.0 mt -99.52 -11.26 21.2 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -172.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -65.93 94.89 0.24 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.316 0.579 . . . . 0.0 110.246 176.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 106.8 22.43 7.65 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.177 -173.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -80.92 142.83 33.13 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 122.732 -0.276 . . . . 0.0 111.715 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -75.06 85.06 2.31 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.852 0.358 . . . . 0.0 111.263 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.559 HD22 ' SD ' ' A' ' 98' ' ' MET . 54.9 tp -103.02 124.84 49.28 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.724 0.297 . . . . 0.0 111.292 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.411 ' HB2' HD11 ' A' ' 38' ' ' ILE . . . 59.82 16.19 5.44 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.85 11.12 59.35 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.42 -0.419 . . . . 0.0 113.309 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 96' ' ' ARG . 16.3 mtp180 -133.7 154.97 80.85 Favored Pre-proline 0 N--CA 1.47 0.57 0 O-C-N 122.474 -0.427 . . . . 0.0 111.877 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.57 130.32 23.3 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.779 2.319 . . . . 0.0 112.26 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.559 ' SD ' HD22 ' A' ' 93' ' ' LEU . 48.6 ttp -97.84 125.67 42.82 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.299 0.571 . . . . 0.0 111.851 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -89.1 108.35 19.55 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.489 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.1 t -116.18 122.28 69.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 121.285 0.564 . . . . 0.0 112.053 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -146.1 146.8 17.26 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.959 175.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -76.26 142.09 41.49 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.268 1.034 . . . . 0.0 110.93 -176.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.1 m -59.54 122.93 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 121.299 0.571 . . . . 0.0 111.412 -177.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.2 t -161.03 61.17 0.29 Allowed 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.892 0.854 . . . . 0.0 110.802 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -78.0 74.81 4.55 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.59 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 106' ' ' ARG . 12.0 ptm180 -142.48 173.69 11.31 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.587 -176.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 50.9 m -100.96 146.36 27.5 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.466 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.1 t70 . . . . . 0 C--O 1.252 1.205 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.319 177.324 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 120.538 0.208 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -56.62 -34.55 64.48 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.428 -0.415 . . . . 0.0 113.986 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -64.36 -29.57 70.64 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -118.32 106.37 12.69 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.869 0.366 . . . . 0.0 110.991 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -89.77 -48.63 7.13 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.546 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -147.08 -110.41 0.09 Allowed 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 111.722 0.267 . . . . 0.0 111.722 176.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.0 m80 58.2 111.61 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.374 0.607 . . . . 0.0 111.962 -172.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -66.36 103.55 1.05 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.555 -178.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 81.1 p -62.91 112.34 2.53 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.785 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -112.57 13.08 19.98 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 177.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.441 ' SD ' ' C ' ' A' ' 11' ' ' MET . 0.2 OUTLIER 74.49 -53.19 0.68 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.589 0.756 . . . . 0.0 113.001 176.076 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.07 25.38 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -172.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.71 -15.63 29.95 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.887 -0.508 . . . . 0.0 111.955 177.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.45 111.6 2.39 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.3 mpt? 56.91 21.76 6.48 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.93 95.79 3.03 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.886 0.374 . . . . 0.0 111.636 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -93.25 -68.87 0.78 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.279 177.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 48.57 95.26 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 176.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 84.5 mt -77.55 76.07 4.09 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.271 0.557 . . . . 0.0 110.469 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.573 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 17.8 pt20 -84.07 167.65 16.62 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.116 -177.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.573 ' HG2' ' O ' ' A' ' 20' ' ' GLN . 0.0 OUTLIER 64.6 -32.31 0.14 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 125.362 1.465 . . . . 0.0 114.362 177.022 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.88 -27.74 59.75 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.195 -0.526 . . . . 0.0 114.297 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.6 m -128.32 12.99 6.58 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 122.544 -0.386 . . . . 0.0 111.916 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -127.27 162.0 27.25 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -173.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -120.56 90.84 0.47 Allowed Glycine 0 CA--C 1.53 1.004 0 CA-C-N 116.218 -0.447 . . . . 0.0 113.096 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -88.54 169.69 5.71 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.13 2.553 . . . . 0.0 112.729 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.2 ttt -124.05 145.73 49.03 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.003 0.43 . . . . 0.0 111.547 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -116.62 119.39 35.39 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.677 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.591 HD22 HD12 ' A' ' 85' ' ' LEU . 60.7 mt -99.25 138.41 36.38 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.087 0.47 . . . . 0.0 112.202 -178.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -92.8 107.26 19.08 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.539 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.7 t -101.06 97.91 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.004 0.431 . . . . 0.0 111.14 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.76 88.99 0.83 Allowed Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.629 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.3 t -175.49 24.18 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.993 0.425 . . . . 0.0 111.359 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 43.0 mt -73.79 92.66 2.05 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.879 -0.513 . . . . 0.0 110.517 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -78.98 65.56 4.19 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -174.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 55.23 8.74 0.29 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.919 1.452 . . . . 0.0 114.919 170.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -155.16 8.73 0.29 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.411 0.55 . . . . 0.0 112.244 178.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.6 mm -78.06 131.41 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 121.946 -0.471 . . . . 0.0 110.811 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.453 ' OG1' ' HG3' ' A' ' 42' ' ' MET . 49.4 p -106.01 160.49 15.25 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -177.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -55.09 -38.49 68.17 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.319 0.58 . . . . 0.0 110.556 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -61.04 -41.41 96.53 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.107 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.453 ' HG3' ' OG1' ' A' ' 39' ' ' THR . 66.8 mtt -62.77 -55.52 25.77 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.251 0.548 . . . . 0.0 110.529 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.1 mt -54.59 -46.58 73.81 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.104 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 50.9 ttt85 -60.22 -46.48 89.62 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.502 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.07 -29.71 59.82 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.117 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.7 mm -86.54 -53.16 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 75' ' ' PHE . 34.0 m-85 -79.83 -36.71 36.46 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -171.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.473 ' HA ' HG13 ' A' ' 53' ' ' ILE . 0.6 OUTLIER -56.43 -48.06 97.75 Favored Pre-proline 0 N--CA 1.482 1.134 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -172.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -47.07 -20.93 1.41 Allowed 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.649 2.232 . . . . 0.0 114.248 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -70.91 -51.6 25.1 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 178.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 52' ' ' ARG . . . -173.52 45.77 0.16 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 119.652 -1.261 . . . . 0.0 115.176 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 73.1 ttt180 72.19 137.19 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 172.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.473 HG13 ' HA ' ' A' ' 48' ' ' GLU . 66.0 mt -128.06 133.18 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.316 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -108.15 -48.09 3.43 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -176.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.7 m -126.94 122.06 33.5 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -176.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 51.8 mt -115.65 106.23 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.853 0.359 . . . . 0.0 110.808 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -99.34 116.3 31.2 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.716 0.293 . . . . 0.0 111.524 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.7 mt -99.0 130.73 45.36 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 173.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 85.0 mmm -93.53 113.41 25.52 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.34 0.591 . . . . 0.0 111.551 -174.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 23.9 ptp -128.95 153.58 47.39 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.895 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.97 103.65 2.74 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.827 0.346 . . . . 0.0 110.667 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.5 t -73.36 70.68 1.22 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.345 0.593 . . . . 0.0 110.844 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -179.24 -59.51 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.8 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.2 p -94.05 -20.24 20.12 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.612 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.78 21.22 66.58 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.202 -0.523 . . . . 0.0 113.536 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -88.84 144.84 25.95 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.059 0.456 . . . . 0.0 111.546 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.7 m -80.92 125.56 30.28 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.276 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.404 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 34.2 mmtp -68.94 -38.1 79.28 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.95 4.16 31.53 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.718 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 68' ' ' LYS . 4.4 p90 -141.14 154.34 45.83 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.322 0.561 . . . . 0.0 112.072 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.32 161.15 28.85 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.839 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -116.17 122.1 44.06 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.523 -0.398 . . . . 0.0 111.828 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.5 mt -108.75 133.09 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 120.96 0.41 . . . . 0.0 111.592 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.4 m -109.52 123.98 50.32 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.735 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.434 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 7.0 m-85 -106.1 150.62 25.62 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.26 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.6 m -70.86 -11.62 61.06 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.081 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -136.76 122.97 20.48 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.031 0.443 . . . . 0.0 111.518 -178.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.8 m -65.1 -41.72 94.7 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.151 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -64.21 -46.49 83.65 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.024 0.44 . . . . 0.0 111.535 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.9 m -64.3 -38.52 91.34 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.211 177.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.434 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . . . -64.53 -42.69 95.61 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.149 0.499 . . . . 0.0 111.386 176.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.433 ' HE3' ' HB2' ' A' ' 82' ' ' LYS . 37.8 ttmt -60.61 -40.93 93.63 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.943 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.46 -45.47 83.61 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.232 174.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.47 -48.63 68.72 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.203 0.525 . . . . 0.0 110.992 176.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.591 HD12 HD22 ' A' ' 29' ' ' LEU . 9.0 tt -54.49 -56.81 15.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.199 175.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -61.17 -36.43 79.79 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -175.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -79.98 -30.57 39.74 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.191 0.519 . . . . 0.0 111.17 -175.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 64.9 mt -103.31 -4.18 24.58 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -176.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -64.81 98.19 0.26 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.878 0.37 . . . . 0.0 110.548 175.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.27 0.18 40.83 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.012 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -68.03 125.44 26.33 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 122.618 -0.342 . . . . 0.0 110.739 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -79.62 91.58 5.24 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.224 0.535 . . . . 0.0 110.472 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.5 tp -77.61 -70.62 0.46 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.713 -174.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.79 45.67 1.31 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.2 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.92 8.68 64.71 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.925 -174.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -141.72 144.1 31.65 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 122.794 0.437 . . . . 0.0 110.332 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.95 135.8 51.41 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.227 2.618 . . . . 0.0 113.637 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.6 ttp -103.23 121.01 41.8 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.387 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -89.05 105.12 17.58 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.767 0.318 . . . . 0.0 111.627 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 85' ' ' LEU . 11.1 t -106.06 105.37 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.737 0.303 . . . . 0.0 110.421 175.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.69 161.65 12.68 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.346 -0.454 . . . . 0.0 113.616 -176.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -72.17 21.34 0.06 Allowed 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 86.4 t 69.47 120.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.208 0.603 . . . . 0.0 111.799 -177.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.3 t -51.12 160.55 0.5 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -50.73 -32.22 18.93 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.584 ' HG3' HG22 ' A' ' 107' ' ' THR . 10.4 ptp180 -155.12 -49.59 0.09 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.956 0.408 . . . . 0.0 110.907 -178.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.584 HG22 ' HG3' ' A' ' 106' ' ' ARG . 8.8 t 177.23 22.0 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.737 0.779 . . . . 0.0 109.788 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.7 t70 . . . . . 0 C--O 1.254 1.318 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.952 -167.733 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 120.705 0.288 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 56.33 -154.04 16.7 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 116.324 -0.398 . . . . 0.0 113.93 178.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -144.19 -89.78 0.11 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 122.738 0.415 . . . . 0.0 109.929 175.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 50.73 18.65 0.51 Allowed 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 169.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 60.17 107.18 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 O-C-N 122.248 -0.282 . . . . 0.0 111.115 -174.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -65.37 -21.06 66.64 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -176.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 64.09 2.19 1.38 Allowed 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 166.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -90.83 118.75 30.48 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -176.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.5 m -111.77 119.96 40.36 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.55 169.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -59.13 -19.27 43.3 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 16.2 tpt 59.05 97.33 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.131 0.491 . . . . 0.0 112.077 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.98 -25.16 0.74 Allowed 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.27 103.93 0.08 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -174.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -173.94 3.58 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 177.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.0 mtt 64.86 -71.86 0.07 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.096 0.558 . . . . 0.0 111.695 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 51.23 85.43 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 176.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -98.76 -5.17 31.82 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.947 0.404 . . . . 0.0 111.381 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -112.32 123.81 51.09 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.551 -176.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.9 tp -141.38 -58.22 0.49 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.266 0.555 . . . . 0.0 110.17 175.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -158.37 96.76 1.44 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.919 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -48.7 109.33 0.24 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.465 0.65 . . . . 0.0 112.235 -176.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.9 -25.85 7.39 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.219 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.3 p 52.56 110.9 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.506 0.723 . . . . 0.0 112.413 -177.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -42.72 -54.47 4.04 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -173.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.85 72.85 0.04 OUTLIER Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.182 -0.533 . . . . 0.0 112.702 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 56.5 Cg_endo -69.29 124.67 11.51 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.561 2.174 . . . . 0.0 113.21 -176.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 13.3 tpt -122.51 138.44 54.56 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.616 176.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.431 ' HD3' ' HB3' ' A' ' 72' ' ' PHE . 36.5 ttm180 -110.94 135.21 51.8 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.07 0.462 . . . . 0.0 111.955 -173.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.9 mt -109.91 137.7 47.33 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.204 0.526 . . . . 0.0 111.945 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -89.94 110.31 21.28 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.524 172.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.7 t -110.71 101.76 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.815 0.34 . . . . 0.0 111.046 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 70' ' ' TYR . . . -113.62 89.72 0.52 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.72 -178.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.43 ' HB2' ' HA ' ' A' ' 98' ' ' MET . 22.6 t -166.39 21.22 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.576 0.703 . . . . 0.0 110.852 176.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.46 ' HB3' ' HB ' ' A' ' 38' ' ' ILE . 18.8 mt -85.72 99.77 11.55 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.704 -176.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.439 ' CG ' ' O ' ' A' ' 35' ' ' HIS . 12.3 p80 -70.01 76.04 0.49 Allowed 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.547 0.689 . . . . 0.0 112.383 -175.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 50.41 16.25 0.26 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 171.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.81 -44.01 0.27 Allowed 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.799 -0.563 . . . . 0.0 112.036 -174.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.582 HD12 ' SD ' ' A' ' 42' ' ' MET . 37.8 mm -49.32 130.86 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -174.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 54.2 p -97.35 170.45 9.06 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.218 0.533 . . . . 0.0 112.158 -176.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.542 ' HG3' HD23 ' A' ' 58' ' ' LEU . 2.6 mp0 -62.59 -38.03 88.54 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.432 175.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.37 -37.81 88.83 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.487 -177.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.582 ' SD ' HD12 ' A' ' 38' ' ' ILE . 28.0 ttt -63.34 -50.5 69.75 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.426 0.632 . . . . 0.0 110.1 177.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.457 ' HB3' HD11 ' A' ' 73' ' ' ILE . 64.4 mt -56.16 -53.24 59.51 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.257 176.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -52.62 -40.63 62.94 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.383 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.41 -33.96 78.61 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.291 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 63.2 mt -85.08 -44.04 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.471 ' HD2' ' HZ ' ' A' ' 75' ' ' PHE . 36.8 m-85 -80.81 -31.54 35.6 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -173.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.504 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 25.2 tp10 -54.73 -46.75 99.31 Favored Pre-proline 0 N--CA 1.481 1.105 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 73.0 Cg_exo -52.13 -18.68 7.68 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 122.736 2.29 . . . . 0.0 114.318 176.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -82.61 -29.8 29.91 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.079 -0.388 . . . . 0.0 112.029 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.428 ' HA3' ' HB3' ' A' ' 80' ' ' CYS . . . -169.83 -99.25 0.12 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.316 -0.469 . . . . 0.0 112.447 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -166.43 136.98 3.36 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.143 0.497 . . . . 0.0 111.784 173.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.457 HG21 HG13 ' A' ' 56' ' ' ILE . 3.5 mp -96.89 129.26 47.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.311 177.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -77.61 -55.37 5.41 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.455 0.645 . . . . 0.0 110.345 173.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 95.9 p -150.67 150.55 31.25 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.13 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.457 HG13 HG21 ' A' ' 53' ' ' ILE . 60.9 mt -119.77 126.97 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 121.004 0.43 . . . . 0.0 111.212 176.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -101.79 118.4 36.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.981 0.42 . . . . 0.0 110.276 173.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.542 HD23 ' HG3' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -98.34 131.19 44.85 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.5 tpt -92.01 93.47 8.78 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.643 0.735 . . . . 0.0 111.047 -171.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 22.1 ptp -132.94 166.32 22.62 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.622 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -99.73 104.83 16.58 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.874 0.368 . . . . 0.0 110.931 -177.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.7 p -80.78 5.19 16.59 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -175.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -96.7 -55.09 3.01 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.364 0.602 . . . . 0.0 110.812 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.6 p -87.82 -22.06 24.71 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.913 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.39 46.62 5.19 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.433 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -128.07 179.5 5.56 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.734 0.414 . . . . 0.0 111.197 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.8 m -124.69 140.07 53.28 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.597 0.237 . . . . 0.0 111.246 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -85.5 -31.3 22.83 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.801 0.334 . . . . 0.0 111.48 178.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.98 12.64 33.78 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.803 175.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.423 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 2.7 m-85 -121.87 160.56 24.48 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.397 -0.473 . . . . 0.0 110.734 178.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.36 130.51 3.27 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.456 -0.402 . . . . 0.0 112.372 175.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.431 ' HB3' ' HD3' ' A' ' 28' ' ' ARG . 89.4 m-85 -98.99 107.2 19.57 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.06 0.457 . . . . 0.0 111.078 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' A' ' 43' ' ' LEU . 69.5 mt -99.49 127.92 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.689 -176.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.9 m -103.25 122.82 45.55 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.007 0.432 . . . . 0.0 111.711 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.503 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 44.3 m-85 -99.31 151.45 21.04 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.453 177.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.1 t -76.91 -5.67 49.4 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.735 0.302 . . . . 0.0 111.205 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.505 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 29.0 t70 -142.6 147.62 36.13 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.021 0.439 . . . . 0.0 111.488 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.6 p -72.26 -42.71 65.31 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.054 -178.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -69.13 -38.12 78.69 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.641 0.258 . . . . 0.0 111.359 -177.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.505 ' SG ' ' HB3' ' A' ' 77' ' ' ASP . 83.7 m -55.4 -45.5 76.65 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.205 0.526 . . . . 0.0 111.178 175.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.08 -40.99 82.58 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.292 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -58.29 -44.5 88.52 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.072 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -65.23 -49.44 69.66 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.625 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.27 -47.47 72.28 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.945 0.403 . . . . 0.0 111.228 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 85' ' ' LEU . 8.8 tt -57.51 -50.7 72.2 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.79 174.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -54.02 -35.09 61.55 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.912 -175.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -93.31 -42.85 9.09 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.7 mt -87.61 -17.21 32.44 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -169.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -71.0 107.98 4.35 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.116 0.484 . . . . 0.0 110.616 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.93 -13.78 37.82 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.245 -174.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -65.67 135.11 54.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.957 0.408 . . . . 0.0 111.885 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 92' ' ' GLU . 9.0 pt-20 -73.73 95.0 2.3 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.195 0.521 . . . . 0.0 111.105 177.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 67.2 tp -67.4 -77.21 0.07 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.28 0.562 . . . . 0.0 111.787 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -108.08 46.41 0.96 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.247 0.546 . . . . 0.0 110.895 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.94 3.42 89.21 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.098 -174.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -128.69 139.68 36.29 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 123.138 0.575 . . . . 0.0 110.255 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.23 134.43 63.97 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.536 2.157 . . . . 0.0 112.048 175.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.43 ' HA ' ' HB2' ' A' ' 33' ' ' SER . 39.3 ttp -98.44 121.73 40.74 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.106 0.479 . . . . 0.0 111.465 -174.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -87.63 100.58 12.91 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.891 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 28.1 t -111.65 102.21 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.829 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -120.18 138.82 13.29 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.725 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -76.33 53.1 0.81 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 122.379 -0.483 . . . . 0.0 111.724 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.2 t 45.07 77.22 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.445 0.641 . . . . 0.0 111.23 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 77.4 p -67.52 149.21 50.46 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.208 -174.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -34.64 62.48 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.565 178.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -86.88 -16.14 36.92 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.777 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.5 m 72.33 -55.56 0.67 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.609 0.764 . . . . 0.0 112.117 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 . . . . . 0 C--O 1.253 1.285 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 174.31 . . . . . . . . 0 0 . 1 stop_ save_